Final Programme - OptiMed France

ECR 2013 – Final Programm

e

March 7–11

The ECR is the annual meeting of the European Society of Radiology.The ECR is the annual meeting of the European Society of Radiology.

myESR.org

Final ProgrammeFinal

.artu

ndwo

rk d

esig

nbür

o

Hitachi Medical Systems Europe Holding AG · Sumpfstrasse 13 · CH-6300 Zugwww.hitachi-medical-systems.eu

Embracing lifethrough better medicalimaging solutions.

Better medical imaging solutions for the needs of our customers

We have been committed to delivering outstanding medical imaging solutions over decades. Original solutions,that have grown out of the groups' expertise and technical know-how, providing innovations that meet equallythe Zeitgeist and the needs of our customers and their patients.

Visit us at booth 320 in Expo C and discover “solution stars in radiology”

Bienvenidosa Viena!

!

Timetable

1

8 9

12

16

13

17

4 5

08:30 – 10:00 10:30 – 12:00 12:15 – 14:00 14:00 – 15:30 16:00 – 17:30 17:45 – 19:15

Thur

sday

, Mar

ch 7 Scientific Sessions

(100)

Siemens Healthcare Symposium

Mini CoursesMC 24A, MC 25A

Bayer HealthCare SymposiumSuperSonic Imagine SymposiumSiemens Healthcare Symposium

E³ SessionScientific Sessions(200)


Professional Challenges SessionPC 3Mini CourseMC 322Multidisciplinary SessionMS 3Refresher CoursesE³ Session(300)

ESR Radiation Protection Session

Opening Ceremony

Presentation of Honorary Members

Opening Lecture

Thursday, March 7

Frid

ay, M

arch

8

State of the Art SymposiumSA 4Special Focus SessionsSF 4a, SF 4bProfessional Challenges SessionPC 4Mini CoursesMC 422, MC 423, MC 428Multidisciplinary SessionMS 4Refresher CoursesE³ SessionUpdate Your Skills (Introductory Lecture)(400)

EIBIR/EORTC Symposium

Rising Stars Basic Session

Post-Processing Face-Off Session

ESR meets SpainMini CourseMC 528E³ SessionsScientific SessionsUpdate Your Skills (Introductory Lecture)(500)

Rising Stars Basic SessionRising Stars Student Workshop

Josef Lissner Honorary Lecture

Gold Medal Awards

Mini CoursesMC 24B, MC 25B

Bayer HealthCare SymposiumBracco SymposiumGE Healthcare SymposiumSiemens Healthcare Symposium

Mini CoursesMC 623, MC 628E³ SessionScientific SessionsUpdate Your Skills (Practical Course)(600)

ESOR Session

Rising Stars Student SessionRising Stars Student Workshop

ESR meets E-AHPBANew Horizons SessionNH 7Special Focus SessionsSF 7a, SF 7b, SF 7cCategorical CourseCC 719Mini CoursesMC 722, MC 723, MC 728Refresher CoursesE³ SessionsUpdate Your Skills (Practical Course)(700)

Rising Stars Student Session

Friday, March 8

Satu

rday

, Mar

ch 9

New Horizons SessionNH 8Special Focus SessionsSF 8a, SF 8bCategorical CoursesCC 818, CC 819Refresher CoursesE³ SessionsUpdate Your Skills (Introductory Lecture)(800)

EFOMP Workshop


ESR meets South AfricaE³ SessionsScientific SessionsUpdate Your Skills (Practical Courses)(900)

EFOMP Workshop

Standards and Audit Session


Wilhelm Conrad Röntgen Honorary Lecture

Mini CoursesMC 24C, MC 25C

E³ FC Self Assessment Test

MIR@ECR

Siemens Healthcare and Bayer HealthCare Joint SymposiumBracco SymposiumSiemens Healthcare SymposiumGE Healthcare SymposiumGuerbet SymposiumPhilips Healthcare Symposia

EFRS meets Spain

Image Interpretation Quiz

Update Your Skills (Practical Courses)(1000)

MIR@ECR

Hologic SymposiumToshiba SymposiaGE Healthcare Nycomed SymposiumPhilips Healthcare Mini Satellite Symposium

State of the Art SymposiumSA 11Special Focus SessionSF 11Professional Challenges SessionPC 11Categorical CoursesCC 1118, CC 1121Multidisciplinary SessionMS 11Refresher CoursesE³ SessionUpdate Your Skills (Practical Course)(1100)

MIR@ECR

Rising Stars Student Workshop

Saturday, March 9

Sund

ay, M

arch

10 Special Focus Session

SF 12Professional Challenges SessionPC 12Categorical CoursesCC 1218, CC 1219, CC 1221Refresher CoursesE³ Session(1200)


ESR meets ChileProfessional Challenges SessionPC 13Categorical CourseCC 1321Scientific SessionsUpdate Your Skills (Practical Courses)(1300)

RTF Highlighted Lectures

Santiago Ramón y Cajal Honorary Lecture

Junior Image Interpretation Quiz

Mini CoursesMC 24D, MC 25D

GE Healthcare SymposiumSamsung SymposiumPhilips Healthcare SymposiumBracco Symposium

New Horizons SessionNH 14Special Focus SessionsSF 14a, SF 14b, SF 14cCategorical CoursesCC 1418, CC 1419, CC 1421Refresher CoursesE³ SessionUpdate Your Skills (Practical Course)(1400)

Rising Stars Student Final Session

State of the Art SymposiumSA 15Special Focus SessionsSF 15a, SF 15bCategorical CoursesCC 1518, CC 1519, CC 1521Refresher CoursesE³ SessionUpdate Your Skills (Practical Course)(1500)


Sunday, March 10

Mon

day,

Mar

ch 1

1 Special Focus SessionsSF 16a, SF 16b, SF 16cCategorical CoursesCC 1618, CC 1619, CC 1621Refresher CoursesE³ Session(1600)

Joint Session of the ESR and EFSUMB

E³ SessionsScientific Sessions(1700)

Mini CoursesMC 24E, MC 25E

Scientific Sessions(1800)

Special Focus SessionSF 19Refresher Courses(1900)

Monday, M

arch 11

4

8

12

16

1

5

9

13

172

Timetable

10 11

14

18

15

19

6 7

2 3

08:30 – 10:00 10:30 – 12:00 12:15 – 14:00 14:00 – 15:30 16:00 – 17:30 17:45 – 19:15

Thur

sday

, Mar

ch 7 Scientific Sessions

(100)


Mini CoursesMC 24A, MC 25A

Bayer HealthCare SymposiumSuperSonic Imagine SymposiumSiemens Healthcare Symposium

E³ SessionScientific Sessions(200)


Professional Challenges SessionPC 3Mini CourseMC 322Multidisciplinary SessionMS 3Refresher CoursesE³ Session(300)

ESR Radiation Protection Session

Opening Ceremony

Presentation of Honorary Members

Opening Lecture

Thursday, March 7

Frid

ay, M

arch

8

State of the Art SymposiumSA 4Special Focus SessionsSF 4a, SF 4bProfessional Challenges SessionPC 4Mini CoursesMC 422, MC 423, MC 428Multidisciplinary SessionMS 4Refresher CoursesE³ SessionUpdate Your Skills (Introductory Lecture)(400)

EIBIR/EORTC Symposium


Post-Processing Face-Off Session

ESR meets SpainMini CourseMC 528E³ SessionsScientific SessionsUpdate Your Skills (Introductory Lecture)(500)

Rising Stars Basic SessionRising Stars Student Workshop

Josef Lissner Honorary Lecture

Gold Medal Awards

Mini CoursesMC 24B, MC 25B

Bayer HealthCare SymposiumBracco SymposiumGE Healthcare SymposiumSiemens Healthcare Symposium

Mini CoursesMC 623, MC 628E³ SessionScientific SessionsUpdate Your Skills (Practical Course)(600)

ESOR Session

Rising Stars Student SessionRising Stars Student Workshop

ESR meets E-AHPBANew Horizons SessionNH 7Special Focus SessionsSF 7a, SF 7b, SF 7cCategorical CourseCC 719Mini CoursesMC 722, MC 723, MC 728Refresher CoursesE³ SessionsUpdate Your Skills (Practical Course)(700)


Friday, March 8

Satu

rday

, Mar

ch 9

New Horizons SessionNH 8Special Focus SessionsSF 8a, SF 8bCategorical CoursesCC 818, CC 819Refresher CoursesE³ SessionsUpdate Your Skills (Introductory Lecture)(800)

EFOMP Workshop


ESR meets South AfricaE³ SessionsScientific SessionsUpdate Your Skills (Practical Courses)(900)

EFOMP Workshop



Wilhelm Conrad Röntgen Honorary Lecture

Mini CoursesMC 24C, MC 25C

E³ FC Self Assessment Test

MIR@ECR

Siemens Healthcare and Bayer HealthCare Joint SymposiumBracco SymposiumSiemens Healthcare SymposiumGE Healthcare SymposiumGuerbet SymposiumPhilips Healthcare Symposia

EFRS meets Spain

Image Interpretation Quiz

Update Your Skills (Practical Courses)(1000)

MIR@ECR

Hologic SymposiumToshiba SymposiaGE Healthcare Nycomed SymposiumPhilips Healthcare Mini Satellite Symposium

State of the Art SymposiumSA 11Special Focus SessionSF 11Professional Challenges SessionPC 11Categorical CoursesCC 1118, CC 1121Multidisciplinary SessionMS 11Refresher CoursesE³ SessionUpdate Your Skills (Practical Course)(1100)

MIR@ECR


Saturday, March 9

Sund

ay, M

arch

10 Special Focus Session

SF 12Professional Challenges SessionPC 12Categorical CoursesCC 1218, CC 1219, CC 1221Refresher CoursesE³ Session(1200)


ESR meets ChileProfessional Challenges SessionPC 13Categorical CourseCC 1321Scientific SessionsUpdate Your Skills (Practical Courses)(1300)

RTF Highlighted Lectures

Santiago Ramón y Cajal Honorary Lecture

Junior Image Interpretation Quiz

Mini CoursesMC 24D, MC 25D

GE Healthcare SymposiumSamsung SymposiumPhilips Healthcare SymposiumBracco Symposium

New Horizons SessionNH 14Special Focus SessionsSF 14a, SF 14b, SF 14cCategorical CoursesCC 1418, CC 1419, CC 1421Refresher CoursesE³ SessionUpdate Your Skills (Practical Course)(1400)

Rising Stars Student Final Session

State of the Art SymposiumSA 15Special Focus SessionsSF 15a, SF 15bCategorical CoursesCC 1518, CC 1519, CC 1521Refresher CoursesE³ SessionUpdate Your Skills (Practical Course)(1500)


Sunday, March 10

Mon

day,

Mar

ch 1

1 Special Focus SessionsSF 16a, SF 16b, SF 16cCategorical CoursesCC 1618, CC 1619, CC 1621Refresher CoursesE³ Session(1600)

Joint Session of the ESR and EFSUMB

E³ SessionsScientific Sessions(1700)

Mini CoursesMC 24E, MC 25E

Scientific Sessions(1800)

Special Focus SessionSF 19Refresher Courses(1900)

Monday, M

arch 11

2

6

10

14

18

3

7

11

15

193

Sessions in Joint Sponsorship with

CIRSE CardiovascularandInterventionalRadiologicalSocietyofEuropeEFOMP EuropeanFederationofOrganisationsforMedicalPhysicsEFRS EuropeanFederationofRadiographerSocietiesESCR EuropeanSocietyofCardiacRadiologyESER EuropeanSocietyofEmergencyRadiologyESGAR EuropeanSocietyofGastrointestinalandAbdominalRadiologyESHNR EuropeanSocietyofHeadandNeckRadiologyESMOFIR EuropeanSocietyofMolecularandFunctionalImaginginRadiologyESNR EuropeanSocietyofNeuroradiologyESOI EuropeanSocietyofOncologicImagingESPR EuropeanSocietyofPaediatricRadiologyESSR EuropeanSocietyofMusculoskeletalRadiologyESTI EuropeanSocietyofThoracicImagingESUR EuropeanSocietyofUrogenitalRadiologyEuroPACS EuropeanSocietyforthePromotionofPictureArchivingandCommunicationSystemsinMedicineEUSOBI EuropeanSocietyofBreastImagingISRRT InternationalSocietyofRadiographersandRadiologicalTechnologists

Congress Venue

AustriaCenterViennaBrunoKreiskyPlatz11220Vienna,Austria

Congress Language

English

Onsite Opening Hours

RegistrationWednesday,March6 12:00–18:00Thursday,March7toMonday,March11 07:00–18:00

Preview Centre – EDIPS ECR’s Digital Preview SystemWednesday,March6 12:00–18:00Thursday,March7toMonday,March11 07:00–18:00

EPOS™ – Scientific ExhibitionThursday,March7toMonday,March11 08:00–18:00

Technical ExhibitionEXPOHallsandEXPOFoyerDFriday,March8toSunday,March10 10:00–18:00Monday,March11 10:00–14:00

FirstLevel(Gallery)Thursday,March7 14:00–18:00Friday,March8toMonday,March11 10:00–18:00

Travel ServiceWednesday,March6 12:00–18:00Thursday,March7toMonday,March11 07:00–18:00

Press Office & Business CentreThursday,March7toMonday,March11 08:00–18:00

25th European Congress of Radiology

4

Table of Contents 6 Welcome by the ESR President 8 Welcome by the ECR 2013

Congress President

Committees 12 ESR Executive Council 12 Congress Committee 13 Programme Planning Committee 14 Scientific Subcommittees 17 Topic Coordinators

Dignitaries 20 Honorary Member George S. Bisset III 22 Honorary Member Tarek A. El-Diasty 24 Honorary Member Gary Glazer†

26 Gold Medallist José Cáceres 28 Gold Medallist Johannes Lammer 30 Gold Medallist Maximilian F. Reiser 32 Opening Lecturer Jesús Prieto 34 Honorary Lecturer Carlo Catalano 36 Honorary Lecturer Jean-François Geschwind 38 Honorary Lecturer Luis Martí-Bonmatí

General Information 42 Information from A to Z 50 CME at ECR 2013 52 ESR Meets Sessions 53 EFRS Meets Session

55 Plenary Sessions 56 Social Media Guide 59 Image Interpretation Quizzes 61 MIR@ECR 62 EPOS™ – Scientific Exhibition 65 eLearning Tools 66 Special Exhibition 67 Cafés & Restaurants 67 Free Publications 71 ECR 2013 welcomes its industry partners 73 ESR Journals 75 Underground Map

77 Floor Plans

Programme Overviews 88 Thursday, March 7 90 Friday, March 8 92 Saturday, March 9 94 Sunday, March 10 96 Monday, March 11

Programme by Topic 100 New Horizons Sessions 101 State of the Art Symposia 102 Special Focus Sessions 107 Professional Challenges Session 108 Multidisciplinary Sessions

109 Categorical Courses 112 Mini Courses 115 Refresher Courses / Scientific Sessions 135 EFOMP Workshop 136 E3 – European Excellence in Education 136 Foundation Course: Neuroimaging 137 Interactive Teaching Sessions 139 Accompanying Sessions 142 EIBIR presents IMAGINE 144 Rising Stars Programme 146 Update Your Skills (Practical Courses) 146 How to biopsy with US guidance 147 Image-guided tumor ablation 149 Satellite Symposia 153 Industry Hands-on Workshops

Educational & Scientific Programme

155 Postgraduate Educational Programme 213 Scientific Sessions 271 List of Authors and Co-Authors 297 List of Moderators

300 Credits

The ESR’s main activities this year have focused very much on international relations, especially on a political level. We have established an office in Brussels so that we can take a proactive approach to making our collective voice heard in the European Commission on topics that affect our profession. The biggest issue on the agenda in this respect is the ongoing debate regarding the EMF Directive. At the time of writing, we are optimistic that we will hear positive news on this matter by the time we meet at the ECR.

We are also intensifying relations with associate ins-titutional members and other societies outside of Europe. We have organised an international sum-mit for representatives of non-European partners, which we hope will help us gain a better understan-ding of how we can and should work together in the future. We are also bringing our institutional mem-ber societies closer to the fold, by having each one represented at ESR committee level by its president.

I was delighted with the involvement of so many groups from all over the world in the first Inter-national Day of Radiology (IDoR), which took place on November 8. Prompted by the success of the European Day of Radiology in 2011, IDoR 2012 was introduced to provide the first truly global cele-bration of radiology. We were very pleased to see so many radiologists joining us in marking the day and helping to promote our profession. We are also ext-remely grateful to both the Radiological Society of North America and the American College of Radio-logy for their joint role in bringing this event to life.

Our efforts to strengthen relations with the many radiological and partner societies throughout the world will continue at ECR 2013, in the form of the ‘ESR Meets’ programme. This year, along with Prof. Bilbao’s home country, Spain, we will have the pleasure of welcoming the national radiological societies of both Chile and South Africa, as well as this year’s partner society, the truly multidiscipli-

As president of the European Society of Radiology (ESR), it gives me enormous pleasure to welcome you to our society’s scientific meeting, the Euro-pean Congress of Radiology (ECR). I would like to extend a special welcome to the numerous young radiologists joining us in Vienna, especially those visiting for the first time and those who are atten-ding thanks to the support of the Invest in the Youth programme.

This event is the culmination of almost two years of intense planning and hard work, by people who have brought many years of valuable experience to the process. I would like to extend not only my con-gratulations, but my heartfelt thanks, to Prof. Bilbao and to all the members of the planning committees, for assembling a truly exemplary scientific and educational programme, as well as to the talented and dedicated ESR staff who have been involved in putting these plans into action.

I wrote in the ECR 2013 Preliminary Programme that everyone involved in the organisation of our annual meeting was delighted and very proud that abstract submission rose again this year. The res-ponse to the call for paper abstracts in the summer was extremely encouraging, and the continuation of that response via the EPOS submission system has demonstrated that the radiological community con-tinues to hold our congress in high regard.

Speaking of community, being involved in so many different projects in so many different areas of inte-rest over the past year has also brought me into contact with a vast number of committed and hard-working people, who are a great source of encoura-gement for the future of our discipline. I would like to thank everyone who has contributed to driving our society forward over the last twelve months. Sadly, one year is far too short to achieve everything we set out to accomplish, but I am satisfied that I can look back on an exciting and very productive period.

Dear colleagues,

6

The content of the EDiR examination is based on the ESR’s European Training Curriculum, and we are currently in the final stages of updating the cur-riculum to make it both more comprehensive and easier to understand. The new version will describe not only knowledge, but also the skills, competen-ces and attitudes required for each subspecialty at each level of training. One particularly important change is that the key stages will be given new, sim-pler names, to avoid any confusion with previous editions of the curriculum. The first three years of common trunk radiological training will be refer-red to as ‘Level 1’ and the final two years of sub-specialty interest training will be ‘Level 2’. The final document should be completed by the time we meet in Vienna.

Last, but by no means least, the ESR’s publications have continued to provide an exceptionally high level of quality this year. European Radiology has enjoyed an extremely successful six-year period under the editorship of Adrian Dixon, and will soon enter a new phase under a new editor-in-chief, who will be formally announced at the ECR.

With all of these activities and developments in mind, I am very much looking forward to seeing what the next twelve months will bring for the ESR, for our members, and for the world of radiology in general. But first, I am relishing the chance to make the most of the many and varied opportunities offe-red by our annual congress and the wonderful city of Vienna. I sincerely hope each and every one of you will enjoy this event to the very fullest.

Gabriel P. Krestin ESR President

nary European-African Hepato-Pancreato-Biliary Association (E-AHPBA). The opportunity to hear from and get to know the visiting experts from these societies is one that should not be missed.

The ESR Executive Council had a very productive brainstorming meeting in The Hague in June, as well as further meetings in October and Decem-ber. One pleasing outcome of these meetings has been the establishment of a concept introduced by ESR Past-President, András Palkó. The idea was to assemble a pool of young, up-and-coming professi-onals in the field of radiology, whom the Executive Council could call upon for opinions, suggestions and feedback, and who would also gain valuable experience in interacting with the ESR committees and becoming acquainted with the structure and processes of our organisation. This body has been named the ‘Leadership Institute’ and has already proven very valuable as a sounding board.

Some of the ESR’s most important creations have enjoyed a very successful 2012. The European School of Radiology (ESOR), which celebrated its fifth anniversary at ECR 2012 has gone from strength to strength under the stewardship of Nicholas Gourtsoyiannis, welcoming an ever incre-asing number of students and fellows into its many courses and programmes. The European Institute for Biomedical Imaging Research (EIBIR) has also flourished during its sixth year, attracting vital fun-ding for research and coordinating various projects under the European Commission’s 7th Framework Programme. Two major projects, peddose.net and HAMAM, have been successfully completed this year and a number of others are still in progress. At the same time, the European Board of Radiology (EBR), in its second year of existence, has become firmly established as a recognised body for radio-logical certification and accreditation in Europe. The increasing profile of the European Diploma in Radiology (EDiR) and its acceptance and acknow-ledgment by national, subspecialty and allied scien-ces societies has confirmed the EBR’s legitimacy.

Dear colleagues,

7

Welcome to ECR2013tastic work in assembling this programme and to the extremely capable team at the ESR Office for all their support. I am honoured to have played a part in the creation and organisation of this congress, and I hope that every one of you will gain just as much pleasure from attending as I will from seeing the carefully laid plans and hard work of so many people come to fruition.

This year’s programme offers many sessions, in many different formats, with the aim of educating and entertaining at the same time. As usual, some of the most successful and popular sessions will be repeated from previous congresses, but plenty of others will be new. The congress is constantly evolving, and the Programme Planning Committee and ESR Office strive tirelessly to stay ahead of the educational needs and demands of radiologists and radiographers.

Categorical Courses are the heart of our pro-gramme, offering the deepest exploration of any topics at the congress. At ECR 2013 there will be three of these courses: ‘Never without Arteries’ will be this year’s contribution to the recently initiated ‘Clinical Lessons for Imaging Core Knowledge – CLICK’ series; ‘Oncologic Imaging: Follow-up of Systemic and Local Therapies’ will summarise the most recent information about how responses to therapy should be evaluated in most oncologic situa-tions; and ‘Urogenital Imaging’ will be a continuation of the ECR 2012 session, covering the latest topics.

The programme is always prepared with a strong emphasis on interaction, since the exchange of ideas is a major way to teach and learn. This year the suc-cessful ‘E3 – European Excellence in Education’ will include fourteen 90-minute sessions, which will cover all the major aspects of radiology, with attractive titles such as ‘tips and tricks’ and ‘pitfalls’. The Foundation Course will deal with neuroima-ging and, as in previous years, will be followed by a self-assessment test. There will also be two practical courses on how to ‘Update your Skills’, which will

It is a great pleasure and a privilege to welcome you to Vienna for the European Congress of Radiology (ECR), the annual meeting of the world’s largest radiological society. The ECR has become one of the most keenly anticipated medical conferences over the last two decades, not only as a place to come and learn about the scientific, medical and professional issues of the day, but to meet our colleagues from throughout the world of imaging, to exchange opi-nions, experience, and knowledge, and to enjoy the inimitable atmosphere of the ECR and its home city, Vienna.

I would especially like to address this welcome to our younger attendees, who have been appearing at our congress in increasing numbers in recent years. It is enormously encouraging to see that new generations are not only developing an interest in radiology and radiography, but that they are com-mitted enough to make the trip to Vienna for what may well be the most inspiring experience of their early careers. I am also personally delighted that we, as a society, are able to make this trip a reality for several thousand young people by providing sup-port through the Invest in the Youth programme. Thanks to this very valuable initiative, as well as free registration for all students, I am looking forward to seeing many budding radiologists and radiogra-phers at the Austria Center this year.

Each ECR is different from the last; each has its own unique character and there are always innovations that make each congress stand out from its prede-cessors. But just as important as these differences are those factors that always remain: the vision and talent that we find within our community and the enduring appeal of radiological science. This is what makes the quality of our scientific and educa-tional programme so exceptionally high, bringing thousands of visitors, who are committed to radio-logy and self-improvement, from all over the world to Vienna each year. On this note, I would like to offer my sincerest thanks to every member of the Programme Planning Committee for their fan-

8

Welcome to ECR2013As well as these few highlights I have mentioned, you will have the opportunity to attend Refresher Courses, Mini Courses, and State-of-the-Art Sym-posia; learn more about the most recent develop-ments in New Horizons Sessions; look into a wide variety of topics in Special Focus Sessions; and hear about how to tackle some of our greatest issues in Professional Challenges Session. You will also have the chance to explore a technical exhibition of more than 26,000m2 in size, and discover the latest products and imaging-related services from around 300 exhibiting companies from all over the world. And if this is not enough stimulation for you, we are lucky enough to be based in one of the most amazing cities in the world, boasting so much in the way of art, culture, cuisine and entertainment that is hard to know where to begin.

Exactly how to arrange your schedule at the ECR is often the biggest problem, but however you divide your time, you can always be certain that it will be well spent. I look forward to sharing the experience with you and wish you all a wonderful congress.

José Ignacio Bilbao ECR 2013 Congress President

provide interactive demonstrations and opportuni-ties for hands-on experience on ‘How to biopsy’ and ‘How to ablate’.

Like interaction, multidisciplinarity has become one of those words that appear in every conversa-tion about the ECR. This principle is an increasingly important influence on our work and so it is only natural that we try to reflect this at our congress. The ECR 2013 programme includes three Multidisci-plinary Sessions that will show how experts from different disciplines within the same institution, interact and decide on the best way to approach specific clinical situations. In addition, it is my ple-asure to welcome the European-African Hepato-Pancreato-Biliary Association (E-AHPBA), a truly multidisciplinary organisation, to the ECR. They will join us as the partner discipline in the ‘ESR Meets’ programme, and I am personally looking forward to strengthening our relationship with this association, from whom I believe we will learn a great deal, in terms of both science and professional cooperation.

Once again, the ESR has invited three countries to share their expertise through the ‘ESR Meets’ pro-gramme. Chile, South Africa, and Spain will pre-sent their most recent scientific developments in joint sessions and bring some international flavour to the entrance hall. For the first time, we will have a new session entitled ‘EFRS meets’, hosted by the European Federation of Radiographers Societies, reflecting the fact that the EFRS recently chose the ECR to be their official annual meeting. They have chosen to invite Spain as their first guest, and I am pleased to report that a great many Spanish radio-graphers have chosen to make their way to Vienna for this occasion. We are of course delighted to offer the EFRS this platform and we look forward to buil-ding even closer relations between our societies and our professions.

9

Committees

12 ESR Executive Council12 Congress Committee13 Programme Planning Committee14 Scientific Subcommittees17 Topic Coordinators

President Gabriel P. Krestin, Rotterdam/NL

1st Vice-President Guy Frija, Paris/FR

2nd Vice-President Lorenzo Bonomo, Rome/IT

Past-President András Palkó, Szeged/HU

Congress Committee Chairman José I. Bilbao, Pamplona/ES

1st Vice-Chairman of the Congress Committee Valentin Sinitsyn, Moscow/RU

2nd Vice-Chairman of the Congress Committee Bernd Hamm, Berlin/DE

ESOR Committee Chairman Nicholas Gourtsoyiannis, Athens/GR

Publications Committee Chairman Paul M. Parizel, Antwerp/BE

Research Committee Chairman Luis Martí-Bonmatí, Valencia/ES

Education Committee Chairperson Birgit Ertl-Wagner, Munich/DE

Professional Organisation Committee Chairman Yves Menu, Paris/FR

National Societies Committee Chairman Luis Donoso, Barcelona/ES

Subspecialties and Allied Sciences Committee Chairman Jim A. Reekers, Amsterdam/NL

Finance and Internal Affairs Committee Chairman Boris Brkljačić, Zagreb/HR

Communication and External Affairs Committee Chairman Lorenzo E. Derchi, Genoa/IT

Strategic Review Committee Chairman Lorenzo Bonomo, Rome/IT

Nominations and Awards Committee Chairman András Palkó, Szeged/HU

Executive DirectorPeter Baierl, Vienna/AT

Congress Committee

Chairperson (Congress President) J.I. Bilbao; Pamplona/ES

1st Vice-Chairperson (1st Congress Vice-President)V. Sinitsyn; Moscow/RU

2nd Vice-Chairperson (2nd Congress Vice-President)B. Hamm; Berlin/DE

Ordinary MembersF. Caseiro-Alves; Coimbra/PTK. Åhlström Riklund; Umea/SEV. Vilgrain; Clichy/FRM.I. Argyropoulou; Ioannina/GR

ESR President G.P. Krestin; Rotterdam/NL

ESR Executive Director P. Baierl; Vienna/AT

Ex-officio Members:

Chairperson of the Finance and Internal Affairs CommitteeB. Brkljačić; Zagreb/HR

Chairperson of the Publications CommitteeP. M. Parizel; Antwerp/BE

ESR Executive Council

12

Programme Planning Committee

E³ – European Excellence in EducationInteractive Teaching SessionsJ. Vilar; Valencia/ESFoundation CourseM.I. Argyropoulou; Ioannina/GR

e-LearningD. Caramella; Pisa/ITP. Pokieser; Vienna/AT

Cases of the DayJ.C. Vilanova; Girona/ES

Physics ProgrammeW.J.M. van der Putten; Galway/IE

Image Interpretation QuizD. Vorwerk; Ingolstadt/DE

Junior Image Interpretation QuizA. Alguersuari; Sabadell/ES

EvaluationD. Weishaupt; Zurich/CH

Publications Committee Chairman (until March 2012)A.K. Dixon; Cambridge/UK

ESR Subspecialties Committee ChairmanJ.A. Reekers; Amsterdam/NL

ESR Education Committee Chairman (until March 2012)É. Breatnach; Dublin/IE

ESR Professional Organisation Committee ChairmanY. Menu; Paris/FR

Postgraduate Educational ProgrammeChairman:B. Hamm; Berlin/DEMembers:V.N. Cassar-Pullicino; Oswestry/UKE. de Kerviler; Paris/FRM.H. Fuchsjäger; Graz/ATH.-U. Kauczor; Heidelberg/DEP.C. Maly Sundgren; Lund/SEA. Rossi; Genoa/ITS.A. Taylor; London/UKA. Trojanowska; Lublin/PLA. van der Lugt; Rotterdam/NL

Scientific PapersChairman:F. Caseiro-Alves; Coimbra/PTMembers:G. Forrai; Budapest/HUM. Raissaki; Iraklion/GR D. Tack; Baudour/BE

Scientific Exhibition (EPOS™)Chairman:K. Åhlström Riklund; Umea/SEMembers:C. Ayuso; Barcelona/ESE.J.R. van Beek; Edinburgh/UK

Categorical CoursesT. de Baère; Villejuif/FRL.E. Derchi; Genoa/ITC. Loewe; Vienna/AT

13

CardiacThe ESR would like to thank the ESCR for their cooperation on this subcommittee

Chairman:M. Garðarsdóttir; Reykjavik/IS

Members:G. Bastarrika; Pamplona/ESF. Cademartiri; Monastier di Treviso/ITB. Graca; Coimbra/PTK. Gruszczynska; Katowice/PLD. Hahn; Würzburg/DES. Katsilouli; Athens/GRE. Mershina; Moscow/RUC. Peebles; Southampton/UKP.K. Vanhoenacker; Aalst/BER. Vliegenthart; Groningen/NLJ. Vymazal; Prague/CZF. Wolf; Vienna/AT

ChestThe ESR would like to thank ESTI for their cooperation on this subcommittee

Chairman:B. Ghaye; Brussels/BE

Members:J. Biederer; Kiel/DEE. Castañer; Sabadell/ESR. Cesar; Ljubljana/SIJ.D. Dodd; Dublin/IEN. Karabulut; Denizli/TRA.P. Parkar; Bergen/NOH. Prosch; Vienna/ATM.-P. Revel; Paris/FRE. Rizzo; Genolier/CHN. Sverzellati; Parma/ITE.J.R. van Beek; Edinburgh/UKJ.E. Wildberger; Maastricht/NL

Computer ApplicationsThe ESR would like to thank EuroPACS for their cooperation on this subcommittee

Chairman:E. Neri; Pisa/IT

Members:U.W. Engelmann; Dossenheim/DEB. Gibaud; Rennes/FRM. Onu; Bucharest/ROP. Sögner; Feldkirch/ATZ. Tarján; Budapest/HU

Abdominal and GastrointestinalThe ESR would like to thank ESGAR for their cooperation on this subcommittee

Chairmen:B.J. Op de Beeck; Antwerp/BES. Romano; Naples/IT

Members:D. Akata; Ankara/TRC. Ayuso; Barcelona/ESG. Brancatelli; Palermo/ITD.J. Breen; Southampton/UKD. Cano; Pamplona/ESV. Cappendijk; ‘s Hertogenbosch/NLL. Curvo-Semedo; Coimbra/PTE. Danse; Brussels/BEV.J. Goh; London/UKS. Gourtsoyianni; London/UKL. Guimaraes; Porto/PTM. Hellström; Gothenburg/SEC. Hoeffel; Reims/FRG.G. Karmazanovsky; Moscow/RUS. Leschka; St. Gallen/CHO. Lucidarme; Paris/FRM.M. Maher; Cork/IEA. Maier; Vienna/ATT. Mang; Vienna/ATS. Phoa; Amsterdam/NLS. Schmidt; Lausanne/CHS. Stojanovic; Novi Sad/RSC. Stroszczynski; Regensburg/DEJ. Votrubová; Prague/CZ

BreastThe ESR would like to thank EUSOBI for their cooperation on this subcommittee

Chairman:H.M. Dobson; Glasgow/UK

Members:C.S. Balleyguier; Villejuif/FRP.A.T. Baltzer; Jena/DEI. Leconte; Brussels/BEM. Lesaru; Bucharest/ROR.M. Mann; Nijmegen/NLF. Pediconi; Rome/ITK. Pinker-Domenig; Vienna/ATM. Torres-Tabanera; Madrid/ES

Scientific Subcommittees

14


Interventional RadiologyThe ESR would like to thank CIRSE for their cooperation on this subcommittee

Chairman:A. Krajina; Hradec Králové/CZ

Members:V. Bérczi; Budapest/HUC. Binkert; Winterthur/CHT.J. Cleveland; Sheffield/UKJ. Luis del Cura; Bilbao/ESL. Lonn; Copenhagen/DKF. Orsi; Milan/ITH. Rousseau; Toulouse/FRM. Schoder; Vienna/ATJ. Tacke; Passau/DEV. Vidjak; Zagreb/HRP. Vilares Morgado; Porto/PTK. Zelenak; Martin/SK

MusculoskeletalThe ESR would like to thank the ESSR for their cooperation on this subcommittee

Chairman:A.J. Grainger; Leeds/UK

Members:N. Boutry; Lille/FRM. Court-Payen; Copenhagen/DKP.M. Cunningham; Navan/IEC. Glaser; Munich/DEA. Klauser; Innsbruck/ATM. Maas; Amsterdam/NLA. Oktay; Izmir/TRA. Plagou; Athens/GRJ. Raposo; Lisbon/PTL.M. Sconfienza; San Donato Milanese/ITP. Van Dyck; Antwerp/BEJ.C. Vilanova; Girona/ES

NeuroThe ESR would like to thank the ESNR for their cooperation on this subcommittee

Chairman:J. Van Goethem; Antwerp/BE

Members:N. Bargalló; Barcelona/ESF. Barkhof; Amsterdam/NLM. Bekiesinska-Figatowska; Warsaw/PLB. Ertl-Wagner; Munich/DEZ. Merhemic; Sarajevo/BAM. Muto; Naples/ITY. Özsunar; Aydin/TRM.A. Papathanasiou; Athens/GRI.N. Pronin; Moscow/RUJ.-P. Pruvo; Lille/FRM.M. Thurnher; Vienna/ATT.A. Yousry; London/UK

Molecular Imaging and Contrast MediaChairman:N. Grenier; Bordeaux/FR

Members:I. Carrió; Barcelona/ESC.C. Cyran; Munich/DEB. Elmståhl; Malmö/SEF.A. Gallagher; Cambridge/UKT. Leiner; Utrecht/NLX. Montet; Geneva/CHF. Stacul; Trieste/ITM. Wozniak; Lublin/PL

GenitourinaryThe ESR would like to thank ESUR for their cooperation on this subcommittee

Chairman:V. Løgager; Copenhagen/DK

Members:M.-F. Bellin; Le Kremlin-Bicêtre/FRD. Beyersdorff; Berlin/DEF.M. Danza; Rome/ITA. Dimopoulou; Uppsala/SEG. Ivanac; Zagreb/HRP. Leonardou; Athens/GRD. Negru; Iasi/ROM.M. Otero-García; Vigo/ESE. Sala; Cambridge/UKH.C. Thoeny; Berne/CHA.T. Turgut; Ankara/TRD. Yakar; Nijmegen/NL

Head and NeckThe ESR would like to thank the ESHNR for their cooperation on this subcommittee

Chairman:S. Bisdas; Tübingen/DE

Members:N. Gritzmann; Vienna/ATP. Halimi; Paris/FRC.Z. Karaman; Aydin/TRR. Kohler; Geneva/CHR. Ljumanovic; Amsterdam/NLJ. Olliff; Birmingham/UKS. Petrovic; Nis/RSL. Preda; Milan/IT

15


VascularThe ESR would like to thank CIRSE for their cooperation on this subcommittee

Chairman:K. Malagari; Athens/GR

Members:J.-P. Beregi; Nîmes/FRL. Crocetti; Pisa/ITE. Esteban; Alzira/ESK.A. Hausegger; Klagenfurt/ATT. Jargiello; Lublin/PLA. Keeling; Dublin/IES. Müller-Hülsbeck; Flensburg/DER. Uberoi; Oxford/UK

Oncologic ImagingChairman:R.G.H. Beets-Tan; Maastricht/NL

Members:M. Bellomi; Milan/ITP. Brader; Vienna/ATF. Caseiro-Alves; Coimbra/PTL. Martí-Bonmatí; Valencia/ESC. Matos; Brussels/BEA.G. Rockall; London/UKH.-P. Schlemmer; Heidelberg/DEM.R Torkzad; Stockholm/SE

Emergency RadiologyChairman:U. Linsenmaier; Munich/DE

Members:I. Arkhipova; Moscow/RUO. Chan; London/UKD.R. Kool; Nijmegen/NLS. Koskinen; Helsinki/FIP.-A. Poletti; Geneva/CHG. Schueller; Bülach/CHM. Stajgis; Poznan/PLM. Zins; Paris/FR

PaediatricThe ESR would like to thank the ESPR for their cooperation on this subcommittee

Chairman:R.R. van Rijn; Amsterdam/NL

Members:G. del Pozo; Madrid/ESC. Fonda; Florence/ITC. Garel; Paris/FRM. Haliloglu; Ankara/TRW. Hirsch; Leipzig/DEP.D. Humphries; London/UKL.-S. Ording-Müller; Tromsø/NOM. Raissaki; Iraklion/GR

Physics in RadiologyThe ESR would like to thank EFOMP for their cooperation on this subcommittee

Chairman:J.N. Vassileva; Sofia/BG

Members:T. Beyer; Zurich/CHD. Bor; Ankara/TRO. Ciraj-Bjelac; Belgrade/RSH. Jarvinen; Helsinki/FIR. Padovani; Udine/ITK. Pedersen; Østerås/NOV. Tsapaki; Athens/GR

RadiographersThe ESR would like to thank the EFRS and the ISRRT for their coop-eration on this subcommittee

Chairmen:D. Pekarovic; Ljubljana/SIV. Vilgrain; Clichy/FR

Members:E. Agadakos; Athens/GRK. Haller; Wiener Neustadt/ATC. Malamateniou; London/UKJ. McNulty; Dublin/IEG. Paulo; Coimbra/PTP. Vahtramae; Pärnu/EE

16

Topic Coordinators

Multidisciplinary SessionsManaging Patients with CancerJ.I. Bilbao; Pamplona/ESB. Hamm; Berlin/DEB. Sangro; Pamplona/ESV. Vilgrain; Clichy/FR

E³ – European Excellence in EducationFoundation Course: NeuroimagingM.I. Argyropoulou; Ioannina/GR

Interactive Teaching SessionsJ. Vilar; Valencia/ES

Update Your Skills (Practical Courses)How to Biopsy with US GuidanceG. Mostbeck; Vienna/AT

Image-Guided Tumour Ablation: How to do itD.J. Breen; Southampton/UK M.H. Fuchsjäger; Graz/AT

6th Post-Processing Face-Off SessionA. Graser; Munich/DE

Categorical CoursesCLICK (Clinical Lessons for Imaging Core Knowledge): Never without ArteriesC. Loewe; Vienna/AT

Oncologic Imaging: Follow-up of Systemic and Local TherapiesT. de Baère; Villejuif/FR

Urogenital ImagingL.E. Derchi; Genoa/IT

Mini CoursesOrgans from A to Z: HeartK. Nikolaou; Munich/DE

Controversies in Breast ImagingF. Sardanelli; Milan/IT

The Beauty of Basic Knowledge: Head and NeckA. Borges; Lisbon/PT

The Beauty of Basic Knowledge: Musculoskeletal ImagingK. Wörtler; Munich/DE

Joint Course of ESR and RSNA (Radiological Society of North America): Essentials in oncologic imaging: what radiologists need to knowR.L. Baron; Chicago, IL/US C.J. Herold; Vienna/AT H. Hricak; New York, NY/US Y. Menu; Paris/FR D.M. Panicek; New York, NY/US M.F. Reiser; Munich/DE

17

Dignitaries

20 Honorary Member George Simpson Bisset III22 Honorary Member Tarek A. El-Diasty24 Honorary Member Gary Glazer†

26 Gold Medallist José Cáceres28 Gold Medallist Johannes Lammer30 Gold Medallist Maximilian F. Reiser32 Opening Lecturer Jesús Prieto34 Honorary Lecturer Carlo Catalano36 Honorary Lecturer Jean-François ‘Jeff’ Geschwind38 Honorary Lecturer Luis Martí-Bonmatí

In recognition of his groundbreaking work in the field of diagnostic radiology

and his dedication to educating the next

generation of radiologists, Professor George Simpson

Bisset III will be awarded Honorary Membership of

the European Society of Radiology at ECR 2013.

George Simpson Bisset IIIHouston, TX/USHonorary Member

20

ESR Dignitaries

appointed a Fellow of the American College of Radiology, an Honorary Member of the American Association of Physicists in Medicine, and an honorary member of both German and Aust-rian national radiological societies.

During his career, Prof. Bisset has shown a great deal of dedi-cation to research and the development of his discipline. With a total of 125 articles published in peer-reviewed journals and more than 20 book chapters, he has written and researched extensively on the subjects of paediatrics, cardiology and radiology.

Prof. Bisset is an active member of many radiological socie-ties, including the American College of Radiologists and the Society for Pediatric Radiology. He is a long-time member of the Radiological Society of North America and is the immedi-ate past president of the society. In 2012, as RSNA President, he strengthened the society’s focus on patient care, choo-sing ‘patients first’ as the theme of the society’s most recent congress.

George Simpson Bisset III serves as chief of paediatric radiology at Texas Children’s Hospital and Edward B. Singleton Professor of Radiology at Baylor College of Medicine.

Prof. Bisset began his studies at the University of Tennessee, before returning to his native Florida, where he received his medical degree from the University of South Florida in 1975. He then went on to complete his residency in paediatrics at the Children’s Hospital Medical Center, Cincinnati, Ohio, where he later carried out a fellowship in cardiology, a residency in radio-logy, and a fellowship in paediatric radiology. Before taking up his current post, Prof. Bisset had already built up a great deal of experience during his career, having not only worked as a radiologist in a number of hospitals, but also as a consultant cardiologist.

As a result of his work in paediatric cardiology and radiology, Prof. Bisset has received a number of honours during his career. At the International Pediatric Radiology Congress in 2001, his manuscript received the John A. Caffey Award. He has also been

21

In recognition of achievements throughout his career, his outstanding

contributions to the development of radiology

in Egypt and his dedication to fostering international

cooperation, Professor Tarek El-Diasty will be awarded Honorary Membership of


Tarek A. El-DiastyMansoura/EGHonorary Member

22

ESR Dignitaries

Egyptian radiology, he has helped to build bridges with the European Society of Radiology and the Radiological Society of North America, to name but a few of the societies he has established links with.

In addition to his clinical work, Prof. El-Diasty has also publis-hed extensively, with more than 100 peer-reviewed papers and six book chapters to his name. He has also delivered 55 invi-ted lectures and served as chairman of the European Society of Urogenital Radiology (ESUR) Symposium, which took place in Cairo in 2006. He has actively participated in every European Congress of Radiology since 1995, as well as every ESUR mee-ting since 1992.

A dedicated teacher, Prof. El-Diasty has, to date, supervised more than 50 postgraduate medical students in the field of radiology during his time at Mansoura University.

Tarek El-Diasty is professor of radiology and chairman of the radiology department at the Urology and Nephrology Centre, Mansoura University, Egypt.

Born in Egypt in 1955, Prof. El-Diasty received his medical degree from the Medical Faculty of Mansoura University, Egypt, in 1979. He then completed his internship and residency peri-ods at the same institution, receiving his master’s degree in 1986 and doctorate in 1990. Throughout his long and distinguished career, he has focused on improving urological care in Egypt and he has dedicated much of his time and effort to establishing Egypt’s first uroradiology department.

An ardent supporter of international cooperation and exchange, Prof. El-Diasty has worked hard to build closer ties between the Egyptian Society of Radiology and other radio-logical societies around the world. As an ambassador for

23

In recognition of his major contributions to the improvement of oncologic

imaging as well as his years of work to create one of the

world’s foremost imaging centres, the late Professor

Gary Glazer will be awarded Honorary Membership of


Gary Glazer†

Stanford, CA/USHonorary Member

24

ESR Dignitaries

to introduce a more patient-centred approach to his depart-ment, as he sought to increase the radiologist’s interaction with patients.

Over the course of his long and distinguished career, Prof. Glazer carried out a great deal of important and influential research. His work in the fields of computed tomography and magnetic resonance imaging led to the development of stan-dards for distinguishing liver and adrenal tumours and staging tumours in lung cancer. These standards remain vital to treat-ment and are still used routinely today. He also published more than 150 peer-reviewed articles, three books and served as con-sultant editor for a range of highly reputable scientific journals including the New England Journal of Medicine and Radiology.

During his career, Prof. Glazer received widespread recogni-tion for his work, which is evidenced by the many awards and honours he received, including Gold Medals from both the Radiological Society of North America and the Association of University Radiologists. He was also an Honorary Member of the French, German and Japanese national radiological socie-ties and served as president of the International Society for Stra-tegic Studies in Radiology from 2003 to 2005.

Gary Glazer is survived by his wife Diane and two sons Daniel and David.

Gary Glazer served as chairman of the department of radiology at the Stanford University School of Medicine, California, for more than 20 years. He was also the Emma Pfeiffer Merner Pro-fessor of the Medical Sciences at the same institution. On Octo-ber 16, 2011, Glazer passed away, at the age of 61, after a long fight with prostate cancer.

Born in Cleveland, Ohio, in 1950, Prof. Glazer was born into a family of healthcare professionals, his father being a paediatric radiologist and founding member of the Society of Paediatric Radiology, while his mother worked as a nurse.

At the University of Michigan, Prof. Glazer studied cellular bio-logy before moving on to receive his medical degree from Case Western University. He carried out his internship, residency and fellowship training in radiology at the University of California, San Francisco (UCSF). He worked for a short time at UCSF, before he returned to the University of Michigan to work as an assistant professor. Six years later he was full professor of radio-logy and serving as director of magnetic resonance imaging.

In 1989, Prof. Glazer became chair of the department of radio-logy at the Stanford University School of Medicine, and under his chairmanship the department underwent a number of major expansions and improvements, making it one of the most sophisticated imaging centres in the world. He worked

25

In recognition of his many years of dedication to radiological education

and training, as well as his tireless efforts to promote

the discipline of radiology in Europe and around

the world, Professor José Cáceres will be awarded the

Gold Medal of the European Society of Radiology at

ECR 2013.

José CáceresBarcelona/ESGold Medallist

26

ESR Dignitaries

ladolid and Barcelona. In 1996, he took up the posts of professor of radiology and head of diagnostic radiology at the H.G.U. Vall d’Hebron Autonomous University of Barcelona, where he ser-ved until his retirement in 2010.

A valued and distinguished member of the international radio-logical community, Prof. Cáceres is a member of a number of scientific societies including, the Radiological Society of North America, the Spanish Society of Radiology, the Spanish Society of Thoracic Imaging (SEIT) and the European Society of Tho-racic Imaging (ESTI). He has served as president of both ESTI and the SEIT, and at ECR 2011 he delivered the Josef Lissner Honorary Lecture.

Over the course of his career, Prof. Cáceres has published exten-sively and has 87 peer-reviewed articles, 12 book chapters and a book to his name. He has also served as chest section editor for the European Journal of Radiology and editor-in-chief of the Spanish radiological publication, Radiología.

José Cáceres is a professor and former head of diagnostic radio-logy at H.G.U. Vall d’Hebron Universidad Autonoma, Barce-lona, Spain. He is also a long-standing member of the ESR and is well-known for his series on the ESR blog, ‘Cáceres’ Corner,’ in which he and his puppet colleague challenge radiologists to solve specific cases and take away some important lessons.

Prof. Cáceres was born in Seville, Spain in 1940. He studied medicine at the University of Seville from 1957 to 1964, before moving to the United States in 1965. In the US, he completed an internship at Cook County Hospital in Chicago and later served his residency at the University of Cincinnati from 1966 to 1969, followed by a one-year fellowship in diagnostic radiology. He went on to serve as assistant professor of radiology at the Uni-versity of Kentucky before returning to Spain in 1971.

Back in his home country, Prof. Cáceres built up a wealth of clinical and academic experience. He served as head of depart-ment and professor in a number of institutions in Madrid, Val-

27

In recognition of his scientific achievements

and his dedication to international exchange and

cooperation in the field of radiology, Professor

Johannes Lammer will be awarded the Gold Medal

of the European Society of Radiology at ECR 2013.

Johannes LammerVienna/ATGold Medallist

28

ESR Dignitaries

active and highly valued member of the Cardiovascular and Interventional Radiological Society of Europe, he has served as its treasurer, secretary and president, which exemplifies his dedication to promoting international cooperation within the field of interventional radiology.

As an author, Prof. Lammer has published more than 300 artic-les in peer-reviewed journals such as Radiology, Circulation, The Lancet and the New England Journal of Medicine. He has also written a number of abstracts and book chapters, as well as a book, Praxis der Interventionellen Radiologie (The Practice of Interventional Radiology). His research interests include CT and MR angiography of coronary and peripheral arteries, IR treatment of peripheral vascular and aortic diseases, as well as HCC and liver metastases.

As a result of his work, Prof. Lammer has received a number of awards and honours throughout his career, including hono-rary membership of the Austrian Society of Radiology, the Austrian Society of Interventional Radiology, the Hungarian Society of Interventional Radiology and the Turkish Society of Radiology. He has also received Honorary Fellowship of the British Society of Interventional Radiology and the Gold Medal of the Cardiovascular and Interventional Radiological Society of Europe.

Johannes Lammer is vice-chairman of the department of radio-logy and director of cardiovascular and interventional radio-logy at the Medical University of Vienna, Austria.

Born in Vienna, Prof. Lammer studied at the University of Vienna Medical School, where he graduated in 1975, before moving on to work as an intern at hospitals in Bregenz and Feldkirch. He then went to Graz, to complete his residency in radiology at Karl Franzens University. In 1982, he travelled to the United States, where he held visiting fellowships at the department of radiology, University of Pennsylvania, Philadel-phia, the MD Anderson Hospital and Tumor Institute at the University of Texas in Houston, and the department of radio-logy at the University of California in San Francisco. In 1984, he took up the post of associate professor of radiology at Karl Franzens University, Graz. In 1990, he became head of the department of angiography and interventional radiology at the University of Vienna.

On top of this impressive academic and clinical career, Prof. Lammer has also been very active in the field of international scientific collaboration and exchange. From 1996 to 1997, he served as president of the International Society of Hepato-Bili-ary-Pancreatic Radiology, followed by presidency of the Aust-rian Society of Angiology, from 1999 to 2000. A long-standing,

29

In recognition of years of groundbreaking work in clinical radiology and his devotion to fostering

cooperation on a European and international level,

Professor Maximilian Reiser will be awarded the Gold

Medal of the European Society of Radiology

at ECR 2013.

Maximilian F. ReiserMunich/DEGold Medallist

30

ESR Dignitaries

served as president of the German Radiological Society, the European Society of Musculoskeletal Radiology and the joint congress of the German Radiological Society and Austrian Radiological Society in 2001.

With more than 500 original publications to his name, Prof. Reiser has authored extensively throughout his distinguished cli-nical and academic career. His main research interests include skeletal radiology, magnetic resonance imaging, abdominal and cardiac imaging, as well as oncologic interventions. Among the many awards he has received throughout his career are Honorary Fellowship of the Royal College of Radiologists and the American College of Radiology. He was also awarded the Holthusen Ring Award of the German Radiological Society. Prof. Reiser is also an honorary member of many national radiological societies, including those of Austria, France, Switzerland, Korea, Greece, Japan, India and Iran, as well as being an honorary member of the Radiological Society of North America. He has also received honorary membership of the Leopoldina, the German National Academy of Science, as well as an honorary doctorate from the veterinary faculty of Ludwig Maximilians University and Tiflis State University. He was also made Foreign Associate of the Nati-onal Academy of Science (USA) Institute of Medicine (IOM).

Maximilian F. Reiser is professor of radiology, chairman of the department of clinical radiology, and dean of medicine at Lud-wig Maximilians University of Munich.

In 1973, Prof. Reiser received his medical degree from the Lud-wig Maximilians University of Munich, the same institution he now heads. He then completed his residency at the diagnostic radiology department of the Technical University of Munich in 1983. He later served as an assistant professor at the same institute, before moving on to become an associate professor at the University of Münster in 1986. He then went on to take up the post of professor and chairman of radiology at the Univer-sity of Bonn in 1989, where he worked until he returned to his alma mater in 1993. He has served as professor and chairman of Ludwig Maximilians University’s department of radiology since 1993, and in 2008 he was appointed dean of medicine.

A well-known figure within the international radiological com-munity, Prof. Reiser has taken an active interest in promoting and furthering the interests of his discipline. A long-time and active member of the European Society of Radiology, he ser-ved as president of the Society’s congress in 2008, and went on to serve as president of the society in 2010–2011. He has also

31

In recognition of his expertise and

groundbreaking work in the field of primary

biliary cirrhosis and gene therapy of liver diseases, the European Society of

Radiology has invited Professor Jesús Prieto

to deliver the Opening Lecture, entitled ‘Promises and facts of liver-directed

gene therapy’, at ECR 2013.

Jesús PrietoPamplona/ESOpening Lecturer

32

ESR Dignitaries

of portal pressure, along with a significant improvement in liver function. In addition, he has identified cardiotrophin-1 as a molecule with potent hepatoprotective properties, making it a natural defence against apoptosis and a potential therapy for patients with acute, severe liver damage.

A member of many national and international societies dedica-ted to the study of the liver, Prof. Prieto has served as president of the Spanish Association for the Study of the Liver and on the Scientific Committee of the European Association for the Study of the Liver. He was made Doctor Honoris Causa by the Uni-versity of Porto (Portugal) and the University Austral of Buenos Aires (Argentina).

Prof. Prieto has authored more than 300 articles, which have appeared in many prestigious peer-reviewed journals such as the New England Journal of Medicine, Journal of Experimental Medi-cine, Journal of Clinical Investigation, Cell Metabolism, PNAS, Gastroenterology, Journal of Clinical Oncology and many others.

Jesús Prieto is professor of medicine and director of the depart-ment of hepatology and gene therapy at the Centre for Applied Medical Research at the University of Navarra, Spain. He also serves as a consultant internist at the University of Navarra Clinic.

An expert in the field of hepatology, Prof. Prieto is considered to be a pioneer of gene therapy in Europe. His research has focused mainly on understanding the underlying mechanisms of liver disease and on the development of new therapies for acute and chronic liver damage. He is credited with contributing to the unravelling of the pathogenesis of primary biliary cirrhosis, where he showed that a defect in bicarbonate transport induces both bile duct injury and immune dysfunction.

Through his research, Prof. Prieto has analysed the role of IGF-I deficiency in the progression of liver cirrhosis and has produced clinical and experimental data to show that IGF-I replacement therapy can induce regression of liver fibrosis and a reduction

33

In recognition of his research and work in the

areas of cardiovascular imaging and interventional

radiology, Professor Carlo Catalano has been invited

to present the Josef Lissner Honorary Lecture, entitled

‘MR-guided focused ultrasound: a new string to

the radiologist’s bow’, at ECR 2013.

Carlo CatalanoRome/ITHonorary Lecturer

34

ESR Dignitaries

years of teaching and research as associate professor. He serves as the Italian delegate to the European Society of Radiology’s Education Committee and has served as a member of the Euro-pean School of Radiology’s faculty for its Teach-the-Teachers programme in Italy, which reflects his experience and passion for the field of radiological education and training.

Prof. Catalano has been an active member of the ESR since the beginning of his career, participating as a panellist and as an organiser for the Junior Film Reading Session at ECR 1999. Fur-thermore, during his career he has shown great dedication to developing relations with less developed countries, with the aim of sharing radiological knowledge.

A prolific author and researcher, Prof. Catalano has authored more than 170 scientific papers, six books and upwards of 50 book chapters. On top of this, he has delivered more than 150 invited lectures at national and international conferences.

Carlo Catalano is professor of radiology and head of the depart-ment of diagnostic radiology at La Sapienza University of Rome Hospital.

Born in Rome in 1965, Prof. Catalano received his medical degree from La Sapienza University of Rome in 1990 before completing his residency at the University of L’Aquila in 1994. Up until 1999, he worked as a staff radiologist in the depart-ment of radiology and the department of emergency radiology at La Sapienza University of Rome. During this time he focused mainly on CT and MR body imaging along with cardiovascu-lar imaging and interventional procedures. In 1999, he became assistant professor of radiology at La Sapienza, as well as assis-tant professor at the Campus Bio-Medico University, Rome.

Throughout his career, Prof. Catalano has dedicated much of his time to research and education. He became full professor of radiology at La Sapienza University of Rome in 2010, after eight

35

In recognition of his work in cancer research and his efforts

to further the development of oncologic imaging and interventional oncology, Professor Jean-François

Geschwind has been invited by the European Society

of Radiology to deliver the Wilhelm Conrad Röntgen

Honorary Lecture, entitled ‘Interventional oncology:

the era of molecular targeted therapy’ at ECR 2013.

Jean-François ‘Jeff’ GeschwindBaltimore, MD/USHonorary Lecturer

36

ESR Dignitaries

A leading figure in the field of liver cancer, Prof. Geschwind has focused most of his research on hepatic cancer. He has received numerous grants from foundations, industry and the federal government for his research in the field.

Prof. Geschwind has authored or co-authored more than 350 sci-entific articles and abstracts on interventional radiology and, more specifically, the treatment of liver cancer. As lead or co-investiga-tor on more than 40 clinical trials, Prof. Geschwind’s research has been published in highly rated peer-reviewed journals, including the Journal of Clinical Oncology, Clinical Cancer Research, Radiol-ogy, European Radiology, Gastroenterology and Annals of Surgery. He has also won numerous national and international awards in recognition of his research accomplishments. In addition to having co-authored the first book dedicated to interventional radiology, entitled Interventional Oncology: Principles and Prac-tice, Prof. Geschwind is currently co-editing the book, Abrams Angiography: Interventional Radiology with Dr. Michael Dake.

A prolific speaker and lecturer, both nationally and internatio-nally, Prof. Geschwind has delivered over 200 keynote speeches at scientific assemblies, annual meetings and symposia. He has also served as visiting professor at many prestigious institutions throughout the world.

Jean-François Geschwind is professor of radiology, surgery, and oncology, and director of the division of vascular and inter-ventional radiology at the Johns Hopkins University School of Medicine in Baltimore, Maryland/US. He is also director of the Interventional Radiology Center and chief of interventional radiology research at the Johns Hopkins Hospital.

Originally from France, Prof. Geschwind began his early medi-cal training at the University of Paris School of Medicine and subsequently moved to the United States, where he studied at the University of Pennsylvania and then completed his medi-cal degree at Boston University School of Medicine in Mas-sachusetts. He completed his residency training in diagnostic radiology as a research scholar (sponsored by the National Institutes of Health) at the University of California, San Fran-cisco in 1996. He went on to complete his two-year training in vascular and interventional radiology at the Johns Hopkins University School of Medicine, before joining the faculty there as an assistant professor. In 2002, he was appointed director of the division of vascular and interventional radiology and the Interventional Radiology Center at Johns Hopkins Hos-pital, and in 2007 he was promoted to professor of radiology, surgery and oncology at the Johns Hopkins University School of Medicine.

37

In recognition of his dedication to scientific

research and development, Professor Luis Martí-

Bonmatí has been invited by the European Society of Radiology to present

the Santiago Ramón y Cajal Honorary Lecture,

‘Research and science: from individuals to societies – the Ramón y Cajal background,’

at ECR 2013.

Luis Martí-BonmatíValencia/ESHonorary Lecturer

38

ESR Dignitaries

contributed to eight books. He has also supervised twenty-two Ph.D. students, and has delivered hundreds of presentations at scientific meetings, symposia, and international conferences.

On top of his work as a clinician and academic, Prof. Martí-Bonmatí has also been engaged in strengthening international ties within the field of radiology. He is an active member of many European scientific societies and has served as president of the Spanish Society of Radiology, the European Society for Magnetic Resonance in Medicine and Biology and the Spanish Society of Abdominal Imaging. In addition to these presiden-cies, he has served as vice-president of the European Society of Gastrointestinal and Abdominal Radiology.

He is a long-time member of the European Society of Radio-logy and currently serves as chairman of the society’s Research Committee.

Luis Martí-Bonmatí is director of medical imaging at La Fe Uni-versity and Polytechnic University Hospital, and chief of radio-logy at Quirón Hospital, Valencia, Spain. He is also professor of radiology at Valencia University.

After completing his undergraduate medical training at the University of Valencia in 1983, Prof. Martí-Bonmatí worked as a resident at La Fe University Hospital Valencia until 1987. He then began work on his Ph.D. thesis, ‘MRI in the study and cha-racterisation of focal liver lesions’, which earned him a doctorate with excellence from the University of Valencia in 1990.

As a researcher, Prof. Martí-Bonmatí’s interests lie mainly in the fields of liver MR and CT, abdominal and pelvic MRI, contrast agents, image processing, and imaging biomarkers. With more than 200 articles listed in PubMed and 55 book chapters to his name, he is an established scientific author. As an editor he has

39

The IPP off ers a great, convenient way to explore the whole ECR programme online and create a custom timetable. You can search or browse for sessions

and posters, read full abstracts, create a personal calendar, and even print your own personalised Book of Abstracts. It’s also optimised for mobile devices, meaning you can keep every detail that’s important to you exactly where you need it – right in your hand.

Plan your own personalised congress and you’ll never lose track again ...

ipp.myESR.org

Customise your congress!

Plan and personalise your ECR 2013 experience with the Interactive Programme Planner.

General Information

42 Information from A to Z50 CME at ECR 201352 ESR Meets Sessions53 EFRS Meets Session55 Plenary Sessions56 Social Media Guide59 Image Interpretation Quizzes61 MIR@ECR62 EPOS™ – Scientific Exhibition65 eLearning Tools66 Special Exhibition67 Cafés & Restaurants67 Free Publications71 ECR 2013 welcomes its industry partners73 ESR Journals75 Underground Map

GeneralInformation

Information from A to Z

Arts & CultureDelegates are encouraged to visit the Arts & Culture Desk in the entrance hall for information on Vienna’s cultural events such as exclusive opera performances, delightful concerts, and the fas-cinating exhibitions in Vienna’s most important and remarkable museums. Pick up your personal Arts & Culture Brochure at this counter to find descriptions of all cultural places.

BadgesFor organisational and security reasons, badges must be worn at the congress venue. Access to the different areas will only be granted upon presentation of an appropriate badge.Please note that in order to obtain CME credits, it is mandatory to affix your Personal ID stickers to the evaluation forms available in each scientific session, and to drop these into the dedicated boxes.

Lost or Forgotten BadgesIn the case of loss, a replacement badge will only be provided on full payment of the applicable onsite registration fee.Forgotten badges will be replaced against a deposit of the full onsite fee.

Book of Abstracts – ‘Insights into Imaging (Supplement 1 to Volume 4)’Professional delegates will find a complimentary copy in their congress bag.Please note that in accordance with the ESR members’ wishes, the print version of the Book of Abstracts contains Scientific Sessions only. The extended version of the Book of Abstracts, including the Postgraduate Educational Programme and Satellite Symposia can be accessed at www.i3-journal.org/articles.You can also create your own personal Book of Abstracts with the help of the popular ECR Interactive Programme Planner (ipp.myESR.org).Abstracts of EPOS™ presentations no longer appear in the Book of Abstracts. Each full EPOS™ presentation can instead be cited by a Digital Object Identifier (DOI), which appears with the presentation at www.myESR.org/EPOS.

Broadcast RoomsFor the second time, the ECR features specific Broadcast Rooms, where you can listen to sessions and view the corresponding pres-entation material in a relaxed atmosphere when the actual lecture rooms are overcrowded. Broadcast Rooms/Zones are located next to room B (2nd level), rooms L/M and N/O (1st level), rooms E1 and F2 (entrance level) and rooms G/H and I/K (lower level).See Floor Plans on pages 78–84.

Business CentreThe Press Office & Business Centre, located on the entrance level, offers copy and fax facilities for a small charge.

Opening hours:Thursday, March 7 to Monday, March 11: 08:00–18:00

Cafés & RestaurantsIf you are looking for an ideal meeting point, or if you just want to take a short break, try one of the various foyer cafés and res-taurants. They are situated throughout the whole congress venue and on all levels of the building, offering a variety of tasty hot and cold snacks.To offer you the broadest possible variety of Austrian and inter-national delicacies, each café and restaurant has its own theme, from Austrian specialties to Italian treats and Asian delights.See page 67.Please see the ‘coffee-cup’ signs on the floor plans on pages 78–84 of this programme to locate the various foyer cafés.

Cases of the DayFrom Thursday to Sunday, five Cases of the Day covering dif-ferent sections of radiology are shown on computer stations in the EPOS™ classroom on the 2nd level. Participants are invited to submit their diagnoses. The winners will be announced on the ESR website.We would like to acknowledge the contribution of the following authors to the Cases of the Day:

Thursday:Case 1: R. Basilico, E. Rodolfino, L. Migliorato, V. Calamita,

A.R. Ferri, A.R. Cotroneo; ItalyCase 2: P. Belli, M. Di Matteo, M. Giuliani; ItalyCase 3: M.B. Damasio, F. Rizzo, C. Mattiuz, G.M. Magnano; ItalyCase 4: R. Viguer, F. Aparici, F. Mas, L. Martí-Bonmati; SpainCase 5: M.P. García-Peña, L. Cadavid Álvarez; Spain

Friday:Case 1: P.I. Davydenko, G.G. Karmazanovsky; RussiaCase 2: K. Gruszczynska, P. Ulbrych, K.S. Gołba, J. Biernat,

J. Baron; PolandCase 3: E. Fisci, A. Tagliafico; ItalyCase 4: G.C. Colleran, M.J. Shelly, B.D Murphy, H.M. Fenlon,

E.C. Kavanagh; IrelandCase 5: C.A. Acevedo, I. Delgado, A. Sanchez-Montanez,

E. Vazquez; Spain

Saturday:Case 1: P.L. Di Paolo, H.A. Vargas, O. Akin, H. Hricak;

Italy/United StatesCase 2: K.-F. Kreitner, N. Abegunewardene; GermanyCase 3: I.I. Reidsma, M. Reijnierse; NetherlandsCase 4: I.G. Lupescu, G.A. Popa, C.A. Nicolae; RomaniaCase 5: S. Speca, C. Borelli, G. Soglia, L. Bonomo; Italy

Sunday:Case 1: E. Astrinakis, N. Courcoutsakis, A. Karayiannakis,

P.K. Prassopoulos; GreeceCase 2: M.-P. Revel, B. Fedida; FranceCase 3: M.J. Shelly, G.C. Colleran, B.D. Murphy, H.M. Fenlon;

IrelandCase 4: L. Holzer-Frühwald, M. Pones, C. Kölblinger,

M.M. Thurnher; AustriaCase 5: M. Teodorescu, E. Coche, B. Ghaye; Belgium

42

Information from A to ZGeneralInformation

Congress VenueAustria Center ViennaBruno Kreisky Platz 11220 Vienna, AustriaPhone: (+43 1) 533 40 64–0To reach the ACV by public transport from the city centre (Stephansplatz) take the U1 underground line (red line, direction Leopoldau). Get off at Vienna International Centre/Kaisermühlen and take the exit marked Schüttaustraße. Travelling time: approximately eight minutes.

‘ECR Live’After last year’s success, the ESR is once again providing a live streaming service for ECR 2013, under the name ECR Live, in an effort to bring the ECR to everyone. The majority of ECR sessions are being broadcast live via the ESR website, with Facebook and Twitter options integrated into the web interface to provide a fully interactive experience. ECR Live is kindly supported by Siemens.Link: live.myESR.org

ECR TodayECR Today, the popular daily newspaper of the congress, is pub-lished from Thursday to Monday (with a special issue dedicated to the European Diploma in Radiology on Wednesday) and dis-tributed in the entrance hall of the congress venue and in the entrance area of the Technical Exhibition.

ECR 2013 Smartphone App The ECR 2013 App gives iPhone and Android users a new way to experience the congress. The app is packed with features, including gen-eral congress information, scientific and educational programme details, top news stories from ECR Today, full abstracts, and even floor plans of the Austria Center. You can download the app from iTunes or via the QR code to the right. The ECR 2013 App is kindly supported by Bracco.

EDIPS – ECR’s Digital Preview SystemSee Preview Centre.

EFOMP (European Federation of Organisations for Medical Physics) WorkshopThis workshop is the 15th in the series of EFOMP Workshops on ‘New Technology in Diagnostic Radiology’. This year’s workshop focuses on ‘New frontiers in imaging of the lung’. It has been organised by EFOMP in collaboration with the ESR to address the current and future technological requirements for radiology imaging equipment (please refer to page 135).

Categorical CoursesThere are two new Categorical Courses, entitled ‘Oncologic Imag-ing: Follow-up of Systemic and Local Therapies’ and ‘CLICK (Clinical Lessons for Imaging Core Knowledge): Never without Arteries’ at ECR 2013. The Categorical Course ‘Urogenital Imag-ing’ is repeated from ECR 2012. The latter and the CLICK Course are interactive courses with electronic voting/self assessment. For both courses, voluntary self-assessment tests will be available after the last session is finished. Tests can be accessed online (assess-ment.myESR.org) as well as via the EPOS™ classroom.Places on each course are allocated on a first-come, first-served basis. Please refer to pages 109–111 for the course programmes.

Churches and Religious Communities in ViennaVienna is a multi-denominational, multi-cultural city. We will be pleased to provide you with information on local religious communities and places of worship at the Travel Service Desk.

CME Accreditation SystemPlease make sure you pick up an evaluation form, which is pro-vided at the entrance of each room. Then affix one of your Per-sonal ID stickers to the evaluation form and drop it into the dedicated box in front of each room. This is mandatory in order to obtain CME credits.See pages 50–51.

Coat CheckThe coat check services are located on the entrance level, in Foyers E and F, as well as on the lower level next to Room D1.

Communication AreasIf you are looking for the perfect place to meet and talk with friends or just to relax and browse through ECR Today, ECR 2013 offers two areas perfectly equipped for communication and recreation; the ESR Welcome Lounge right in the middle of the entrance hall and the EPOS™ Lounge on the 2nd level of the congress venue.

Confirmation of Payment and Attendance / CME AccreditationCongress-related confirmation will be available during and after the congress from the ESR website (www.myESR.org) via the MyUserArea (login with your last name and your Personal ID as printed on your badge). Internet access is provided at the registra-tion terminals (from Saturday, March 9, afternoon onwards) as well as at the internet points (see floor plans) and W-LAN areas, which are available throughout the congress venue.

Congress LanguageEnglish

43

GeneralInformation


‘ESR Meets’ SessionsThe purpose of ‘ESR meets’ is to forge closer ties between the ESR and its guest societies. The three guest nations of this year’s ECR are Chile, South Africa and the Congress President’s home country, Spain. There are dedicated sessions for the radiological communities of these nations to demonstrate the excellence of radiology in their countries.In addition, ECR 2013 again features special activities focusing on a partner discipline, providing a platform to establish closer ties. This year’s guest in the series will be the European-African Hepato-Pancreato-Biliary Association.Places at these sessions are allocated on a first-come, first-served basis. Please refer to pages 52–53 for the programme of the sessions.

ESR Welcome LoungeVisit the ESR Welcome Lounge in the entrance hall! Whether you are looking for an ideal meeting point or just want to take a short break – the ESR Welcome Lounge will suit your needs. Free wireless LAN is provided for your convenience.Watch out for artistic performances from the ‘ESR meets’ coun-tries during the lunch breaks!

European Diploma in Radiology (EDiR)An examination for the European Diploma in Radiology is being held at ECR 2013. The electronic-based written examination takes place on Wednesday, March 6, in the EPOS™ Area on the 2nd level, whereas the case-based oral examinations take place on Thursday, March 7, and Friday, March 8, in various rooms close to the EPOS™ Area.Success in the examination certifies a standard of radiologi-cal knowledge deemed appropriate by the ESR for independent practise in General Radiology.Make sure you grab the special EDiR edition of ECR Today on Wednesday.www.myESR.org/diploma

‘European Radiology’Visit the booth of the ESR’s flagship journal, European Radiology, in the entrance hall.See page 73.

EURORADEURORAD is the largest peer-reviewed radiological teaching database on the internet, accessible free of charge to all ESR members. Please visit the EURORAD booth in the entrance hall.

Expo GalleryOpening hours:Thursday, March 7: 14:00–18:00Friday, March 8 to Monday, March 11: 10:00–18:00

Visit the additional technical exhibition area on the 1st level of the congress venue!

‘EFRS Meets’ SessionAt ECR 2013 the relationship between the ESR and the European Federation of Radiographer Societies (EFRS) will reach a new level of cooperation. The EFRS is hosting the session ‘EFRS meets Spain’, underlining the essential role of radiographers in medical imaging. Please refer to page 53 for the programme of the session.

EIBIR BoothVisit the EIBIR Booth in the entrance hall for the most recent news on the European Institute for Biomedical Imaging Research.

EIBIR presents IMAGINEAfter last year’s success, EIBIR again presents the IMAGINE Workshop. The sessions will feature research institutes, university groups and research departments of industrial companies, pre-senting novel and exciting technological developments in the field of diagnostic and interventional radiology. See pages 142–143.

Emergency Information/First AidFor fire, medical or police assistance, please contact ACV Infor-mation or the nearest available ECR or ACV staff member. A medical specialist trained in emergency medicine will be present for the duration of the congress.

EPOS™ – Scientific ExhibitionThe ECR 2013 electronic scientific exhibition is open Thursday to Monday from 08:00 to 18:00. The EPOS™ Area, consisting of a classroom with 80 workstations and a lounge, is located in Foyer A on the 2nd level.A wireless internet network is available in the EPOS™ Lounge (name ‘EPOS WiFi’), through which the poster exhibition can be accessed as if from within the classroom.At ECR 2013, EPOS™ is again offering discussions on hot topics in radiology, where authors of the highest-scored posters in each field will discuss them with a moderator.Note: On Saturday, March 9, 12:15–13:15, the EPOS™ classroom will be closed for the self-assessment test for the participants of the Foundation Course on Neuroimaging.EPOS™ is kindly supported by Hewlett-Packard.See pages 62–63.

ESOR BoothVisit the ESOR Booth in the entrance hall for the latest news on the European School of Radiology. In addition, there is an ESOR Info Desk in the Rising Stars Lounge.

44


Interactive Teaching SessionsUnder the heading of E3 – European Excellence in Education, ECR 2013 presents 14 interactive teaching sessions dealing with specific topics of common radiological problems, emergencies, imaging of cancer and infections, establishing a two-way interac-tion between the presenters and the participants.The material is presented in an interactive way, with audience participation and self assessment through the use of an electronic voting system (key-pads).Places are allocated on a first-come, first-served basis.Please refer to page 137 for the programme of the sessions.

Internet PointsComputer terminals with internet connections are available on the 1st level and in Extension Expo A, and can be used for various purposes. Delegates can compile their personal session itinerar-ies using the Interactive Programme Planner, send e-mails and browse the internet.

(Junior) Image Interpretation QuizThe Image Interpretation Quizzes are two traditional highlights of every ECR. This year’s themes are ‘Radiology is global’ and ‘Golden Eye’ (see page 59).

LiabilityESR and the Austria Center Vienna are free from all liabilities that may arise from the delegates’ and presenters’ participation in ECR 2013 and its activities.

Lost and FoundLost and found articles may be picked up or handed in at the ACV Information Desk located in the entrance area.

Meditation & Prayer RoomThe Meditation & Prayer Room is located on the lower level in Foyer G/H. You will find it marked on the floor plan.

Meeting RoomsMeeting rooms at ECR 2013 are to be found on:3rd Level Meeting Rooms 1–92nd Level Meeting Rooms 10–131st Level Meeting Room 14Lower Level Meeting Rooms 15–16

You will find them marked on the floor plan.Please contact the Info Service Desk on the 3rd level for access to and onsite booking of meeting rooms.

MembershipFor membership application and renewal, please go to the regis-tration desks in the entrance hall.

Face-Off SessionSee Post-Processing Face-Off Session.

Foundation CourseThis basic teaching course, which takes place under the heading of E³ – European Excellence in Education, in room E2 on the entrance level, is designed to be suitable for trainees and for those who wish to refresh their knowledge. The motto of the course is ‘All you need to know about neuroimaging in 18 easy lessons. This course answers your questions!’The course concludes with a self-assessment test in the EPOS™ Area on Saturday, March 9, 12:15–13:15.Course places are allocated on a first-come, first-served basis. Please refer to page 136 for the course programme.

Free PublicationsThe ESR again presents the ‘Free Publications’ Booth on the 2nd level, integrated into the EPOS™ Lounge. Pick up free copies of radiology journals and magazines and get free access to online radiology journals. Free bags are provided for your convenience.

Future Meetings DeskThis area – located on the lower level next to Rooms D1 and D2 – offers you an overview of future meetings in the field of radiology and related disciplines, from all over the world. Feel free to contribute flyers and posters to promote your own meet-ings and courses.

Hands-On WorkshopsSee Update Your Skills (Practical Courses).

IMAGINESee EIBIR presents IMAGINE.

‘Insights into Imaging’Insights into Imaging is the ESR’s journal for education and guide-lines. It is open access and PubMed indexed. A special printed issue of Insights into Imaging has been placed in all students’ and residents’ congress bags. Free copies are also available at the Insights into Imaging booth in the entrance hall.See page 73.

Industry Hands-On WorkshopsAt ECR 2013 there are various Industry Hands-On Workshops scheduled, organised by Hologic and Siemens Healthcare.See page 153 for details.

Interactive Programme PlannerThe ESR is again proud to present this popular interactive tool for ECR 2013. The IPP provides a convenient way to explore and customise the congress programme online, in both traditional browser and mobile device versions.Featuring various search and browse functions for sessions as well as posters, the IPP also includes a ‘basket’ option, which enables users to collate items from the programme to create their own per-sonal calendar and even print a personalised Book of Abstracts.The IPP 2013 is kindly supported by Siemens.Link: ipp.myESR.org

45

GeneralInformation


Post-Processing Face-Off SessionThe ‘Workstation Face-Off ’ session takes place in Room B on Friday, March 8, 08:30–10:00.The aim of this session is to simulate a realistic ‘reading room’ atmosphere and to give an impression of how different worksta-tions perform in a clinical scenario. We would like to cordially invite you to attend this exciting tournament of post-processing (see page 139).

PressThe ECR 2013 Opening Press Conference takes place on Thurs-day, March 7, at 09:30 at the Austria Center Vienna, Meeting Room 14 (1st level). For press accreditation, please contact the Press Office & Business Centre on the entrance level. To obtain a press badge, you must present an international press ID or a confirmation letter from the relevant medium.Delegates and exhibitors may display their press kits in the Press Office & Business Centre. There are also several publicly available computer terminals as well as workspace and plug points for you to work with your personal laptop.

Opening hours:Thursday, March 7 to Monday, March 11: 08:00–18:00

Preview Centre – EDIPSEDIPS, the ECR’s digital preview system, allows for fast and easy presenter identification through badge scanning. Large screens in the waiting area display the names of the presenters who are asked to proceed to the Check-In counter, where they can hand in their presentations. At the Preview Stations, presenters have the opportunity to do a final check on their presentations. This year, presenters were offered the option of submitting their material prior to the congress.The Preview Centre is located on the 1st level, next to Room N/O.

Opening hours:Wednesday, March 6: 12:00–18:00Thursday, March 7 to Monday, March 11: 07:00–18:00

Please note that only digital material will be allowed for oral presentations.The material must be in English and must be provided on CD-ROM, DVD, ZIP disk or USB devices so that it can be transferred to a central server onsite. It is mandatory that the data carriers are delivered to the audiovisual preview centre 2 hours prior to the session, at the latest. Computers connected to data projec-tors are provided in each lecture room for the speaker to retrieve the saved data.The material remains the property of the speakers.

Professional Challenges SessionsThese sessions are intended to communicate and exchange issues on radiological training and education, research networking, radiological management and professional developments. This year’s topics are ‘Bringing radiology to medical undergraduates’, ‘The visibility of the radiologist’, ‘Personalised radiology’, ‘Legal matters related to multimodality techniques’ and ‘The radiologist, the clinician and the patient: an impossible trio?’.Places are allocated on a first-come, first-served basis. Please refer to page 107 for the sessions’ programme.

Mini CoursesECR 2013 features three new Mini Courses, ‘Controversies in Breast Imaging’, ‘The Beauty of Basic Knowledge: Head and Neck’ and ‘The Beauty of Basic Knowledge: Musculoskeletal Imaging’. The joint course of the ESR and RSNA ‘Essentials in Oncologic Imaging: What Radiologists Need to Know’ is repeated from last year. The ‘Organs from A to Z’ series, introduced at ECR 2010, will this year focus on the heart.The ‘Organs from A to Z’ course, the course on breast imaging and the ESR/RSNA course sessions will be interactive with electronic voting/self assessment.Places for all courses are allocated on a first-come, first-served basis.The ‘Organs from A to Z’ course is accompanied by a voluntary self-assessment test that will be available after the last session is finished. Tests can be accessed online (assessment.myESR.org) as well as via the EPOS™ classroom.Please refer to pages 112–114 for the courses’ programmes.

MIR@ECRAfter last year’s success, the ESR Subcommittee on Management in Radiology has again organised a special session at the ECR on core managerial issues and supportive methods and techniques. It takes place on Saturday, March 9, 13:00–17:30 in Room Q.See page 61.

Mobile GuideGet the ECR on your smartphone and always stay up to date! The ECR Mobile Guide brings ECR 2013 to the palm of your hand. Find out all about sessions/lectures, abstracts, exhibitors, floor plans and places to be.Link: m.myESR.org

Multidisciplinary Sessions: Managing Patients with CancerThese sessions are intended to promote a multidisciplinary approach to cancer detection and treatment, by bringing together radiologists, surgeons and oncologists to share their expertise. The topics that are covered this year are: colorectal liver metas-tases, hepatocellular carcinoma and cholangiocarcinoma.Please refer to page 108 for the programme of the sessions.

New Horizons SessionsThe aim of the New Horizons Sessions is to provide practition-ers with an overview of the new developments in a specific area of practice e.g. specialty, technique, or disease. These develop-ments may become routine within a few years, or may indicate a new direction for research and clinical application. There are three New Horizons Sessions, entitled ‘Cartilage imaging’, ‘MR/PET: a marriage made in heaven or hell?’ and ‘Imaging of the mind’, at ECR 2013. Session places are allocated on a first-come, first-served basis. Please refer to page 100 for the programme of the sessions.

Plenary SessionsSee page 55.

46


Rising Stars Lounge / Residents & Students LoungeThe Rising Stars Lounge for residents and students is located on the 2nd level, Foyer B. In the lounge you will find information on the European School of Radiology, the European Diploma of Radiology and the Radiology Trainees Forum.

Rising Stars ProgrammeSee pages 144–145.

Satellite SymposiaIndustrial Satellite Symposia are presented by international com-panies. CME credits can be claimed for attendance of these sym-posia on condition that the relevant completed evaluation form has been received by the organisation. Places are allocated on a first-come, first-served basis.See pages 149–152 for details.

Scientific Presentation Awards The authors of the best scientific papers and scientific/educational exhibits will be presented with a certificate and given free ECR 2014 registration.Scientific Papers: The award will be assigned to the best paper presentation of each topic based on the evaluation by session moderators, subcommittee members and session participants. Selection criteria comprise quality of presentation, scientific con-tent and overall impression of the performance. The award winners will be informed after the con-gress and will be published on the ESR website. Scientific/educational exhibits: See page 62 (Scientific Exhibi-tion Awards).

Security / SafetyThe safety of all congress attendees is of utmost importance to the European Society of Radiology. The Austria Center Vienna and the ESR have taken security precautions to ensure the maxi-mum possible safety for all ECR participants. Please inform our staff, especially our room attendants, immediately if security problems occur.The ESR reserves the right to check your identification upon admission to the congress centre and/or inside the building. You may be asked at any time to present adequate proof of identity by showing your passport, driver’s licence, national or military identification, or student ID, all with photograph and signature.

Smoking Smoking is not permitted inside the Austria Center Vienna. The ECR is a non-smoking congress. Outside the building, we kindly ask you to use the ashtrays provided. In addition, there is a dedi-cated smokers’ area on the right side of the main building. Please note that smoking is prohibited in front of the main entrance.

Society BoothsUp to 50 national and international radiological societies present their meetings and societies in the society booths area, which is located on the entrance level, next to the registration desks and the coat checks.

Public TransportTickets for public transportation are available at the registration desks in the entrance area.

Special ECR Ticket:6 days (valid from March 6–11): € 20.00Underground map; see page 75.

Publishers Row (1st level) & Partner Publishers (entrance level)Opening hours:Thursday, March 7: 14:00–18:00Friday, March 8 to Monday, March 11: 10:00–17:30

Browse through a wide range of scientific publications displayed by the most important publishers in the field of medicine.

Radiology Trainees Forum (RTF)The RTF promotes and coordinates the efforts of radiology train-ees at a European level in order to improve the progress of radiol-ogy and related sciences. One of the RTF’s most important goals is to provide an equal level of radiological knowledge and skills for radiology trainees all over Europe.Highlighted Lectures organised by the RTF will be given on Sunday, March 10, 10:30–12:00 in Room Q (see page 141).The RTF General Assembly takes place on Sunday, March 10, 14:30–16:00, in Meeting Room 9 (3rd level). For more detailed information please visit the RTF Meeting Point in the Rising Stars Lounge (Foyer B, 2nd Level).

Recording / PhotographyVideo or audio recording of presentations is not allowed without the speaker’s/exhibitor’s and ECR’s prior permission. Flash pho-tography is not permitted during presentations. Interviews must take place outside the lecture room. For queries, please contact the ESR Press Office.

Refresher Courses75 Refresher Courses have been organised by the various sci-entific subcommittees for ECR 2013. Based on the topic of the session, some refresher courses are presented in an ‘integrated’ format with an organised panel discussion, similar to Special Focus Sessions.Places are allocated on a first-come, first-served basis.Please refer to pages 115–134 for the programme of the sessions.

Registration Opening HoursWednesday, March 6: 12:00–18:00Thursday, March 7: 07:00–18:00Friday, March 8: 07:00–18:00Saturday, March 9: 07:00–18:00Sunday, March 10: 07:00–18:00Monday, March 11: 07:00–18:00

Restaurant ReservationsOur staff at the Dining & Shopping Desk in the entrance hall will be pleased to recommend places to eat close to your hotel or near a certain theatre, and will be happy to reserve a table for you.

47

BOOST YOURCAREER.

TAKE THE EUROPEAN DIPLOMA IN RADIOLOGY (EDiR)

www.myESR.org/diploma

EXAM DATES:June 6–8, 2013, Wroclaw/PL

(Congress of the Polish Medical Society of Radiology)

October 18–22, 2013, Paris/FR (JFR)

October 28 – November 2, Antalya/TR (TURKRAD 2013)


Special AssistanceDelegates with special needs may park on the lower level with direct elevator access to the ACV. All lecture rooms are accessible by wheelchair.

Special ExhibitionIn compliance with the ECR’s tradition of offering its delegates an ambitious supporting programme at the annual congress, the ECR is again proud to present an exhibition by Prof. Vogel from Hamburg/DE, in cooperation with the German Röntgenmuseum. This year’s exhibit is entitled X-Rays: Evidence and Threat and is presented on the 2nd level, next to the EPOS™ Lounge.See page 66.

Special Focus SessionsSpecial Focus Sessions deal with a topic at the cutting edge of development and clinical application. The topics of these sessions are presented so as to promote debate and to give an in-depth analysis. The chairman introduces each aspect of the topic and the panellists then discuss their different perspectives and opinions. The audience is also given the opportunity to discuss their ideas with the lecturers. Places are allocated on a first-come, first-served basis. Please refer to pages 102–106 for the programme of the sessions.

State of the Art SymposiaThese sessions are intended to inform the audience about the ‘real state of the art’ of a given subject. Each of the lecturers is an expert on the topic as a whole or on some specific aspect of the topic, which will be the subject of the respective session. The presenta-tions are followed by a discussion conducted by the panellists, led by the chairman. Places are allocated on a first-come, first-served basis. Please refer to page 101 for the programme of the sessions.

Students’ SessionsAt ECR 2013, students have the chance to present their own abstracts in front of a huge audience. The submitters of the best 20 abstracts have been invited to Vienna to present their work in dedicated sessions.See pages 144–145.

TaxiThere is a taxi stand outside the main entrance.

Technical Exhibition

Opening hours:EXPO Halls and EXPO Foyer DFriday, March 8 to Sunday, March 10: 10:00–18:00Monday, March 11: 10:00–14:00

First Level (Gallery)Thursday, March 7: 14:00–18:00Friday, March 8 to Monday, March 11: 10:00–18:00

Detailed information on the Technical Exhibition can be found in the ‘On-Show exhibition guide – Exhibitor Directory and Product Information’, which is distributed together with the congress bags.

Travel ServiceThe ESR and ECR are proud to offer their delegates services that should facilitate their travel arrangements and make their stay in Vienna as pleasant as possible. The ESR’s Travel Service Desk is located on the entrance level of the Austria Center Vienna. Next to it you can find the ECR’s official travel agency Mondial.

Opening hours:Wednesday, March 6: 12:00–18:00Thursday, March 7 to Monday, March 11: 07:00–18:00

Air TravelThe Austrian Airlines desk in the entrance area offers the fol-lowing services for Austrian Airlines and Star Alliance flights:

Ticket office & Check-in services: Friday, March 8 to Monday, March 11: 09:00–18:00

• Check-in for Star Alliance flights• Issue of boarding passes

At Vienna Airport• Check-in for Star Alliance flights with hand-baggage only;

deadline: latest passengers to show up at the respective boar-ding gate at Vienna Airport according to boarding time shown on boarding pass

• Check-in for Star Alliance flights (except flights to Tel-Aviv and USA) with baggage; deadline: latest passenger to show up with baggage at the Baggage Drop Off Counters / Terminal 1 at Vienna Airport 45 minutes before departure.

Update Your Skills (Practical Courses)The following Update Your Skills (Practical Courses) are pre-sented at ECR 2013:– How to biopsy with US guidance– Image-guided tumour ablation: How to do itThe number of participants of each workshop is restricted. Please refer to pages 146–147 for the course programmes.

Wireless LANFree wireless LAN access is available throughout the congress venue. The public WiFi ‘ECR’ requires a login. Please log in with the following data:Username: ecrPassword: ecr2013In addition, every lecture room is equipped with a dedicated WiFi network. Login data will be provided onsite.

49

GeneralInformation

CME at ECR 2013

UEMSThe ESR – European Society of Radiology is accredited by the European Accreditation Council for Continuing Medical Educa-tion (EACCME) to provide the following CME activity for medi-cal specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS).The ECR 2013 is designated for a maximum of 27 hours of European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. European Accreditation is granted by the EACCME in order to allow participants to validate the credits obtained at this activity in their home European Country.

USADue to an agreement of mutual recognition the American Medical Association (AMA) will convert European continuing medical education (CME) credits to AMA PRA Category 1 Credits™. For further information about the conversion of European credits into AMA PRA Category 1 credits, please contact the AMA at [email protected] or visit the AMA website.

WorldwideCME claimed at the ECR are accepted by almost all national CME authorities worldwide.

CME Acquisition ProcedureCME (continuing medical education) credits will only be awarded, if• the questionnaire provided at the entrance of each session is

fully completed,• your unique personal CME sticker, which you will receive

together with your badge, is affixed,• and the form is dropped into the provided box immediately

after the relevant scientific session.• The combined participation and evaluation questionnaire

considerably helps the next organising committee to select subjects for future ECRs. Evaluation sheets differ depending on the types of the scientific event.

• Please note that confirmation of any additional attendance of the scientific programme, for which you have not submitted an evaluation form during the congress, cannot be claimed at a later date as late requests cannot be processed and can thus not be included in your record of attendance.

GuidanceConfirmation of participation in the scientific programme is to be obtained as follows:

Scientific Sessions 1. Participate in the event of your interest.2. Personalise the relevant questionnaire (evaluation form) using

your CME sticker, since otherwise it is not possible to sort out the forms afterwards and to provide confirmation.

3. Fill in this form completely during the session.4. Drop the completed form into the box provided at the exit of

the room when leaving the session.

General InformationEach ECR delegate receives confirmation of all activities attended (CME confirmation – Record of attendance). The approximate maximum number of hours of scientific activity attendance is 40 (please note that this number differs from the maximum number of UEMS/EACCME credits).

CME Accreditation

EuropeThe following European countries accept the ECR 2013 CME accreditation:

■ Austria* ■ Azerbaijan ■ Belgium ■ Bulgaria ■ Croatia ■ Cyprus ■ Czech Republic ■ Denmark ■ Estonia ■ Finland ■ France ■ Georgia ■ Germany** ■ Greece ■ Hungary ■ Iceland ■ Ireland ■ Italy ■ Latvia ■ Lithuania ■ Luxembourg ■ Malta ■ Netherlands ■ Norway ■ Poland ■ Portugal ■ Romania ■ Slovakia ■ Slovenia ■ Spain ■ Sweden ■ Switzerland*** ■ Turkey ■ United Kingdom

* The ESR is an accredited CME provider of the Austrian Medical Chamber. The Austrian Medical Chamber has granted a maximum of 40 DFP (Diplom-Fortbildungs-Programm der Österreichischen Akademie der Ärzte) credits for ECR 2013.

** The German Society of Radiology (DRG) has granted a minimum of 27 Category 1-credits for ECR 2013. The actual number of credits granted will depend on the respective German State Chamber of Physicians (Landesärztekammer) and can be accordingly higher.

*** The Swiss Society of Radiology (SGR-SSR) has granted a maximum of 40 Category 1-credits for ECR 2013.

50

GeneralInformation

Scientific ExhibitionAttendance and evaluation are recorded online in EPOS™.1. Enter EPOS™ (Electronic Presentation Online System) and

view the posters of your interest. When logging out from EPOS, you will be asked to complete the evaluation form.

2. Fill in this form completely and press the ‘Submit’ button.A maximum of 3 hours of attendance at the scientific exhibition (SE) will be listed if the participant has completed and submitted the online SE evaluation form using EPOS™ (Electronic Presenta-tion Online System).

CME ConfirmationsEvery participant will be able to view and print his/her personal record of attendance from the internet at the MyUserArea on the condition that the above mentioned procedures have been accom-plished. This service is already available onsite at the numerous computer terminals and at the registration desk. Please note that your Personal ID, printed on your badge, is required for login.The printout of your record will be recognised by the national accreditation society upon submission. Please note that the record of attendance will be issued only to the participant. It will not be supplied to any accreditation agency or other organisation/health authority.After the congress CME certificates will still be available online. To show and print your CME certificates after the congress, please log into the MyUserArea with your last name and Personal ID.Although participants may partially attend multiple concurrent sessions, the total number of hours printed at the end of the list limits the credit to the equivalent of a single session during that time slot.For further information, please contact the ECR CME Support at [email protected].

GeneralInformation

ESR Meets Sessions

Friday, March 8, 10:30–12:00, Room BESR meets Spain EM 1: Imaging: essential tool from

diagnosis to treatment

Welcome by the ESR President G.P. Krestin; Rotterdam/NL

Presiding: C. Ayuso; Barcelona/ESJ.I. Bilbao; Pamplona/ES

• Introduction [A-111]C. Ayuso; Barcelona/ES

• Ischaemic stroke [A-112]J. Macho; Barcelona/ES

• Interlude: Spanish radiologists:open to the world [A-113]E. Fraile Moreno; Madrid/ES

• Aortic aneurisms [A-114]J.J. Martínez Rodrigo; Valencia/ES

• Interlude: Radiologists and Spanish wines [A-115]L. Martí-Bonmatí; Valencia/ES

• Hepatocellular carcinoma: the BCLC approach [A-116]M. Burrel; Barcelona/ES

• Panel discussion: Is the multidisciplinary environment the natural way to develop excellence and leadership in clinical imaging?

Friday, March 8, 16:00–17:30, Room BESR meets E-AHPBA (European-African Hepato-Pancreato-Biliary Association) EM 2: Pancreatic cystic neoplasms 2013


Presiding: J.I. Bilbao; Pamplona/ESP.-A. Clavien; Zurich/CH

• Introduction [A-144]P.-A. Clavien; Zurich/CH K. Conlon; Dublin/IE

• Classification/pathology [A-145]C. Verbeke; Stockholm/SE

• Radiological diagnosis [A-146]S. Skehan; Dublin/IE

• Current role of endoscopic ultrasonography [A-147]P. Bauerfeind; Zurich/CH

• How aggressive should the surgeon be? [A-148]K. Conlon; Dublin/IE

• Panel discussion

Saturday, March 9, 10:25–12:00, Room BESR meets South Africa EM 3: Imaging HIV and TB


Presiding: J.I. Bilbao; Pamplona/ESC.W. Sperryn; Cape Town/ZA

• ‘Big Five’ video• Introduction [A-256]

C.W. Sperryn; Cape Town/ZA• HIV-related cerebrovascular disease:

the South African experience [A-257]V. Mngomezulu; Johannesburg/ZA

• Interlude: Radiology training in South AfricaZ. Lockhat; Pretoria/ZA

• New concepts in the pathogenesis of cerebral TB [A-258]P. Janse van Rensburg; Stellenbosch/ZA

• Interlude: South Africa: the country, its people, its diversity and its attractions [A-259]Z. Lockhat; Pretoria/ZA

• Spinal tuberculosis in children [A-260]T. Kilborn; Cape Town/ZA

• Chronic chest radiographic changes in a cohort of HIV-infected South African children [A-261]R. Pitcher; Cape Town/ZA

• Panel discussion: HIV and TB: What impact do they have on health care workers?

52

GeneralInformation

Sunday, March 10, 10:30–12:00, Room BESR meets Chile EM 4: Topics of ongoing radiological research

from the Andes


Presiding: J.I. Bilbao; Pamplona/ESM.A. Pinochet; Santiago/CL

• Introduction: Radiology in Chile: reality and challenges [A-403]P. Soffia; Santiago/CL M.A. Pinochet; Santiago/CL

• TI-RADS: a US classification of thyroid nodules related to cancer risk [A-404]E. Horvath; Santiago/CL

• Interlude: Chile, land of geographical and cultural contrasts [A-405]G. Soto Giordani; Santiago/CL

• Neuroimaging in epilepsy: in search of invisible lesions [A-406]M. Galvez; Santiago/CL

• Interlude: Chile, land of wine and poets [A-407]G. Soto Giordani; Santiago/CL

• MDCT patterns in mesenteric ischaemia: usefulness in predicting clinical outcome [A-408]A. Huete; Santiago/CL

• Panel discussion: Creating networks between Latin American and European radiology: a unique opportunity for collaborative research projects

ESR/EFRS Meets Sessions

Saturday, March 9, 14:00–15:30, Room BEFRS meets Spain (European Federation of Radiographer Societies) EM 5: Knowledge development as a tool for

radiographers’ professional improvement

Presiding: G. Paulo; Coimbra/PTC. Ruiz Blanco; Madrid/ES

• Introduction [A-284]G. Paulo; Coimbra/PTC. Ruiz Blanco; Madrid/ES

• The Spanish radiographer’s role in advanced MRI research [A-285]E. Alfayate Sáez; Madrid/ES

• The radiographer’s specialisation in ultrasound: two decades of experience in a public hospital [A-286]M.P. Peña Fernández; Madrid/ES

• Interlude: Radiology and Spanish art [A-287]C. Ruiz Blanco; Madrid/ES

• The radiographer as the interface between patient and technology in promoting safety in radiation protection [A-288]J.A. Sória Jerez; Madrid/ES

• Educational status of radiographers in Spain: comparison with the EU [A-289]M.R. Soto García; Barcelona/ES

• Panel discussion:Could a transnational and multi-professional combined statement contribute to professional development?

53

myESR

When you‘ve checked in to ECR 2013 on . catch up with the latest #ECR2013 news on .

become a fan and post us a photo on . and then check out our videos on .

’ECR 2013' on 4sq - twitter.com/myESR - facebook.com/myESR - youtube.com/myESR

Plenary Sessions PlenarySessionsThursday, March 7, 17:45–19:15, Room A

Opening CeremonyMusical entertainment by Janoska Ensemble & Friends

Welcome Addresses Gabriel P. Krestin; Rotterdam/NL

ESRPresidentJosé Ignacio Bilbao; Pamplona/ES

ECR2013CongressPresident

Presentation of ESR Honorary MembershipPresentation of ESR Honorary Membership toGeorge S. Bisset III; Houston, TX/US

Tarek A. El-Diasty; Mansoura/ETGary M. Glazer; Stanford, CA/US†

Opening LecturePromises and facts of liver-directed gene therapy

Jesus Prieto; Pamplona/ES

Friday, March 8, 12:15–13:15, Room A

Presentation of the ESR Gold Medal AwardPresentation of the ESR Gold Medal Award to

José Cáceres; Barcelona/ESJohannes Lammer; Vienna/AT

Maximilian F. Reiser; Munich/DE

Josef Lissner Honorary LectureMR-guided focused ultrasound: a new string to the radiologist’s bow

Carlo Catalano; Rome/IT

Saturday, March 9, 12:15–12:45, Room A

Wilhelm Conrad Röntgen Honorary LectureInterventional oncology: the era of molecular targeted therapy

Jean-François Geschwind; Baltimore, MD/US

Saturday, March 9, 14:00–15:30, Room A

Image Interpretation QuizRadiology is global

Moderator: Dierk Vorwerk; Ingolstadt/DE

Sunday, March 10, 12:15–12:45, Room A

Santiago Ramón y Cajal Honorary LectureResearch and science: from individuals to societies – the Ramón y Cajal background

Luis Martí-Bonmatí; Valencia/ES

Sunday, March 10, 13:00–14:00, Room A

Junior Image Interpretation QuizGolden Eye

Moderator: Anna Alguersuari; Sabadell/ESCo-Moderator: Ernest Belmonte; Barcelona/ES

55

GeneralInformation


myESR Facebook Page | facebook.com/myESRFull congress coverage, daily photo uploads, daily news, competitions and much more. If you have photos or tips for the myESR community, post them on our wall!

ECR 2013 Facebook EventSince you’re attending ECR 2013, it’s time to update your Facebook Timeline and RSVP to the official Facebook event.

myESR Twitter | twitter.com/myESR Get the latest and hottest news live from the congress. Follow @myESR and tweet at us to let us know you’re here.

Tweeting about ECR? Using Google+? Taking pictures with Instagram? Here are the official hashtags: General: #ECR2013 | ESR Rising Stars: #ESRRisingStars

Tweeting about a particular session or room? Add the room name to the hashtag: #ECR2013A, #ECR2013B, #ECR2013Studio, etc. You can also add a simplified presentation or session number: e.g.: A-123 ‣ #A123 or SF 4 ‣ #SF4

Other useful hashtags: ECR 2013 Party: #ECRParty

Check in at ECR 2013: Facebook Places & FoursquareLook out for the official venues and check in!

Communication at ECR 2013Bring all your ECR 2013 social media activity together in one place by using our ECR Social Media Wall. The wall will collect posts and tweets in one convenient stream, which will be visible to participants throughout the congress venue. But you can also access it from anywhere, whether you’re at the congress venue, in your hotel, at home, using your laptop or smartphone, or at our internet terminals.

ECR LiveYour colleagues can also join you at the ECR, online and live via our video and social media stream. Sessions will be streamed for free: just visit the myESR.org homepage and look out for ECR Live.And don’t forget to subscribe to our YouTube channel: www.youtube.com/myESR

Want more? Add our other pages to your stream:ESR Rising Stars: facebook.com/ESRRisingStarsInsights into Imaging: facebook.com/insights.into.imagingEuropean Radiology: facebook.com/EurRadiolEuropean Diploma in Radiology: facebook.com/EuropeanDiplomainRadiologyESOR: facebook.com/EuropeanSchoolofRadiology

Social Media GuidemyESR, @myESR & #ECR2013

The whole ECR in your hand: ECR 2013 AppBrowse through the programme, schedule your favourite sessions and download your personal book of abstracts. No need to carry all those congress booklets with you ...


myESR Facebook Page | facebook.com/myESRFull congress coverage, daily photo uploads, daily news, competitions and much more. If you have photos or tips for the myESR community, post them on our wall!

ECR 2013 Facebook EventSince you’re attending ECR 2013, it’s time to update your Facebook Timeline and RSVP to the official Facebook event.

myESR Twitter | twitter.com/myESR Get the latest and hottest news live from the congress. Follow @myESR and tweet at us to let us know you’re here.

Tweeting about ECR? Using Google+? Taking pictures with Instagram? Here are the official hashtags: General: #ECR2013 | ESR Rising Stars: #ESRRisingStars

Tweeting about a particular session or room? Add the room name to the hashtag: #ECR2013A, #ECR2013B, #ECR2013Studio, etc. You can also add a simplified presentation or session number: e.g.: A-123 ‣ #A123 or SF 4 ‣ #SF4

Other useful hashtags: ECR 2013 Party: #ECRParty

Check in at ECR 2013: Facebook Places & FoursquareLook out for the official venues and check in!

Communication at ECR 2013Bring all your ECR 2013 social media activity together in one place by using our ECR Social Media Wall. The wall will collect posts and tweets in one convenient stream, which will be visible to participants throughout the congress venue. But you can also access it from anywhere, whether you’re at the congress venue, in your hotel, at home, using your laptop or smartphone, or at our internet terminals.

ECR LiveYour colleagues can also join you at the ECR, online and live via our video and social media stream. Sessions will be streamed for free: just visit the myESR.org homepage and look out for ECR Live.And don’t forget to subscribe to our YouTube channel: www.youtube.com/myESR

Want more? Add our other pages to your stream:ESR Rising Stars: facebook.com/ESRRisingStarsInsights into Imaging: facebook.com/insights.into.imagingEuropean Radiology: facebook.com/EurRadiolEuropean Diploma in Radiology: facebook.com/EuropeanDiplomainRadiologyESOR: facebook.com/EuropeanSchoolofRadiology

Social Media GuidemyESR, @myESR & #ECR2013

The whole ECR in your hand: ECR 2013 AppBrowse through the programme, schedule your favourite sessions and download your personal book of abstracts. No need to carry all those congress booklets with you ...

Visiting SchoolsVisiting Seminars

Visiting Scholarship ProgrammesExchange Programmes for FellowshipsTeach-the-Teachers Programme

Visiting Professorship Programme

Activ

ities

201

3

GeneralInformation

(Junior) Image Interpretation Quizzes

The Image Interpretation sessions, two traditional highlights of every ECR, provide both education and entertainment. Two panels of distinguished radiologists will share their knowledge and diagnosis strategies with you.The slogan for this year’s ‘senior’ quiz is ‘Radiology is global’. Radiologists will challenge each other in an enjoyable and ex-citing competition where they will face some tricky cases. The session will be presented interactively and e-voting units will be provided to the audience.In the ‘junior’ quiz, with its theme ‘Golden Eye’, the panellists will compete with each other in teams. While solving a variety of cases, the moderator will guarantee a scientifically challeng-ing and entertaining session.

Saturday, March 9, 14:00–15:30, Room A Image Interpretation Quiz: Radiology is global

Moderator: D. Vorwerk; Ingolstadt/DE

Referee: A. Agrawal; Delhi/IN

Panellists:Team 1:A.R. Gillams; London/UKT. Leiner; Utrecht/NLA. Oikonomou; Alexandroupolis/GRC.W. Sperryn; Cape Town/ZA

Team 2:F.M. Danza; Rome/ITH.B. Eggesbø; Oslo/NOP. Rogalla; Toronto, ON/CAM. Studniarek; Gdansk/PL

Sunday, March 10, 13:00–14:00, Room A Junior Image Interpretation Quiz: Golden Eye

Moderator: A. Alguersuari; Sabadell/ESCo-Moderator: E. Belmonte; Barcelona/ES

Panellists:G. Gherarducci; Pisa/ITC. Sayer; Brighton/UKC.M. Sommer; Heidelberg/DEL. Tzarouchi; Ioannina/GRA. Vanrossomme; Brussels/BE

= Interactive session with electronic voting/self assessment

Visiting SchoolsVisiting Seminars

Visiting Scholarship ProgrammesExchange Programmes for FellowshipsTeach-the-Teachers Programme

Visiting Professorship Programme

Activ

ities

201

3

59

EIBIR SUMMER SCHOOL on Neurology Imaging

GOALThe EIBIR Summer School on Neurology Imaging is a multidisciplinary summer school, uniting 50 young researchers coming from a variety of backgrounds. The high scientific level and the relaxed atmosphere invite a close and fruitful interaction between everybody present, both participants and staff.

TOPICSImaging modalities (MR, PET, CT), quantitative image analysis, (open-source) tools for image analysis, neuro- and population imaging and image analysis in clinical practice, validation and open-source databases, atlases, applications in the clinic, small animals and clinical trials.

FACULTYDirk Loeckx

Wiro Niessen

Sébastien Ourselin

Daniel Rueckert

Xavier Golay

Roger Gunn (tbc)

Nick Fox (tbc)

Aad Van der Lugt (tbc)

Julia Schnabel

Alex Hammers

August 26–30, 2013, Dubrovnik/HR

Registration and more info on www.eibir.org/school

Due to the great success in 2011, we proudly present the third edition of the EIBIR Summer School.

Management in Radiology

MIR@ECR

Session 1: Innovation management and the future of radiology and radiologists

Chairmen: Yves Menu; Paris/FR Peter Mildenberger; Mainz/DE

13:00 Welcome by the chairs

13:10 Imaging innovation and the future practice of radiology Bruce Hillman; Charlottesville, VA/US

13:40 Resident training: preparing young radiologists for the future Birgit Ertl-Wagner; Munich/DE

13:45 Research, EIBIR, HTA Luis Donoso; Barcelona/ES

13:50 Health technology assessment: can we show that radiology is value for money? Jane Adam; London/UK

13:55 Leadership and personal development Yves Menu; Paris/FR

14:00 New imaging methods Moshe Graif; Tel Aviv/IL

14:05 Radiology 2020: residents’ and fellows’ perspectives Myriam Edjlali-Goujon; Tours/FR

14:10 Debate on innovation management and requirements of radiology

14:45 –15:15 Coffee Break

Saturday, March 9, 13:00–17:30, Room QAfter its great success at ECR 2012, MIR (Management in Radiology), a subcommittee of the ESR Professional Organisation Committee, will again coordinate a session on core managerial issues as well as supportive methods and techniques.

Session 2: Radiology in modern times: challenges by telemedicine, eHealth, appropriateness and safety

Chairmen: Guy Frija; Paris/FR Jan Schillebeeckx; Bonheiden/BE

15:15 The radiologist's perspective: report on the development of an ESR White Paper for Teleradiology Eric Ranschaert; s’Hertogenbosch/NL

15:35 The requirements of citizens and the role of patients using telemedicine Karim Berkouk; Brussels/BE

15:55 Imaging referral guidelines in Europe: impetus, innovations and initiatives Denis Remedios; Harrow/UK

16:15 Factors affecting safety of patients: workload, reporting speed, etc. Richard FitzGerald; Wolverhampton/UK

16:35 Evidence Based Radiology: The math of decision in radiology Utku Senol; Antalya/TR

16:55 Discussion

17:15 Closing remarks

61

GeneralInformation

EPOS™ – Scientific Exhibition

EPOS DiscussionsTo enhance interaction, discussions on hot topics in radiology have been arranged, where authors of the selected and best-scored posters in each field will discuss them with a moderator.All discussions take place in the EPOS™ Area in Foyer A (2nd level) and ECR delegates are welcome to join, listen, and discuss with the experts. The discussion rounds will be:

Friday, March 8, 10:00–10:30Imaging of the scrotum: why considering MR?

Moderator: Lorenzo E. Derchi; Genoa/IT

Friday, March 8, 12:30–13:00Paediatric neuroimaging

Moderator: Andrea Rossi; Genoa/IT

Friday, March 8, 15:30–16:00Plaque imaging and myocardial characterisation

Moderator: Valentin Sinitsyn; Moscow/RU

Saturday, March 9, 10:00–10:30CT and MRI diagnosis of focal liver masses: when to use what?

Moderator: Pablo Ros; Cleveland, OH/US

Saturday, March 9, 15:30–16:00Paediatric chest and heart: state of the art imaging of the young patient

Moderator: Rick R. van Rijn; Amsterdam/NL

Sunday, March 10, 12:30–13:00Vascular imaging: CT, MR – or something completely different? Challenges in imaging peripheral artery occlusive disease

Moderator: Christian Loewe; Vienna/AT

Attendance (CME) and EvaluationAttendance of the scientific exhibition is recorded online in EPOS™:1. Enter EPOS™ and view the posters of your interest. When

logging out, you will be asked to complete the evaluation form.2. Fill in this form and press the ‘Submit’ button.The evaluation of the electronic scientific exhibition is very important for future planning and your opinion and comments will be highly appreciated.For those who login and submit completed evaluation forms, a maximum of 3 hours attendance at the scientific exhibition will be listed in the record of attendance (CME confirmation).

EPOS™ at ECR 2013 is kindly supported by Hewlett-Packard.

Opening HoursThursday, March 7 to Monday, March 11: 08:00–18:00

The staff of the EPOS™ Service Desk will be glad to assist you during these times.

LocationFoyer A, 2nd level

Note: On Saturday, March 9, 12:15–13:15, EPOS™ will be closed for a self assessment test for the participants of the foundation course on neuroimaging.Thank you for your understanding!

WiFi in the EPOS™ LoungeECR delegates can access all posters of ECR 2013 at the computer terminals in the EPOS classroom. In addition, a dedicated wireless internet network is available in the EPOS™ Lounge (name ‘EPOS WiFi’), through which the poster exhibition can be accessed as if from within the classroom. Connect your mobile device to the network and open your internet browser, which will direct you to EPOS™. (Please note that this dedicated network only allows access to EPOS™).

What’s in EPOS™ at ECR 2013?• Over 2,600 new scientific and educational exhibits and scien-

tific paper presentations• 20 new Cases-of-the-Day (five new cases each day)• 4 Self-Assessment modules on ECR 2013 courses:

– Categorical Course ‘CLICK (Clinical Lessons for Imaging Core Knowledge): Never without Arteries’

– Categorical Course ‘Urogenital Imaging’ – Mini Course ‘Organs from A to Z: Heart’ – Foundation Course ‘Neuroimaging’

• EURORAD – Europe’s largest radiological case database

Scientific Exhibition AwardsA jury of European radiologists has judged all scientific and educational exhibits with regard to their scientific content, educa-tional value, originality and visual impression. Taking advantage of EPOS™, the rating was carried out online, prior to the congress, enabling a detailed and considered assessment. On this basis, the Scientific Exhibition Committee has awarded the best posters with Magna Cum Laude, Cum Laude and Certificate of Merits.Awardees can pick up their certificates at the EPOS™ Service Desk. Each of the Magna Cum Laude awardees will also be granted free ECR 2014 registration.All awarded posters are flagged in EPOS™ and will be published on the ESR website and on myESR.org/epos

62

GeneralInformation

EPOS™ – Scientific Exhibition

ESR thanks all reviewersWe cordially thank the members of the Scientific Exhibition Committee and the EPOS Reviewers who reviewed abstracts and graded electronic posters in the past months, establishing the basis for present-ing the awards.(in alphabetical order)

E. Ada; Izmir/TRH.C. Addley; Cambridge/UKH. Ahmadzadehfar; Bonn/DEA. Alberich-Bayarri; Valencia/ESH. Alkadhi; Zurich/CHG.C. Anselmetti; Candiolo/ITI. Arkhipova; Moscow/RU

N. Bargalló Alabart; Barcelona/ESI. Bargellini; Pisa/ITA. Barile; L’Aquila/ITT.V. Bartolotta; Palermo/ITG. Bastarrika; Pamplona/EST. Baumann; Freiburg/DEA.J. Beer; Munich/DEM.-F. Bellin; Villejuif/FRK.S.S. Bhatia; Hampton/UKA. Blandino; Contemplazione, Messina/ITJ.G. Blickman; Rochester/USE. Blumfield; New York/USA. Bozzao; Rome/IT

F. Cademartiri; Monastier di Treviso/ITC. Calli; Izmir/TRF. Calliada; Pavia/ITR.S.D. Campbell; Liverpool/UKD. Caramella; Pisa/ITN.M. Caserta; Campinas/BRW. Chamroonrat; Philadelphia/UST.M. Cunha; Lisbon/PT

J. Damilakis; Iraklion/GRA.I.B. De Backer; Ghent/BEA. de Roos; Leiden/NLS. Delorme; Heidelberg/DEV. Dialani; Boston/US

O. Ekberg; Malmö/SEB.B. Ertl-Wagner; Munich/DE

Y. Fargeaudou; Clichy/FRE.F.C. Fleury; Sao Paulo/BRR. Forstner; Salzburg/ATA. Fotiadou; Huntingdon/UKF. Frauscher; Innsbruck/ATS. Freeman; Cambridge/UK

M.T.G. Gaskarth; Cambridge/UKJ.-T. Geitung; Bergen/NOA. Ghiatas; Ekali-Athens/GRS. Gourtsoyianni; London/UKA. Guermazi; Boston/US

B. Hansson; Stockholm/SEC. Herzog; Munich/DEJ. Heverhagen; Marburg/DEJ. Hodel; Paris/FR

A. Jackson; Manchester/UKT. Jakobs; Munich/DEJ.A. Jakobsen; Oslo/NO

C. Kahn; Milwaukee/USN. Kalyvas; Athens/GRA. Kassarjian; Majadahonda (Madrid)/ESF. Knollmann; Pittsburgh/USE. Kotter; Freiburg/DEK.-F. Kreitner; Mainz/DEM. Krokidis; Cambridge/UK

A. Laghi; Latina/ITJ. Laissy; Paris/FRM. Lemmerling; Beervelde/BED. Litmanovich; Boston/USE. Llopis; Alzira/ESR. Llorens; Valencia/ESI.G. Lupescu; Bucharest/RO

M.G. Mack; Baierbrunn/DEA. Mahnken; Marburg/DEL. Mannelli; Seattle/USR. Manns; Telford/UKK. Marten-Engelke; Göttingen/DEC. Matos; Brussels/BEJ. McHugo; Birmingham/UKE. Mershina; Moscow/RUP. Mildenberger; Mainz/DEM. Minami; Ibaraki/JPG. Morana; Treviso/ITP.L. Moyle; Cambridge/UKV.F. Muglia; Ribeirao Preto/BR

K. Nikolaou; Munich/DEM. Notohamiprodjo; Munich/DES. Nougaret; St. Clement de Riviere/FR

A. Offiah; Sheffield/UKA. Oikonomou; Alexandroupolis/GRY. Oishi Tanaka; Tsukuba/JPM. Onu; Bucharest/RO

L. Pallwein-Prettner; Linz/ATV. Panebianco; Rome/IT

G. Pärtan; Vienna/ATA. Paterson; Belfast/IEL.J. Pina Insausti; Pamplona/ESK. Pinker-Domenig; Vienna/ATT.J. Popiela; Krakow/PLP.K. Prassopoulos; Alexandroupolis/GRL. Preda; Milan/ITS. Puig; Vienna/AT

E. Quaia; Trieste/IT

D. Regge; Candiolo-Torino/ITA. Righini; Milan/ITP. Rinaldi; Rome/ITS. Robinson; Vienna/ATJ. Romero; Boston/USA. Rovira-Canellas; Barcelona/ESR. Rzanny; Jena/DE

R. Sanz-Requena; Valencia/ESG. Savino; Rome/ITM. Scharitzer; Vienna/ATK. Schürmann; Aachen/DET.C. See; Cambridge/UKM.J. Shelly; Dublin/IEP. Sijens; Groningen/NLG.N. Simao; Ribeirao Preto/BRW.H. Sommer; Munich/DES. Steens; Nijmegen/NLW. Stiller; Heidelberg/DEM. Sumi; Nagasaki/JP

D. Tack; Braine-L’Alleud/BEA. Taibbi; Palermo/ITS.A. Taylor; London/UKG. Thornbury; Belfast/UKM. Toepker; Vienna/ATM. Torkzad; Sollentuna/SED. Tsetis; Iraklion/GRA. Tsili; Ioannina/GR

S. Ulmer; Kiel/DE

E.J.R. van Beek; Edinburgh/UKW.J.M. van der Putten; Galway/IEM.I. Vargas; Geneva/CHB. Verbist; Leiden/NLJ.A. Verschakelen; Leuven/BE

M.G. Wallis; Cambridge/UKA. Wibmer; Vienna/ATD. Wormanns; Berlin/DEK. Wörtler; Munich/DEX. Wortsman; Santiago/CLP. Wunderlich; Radebeul/DE

63

T R A D E M A R K O F

Visit the EPOSTM Area on the second level.

Browse through thousands of electronic posters from

ECR 2003–2013 and other congresses.www.myESR.org/epos

GeneralInformation

eLearning Tools

EPOS™ – Electronic Presentation Online System

Let’s celebrate the 10th anniversary of EPOSTM!

In 2003, ECR introduced an all-electronic scientific exhibi-tion using EPOS™, the Electronic Presentation Online System, thus setting new standards in the medical meeting industry.

EPOS™ contains over 16,000 electronic exhibits from ECR 2003–2013 and from other congresses: Online at www.myESR.org/epos or in the EPOS™ Area on the 2nd level.

EPOS™ at ECR 2013 is kindly supported by Hewlett-Packard.

www.myESR.org/epos

EURORAD – Radiological Case Database

The largest peer-reviewed teaching database of radiology on the internet offers free access to a wealth of medical informa-tion and imaging data, whose accuracy and quality have been validated by some of the most experienced radiologists in Europe. Submitting to and publishing in EURORAD is an exclusive benefit of ESR membership.

EURORAD contains case reports for medical students (simple cases), residents in radiology (everyday cases) and senior radi-ologists (complex cases) in all radiological specialties.

For easy retrieval of required cases, the website offers a power-ful search engine as well as multi-lingual navigation (English / Spanish / French). EURORAD allows you to download, save, and print the cases as PDF documents, or e-mail them via the web-based e-mail client. All EURORAD cases are registered with a unique DOI (Digital Object Identifier), which makes all cases citable.

www.eurorad.org

65

GeneralInformation

ECR 2013 SPECIAL EXHIBITION

H. and B. VogelInstitut für Rechtsmedizin

U. HennigDeutsches Röntgen-Museum

A notably popular feature at the European Congress of Radiology is the special exhibition, initiated and compiled by Prof. Hermann Vogel from Hamburg, Germany, in cooperation with the Deutsches Röntgenmuseum, which has been part of the annual meeting for years. This year’s exhibit is entitled: X-Rays: Evidence and Threat.

This year’s exhibition covers a wide variety of instances where imaging has been used, from the outlandish to the downright gruesome. It includes images of injuries sustained from terrorist attacks, accidents and torture. It also demonstrates how imaging has been used to detect drugs and explosives hidden inside the human body, as well as some other more benign cosmetic implants.

This exhibition provides a unique insight into the physical aftermath of many tragic incidents while also delving into some non-medical imaging applications. It promises to be an eye-opening experience for all.

Prof. Hermann Vogel is head physician at the Albers-Schönberg-Institute, the department of radiology at St. Georg Hospital in Hamburg. The new exhibition, which will be shown for the first time at ECR 2013, again features more than 20 posters with partly provocative images.

The exhibition is presented on the 2nd level of the congress venue next to the EPOS Area.

X-RAyS: EvidEncE And ThREAT

66

GeneralInformation

Cafés & Restaurants at ECR 2013Want to take a short break? Looking for the right place to eat? – The best spots to relax and enjoy tasty hot and cold snacks are our various foyer cafés and restaurants. They are situated throughout the whole congress venue and across all levels of the building.To offer you the broadest variety of Austrian and international delicacies, each café and restaurant has its own theme, from Austrian specialties and Italian treats to Mediterranean pleasures and Asian delights.

Lower level, Expo Foyer DItalian Snack Lounge

Lower level, Foyer G/H (next to Room G/H)Mediterranean Corner

Lower level, Foyer I/K (next to Room I/K)Asian Delights – authentic Asian cuisine

Entrance level (next to the main entrance)Café Accademia: Accademia del Caffè

1st level, within EDIPS – Preview CentreVital Lounge

2nd level, Foyer A (in the EPOS Area)Viennese Snacks & Pastries

2nd level, Foyer B (in the Rising Stars Lounge)Snack Lounge

2nd level, Foyer C (next to Room C)Italian Restaurant

Expo CCafé Vienna: Austrian Specialties

Expo EBar XXL

Expo Extension ASnack Café

Broaden your horizons with Free Publications at ECR 2013

The Free Publications initiative will run for the seventh consecu-tive year after attracting increasing levels of attention at ECR 2012. The Free Publications booth will be located on the second level of the ACV next to the EPOS Area. The booth will be richly stocked with a galaxy of fascinating reading material from many of our associated organisations and publishing houses from around the world, such as Globetech, Diagnostic Imaging, MindByte and European Hospital.In addition to a broad library of print media, internet terminals will also be installed nearby, providing access to a wide variety of online publications.About 20 publishers will provide more than 30 different titles for this initiative, ranging from copies of the ESR’s flagship journals European Radiology and Insights into Imaging, to issues from as far afield as Lebanon, many of which will also be available online. Interested delegates can peruse La Radiologia Medica, pick up a copy of International Hospital and browse the online Imaging Management, among others. It is a rare chance to learn from so many diverse medical imaging communities from around the globe, and in this case it is something you can take away with you, with free bags provided to help you make the very best of the opportunity. We are of course enormously grateful for the enthusiasm of our friends in the publishing industry for making the Free Publica-tions initiative possible, and allowing us to provide ECR partici-pants with the chance to pick up some literature and broaden their medical imaging horizons.

Free Publications Booth: 2nd level, next to the EPOS Area.

Free Publications at ECR 2013

67

EnjoyVienna‘sculturalhighlightsVisit the Arts & Culture Desk in the entrance hall

Friedensreich Hundertwasser, The Large Path, 1955© 2012 Namida AG, Glarus, Switzerland

Andlearnallaboutthemostrecentdevelopmentsinhealthcaretechnology.

Opening hours:

EXPO Halls and EXPO Foyer DFriday,March8toSunday,March10: 10:00–18:00Monday,March11: 10:00–14:00

First Level (Gallery)Thursday,March7: 14:00–18:00Friday,March8toMonday,March11: 10:00–18:00

Visit the Technical Exhibition!

GeneralInformation

ECR 2013 welcomes its industry partners

The ESR welcomes its Supporting Members The ESR gives a warm welcome to all its existing and newly joined supporting membership companies!As the ECR puts a special focus on innovation and keeping up to date with recent developments in the field, a close cooperation with the industry leaders is indispensable.The companies contribute with their active involvement to the success of the society and its congress with their continuous support for the cause of radiology in Europe.

ESR Supporting Members:4-star: Agfa HealthCare Bayer HealthCare Bracco Imaging Canon Europe Carestream Health Covidien – Mallinckrodt Esaote Fujifilm Europe GE Healthcare Guerbet Hitachi Medical Systems Europe Hologic Philips Healthcare Samsung Medison Siemens Healthcare Sector3-Star: Shenzhen Mindray Bio-Medical Electronics TeraRecon2-Star: Cerner Corporation Novarad Corporation Paramed Medical Systems Shimadzu Europa Swissray Medical

Thank you for your involvement!

‘ESR meets’ countriesEach year the ECR places a special focus on its ‘ESR meets’ coun-tries – in 2013 namely Spain, South Africa and Chile – with particular emphasis on their scientific and technological develop-ments. The ESR, industry companies and the national societies work closely together to highlight these countries.Additionally, we are proud to present you the ‘ESR meets’ partner discipline; E-AHPBA (European-African Hepato-Pancreato-Biliary Association).

71

4starlevel

3starlevel

2starlevel

Pantone 158C R-245 G-128 B-37

Colors

CMYK Green 65C /100Y Blue 100C /10M /10K Gray 70K Black 100K

Pantone Green 368 Blue Process Blue Gray Cool Gray 11 Black Black

Professional printing BHC_Logo_4c_100801.epsBHC_Logo_Pant_100801.epsBHC_Logo_Blk_100801.epsBHC_Logo_Wht_100801.eps

ScreenBHC_Logo_RGB_100801.pngBHC_Logo_Wht_100801.pngBHC_Logo_Blk_100801.pngBHC_Logo_RGB_100801.emfBHC_Logo_Wht_100801.emfBHC_Logo_Blk_100801.emf

Professional printing BHC_Logo_Cent_4c_100801.epsBHC_Logo_Cent_Pant_100801.epsBHC_Logo_Cent_Blk_100801.epsBHC_Logo_Cent_Wht_100801.eps

ScreenBHC_Logo_Cent_RGB_100801.pngBHC_Logo_Cent_Wht_100801.pngBHC_Logo_Cent_Blk_100801.pngBHC_Logo_Cent_RGB_100801.emfBHC_Logo_Cent_Wht_100801.emfBHC_Logo_Cent_Blk_100801.emf

Professional printing BHC_Logotype_4c_100801.epsBHC_Logotype_Pant_100801.epsBHC_Logotype_Blk_100801.epsBHC_Logotype_Wht_100801.eps

ScreenBHC_Logotype_RGB_100801.pngBHC_Logotype_Wht_100801.pngBHC_Logotype_Blk_100801.pngBHC_Logotype_RGB_100801.emfBHC_Logotype_Wht_100801.emfBHC_Logotype_Blk_100801.emf

File namesLogo and logotype overview Abbreviations

BHC Bayer HealthCareCent Centered

4c CMYK (Euroscale)Pant PantoneBlk Black (Lineart)Wht WhiteRGB Red Green Blue (screen)

.eps encapsulated postscript file

.emf enhanced meta file

.png portable network graphics

Please Note !The .emf files are only for use with PC Computers and Microsoft Office 2003 (Windows, PowerPoint)!

© Bayer AG, A

ugust 1

, 2010

Top radiologists read more than just images

GeneralInformation

ESR Journals

European RadiologyEuropean Radiology at your fingertips!Carry Europe’s leading radiology journal with you wherever you go – with the European Radiology App – download the app from iTunes or via the QR code below.

European Radiology is the official journal of the ESR and official organ of numerous subspecialty organisations. It acts as a flagship, publishing original scientific papers in the radiological field with an Impact Factor of 3.222 for 2011.Full access to the online version of European Radiology is included in the ESR membership fee. ESR members can also arrange sub-scriptions for the printed version at special rates in the MyUserA-rea (www.myESR.org/MyUserArea under ‘MyJournals’)!

Insights into ImagingThe clearest insights … for all to see!Insights into Imaging is the ESR journal for education and strate-gies in radiology. Besides excellent review articles, it publishes articles on professional issues, several official documents and political statements.Insights into Imaging is an Open Access journal on the Spring-erOpen platform – therefore all articles published are freely available. As benefit for ESR members, ESR covers the Article Processing Charges for all its active members!As a reminder of the valuable content and its importance to every radiologist’s daily practice, a special printed issue of Insights into Imaging has been placed in all Students and Residents congress bags!Free copies of this booklet are available from the journal’s booth in the entrance hall.

Links to the journalswww.european-radiology.orgwww.i3-journal.org

73

Insights into ImagingEducation and strategies in European radiology

The clearest insights… for all to see!Now Open Access – Read Insights into Imaging without subscription and without restrictions

www.i3-journal.org

Full articles at www.i3-journal.org/articles

GeneralInformation

Underground MapU-Bahn

© Wiener Linien, November 2012

ACV

ECR

STO

P:

Kai

serm

ühle

n /

Vien

na In

t. C

entr

e

Unde

rgro

und

Line

(U-B

ahn)

Com

mut

er T

rain

(S-B

ahn)

City

Airp

ort T

rain

Urba

n Tr

ain

(Lok

alba

hn)

Vien

na In

tern

atio

nal B

uste

rmin

al

Cust

omer

Ser

vice

Cen

tre

(U3

Erdb

erg)

Info

poin

ts

Tick

et S

ales

Park

& R

ide

75

More about theatres in Vienna:www.myESR.org/arts_culture

Johannes Krisch in Der Alpenkönig und der Menschenfeind by Ferdinand Raimund© Reinhard Werner / Burgtheater

Floor Plans

78 U2–LowerLevel79 U2–LowerLevelEXPO80 OE–EntranceLevel81 OE–EntranceLevelEXPO82 O1–FirstLevel83 O2–SecondLevel84 O3–ThirdLevel

Floor Plans

U2 – Lower Level

1. Meditation & Prayer Room

2. Broadcast Room G/H

3. Meeting Room 16

4. Meeting Room 15

5. Broadcast Room I/K

6. Future Meetings

U2 - LOWER LEVEL

Meditation & Prayer Room

Future Meetings

SMOK

ING

AREA

Meeting Room 15

15

16

Broadcast Room I/K

Meeting Room 16

COAT CHECK

COAT CHECK 3 COAT CHECK 4

Broadcast Room G/H

EXPO C

EXPO E

EXPO B

TO EXPOB/C/E

EXPO FOYER D

Room

D1

Room

D2

TO EXPO E

REST

AURA

NTRESTAURANT

Room

G/HRoom

I/K

1

2

3

4

5

6

78

Floor Plans

U2 – Lower Level EXPO

1. Meeting Room 16

2. Future Meetings

U2 - LOWER LEVEL

Meditation & Prayer Room

Future Meetings

SMOK

ING

AREA

Meeting Room 15

15

16

Broadcast Room I/K

Meeting Room 16

COAT CHECK

COAT CHECK 3 COAT CHECK 4

Broadcast Room G/H

EXPO C

EXPO E

EXPO B

TO EXPOB/C/E

EXPO FOYER D

Room

D1

Room

D2

TO EXPO E

REST

AURA

NT

RESTAURANT

Room

G/HRoom

I/K

1

2

79

Floor Plans

OE – Entrance Level

Society Booths Socie

ty B

ooth

s

OE - ENTRANCE LEVEL

Photo CompetitionCOAT

CHEC

K 1

ESR MEETS

TO / FROM UNDERGROUND

= CASH DISPENSER / ATM

ESRWELCOMELOUNGE

MAIN ENTRANCE

EXTENSION EXPO AEXPO A

Room

E2Room

F1

Room

E1Room

F2

CONGRESSOFFICE

COAT

CHECK 2

ECRInfo

ACVInfo

AustrianAirlines

SIEMENS

Industry Hands-On Experience Lounge

Workshop

BAGS

Expo Services

and Exhibitors’

Registration

PRESS OFFICE AND

BUSINESS CENTRE

PHILIPS

Mondial

Travel Service

Arts & Culture

Restaurant Reservations

Broadcast Zone F1/F2

BAGSSM

OKIN

GAR

EA

RECREATIONAREA

INTERNETTERMINALS

Broadcast Zone E1/E2

Water

Society BoothsPa

rtne

r Pub

lishe

rs

Part

ner P

ublis

hers

Soci

ety

Boot

hs

REGISTRATION REGISTRATION

Society

BoothsSocietyBooths

123

4

1. Mondial

2. Travel Service

3. Arts & Culture

4. Restaurant Reservations

5. Registration

6. Broadcast Zone F1/F2

7. Photo Competition

8. Broadcast Zone E1/E2

5 5

67

8

80

Floor Plans

OE – Entrance Level EXPO

Society Booths Socie

ty B

ooth

s

OE - ENTRANCE LEVEL

Photo CompetitionCOAT

CHEC

K 1

ESR MEETS

TO / FROM UNDERGROUND

= CASH DISPENSER / ATM

ESRWELCOMELOUNGE

MAIN ENTRANCE

EXTENSION EXPO AEXPO A

Room

E2Room

F1

Room

E1Room

F2

CONGRESSOFFICE

COAT

CHECK 2

ECRInfo

ACVInfo

AustrianAirlines

SIEMENS

Industry Hands-On Experience Lounge

Workshop

BAGS

Expo Services

and Exhibitors’

Registration

PRESS OFFICE AND

BUSINESS CENTRE

PHILIPS

Mondial

Travel Service

Arts & Culture

Restaurant Reservations

Broadcast Zone F1/F2

BAGS

SMOK

ING

AREA

RECREATIONAREA

INTERNETTERMINALS

Broadcast Zone E1/E2

Water

Society Booths

Part

ner P

ublis

hers

Part

ner P

ublis

hers

Soci

ety

Boot

hs

REGISTRATION REGISTRATION

Society

BoothsSocietyBooths

81

Floor Plans

O1 - FIRST LEVEL

HologicIndustry Hands-OnWorkshop Room

EXPO GALLERY

Room

N/O

Room

QRoom

X

Room

L/M

Room

P

Internet Terminals

Broadcast Zone N/O

PREVIEW CENTRE

EDIPS

Broadcast Zone L/M

Room

Y

Studio 2013

O1 – First Level

1. Broadcast Zone L/M

2. Hologic Industry Hands-On Workshop Room

3. Broadcast Zone N/O

4. Meeting Room 14

1

2

3

4

82

Floor Plans

O2 – Second Level

13

O2 - SECOND LEVEL

Risin

g Sta

rsLo

unge

Room

A

Room

CRoom

B

RESTAURANT

EDiR

Exa

min

atio

n Ar

eaRoom

ZRoom

U

EPOSTM

Free Publications

1011

12

Meeting Room 13

Broadcast Room B/C

Meeting Room 11

Meeting Room 12

EPOS Discussions Corner

Meeting Room 10

Special Exhibition

eHealth and Imaging Informatics

EIBIR IMAGINE Theatre

1

2

3

4

5

6

7 8

9

1. Meeting Room 13

2. Broadcast Room B/C

3. Meeting Room 12

4. Meeting Room 11

5. Meeting Room 10

6. Special Exhibition

7. EPOS Discussions Corner

8. eHealth and Imaging Informatics

9. EIBIR IMAGINE Theatre

83

Floor Plans

O3 – Third Level

1. Meeting Room 1

2. Meeting Room 2

3. Meeting Room 3

4. Meeting Room 4

5. Meeting Room 5

6. Meeting Room 6

7. Meeting Room 7

8. Meeting Room 8

9. Meeting Room 9

10. Info Service Desk

11. Past Presidents Circle

O3 - THIRD LEVEL

OFFICES 21–33OFFIC

ES 1

–17

Meeting Room 7

7 8

9

Meeting Room 8

Info Service Desk

PRESIDENTS’OFFICE

65

Meeting Room 6

Meeting Room 5

Meeting Room 1

2 Meeting Room 2

1

34

Meeting Room 3

Meeting Room 4

Meeting Room 9

Past Presidents Circle

12

34

56

7 8

9

84

Free ECR Student RegistrationStudentsandradiographers-in-trainingundertheageof30,

withoutanyacademicdegree,canregisterforfree.

Rising Stars LoungeWewantallstudentsandresidentstofeelathomeattheECR,whichiswhywehave

providedtheexclusiveRisingStarsLounge,locatedonthe2ndlevelinFoyerB.

Basic Sessions for Students, Residents and Radiographers-in-training

Student Sessions

Student Hands-On Workshops on Ultrasound

Seepages144–145formoredetailsFindmoreinformationonmyESR.org/RisingStarsand

becomeaRisingStaronFacebook:facebook.com/ESRRisingStars

Programme Overviews

88 Thursday, March 790 Friday, March 892 Saturday, March 994 Sunday, March 1096 Monday, March 11

88

Programme OverviewThursday, March 7

Room/ Time

A2nd Level

B2nd Level

C2nd Level

D1Lower Level

D2Lower Level

E1Entrance Level

E2Entrance Level

F1Entrance Level

F2Entrance Level

G/HLower Level

08:30

09:00

09:30

10:00

10:30SS 103Cardiac

CT and MRI in preoperative

and postopera-tive evaluation

(p. 214)

SS 111Neuro

From structure to function)

(p. 214)

SS 104Chest

Lung cancer: from tissue

characterisation to treatment

(p. 215)

SS 109Interventional

RadiologyChemoembo-lisation and

radioembolisation of liver tumours

(p. 215)

SS 110Musculoskeletal

Shoulder and hand

(p. 216)

SS 101aGI Tract

Acute bowel diseases:

challenges and solutions(p. 216)

SS 116Oncologic Imaging

Perfusion CT and MRI: ready

for clinical practice(p. 217)

SS 102Breast

Breast MRI: improving

accuracy and tissue charac-

terisation(p. 217)

SS 107Genitourinary

Prostate imaging(p. 218)

11:00

11:30

12:00

12:30SY 2

SuperSonic Imagine Satellite

Symposium(p. 149)13:00

13:30

14:00E³ 220

Interactive Teaching Session

Lung cancer(p. 156)

SS 208Head and

NeckHead and neck cancer: func-tional imaging

and hybrid modalities(p. 221)

SS 204Chest

Airways and infiltrative lung

diseases(p. 222)


RadiologyAblation and biopsy of the prostate and the kidney(p. 222)


Lower limb: tricks for impro-

ved imaging(p. 223)

SS 201aGI Tract

Bowel imaging: protocol opti-misation and intervention

(p. 223)


New biomarkers for tumour

quantification(p. 224)

SS 202Breast

Improvements in preoperative

staging of breast cancer

(p. 224)

SS 211Neuro

Infection and inflammation

(p. 225)14:30

15:00

15:30

16:00E³ 320

Interactive Teaching SessionMalignant pancreatic tumours(p. 156)

RC 301GI Tract

Staging and restaging of

rectal and anal cancer

(p. 156)

RC 303Cardiac

Cardiac imaging: the cutting

edge(p. 157)

RC 306Molecular ImagingMolecular imaging in oncology(p. 157)

MS 3Multidis-ciplinary Sessions: Managing

Patients with Cancer

Colorectal liver metastases

(p. 157)

PC 3Professional Challenges

SessionBringing radio-logy to medical undergraduates

(p. 157)

RC 302Breast

Functional imaging of the

breast(p. 158)

RC 307GenitourinaryRenal and adre-

nal tumours(p. 158)

16:30

17:00

17:30

17:45-19:15 Room A: Opening Ceremony / Presentation of Honorary Members / Opening Lecture [p. 160]

Registration: Wednesday, March 6: 12:00–18:00 / Thursday, March 7 to Monday, March 11: 07:00–18:00

89

Programme OverviewThursday, March 7

I/KLower Level

L/M1st Level

N/O1st Level

P1st Level

Q1st Level

X1st Level

Y1st Level

Z2nd Level

Studio 20131st Level

EPOS2nd Level

Room/ Time

08:30

09:00

09:30

10:00

SS 101bAbdominal

VisceraLiver fibrosis and cirrhosis: elastography

and biomarkers(p. 218)

SS 113Physics in Radiology

Multi modality imaging and MR

safety(p. 219)

SS 115Vascular

Carotid plaque evaluation(p. 219)

SS 117Emergency Radiology

An update on emergency

thoraco-abdo-minal imaging

(p. 220)

SS 114RadiographersImportance of education in

practice(p. 220)

SS 105Computer

ApplicationsIT infrastruc-ture, learning support and teleradiology

(p. 221)

SY 1Siemens

Healthcare Satellite

Symposium(p. 149)

10:30

11:00

11:30

SY 4Siemens


Symposium(p. 149)

12:00

SY 3Bayer Health-Care Satellite Symposium

(p. 149)

MC 24AThe Beauty

of Basic Knowledge:

Head and NeckA taste of the oral cavity and salivary

glands(p. 156)

MC 25AThe Beauty

of Basic Knowledge:

Musculoskeletal ImagingTrauma(p. 156)

12:30

13:00

13:30

SS 201bAbdominal

VisceraHepatocellular

carcinoma: diagnosis and management

(p. 225)


Innovations in CT technology and data pro-

cessing(p. 226)

SS 215Vascular

Major vessel imaging(p. 226)

SS 203CardiacPlanning

cardiac inter-ventions(p. 227)

SS 214Radiographers

Managing quality and dose in CT(p. 227)

SS 205Computer

ApplicationsQuantitative

image analysis and optimisa-

tion(p. 228)

SY 5Siemens


Symposium(p. 149)

14:00

14:30

15:00

15:30

RC 304Chest

How I report(p. 158)

MC 322Organs from A to Z: HeartTechnical and

anatomical fundamentals

for imaging the heart

(p. 159)

RC 309Interventional

RadiologyPercutaneous

treatment of chronic

back pain and sciatica(p. 159)

RC 315VascularVascular

imaging in ischaemic

stroke(p. 159)

RC 305Computer

ApplicationsNew PACS

architecture: decoup-

ling image management from image navigation(p. 159)

ESR Radiation Protection

SessionSecurity scan-

ners at airports: are they safe?

(p. 160)

16:00

16:30

17:00

17:30

EPOS™ – Scientific Exhibition: 08:00–18:00

Technical Exhibition: EXPO First Level (Gallery): 14:00–18:00

90

Programme OverviewFriday, March 8

Room/ Time

A2nd Level

B2nd Level

C2nd Level

D1Lower Level

D2Lower Level

E1Entrance Level

E2Entrance Level

F1Entrance Level

F2Entrance Level

G/HLower Level

08:30RC 401

Abdominal VisceraPitfalls in

interpretation of pancreatic

imaging(p. 161)

6th Post Processing

Face-Off Session(p. 139)

RC 416Oncologic Imaging

MR imaging for prostate cancer management: the essential

guide for radio-logists

(p. 161)

MC 423Controversies

in Breast Imaging

Overdiagnosis from screening mammography: should we care

about it?(p. 161)

RC 417Emergency Radiology

ER: basic prin-ciples

(p. 161)

SA 4State of the

Art SymposiumDiffusion-weigh-

ted imaging (DWI) of the

abdomen(p. 162)

E³ 420Foundation

Course: Neuroimaging

The orbit, the petrous bone and the sella

(p. 162)

MS 4Multidiscipli-

nary Sessions: Managing


Hepatocellular carcinoma(p. 162)

SF 4aSpecial Focus

Session„MRI of the lung:

to go?“(p. 163)

RC 411Neuro

The paediatric brain: not just a

small brain(p. 163)09:00

09:30

10:00

10:30E³ 520a


Pitfalls in abdo-minal imaging

(p. 165)

EM 1ESR meets

SpainImaging:

essential tool from diagnosis to

treatment(p. 165)

E³ 520bInteractive Teaching SessionPitfalls in

head and neck imaging(p. 166)

SS 504Chest

Lung nodules(p. 229)


RadiologyNeurovascular

and spine inter-ventions(p. 229)


Tendon, muscle and tissue

composition(p. 230)

E³ 520cFoundation


Paediatric(p. 166)


Cutting edge imaging in

oncology: when and how?(p. 230)

SS 502Breast

Elastography and other advances

in breast ultrasound

(p. 231)

SS 507GenitourinaryNew frontiers in

GU imaging(p. 231)

11:00

11:30

12:0012:15–12:45 Gold Medal

Awards(p. 55)

12:45–13:15 Honorary Lecture 1

(p. 167)

12:15–13:30 SY 6

Bayer Health-Care Satellite Symposium

(p. 149)12:30SY 7

Bracco Satellite

Symposium(p. 150)

13:00

13:30

14:00SS 607

GenitourinaryFemale pelvis

imaging(p. 234)

SS 611Neuro

Alzheimer‘s and Parkinson‘s

(p. 234)

SS 603aCardiac

CT and MRI: risk stratifi-

cation(p. 235)

MC 623Controversies

in Breast Imaging

Preoperative MRI in newly

diagnosed breast cancer: to do or

not to do?(p. 167)

SS 609aInterventional

RadiologyOncologic abla-tion and guided interventions

(p. 235)

SS 610aMusculoskeletalMusculoskeletal

tumours(p. 236)

E³ 620Foundation


Trauma and vascularity

(p. 167)

SS 601Abdominal

VisceraLiver steatosis:

imaging and quantification

(p. 236)

SS 602Breast

Breast imaging after neoadju-vant therapy and surgery

(p. 237)

SS 603bCardiac

Cardiomyopa-thy and fibrosis

(p. 237)14:30

15:00

15:30

16:00E³ 720a


Neurological emergencies

(p. 168)

EM 2ESR meets E-AHPBAPancreatic cystic neo-

plasms 2013(p. 168)

NH 7New Horizons

SessionCartilage imaging(p. 168)

MC 723Controversies

in Breast Imaging

Should we add ultrasound to

mammographic screening of

dense breasts?(p. 169)

CC 719Oncologic Imaging:

Follow-up of Systemic and Local TherapiesImaging after

systemic thera-pies: the standards

(p. 169)

RC 710MusculoskeletalPeripheral nerve

imaging: MRI and US(p. 169)

E³ 720bFoundation

Course: NeuroimagingInfection and inflammation

(p. 169)

SF 7aSpecial Focus

SessionRadiographers and ultraso-nography in

Europe(p. 170)

SF 7bSpecial Focus

SessionImaging and radiotherapy:

all you need to know

(p. 170)

RC 707GenitourinaryDiagnosis and management

of GU tract trauma(p. 170)

16:30

17:00

17:30

Registration: 07:00–18:00 EPOS™ – Scientific Exhibition: 08:00–18:00

91

Programme OverviewFriday, March 8

I/KLower Level

L/M1st Level

N/O1st Level

P1st Level

Q1st Level

X1st Level

Y1st Level

Z2nd Level


EPOS2nd Level

Room/ Time

MC 428Joint Course of ESR and RSNA (Radiological

Society of North America)Essentials in onco-logic imaging: what radiologists need to

know (part 1)(p. 163)

MC 422Organs from A

to Z: HeartNon-ischaemic heart disease

(p. 164)

EIBIR/EORTC Joint WorkshopA radiologist with a ruler in his hand

is a dangerous person: seeking standardisation in multicenter imaging trials

(p. 164)


SessionThe visibility of the radiologist

(p. 164)

SF 4bSpecial Focus

SessionJustifying CT in paediatric

radiology(p. 165)

SK 427Image-Guided

Tumour Ablation(p. 147)

Rising Stars Basic 1(p. 144)

08:30

09:00

09:30

Student Workshop 1

(p. 145)10:00




SS 511Neuro

Stroke-related arterial disease

(p. 232)

SS 515Vascular

Novel tools for blood flow

evaluation(p. 232)

SS 503Cardiac

Advances in coronary CT angiography

(p. 233)

SS 514Radiographers

The radiographer‘s role as health

care team member(p. 233)

SK 527Image-Guided



10:30

11:00

11:30

12:00

SY 8GE


Symposium(p. 150)

SY 9Siemens


Symposium(p. 150)

MC 25BThe Beauty of

Basic Knowledge: Musculoskeletal

ImagingDegenerative

disorders(p. 166)

MC 24BThe Beauty of

Basic Knowledge: Head and Neck

The infrahyoid neck and lymph nodes

(p. 167)

EPOS discussion

Paediatric neuroimaging(p. 62)

12:30

13:00

13:30




SS 608Head and NeckTechnical innova-tions, TMJ disease and rare entities

(p. 238)

SS 610bMusculoskeletalCartilage: advan-

ced imaging(p. 238)

SS 609bInterventional

RadiologyGynaecological and obstetric interventions

(p. 239)

ESOR SessionFostering future

researchers(p. 139)

Student Workshop 2

(p. 145)

SK 627Image-Guided


SS 606Molecular Imaging

MR/PET and PET/CT(p. 239)

Student Session 1

(p. 144)14:00

14:30

15:00

EPOS discussionPlaque imaging and myo-cardial characterisation

(p. 62)15:30




MC 722Organs from A

to Z: HeartIschaemic heart

disease(p. 171)


RadiologyExpanding the

role of interven-tional radiology

in hepatocellular carcinoma(p. 171)

RC 714Radiographers

Clinical audit: from EURATOM to the clinical environment

(p. 172)

SF 7cSpecial Focus

SessionImaging in

intensive care patients(p. 172)

SK 727Image-Guided


RC 715Vascular

Dialysis fistula(p. 173)

Student Session 2

(p. 144)16:00

16:30

17:00

17:30

Technical Exhibition: EXPO Halls and EXPO Foyer D:10:00–18:00


92

Programme OverviewSaturday, March 9

Room/ Time

A2nd Level

B2nd Level

C2nd Level

D1Lower Level

D2Lower Level

E1Entrance Level

E2Entrance Level

F1Entrance Level

F2Entrance Level

G/HLower Level

08:30E³ 820a


Pitfalls in heart imaging(p. 175)

SF 8aSpecial Focus

SessionIs diagnostic

catheter angiography still useful in

neuroimaging?(p. 175)

NH 8New Horizons

SessionMR/PET: a

marriage made in heaven or

hell?(p. 175)

CC 818CLICK (Clinical

Lessons for Imaging Core Knowledge):

Never without Arteries

How old are you in reality?

Vascular age and clinical events

(p. 175)


Follow-up of Systemic and Local TherapiesImaging after

systemic thera-pies: advanced

techniques(p. 176)

RC 817Emergency RadiologyPolytrauma:

redefining ima-ging issues for management

priorities(p. 176)

E³ 820bFoundation

Course: NeuroimagingMetabolic and neurodegene-rative disorders

(p. 176)

RC 802BreastClinical

challenges in breast MRI

(p. 177)

SF 8bSpecial Focus

SessionGI imaging:

technological advances

and clinical applications

(p. 177)

EF 1EFOMP

WorkshopLung and chest imaging: new approaches

(p. 177)09:00

09:30

10:00

10:30E³ 920a

Interactive Teaching SessionTips and

tricks in chest imaging(p. 179)

10:25–12:00 EM 3

ESR meets South AfricaImaging HIV

and TB(p. 179)

SS 911Neuro

New insights into brain gliomas(p. 241)

SS 904Chest

Image quality and dose reduction(p. 241)


RadiologyThoracic inter-

ventions(p. 242)

SS 910MusculoskeletalSpine: advancing the use of CT and

MRI(p. 242)

E³ 920bFoundation


Tumours and phacomatosis

(p. 180)


Whole-body imaging: how

to do it(p. 243)

SS 902Breast

Increased risk of breast

cancer(p. 243)

EF 2EFOMP

WorkshopLung imaging:

multidisciplinary scenario(p. 180)

11:00

11:30

12:0012:15–12:45

Honorary Lecture 2

(p. 181)

12:30SY 10

Siemens Healthcare and Bayer HealthCare

Joint Satellite Symposium

(p. 150)

SY 11Bracco

Satellite Symposium

(p. 150)

SY 12Siemens


Symposium(p. 150)

SY 13GE

HealthCare Satellite

Symposium(p. 150)

SY 14Guerbet Satellite

Symposium(p. 151)

13:00

13:30

14:00IIQ

Image Interpretation

Quiz(p. 140)

EM 5EFRS meets

SpainKnowledge

development as a tool for

radiographers‘ professional

improvement(p. 181)

SY 17Hologic Satellite

Symposium(p. 151)

SY 18Toshiba Satellite

Symposium(p. 151)

SY 19Toshiba Satellite

Symposium(p. 151)

14:30

15:00

15:30

16:00E³ 1120


Breast cancer(p. 182)

SA 11State of the Art

SymposiumEvaluation of response in

haematological malignancy

(p. 182)

CC 1121Urogenital ImagingStones:

diagnosis and intervention

(p. 182)




Stroke(p. 182)

RC 1108Head and

NeckSkull base le-sions: imaging

studies and differential diagnosis(p. 183)

RC 1110Musculoskeletal

The knee(p. 183)

MS 11Multidis-ciplinary Sessions: Managing


Cholangiocarci-noma

(p. 183)

SF 11Special Focus

SessionAdults with congenital

heart disease (GUCH)(p. 184)


SessionPersonalised

radiology(p. 184)

RC 1111Neuro

Brain tumours: advanced

imaging tech-niques in daily practice - do

we really need them?

(p. 185)

16:30

17:00

17:30


93

Programme OverviewSaturday, March 9

I/KLower Level

L/M1st Level

N/O1st Level

P1st Level

Q1st Level

X1st Level

Y1st Level

Z2nd Level


EPOS2nd Level

Room/ Time

RC 804Chest

Patterns in chest radiolo-gy: are there subtype pat-

terns of ground glass opacity

(GGO)?(p. 178)

RC 815Vascular



RadiologyWhat should

every radiologist know about the

endovascular treatment of

abdominal aortic aneurysms?

(p. 178)

RC 803CardiacPractical

approach to cardiovascular risk stratifica-tion with CT

and MRI(p. 178)

RC 812PaediatricImaging the paediatric

spine(p. 179)

SK 826How to

biopsy with US guidance (p. 146)

Student Session 3

(p. 145)08:30

09:00

09:30

10:00

SS 901Abdominal

VisceraCross-sectional

pancreatic imaging and biomarkers

(p. 244)


Assessment of radiologists‘

professional performance

(p. 180)

SS 903Cardiac

Myocardial perfu-sion and coronary

artery disease(p. 244)

SS 912Paediatric

Paediatric body and bones(p. 245)

SS 914Radiographers

Dose optimi-sation as daily

challenge(p. 245)

SK 926How to

Biopsy with US Guidance(p. 146)

SK 927Image-Guided


SS 905Computer

ApplicationsComputer-aided

diagnosis(p. 246)

Student Session 4

(p. 145)

EPOS discussionCT and MRI diagnosis of

focal liver masses: when to use what?

(p. 62)

10:30

11:00

11:30

12:15-13:15 FC Self

Assessment Test

(p. 136)

12:00

SY 15Philips


Symposium (p. 151)

SY 16Philips


Symposium (p. 151)

MC 24CThe Beauty of

Basic Knowledge: Head and NeckMain pipelines of the neck: pharynx

and larynx(p. 181)

MC 25CThe Beauty of


ImagingInflammatory/infec-

tious disorders(p. 181)

12:45–14:15 EIBIR Session

(p. 140)12:30

13:00–14:45 MIR@ECRInnovation

management and the future

of radiology and radiologists

(p. 61)

13:00

13:30

SY 20GE Healthcare

Nycomed Satellite

Symposium (p. 152)

MSY 1Philips Healthcare

Mini Satellite Symposium

(p. 151)

SK 1026How to

Biopsy with US Guidance (p. 146)

SK 1027Image-Guided

Tumour Ablation (p. 147)

14:00

14:30

15:15–17:30 MIR@ECR

Radiology in modern times: challenges by telemedicine,

eHealth, appro-priateness and

safety(p. 61)

15:00

EPOS discussionPaediatric chest and heart: state of the art imaging of

the young patient(p. 62)

15:30

RC 1104Chest

Pulmonary infec-tions: the old and

the new(p. 185)

RC 1113Physics in RadiologyCone-beam

imaging(p. 185)


RadiologyUpdate on biliary

interventions(p. 185)

RC 1114RadiographersHot topics in ma-gnetic resonance

imaging(p. 186)

16:00–18:00 Student

Workshop 3(p. 145)

SK 1127Image-Guided


Euro- BioImaging

Session(p. 141)

16:00

16:30

17:00

17:30



94

Programme OverviewSunday, March 10

Room/ Time

A2nd Level

B2nd Level

C2nd Level

D1Lower Level

D2Lower Level

E1Entrance Level

E2Entrance Level

F1Entrance Level

F2Entrance Level

G/HLower Level

08:30E³ 1220


Pitfalls in brain imaging(p. 187)

RC 1201GI Tract


CC 1221Urogenital Imaging

Retroperitoneal anatomy, variants

and diseases(p. 187)




Chest pain: vascular non-cardiac causes

(p. 187)


Follow-up of Systemic and

Local TherapiesAssessing HCC

response(p. 188)

RC 1210MusculoskeletalOveruse injuries in sport: a multimo-dality approach

(p. 188)

RC 1211Neuro

Stroke: is the prognosis getting

any better?(p. 188)

SF 12Special Focus

SessionQuantitative

imaging biomar-kers in cardiac

radiology(p. 188)

RC 1202Breast

Multi-modality breast imaging

(p. 189)

RC 1207Genitourinary


09:00

09:30

10:00

10:30SS 1316

Oncologic Imaging

Rectal cancer imaging: the next

step(p. 247)

EM 4ESR meets

ChileTopics of ongoing

radiological research from the

Andes(p. 191)


The female pelvis(p. 192)

SS 1304Chest

CTPA techniques in lung perfusion and pulmonary hypertension

(p. 247)


RadiologySkeletal and

endocrinologic interventions

(p. 248)


Arthritis and metabolic bone

disease(p. 248)

SS 1303Cardiac

Towards improved image quality and

detection(p. 249)

SS 1311Neuro

Brain tumours: imaging and

therapy(p. 249)

SS 1302Breast

How to get more from breast ima-ging modalities

(p. 250)

SS 1307GenitourinaryThe bladder and

below(p. 250)

11:00

11:30

12:0012:15–12:45

Honorary Lecture 3

(p. 192)

12:30SY 21

GE Healthcare

Satellite Symposium

(p. 152)

SY 22Samsung Satellite

Symposium(p. 152)

13:00JIIQ

Junior Image Interpretation

Quiz(p. 141)

13:30

14:00E³ 1420


Common and uncommon errors in plain film and CT imaging of the chest: how to improve your

performance(p. 193)

NH 14New Horizons

SessionImaging of the

mind(p. 193)


The male genital system(p. 193)




Angina, non-occlusive mesenteric

ischaemia (NOMI) and friends: vascular

causes of acute abdomen(p. 194)



Local TherapiesFollow-up of

thermal ablation (part I)(p. 194)




The essentials of lymph node

imaging of solid tumours: what the radiologist needs to know

(p. 194)

SF 14aSpecial Focus

SessionPalliative

interventional techniques in

cancer(p. 195)

RC 1402Breast


SF 14bSpecial Focus

SessionComprehensive

CT cardiothoracic imaging: a new challenge for radiologists

(p. 195)

14:30

15:00

15:30

16:00E³ 1520

Interactive Teaching SessionThoracic

emergencies(p. 198)

RC 1501GI Tract

CT colonogra-phy: when the ‚new‘ becomes

‚ordinary‘(p. 198)


Paediatrics(p. 198)




When every step counts: imaging and

management of peripheral arterial occlusive disease

(PAOD)(p. 199)

CC 1519Oncologic maging:

Follow-up of Systemic and Local Therapies

Follow-up of thermal ablation

(part II)(p. 199)

RC 1517Emergency RadiologyER: com-

prehensive imaging of

non-traumatic abdominal

emergencies(p. 199)

SA 15State of the Art

SymposiumImaging

impingement syndromes

(p. 199)

SF 15aSpecial Focus

SessionTraumatic brain

injury(p. 200)

SF 15bSpecial Focus

SessionDigital breast

tomosynthesis(p. 200)

RC 1511Neuro

Epilepsy: a lack of

knowledge can be dangerous

(p. 201)16:30

17:00

17:30


Programme OverviewSunday, March 10

95

I/KLower Level

L/M1st Level

N/O1st Level

P1st Level

Q1st Level

X1st Level

Y1st Level

Z2nd Level


EPOS2nd Level

Room/ Time

RC 1204Chest

Lung cancer staging in 2013

(p. 189)

RC 1213Physics in Radiology

Risk assessment and risk commu-

nication(p. 190)


RadiologyGynaecological and obstetrical haemorrhagic emergencies

(p. 190)

RC 1214Radiographers

Dose optimisation in computed tomography

(p. 190)

RC 1212PaediatricOncologic

imaging: how to image, follow up

and report(p. 191)


SessionLegal matters

related to multimodality

techniques(p. 191)


08:30

09:00

09:30

10:00

SS 1301Abdominal

VisceraAbdominal CT: dose reduction and technical improvements

(p. 251)

SS 1308Head and NeckAdvanced imaging

of the ear, orbit and glands

(p. 251)

SS 1317Emergency RadiologyTechnical

issues and clinical results

(p. 252)

SS 1312PaediatricChest, heart and radiation

awareness(p. 252)

TF 1RTF - Radiology Trainees Forum

Highlighted Lectures(p. 192)

SK 1326How to

Biopsy with US Guidance(p. 146)

SK 1327Image-Guided


SS 1306Contrast MediaNew agents and

protocols(p. 253)


SessionThe radiologist, the clinician and the patient: an

impossible trio?(p. 107)

10:30

11:00

11:30

12:00

SY 23Philips Health-care Satellite Symposium

(p. 152)

SY 24Bracco Satellite

Symposium(p. 152)

MC 25DThe Beauty of


ImagingNeoplastic/non-

neoplastic lesions(p. 192)

MC 24DThe Beauty of Basic Knowledge: Head

and NeckThe suprahyoid

neck: anatomy and diagnostic algorithm of

the neck mass(p. 193)

EPOS discussionVascular imaging: CT, MR - or something

completely different? Challenges in imaging

peripheral artery occlusive disease

(p. 62)

12:30

13:00

13:30

RC 1407GenitourinaryContrast media safety: update

(p. 196)


Hybrid imaging systems(p. 196)

RC 1408Head and

NeckLaryngeal

cancer and radiology(p. 196)

RC 1414Radiographers

Towards advancing and

developing the role of

radiographers(p. 197)

RC 1412PaediatricPaediatric

emergencies(p. 197)

SK 1427Image-Guided


SF 14cSpecial Focus

SessionAdvances in fo-rensic radiology

(p. 197)

Student Final Session(p. 145)

14:00

14:30

15:00

15:30

RC 1503Cardiac

Cardiac CT and MRI in difficult patients: what

to do?(p. 201)


Novel develop-ments in CT and their impact on

dose(p. 201)

RC 1508Head and NeckPerforming and reporting head and neck exa-minations: how should I do it?

(p. 201)

RC 1514RadiographersHybrid imaging technologies

(p. 202)

RC 1512Paediatric

Paediatric MSK radiology: what is

important?(p. 202)

16:00–18:00 Student

Workshop 4(p. 145)

SK 1527Image-Guided


16:00

16:30

17:00

17:30



96

Programme OverviewMonday, March 11

Room/ Time

A2nd Level

B2nd Level

C2nd Level

D1Lower Level

D2Lower Level

E1Entrance Level

E2Entrance Level

F1Entrance Level

F2Entrance Level

G/HLower Level

08:30E³ 1620


Acute abdominal inflammatory

disorders(p. 203)

SF 16aSpecial Focus

SessionMy most beautiful mistakes in paedi-

atric radiology(p. 203)


The usual, the unusual and the

dangerous(p. 203)




The fast and the furious: vascular trauma resulting

from traffic accidents(p. 203)



Local TherapiesFollow-up of local

treatments of breast cancer

(p. 204)

RC 1601aGI Tract

Diagnosis and staging of eso-phageal cancer

(p. 204)


Complications of cancer treatment and the detection

of recurrences(p. 204)

RC 1601bAbdominal

Viscera/GI TractAbdominal MRI:

standard and ad-vanced protocols in clinical settings

(p. 205)

ESR General Assembly

RC 1611Neuro

Spine: update on postoperative imaging and

minimally invasive procedures

(p. 205)

09:00

09:30

10:00

10:30E³ 1720b

Interactive Teaching SessionMusculo-skeletal

emergencies(p. 207)

E³ 1720aInteractive Teaching Session

Pitfalls in pel-vic imaging

(p. 208)

SS 1711Neuro

Brain ischa-emia: perfusion

and diffusion(p. 255)

SS 1704Chest

Technological refinements:

from x-rays to micro-imaging

(p. 255)


RadiologyAbdominal

interventions: from TIPS to

bile ducts(p. 256)


Hip: CT and MRI applications

(p. 256)

SS 1701aGI Tract

CT/MR colono-graphy:

technical issu-es and clinical

studies(p. 257)

SS 1716Oncologic ImagingResponse

evaluation in oncology:

beyond RECIST(p. 257)

SS 1702Breast

Tomosynthesis: a role in clinical

practice?(p. 258)

SS 1707Genitourinary

Hints on haematuria

and adrenals for all

(p. 258)11:00

11:30

12:00

12:30

13:00

13:30

14:00SS 1811a

NeuroLatest deve-lopments in

neuroimaging(p. 262)

SS 1811bNeuro

Spinal imaging(p. 262)

SS 1803Cardiac

Cardiac imaging: into the future

(p. 263)


RadiologyNew approaches

to aortic and peripheral

interventions(p. 263)


Knee: new horizons(p. 264)

SS 1801aGI TractColorectal

cancer: diagnostic biomarkers and

response assess-ment

(p. 264)

SS 1802aBreast

Newer techniques in breast imaging

and therapy(p. 265)

SS 1802bBreast

Maximising cancer detection in

breast screening(p. 265)

SS 1807Genitourinary

Mixed modalities in GU imaging

(p. 266)14:30

15:00

15:30

16:00RC 1901GI Tract

Cross-sectional imaging of colitis

(p. 208)

RC 1906Contrast MediaHow I optimise contrast media administration

(p. 208)


Intra-articular imaging(p. 209)


Gastro-entero-pancreatic neuro-

endocrine tu-mours (GEP-NET): a multidisciplinary

update(p. 209)

SF 19Special Focus

SessionTablet-computers

in radiology: friend or foe?

(p. 209)

RC 1902Breast

Breast ultrasound(p. 210)

RC 1911Neuro

Multiple sclerosis: 2013 update

(p. 210)16:30

17:00

17:30

Registration: 07:00–18:00 Technical Exhibition: EXPO Halls and EXPO Foyer D:10:00–14:00

97

Programme OverviewMonday, March 11

I/KLower Level

L/M1st Level

N/O1st Level

P1st Level

Q1st Level

X1st Level

Y1st Level

Z2nd Level


EPOS2nd Level

Room/ Time

RC 1604Chest

Pulmonary em-bolism: guidelines and best practice

throughout Europe(p. 205)

SF 16cSpecial Focus

SessionMaking homo-geneous HCC

readings(p. 205)

SF 16bSpecial Focus

SessionHead and neck

cancer battle: the power of imaging

studies(p. 206)

RC 1603Cardiac


RC 1605Computer

ApplicationsImproving work-flow efficiency

and quality(p. 207)

Joint Session of the ESR and

EFSUMBAdvances in

diagnostic ult-rasound: better results through

cooperation(p. 207)

08:30

09:00

09:30

10:00

SS 1701bAbdominal

VisceraDWI in pancreatic and hepatobiliary

diseases(p. 259)


Breast imaging and novel CT techniques

(p. 259)

SS 1703Cardiac

Biomarkers, tissue characterisation and remodelling

(p. 260)

SS 1712Paediatric

Foetal and neona-tal imaging

(p. 260)

SS 1714RadiographersMammography

(p. 261)

SS 1706Molecular Imaging

Molecular imaging in cancer and degenerative

diseases(p. 261)

10:30

11:00

11:30

12:00

MC 24EThe Beauty of Basic Knowledge: Head

and NeckTemporal bone: so

beautiful, yet so complicated

(p. 208)

MC 25EThe Beauty of


ImagingMetabolic/endocrine

disease(p. 208)

12:30

13:00

13:30

SS 1801bAbdominal

VisceraLiver volume,

function and focal lesions

(p. 266)


Patient dose management and

dose surveys(p. 267)

SS 1815Vascular

Vascular research(p. 267)

SS 1812Paediatric

Paediatric brain(p. 268)

SS 1814Radiographers

Challenges of different imaging

techniques(p. 268)

SS 1806Contrast MediaFunctional studies

and safety(p. 269)

14:00

14:30

15:00

15:30

RC 1904Chest

Phenotypes in obstructive airway

disease: how should I image,

analyse and report?(p. 210)

RC 1908Head and NeckTemporal bone:

imaging the most common symp-toms and signs

(p. 210)

RC 1915Vascular

Lower extremity venous insuffici-

ency(p. 211)

RC 1912Paediatric

Normal variants in paediatric

imaging: not to be confused with

disease(p. 211)

16:00

16:30

17:00

17:30


Programme by Topic

100 New Horizons Sessions101 State of the Art Symposia102 Special Focus Sessions107 Professional Challenges Session108 Multidisciplinary Sessions

Managing Patients with Cancer109 Categorical Courses

109 CLICK (Clinical Lessons for Imaging Core Knowledge): Never without Arteries

110 Oncologic Imaging: Follow-up of Systemic and Local Therapies

111 Urogential Imaging112 Mini Courses

112 Organs from A to Z: Heart112 Controversies in Breast Imaging113 The Beauty of Basic Knowledge:

Head and Neck113 The Beauty of Basic Knowledge:

Musculoskeletal Imaging114 Joint Course of ESR and RSNA

115 Refresher Courses / Scientific Sessions115 Abdominal and Gastrointestinal117 Breast118 Cardiac120 Chest121 Computer Applications122 Molecular Imaging and Contrast

Media122 Genitourinary123 Head and Neck124 Interventional Radiology126 Musculoskeletal127 Neuro129 Paediatric130 Physics in Radiology131 Radiographers132 Vascular133 Oncologic Imaging134 Emergency Radiology

135 EFOMP Workshop136 E3 – European Excellence in Education

136 Foundation Course: Neuroimaging137 Interactive Teaching Sessions

139 Accompanying Sessions 139 ESR Radiation Protection Session 139 6th Post-Processing Face-Off

Session 139 EIBIR/EORTC Symposium 139 ESOR Session 140 Standards and Audit Session 140 EIBIR/EuroAIM Session 140 EIBIR Session / Horizon 2020 140 Image Interpretation Quiz 141 Euro-BioImaging 141 RTF Highlighted Lectures 141 Junior Image Interpretation Quiz 141 Joint Session ESR/EFSUMB142 EIBIR presents IMAGINE144 Rising Stars Programme146 Update Your Skills (Practical Courses) 146 How to biopsy with US guidance 147 Image-guided tumor ablation149 Satellite Symposia153 Industry Hands-on Workshops

Especiallymarkedfor ANCEDand IORradiologistsorsuitablefor

=Interactivesessionwithelectronicvoting/selfassessment

=SessionbroadcastliveatmyESR.org

New Horizons Sessions

Friday, March 8, 16:00–17:30, Room C NH 7: Cartilage imaging

• Chairman’s Introduction [A-149]V.N. Cassar-Pullicino; Oswestry/UK

• Sodium imaging [A-150]S. Trattnig; Vienna/AT

• dGEMRIC (delayed gadolinium-enhanced MR imaging of cartilage) [A-151]G. Welsch; Erlangen/DE

• Diffusion tensor imaging [A-152]C. Glaser; Munich/DE

• CEST (chemical exchange saturation transfer) [A-153]B. Schmitt; Vienna/AT

• Panel discussion: What are the envisaged future advances in these cartilage imaging techniques and can we expect to introduce them into clinical practice?

Saturday, March 9, 08:30–10:00, Room C NH 8: MR/PET: a marriage made in heaven

or hell?

• Chairman’s Introduction [A-207]B. Hamm; Berlin/DE

• MR/PET in neuroimaging: nuclear medicine [A-208]O. Sabri; Leipzig/DE

• MR/PET in neuroimaging: radiology [A-209]B.R. Rosen; Charlestown, MA/US

• MR/PET in oncologic imaging: nuclear medicine [A-210]O. Ratib; Geneva/CH

• MR/PET in oncologic imaging: radiology [A-211]H.-P. Schlemmer; Heidelberg/DE

• Panel discussion: What benefits and risks should we expect in terms of basic research, clinical service, and economics?

Sunday, March 10, 14:00–15:30, Room B NH 14: Imaging of the mind

• Chairman’s introduction: New insights into the state of consciousness through neuroimaging [420]S. Sunaert; Leuven/BE

• Brain wiring: resting state fMRI [A-421]F. Barkhof; Amsterdam/NL

• fMRI in disorders of consciousness: diagnostic and legal challenges [A-422]C. Di Perri; Liège/BE

• fMRI of cognitive functions: discriminating normal aging, minimal cognitive impairment and Alzheimer’s disease [A-423]A. Falini; Milan/IT

• Panel discussion: New insights into the state of consciousness through neuroimaging. Where are we and where should we go?

100

State of the Art SymposiaState of the Art Symposia

Friday, March 8, 08:30–10:00, Room E1 SA 4: Diffusion-weighted imaging (DWI)

of the abdomen

• Chairman’s Introduction [A-068]Y. Menu; Paris/FR

• DWI of the abdomen: a tutorial for beginners [A-069]H.C. Thoeny; Berne/CH

• Liver and pancreas: answering burning questions [A-070]F. Caseiro-Alves; Coimbra/PT

• DWI of abdominal lymph nodes: PET competitive or just pseudo? [A-071]S. Gourtsoyianni; London/UK

• Clinical cases

Saturday, March 9, 16:00–17:30, Room B SA 11: Evaluation of response in

haematological malignancy

• Chairman’s Introduction [A-298]E. de Kerviler; Paris/FR

• Opportunities and limitations of PET, CT and MRI answering the haematologist’s questions [A-299]T.C. Kwee; Utrecht/NL

• Evaluation of response in multiple myeloma [A-300]J. Hillengass; Heidelberg/DE

• Evaluation of response in lymphoma with PET/CT [A-301]S.F. Barrington; London/UK

• Panel discussion: Is it time for biomarker response criteria in haematological malignancies?

Sunday, March 10, 16:00–17:30, Room E2 SA 15: Imaging impingement syndromes

• Chairman’s Introduction [A-496]C.W.A. Pfirrmann; Zurich/CH

• Shoulder [A-497]P. Robinson; Leeds/UK

• Ankle [A-498]M. Maas; Amsterdam/NL

• Hip [A-499]K. Wörtler; Munich/DE

• Panel discussion: Form or function: is impingement a clinical or imaging diagnosis?

101

Special Focus Sessions

Friday, March 8, 08:30–10:00, Room F2 SF 4a: ‘MRI of the lung: to go?‘

• Chairman’s introduction: ‘Apéritif ’ [A-080]H. Kauczor; Heidelberg/DE

• ‘The sequence buffet’ [A-081]J.M. Wild; Sheffield/UK

• ‘Preparing your menu’ [A-082]J. Biederer; Heidelberg/DE

• ‘Bon appétit! Starters’: cystic fibrosis, pneumonia and pulmonary embolism [A-083]M.U. Puderbach; Heidelberg/DE

• ‘Bon appétit! Main course’: pulmonary and mediastinal neoplasms [A-084]E.J.R. van Beek; Edinburgh/UK

• Panel discussion: ‘Bon appétit! Dessert’: what are the benefits of MRI of the lung in clinical workflow and decision-making?

Friday, March 8, 08:30–10:00, Room QSF 4b: Justifying CT in paediatric radiology

• Chairman’s Introduction [A-105]C. Owens; London/UK

• How should CT be optimised? [A-106]W.A. Kalender; Erlangen/DE

• When, how, and why I perform CT [A-107]C. Owens; London/UK

• Why and when CT does not need to be performed [A-108]M. Claudon; Vandoeuvre-les-Nancy/FR

• Panel discussion: Do we have guidelines for paediatric CT? Do we have alternatives?

Friday, March 8, 16:00–17:30, Room F1 SF 7a: Radiographers and ultrasonography

in Europe

• Chairmen’s Introduction [A-167]D. Pekarovic; Ljubljana/SI V. Vilgrain; Clichy/FR

• Levels of training and competencies across Europe [A-169]M. Stanton; Dublin/IE

• The role and impact of the radiographer conducted US in Portugal [A-169]R. Ribeiro; Lisbon/PT

• Evolution of radiography education for US in the Netherlands since 1990, and its influence on their role [A-170]G. Plug; Haarlem/NL

• Panel discussion: What are the challenges and barriers facing role extension?

102


Friday, March 8, 16:00–17:30, Room F2 SF 7b: Imaging and radiotherapy:

all you need to know

• Chairman’s Introduction [A-171]V.J. Goh; London/UK

• Modern radiotherapy: what are the new technologies? [A-172]V. Valentini; Rome/IT

• PET/CT for radiotherapy planning: how does it assist IMRT? [A-173]A. Loft; Copenhagen/DK

• Response evaluation and treatment adaptation [A-174]K. Haustermans; Leuven/BE

• MR imaging biomarkers for response evaluation [A-175]R.G.H. Beets-Tan; Maastricht/NL

• Panel discussion: How can imaging improve outcomes in radiotherapy?

Friday, March 8, 16:00–17:30, Room QSF 7c: Imaging in intensive care patients

• Chairman’s Introduction [A-193]A. Palkó; Szeged/HU

• Value of MRI for intensive care coma patients with unclear brain pathology [A-194]P.C. Maly Sundgren; Lund/SE

• Computed tomography of pathologic lung conditions complicating intensive care treatment [A-195]C.M. Schaefer-Prokop; Amersfoort/NL

• Point-of-care versus diagnostic ultrasound in the intensive care unit [A-196]E. Danse; Brussels/BE

• Imaging in polyTrauma [A-197]U. Linsenmaier; Munich/DE

• Panel discussion: What training and special skills are radiologists expected to have in order to work with intensive care units? How should we manage the clinical and technical challenges posed by this very specific environment?

Saturday, March 9, 08:30–10:00, Room B SF 8a: Is diagnostic catheter angiography still

useful in neuroimaging?

• Chairman’s Introduction [A-203]M. Essig; Erlangen/DE

• What can we expect from vascular diagnostic procedures? [A-204]R. Siemund; Lund/SE

• Can non-invasive techniques as CTA and MRA replace catheter angio for diagnostic work-up? [A-205]L. Van den Hauwe; Brasschaat/BE

• Diagnostic catheter angiography is not dead: current indications and advantages over the non-invasive techniques [A-206]T. Engelhorn; Erlangen/DE

• Panel discussion: The pros and cons of diagnostic catheter angiography in neuroimaging

Saturday, March 9, 08:30–10:00, Room F2 SF 8b: GI imaging: technological advances and

clinical applications

• Chairman’s Introduction [A-229]S.A. Jackson; Plymouth/UK

• CEUS of the bowel wall: when and how [A-230]F. Maccioni; Rome/IT

• Dual-energy (spectral) CT: GI applications [A-231]P. Rogalla; Toronto, ON/CA

• MR imaging of GI tract motility [A-232]S.A. Taylor; London/UK

• Panel discussion: When should we integrate these technological advances into our routine practice?

Saturday, March 9, 16:00–17:30, Room F1 SF 11: Adults with congenital heart disease

(GUCH)

• Chairman’s introduction: Why should a radiologist gather information on GUCH patients? [A-321]M. Gutberlet; Leipzig/DE

• A list of typical surgical procedures: the top ten in GUCH [A-322]M. Hübler; Zurich/CH

• ‘Adults are not just big children’: differences between children and adults [A-323]A.M. Taylor; London/UK

• Which modality, for which patient? MRI or CT, that’s the question [A-324]J. Bremerich; Basle/CH

• Panel discussion: Can we now get all the information we need to treat GUCH patients, non-invasively?

103


Sunday, March 10, 14:00–15:30, Room ZSF 14c: Advances in forensic radiology

• Chairman’s Introduction [A-471]G. Guglielmi; Foggia/IT

• Imaging in forensic medicine [A-472]M. Thali; Zurich/CH

• Advances in post-mortem CT angiography [A-473]S. Grabherr; Lausanne/CH

• Virtual anthropology and forensic identification using MDCT [A-474]F. Dedouit; Toulouse/FR

• Forensic MR imaging [A-475]T. Ruder; Zurich/CH

• Panel discussion: Which imaging technique for which forensic scenario?

Sunday, March 10, 16:00–17:30, Room F1 SF 15a: Traumatic brain injury

• Chairman’s Introduction [A-500]A. Rovira-Cañellas; Barcelona/ES

• Acute brain trauma: CT vs MRI [A-501]M. Muto; Naples/IT

• New imaging techniques in the detection and quantification of brain damage [A-502]S. Sunaert; Leuven/BE

• Advanced imaging of brain trauma: outcome prediction [A-503]D. Galanaud; Paris/FR

• Cerebrovascular trauma: diagnosis and therapy [A-504]T. Krings; Toronto, ON/CA

• Panel discussion: Role of neuroimaging in traumatic brain injury in 2013

Sunday, March 10, 16:00–17:30, Room F2 SF 15b: Digital breast tomosynthesis

• Chairman’s Introduction [A-505]G. Gennaro; Padua/IT

• Optimisation of image acquisition and reconstruction in DBT [A-506]M.J. Yaffe; Toronto, ON/CA

• Current role of DBT in diagnostic imaging [A-507]S. Zackrisson; Malmö/SE

• Clinical aspects of computer aided detection and diagnosis in DBT [A-508]H.-P. Chan; Ann Arbor, MI/US

• Panel discussion: Digital breast tomosynthesis: replacing or just supporting standard mammography?

Sunday, March 10, 08:30–10:00, Room F1 SF 12: Quantitative imaging biomarkers in

cardiac radiology

• Chairman’s Introduction [A-368]A. van der Lugt; Rotterdam/NL

• Imaging biomarkers [A-369]J.-P. Vallée; Geneva/CH

• Imaging biomarkers for myocardial function [A-370]J. Bogaert; Leuven/BE

• Imaging biomarkers of myocardial viability [A-371]P. Croisille; Saint-Etienne/FR

• Imaging biomarkers of myocardial ischaemia [A-372]L. Natale; Sesto Fiorentino/IT

• Panel discussion: How should we implement quantitative biomarkers in clinical practice?

Sunday, March 10, 14:00–15:30, Room F1 SF 14a: Palliative interventional techniques

in cancer

• Chairman’s Introduction [A-441]K.A. Hausegger; Klagenfurt/AT

• Cementoplasty of lytic bone metastasis [A-442]A. Gangi; Strasbourg/FR

• Pleural drainage, pleurodesis [A-443]F. Gleeson; Oxford/UK

• Percutaneous nephrostomy (PCN) and ureteral stenting [A-444]F. Orsi; Milan/IT

• Biliary procedures [A-445]M. Krokidis; Cambridge/UK

• Panel discussion: How invasive can palliation be? When to say no to palliative treatment?

Sunday, March 10, 14:00–15:30, Room G/H SF 14b: Comprehensive CT cardiothoracic

imaging: a new challenge for radiologists

• Chairman’s Introduction [A-449]L. Bonomo; Rome/IT

• How to optimise integrated cardiothoracic imaging with CT [A-450]U.J. Schoepf; Charleston, SC/US

• Coronary artery imaging from a chest CT examination: when and how [A-451]R. Marano; Rome/IT

• Cardiopulmonary functional imaging from a chest CT examination: when and how [A-452]E.J.R. van Beek; Edinburgh/UK

• Panel discussion: Is a single CT scan technique and protocol feasible for all the cardiothoracic problems?

104


Monday, March 11, 08:30–10:00, Room B SF 16a: My most beautiful mistakes in

paediatric radiology

• Chairman’s Introduction [A-530]P. Tomà; Rome/IT

• Abdomen [A-531]S.G.F. Robben; Maastricht/NL

• CNS [A-532]B. Bernardi; Rome/IT

• Musculoskeletal [A-533]K. Rosendahl; Bergen/NO

• Panel discussion: How have you changed or improved yourself after recognising your mistakes?

Monday, March 11, 08:30–10:00, Room N/O SF 16b: Head and neck cancer battle:

the power of imaging studies

• Chairman’s Introduction [A-568]V. Vandecaveye; Leuven/BE

• Building blocks for locoregional staging of head and neck tumours [A-569]F.A. Pameijer; Utrecht/NL

• Detection of tumour recurrence in head and neck cancer: challenges and pitfalls [A-570]M. Becker; Geneva/CH

• Locoregional treatment failure in head and neck cancer: causes and clinical implications [A-571]R. Maroldi; Brescia/ITP. Nicolai; Brescia/IT

• Panel discussion: Advanced imaging in clinical practice: how does it help the patient?

105


Monday, March 11, 08:30–10:00, Room L/M SF 16c: Making homogeneous HCC readings

• Chairman’s Introduction [A-563]C. Bartolozzi; Pisa/IT

• HCC diagnosis: how to report ‘typical’ findings [A-564]C. Ayuso; Barcelona/ES

• How to interpret and report ‘atypical’ findings [A-565]C.J. Zech; Basle/CH

• How to evaluate tumour response to therapies [A-566]J. Ricke; Magdeburg/DE

• Information technology: the practical impact on the management of HCC patients [A-567]I. Bargellini; Pisa/IT

• Panel discussion: Case-based discussion: a practical demonstration of how interpretation and reporting affect patient management

Monday, March 11, 16:00–17:30, Room F1 SF 19: Tablet computers in radiology:

friend or foe?

• Chairman’s Introduction [A-605]E. Neri; Pisa/IT

• Tablet computers: a technical overview [A-606]J. Fernandez-Bayó; Sabadell/ES

• Radiological features of the tablet computer [A-607]L. Faggioni; Pisa/IT

• Reading DICOM images on the tablet [A-608]O. Ratib; Geneva/CH

• Mobile teleradiology with tablet computers: a critical appraisal [A-609]E.R. Ranschaert; ‘s-Hertogenbosch/NL

• Panel discussion: Are we ready and confident enough to use tablet computers in clinical practice? How and when?

106

Professional Challenges Sessions

Thursday, March 7, 16:00–17:30, Room F1 PC 3: Bringing radiology to medical

undergraduates

• Chairman’s introduction: why does it matter? [A-022]S.J. Golding; Oxford/UK

• Establishing a radiological presence in the undergraduate curriculum [A-023]R.N. Gibson; Melbourne, VIC/AU

• Finding the time and resources in the radiology department [A-024]J.L. del Cura; Bilbao/ES

• Involving the undergraduate with the radiology department [A-025]K. Verstraete; Gent/BE

• How to ensure teachers are suitably trained [A-026]E. Szabó; Szeged/HU

• Panel discussion: What needs to be done to overcome the constraints on radiologists?

Friday, March 8, 08:30–10:00, Room PPC 4: The visibility of the radiologist

• Chairman’s introduction [A-100]J.A. Reekers; Amsterdam/NL

• How to optimise the visibility of the radiology department [A-101]J.A. Reekers; Amsterdam/NL

• Start early with radiological visibility [A-102]M. Maas; Amsterdam/NL

• Clinical radiology puts you in the spotlight: taking over the clinical responsibility [A-103]E. de Kerviler; Paris/FR

• Radiology in the 21st century: time to come out of the dark? [A-104]A. Adam; London/UK

• Panel discussion: Should we improve the visibility of the radiologist? And if yes, how?

Saturday, March 9, 16:00–17:30, Room F2 PC 11: Personalised radiology

• Chairman’s introduction [A-325]G.P. Krestin; Rotterdam/NL

• Personalised medicine: hope or hype? [A-326]O. Golubnitschaja; Bonn/DE

• Imaging for disease prediction [A-327]M. Vernooij; Rotterdam/NL

• Molecular imaging: a solution for personalised diagnosis and treatment? [A-328]F.M.A. Kiessling; Aachen/DE

• Role of imaging in personalised therapy monitoring [A-329]A.R. Padhani; Northwood/UK

• Panel discussion: Is imaging providing an added value to the ‘omics’ of personalised medicine?

Sunday, March 10, 08:30–10:00, Room ZPC 12: Legal matters related to

multimodality techniques

• Chairman’s introduction [A-398]K. Åhlström Riklund; Umea/SE

• Radiological legal matters in eastern Europe [A-399]M. Studniarek; Gdansk/PL

• Legal matters in nuclear medicine [A-400]G.K. von Schulthess; Zurich/CH

• Legal matters in Scandinavia [A-401]K. Åhlström Riklund; Umea/SE

• International, regional, national and local framework requirements [A-402]A. Perkins; Nottingham/UK

• Panel discussion: A discussion with questions from the audience about the differences across Europe

Sunday, March 10, 10:30–12:00, Studio 2013PC 13: The radiologist, the clinician and the

patient: an impossible trio?

Chairman: C.D. Claussen; Tübingen/DE

Moderator: W. Wagner; Vienna/AT The aim of this session is to initiate an open and frank discussion among different stakeholders about the current role of the radiologist in relation to the patient, other clinicians and the public. Which procedures are efficient? Which are inefficient? What should be changed in future and what is manageable during clinical routine? As the participants represent various disciplines, we hope to come to a realistic outlook.

Participants:• A. Adam; London/UK (Radiologist)• G. Marckmann; Munich/DE (Medical Ethicist)• M. Peck-Radosavljevic; Vienna/AT (Internal Medicine Doctor)• J.A. Reekers; Amsterdam/NL (Radiologist)

107

Multidisciplinary Sessions

Thursday, March 7, 16:00–17:30, Room E2 MS 3: Colorectal liver metastases

• Chairman’s introduction [A-017]V. Vilgrain; Clichy/FR

• Role of imaging in the pretreatment assessment [A-018]V. Vilgrain; Clichy/FR

• Surgical resection of liver metastases: when and how [A-019]J. Belghiti; Clichy/FR

• Chemotherapy and novel therapy in colorectal liver metastases: rationale, indications and results [A-020]S. Faivre; Clichy/FR

• Role of image-guided treatment in colorectal liver metastases [A-021]M. Abdel Rehim; Clichy/FR

• Case presentation and discussion

Friday, March 8, 08:30–10:00, Room F1 MS 4: Hepatocellular carcinoma

• Chairman’s introduction [A-075]B. Sangro; Pamplona/ES

• Abdominal radiology [A-076]A. Benito; Pamplona/ES

• Interventional radiology [A-077]J.I. Bilbao; Pamplona/ES

• Surgery [A-078]F. Pardo; Pamplona/ES

• Hepatology/oncology [A-079]B. Sangro; Pamplona/ES

• Case presentation and discussion

Saturday, March 9, 16:00–17:30, Room E2 MS 11: Cholangiocarcinoma

• Chairman’s introduction [A-316]B. Hamm; Berlin/DE

• Surgery of hilar and extrahepatic cholangiocarcinoma [A-317]P. Neuhaus; Berlin/DE

• Radiology – diagnostics and portal vein embolisation in hilar and extrahepatic cholangiocarcinoma [A-318]T. Denecke; Berlin/DE

• Medical treatment of cholangiocarcinomas [A-319]H. Riess; Berlin/DE

• Radiology – diagnostics and image guided therapies in intrahepatic cholangiocarcinomas [A-320]B. Gebauer; Berlin/DE

• Case presentation (part 1): hilar cholangiocarcinoma

• Case presentation (part 2): CCC multimodal treatment

Multidisciplinary SessionsManagingPatientswithCancer

108

Categorical Courses

Sunday, March 10, 14:00–15:30, Room D1 CC 1418: Angina, non-occlusive mesenteric

ischaemia (NOMI) and friends: vascular causes of acute abdomen

Moderator: O. Chan; London/UK

A. Clinical considerations [A-428]P. Rogalla; Toronto, ON/CA

B. Imaging techniques and typical findings [A-429]M. Prokop; Nijmegen/NL

C. Interactive case discussion: how to proceed? [A-430]A. Palkó; Szeged/HU

Sunday, March 10, 16:00–17:30, Room D1 CC 1518: When every step counts: imaging and

management of peripheral arterial occlusive disease (PAOD)

Moderator: J.F.M. Meaney; Dublin/IE

A. Clinical considerations [A-486]M. Schillinger; Vienna/AT

B. Imaging techniques and typical findings [A-487]T. Leiner; Utrecht/NL

C. Interactive case discussion: how to deal with the results? Typical cases, pitfalls, and what is next? [A-488]L.P. Lawler; Dublin/IE

Monday, March 11, 08:30–10:00, Room D1 CC 1618: The fast and the furious: vascular

trauma resulting from traffic accidents

Moderator: U. Linsenmaier; Munich/DE

A. Clinical considerations [A-538]H. Hoppe; Berne/CH

B. Imaging techniques and typical findings [A-539]H. Alkadhi; Zurich/CH

C. Interactive case discussion [A-540]R. Morgan; London/UK

Saturday, March 9, 08:30–10:00, Room D1 CC 818: How old are you in reality?

Vascular age and clinical events

Moderator: L. Lonn; Copenhagen/DK

A. Clinical considerations [A-212]E. Minar; Vienna/AT

B. Imaging techniques and typical findings [A-213]H.J. Lamb; Leiden/NL

C. Interactive case discussion: how to deal with the results? [A-214]A. van der Lugt; Rotterdam/NL

Saturday, March 9, 16:00–17:30, Room D1 CC 1118: Stroke

Moderator: M.M. Thurnher; Vienna/AT

A. Clinical considerations [A-306]P.M. Parizel; Antwerp/BE

B. Imaging techniques and typical findings [A-307]J. Vymazal; Prague/CZ

C. Interactive case discussion: what is next after diffusion and perfusion? [A-308]A. Dörfler; Erlangen/DE

Sunday, March 10, 08:30–10:00, Room D1 CC 1218: Chest pain:

vascular non-cardiac causes

Moderator: E. Brountzos; Athens/GR

A. Clinical considerations [A-355]R. Iezzi; Rome/IT

B. Imaging techniques and typical findings [A-356]F. Wolf; Vienna/AT

C. Interactive case discussion: what is really important? [A-357]T.R.C. Johnson; Munich/DE

CLICK(ClinicalLessonsforImagingCoreKnowledge):NeverwithoutArteries


109

Categorical Courses

Sunday, March 10, 14:00–15:30, Room D2CC 1419: Follow-up of thermal ablation (part I)

Moderator: W. Prevoo; Amsterdam/NL

A. The zone of cell death and collateral phenomena on cross-sectional imaging: from histopathology to the standardisation of terms [A-431]A. Denys; Lausanne/CH

B. PET/CT for the evaluation of ablative therapy: Who? Where? When? Does it help? [A-432]D. Deandreis; Villejuif/FR

C. Everyday practice: MR and CT for evaluating response to thermal ablation [A-433]C. Dromain; Villejuif/FR

Sunday, March 10, 16:00–17:30, Room D2CC 1519: Follow-up of thermal ablation (part II)

Moderator: P.L. Pereira; Heilbronn/DE

A. Follow-up imaging of thermal ablative therapies for lung tumours [A-489]A.R. Gillams; London/UK

B. Follow-up imaging of percutaneous local treatment of bone tumours [A-490]F. Deschamps; Villejuif/FR

C. Follow-up imaging of thermal ablative therapies for kidney tumours [A-491]D.J. Breen; Southampton/UK

Monday, March 11, 08:30–10:00, Room D2CC 1619: Follow-up of local treatments of

breast cancer

Moderator: M.H. Fuchsjäger; Graz/AT

A. MRI-guided HIFU therapies in the breast [A-541]M. Sklair-Levy; Tel Aviv/IL

B. Pre- and post- imaging appearance of breast lesion excision system (BLES) lesions [A-542]S. Allen; Sutton/UK

C. Common features and pitfalls in imaging the treated breast [A-543]J. Camps Herrero; Valencia/ES

Friday, March 8, 16:00–17:30, Room D2CC 719: Imaging after systemic therapies:

the standards

Moderator: E.L. van Persijn van Meerten; Leiden/NL

A. RECIST criteria [A-157]Y. Menu; Paris/FR

B. PERCIST: evolving considerations for PET response criteria in solid tumours [A-158]T.F. Hany; Zurich/CH

C. Evaluation of brain tumours [A-159]C. Majós; L’Hospitalet de Llobregat/ES

Saturday, March 9, 08:30–10:00, Room D2CC 819: Imaging after systemic therapies:

advanced techniques

Moderator: D.-M. Koh; Sutton/UK

A. What can we expect from biomarkers [A-215]B. Van Beers; Clichy/FR

B. MRI biomarkers: from acquisition to post-processing [A-216]O. Lucidarme; Paris/FR

C. Assessing the precision and accuracy of biomarker imaging: is it reproducible? [A-217]C.B. Sirlin; San Diego, CA/US

Sunday, March 10, 08:30–10:00, Room D2CC 1219: Assessing HCC response

Moderator: R. Lencioni; Pisa/IT

A. Systemic therapies [A-358]V. Vilgrain; Clichy/FR

B. Endovascular therapies [A-359]R. Salem; Chicago, IL/US

C. Ablative therapies [A-360]C. Ayuso; Barcelona/ES

OncologicImaging:Follow-upofSystemicandLocalTherapies

110

Categorical CoursesUrogentialImaging

Sunday, March 10, 14:00–15:30, Room C CC 1421: The male genital system

Moderator: J.O. Barentsz; Nijmegen/NL

A. Imaging of prostate cancer: an update [A-424]J.J. Fütterer; Nijmegen/NL

B. Scrotal tumours [A-425]P.S. Sidhu; London/UK

C. The penis [A-426]M. Bertolotto; Trieste/IT

D. Interactive case discussion [A-427]J.O. Barentsz; Nijmegen/NL

Sunday, March 10, 16:00–17:30, Room C CC 1521: Paediatrics

Moderator: M. Claudon; Vandoeuvre-les-Nancy/FR

A. Imaging strategies for children: urinary tract infection and vesico-ureteral reflux [A-482]M. Riccabona; Graz/AT

B. Paediatric adrenal tumours [A-483]P.-H. Vivier; Rouen/FR

C. Prenatal detection of GU diseases [A-484]F.E. Avni; Lille/FR

D. Interactive case discussion [A-485]M. Claudon; Vandoeuvre-les-Nancy/FR

Monday, March 11, 08:30–10:00, Room C CC 1621: The usual, the unusual

and the dangerous

Moderator: S.K. Morcos; Sheffield/UK

A. Imaging of renal Trauma [A-534]V. Logager; Copenhagen/DK

B. Postoperative anatomy and complications after GU interventions [A-535]H.C. Thoeny; Berne/CH

C. GU complications in patients with spinal cord damage [A-536]S. Agarwal; Wrexham/UK

D. Interactive case discussion [A-537]S.K. Morcos; Sheffield/UK

Saturday, March 9, 16:00–17:30, Room C CC 1121: Stones: diagnosis and intervention

Moderator: N.C. Cowan; Oxford/UK

A. Imaging patients with renal colic [A-302]G. Heinz-Peer; St. Pölten/AT

B. Percutaneous treatment of renal stones [A-303]S. Moussa; Edinburgh/UK

C. Intervention in ureteral obstruction and ureteral trauma [A-304]A. Magnusson; Uppsala/SE

D. Interactive case discussion [A-305]N.C. Cowan; Oxford/UK

Sunday, March 10, 08:30–10:00, Room C CC 1221: Retroperitoneal anatomy, variants

and diseases

Moderator: U.G. Mueller-Lisse; Munich/DE

A. Retroperitoneal anatomy: an embryology based approach [A-351]F.M. Danza; Rome/IT

B. Anatomical variants and benign diseases [A-352]S. Merran; Paris/FR

C. Malignant tumours [A-353]R.H. Oyen; Leuven/BE

D. Interactive case discussion [A-354]U.G. Mueller-Lisse; Munich/DE

Sunday, March 10, 10:30–12:00, Room C CC 1321: The female pelvis

Moderator: E. Sala; New York, NY/US

A. Imaging congenital anomalies of the female genital system [A-409]K. Kinkel; Chêne-Bougeries/CH

B. Benign ovarian masses [A-410]R. Forstner; Salzburg/AT

C. Imaging the infertile couple [A-411]J. McHugo; Birmingham/UK

D. Interactive case discussion [A-412]E. Sala; New York, NY/US


111

Mini Courses

Thursday, March 7, 16:00–17:30, Room L/M MC 322: Technical and anatomical

fundamentals for imaging the heart

Moderator: A. de Roos; Leiden/NL

A. Anatomy: too many details in cardiac imaging? [A-036]A.J.B.S Madureira; Porto/PT

B. Examination protocols for imaging the heart: CT [A-037]H. Alkadhi; Zurich/CH

C. Examination protocols for imaging the heart: MRI [A-038]N.L. Kelekis; Athens/GR

• Interactive case discussion [A-039]A. de Roos; Leiden/NL

Friday, March 8, 08:30–10:00, Room L/M MC 422: Non-ischaemic heart disease

Moderator: V.E. Sinitsyn; Moscow/RU

A. Congenital heart disease [A-091]M. Gutberlet; Leipzig/DE

B. Valvular disease [A-092]J. Bogaert; Leuven/BE

C. Cardiomyopathies [A-093]P. Sipola; Kuopio/FI

• Interactive case discussion [A-094]V.E. Sinitsyn; Moscow/RU

Friday, March 8, 16:00–17:30, Room L/M MC 722: Ischaemic heart disease

Moderator: C. Catalano; Rome/IT

A. Imaging of the coronary arteries: the Holy Grail [A-182]G. Roditi; Glasgow/UK

B. The ischaemic myocardium: what to do? [A-183]C. Loewe; Vienna/AT

C. The ischaemic heart after treatment: still alive? [A-184]G. Bastarrika; Pamplona/ES

• Interactive case discussion [A-185]C. Catalano; Rome/IT

OrgansfromAtoZ:Heart ControversiesinBreastImaging

Friday, March 8, 08:30–10:00, Room D1 MC 423: Overdiagnosis from screening

mammography: should we care about it?

Moderator: T.H. Helbich; Vienna/AT Teaser: H.J. de Koning; Rotterdam/NL

A. The risk of overdiagnosis from screening mammography [A-062]E. Paci; Florence/IT

B. How breast radiologists should control the risk of overdiagnosis [A-063]U. Bick; Berlin/DE

• Discussion [A-064]T.H. Helbich; Vienna/AT H.J. de Koning; Rotterdam/NL

Friday, March 8, 14:00–15:30, Room D1 MC 623: Preoperative MRI in newly diagnosed

breast cancer: to do or not to do?

Moderator: F. Sardanelli; Milan/IT Teaser: N. Houssami; Sydney/AU

A. Why we should do preoperative MRI [A-128]W.A. Kaiser; Jena/DE

B. Reasons not to do preoperative MRI [A-129]M.G. Wallis; Cambridge/UK

• Discussion [A-130]F. Sardanelli; Milan/IT N. Houssami; Sydney/AU

Friday, March 8, 16:00–17:30, Room D1 MC 723: Should we add ultrasound to

mammographic screening of dense breasts?

Moderator: F.J. Gilbert; Cambridge/UK Teaser: A. Tardivon; Paris/FR

A. We can reduce the interval cancer rate [A-154]W. Berg; Pittsburgh, PA/US

B. Do we have enough radiologists to do it? Alternatives to ultrasound to reduce interval cancers [A-155]A. Frigerio; Turin/IT

• Discussion [A-156]F.J. Gilbert; Cambridge/UK A. Tardivon; Paris/FR


112

Mini CoursesTheBeautyofBasicKnowledge:MusculoskeletalImaging

TheBeautyofBasicKnowledge:HeadandNeck

Thursday, March 7, 12:30–13:30, Room PMC 25A: Trauma [A-002]

A. Kassarjian; Majadahonda/ES

Friday, March 8, 12:30–13:30, Room PMC 25B: Degenerative disorders [A-125]

T.M. Link; San Francisco, CA/US

Saturday, March 9, 12:30–13:30, Room PMC 25C: Inflammatory/infectious disorders

[A-275]

V.N. Cassar-Pullicino; Oswestry/UK

Sunday, March 10, 12:30–13:30, Room PMC 25D: Neoplastic/non-neoplastic lesions

[A-417]

F.M.H.M. Vanhoenacker; Antwerp/BE

Monday, March 11, 12:30–13:30, Room PMC 25E: Metabolic/endocrine disease [A-589]

J. Freyschmidt; Bremen/DE

Thursday, March 7, 12:30–13:30, Room N/O MC 24A: A taste of the oral cavity and

salivary glands [A-001]

A. Borges; Lisbon/PT

Friday, March 8, 12:30–13:30, Room QMC 24B: The infrahyoid neck and lymph nodes

[A-126]

M.G. Mack; Munich/DE

Saturday, March 9, 12:30–13:30, Room N/O MC 24C: Main pipelines of the neck:

pharynx and larynx [A-274]

M. Becker; Geneva/CH

Sunday, March 10, 12:30–13:30, Room QMC 24D: The suprahyoid neck: anatomy and

diagnostic algorithm of the neck mass [A-418]

A. Trojanowska; Lublin/PL

Monday, March 11, 12:30–13:30, Room N/O MC 24E: Temporal bone: so beautiful, yet

so complicated [A-588]

B. De Foer; Antwerp/BE

113

Mini Courses

Friday, March 8, 14:00–15:30, Room I/K MC 628: Essentials in oncologic imaging:

what radiologists need to know (part 3)

Moderator: Y. Menu; Paris/FR

A. Oncologic imaging: terminology, definitions and buzzwords [A-134]Y. Menu; Paris/FR

B. Liver cancers (primary, metastases) [A-135]R.L. Baron; Chicago, IL/US

C. Prostate cancer [A-136]J.O. Barentsz; Nijmegen/NL

• Questions

Friday, March 8, 16:00–17:30, Room I/K MC 728: Essentials in oncologic imaging: what

radiologists need to know (part 4)

Moderator: M.F. Reiser; Munich/DE

A. Lymphoma [A-179]H. Schoder; New York, NY/US

B. Musculoskeletal neoplasms [A-180]M.F. Reiser; Munich/DE

C. Chemo- and radiation therapy-induced toxicity [A-181]H.-U. Kauczor; Heidelberg/DE

• Questions



Moderator: D.M. Panicek; New York, NY/US

A. Principles of oncologic imaging and reporting [A-088]D.M. Panicek; New York, NY/US

B. Lung cancers (primary, metastases) [A-089]C.J. Herold; Vienna/AT

C. Colon cancer [A-090]R.M. Gore; Evanston, IL/US

• Questions



Moderator: H. Hricak; New York, NY/US

A. Pancreatic cancer [A-122]F. Caseiro-Alves; Coimbra/PT

B. Kidney cancer [A-123]E.K. Fishman; Baltimore, MD/US

C. Ovarian cancer [A-124]H. Hricak; New York, NY/US

• Questions

JointCourseofESRandRSNA(RadiologicalSocietyofNorthAmerica)


114

Refresher Courses / Scientific Sessions

Friday, March 8, 14:00–15:30, Room F1 SS 601: Liver steatosis: imaging

and quantification [B-0440 – B-0449]

Moderators: I. Bargellini; Pisa/IT B. Van Beers; Clichy/FR

Saturday, March 9, 10:30–12:00, Room I/K SS 901: Cross-sectional pancreatic imaging

and biomarkers [B-0570 – B-0579]

Moderators: B. Marincek; Cleveland, OH/US G. Zamboni; Verona/IT

Sunday, March 10, 08:30–10:00, Room B RC 1201: How I report

Moderator: G.A. Rollandi; Genoa/IT

A. MDCT in the post-operative abdomen [A-348]D.J.M. Tolan; Leeds/UK

B. MDCT in a patient with small bowel ischaemia [A-349]S. Romano; Naples/IT

C. MDCT in a patient with small bowel obstruction [A-350]P. Taourel; Montpellier/FR

Sunday, March 10, 10:30–12:00, Room I/K SS 1301: Abdominal CT: dose reduction

and technical improvements [B-0699 – B-0708]

Moderators: D. Tack; Baudour/BE A. Taibbi; Palermo/IT

Sunday, March 10, 16:00–17:30, Room B RC 1501: CT colonography: when the ’new‘

becomes ’ordinary‘

• Chairman’s introduction [A-478]A. Laghi; Latina/IT

A. State-of-the-art techniques in 2013 [A-479]T. Mang; Vienna/AT

B. How to set up a service [A-480]P. Lefere; Roeselare/BE

C. Interaction with gastroenterologists: friends or enemies? [A-481]A. Graser; Munich/DEC. Hassan; Rome/IT

• Panel discussion: How to create an efficient CTC team?

Thursday, March 7, 10:30–12:00, Room E2 SS 101a: Acute bowel diseases: challenges

and solutions [B-0051 – B-0060]

Moderators: J.B. Dormagen; Oslo/NO S. Leschka; St. Gallen/CH

Thursday, March 7, 10:30–12:00, Room I/K SS 101b: Liver fibrosis and cirrhosis:

elastography and biomarkers [B-0091 – B-0100]

Moderators: R. Faschingbauer; Innsbruck/AT T.J. Kroencke; Berlin/DE

Thursday, March 7, 14:00–15:30, Room E2 SS 201a: Bowel imaging: protocol optimisation

and intervention [B-0190 – B-0199]

Moderators: V. Cantisani; Rome/IT P. Popovic; Ljubljana/SI

Thursday, March 7, 14:00–15:30, Room I/K SS 201b: Hepatocellular carcinoma:

diagnosis and management [B-0230 – B-0239]

Moderators: G. Brancatelli; Palermo/IT M. Bruegel; Munich/DE

Thursday, March 7, 16:00–17:30, Room C RC 301: Staging and restaging of rectal and

anal cancer

• Chairman’s introduction [A-007]R.G.H. Beets-Tan; Maastricht/NL

A. Local staging of anal and rectal cancer and impact on initial therapeutic strategy [A-008]S. Gourtsoyianni; London/UK

B. Assessment of rectal cancer response [A-009]L. Curvo-Semedo; Coimbra/PT

C. Assessment of anal cancer response [A-010]V.J. Goh; London/UK

• Panel discussion: What clinicians expect from us in rectal and anal cancer staging and re-staging? How should we image patients?

Friday, March 8, 08:30–10:00, Room A RC 401: Pitfalls in interpretation of

pancreatic imaging

Moderator: H.-J. Brambs; Ulm/DE

A. Pancreatic cancer or pancreatitis? [A-055]B.J. Op de Beeck; Antwerp/BE

B. How can we differentiate cystic neoplasms from pseudocysts? [A-056]T. Denecke; Berlin/DE

C. How to manage incidental findings [A-057]C. Triantopoulou; Athens/GR

AbdominalandGastrointestinal

115

Refresher Courses / Scientific SessionsAbdominalandGastrointestinal

Monday, March 11, 14:00–15:30, Room E2 SS 1801a: Colorectal cancer: diagnostic biomarkers and response assessment [B-0939 – B-0948]

Moderators: A. Filippone; Chieti/IT J. Husty; Brno/CZ

Monday, March 11, 14:00–15:30, Room I/K SS 1801b: Liver volume, function and focal lesions [B-0979 – B-0988]

Moderators: B.I. Choi; Seoul/KR C. Nyhsen; Sunderland/UK

Monday, March 11, 16:00–17:30, Room C RC 1901: Cross-sectional imaging of colitis

• Chairman’s introduction [A-590]S.A. Taylor; London/UK

A. What protocol to use? [A-591]S. Schmidt; Lausanne/CH

B. Differentiating between the causes of colitis [A-592]B. Gallix; Montpellier/FR

C. The role of cross-sectional imaging in colonic inflammatory bowel disease [A-593]J. Rimola; Barcelona/ES

• Panel discussion: The role of cross-sectional imaging in the diagnosis and follow-up of colitis

Monday, March 11, 08:30–10:00, Room E1 RC 1601a: Diagnosis and staging of

esophageal cancer

• Chairman’s introduction [A-544]Z. Tarján; Budapest/HU

A. Diagnosis [A-545]M. Krokidis; CambridgeUK

B. Staging [A-546]V. Válek; Brno/CZ

C. Treatment response [A-547]B. Mahon; Birmingham/UK

• Panel discussion: Cross-sectional techniques: developing an integrated imaging algorithm in oesophageal cancer

Monday, March 11, 08:30–10:00, Room F1 RC 1601b: Abdominal MRI: standard

and advanced protocols in clinical settings

Moderator: M.A. Patak; Zurich/CH

A. Fistula in ano [A-552]A. Gupta; London/UK

B. Pelvic floor disease [A-553]M. Bazot; Paris/FR

C. Suspected biliary tumour [A-554]C. Matos; Brussels/BE

Monday, March 11, 10:30–12:00, Room E2 SS 1701a: CT/MR colonography: technical issues and clinical studies [B-0789 – B-0798]

Moderators: D. Cano; Pamplona/ES D.Z. Saranovic; Belgrade/RS

Monday, March 11, 10:30–12:00, Room I/K SS 1701b: DWI in pancreatic and hepatobiliary diseases [B-0829 – B-0838]

Moderators: G.J. Munneke; London/UK D. Weishaupt; Zurich/CH

116


Saturday, March 9, 08:30–10:00, Room F1 RC 802: Clinical challenges in breast MRI

• Chairman’s introduction [A-225]F.J. Gilbert; Cambridge/UK

A. High risk patients: establishing clinical protocols [A-226]J. Veltman; Almelo/NL

B. Non-mass like enhancement (NMLE): when to biopsy? [A-227]C.K. Kuhl; Aachen/DE

C. Monitoring response to neo-adjuvant chemotherapy [A-228]T.H. Helbich; Vienna/AT

• Panel discussion: how can the specificity and sensitivity of breast MRI in these indeterminate clinical and imaging scenarios be maximised?

Saturday, March 9, 10:30–12:00, Room F2 SS 902: Increased risk of breast cancer

[B-0559 – B-0569]

Moderators: L.A. Carbonaro; San Donato Milanese/IT L. Ollivier; Paris/FR

Sunday, March 10, 08:30–10:00, Room F2 RC 1202: Multi-modality breast imaging

• Chairman’s introduction [A-373]M. Lesaru; Bucharest/RO

A. Conventional, functional and interventional lymph node assessment [A-374]P.D. Britton; Cambridge/UK

B. Multi-modality assessment of the breast following oncoplastic Surgery [A-375]M. Torres-Tabanera; Madrid/ES

C. Image guided therapy in breast lesions: indications and techniques [A-376]G. Manenti; Rome/IT

• Panel discussion: how is the evolution of multi-modality breast imaging changing the nature of the multi-disciplinary meeting (MDM)?

Sunday, March 10, 10:30–12:00, Room F2 SS 1302: How to get more from breast imaging

modalities [B-0679 – B-0688]

Moderators: N. Houssami; Sydney/AU M. Nadrljanski; Belgrade/RS

Sunday, March 10, 14:00–15:30, Room F2 RC 1402: How I report

Moderator: A. Tardivon; Paris/FR

A. Mammography [A-446]E. Azavedo; Stockholm/SE

B. Breast US [A-447]J. Camps Herrero; Valencia/ES

C. Breast MRI [A-448]R.M. Mann; Nijmegen/NL

Breast

Thursday, March 7, 10:30–12:00, Room F2 SS 102: Breast MRI: improving accuracy

and tissue characterisation [B-0071 – B-0080]

Moderators: R. Schulz-Wendtland; Erlangen/DE M. Telesca; Rome/IT

Thursday, March 7, 14:00–15:30, Room F2 SS 202: Improvements in preoperative staging

of breast cancer [B-0210 – B-0219]

Moderators: R.A. Kubik-Huch; Baden/CH A. Zytoon; Shebin El-Kom/EG

Thursday, March 7, 16:00–17:30, Room F2 RC 302: Functional imaging of the breast

Moderator: G. Esen; Istanbul/TR

A. Contrast-enhanced mammography [A-027]C.S. Balleyguier; Villejuif/FR

B. Ultrasound elastography [A-028]A. Athanasiou; Paris/FR

C. MRI diffusion, perfusion and spectroscopy [A-029]P.A.T. Baltzer; Jena/DE

Friday, March 8, 10:30–12:00, Room F2 SS 502: Elastography and other advances in

breast ultrasound [B-0330 – B-0339]

Moderators: D. Djilas-Ivanovic; Sremska Kamenica/RS P. Skaane; Oslo/NO

Friday, March 8, 14:00–15:30, Room F2 SS 602: Breast imaging after neoadjuvant

therapy and surgery [B-0450 – B-0459]

Moderators: G. Gennaro; Padua/IT P. Martinez-Miravete; Zaragoza/ES

117

Refresher Courses / Scientific SessionsBreast Cardiac

Monday, March 11, 10:30–12:00, Room F2 SS 1702: Tomosynthesis: a role in clinical

practice? [B-0809 – B-0818]

Moderators: S. Allen; Sutton/UK E.M. Jung; Regensburg/DE

Monday, March 11, 14:00–15:30, Room F1 SS 1802a: Newer techniques in breast imaging and therapy [B-0949 – B-0958]

Moderators: F. Chamming’s; Paris/FR M. Sklair-Levy; Tel Aviv/IL

Monday, March 11, 14:00–15:30, Room F2 SS 1802b: Maximising cancer detection in

breast screening [B-0959 – B-0968]

Moderators: M. Álvarez-Benito; Córdoba/ES E. Szabó; Szeged/HU

Monday, March 11, 16:00–17:30, Room F2 RC 1902: Breast ultrasound

Moderator: M. Müller-Schimpfle; Frankfurt a. Main/DE

A. Physics and practical aspects of high-quality hand-held and automated breast US [A-610]M.H. Fuchsjäger; Graz/AT

B. Complicated cysts and complex-cystic lesions: differentiation and management [A-611]C.F. Weismann; Salzburg/AT

C. The use of ultrasound in the evaluation of the nipple-areolar complex [A-612]R. Salvador; Barcelona/ES

Thursday, March 7, 10:30–12:00, Room B SS 103: CT and MRI in preoperative

and postoperative evaluation [B-0001 – B-0010]

Moderators: G.A. Krombach; Giessen/DE R. Sanz-Requena; Valencia/ES

Thursday, March 7, 14:00–15:30, Room PSS 203: Planning cardiac interventions

[B-0260 – B-0269]

Moderators: I. Arkhipova; Moscow/RU P. Mildenberger; Mainz/DE

Thursday, March 7, 16:00–17:30, Room D2RC 303: Cardiac imaging: the cutting edge

Moderator: E. Di Cesare; L’Aquila/IT

A. Cardiac MRI: do we need more than 1.5T? [A-011]B.J. Wintersperger; Toronto, ON/CA

B. Cardiac CT: technique in 2020; where to next? [A-012]K. Nikolaou; Munich/DE

C. Cardiac hybrid imaging: “One-Stop-Shop” [A-013]P.A. Kaufmann; Zurich/CH

Friday, March 8, 10:30–12:00, Room PSS 503: Advances in coronary CT angiography

[B-0370 – B-0379]

Moderators: S. Bohata; Brno/CZ L. Natale; Sesto Fiorentino/IT

Friday, March 8, 14:00–15:30, Room C SS 603a: CT and MRI: risk stratification

[B-0410 – B-0419]

Moderators: E. Mershina; Moscow/RU M.R. Rees; Gwynedd/UK

Friday, March 8, 14:00–15:30, Room G/H SS 603b: Cardiomyopathy and fibrosis

[B-0460 – B-0469]

Moderators: P. Donato; Coimbra/PT R. Maksimović; Belgrade/RS

118


Monday, March 11, 08:30–10:00, Room PRC 1603: How I report

Moderator: R. Vliegenthart; Groningen/NL

A. Chest x-ray in cardiac disease [A-572]M. Rubens; London/UK

B. Coronary CTA [A-573]F. Wolf; Vienna/AT

C. Cardiac MRI in ischaemic heart disease [A-574]J. Bremerich; Basle/CH

Monday, March 11, 10:30–12:00, Room N/O SS 1703: Biomarkers, tissue characterisation

and remodelling [B-0849 – B-0858]

Moderators: M. Das; Maastricht/NL K. Gruszczynska; Katowice/PL

Monday, March 11, 14:00–15:30, Room D1 SS 1803: Cardiac imaging: into the future

[B-0909 – B-0918]

Moderators: R.W. Bauer; Frankfurt/DE E. Canet Soulas; Bron/FR

Saturday, March 9, 08:30–10:00, Room PRC 803: Practical approach to cardiovascular

risk stratification with CT and MRI

Moderator: C. Peebles; Southampton/UK

A. Modern views on value of coronary calcium scoring for risk assessment [A-248]A. Stadler; Vienna/AT

B. Coronary CTA: from detection of stenosis to prognosis [A-249]N.R. Mollet; Turnhout/BE

C. Myocardial perfusion and viability for risk scoring [A-250]A. de Roos; Leiden/NL

Saturday, March 9, 10:30–12:00, Room N/O SS 903: Myocardial perfusion and coronary

artery disease [B-0580 – B-0589]

Moderators: F. Cademartiri; Monastier di Treviso/IT G.I. Kirova-Nedialkova; Sofia/BG

Sunday, March 10, 10:30–12:00, Room E2 SS 1303: Towards improved image quality

and detection [B-0660 – B-0669]

Moderators: G. Feuchtner; Innsbruck/AT C. Herzog; Munich/DE

Sunday, March 10, 16:00–17:30, Room I/K RC 1503: Cardiac CT and MRI in difficult

patients: what to do?

• Chairman’s introduction [A-512]M. Hamilton; Bristol/UK

A. Coronary CTA in patients with severe arrhythmias and high heart rate [A-513]C. Loewe; Vienna/AT

B. Severe coronary calcinosis and stents: tips and tricks in image acquisition and interpretation [A-514]F. Pugliese; London/UK

C. Cardiac MRI: possible problems and how to avoid them [A-515]E. Mershina; Moscow/RU

• Panel discussion: When to scan and when not to? How can we make the best of what we have?

Cardiac

119


Saturday, March 9, 16:00–17:30, Room I/K RC 1104: Pulmonary infections:

the old and the new

Moderator: F. Gleeson; Oxford/UK

A. Mycobacterial infections [A-333]C. Beigelman; Lausanne/CH

B. Infectious disease in immuno-compromised patients [A-334]C.P. Heussel; Heidelberg/DE

C. Emerging infections [A-335]T. Franquet; Barcelona/ES

Sunday, March 10, 08:30–10:00, Room I/K RC 1204: Lung cancer staging in 2013

• Chairman’s introduction: the latest TNM classification [A-380]J. Biederer; Heidelberg/DE

A. Local tumour staging [A-381]L. Bonomo; Rome/IT

B. Lymph node staging [A-382]W.F.M. De Wever; Leuven/BE

C. Distant metastasis and whole body imaging [A-383]G. Antoch; Düsseldorf/DE

• Panel discussion: Facts and controversies in lung cancer staging

Sunday, March 10, 10:30–12:00, Room D1 SS 1304: CTPA techniques in lung perfusion

and pulmonary hypertension [B-0630 – B-0639]

Moderators: I. Hartmann; Rotterdam/NL E.J. Stern; Seattle, WA/US

Thursday, March 7, 10:30–12:00, Room D1 SS 104: Lung cancer: from tissue

characterisation to treatment [B-0021 – B-0030]

Moderators: E. Castañer; Sabadell/ES N. Tacelli; Brussels/BE

Thursday, March 7, 14:00–15:30, Room D1 SS 204: Airways and infiltrative lung diseases

[B-0160 – B-0169]

Moderators: G.R. Ferretti; Grenoble/FR C. Mueller-Mang; Vienna/AT

Thursday, March 7, 16:00–17:30, Room I/K RC 304: How I report

Moderator: J. Cáceres; Barcelona/ES

A. Bedside chest radiography [A-033]R. Eibel; Schwerin/DE

B. CTA and MRA of the pulmonary arteries [A-034]J.E. Wildberger; Maastricht/NL

C. PET/CT [A-035]C. Keyzer; Brussels/BE

Friday, March 8, 10:30–12:00, Room D1 SS 504: Lung nodules[B-0290 – B-0299]

Moderators: S. Diederich; Düsseldorf/DE N. Karabulut; Denizli/TR

Saturday, March 9, 08:30–10:00, Room I/K RC 804: Patterns in chest radiology: are there

subtype patterns of ground glass opacity (GGO)?

• Chairman’s introduction [A-237]A. Oikonomou; Alexandroupolis/GR

A. Ground glass opacification: why do we see it and what does it mean? [A-238]S.R. Desai; London/UK

B. Inflammatory and infectious GGO [A-239]K. Marten-Engelke; Göttingen/DE

C. GGO in dysplasia and neoplasia [A-240]G.R. Ferretti; Grenoble/FR

• Panel discussion: How should we report and manage ground glass opacity?

Saturday, March 9, 10:30–12:00, Room D1 SS 904: Image quality and dose reduction

[B-0519 – B-0528]

Moderators: P.A. Grenier; Paris/FR J. Vlahos; London/UK

Chest

120


Monday, March 11, 08:30–10:00, Room I/K RC 1604: Pulmonary embolism: guidelines and

best practice throughout Europe

• Chairman’s introduction [A-559]M. Rémy-Jardin; Lille/FR

A. Pioped 1-2-3: what have we learned so far? [A-560]C. Engelke; Göttingen/DE

B. PE in oncologic patients [A-561]B. Ghaye; Brussels/BE

C. PE during pregnancy and puerperium [A-562]M.-P. Revel; Paris/FR

• Panel discussion: Pulmonary embolism work-up in 2013

Monday, March 11, 10:30–12:00, Room D1 SS 1704: Technological refinements:

from x-rays to micro-imaging [B-0759 – B-0768]

Moderators: A.P. Parkar; Bergen/NO C.M. Schaefer-Prokop; Amersfoort/NL

Monday, March 11, 16:00–17:30, Room I/K RC 1904: Phenotypes in obstructive airway

disease: how should I image, analyse and report?

Moderator: P.A. Gevenois; Brussels/BE

A. Asthma and associated conditions [A-616]P.-Y. Brillet; Bobigny/FR

B. Chronic obstructive pulmonary disease (COPD) [A-617]N. Sverzellati; Parma/IT

C. Cystic fibrosis and other bronchiectatic diseases [A-618]M.U. Puderbach; Heidelberg/DE

Chest ComputerApplications

Thursday, March 7, 10:30–12:00, Room ZSS 105: IT infrastructure, learning support

and teleradiology [B-0141 – B-0149]

Moderators: B. Gibaud; Rennes/FR A. Simisker; Tartu/EE

Thursday, March 7, 14:00–15:30, Room ZSS 205: Quantitative image analysis

and optimisation [B-0280 – B-0289]

Moderators: L. Faggioni; Pisa/IT M. Fatehi; Tehran/IR

Thursday, March 7, 16:00–17:30, Room QRC 305: New PACS architecture: decoupling

image management from image navigation

• Chairman’s introduction [A-047]H.U. Lemke; Berlin/DE

A. Image navigation and new PACS architecture [A-048]J. Reponen; Raahe/FI

B. Intraoperative imaging for surgeons [A-049]A. Pietrabissa; Pavia/IT

C. Dismantling PACS: separating image viewing from the data storage and sharing [A-050]B. Gibaud; Rennes/FR

• Panel discussion: How should we manage our images today?

Saturday, March 9, 10:30–12:00, Room ZSS 905: Computer-aided diagnosis

[B-0610 – B-0619]

Moderators: T. Mang; Vienna/AT D. Regge; Turin/IT

Monday, March 11, 08:30–10:00, Room QRC 1605: Improving workflow efficiency

and quality

• Chairman’s introduction [A-575]D. Caramella; Pisa/IT

A. Improving quality and efficiency of computerised order entry through decision support [A-576]P. Mildenberger; Mainz/DE

B. Improving quality and efficiency of reporting by structure and templates [A-577]N. Dugar; Doncaster/UK

C. Improving quality and efficiency of dose management through exchange between modalities and registries [A-578]E. Vaño; Madrid/ES

• Panel discussion: Will novel IT tools really improve quality and efficiency in daily radiological practice?

121

Refresher Courses / Scientific SessionsMolecularImagingandContrastMedia Genitourinary

Thursday, March 7, 16:00–17:30, Room E1 RC 306: Molecular imaging in oncology

Moderator: O. Clément; Paris/FR

A. New PET-tracers for oncology [A-014]P.L. Choyke; Bethesda, MD/US

B. Potential of MRI for molecular imaging in oncology [A-015]F.A. Gallagher; Cambridge/UK

C. Emerging molecular imaging techniques [A-016]F.M.A. Kiessling; Aachen/DE

Friday, March 8, 14:00–15:30, Room ZSS 606: MR/PET and PET/CT [B-0500 – B-0508]

Moderators: N. Belcari; Pisa/IT P.R. Ros; Cleveland, OH/US

Sunday, March 10, 10:30–12:00, Room ZSS 1306: New agents and protocols

[B-0739 – B-0748]

Moderators: L. Grazioli; Brescia/IT T.C. Lauenstein; Essen/DE

Monday, March 11, 10:30–12:00, Room ZSS 1706: Molecular imaging in cancer

and degenerative diseases [B-0879 – B-0888]

Moderators: J. Hakumäki; Kuopio/FI E. Lopci; Rozzano/IT

Monday, March 11, 14:00–15:30, Room ZSS 1806: Functional studies and safety

[B-1029 – B-1038]

Moderators: T. Gleeson; Wexford/UK E.M. Merkle; Basle/CH

Monday, March 11, 16:00–17:30, Room D2RC 1906: How I optimise contrast

media administration

Moderator: W. Semmler; Heidelberg/DE

A. CT [A-594]P. Leander; Malmö/SE

B. MRI [A-595]G.M. Bongartz; Basle/CH

C. PET/CT [A-596]X. Montet; Geneva/CH

Thursday, March 7, 10:30–12:00, Room G/H SS 107: Prostate imaging [B-0081 – B-0090]

Moderators: S. Morozov; Moscow/RU J. Richenberg; Brighton/UK

Thursday, March 7, 16:00–17:30, Room G/H RC 307: Renal and adrenal tumours

Moderator: B. Brkljačić; Zagreb/HR

A. Adrenal masses, a practical approach [A-030]G. Heinz-Peer; St. Pölten/AT

B. Staging renal cancer [A-031]R. Pozzi-Mucelli; Verona/IT

C. How to deal with small indeterminate renal masses [A-032]O. Hélénon; Paris/FR

Friday, March 8, 10:30–12:00, Room G/H SS 507: New frontiers in GU imaging

[B-0340 – B-0349]

Moderators: G. Hagen; Oslo/NO C.M.A. Hoeks; Nijmegen/NL

Friday, March 8, 14:00–15:30, Room A SS 607: Female pelvis imaging

[B-0390 – B-0399]

Moderators: L.S. Fournier; Paris/FR A.G. Rockall; London/UK

Friday, March 8, 16:00–17:30, Room G/H RC 707: Diagnosis and management of

GU tract trauma

Moderator: A. Magnusson; Uppsala/SE

A. Imaging the kidney and ureter [A-176]M.-F. Bellin; Le Kremlin-Bicêtre/FR

B. Imaging the bladder and urethra [A-177]U.G. Mueller-Lisse; Munich/DE

C. Interventional radiology for GU Trauma [A-178]B. Peynircioglu; Ankara/TR

122


Thursday, March 7, 14:00–15:30, Room C SS 208: Head and neck cancer: functional

imaging and hybrid modalities [B-0150 – B-0159]

Moderators: N. Abolmaali; Dresden/DE S. Steens; Nijmegen/NL

Friday, March 8, 14:00–15:30, Room L/M SS 608: Technical innovations, TMJ disease and

rare entities [B-0470 – B-0479]

Moderators: J. Frühwald-Pallamar; Vienna/AT J. Widelec; Brussels/BE

Saturday, March 9, 16:00–17:30, Room D2RC 1108: Skull base lesions: imaging studies

and differential diagnosis

Moderator: L. Grzycka-Kowalczyk; Lublin/PL

A. Anterior cranial fossa with special emphasis on olfactory apparatus lesions [A-309]T.P.J. Duprez; Brussels/BE

B. Middle cranial fossa pathologies [A-310]A. Borges; Lisbon/PT

C. Posterior cranial fossa pathologies [A-311]H. Tanghe; Rotterdam/NL

Sunday, March 10, 10:30–12:00, Room L/M SS 1308: Advanced imaging of the ear, orbit

and glands [B-0709 – B-0718]

Moderators: R. Elias; Rotterdam/NL B.F. Schuknecht; Zurich/CH

Sunday, March 10, 14:00–15:30, Room N/O RC 1408: Laryngeal cancer and radiology

• Chairman’s introduction [A-460]J.E. Kabala; Bristol/UK

A. Staging of laryngeal cancer: pearls and pitfalls [A-461]R. Maroldi; Brescia/IT

B. Evaluation after surgery and non-surgical treatment: expected findings [A-462]S. Bisdas; Tübingen/DE

C. Cancer recurrence: how to address clinical dilemmas [A-463]B. Verbist; Leiden/NL

• Panel discussion: Diagnostic algorithms for diagnosis and follow-up of laryngeal cancer

HeadandNeckGenitourinary

Sunday, March 10, 08:30–10:00, Room G/H RC 1207: How I report

Moderator: G.M. Villeirs; Gent/BE

A. Female pelvis MRI [A-377]A.G. Rockall; London/UK

B. Prostate MRI [A-378]J.J. Fütterer; Nijmegen/NL

C. CT urography [A-379]N.C. Cowan; Oxford/UK

Sunday, March 10, 10:30–12:00, Room G/H SS 1307: The bladder and below

[B-0689 – B-0698]

Moderators: M. Baramia; Tbilisi/GE R.H. Oyen; Leuven/BE

Sunday, March 10, 14:00–15:30, Room I/K RC 1407: Contrast media safety: update

• Chairman’s introduction [A-453]P. Reimer; Karlsruhe/DE

A. Acute non-renal reactions to contrast media: new concepts [A-454]O. Clément; Paris/FR

B. Nephrogenic systemic fibrosis: from pathophysiology to recommendations [A-455]H.S. Thomsen; Herlev/DK

C. Contrast medium-induced nephropathy and new guidelines [A-456]F. Stacul; Trieste/IT

• Panel discussion: What is the most appropriate radiological approach to patients with falling eGFR and when should contrast media be administered and when should it not?

Monday, March 11, 10:30–12:00, Room G/H SS 1707: Hints on haematuria and adrenals for

all [B-0819 – B-0828]

Moderators: O. Nikolic; Novi Sad/RS K. Sugimura; Kobe/JP

Monday, March 11, 14:00–15:30, Room G/H SS 1807: Mixed modalities in GU imaging

[B-0969 – B-0978]

Moderators: A.J. Beer; Munich/DE I. Vivas; Pamplona/ES

123

Refresher Courses / Scientific SessionsHeadandNeck InterventionalRadiology

Thursday, March 7, 10:30–12:00, Room D2SS 109: Chemoembolisation and

radioembolisation of liver tumours [B-0031 – B-0040]

Moderators: A. Denys; Lausanne/CH P. Paprottka; Munich/DE

Thursday, March 7, 14:00–15:30, Room D2SS 209: Ablation and biopsy of the prostate and

the kidney [B-0170 – B-0179]

Moderators: J.J. Fütterer; Nijmegen/NL J. Kettenbach; Berne/CH

Thursday, March 7, 16:00–17:30, Room N/O RC 309: Percutaneous treatment of chronic

back pain and sciatica

• Chairman’s introduction [A-040]A.D. Kelekis; Athens/GR

A. Sacroiliac joint syndrome [A-041]D.J. Wilson; Oxford/UK

B. Facet syndrome [A-042]M. Gallucci; L’Aquila/IT

C. Intervertebral disc syndromes [A-043]A. Gangi; Strasbourg/FR

• Panel discussion: How can imaging methods separate candidates for percutaneous therapy and surgery?

Friday, March 8, 10:30–12:00, Room D2SS 509: Neurovascular and spine interventions

[B-0300 – B-0309]

Moderators: E.R. Gizewski; Innsbruck/AT L. Pierot; Reims/FR

Friday, March 8, 14:00–15:30, Room D2SS 609a: Oncologic ablation and

guided interventions [B-0420 – B-0429]

Moderators: P. Almeida; Coimbra/PT A. Basile; Catania/IT

Friday, March 8, 14:00–15:30, Room PSS 609b: Gynaecological and

obstetric interventions [B-0490 – B-0499]

Moderators: P.E. Andersen; Odense/DK R. Nijenhuis; Maastricht/NL

Sunday, March 10, 16:00–17:30, Room N/O RC 1508: Performing and reporting head and

neck examinations: how should I do it?

Moderator: K. Surlan Popovič; Ljubljana/SI

A. Sinonasal CT scans: technique and evaluation [A-519]H.B. Eggesbø; Oslo/NO

B. Temporal bone: CT and MRI [A-520]M.M. Lemmerling; Gent/BE

C. CT and MRI of the neck: how to address key clinical questions [A-521]D. Farina; Brescia/IT

Monday, March 11, 16:00–17:30, Room N/O RC 1908: Temporal bone: imaging the most

common symptoms and signs

Moderator: T. Beale; London/UK

A. Conductive hearing loss: what’s behind it? [A-619]A. Trojanowska; Lublin/PL

B. Sensorineural hearing loss: a challenge for radiologists [A-620]J.W. Casselman; Bruges/BE

C. Tinnitus and vertigo: diagnostic algorithm [A-621]R.B.-J. de Bondt; Zwolle/NL

124

Refresher Courses / Scientific SessionsInterventionalRadiology

Sunday, March 10, 08:30–10:00, Room N/O RC 1209: Gynaecological and obstetrical

haemorrhagic emergencies

• Chairman’s introduction [A-388]A.-M. Belli; London/UK

A. Etiology and treatment of gynaecological benign and malignant causes of massive bleeding [A-389]A. Keeling; Dublin/IE

B. Can we prevent post-partum haemorrhage in high-risk patients? [A-390]J.-P. Pelage; Caen/FR

C. Treatment of post-partum haemorrhage [A-391]M. Szczerbo-Trojanowska; Lublin/PL

• Panel discussion: How to reduce the radiation doses of these methods?

Sunday, March 10, 10:30–12:00, Room D2SS 1309: Skeletal and endocrinologic

interventions [B-0640 – B-0649]

Moderators: L. Crocetti; Pisa/IT D.K. Tsetis; Iraklion/GR

Monday, March 11, 10:30–12:00, Room D2SS 1709: Abdominal interventions:

from TIPS to bile ducts [B-0769 – B-0778]

Moderators: R.F. Dondelinger; Liège/BE B. Sekovski; Split/HR

Monday, March 11, 14:00–15:30, Room D2SS 1809: New approaches to aortic

and peripheral interventions [B-0919 – B-0928]

Moderators: S. Kudrnova; Budapest/HU R. Morgan; London/UK

Friday, March 8, 16:00–17:30, Room N/O RC 709: Expanding the role of interventional

radiology in hepatocellular carcinoma

• Chairman’s introduction [A-186]V. Válek; Brno/CZ

A. RF ablation [A-187]J.L. del Cura; Bilbao/ES

B. Intra-arterial procedures [A-188]F. Orsi; Milan/IT

C. Portal vein embolisation before Surgery [A-189]A. Denys; Lausanne/CH

• Panel discussion: How to allow for more patients with HCC to be treated?

Saturday, March 9, 08:30–10:00, Room N/O RC 809: What should every radiologist know

about the endovascular treatment of abdominal aortic aneurysms?

• Chairman’s introduction [A-244]H. Rousseau; Toulouse/FR

A. Pre-therapeutic radiological evaluation [A-245]J. Raupach; Hradec Kralove/CZ

B. EVAR techniques and results [A-246]F. Fanelli; Rome/IT

C. Imaging follow-up and treatment of complications [A-247]R. Morgan; London/UK

• Panel discussion: What are the best imaging methods for follow-up?

Saturday, March 9, 10:30–12:00, Room D2SS 909: Thoracic interventions

[B-0529 – B-0538]

Moderators: J. Tacke; Passau/DE K. Zelenak; Martin/SK

Saturday, March 9, 16:00–17:30, Room N/O RC 1109: Update on biliary interventions

• Chairman’s introduction [A-339]M. Krokidis; Cambridge/UK

A. Fistula and benign stenosis [A-340]M. Bezzi; Rome/IT

B. Interventions after liver transplantation [A-341]P. Goffette; Brussels/BE

C. In tandem with endoscopy [A-342]D.F. Martin; Manchester/UK

• Panel discussion: Are there new possibilities in the area of biliary interventions?

125


Saturday, March 9, 10:30–12:00, Room E1 SS 910: Spine: advancing the use of CT and MRI

[B-0539 – B-0548]

Moderators: P.M. Cunningham; Navan/IE J. Labuscagne; Bunbury, WA/AU

Saturday, March 9, 16:00–17:30, Room E1 RC 1110: The knee

• Chairman’s introduction [A-312]F.M.H.M. Vanhoenacker; Antwerp/BE

A. Patterns of injury [A-313]P. Van Dyck; Antwerp/BE

B. Inflammatory disease [A-314]A. Cotten; Lille/FR

C. Soft tissue tumours/tumour-like lesions [A-315]J.C. Vilanova; Girona/ES

• Panel discussion: What are the remaining clinical questions that imaging currently cannot answer and how can we answer them in the future?

Sunday, March 10, 08:30–10:00, Room E1 RC 1210: Overuse injuries in sport:

a multimodality approach

Moderator: E. Llopis; Valencia/ES

A. Overuse injuries in the footballer’s ankle [A-361]S.J. Eustace; Dublin/IE

B. Overuse injuries in the gymnast’s spine [A-362]M.C. De Jonge; Amsterdam/NL

C. Upper limb overuse injuries in golfers [A-363]P.J. O’Connor; Leeds/UK

Sunday, March 10, 10:30–12:00, Room E1 SS 1310: Arthritis and metabolic bone disease

[B-0650 – B-0659]

Moderators: A.J. Grainger; Leeds/UK A. Plagou; Athens/GR

Sunday, March 10, 14:00–15:30, Room E1 RC 1410: How I report

Moderator: M. Padrón; Madrid/ES

A. Soft tissue mass: US/MR [A-434]C. van Rijswijk; Leiden/NL

B. MR of vertebral body collapse [A-435]R. Lalam; Oswestry/UK

C. MR of the unstable shoulder [A-436]M. Zanetti; Zurich/CH

Musculoskeletal

Thursday, March 7, 10:30–12:00, Room E1 SS 110: Shoulder and hand [B-0041 – B-0050]

Moderators: C. Schüller-Weidekamm; Vienna/AT M. Shahabpour; Brussels/BE

Thursday, March 7, 14:00–15:30, Room E1 SS 210: Lower limb: tricks for improved imaging

[B-0180 – B-0189]

Moderators: A. Klauser; Innsbruck/AT L.M. Sconfienza; San Donato Milanese/IT

Friday, March 8, 10:30–12:00, Room E1 SS 510: Tendon, muscle and tissue composition

[B-0310 – B-0319]

Moderators: J. Healy; London/UK A. Mileto; Durham, NC/US

Friday, March 8, 14:00–15:30, Room E1 SS 610a: Musculoskeletal tumours

[B-0430 – B-0439]

Moderators: R. Lalam; Oswestry/UK E. Quaia; Trieste/IT

Friday, March 8, 14:00–15:30, Room N/O SS 610b: Cartilage: advanced imaging

[B-0480 – B-0489]

Moderators: A. Karpenko; St. Petersburg/RU P. Omoumi; Brussels/BE

Friday, March 8, 16:00–17:30, Room E1 RC 710: Peripheral nerve imaging: MRI and US

• Chairman’s introduction [A-160]J. Renoux; Paris/FR

A. Applied radiological anatomy and pathology of the brachial plexus [A-161]S. Gerevini; Milan/IT

B. Upper limb nerve entrapment [A-162]D. Weishaupt; Zurich/CH

C. Lower limb nerve entrapment [A-163]C. Martinoli; Genoa/IT

• Panel discussion: Which on-going technological advances in MRI and US could influence the way we image peripheral nerves in the future?

126

Refresher Courses / Scientific SessionsMusculoskeletal Neuro

Thursday, March 7, 10:30–12:00, Room C SS 111: From structure to function

[B-0011 – B-0020]

Moderators: S.J. Bakke; Oslo/NO B. Ertl-Wagner; Munich/DE

Thursday, March 7, 14:00–15:30, Room G/H SS 211: Infection and inflammation

[B-0220 – B-0229]

Moderators: E. Marco de Lucas; Santander/ES G. Schroth; Berne/CH

Friday, March 8, 08:30–10:00, Room G/H RC 411: The paediatric brain:

not just a small brain

Moderator: C. Venstermans; Antwerp/BE

A. Neurocutaneous syndromes: more than neurofibromatosis [A-085]B. Ertl-Wagner; Munich/DE

B. Patterns of white matter disease in children [A-086]A. Rossi; Genoa/IT

C. Paediatric brain tumours [A-087]C. Hoffmann; Tel Hashomer/IL

Friday, March 8, 10:30–12:00, Room L/M SS 511: Stroke-related arterial disease

[B-0350 – B-0359]

Moderators: E. Avdagic; Sarajevo/BA P. Barsi; Budapest/HU

Friday, March 8, 14:00–15:30, Room B SS 611: Alzheimer’s and Parkinson’s

[B-0400 – B-0409]

Moderators: B. Góraj; Nijmegen/NL T. Meindl; Landshut/DE

Monday, March 11, 10:30–12:00, Room E1 SS 1710: Hip: CT and MRI applications

[B-0779 – B-0788]

Moderators: M.H. Maurer; Berlin/DE A. Vieira; Porto/PT

Monday, March 11, 14:00–15:30, Room E1 SS 1810: Knee: new horizons

[B-0929 – B-0938]

Moderators: M.P. Aparisi Gomez; Valencia/ES A. Cotten; Lille/FR

Monday, March 11, 16:00–17:30, Room E1 RC 1910: Intra-articular imaging

• Chairman’s introduction [A-597]A.H. Karantanas; Iraklion/GR

A. Standard MR techniques [A-598]C. Faletti; Turin/IT

B. CT arthrography [A-599]C.W.A. Pfirrmann; Zurich/CH

C. MR arthrography [A-600]J. Kramer; Linz/AT

• Panel discussion: Which imaging technique for which clinical scenario?

127

Refresher Courses / Scientific SessionsNeuro

Monday, March 11, 08:30–10:00, Room G/H RC 1611: Spine: update on postoperative

imaging and minimally invasive procedures

• Chairman’s introduction [A-555]J. Van Goethem; Antwerp/BE

A. Postoperative spine [A-556]L. Van den Hauwe; Brasschaat/BE

B. Indications for vertebroplasty [A-557]A. Gangi; Strasbourg/FR

C. Percutaneous treatment of spinal diseases [A-558]M. Muto; Naples/IT

• Panel discussion: Minimally invasive spinal procedures: the radiologist’s future role?

Monday, March 11, 10:30–12:00, Room C SS 1711: Brain ischaemia: perfusion

and diffusion [B-0749 – B-0758]

Moderators: L. Oleaga Zufiría; Barcelona/ES M. Vernooij; Rotterdam/NL

Monday, March 11, 14:00–15:30, Room B SS 1811a: Latest developments

in neuroimaging [B-0889 – B-0898]

Moderators: S. Haller; Geneva/CH E. Papadaki; Iraklion/GR

Monday, March 11, 14:00–15:30, Room C SS 1811b: Spinal imaging [B-0899 – B-0908]

Moderators: M. Buruian; Targu-Mures/RO A. Cianfoni; Lugano/CH

Monday, March 11, 16:00–17:30, Room G/H RC 1911: Multiple sclerosis: 2013 update

Moderator: E.T. Tali; Ankara/TR

A. Differential diagnosis of multiple T2-HI white matter lesions [A-613]A. Rovira-Cañellas; Barcelona/ES

B. New developments in the diagnosis of multiple sclerosis [A-614]F. Barkhof; Amsterdam/NL

C. Imaging of MS treatment-related complications [A-615]M.M. Thurnher; Vienna/AT

Saturday, March 9, 10:30–12:00, Room C SS 911: New insights into brain gliomas

[B-0509 – B-0518]

Moderators: L.C. Tzarouchi; Ioannina/GR P. Vilela; Almada/PT

Saturday, March 9, 16:00–17:30, Room G/H RC 1111: Brain tumours: advanced imaging

techniques in daily practice – do we really need them?

Moderator: Z. Merhemic; Sarajevo/BA

A. Diffusion-weighted imaging (DWI) and diffusion tensor imaging (DTI) [A-330]M. Law; Los Angeles, CA/US

B. Perfusion imaging [A-331]Y. Özsunar; Aydin/TR

C. Follow-up after treatment [A-332]P.C. Maly Sundgren; Lund/SE

Sunday, March 10, 08:30–10:00, Room E2 RC 1211: Stroke: is the prognosis getting any

better?

• Chairman’s introduction [A-364]J.-P. Pruvo; Lille/FR

A. Initial imaging work-up: CT or MR? [A-365]P.M. Parizel; Antwerp/BE

B. Stroke: is there really any therapy? [A-366]V. Mendes Pereira; Geneva/CH

C. Stenting: does it prevent stroke? [A-367]P. Vilela; Almada/PT

• Panel discussion: What is the future of stroke prevention and treatment?

Sunday, March 10, 10:30–12:00, Room F1 SS 1311: Brain tumours: imaging and therapy

[B-0670 – B-0678]

Moderators: X. Golay; London/UK A. Zimny; Wroclaw/PL

Sunday, March 10, 16:00–17:30, Room G/H RC 1511: Epilepsy: a lack of knowledge can

be dangerous

Moderator: M.A. Papathanasiou; Athens/GR

A. Anatomy of the limbic system [A-509]T.A. Yousry; London/UK

B. Temporal lobe epilepsy [A-510]I.N. Pronin; Moscow/RU

C. fMRI in epilepsy [A-511]N. Bargalló; Barcelona/ES

128


Sunday, March 10, 16:00–17:30, Room QRC 1512: Paediatric MSK radiology:

what is important?

Moderator: M. Raissaki; Iraklion/GR

A. Scoliosis: what the radiologist needs to know [A-525]J.-F. Chateil; Bordeaux/FR

B. Benign bone tumours and pseudotumours in children: the pitfalls [A-526]K.J. Johnson; Birmingham/UK

C. Congenital bone dysplasias [A-527]A.C. Offiah; Sheffield/UK

Monday, March 11, 10:30–12:00, Room PSS 1712: Foetal and neonatal imaging

[B-0859 – B-0868]

Moderators: N. De Graaf; Rotterdam/NL H. Ringertz; Linköping/SE

Monday, March 11, 14:00–15:30, Room PSS 1812: Paediatric brain [B-1010 – B-1018]

Moderators: M.A. Lucic; Sremska Kamenica/RS M. Stenzel; Jena/DE

Monday, March 11, 16:00–17:30, Room QRC 1912: Normal variants in paediatric imaging:

not to be confused with disease

Moderator: Ø.E. Olsen; London/UK

A. Brain [A-626]A. Rossi; Genoa/IT

B. Chest and abdomen [A-627]S.G.F. Robben; Maastricht/NL

C. Musculoskeletal [A-628]F. Saez; Barakaldo/ES

Paediatric

Saturday, March 9, 08:30–10:00, Room QRC 812: Imaging the paediatric spine

Moderator: C.J. Kellenberger; Zurich/CH

A. Craniocervical junction abnormalities [A-251]B. Ozgen Mocan; Ankara/TR

B. Inflammation, infection and tumours: the role of imaging [A-252]M.I. Argyropoulou; Ioannina/GR

C. Imaging spinal trauma in childhood [A-253]M. Maas; Amsterdam/NL

Saturday, March 9, 10:30–12:00, Room PSS 912: Paediatric body and bones

[B-0590 – B-0599]

Moderators: K.J. Johnson; Birmingham/UK L.-S. Ording-Müller; Tromsø/NO

Sunday, March 10, 08:30–10:00, Room QRC 1212: Oncologic imaging: how to image,

follow up and report

• Chairman’s introduction [A-394]D. Roebuck; London/UK

A. Renal and adrenal tumours in children [A-395]A.M.J.B. Smets; Amsterdam/NL

B. Paediatric liver malignancies [A-396]D. Roebuck; London/UK

C. Oncologic imaging in the paediatric brain [A-397]G. Hahn; Dresden/DE

• Panel discussion: How far should the radiologist go in suggesting tumour recurrence or post-treatment complications?

Sunday, March 10, 10:30–12:00, Room PSS 1312: Chest, heart and radiation awareness

[B-0729 – B-0738]

Moderators: W. Hirsch; Leipzig/DE P.D. Humphries; London/UK

Sunday, March 10, 14:00–15:30, Room QRC 1412: Paediatric emergencies

Moderator: V. Donoghue; Dublin/IE

A. The acute non-traumatic neurological patient: CT or MRI? [A-468]E. Vázquez; Barcelona/ES

B. Imaging of acute chest pain and/or distress in children [A-469]C.E. de Lange; Oslo/NO

C. The role of the interventional radiologist in paediatric Trauma [A-470]J.B. Karani; London/UK

129


Sunday, March 10, 16:00–17:30, Room L/M RC 1513: Novel developments in CT

and their impact on dose

Moderators: M. Prokop; Nijmegen/NLV. Tsapaki; Athens/GR

A. Patient dose assessment in CT [A-516]P.C. Shrimpton; Didcot/UK

B. New frontiers in CT: functional and spectral imaging [A-517]N. Pelc; Stanford, CA/US

C. New image reconstruction techniques [A-518]J. Sijbers; Antwerp/BE

Monday, March 11, 10:30–12:00, Room L/M SS 1713: Breast imaging and novel

CT techniques [B-0839 – B-0848]

Moderators: N. Karssemeijer; Nijmegen/NL M. Koutalonis; Colchester/UK

Monday, March 11, 14:00–15:30, Room L/M SS 1813: Patient dose management and

dose surveys [B-0989 – B-0998]

Moderators: H. Bosmans; Leuven/BE W. Stiller; Heidelberg/DE

Thursday, March 7, 10:30–12:00, Room L/M SS 113: Multi modality imaging and MR safety

[B-0101 – B-0110]

Moderators: O. Ciraj-Bjelac; Belgrade/RS O. Speck; Magdeburg/DE

Thursday, March 7, 14:00–15:30, Room L/M SS 213: Innovations in CT technology and

data processing [B-0240 – B-0249]

Moderators: C. Leidecker; Forchheim/DE R. Padovani; Udine/IT

Saturday, March 9, 16:00–17:30, Room L/M RC 1113: Cone-beam imaging

Moderators: O. Ciraj-Bjelac; Belgrade/RSA. Trianni; Udine/IT

A. Fundamentals of cone-beam imaging [A-336]M. Kachelrieß; Heidelberg/DE

B. Medical applications of CB imaging [A-337]M. Grass; Hamburg/DE

C. 3D dentomaxillofacial imaging [A-338]K. Horner; Manchester/UK

Sunday, March 10, 08:30–10:00, Room L/M RC 1213: Risk assessment and

risk communication

• Chairmen’s introduction [A-384]M.M. Rehani; Vienna/AT P. Vock; Berne/CH

A. Radiation risks for patients and staff [A-385]E. Vaño; Madrid/ES

B. Risk in MRI [A-386]R. Peeters; Leuven/BE

C. Communication of risk to patients and public [A-387]G. Gamhewage; Geneva/CH

• Panel discussion: How to communicate risk to patients and the public?

Sunday, March 10, 14:00–15:30, Room L/M RC 1413: Hybrid imaging systems

Moderators: D.G. Sutton; Dundee/UKJ. Votrubová; Prague/CZ

A. Clinical SPECT/CT and PET/CT [A-457]T. Beyer; Zurich/CH

B. Clinical MR/PET [A-458]G. Antoch; Düsseldorf/DE

C. Preclinical hybrid imaging [A-459]N. Belcari; Pisa/IT

PhysicsinRadiology

130

Refresher Courses / Scientific SessionsRadiographers

Sunday, March 10, 08:30–10:00, Room PRC 1214: Dose optimisation in

computed tomography

Moderators: G. Frija; Paris/FRD. Pekarovic; Ljubljana/SI

A. Innovations in dose optimisation [A-392]S. Foley; Dublin/IE

B. Developing patient specific examination protocols [A-393]H. Precht; Odense/DK

Sunday, March 10, 14:00–15:30, Room PRC 1414: Towards advancing and developing

the role of radiographers

• Chairmen’s introduction [A-464]S. Mathers; Aberdeen/UK D. Tscholakoff; Vienna/AT

A. The current status: a clinical perspective [A-465]C. McLaren; London/UK

B. The importance of evidence-based practice for the future of advanced practice in radiography [A-466]A. England; Liverpool/UK

C. The view from the European level [A-467]G. Paulo; Coimbra/PT

• Panel discussion: How to use the EFRS guidance document on role development

Sunday, March 10, 16:00–17:30, Room PRC 1514: Hybrid imaging technologies

Moderators: C.D. Claussen; Tübingen/DEC. Malamateniou; London/UK

A. Recent developments [A-522]S. Rep; Ljubljana/SI

B. Clinical applications [A-523]T. Lindner; Ternitz/AT

C. Trends in radiography education [A-524]P. Hogg; Manchester/UK

Monday, March 11, 10:30–12:00, Room QSS 1714: Mammography [B-0869 – B-0878]

Moderators: S.J. Foley; Dublin/IE P. Vahtramae; Pärnu/EE

Monday, March 11, 14:00–15:30, Room QSS 1814: Challenges of different

imaging techniques [B-1019 – B-1028]

Moderators: H.H. Hjemly; Oslo/NO J. McNulty; Dublin/IE

Thursday, March 7, 10:30–12:00, Room QSS 114: Importance of education in practice

[B-0131 – B-0140]

Moderators: R. Ribeiro; Lisbon/PT T. Roding; Haarlem/NL

Thursday, March 7, 14:00–15:30, Room QSS 214: Managing quality and dose in CT

[B-0270 – B-0279]

Moderators: E. Agadakos; Athens/GR A. Yule; Cardiff/UK

Friday, March 8, 10:30–12:00, Room QSS 514: The radiographer’s role as health care

team member [B-0380 – B-0389]

Moderators: V. Syrgiamiotis; Athens/GR C. Vandulek; Kaposvár/HU

Friday, March 8, 16:00–17:30, Room PRC 714: Clinical audit: from EURATOM to the

clinical environment

Moderators: E.J. Adam; London/UKD. Pronk-Larive; Middelburg/NL

A. Clinical audit: from the EURATOM treaty to EU guidelines: clinical audit RP 159 [A-190]P. Wood; Helsinki/FI

B. Implementation in practice: a comparison of different models [A-191]S. Geers-van Gemeren; Utrecht/NL

C. A perspective on the impact and benefits of clinical audit [A-192]S. O’Connor; Dublin/IE

Saturday, March 9, 10:30–12:00, Room QSS 914: Dose optimisation as daily challenge

[B-0600 – B-0609]

Moderators: P. Blackburn Andersen; Kolding/DK A. Petakovic; Novo Mesto/SI

Saturday, March 9, 16:00–17:30, Room PRC 1114: Hot topics in magnetic

resonance imaging

Moderators: K. Haller; Wiener Neustadt/ATL. Martí-Bonmatí; Valencia/ES

A. New trends in MR safety [A-343]P. Bauer; Vienna/AT

B. MR spectroscopy: the role of radiographers in data optimisation [A-344]J. McNulty; Dublin/IE

C. Challenges and opportunities in paediatric MR [A-345]V. Syrgiamiotis; Athens/GR

131


Saturday, March 9, 08:30–10:00, Room L/M RC 815: How I report

Moderator: D. Bilecen; Basle/CH

A. CTA and MRA of supra-aortic arteries [A-241]J.H. Gillard; Cambridge/UK

B. CTA and MRA of thoracic and abdominal aorta [A-242]H.J. Michaely; Mannheim/DE

C. CTA and MRA of peripheral arteries [A-243]T. Leiner; Utrecht/NL

Monday, March 11, 14:00–15:30, Room N/O SS 1815: Vascular research [B-0999 – B-1008]

Moderators: S. Kuribayashi; Tokyo/JP A. Pellegrin; Trento/IT

Monday, March 11, 16:00–17:30, Room PRC 1915: Lower extremity venous insufficiency

• Chairman’s introduction [A-622]D.J. West; Stoke-on-Trent/UK

A. Venous anatomy and ultrasound [A-623]H. Moschouris; Piraeus/GR

B. Rare venous diseases of the lower extremities [A-624]M. Greiner; Neuilly sur Seine/FR

C. CT venography and MR venography [A-625]G. O’Sullivan; Galway/IE

• Panel discussion: Which imaging modality is best for planning endovascular management?

Thursday, March 7, 10:30–12:00, Room N/O SS 115: Carotid plaque evaluation

[B-0111 – B-0120]

Moderators: M.A. Aschauer; Graz/AT D. Filippiadis; Athens/GR

Thursday, March 7, 14:00–15:30, Room N/O SS 215: Major vessel imaging

[B-0250 – B-0259]

Moderators: W.R. Jaschke; Innsbruck/AT O. Pellerin; Paris/FR

Thursday, March 7, 16:00–17:30, Room PRC 315: Vascular imaging in ischaemic stroke

Moderator: J. Hendrikse; Utrecht/NL

A. Intracranial atherosclerotic disease of carotid arteries [A-044]T. Jargiello; Lublin/PL

B. Vertebrobasilar atherosclerotic disease [A-045]L. Valvassori; Milan/IT

C. Dissection and vasculitis of intracranial and extracranial arteries [A-046]H.R. Jäger; London/UK

Friday, March 8, 10:30–12:00, Room N/O SS 515: Novel tools for blood flow evaluation

[B-0361 – B-0369]

Moderators: J. Barkhausen; Lübeck/DE F.G. Garaci; Rome/IT

Friday, March 8, 16:00–17:30, Room ZRC 715: Dialysis fistula

Moderator: H. Deutschmann; Graz/AT

A. Preoperative mapping [A-198]L. Turmel-Rodrigues; Tours/FR

B. Screening for problems [A-199]D. Vorwerk; Ingolstadt/DE

C. Evaluation of malfunction [A-200]R. Uberoi; Oxford/UK

Vascular

132


Sunday, March 10, 14:00–15:30, Room E2 RC 1416: The essentials of lymph node imaging

of solid tumours: what the radiologist needs to know

• Chairman’s introduction [A-437]R.G.H. Beets-Tan; Maastricht/NL

A. The current criteria for nodal involvement on CT/MRI [A-438]W. Schima; Vienna/AT

B. DWI MR: what does it contribute? [A-439]H.C. Thoeny; Berne/CH

C. Nuclear medicine: PET and other nuclear medicine techniques [A-440]P.L. Choyke; Bethesda, MD/US

• Panel discussion: When and how could imaging make diagnostic biopsy unnecessary?

Monday, March 11, 08:30–10:00, Room E2 RC 1616: Complications of cancer treatment

and the detection of recurrences

• Chairman’s introduction [A-548]M. Laniado; Dresden/DE

A. Head and neck cancer [A-549]L. Oleaga Zufiría; Barcelona/ES

B. Liver and pancreatic cancer [A-550]C. Catalano; Rome/IT

C. Rectal cancer [A-551]L.C.O. Blomqvist; Stockholm/SE

• Panel discussion: How to differentiate between treatment sequelae and active disease

Monday, March 11, 10:30–12:00, Room F1 SS 1716: Response evaluation in oncology:

beyond RECIST [B-0799 – B-0808]

Moderators: T. Denecke; Berlin/DE M.I. Furmanek; Warsaw/PL

Monday, March 11, 16:00–17:30, Room E2 RC 1916: Gastro-entero-pancreatic

neuro-endocrine tumours (GEP-NET): a multidisciplinary update

• Chairman’s introduction [A-601]C. Matos; Brussels/BE

A. Tumour biology, pathogenesis and classification [A-602]B. Wiedenmann; Berlin/DE

B. The current role of nuclear medicine techniques [A-603]C. Deroose; Leuven/BE

C. Anatomical imaging: transabdominal US, endoscopic US, MDCT and MRI. What is the most appropriate imaging approach? [A-604]V. Vilgrain; Clichy/FR

• Panel discussion: The future of hybrid imaging?

OncologicImaging

Thursday, March 7, 10:30–12:00, Room F1 SS 116: Perfusion CT and MRI: ready for

clinical practice [B-0061 – B-0070]

Moderators: S. Delorme; Heidelberg/DE F.A. Gallagher; Cambridge/UK

Thursday, March 7, 14:00–15:30, Room F1 SS 216: New biomarkers for

tumour quantification [B-0200 – B-0209]

Moderators: C.J. Herold; Vienna/AT C. Keyzer; Brussels/BE

Friday, March 8, 08:30–10:00, Room C RC 416: MR imaging for prostate cancer

management: the essential guide for radiologists

• Chairman’s introduction [A-058]H.-P. Schlemmer; Heidelberg/DE

A. Clinical challenges: how to treat prostate cancer [A-059]B.A. Hadaschik; Heidelberg/DE

B. The radiologist’s contribution: how to detect and characterise a tumour [A-060]A.R. Padhani; Northwood/UK

C. The radiologist’s influence on management. Staging prostate cancer: how it impacts on treatment selection [A-061]H. Hricak; New York, NY/US

• Panel discussion: Is MRI an integral part of the clinical routine?

Friday, March 8, 10:30–12:00, Room F1 SS 516: Cutting edge imaging in oncology: when

and how? [B-0320 – B-0329]

Moderators: K. Coenegrachts; Bruges/BE E.J. Rummeny; Munich/DE

Saturday, March 9, 10:30–12:00, Room F1 SS 916: Whole-body imaging: how to do it

[B-0549 – B-0558]

Moderators: T.F. Hany; Zurich/CH D. Lambregts; Maastricht/NL

Sunday, March 10, 10:30–12:00, Room A SS 1316: Rectal cancer imaging: the next step

[B-0620 – B-0629]

Moderators: L. Curvo-Semedo; Coimbra/PT C. Hoeffel; Reims/FR

133


Sunday, March 10, 10:30–12:00, Room N/O SS 1317: Technical issues and clinical results

[B-0719 – B-0728]

Moderators: M. Brink; Nijmegen/NL G. Schueller; Bülach/CH

Sunday, March 10, 16:00–17:30, Room E1 RC 1517: ER: comprehensive imaging of

non-traumatic abdominal emergencies

• Chairman’s introduction: logistics and management of critical patients with abdominal complaints [A-492]S. Wirth; Munich/DE

A. Imaging of the most frequent emergencies of the upper abdomen [A-493]C.J. Zech; Basle/CH

B. Imaging of the most frequent emergencies of the gastrointestinal tract [A-494]M. Zins; Paris/FR

C. Imaging of the most frequent emergencies of the genitourinary tract [A-495]L.E. Derchi; Genoa/IT

• Panel discussion: How to speed up your diagnoses?

EmergencyRadiology

Thursday, March 7, 10:30–12:00, Room PSS 117: An update on emergency thoraco-

abdominal imaging [B-0121 – B-0130]

Moderators: B. Feragalli; Chieti/IT A. Huete; Santiago/CL

Friday, March 8, 08:30–10:00, Room D2RC 417: ER: basic principles

Moderator: P. Valdés Solís; Marbella/ES

A. Logistics and organisation of an emergency radiology department [A-065]M. Körner; Munich/DE

B. Advanced trauma life support: basic knowledge for radiologists [A-066]D.R. Kool; Nijmegen/NL

C. Mechanism of injury and MDCT protocols: choosing the right protocol for the right patient [A-067]S. Voelckel; Innsbruck/AT

Saturday, March 9, 08:30–10:00, Room E1 RC 817: Polytrauma: redefining imaging issues

for management priorities

• Chairman’s introduction: advanced imaging, logistics and management priorities in patients after polytrauma [A-218]H. Alkadhi; Zurich/CH

A. Vascular Trauma [A-219]G. Schueller; Bülach/CH

B. Chest and abdomen [A-220]M. Scaglione; Castel Volturno/IT

C. Extremities [A-221]U. Linsenmaier; Munich/DE

• Panel discussion: How to speed up your diagnoses?

134

EFOMP Workshop

Organising Committee:

Chairman: P. Sharp; Aberdeen/UKMembers: A. Torresin; Milan/IT

W.J.M. van der Putten; Galway/IE J. Vassileva; Sofia/BG

Saturday, March 9, 08:30–10:00, Room G/H EF 1: Lung and chest imaging:

new approaches

Moderators: P. Sharp; Aberdeen/UK W.J.M. van der Putten; Galway/IE

• Welcome address [A-233] J.I. Bilbao; Pamplona/ES P. Sharp; Aberdeen/UK

• Radiologist’s point of view: clinical and technical requirements for imaging of the lung [A-234]H.-U. Kauczor; Heidelberg/DE

• Respiratory motion correction in lung imaging [A-235] J. Schnabel; Oxford/UK

• Role of tomosynthesis in lung imaging [A-236] M. Båth; Gothenburg/SE

Saturday, March 9, 10:30–12:00, Room G/H EF 2: Lung imaging:

multidisciplinary scenario

Moderators: A. Torresin; Milan/ITJ. Vassileva; Sofia/BG

• Pulmonary nodule detection using CAD [A-266] A. Retico; Pisa/IT

• Optimisation in lung imaging of children [A-267] C. Owens; London/UK

• Lung imaging: developments in role of PET [A-268] M.-E. Meyer; Amiens/FR

• Lung imaging: developments in role of MR [A-269] J.M. Wild; Sheffield/UK

Newtechnologyindiagnosticradiology:newfrontiersinimagingofthelung

135

E3 – European Excellence in Education

Saturday, March 9, 08:30–10:00, Room E2 E³ 820b: Metabolic and

neurodegenerative disorders

Moderator: S. Lehéricy; Paris/FR

A. Dementia [A-222]B. Gómez-Ansón; Barcelona/ES

B. Movement disorders [A-223]T.A. Yousry; London/UK

C. Metabolic disorders [A-224]J.F. Schneider; Basle/CH

Saturday, March 9, 10:30–12:00, Room E2 E³ 920b: Tumours and phacomatosis

Moderator: N. Girard; Marseille/FR

A. Brain tumours [A-263]M.M. Thurnher; Vienna/AT

B. Tumours of the spinal cord [A-264]J. Van Goethem; Antwerp/BE

C. Phacomatosis [A-265]M.A. Papathanasiou; Athens/GR

Saturday, March 9, 12:15–13:15, EPOS AreaSelf assessment test

Moderator: M.I. Argyropoulou; Ioannina/GR

• Interactive computer evaluation of course learning

Friday, March 8, 08:30–10:00, Room E2 E³ 420: The orbit, the petrous bone and

the sella

Moderator: B. De Foer; Antwerp/BE

A. Imaging of the orbit: the globe and conal lesions [A-072]P.C. Maly Sundgren; Lund/SE

B. The petrous bone [A-073]F. Veillon; Strasbourg/FR

C. Sella and parasellar pathology [A-074]R. Gasparotti; Brescia/IT

Friday, March 8, 10:30–12:00, Room E2 E³ 520c: Paediatric

Moderator: D. Prayer; Vienna/AT

A. Neonatal hypoxic-ischaemic brain injury [A-119]M.I. Argyropoulou; Ioannina/GR

B. Spine and spinal cord malformations [A-120]A. Rossi; Genoa/IT

C. Imaging of the foetal brain [A-121]C. Garel; Paris/FR

Friday, March 8, 14:00–15:30, Room E2 E³ 620: Trauma and vascularity

Moderator: A. Molyneux; Oxford/UK

A. CNS Trauma [A-131]P.M. Parizel; Antwerp/BE

B. Cerebral ischaemia and infarction [A-132]L. Pierot; Reims/FR

C. Vascular malformations of the spinal cord [A-133]D.A. Rüfenacht; Zurich/CH

Friday, March 8, 16:00–17:30, Room E2 E³ 720b: Infection and inflammation

Moderator: A.D. Gouliamos; Athens/GR

A. Infection [A-164]E.T. Tali; Ankara/TR

B. Multiple sclerosis [A-165]F. Barkhof; Amsterdam/NL

C. Mimics of multiple sclerosis [A-166]V. Dousset; Bordeaux/FR

FoundationCourse:Neuroimaging

136

E3 – European Excellence in EducationInteractiveTeachingSessions

Saturday, March 9, 16:00–17:30, Room A E³ 1120: Breast cancer

A. Detection [A-296] C.S. Balleyguier; Villejuif/FR

B. Follow-up [A-297]G. Forrai; Budapest/HU

Sunday, March 10, 08:30–10:00, Room A E³ 1220: Pitfalls in brain imaging

A. CT [A-346] L. Van den Hauwe; Brasschaat/BE

B. MRI [A-347]M. Essig; Erlangen/DE

Sunday, March 10, 14:00–15:30, Room A E³ 1420: Common and uncommon errors in plain

film and CT imaging of the chest: how to improve your performance

D. Tack; Baudour/BE [A-419] N. Howarth; Chêne-Bougeries/CH

Sunday, March 10, 16:00–17:30, Room A E³ 1520: Thoracic emergencies

A. Vascular [A-476] E. Castañer; Sabadell/ES

B. Pulmonary [A-477]C.M. Schaefer-Prokop; Amersfoort/NL

Monday, March 11, 08:30–10:00, Room A E³ 1620: Acute abdominal

inflammatory disorders

A. Colitis and enterocolitis [A-528] D.J.M. Tolan; Leeds/UK

B. Liver and bile ducts [A-529]C.D. Becker; Geneva/CH

Monday, March 11, 10:30–12:00, Room B E³ 1720a: Pitfalls in pelvic imaging

A. Pitfalls in MRI of the pelvis [A-586] E. Sala; New York, NY/US

B. Pitfalls in pelvic ultrasound [A-587]K. Kinkel; Chêne-Bougeries/CH

Monday, March 11, 10:30–12:00, Room A E³ 1720b: Musculoskeletal emergencies

A. Axial skeleton [A-584] E. Llopis; Valencia/ES

B. Peripheral skeleton [A-585]V.N. Cassar-Pullicino; Oswestry/UK

Thursday, March 7, 14:00–15:30, Room B E³ 220: Lung cancer

A. Detection [A-003] S. Diederich; Düsseldorf/DE

B. Follow-up [A-004]F. Gleeson; Oxford/UK

Thursday, March 7, 16:00–17:30, Room B E³ 320: Malignant pancreatic tumours

A. Solid tumours [A-005] W. Schima; Vienna/AT

B. Cystic tumours [A-006]G. Morana; Treviso/IT

Friday, March 8, 10:30–12:00, Room A E³ 520a: Pitfalls in abdominal imaging

A. Liver [A-109] V. Vilgrain; Clichy/FR

B. Pancreas and bile ducts [A-110]R. Manfredi; Verona/IT

Friday, March 8, 10:30–12:00, Room C E³ 520b: Pitfalls in head and neck imaging

A. Pitfalls in neck imaging [A-117] F.A. Pameijer; Utrecht/NL

B. Pitfalls in maxillofacial and skull base imaging [A-118]R. Hermans; Leuven/BE

Friday, March 8, 16:00–17:30, Room A E³ 720a: Neurological emergencies

A. Non-traumatic [A-142] C. Ozdoba; Berne/CH

B. Traumatic [A-143]M. Stajgis; Poznan/PL

Saturday, March 9, 08:30–10:00, Room A E³ 820a: Pitfalls in heart imaging

A. CT [A-201] G. Bastarrika; Pamplona/ES

B. MRI [A-202]M. Francone; Rome/IT

Saturday, March 9, 10:30–12:00, Room A E³ 920a: Tips and tricks in chest imaging

A. Plain radiography [A-254] J. Cáceres; Barcelona/ES

B. CT [A-255]J. Vilar; Valencia/ES


137

More about museums and exhibitions in Vienna:www.myESR.org/arts_culture

Gustav Klimt, Design Drawing Tree, 1910/11 © MAK/Georg Mayer

Accompanying Sessions

Friday, March 8, 08:30–10:00, Room N/O EIBIR/EORTC (European Organisation for Research and Treatment of Cancer) Symposium A radiologist with a ruler in his hand is a dangerous person: seeking standardisation in multicentre imaging trials

Moderators: P. Brader; Vienna/ATY. Liu; Brussels/BE

• Introduction: Who, what, why, outcome at the end of the symposium [A-095]P. Brader; Vienna/ATY. Liu; Brussels/BE

• Setting up clinical trials with functional imaging end-points: trials and tribulations [A-096]N. deSouza; Sutton/UK

• Challenges, problems on key imaging techniques [A-097]B. van Beers; Clichy/FR

• Advanced MR neuroimaging in multicentre trials: experience from the EORTC Brain Tumour Group [A-098]M. Smits; Rotterdam/NL

• Presentation of LUNG study: from the beginning until today [A-099]U. Nestle; Freiburg/DE

• Discussion, Questions and Answers

Friday, March 8, 14:00–15:30, Room QESOR Session Fostering future researchers

Moderators: N. Gourtsoyiannis; Athens/GRG.P. Krestin; Rotterdam/NL

During this session, the European School of Radiology (ESOR) will give participants an insight into the variety of its training programmes and opportunities. Crucial and evolving obstacles to research training in radiology will be put forward for discussion.

• IntroductionG.P. Krestin; Rotterdam/NL

• ESOR in action 2013N. Gourtsoyiannis; Athens/GR

• Research training for residentsL. Martí-Bonmatí; Valencia/ES

• PhD in residency programmes S. Trattnig; Vienna/AT

• Preparing research trials R.G.H. Beets-Tan; Maastricht/NL

• AwardsDuring the session, scholars and fellows will be awarded certificates for successfully completing the 2012 ESOR Scholarship and Fellowship Programmes.

Thursday, March 7, 16:00–17:30, Room ZESR Radiation Protection Session Security scanners at airports: are they safe?

Moderators: J. Damilakis; Iraklion/GRP. Vock; Berne/CH

• X-ray backscatter security scanners: principles, performance and potential health risks [A-051]J. Damilakis; Iraklion/GR

• Cumulative low-level x-ray radiation exposure: is it harmful? [A-052]P. Vock; Berne/CH

• Security scanners using non-ionising radiation: current status and trends for development [A-053]M. Kemp; Cambridge/UK

Friday, March 8, 08:30–10:00, Room B 6th Post-Processing Face-Off Session

Chairman: A. Graser; Munich/DECo-chairmen: M. D’Anastasi; Munich/DE

F. Schwarz; Munich/DE

After the great success in the last years, ECR 2013 will, for the sixth time, feature a ‘Workstation Face-Off ’ session. Continuous rapid technical advances in CT require state-of-the-art post-processing tools and workstations. Currently, most solutions are based on a thin client-server architecture which significantly speeds up loading times and workflow.

In the 21st century, radiologists are required to interpret 3D data-sets and to handle very large data volumes. For several clinical applications, dedicated post-processing workflows are now avail-able. All major vendors offer a variety of hardware and software, and it is often difficult to recognise the individual strengths and weaknesses of different systems. Our 6th annual Post-Process-ing Face-Off Session will allow you to get an impression of the 3D capabilities and large data volume handling provided by the latest workstation technology.

Several workstations from different vendors (aycan, GE Healthcare, Philips Healthcare, Siemens, TeraRecon, Vital Images) will be set up on stage next to each other, and two cases provided by the ESR will be demonstrated by expert users. This year, one of the cases is a cardiac case involving CTA of the coronary arteries and functional MRI with rest and stress perfusion imaging. The second case will be an oncology patient with a metastasised malignant melanoma. Tasks will include detection of lung nodules with CAD and segmentation of lesions over time assessing response.

The aim of this session is to simulate a realistic ‘reading room’ atmosphere and to give an impression of how different worksta-tions perform in a clinical scenario. We cordially invite you to attend this exciting ‘tournament’ of post-processing.

139


Saturday, March 9, 12:45–14:15, Room ZEIBIR Session Horizon 2020 – Setting the scene for Europe’s next research programme

Moderators: G.P. Krestin; Rotterdam/NLJ. Hennig; Freiburg/DE

• Horizon 2020: setting the scene – insight into Horizon 2020 health priorities, including the research infrastructure perspectiveK. Berkouk; Brussels/BE

• IMI – How to speed up the development of better and safer medicines for patientsE. Vaudano; Brussels/BE

• Public private partnerships as a booster for research and economic growth in the futureN. Denjoy; Brussels/BE

• The role of imaging in health research in the era of Personalised MedicineL. Martí-Bonmatí; Valencia/ES

• How EIBIR supports biomedical imaging scientists in their grant applications and research managementJ. Hennig; Freiburg/DE

• Questions/Answers

Saturday, March 9, 14:00–15:30, Room A Image Interpretation Quiz: Radiology is global

Moderator: D. Vorwerk; Ingolstadt/DE Referee: A. Agrawal, Delhi/IN

Panellists:Team 1:A.R. Gillams; London/UKT. Leiner; Utrecht/NLA. Oikonomou; Alexandroupolis/GRC.W. Sperryn; Cape Town/ZA

Team 2:F.M. Danza; Rome/ITH.B. Eggesbø; Oslo/NOP. Rogalla; Toronto, ON/CAM. Studniarek; Gdansk/PL

Saturday, March 9, 10:30–12:00, Room L/M Standards and Audit Session Assessment of radiologists’ professional performance

Moderator: E.J. Adam; London/UK

• Radiologists’ performance: assessment using peer review [A-270]G. Boland; Wellesley, MA/US

• Radiologists’ individual performance: use of standardised test images [A-271]A.G. Gale; Loughborough/UK

• Radiologists’ performance: referrers’ view [A-272]J.M.L. Bosmans; Gent/BE

Saturday, March 9, 10:30–12:00, Meeting Room 14, 1st Level

EIBIR/EuroAIM Session Evidence-based radiology

Moderators: F. Sardanelli; Milan/ITM.G.M. Hunink; Rotterdam/NL

• Systematic reviews and meta-analyses in radiologyG. Di Leo; Milan/IT

• Guidelines in radiologyL.M. Sconfienza; Milan/IT

• Clinical decision support for the safe and effective use of imaging testsM.G.M. Hunink; Rotterdam/NL

• Preoperative breast MRI: the MIPA studyR.M. Trimboli; Milan/IT

• Discussion


140


Sunday, March 10, 13:00–14:00, Room A Junior Image Interpretation Quiz: Golden Eye

Moderator: A. Alguersuari; Sabadell/ESCo-Moderator: E. Belmonte; Barcelona/ES

Panellists:G. Gherarducci; Pisa/ITC. Sayer; Brighton/UKC.M. Sommer; Heidelberg/DEL. Tzarouchi; Ioannina/GRA. Vanrossomme; Brussels/BE

Monday, March 11, 08:30–10:00, Room ZJoint Session of the ESR and EFSUMB (European Federation of Societies for Ultrasound in Medicine and Biology) Advances in diagnostic ultrasound: better results through cooperation

Moderators: L.E. Derchi; Genoa/ITF. Piscaglia; Bologna/IT

• Introducing the EFSUMB: the world’s largest ultrasound society [A-579]N. Gritzmann; Vienna/AT

• ESR/EFSUMB collaboration: a newly established platform for joint development of ultrasound in radiology and clinical specialties [A-580]L.E. Derchi; Genoa/IT

• Image fusion and intervention [A-581]T. Lorentzen; Herlev/DK

• The EFSUMB non-liver CEUS guidelines [A-582]F. Piscaglia; Bologna/IT

• The EFSUMB/WFUMB liver-CEUS guidelines [A-583]M. Claudon; Vandœuvre-les-Nancy/FR

Saturday, March 9, 16:00–17:30, Room ZEuro-BioImaging Towards implementation of a pan-European imaging infrastructure

Moderator: J. Hennig; Freiburg/DE

• Euro-BioImaging – Towards implementation of a European open access imaging research infrastructureJ. Hennig; Freiburg/DE

• Making the case: development of a node for UHF-MRIO. Speck; Magdeburg/DEJ. Hennig; Freiburg /DE

• Potential of Phase-Contrast Imaging as a node within Euro-BioImagingF. Bamberg; Munich/DE

• Discussion

Sunday, March 10, 10:30–12:00, Room QRadiology Trainees Forum RTF Highlighted Lectures

Moderators: D. Bulja; Sarajevo/BAV.H. Koen; Harleem/NL

• Emergency radiology management in patients with polytrauma [A-413] U. Linsenmaier; Munich/DE

• Imaging of non-traumatic intracranial haemorrhage [A-414] Z. Merhemic; Sarajevo/BA

• Case-based learning in radiology [A-415] P. Pokieser; Vienna/AT


141

EIBIR presents IMAGINE

Thursday March 7 to Sunday March 10Novel technology that shapes radiology: EIBIR presents IMAGINE

IMAGINE aims to stimulate interaction between imaging researchers and radiologists. Internationally leading academic and industrial research groups present their latest developments in medical image analysis and image-guided interventions. During the interactive software demonstration sessions the visitors get hands-on experience with developed techniques and tools.

EIBIR IMAGINE committee to chair the oral presentations:

Chair & coordinator:

Marleen de Bruijne, Erasmus MC; Rotterdam/NL & University of Copenhagen; Copenhagen/DK;

EIBIR IMAGINE committee:

Mari Cruz Villa, Universitat Pompeu Fabra – CISTIB Computional Imaging; Barcelona/ES

Sune Darkner, Københavns Universitet – Datalogisk Institut (DIKU-NC); Copenhagen/DK

Jan Klein, Fraunhofer MEVIS – Institute for Medical Image Computing; Bremen/DE

Emanuele Neri, University of Pisa/Diagnostic and Interventional Radiology; Pisa/IT

Christine Tanner, Computer Vision Laboratory / ETH Zurich; Zurich/CH

Eva van Rikxoort, Radboud University Nijmegen – Medical Center, Diagnostic Image Analysis Group; Nijmegen/NL

Setting:• One lecture (oral presentation) per topic (90 minutes)

• Two software demonstration sessions per topic: hands-on experience of the techniques and tools.

The first session is right after the oral presentation (60 minutes); a second session is held the next day at 12:00–13:00.

Programme/Schedule:Thursday, March 7, 16:30–17:30, Room UNovel technology that shapes radiology: EIBIR presents IMAGINE Scientific exchange get-together

Oncological image analysisThursday, March 7, 14:00–15:30, EIBIR IMAGINE Theatre, Room U

Oral presentationsModerators: EIBIR IMAGINE committee

• Quantifying response to CRT in colorectal cancer patients from dynamic imagingM. Bhushan; Oxford /UK

• Efficient workflows and reporting for RECIST and other quantitative imaging standards in cancer research and clinical practiceM. Baumhauer; Heidelberg/DE M. Seitel; Heidelberg/DE

• IMBIS: Imaging biomarkers information system for medical images post-processing and structured reportingA. Alberich-Bayarri; Valencia/ES

• Fully automatic estimation of film-based breast percentage density separate out postmenopausal hormone replacement treatment effects as well as expert’s estimationK. Petersen; Frederiksberg/DK

• CT colonography: Accurate registration of prone and supine endoluminal surfaces of the colonT.E. Hampshire; London/UK

• Optimised workflow for low dose thoracic CT lung cancer screening: automated detection, measurement, temporal matching and volumetry and mass analysis, individualised prediction of cancer risk, structured reporting with follow-up recommendationC. Jacobs; Nijmegen/NL

Software demonstrations ‘Oncological image analysis’Thursday, March 7, 15:30–16:30, Room UFriday, March 8, 12:00–13:00, Room U

142

EIBIR presents IMAGINE

Image guided interventions and computer aided diagnosisSaturday, March 9, 14:00–15:30, EIBIR IMAGINE Theatre, Room U


• Markerlessly tracking lung tumours during radiotherapy treatment using Align RT optical surrogate and motion model built from cone-beam CT on day of treatmentJ. McClelland; London/UK

• FUSIMO: A prototype for patient-specific prediction of focused ultrasound surgery in moving organsJ. Strehlow; Bremen/DE

• SlicerRT – 3D Slicer based open-source toolkit for radiation therapy researchC. Pinter; Kingston, ON/CA

• MRI guided prostate biopsy: a multiparametric, multireader, registration assisted, template based workflowT. Penzkofer; Bosten, MA/US

• BRIC1936: software package for lesion assessment: segmentation, progression and intensity analysis, in magnetic resonance imagingM.C. Valdés Hernández; Edinburgh/UK

• Automated labelling framework applied on full and partial spine CT scansJ. Hladuvka; Vienna/AT

Software demonstrations ‘Image guided interventions and computer aided diagnosis’Saturday, March 9, 15:30–16:30, Room USunday, March 10, 12–13, Room U

Quantitative image analysisFriday, March 8, 14:00–15:30, EIBIR IMAGINE Theatre, Room U


• An automatic system for segmentation, matching, anatomical labelling and measurement of airways from CT imagesJ. Petersen; Copenhagen/DK

• New algorithms for quantitative image analysis inspired by functional brain mechanismsB.M. Ter Haar Romeny; Eindhoven/NL

• Patterns in radiology: spatio-temporal image analysis in research and clinical applicationR. Donner; Vienna/AT

• QuantaVita for clinical practice: fully-automated quantitative MRI with normative rangesA. Cherubini; Catanzaro/IT

• BrainCON: graph theory based multimodal brain connectivity analysis and visualisation software; BrainMOD: multi-purpose software for 4-dimensional multimodal medical image analysisT. Spisák; Debrecen/HU

• The 3DSlicer open-source platform for segmentation, registration, quantitative imaging and 3D visualisation of biomedical image dataS. Pujol; Boston, MA/US

Software demonstrations ‘Quantitative image analysis’ Friday, March 8, 15:30–16:30, Room USaturday March 9, 12:00–13:00, Room U

143

Rising Stars Programme

Basic Sessions

Friday, March 8, 08:30–10:00, Studio 2013 Basic Session on Cardiac Radiology

• Imaging of myocardial infarction and viabilityM. Francone; Rome/IT

• Acute aortic syndromeA.J.B.S. Madureira; Porto/PT

• Cardiac CT in the Workup of Coronary Heart DiseaseU.J. Schoepf; Charleston, SC/US

Friday, March 8, 10:30–12:00, Studio 2013 Basic Session on Neuroradiology

• Aging, degeneration, and inflammation in the brain: an imaging perspectiveB. Gómez-Ansón; Barcelona/ES

• Is the Circle of Willis a circle?H.R. Jäger; London/UK

• CNS InfectionsM.M. Thurnher; Vienna/AT

Sunday, March 10, 08:30–10:00, Studio 2013 Basic Session on Interventional Radiology

• Management of aortic aneurysm and dissection R. Morgan; London/UK

• Overview of the development of interventional radiology techniquesB. Ganai; Newcastle/UK

• Embolisation of liver malignanciesM.A.A.J. van den Bosch; Utrecht/NL

Student Sessions

Friday, March 8, 14:00–15:30, Studio 2013 Student Session 1

• Provisional reporting – maintaining high standards in radiologyF. Seker; Mannheim/DE

• Provisional reporting – radiology versus emergency doctorsR. Coroiu; Covasna/RO

• Provisional reporting – The key for diagnosis of polytrauma patientsJ. Lee; Seoul/KR

• With the patient; let us establish a rapportK. Song; Seoul/KR

• Theory and practice in medical educationM. Aleksandrova-Moiseja; Riga/LV

Friday, March 8, 16:00–17:30, Studio 2013 Student Session 2

• Theory vs. practiceV. Nechaev; Moscow/RU

• The imaging professional of the future: how can tasks be distributed?Z. Demeter; Nyíregyháza/HU

• Theory and practice – supposed dichotomy – exemplifying the practical role of MRI in diagnosing knee injuriesC.G. Iacoban; Baia Mare/RO

• MRI contrast agents: what radiographers-in-training need to knowC. Fraga Piñeiro; Vigo/ES

• Radiographer students’ role in large-scale research projects of the European community: my educational perspectiveM. Breikss; Riga/LV

144

Rising Stars Programme

Saturday, March 9, 08:30–10:00, Studio 2013 Student Session 3

• CT, MRI, US or x-rays for blunt trauma in pregnancyJ. Bojarovska; Riga/LV

• Cervical trauma: is plain x-ray still necessary?H.A. Hanelore; Bistrita/RO

• Utilisation of radiological examinations in patients with traumaE. Dappa; Pfungstadt/DE

• Can the anatomy of the heart be taught using reconstructed CT images? A pilot studyM. Kolossvary; Budapest/HU

• Scaphoid and cervical spine fractures: are plain x-rays really enough?D. Grant; Aylesbury/UK

Saturday, March 9, 10:30–12:00, Studio 2013 Student Session 4

• New algorithm for treatment of trauma patients required: considering total body imaging instead of plain x-ray as initial managementH. Emich; Mannheim/DE

• Post-mortem CT characteristics and its influence on virtual autopsyJ.H. van Mourik; Amsterdam/NL

• Implementing student to student mentorship in the Faculty of Medicine from ‘Grigore T. Popa’ University of Medicine and Pharmacy, IasiG.-E. Gilca; Iasi/RO

• Peer teaching for sonographic and orthopaedic assessment of the large jointsB.J. Neubauer; Vienna/AT

• Occupational exposure in interventional procedures: do active dosimeters influence professional behaviour?C. Paulo; Coimbra/PT

Sunday, March 10, 14:00–15:00, Studio 2013 Final Student Session

The four best student presenters will be awarded by the ESR during this session.

Student Hands-on Workshops on Ultrasound In cooperation with Sono4YouAfter last year’s success, hands-on workshops exclusively for students will again be held at ECR 2013.

An expert team of tutors will lead the students through the workshops, which will include six different workstations to give every participant the chance to familiarise themselves with the wide range of possibilities with ultrasound.

• Workshop 1: Friday, March 8, 10:00–12:00

• Workshop 2: Friday, March 8, 14:00–16:00

• Workshop 3: Saturday, March 9, 16:00–18:00

• Workshop Advanced: Sunday, March 10, 16:00–18:00

Suitable for advanced students and residents.

All workshops take place in Room X (1st level).

Registration:These workshops are fully booked. Places may become avail-able at short notice onsite.

145

Introductory lectures

• Introduction: why choose US for biopsy guidance?G. Mostbeck; Vienna/AT

• All you need to know: protocols, patient preparation and consent, needles and guns, aspiration vs. core, indications and contraindicationsJ.-M. Correas; Paris/FR

• Do we always need the pathologist onsite? What is ‘enough’ material? Specimen preparation and handlingW. Pokieser; Vienna/AT

• Image fusion: when do we need it?L. Solbiati; Busto Arsizio/IT

ScheduleSaturday, March 9SK 826 08:30-10:00 Introductory Lectures

(Room Z, 2nd level)SK 926 10:30-12:00 Practical Training CourseSK 1026 14:00-15:30 Practical Training Course

Sunday, March 10SK 1326 10:30-12:00 Practical Training Course

All courses take place in Room X (1st level).

How to biopsy with US guidance Coordinator: G. Mostbeck; Vienna/ATSpeakers: J.-M. Correas; Paris/FR

G. Mostbeck; Vienna/AT W. Pokieser; Vienna/AT L. Solbiati; Busto Arsizio/IT

Instructors: F. Deschamps; Villejuif/FRH. Kopf; Vienna/AT G. Mauri; Busto Arsizio/IT W. Pokieser; Vienna/AT H. Schuster; Vienna/AT

This practical course teaches participants the fundamentals of US-guided biopsy. US-guided biopsy is faster, less invasive and less expensive than surgical biopsy and technically less demand-ing compared to CT und MR guidance. Tissue acquisition is performed with aspiration needles and/or automated large-core needles and biopsy guns. The choice of the needle depends on the lesion type as well as the pre-test probability of a specific malignancy. This practical course reviews indications, patient preparation, techniques, material preparation and contraindica-tions of US-guided biopsy.Participants will work on phantoms to learn the device-related technical aspects of the performance, how to prepare the patient and percutaneous biopsy device, and how to adequately approach a lesion. State-of-the-art equipment, including different auto-mated large core needles and/or guns will be available. The practical training courses are organised to allow time for each participant to perform interventions under expert supervision.It is recommended to follow the introductory lectures before entering the practical training courses.

Learning objectives1. To know the indications and contraindications and the tech-

nical requirements to perform US-guided biopsy procedures.2. To know requirements for patient preparation, selection of

material and specimen preparation for optimal results as well as management of complications.

3. To become familiar with the handling of needles, scan-heads and biopsy guns.

RegistrationThe number of participants for each course is limited.Pre-registration has been arranged according to the order in which applications were received. Registration will be possible onsite if seats are still available. Please register in front of Room X, 20 minutes before the start of the course. Please note that an extra fee of €50 per participant is charged for this course.Attendance of the lecture session on Monday morning is manda-tory in order to participate in the pre-registered practical training courses.

Update Your Skills (Practical Courses)

146

RegistrationThe number of participants for each course is limited.Pre-registration has been arranged according to the order in which applications were received. Registration will be possible onsite if seats are still available. Please register in front of Room Y, 20 minutes before the start of the course. Please note that an extra fee of €50 per participant is charged for this course.Attendance of the lecture sessions on Friday morning is manda-tory in order to participate in the pre-registered practical training courses.

Introductory lectures

Theoretical introduction: liver ablation• Understanding ablation devices and treatment strategies

D.J. Breen; Southampton/UK • Optimised outcomes in hepatocellular carcinoma ablation

L. Crocetti; Pisa/IT • Optimised outcomes in ablation of colorectal metastases

T. Helmberger; Munich/DE• Outcomes: making the case for image-guided ablation in

the multidisciplinary patient managementP.L. Pereira; Heilbronn/DE

Theoretical introduction: breast ablation• Indications, patient selection and limitations for

imaging-guided breast ablationB. Brkljačić; Zagreb/HR

• Technical considerations: guidance modalities, treatment devicesM. Fuchsjäger; Graz/AT

• Practical considerations: multidisciplinary patient managementE. Cossu; Rome/IT

Schedule

Friday, March 8SK 427 08:30–10:00 Introductory Lectures

(liver ablation; Room Z)SK 527 10:30–12:00 Introductory Lectures

(breast ablation; Room Z)SK 627 14:00–15:30 Liver ablation SK 727 16:00–17:30 Breast ablation

Saturday, March 9 SK 927 10:30–12:00 Liver ablation SK 1027 14:00–15:30 Breast ablation SK 1127 16:00–17:30 Liver ablation

Sunday, March 10 SK 1327 10:30–12:00 Breast ablation SK 1427 14:00–15:30 Liver ablation SK 1527 16:00–17:30 Breast ablation

All practical training courses will take place in Room Y (1st level).

Update Your Skills (Practical Courses)

Image-Guided Tumour Ablation: How to do it

Coordinators: D.J. Breen; Southampton/UK,M.H. Fuchsjäger; Graz/AT

Speakers: Liver AblationD.J. Breen; Southampton/UK L. Crocetti; Pisa/IT T. Helmberger; Munich/DE P.L. Pereira; Heilbronn/DE

Breast Ablation B. Brkljačić; Zagreb/HR E. Cossu; Rome/IT M.H. Fuchsjäger; Graz/AT

Instructors: Liver AblationD. Alcorn; Glasgow/UK, P. Almeida; Coimbra/PT, E.M. Anderson; Oxford/UK, R. Bale; Innsbruck/AT, D.J. Breen; Southampton/UK, X. Buy; Strasbourg/FR, R. Illing; London/UK, J. Tacke; Passau/DE

Breast Ablation E. Bonanno; Rome/IT, E. Cossu; Rome/IT, M.H. Fuchsjäger; Graz/AT, G. Ivanac; Zagreb/HR, A. Malich; Nordhausen/DE H. Schöllnast; Graz/AT

This practical course reviews indications, advantages, limita-tions and controversial issues in percutaneous image-guided ablation of liver and breast lesions under multimodality imaging guidance. Participants will work on phantoms not only to learn the device-related technical aspects of the performance but also how to choose the adequate guidance method, how to prepare the patient and the percutaneous ablation device, and how to adequately approach the lesion. Oncological as well as quality assurance aspects will be emphasised. State-of-the-art equip-ment, including different ablation devices (Radio-frequency-, microwave-, cryo-Ablation, irreversible electroporation), is avail-able; the practical courses are organised to allow time for each participant to perform interventions under expert supervision.Participants are required to attend the complete practical course (lectures and practical course).

Learning objectives1. To understand the range of ablation technologies currently

on offer, their surgical properties, merits and limitations.2. To comprehend the indications and limitations of percuta-

neous image-guided tumour ablation.3. To achieve appropriate case selection and understand the

interface with resection and chemo/radio-embolisation.4. To learn how to plan an appropriate treatment strategy to

achieve optimal clinical results.5. To plan appropriate follow-up and participate fully in

multi-disciplinary patient management.6. To perform image-guided tumour ablation under ultrasound

and guidance in accordance to international standards.

147

More about opera in Vienna:www.myESR.org/arts_culture

Florian Boesch in Radamisto by Georg Friedrich Händel © Monika Rittershaus

Satellite Symposia

Thursday, March 7, 12:00–13:30, Studio 2013 Satellite Symposium organised by Siemens Healthcare

SY 4: Challenges in breast imaging

Moderator: J. Barkhausen; Lübeck/DE

• 3D automated breast ultrasound: accuracy and diagnostic potentialsM.J.C.M. Rutten; s’Hertogenbosch/NL

• High image quality with lower dose mammographyD. Uhlenbrock; Dortmund/DE

• Breast imaging from a pathologist’s perspective A. Hartmann; Erlangen/DE

• MR breast in clinical routine W.A. Kaiser; Jena/DE

• Panel discussion


SY 5: Chances with digital breast tomosynthesis (DBT)

Moderator: T.H. Helbich; Vienna/AT

• Physical challenges with digital breast tomosynthesis H. Bosmans; Leuven/BE

• Experiences with digital breast tomosynthesis in screeningS. Zachrisson; Malmö/SE

• Value of tomosynthesis for the assessment of screen-detected abnormalitiesS.H. Heywang-Köbrunner; Munich/DE

• Clinical experiences with digital breast tomosynthesis in follow up diagnosticsF. Taşkın; Aydin/TR

• The future of breast tomosynthesisT.H. Helbich; Vienna/AT

• Panel Discussion

Friday, March 8, 12:15–13:30, Room D1 Satellite Symposium organised by Bayer HealthCare

SY 6: 25 years of contrast-enhanced MRI: there is more to see!

Moderator: F. Caseiro-Alves; Coimbra/PT

• Contrast enhanced MRI: illuminating the shadowsF. Caseiro-Alves; Coimbra/PT

• Optimising MRI in CNS for treatment planningJ. Provenzale; Durham, NC/US

• The role of contrast in breast MRIF. Pediconi; Rome/IT

• Cardiovascular MR – assessment of viability today and tomorrowJ. Schulz-Menger; Berlin/DE

• Primovist®-enhanced MRI in the preoperative assessment of liver functionJ.M. Lee; Seoul/KR


SY 1: Advanced multimodality breast image reading

Moderator: T. Hartley; Erlangen/DE

• Place of digital breast tomosynthesis in diagnostic investigation of breast lesions: old and new paradigms C. Van Ongeval; Leuven/BE

• Place of breast MRI in diagnostic investigation of breast lesions E. Wenkel; Erlangen/DE

• Panel Discussion

Thursday, March 7, 12:30–13:30, Room G/HSatellite Symposium organised by SuperSonic Imagine

SY 2: The benefits UltraFastTM imaging brings to ultrasound

Moderator: J. Souquet; Aix-en-Provence/FR

• Advantages and limitations of ShearWaveTM elastography for imaging prostate cancer and guiding biopsyP.S. Zoumpoulis; Athens/GR

• Benefits of UltraFastTM Doppler in the clinical workflowG. Ivanac; Zagreb/HR

• Experiences with the Aixplorer and ShearWaveTM elastography for the staging of liver fibroses V. Vilgrain; Clichy/FR

• Advances in breast imaging with ShearWaveTM elastography F.K.W. Schäfer; Kiel/DE

Thursday, March 7, 12:30–13:30, Room I/KSatellite Symposium organised by Bayer HealthCare

SY 3: New insight in breast cancer imaging

Moderator: J. Camps Herrero; Valencia/ES

• Breast MRI for screening breast cancer, why, who and when? L. Umutlu; Essen/DE

• Overtreatment due to breast MRI – a threat, a myth, or both?C.K. Kuhl; Aachen/DE

• MIPA study: study design, goals, rolloutF. Sardanelli; Milan/IT

149

Satellite Symposia

Saturday, March 9, 12:30–13:30, Room E1 Satellite Symposium organised by Bracco

SY 11: Personalised CT imaging: a patient centric approach

Moderator: M. Prokop; Nijmegen/NL

• Tailoring CT exams: when and how? C. Loewe; Vienna/AT

• How to balance radiation dose and diagnostic yield? H.-C. Becker; Munich/DE

• What if the patient is at risk? M.-F. Bellin; Le Kremlin-Bicêtre/FR

Saturday, March 9, 12:30–13:30, Room E2 Satellite Symposium organised by Siemens Healthcare

SY 12: Leading. With MAGNETOM.

Moderator: T.J. Vogl; Frankfurt a. Main/DE

• Leading. With MAGNETOM. N. Bolle; Erlangen/DE

• Novel imaging techniques in abdominal imaging H.J. Michaely; Mannheim/DE

• Sustainability in a complex healthcare environment T.J. Vogl; Frankfurt a. Main/DE

Saturday, March 9, 12:30–13:30, Room F2Satellite Symposium organised by GE Healthcare

SY 13: Developing innovative breast care solutions to improve clinical confidence

Moderator: R.C. Sigal; Velizy/FR

• Case clarification with digital breast tomosynthesis versus mammography special views A. Stork; Düsseldorf/DE

• Contrast enhanced spectral mammography versus breast MRI: clinical experience E.M. Fallenberg; Berlin/DE

• New frontiers of advanced breast ultrasound A. Mundinger; Osnabrück/DE

• Role of MR DWI in breast cancer: correlation with histopathology V. Martinez de Vega; Madrid/ES

Friday, March 8, 12:30–13:30, Room G/H Satellite Symposium organised by Bracco

SY 7: Breast MRI: where are we, and where are we going?

Moderator: T.H. Helbich; Vienna/AT

• Current and future role of breast MRI C.K. Kuhl; Aachen/DE

• Challenges to contrast-enhanced breast MRI: pros and cons T.H. Helbich; Vienna/AT

• Contrast protocols F. Sardanelli; Milan/IT

Friday, March 8, 12:30–13:30, Room I/KSatellite Symposium organised by GE Healthcare

SY 8: Evidence of avant-garde MR

Moderator: D. Pickuth; Saarbrücken/DE

• Sharing GE MR vision and futureR. Hausmann; Waukesha, WI/US

• Innovativ technology: the clinical application of silent MRA. van der Lugt; Rotterdam/NL

• Getting closer to metallic implants M. Padrón; Madrid/ES

Friday, March 8, 12:30–13:30, Room L/M Satellite Symposium organised by Siemens Healthcare

SY 9: Pioneering futures in ultrasound

Moderator: P.S. Sidhu; London/UK

• Strain imaging in the breast – with a focus on the new VTIQ technology C.S. Balleyguier; Villejuif/FR

• Ultrasound study of the pancreas with CPS (CEUS) and ARFI (elastography): improving the diagnosis of pancreatic tumours M. D’Onofrio; Verona/IT

• Image fusion: is this something we need? A. Nilsson; Uppsala/SE

Saturday, March 9, 12:30–13:30, Room D1 Satellite Symposium jointly organised by Siemens Healthcare and Bayer HealthCare

SY 10: Synergies in CT for better patient care: cutting edge CT and optimised contrast media application

Moderator: J.E. Wildberger; Maastricht/NL

• Clinical benefits of a new fully integrated CT detector H. Alkadhi; Zurich/CH

• Optimise your CT results from scan to contrast media application J.E. Wildberger; Maastricht/NL

• Protocol optimisation in cutting edge CT A.H. Mahnken; Marburg/DE

150

Satellite Symposia

Saturday, March 9, 14:00-14:30, Room N/OMini Satellite Symposium organised by Philips Healthcare

MSY 1: Transforming healthcare with CT

Moderator: L. De Vries; Amsterdam/NL

• Clinical outcomes of novel CT reconstruction techniquesE.E.J.G. Coche; Brussels/BE

Saturday, March 9, 14:00–15:30, Room CSatellite Symposium organised by Hologic

SY 17: Celebrating the evolution of breast tomosynthesis: from research to large-scale, population-based screening programs, to advanced applications

Moderator: A. Smith; Bedford, MA/US

• A review of the evolution of breast tomosynthesis A. Smith; Bedford, MA/US

• The Oslo clinical tomosynthesis screening experience P. Skaane; Oslo/NO

• Initial experience with tomosynthesis biopsy D. Bernardi; Trento/IT

Saturday, March 9, 14:00–15:30, Room E1 Satellite Symposium organised by Toshiba

SY 18: Clinical advances in multimodality applications – new perspectives in perfusion and fusion imaging

Moderator: B. Hamm; Berlin/DE

• The impact of smart fusion on the diagnostic outcome T. Fischer; Berlin/DE

• CEUS of the kidney: from new technology to patient management improvement J.-M. Correas; Paris/FR

• Liver and pancreatic perfusion using Aquilion ONE vision J. Hermans; Nijmegen/NL

Saturday, March 9, 14:00–15:30, Room F2Satellite Symposium organised by Toshiba

SY 19: Multimodal imaging for neuro applications

Moderator: P.A. Brouwer; Leiden/NL

• Neuro applications using Aquilion ONE P.A. Brouwer; Leiden/NL

• Advanced neuroimaging at 3T with a 32ch head coil T. Okada; Kyoto/JP

• Neurological interventions using Toshiba Infinix H. Fransen; Gent/BE

Saturday, March 9, 12:30–13:30, Room G/HSatellite Symposium organised by Guerbet

SY 14: Combining high tolerance with high diagnostic performance in contrast enhanced MRI

Moderator: S.O. Schönberg; Mannheim/DE

• IntroductionS.O. Schönberg; Mannheim/DE

• Tolerance of MR contrast agent in at risk patients G. Deray; Paris/FR

• Optimal gadolinium concentration with high diagnostic accuracy M. Lell; Erlangen/DE

• MRI follow-up after kidney cancer cryoablation E. de Kerviler; Paris/FR

• Questions and conclusion S.O. Schönberg; Mannheim/DE

Saturday, March 9, 12:30–13:30, Room I/K Satellite Symposium organised by Philips Healthcare

SY 15: Transforming healthcare through innovative MR technology

Moderator: J. van den Heuvel; Eindhoven/NL

• Imaging in cancer: multi-parametric whole-body and prostate imaging S. Punwani; London/UK

• New MR imaging approaches in assessing the aging brain M.A. van Buchem; Leiden/NL

Saturday, March 9, 12:30–13:30, Room L/MSatellite Symposium organised by Philips Healthcare

SY 16: News in mammography: spectral imaging in mammography screening

Moderator: M. Danielsson; Solna/SE

• Experiences of MicroDose in tailored breast cancer screening program including women between 40-49 years P. Panizza; Milan/IT

• Latest development in mammography: non-invasive single-shot spectral imaging S. Suryanarayanan; Andover, MA/US

• Spectral lesion evaluation: will it be possible to distinguish cysts from solid masses on the screening mammogram? M.G. Wallis; Cambridge/UK

• Questions

151

Satellite Symposia

Sunday, March 10, 12:30–13:30, Room L/MSatellite Symposium organised by Philips Healthcare

SY 23: Transforming healthcare with ultrasound

Moderator: S.T. Elliott; Newcastle upon Tyne/UK

• Opening

• Sonoelastography of the liver: the clinical point of view C. Filice; Pavia/IT

• Results with ElastPQ in the assessment of diffuse liver disease G. Ferraioli; Pavia/IT

• Fusion imaging with contrast enhanced ultrasound in the abdomen A. Martegani; Como/IT

• Innovation in high resolution breast ultrasound D.A. Clevert; Munich/DE

• Questions and answers

Sunday, March 10, 12:30–13:30, Room N/OSatellite Symposium organised by Bracco

SY 24: Cost-effectiveness and improvement of patient management with contrast enhanced ultrasound (CEUS)

Moderator: G.H. Mostbeck; Vienna/AT• Implementation of CEUS in the daily practice of the

imaging center M. Wüstner; Trier/DE

• CEUS in interventional radiology: clinical outcomes and impact on patient management E.M. Jung; Regensburg/DE

• Clinical and cost effectiveness of CEUS for liver imaging: the NICE diagnostics guidance T. Hoare; Newcastle Upon Tyne/UK

Saturday, March 9, 14:00–15:30, Room L/MSatellite Symposium organised by GE Healthcare Nycomed

SY 20: CT and MR diagnostic capabilities and safety: new tendency

Moderators: V.N. Kornienko; Moscow/RU I.E. Tyurin; Moscow/RU

• Low-dose and low-iodine CT coronary angiography V.E. Sinitsyn; Moscow/RU

• MRI safety – actual issues E. Mershina; Moscow/RU

• Brain – heart – axis R. Rienmüller; Graz/AT

• Russian radiology best practice – clinical experience sharing A. Lukianchenko; Moscow/RU

• GE Healthcare innovative solutions for modern healthcare V.I. Grischenko; Moscow/RU

Sunday, March 10, 12:30–13:30, Room CSatellite Symposium organised by GE Healthcare

SY 21: Patient care and image quality: at the forefront of CT innovations and contrast media

Moderator: V.E. Sinitsyn; Moscow/RU• Key properties of isosmolar contrast media

R.P. Franke; Ulm/DE• Optimising image quality and patient care in cardiac CT

D. Andreini; Milan/IT• Spectral imaging: clinical breakthrough in oncology

P. Ardies; Malle/BE

Sunday, March 10, 12:30–13:30, Room G/H Satellite Symposium organised by Samsung

SY 22: A new tool for detecting and diagnosing breast cancer: ultrasound ElastoScan™

Moderator: W. van de Vooren; Delft/NL

• Introduction to ElastoScan™W. van de Vooren; Delft/NL

• The positive influence of ElastoScan™ on early breast cancer detection V.F. Duda; Marburg/DE

• Has ElastoScan™ positively influenced the way of breast surgery? C. Kohler; Marburg/DE

152

Industry Hands-on Workshops

Thursday, March 7 to Sunday, March 10, Hologic Hands-on Workshop Room, 1st LevelIndustry Hands-on Workshops organised by Hologic

Hologic is offering a series of 75-minute educational sessions for radiologists throughout the congress. The workshops include hands-on experience reading 3D breast tomosynthesis images in combination with conventional and synthesised 2D images. Brief lectures will provide an overview of the technologies prior to the hands-on. This programme is intended for radiologists interested in learning more about this breast cancer screening and diagnosis technology.

Hologic Breast Tomosynthesis Hands-on Workshops

Schedule

Thursday, March 7:13:00–14:1515:00–16:15

Friday, March 8:10:15–11:3013:45–15:0015:30–16:45

Saturday, March 9:10:15–11:30

Sunday, March 10:10:15–11:3013:45–15:0015:30–16:45

Thursday, March 7 to Sunday, March 10, Siemens Experience Lounge, Entrance LevelIndustry Hands-on Workshops organised by Siemens Healthcare

Clinical experts will demonstrate how to better use and further benefit from our solutions for advanced multimodality reading. A special focus will be placed on

the imaging software syngo.via. Benefit from experts’ experience and receive an update on state-of-the-art techniques in computed tomography, magnetic resonance, molecular imaging and breast imaging. As a registered attendee for ECR 2013 these workshops are free of charge.

Thursday, March 7:14:00–15:30: MRIbreastreadingandreporting

W.A. Kaiser; Jena/DE16:00–17:30: Digitalbreasttomosynthesis

J. Barkhausen; Lübeck/DE

Friday, March 8:10:00–11:30: CTColonography

T. Mang; Vienna/AT12:00–13:30: Digitalbreasttomosynthesis

J. Barkhausen; Lübeck/DE14:00–15:30: AdvancedorthopaedichipandkneeMRI

R. Sutter; Zurich/CH16:00–17:30: CToncology

A. Graser; Munich/DE

Saturday, March 9:10:00–11:30: MultimodalprostateMRI

M. Röthke; Heidelberg/DE12:00–13:30: MRIandCTforimagingacutestroke

Karl-Olof Loevblad, Geneva P. Schramm; Göttingen/DE

14:00–15:30: Hybridimagingindailyroutine:SPECT-CTandPET-CTinorthopaedicsandoncologyC. von Gall; Erlangen/DE

16:00–17:30: DigitalbreasttomosynthesisJ. Barkhausen; Lübeck/DE

Sunday, March 10:10:00–11:30: CTDualEnergy

M. Kerl; Frankfurt/DE12:00–13:30: Hybridimagingindailyroutine:

SPECT-CTandPET-CTinorthopaedicsandoncologyC. von Gall; Erlangen/DE

14:00–15:30: CTcardiacR. Bauer; Frankfurt/DE

16:00–17:30: MRIbreastreadingandreportingW.A. Kaiser; Jena/DE

153

More about concerts in Vienna:www.myESR.org/arts_culture

Zubin Mehta at the Musikverein© www.flonthego.com

Postgraduate Educational Programme

Session numbers are prefixed by CC, E3, EF, EM, HL, MC, MS, NH, OL, PC, RC, SA, SF, TF

Presentation numbers are prefixed by the letter A

Key to Abbreviations CC Categorical CourseE3 European Excellence in EducationEF EFOMP WorkshopEM ESR meets Session

HL Honorary Lecture

MC Mini Course

MS Multidisciplinary Session

NH New Horizons Session

OL Opening Lecture

PC Professional Challenges Session

RC Refresher Course

SA State of the Art Symposium

SF Special Focus Session

TF Radiology Trainees Forum

A-00

1 –

A-01

0 12:30–13:30 Room N/O

The Beauty of Basic Knowledge: Head and Neck MC 24A A taste of the oral cavity

and salivary glands 12:30A-001 A taste of the oral cavity and salivary glands


Learning Objectives:1. To become familiar with the anatomy of the oral cavity and salivary

glands.2. To learn how to tailor imaging approaches to the patient’s clinical

presentation.3. To appreciate the main pathologic processes of the oral cavity and

salivary glands.

12:30–13:30 Room P

The Beauty of Basic Knowledge: Musculoskeletal Imaging MC 25A Trauma 12:30A-002 Trauma

A. Kassarjian; Majadahonda/ES

Learning Objectives:1. To learn about the basic mechanisms of musculoskeletal trauma.2. To become familiar with typical musculoskeletal injuries and injury

patterns.3. To understand the impact of different radiological methods in the

trauma setting.

14:00–15:30 Room B

Interactive Teaching Session E³ 220 Lung cancer 14:00A-003 A. Detection

S. Diederich; Düsseldorf/DE

Learning Objectives:1. To learn which imaging techniques are appropriate for detecting lung

cancer.2. To learn about the most relevant imaging findings in lung cancer.3. To understand the behaviour of lung cancer related to imaging.

14:45A-004 B. Follow-up

F. Gleeson; Oxford/UK

Learning Objectives:1. To know the common features of lung cancer recurrence.2. To learn how to establish follow-up protocols after treatment of lung

cancer.

16:00–17:30 Room B

Interactive Teaching Sessions E³ 320 Malignant pancreatic tumours 16:00A-005 A. Solid tumours

W. Schima; Vienna/AT

Learning Objectives:1. To learn how to differentiate tumours from other non-tumoural

pathology.2. To understand how to choose the proper imaging technology.3. To appreciate how to determine resectability and extension of the

tumour.

16:45A-006 B. Cystic tumours

G. Morana; Treviso/IT

Learning Objectives:1. To learn how to choose the proper imaging modality.2. To understand the criteria of malignancy and benignity.3. To learn how to follow-up the lesions.

16:00–17:30 Room C

GI Tract RC 301 Staging and restaging of rectal

and anal cancer 16:00A-007 Chairman‘s introduction

R.G.H. Beets-Tan; Maastricht/NL

16:05A-008 A. Local staging of anal and rectal cancer and impact on

initial therapeutic strategy S. Gourtsoyianni; London/UK

Learning Objectives:1. To learn about optimised MR techniques for rectal and anal cancer

staging.2. To become familiar with the role of endorectal ultrasound in

anorectal cancer staging.3. To understand basic TNM staging and assessment of the CRM on

imaging.4. To understand how imaging findings influence the initial therapeutic

approach.

16:35A-009 B. Assessment of rectal cancer response

L. Curvo-Semedo; Coimbra/PT

Learning Objectives:1. To learn the rationale for following-up on patients after neoadjuvant

chemoradiation.2. To understand conventional imaging criteria for assessing tumour

response.3. To learn about new techniques for assessing response, including

diffusion MRI and PET/CT.

16:55A-010 C. Assessment of anal cancer response

V.J. Goh; London/UK

Learning Objectives:1. To learn the rationale for restaging after therapy.2. To know how to assess the tumour response with conventional

imaging criteria.3. To learn about new techniques for assessing response in anal cancer,

including diffusion MRI and PET/CT.

Panel discussion: 17:15 What clinicians expect from us in rectal and anal cancer

staging and restaging? How should we image patients?


156

A-01

1 –

A-02

216:00–17:30 Room D2

Cardiac RC 303 Cardiac imaging: the cutting edge

Moderator: E. Di Cesare; L‘Aquila/IT

16:00A-011 A. Cardiac MRI: do we need more than 1.5T?

B.J. Wintersperger; Toronto, ON/CA

Learning Objectives:1. To learn about the differences between 1.5T and 3T cardiac MRI.2. To understand the clinical applications of high-field cardiac MRI.3. To become familiar with the problems of using high-field cardiac

MRI in daily routine.

16:30A-012 B. Cardiac CT: technique in 2020; where to next?

K. Nikolaou; Munich/DE

Learning Objectives:1. To learn about the latest technical developments in state-of-the-art

cardiac CT.2. To explore what new developments will influence cardiac CT over the

next few years.3. To understand if what you need is a lot of rows, tubes or both for

optimal cardiac CT.

17:00A-013 C. Cardiac hybrid imaging: „One-Stop-Shop“

P.A. Kaufmann; Zurich/CH

Learning Objectives:1. To understand the principles of cardiac hybrid imaging.2. To learn about the diagnostic value of hybrid imaging.3. To know about possible indications for performing hybrid imaging.

16:00–17:30 Room E1

Molecular Imaging RC 306 Molecular imaging in oncology

Moderator: O. Clément; Paris/FR

16:00A-014 A. New PET-tracers for oncology

P.L. Choyke; Bethesda, MD/US

Learning Objectives:1. To learn about the new specific tracers that can be used in oncologic

patients.2. To become familiar with their possible impact on patient

management.3. To understand their potential and limitations for practice.

16:30A-015 B. Potential of MRI for molecular imaging in oncology

F.A. Gallagher; Cambridge/UK

Learning Objectives:1. To become familiar with the different approaches to molecular

imaging with MRI.2. To understand the role of molecular imaging in oncology.3. To learn about emerging MRI techniques for molecular imaging.

17:00A-016 C. Emerging molecular imaging techniques

F.M.A. Kiessling; Aachen/DE

Learning Objectives:1. To become familiar with optical imaging techniques and probes.2. To learn about the potential of targeted US contrast agents.3. To appreciate emerging hybrid imaging techniques.

16:00–17:30 Room E2

Multidisciplinary Session: Managing Patients with Cancer MS 3 Colorectal liver metastases 16:00A-017 Chairman‘s introduction

V. Vilgrain; Clichy/FR

Session Objectives:1. To learn about the prognostic factors of colorectal liver metastases.2. To become familiar with the most common therapeutic strategies.3. To understand the role of the multidisciplinary team in patients with

colorectal liver metastases.

16:05A-018 Role of imaging in the pretreatment assessment

V. Vilgrain; Clichy/FR

Learning Objectives:1. To become familiar with imaging findings indicating surgical

resectability.2. To understand the role of CT and MR imaging in staging liver

metastases.3. To learn about the role of new imaging techniques in staging liver

metastases.

16:20A-019 Surgical resection of liver metastases: when and how

J. Belghiti; Clichy/FR

Learning Objectives:1. To become familiar with surgical indications of liver metastases.2. To understand treatment planning strategies.3. To learn about prognostic factors for surgical candidates.

16:35A-020 Chemotherapy and novel therapy in colorectal liver

metastases: rationale, indications and results S. Faivre; Clichy/FR

Learning Objectives:1. To appreciate the rationale behind chemotherapy and novel therapy.2. To learn about the most common protocols of chemotherapy and

novel therapy.3. To consolidate knowledge in treatment efficacy.

16:50A-021 Role of image-guided treatment in colorectal liver

metastases M. Abdel Rehim, A. Sibert, V. Barrau, Z. Ben Lakhdar, V. Vilgrain; Clichy/FR

Learning Objectives:1. To learn about the most common image-guided treatments.2. To understand advantages and drawbacks of each treatment.3. To become familiar with the role of image-guided treatments.

17:05 Case presentation and discussion

16:00–17:30 Room F1

Professional Challenges Session PC 3 Bringing radiology to medical

undergraduates 16:00A-022 Chairman‘s introduction: why does it matter?

S.J. Golding; Oxford/UK

Session Objectives:1. To understand why radiologists need to make undergraduate

teaching a priority.2. To become familiar with the effect of teaching undergraduates on the

student and the institution.3. To appreciate the objectives with which the undergraduate should be

taught.

Postgraduate Educational ProgrammeTh

ursday

157

A-02

3 –

A-03

4 16:05A-023 Establishing a radiological presence in the undergraduate

curriculum R.N. Gibson; Melbourne/AU

Learning Objectives:1. To understand the importance of radiology‘s undergraduate profile.2. To understand the effect of a presence throughout the curriculum on

education.3. To become familiar with the ways in which radiology‘s curricular

presence may be achieved at individual stages.

16:20A-024 Finding the time and resources in the radiology

department J. del Cura; Bilbao/ES

Learning Objectives:1. To be aware of the competing demands on departmental resources.2. To understand the available methods for creating time for teaching.3. To understand the physical resources that aid effective and efficient

teaching.

16:35A-025 Involving the undergraduate with the radiology

department K.L.A. Verstraete; Gent/BE

Learning Objectives:1. To understand the effect of involvement in radiology on learning.2. To become familiar with the potential methods of undergraduate

involvement.3. To understand the value and management of short-term and long-

term attachments to the radiology department.

16:50A-026 How to ensure teachers are suitably trained

E. Szabó, Z. Morvay, E. Nagy, I. Mátéka; Szeged/HU

Learning Objectives:1. To learn that teaching is a psychomotor skill with its own training

requirements.2. To understand the importance of course design and methods of

assessment to learning.3. To understand the ways in which radiological teachers may obtain

training appropriate to their needs.

Panel discussion:17:05 What needs to be done to overcome the constraints on

radiologists?

16:00–17:30 Room F2

Breast RC 302 Functional imaging of the breast

Moderator: G. Esen; Istanbul/TR

16:00A-027 A. Contrast-enhanced mammography

C.S. Balleyguier1, E. Fallenberg2, S. Canale1, C. Dromain1; 1Villejuif/FR, 2Berlin/DE

Learning Objectives:1. To understand the underlying physical principles of contrast-

enhanced mammography (CEM).2. To become familiar with different protocols.3. To appreciate the potential impact of CEM on every day clinical

practice.

16:30A-028 B. Ultrasound elastography

A. Athanasiou; Paris/FR

Learning Objectives:1. To understand the basic principles of US elastography.2. To learn about the difference between strain and shear wave

elastography and their respective results.3. To appreciate the additional value of US elastography to B-mode US.

17:00A-029 C. MRI diffusion, perfusion and spectroscopy

P.A.T. Baltzer; Vienna/AT

Learning Objectives:1. To understand the diagnostic value of diffusion weighted imaging

(DWI) in its present clinical applications.2. To learn about the technical basics and potential use of MRI

perfusion in the breast.3. To understand promises and challenges of MR spectroscopy in

clinical practice.

16:00–17:30 Room G/H

Genitourinary RC 307 Renal and adrenal tumours

Moderator: B. Brkljacic; Zagreb/HR

16:00A-030 A. Adrenal masses, a practical approach

G. Heinz-Peer; St. Pölten/AT

Learning Objectives:1. To become familiar with the different imaging appearances of adrenal

masses including pathological relation.2. To learn the different imaging techniques to improve evaluation of

benign versus malignant adrenal masses.3. To understand the impact of imaging given the information that the

patient has/has not a known malignancy.

16:30A-031 B. Staging renal cancer

R. Pozzi-Mucelli; Verona/IT

Learning Objectives:1. To recognise the CT/MRI/US findings for staging.2. To learn about the optimal imaging protocol for the diagnosis and

staging of renal cancer.3. To understand treatment options and implications.

17:00A-032 C. How to deal with small indeterminate renal masses

O. Hélénon; Paris/FR

Learning Objectives:1. To become familiar with the various appearances of small

indeterminate renal masses.2. To learn about the respective roles of US, CT and MR imaging in

investigating small renal masses.3. To learn the main pitfalls in assessing small renal masses.

16:00–17:30 Room I/K

Chest RC 304 How I report

Moderator: J. Cáceres; Barcelona/ES

16:00A-033 A. Bedside chest radiography

R. Eibel; Schwerin/DE

Learning Objectives:1. To learn a structured reporting approach.2. To understand key imaging findings in different clinical settings.3. To improve confidence by linking pattern recognition, interpretation

and diagnosis.

16:30A-034 B. CTA and MRA of the pulmonary arteries

J.E. Wildberger; Maastricht/NL

Learning Objectives:1. To learn more about recent improvements in CT

and MR angiography.2. To learn a structured approach to reporting CTA or MRA.3. To become familiar with the role of CT angiography in comparison

to MR angiography.


158

A-03

5 –

A-04

717:00A-035 C. PET/CT

C. Keyzer; Brussels/BE

Learning Objectives:1. To understand the basic principles of PET/CT using FDG.2. To become familiar with physiologic FDG uptake

and frequent pitfalls.3. To learn about FDG PET/CT in non-oncologic and oncologic

disorders and how to report.

16:00–17:30 Room L/M

Organs from A to Z: Heart MC 322 Technical and anatomical

fundamentals for imaging the heart Moderator: A. de Roos; Leiden/NL

16:00A-036 A. Anatomy: too many details in cardiac imaging?

A.J.B.S. Madureira; Porto/PT

Learning Objectives:1. To learn about the detailed anatomy of the heart.2. To learn about the anatomy of the thoracic vasculature and great

vessels.3. To get an overview of important incidental findings in cardiac

imaging.

16:20A-037 B. Examination protocols for imaging the heart: CT

H. Alkadhi; Zurich/CH

Learning Objectives:1. To get an overview of different examination protocols.2. To learn about various strategies in radiation dose optimisation.3. To identify suitable clinical indications for cardiac CT.

16:40A-038 C. Examination protocols for imaging the heart: MRI

N.L. Kelekis; Athens/GR

Learning Objectives:1. To get an overview of different examination protocols.2. To learn about typical cardiac MR artefacts and pitfalls.3. To identify suitable clinical indications for cardiac MRI.

17:00A-039 Interactive case discussion

A. de Roos; Leiden/NL

16:00–17:30 Room N/O

Interventional Radiology RC 309 Percutaneous treatment of chronic

back pain and sciatica 16:00A-040 Chairman‘s introduction

A.D. Kelekis; Athens/GR

16:05A-041 A. Sacroiliac joint syndrome

D.J. Wilson; Oxford/UK

Learning Objectives:1. To learn about relevant anatomy and clinical presentations of the

syndrome.2. To know more about the available treatments.3. To learn about clinical results and possible further developments.

16:28A-042 B. Facet syndrome

M. Gallucci; L‘Aquila/IT

Learning Objectives:1. To understand the difference between facet joint and disc disease.2. To learn about different treatment options for facet disease.3. To learn how to manage patients.

16:51A-043 C. Intervertebral disc syndromes

A. Gangi, J. Garnon, G. Tsoumakidou, I. Enescu; Strasbourg/FR

Learning Objectives:1. To understand possible treatment techniques for disc disease.2. To know more about clinical and imaging findings in treatment.3. To learn about published results on percutaneous disc treatment.

Panel discussion: 17:14 How can imaging methods separate candidates for

percutaneous therapy and surgery?

16:00–17:30 Room P

Vascular RC 315 Vascular imaging in ischaemic stroke

Moderator: J. Hendrikse; Utrecht/NL

16:00A-044 A. Intracranial atherosclerotic disease of carotid arteries

T. Jargiello; Lublin/PL

Learning Objectives:1. To become familiar with appropriate imaging protocols for all

imaging modalities and the pros and cons of each modality.2. To learn about imaging signs of atherosclerotic disease in the carotid

artery territory.3. To learn about the classification of lesions and indications for

treatment.

16:30A-045 B. Vertebrobasilar atherosclerotic disease

L. Valvassori, M. Piano; Milan/IT

Learning Objectives:1. To learn about the appropriate imaging protocol and the imaging

signs of extracranial and intracranial atherosclerosis.2. To learn about the epidemiology, symptomatology and natural

history.3. To learn about the classification of lesions and indications for

treatment.

17:00A-046 C. Dissection and vasculitis of intracranial and extracranial

arteries H.R. Jäger; London/UK

Learning Objectives:1. To learn the imaging signs of dissection and different types of large/

medium vessel vasculitis.2. To learn about lesion morphology and haemodynamic consequences

of dissection and vasculitis.3. To learn about imaging protocols for detection of dissection and

large/medium vessel vasculitis.

16:00–17:30 Room Q

Computer Applications RC 305 New PACS architecture: decoupling

image management from image navigation

16:00A-047 Chairman‘s introduction

H.U. Lemke; Berlin/DE

Session Objectives:1. To introduce models of image management and workflow.2. To present the evolution of image management outside of radiology

(surgery, interventions etc.).3. To discuss the technical requirements for better image sharing and

distribution.

Postgraduate Educational ProgrammeTh

ursday

159

A-04

8 –

A-05

4 16:05A-048 A. Image navigation and new PACS architecture

J. Reponen; Raahe/FI

Learning Objectives:1. To learn about recent changes in PACS design and infrastructure.2. To understand the role of data management in PACS architecture.3. To become acquainted with different PACS architectures.4. To understand technical, workflow and legal aspects of innovative

technologies.

16:28A-049 B. Intraoperative imaging for surgeons

A. Pietrabissa1, L. Pugliese1, A. Peri1, F.P. Tinozzi1, V. Ferrari2; 1Pavia/IT, 2Pisa/IT

Learning Objectives:1. To understand why surgeons need more intraoperative guidance.2. To learn about the role of robotics and augmented reality in general

surgery.3. To become familiar with patient-specific simulation.4. To appreciate the place of surgical training and accreditation.

16:51A-050 C. Dismantling PACS: separating image viewing from the

data storage and sharing B. Gibaud; Rennes/FR

Learning Objectives:1. To learn about strategic issues of generic image archiving and

distribution.2. To understand new concepts of independent ‚front ends‘ of PACS.3. To become familiar with new examples of PACS implementation

based on component architecture.4. To appreciate new strategies of PACS architecture and migration.

Panel discussion: 17:14 How should we manage our images today?

16:00–17:30 Room Z

ESR Radiation Protection Session Security scanners at airports: are they safe? Moderators: J. Damilakis; Iraklion/GR, P. Vock; Berne/CH

16:00A-051 X-ray backscatter security scanners: principles,

performance and potential health risks J. Damilakis; Iraklion/GR

Learning Objectives:1. To become familiar with the technological principles of security

scanners.2. To learn about the detection performance of x-ray security scanners.3. To understand the radiation doses and risks from x-ray backscatter

security scanners.

16:30A-052 Cumulative low-level x-ray radiation exposure: is it

harmful? P. Vock; Berne/CH

Learning Objectives:1. To learn about risks of x-ray exposure in relation to age.2. To appreciate the difference between individual and collective

radiogenic risks.3. To understand issues related to cumulative radiation doses and

possible risks from medical x-ray screening procedures.

17:00A-053 Security scanners using non-ionising radiation: current

status and trends for development M. Kemp; Cambridge/UK

Learning Objectives:1. To understand the current status of non-ionising radiation

technology for the detection of explosives and other threats.2. To learn about trends for development of millimetre-wave and

terahertz technology.3. To learn about the challenges and limitations of these technologies.

18:30–18:50 Room A

Plenary Session OL Opening Lecture

Presiding: J.I. Bilbao; Pamplona/ES

18:30A-054 Promises and facts of liver-directed gene therapy

J.M. Prieto; Pamplona/ES

Learning Objectives:1. To learn about novel therapeutic approaches in hepatology.2. To understand principles and applications of liver-directed gene

therapy.3. To appreciate flexibility, potential and limitations of the procedure.4. To become familiar with gene therapy vectors and their clinical use.5. To consolidate knowledge of novel approaches to treat liver diseases.


160

A-05

5 –

A-06

708:30–10:00 Room A

Abdominal Viscera RC 401 Pitfalls in interpretation of

pancreatic imaging Moderator: H.-J. Brambs; Ulm/DE

08:30A-055 A. Pancreatic cancer or pancreatitis?

B.J. Op de Beeck, A. Snoeckx, M. Spinhoven, R. Salgado, P.M. Parizel; Antwerp/BE

Learning Objectives:1. To become familiar with the common benign mimickers of

pancreatic malignancy.2. To learn how to differentiate between benign and malignant lesions.3. To know the limitations and complementary roles of CT and MR.

09:00A-056 B. How can we differentiate cystic neoplasms from

pseudocysts? T. Denecke; Berlin/DE

Learning Objectives:1. To learn the most common cystic lesions of the pancreas.2. To know typical imaging findings of pseudocysts and cystic tumours.3. To become familiar with imaging elements that help differentiate

between cystic lesions.

09:30A-057 C. How to manage incidental findings

C. Triantopoulou; Athens/GR

Learning Objectives:1. To learn how to differentiate between benign and malignant cystic

lesions.2. To know the correct management of unclassified cystic lesions

through imaging.3. To become familiar with the reference imaging criteria suggesting

treatment.

08:30–10:00 Room C

Oncologic Imaging RC 416 MR imaging for prostate cancer

management: the essential guide for radiologists


H.-P. Schlemmer; Heidelberg/DE

08:35A-059 A. Clinical challenges: how to treat prostate cancer

B.A. Hadaschik; Heidelberg/DE

Learning Objectives:1. To understand how diagnosis is established through PSA evaluation

and biopsy.2. To learn about different treatment options.

08:58A-060 B. The radiologist‘s contribution: how to detect and

characterise a tumour A.R. Padhani; Northwood/UK

Learning Objectives:1. To understand how multiparametric MRI detects prostate cancer.2. To learn how to perform, interpret and communicate multi

parametric MRIs.3. To learn how to support image guided biopsy.4. To understand the need for the standardisation of MRI protocols and

reports.

09:21A-061 C. The radiologist‘s influence on management. Staging

prostate cancer: how it impacts on treatment selection H. Hricak; New York, NY/US

Learning Objectives:1. To learn how advanced MR techniques improve staging.

2. To learn how imaging impacts on clinical management (treatment selection and response monitoring).

3. To understand the need for the implementation of MRI in clinical practice and clinical trials.

4. To understand the need for specialised training of radiologists in prostate cancer imaging.

Panel discussion: 09:44 Is MRI an integral part of the clinical routine?

08:30–10:00 Room D1

Controversies in Breast Imaging MC 423 Overdiagnosis from screening

mammography: should we care about it? Moderator: T.H. Helbich; Vienna/AT Teaser: H.J. de Koning; Rotterdam/NL

08:30A-062 A. The risk of overdiagnosis from screening

mammography E. Paci, D. Puliti; Florence/IT

08:55A-063 B. How breast radiologists should control the risk of

overdiagnosis U. Bick; Berlin/DE

09:20A-064 Discussion

T.H. Helbich1, H.J. de Koning2; 1Vienna/AT, 2Rotterdam/NL

08:30–10:00 Room D2

Emergency Radiology RC 417 ER: basic principles

Moderator: P. Valdés Solís; Marbella/ES

08:30A-065 A. Logistics and organisation of an emergency radiology

department M. Körner; Landshut/DE

Learning Objectives:1. To understand how an emergency radiology department should be

organised.2. To become familiar with the logistics, staffing and technical

equipment of an ER department operating 24/7.

09:00A-066 B. Advanced trauma life support: basic knowledge for

radiologists D.R. Kool; Nijmegen/NL

Learning Objectives:1. To understand the relationship between ATLS and emergency

radiology.2. To know more about the rational use of CR, US and CT according to

patient priorities in the emergency setting.3. To become familiar with priority-oriented reporting of findings.

09:30A-067 C. Mechanism of injury and MDCT protocols: choosing the

right protocol for the right patient S. Voelckel1, M. Rieger2; 1Innsbruck/AT, 2Hall in Tirol/AT

Learning Objectives:1. To understand mechanisms of traumatic injuries.2. To become familiar with established whole body MDCT protocols

and their possible relation to injuries.3. To know the impact of MDCT findings on patient management.


161

Friday

A-06

8 –

A-07

8 08:30–10:00 Room E1

State of the Art Symposium SA 4 Diffusion-weighted imaging (DWI)

of the abdomen 08:30A-068 Chairman‘s introduction

Y. Menu; Paris/FR

Session Objectives:1. To understand DWI principles.2. To learn about appropriate protocols for DWI of the abdomen.3. To learn how to analyse and report DWI images.4. To understand the clinical value of DWI for detection,

characterisation and prognostic evaluation.

08:35A-069 DWI of the abdomen: a tutorial for beginners

H.C. Thoeny; Berne/CH

Learning Objectives:1. To understand the principles of DWI.2. To learn the different acquisition protocols (optimal b values, optimal

sequences) and their advantages and disadvantages.3. To learn how DWI can be integrated into acquisition protocols, and

whether it precludes the need for other sequences.4. To learn how to interpret ADC maps and values.

08:55

A-070 Liver and pancreas: answering burning questions F. Caseiro-Alves; Coimbra/PT

Learning Objectives:1. To understand the images observed in the main focal liver and

pancreatic diseases.2. To learn if DWI can provide useful information concerning tissue

characterisation.3. To understand the clinical circumstances in which DWI is most

helpful.4. To learn if DWI helps in the evaluation of diffuse liver diseases and

how iron and fat could be misleading issues.

09:15A-071 DWI of abdominal lymph nodes: PET competitive or just

pseudo? S. Gourtsoyianni; London/UK

Learning Objectives:1. To understand the signal of lymph nodes on DWI sequences, and to

identify the correlation between histological changes and DWI signal in benign and malignant lymph nodes involvement.

2. To learn whether or not ADC value is helpful for characterisation.3. To compare DWI and PET and understand their respective roles.4. To open the door to the future combination of PET and MRI.

09:35 Clinical cases

08:30–10:00 Room E2

Foundation Course: Neuroimaging E³ 420 The orbit, the petrous bone

and the sella Moderator: B. De Foer; Antwerp/BE

08:30A-072 A. Imaging of the orbit: the globe and conal lesions

P.C. Maly Sundgren; Lund/SE

Learning Objectives:1. To understand the embryology and imaging findings of the most

common malformations of the orbit.2. To learn about space occupying lesions and the differential diagnosis

of tumours and inflammatory conditions.3. To become familiar with the role of conventional and advanced MR

sequences in the diagnostic approach of lesions in the orbit.

09:00A-073 B. The petrous bone

F. Veillon; Strasbourg/FR

Learning Objectives:1. To understand the normal imaging anatomy.2. To learn about the role of CT and MRI in the evaluation of congenital

malformations.3. To become familiar with the most common acquired lesions of the

middle and inner ear.

09:30A-074 C. Sella and parasellar pathology

R. Gasparotti; Brescia/IT

Learning Objectives:1. To consolidate knowledge about the normal anatomy and the age

related patterns of the normal pituitary gland.2. To learn how to evaluate congenital and acquired lesions of the sella

and parasellar region.3. To become familiar with imaging protocols.

08:30–10:00 Room F1

Multidisciplinary Session: Managing Patients with Cancer MS 4 Hepatocellular carcinoma 08:30A-075 Chairman‘s introduction

B. Sangro; Pamplona/ES

Session Objectives:1. To learn the current management of HCC as laid out in scientific

guidelines.2. To identify those areas of uncertainty, where multidisciplinary teams

are needed most.3. To understand the basis of personalised care for HCC patients and

the need for multidisciplinary teams.

08:35A-076 Abdominal radiology

A. Benito; Pamplona/ES

Learning Objectives:1. To learn which imaging procedures should be considered standard

of care for staging HCC and which are potential improvements that await confirmation.

2. To understand the limitations of imaging in the diagnosis and evaluation of response to locoregional and antiangiogenic therapies.

3. To learn about the scientific evidence supporting the use of percutaneous ablation procedures other than radiofrequency.

08:50A-077 Interventional radiology

J.I. Bilbao; Pamplona/ES

Learning Objectives:1. To learn about locoregional intraarterial therapies currently being

used for HCC and the rationale behind their use.2. To become familiar with patient selection for embolising procedures

prior to and after angiographic evaluation.3. To learn some tips that may help reduce side effects and prevent

complications of transarterial therapies.4. To understand how IRs can help patients with unresectable tumours

being evaluated for resection.

09:05A-078 Surgery

F. Pardo; Pamplona/ES

Learning Objectives:1. To learn about the main factors behind the resectability of HCC.2. To learn about the evolving criteria for liver transplantation.3. To understand the potential role of radiologists in the intraoperative

or postoperative management of HCC.4. To learn about complications of locoregional therapies (percutaneous

ablation or intraarterial therapies) that could complicate resection or transplantation.


162

A-07

9 –

A-08

909:20A-079 Hepatology/oncology

B. Sangro; Pamplona/ES

Learning Objectives:1. To learn the basis of tumour staging in HCC and the general

treatment paradigm.2. To learn about the discrepancies between different treatment

guidelines and clinical practice.3. To become familiar with systemic anticancer agents and their impact

on locoregional and surgical treatment of HCC.

09:35 Case presentation and discussion

08:30–10:00 Room F2

Special Focus Session SF 4a „MRI of the lung: to go?“ 08:30A-080 Chairman‘s introduction: „Apéritif

H.-U. Kauczor; Heidelberg/DE

Session Objectives:1. To learn how to do MRI of the lung in clinical routine.2. To understand the rationales and potential clinical applications of

MRI of the lung.3. To understand the prerequisites for acceptance of MRI of the lung by

our clinical colleagues.

08:33A-081 The sequence buffet

J.M. Wild; Sheffield/UK

Learning Objectives:1. To learn about the basic physics of MR imaging of protons in the

lung.2. To understand the role of different magnetic field strengths and

parallel receiver coils.3. To appreciate the potential of fast imaging sequences for imaging the

lung.

08:48A-082 Preparing your menu

J. Biederer; Heidelberg/DE

Learning Objectives:1. To learn how to combine MR sequences with a comprehensive

imaging protocol.2. To become familiar with the different diagnostic scopes of the

protocol components.3. To learn how to apply protocol variations for specific clinical

questions.4. To learn when to use IV contrast-enhanced series.

09:03A-083 Bon appétit! Starters“: cystic fibrosis, pneumonia and

pulmonary embolism M.U. Puderbach; Heidelberg/DE

Learning Objectives:1. To understand the application of MRI to morphological and

functional imaging of airway diseases.2. To appreciate the potential of MRI for imaging pulmonary

embolisms using different morphological and functional MR-techniques.

09:23A-084 Bon appétit! Main course“: pulmonary and mediastinal

neoplasms E.J.R. van Beek; Edinburgh/UK

Learning Objectives:1. To understand the application of MRI sequences to the staging of

lung cancer.2. To become familiar with the role of MRI in lung cancer work-ups.3. To learn about the limitations of MRI in chest tumours.

Panel discussion: 09:43 „Bon appétit! Dessert“: what are the benefits of MRI of the

lung in clinical workflow and decision-making?

08:30–10:00 Room G/H

Neuro RC 411 The paediatric brain:

not just a small brain Moderator: C. Venstermans; Edegem/BE

08:30A-085 A. Neurocutaneous syndromes: more than

neurofibromatosis B. Ertl-Wagner; Munich/DE

Learning Objectives:1. To become familiar with the typical clinical presentations of

neurocutaneous syndromes.2. To consolidate knowledge of the typical imaging patterns of the

major neurocutaneous syndromes.3. To become familiar with some less common features of

neurocutaneous syndromes.

09:00A-086 B. Patterns of white matter disease in children

A. Rossi; Genoa/IT

Learning Objectives:1. To become familiar with the most common white matter diseases in

children.2. To learn how to differentiate between white matter diseases in

children.3. To consolidate knowledge of appropriate imaging protocols for MRI

of children with white matter disease.

09:30A-087 C. Paediatric brain tumours

C. Hoffmann; Tel Hashomer/IL

Learning Objectives:1. To learn about the difference between paediatric and adult brain

tumours.2. To understand the imaging strategy for the paediatric population.3. To recognise the most common paediatric brain tumours.

08:30–10:00 Room I/K

Joint Course of ESR and RSNA (Radiological Society of North America) MC 428 Essentials in oncologic imaging: what

radiologists need to know (part 1) Moderator: D.M. Panicek; New York, NY/US

08:30A-088 A. Principles of oncologic imaging and reporting

D.M. Panicek; New York, NY/US

Learning Objectives:1. To review general principles of oncologic imaging.2. To understand the critical importance of clinical context during

interpretation of oncologic exams.3. To evaluate ways to ensure that our reports provide added value and

reflect the radiologist’s role as consultant.

08:55A-089 B. Lung cancers (primary, metastases)

C.J. Herold; Vienna/AT

Learning Objectives:1. To review the strengths and limitations of radiologic techniques

suitable for detecting and characterising primary and metastatic lesions in the lungs.

2. To understand the imaging findings relevant for lung cancer T, N and M staging, and appraise the implications of the new IASLC lung cancer staging system.

3. To evaluate the imaging findings used to assess response to conventional and new therapies for lung cancers.


163

Friday

A-09

0 –

A-10

4 09:25A-090 C. Colon cancer

R.M. Gore, R. Silvers; Evanston, IL/US

Learning Objectives:1. To get an overview of current recommendations for the diagnosis of

colorectal cancer.2. To understand the specific role of MDCT, MR imaging, endoscopic

ultrasound, and PET/CT in the staging of colorectal cancer in optimising patient management.

3. To learn the utility of imaging in assessing tumour response to therapy and in the general follow-up of patients with colorectal cancer.

09:50 Questions

08:30–10:00 Room L/M

Organs from A to Z: Heart MC 422 Non-ischaemic heart disease

Moderator: V.E. Sinitsyn; Moscow/RU

08:30A-091 A. Congenital heart disease

M. Gutberlet; Leipzig/DE

Learning Objectives:1. To understand the value of available imaging modalities in congenital

heart disease.2. To get an overview of common cases of congenital heart failure.3. To learn how to read post-surgical cases in patients with congenital

heart disease.

08:50A-092 B. Valvular disease

J. Bogaert; Leuven/BE

Learning Objectives:1. To learn about various imaging modalities available for imaging the

cardiac valves.2. To get an overview of various types of valvular diseases.3. To understand myocardial changes caused by valvular pathologies.

09:10A-093 C. Cardiomyopathies

P. Sipola; Kuopio/FI

Learning Objectives:1. To get an overview of different types of cardiomyopathies.2. To differentiate typical imaging findings in various cardiomyopathies.


V.E. Sinitsyn; Moscow/RU

08:30–10:00 Room N/O

EIBIR/EORTC Joint WorkshopA radiologist with a ruler in his hand isa dangerous person: seeking standardisation inmulticenter imaging trials Moderators: P. Brader; Vienna/AT, Y. Liu; Brussels/BE

08:30A-095 Introduction: imaging and the future of cancer therapy

P. Brader1, Y. Liu2; 1Vienna/AT, 2Brussels/BE

Learning Objectives:1. To seek standardisation of imaging biomarkers in multicenter cancer

clinical trials.2. To demonstrate examples of imaging implementation in optimised

study design.3. To explore future collaboration between EORTC and EIBIR.

08:40A-096 Setting up clinical trials with functional imaging end-

points: trials and tribulations N.M. deSouza; Sutton/UK

Learning Objective:1. To understand the processes involved in incorporating functional

imaging end points into clinical trials and appreciate the limitations.

09:00A-097 Challenges, problems on key imaging techniques

B. Van Beers; Clichy/FR

09:20A-098 Advanced MR neuroimaging in multicentre trials:

experience from the EORTC Brain Tumour Group M. Smits; Rotterdam/NL

09:40A-099 Presentation of LUNG study: from the beginning until

today U. Nestle; Freiburg/DE

08:30–10:00 Room P

Professional Challenges Session PC 4 The visibility of the radiologist 08:30A-100 Chairman‘s introduction

J.A. Reekers; Amsterdam/NL

Session Objectives:1. To learn how the visibility of the radiologist can be increased.2. To understand that radiology needs to play a central role in diagnosis

and treatment.3. To learn from the experts and increase understanding through Q &

A.

08:33A-101 How to optimise the visibility of the radiology department

J.A. Reekers; Amsterdam/NL

Learning Objectives:1. To learn how to organise a radiology department within a hospital.2. To learn how to optimise contact with clinical partners.3. To learn how to create an open radiology department.

08:45A-102 Start early with radiological visibility

M. Maas; Amsterdam/NL

Learning Objectives:1. To learn how to set up an undergraduate teaching programme for

radiology.2. To learn how to overcome the barriers of a traditional curriculum.3. To learn about the results of an undergraduate teaching programme

for radiology.

09:05A-103 Clinical radiology puts you in the spotlight: taking over

the clinical responsibility E. de Kerviler; Paris/FR

Learning Objectives:1. To learn how to become more clinically involved.2. To learn about the requirements of clinical radiology.3. To learn how to manage the clinical problems of others.

09:25A-104 Radiology in the 21st century: time to come out of the

dark? A. Adam; London/UK

Learning Objectives:1. To learn about the role of the radiologist as quality controller.2. To learn how to become proactive and drive patient pathways rather

than simply responding to requests.3. To learn about improved visibility through improved service.

Panel discussion: 09:45 Should we improve the visibility of the radiologist?

And if yes, how?


164

A-10

5 –

A-11

608:30–10:00 Room Q

Special Focus Session SF 4b Justifying CT in paediatric radiology 08:30A-105 Chairman‘s introduction

C. Owens; London/UK

Session Objectives:1. To become familiar with the importance of CT justification and

optimisation.2. To understand the evidence base for concern.3. To become familiar with realistic alternatives to CT.

08:34A-106 How should CT be optimised?

W.A. Kalender; Erlangen/DE

Learning Objectives:1. To become familiar with the dose levels currently encountered in

paediatric CT.2. To become familiar with new developments towards dose reduction

in CT.3. To learn about tools for assessing organ dose and effective dose

values.

08:56A-107 When, how, and why I perform CT

C. Owens; London/UK

Learning Objectives:1. To become familiar with the concept of CT ‘fit for purpose’.2. To appreciate the role of CT in paediatric body imaging.3. To become familiar with suggested parameters for use of CT in

cardiothoracic imaging, describing risks and benefits.

09:18A-108 Why and when CT does not need to be performed

M. Claudon; Vandoeuvre-les-Nancy/FR

Learning Objectives:1. To become familiar with alternative imaging methods to replace CT.2. To appreciate the advantages and disadvantages of these alternative

methods of imaging.3. To become familiar with a practical model for CEUS and MRI in

body imaging.

Panel discussion: 09:40 Do we have guidelines for paediatric CT?

Do we have alternatives?

10:30–12:00 Room A

Interactive Teaching Session E³ 520a Pitfalls in abdominal imaging 10:30A-109 A. Liver

V. Vilgrain, M. Ronot, A. Kerbaol, O. Bruno; Clichy/FR

Learning Objectives:1. To learn about morphologic changes in the liver observed in non-

cirrhotic diseases.2. To understand imaging features enabling distinction between intra

and extrahepatic tumours.3. To become familiar with liver lesions mimicking liver tumours.

11:15A-110 B. Pancreas and bile ducts

R. Manfredi; Verona/IT

Learning Objectives:1. To understand the MRI technique for evaluating the pancreatic

parenchyma, the pancreatic duct system and the biliary tree, the functional assessment following secretin stimulation.

2. To appreciate the signs in MR imaging of the pancreas and bile ducts.3. To understand the diagnostic imaging criteria useful for differential

diagnosis.

10:30–12:00 Room B

ESR meets Spain EM 1 Imaging: essential tool from

diagnosis to treatment Welcome by the ESR President: G.P. Krestin; Rotterdam/NL

Presiding: C. Ayuso; Barcelona/ES J.I. Bilbao; Pamplona/ES

10:30A-111 Introduction

C. Ayuso; Barcelona/ES

Session Objectives:1. To discuss the role of imaging techniques in different clinical

scenarios where radiologists are key, from diagnosis to treatment.2. To present technical imaging innovations that assist the diagnosis,

treatment and follow-up in three different clinical scenarios: ischaemic stroke, aortic aneurism and hepatocellular carcinoma.

3. To present specific clinical advantages and results of the multimodality approach.

10:35A-112 Ischaemic stroke

J. Macho; Barcelona/ES

Learning Objectives:1. To discuss the clinical and neuroradiologic implications of an early

diagnosis. Evaluation of CT and MR diffusion/perfusion in patient selection for endoarterial treatment.

2. To understand the rationale behind mechanical endoarterial reperfusion of acute vascular occlusion.

3. To analyse the short and medium term results of a regional programme for acute stroke treatment after three years.

10:55A-113 Interlude: Spanish radiologists: open to the world

E. Fraile Moreno; Madrid/ES

11:00A-114 Aortic aneurisms

J.J. Martínez Rodrigo; Valencia/ES

Learning Objectives:1. To understand the role of imaging modalities in diagnosis and

endovascular treatment of aortic aneurisms.2. To learn about the role of 3D imaging techniques to assist the

endovascular treatment of aortic aneurisms.3. To appreciate the role of imaging modalities in evaluating the

complications of endovascular aortic repair.

11:20A-115 Interlude: Radiologists and Spanish wines

L. Martí-Bonmatí; Valencia/ES

Learning Objectives:1. To understand the influence of the country, the climate and the

situation in the quality of wines.2. To learn about Spain‘s characteristics that influence the wine quality.3. To appreciate why the soil (and by extension the terroir) is so

important.

11:25A-116 Hepatocellular carcinoma: the BCLC approach

M. Burrel; Barcelona/ES

Learning Objectives:1. To understand the clinical implications of an early diagnosis, when

the lesion is small and asymptomatic.2. To learn about the rationale behind the current guidelines for model

treatment options.3. To appreciate the spectrum of locoregional therapies for HCC from

percutaneous to intravascular approaches.

Panel discussion: 11:45 Is the multidisciplinary environment the natural way to

develop excellence and leadership in clinical imaging?


165

Friday

A-11

7 –

A-12

5 10:30–12:00 Room C

Interactive Teaching Sessions E³ 520b Pitfalls in head and neck imaging 10:30A-117 A. Pitfalls in neck imaging

F.A. Pameijer; Utrecht/NL

Learning Objectives:1. To understand the variations of normal anatomy in the neck that

should not be interpreted as abnormal.2. To become familiar with the incidental findings that are frequently

encountered when searching for neck disease.3. To recognise suboptimal neck studies, or technique related problems

and understand how these may influence interpretation.

11:15A-118 B. Pitfalls in maxillofacial and skull base imaging

R. Hermans; Leuven/BE

Learning Objectives:1. To understand the basic requirements for an optimal imaging study

of the skull base and maxillofacial region.2. To become familiar with anatomical variants, potentially mimicking

disease.3. To learn to appreciate incidental findings, avoiding unnecessary

concern while recognising relevant pathology.

10:30–12:00 Room E2

Foundation Course: Neuroimaging E³ 520c Paediatric

Moderator: D. Prayer; Vienna/AT

10:30A-119 A. Neonatal hypoxic-ischaemic brain injury

M.I. Argyropoulou; Ioannina/GR

Learning Objectives:1. To understand gestational age-related patterns of brain injury.2. To understand the role of ultrasound and MRI for the initial

diagnosis and follow-up of these patients.3. To understand when and how to use advanced MRI techniques for

delineation of lesions and for prognosis.

11:00A-120 B. Spine and spinal cord malformations

A. Rossi; Genoa/IT

Learning Objectives:1. To understand the embryology underlying the different categories of

malformations.2. To learn the key morphological features.3. To learn how to use a simplified diagnostic imaging approach.

11:30A-121 C. Imaging of the foetal brain

C. Garel; Paris/FR

Learning Objectives:1. To become familiar with the normal appearance of the developing

brain.2. To learn about the protocols and the limitations of foetal imaging.3. To gain knowledge about the imaging findings of the most common

brain abnormalities.

10:30–12:00 Room I/K


radiologists need to know (part 2) Moderator: H. Hricak; New York, NY/US

10:30A-122 A. Pancreatic cancer

F. Caseiro-Alves; Coimbra/PT

Learning Objectives:1. To understand current pathologic concepts for the classification of

pancreatic tumours.2. To learn about imaging findings used for tumour detection, staging,

and restaging after adjuvant therapy.3. To understand the role of functional and molecular information

provided by PET/CT, DWI and perfusion imaging when assessing pancreatic tumours.

10:55A-123 B. Kidney cancer

E.K. Fishman; Baltimore, MD/US

Learning Objectives:1. To understand the diagnostic implications of minimally invasive

treatments of renal cancer.2. To review the genetic causes of renal cancer and the radiologic

appearances of specific histologic subtypes.3. To review the potential role of molecular imaging in the management

of advanced renal cancer.

11:20A-124 C. Ovarian cancer

H. Hricak; New York, NY/US

Learning Objectives:1. To get an overview of the essential imaging findings in

characterisation and staging of ovarian cancer.2. To learn the key imaging findings that affect management of ovarian

cancer.3. To understand the changes in imaging armamentarium in ovarian

cancer, and learn the best practice in proper image utilisation.

11:50 Questions

12:30–13:30 Room P

The Beauty of Basic Knowledge: Musculoskeletal Imaging MC 25B Degenerative disorders 12:30A-125 Degenerative disorders

T.M. Link; San Francisco, CA/US

Learning Objectives:1. To understand the basic pathophysiology of degenerative processes in

peripheral joints and in the spine.2. To become familiar with typical imaging findings of osteoarthritis

and degenerative changes in the spine.3. To learn about the differential diagnosis of degenerative disorders.


166

A-12

6 –

A-13

612:30–13:30 Room Q

The Beauty of Basic Knowledge: Head and Neck MC 24B The infrahyoid neck and lymph nodes 12:30A-126 The infrahyoid neck and lymph nodes

M.G. Mack; Munich/DE

Learning Objectives:1. To become familiar with the different anatomic compartments of the

infrahyoid neck.2. To understand lymph node classification and level system.3. To learn about the best imaging approach to an IHN mass.4. To be able to localise and provide a useful differential diagnosis.

12:45–13:15 Room A

Plenary Session HL 1 Josef Lissner Honorary Lecture

Presiding: J.I. Bilbao; Pamplona/ES

12:45A-127 MR guided focused ultrasound: a new string to the

radiologist‘s bow C. Catalano; Rome/IT

Learning Objectives:1. To learn about the technical and physical principles of MR guided

focused ultrasound.2. To understand the advantages of MR guidance.3. To become familiar with the approved clinical applications and the

ongoing clinical trials.4. To learn the research activities and the possible future applications in

the fields of drug delivery and gene therapy.

14:00–15:30 Room D1

Controversies in Breast Imaging MC 623 Preoperative MRI in newly diagnosed

breast cancer: to do or not to do? Moderator: F. Sardanelli; Milan/IT Teaser: N. Houssami; Sydney/AU

14:00A-128 A. Why we should do preoperative MRI

W.A. Kaiser; Jena/DE

14:25A-129 B. Reasons not to do preoperative MRI

M.G. Wallis; Cambridge/UK


F. Sardanelli1, N. Houssami2; 1Milan/IT, 2Sydney/AU

14:00–15:30 Room E2

Foundation Course: Neuroimaging E³ 620 Trauma and vascularity

Moderator: A. Molyneux; Oxford/UK

14:00A-131 A. CNS trauma

P.M. Parizel, C. Venstermans, F. De Belder, T. Van der Zijden, L. van den Hauwe, M. Voormolen, J. Van Goethem; Antwerp/BE

Learning Objectives:1. To become familiar with the different types of intracranial injury and

the appropriate imaging patterns.

2. To learn about the imaging characteristics of intracranial haemorrhage by CT and MR.

3. To be able to recognise imaging findings that are critical for the patient‘s prognosis.

14:30A-132 B. Cerebral ischaemia and infarction

L. Pierot; Reims/FR

Learning Objectives:1. To consolidate knowledge of CT findings and conventional MRI

findings.2. To become familiar with the imaging findings and diagnostic role of

diffusion and perfusion MRI.3. To be informed of the indications and techniques for endovascular

stroke treatment.

15:00A-133 C. Vascular malformations of the spinal cord

D.A. Rüfenacht, I. Wanke; Zurich/CH

Learning Objectives:1. To understand the pathophysiology of vascular anomalies.2. To become familiar with imaging protocols.3. To be informed of the indications of interventional therapeutic

procedures.

14:00–15:30 Room I/K


radiologists need to know (part 3) Moderator: Y. Menu; Paris/FR

14:00A-134 A. Oncologic imaging: terminology, definitions and

buzzwords Y. Menu; Paris/FR

Learning Objectives:1. To get an overview and precise explanation of current cancer-related

terminology, definitions and „buzz“ words used in everyday practice.2. To understand why and how this terminology should ensure and

simplify communication with all specialists involved in cancer management, including clinicians, researchers as well as other radiologists.

3. To learn common tricks and traps in providing a radiology report, illustrated with clinical cases.

14:20A-135 B. Liver cancers (primary, metastases)

R.L. Baron; Chicago, IL/US

Learning Objectives:1. To get an overview of the AASLD/EASL imaging criteria for

noninvasive diagnosis of hepatocellular carcinoma.2. To learn about best practice CT/MR/US imaging techniques that

optimise characterisation, detection and staging of primary and metastatic liver tumours.

3. To understand the key role specific findings reported by radiologists have in determining patient treatment options for hepatocellular carcinoma.

14:55A-136 C. Prostate cancer

J.O. Barentsz; Nijmegen/NL

Learning Objectives:1. To learn the key clinical indications for MR imaging in prostate

cancer.2. To get an overview of essential MR imaging techniques in detection,

characterisation, localisation and staging of prostate cancer.3. To understand how MR imaging influences therapeutic decisions and

how best to provide a value added MR report.

15:20 Questions


167

Friday

A-14

2 –

A-15

3 16:00–17:30 Room A

Interactive Teaching Session E³ 720a Neurological emergencies 16:00A-142 A. Non-traumatic

C. Ozdoba; Berne/CH

Learning Objectives:1. To learn which imaging modality to use.2. To understand how to identify early ischaemia.3. To be able to select patients for treatment.

16:45A-143 B. Traumatic

M. Stajgis; Poznan/PL

Learning Objectives:1. To understand the proper imaging protocols for trauma patients.2. To become familiar with imaging findings in acute head trauma.3. To learn about the imaging findings in spinal cord trauma.

16:00–17:30 Room B

ESR meets E-AHPBA EM 2 Pancreatic cystic neoplasms 2013

Welcome by the ESR President: G.P. Krestin; Rotterdam/NL

Presiding: J.I. Bilbao; Pamplona/ES P.-A. Clavien; Zurich/CH


P.-A. Clavien1, K. Conlon2; 1Zurich/CH, 2Dublin/IE

Session Objectives:1. To understand the importance of the recent WHO classification and

its relevance to therapy.2. To become familiar with the radiological work-up for patients with

pancreatic cystic tumours.3. To appreciate the current role of endoscopic ultrasonography in

diagnosis and management.4. To become familiar with the indications for surgical intervention and

the role of organ-sparing therapies.

16:03A-145 Classification/pathology

C. Verbeke; Stockholm/SE

Learning Objectives:1. To understand the morphological classification of pancreatic cystic

lesions based on the distinction between neoplastic/non-neoplastic and epithelial/non-epithelial cysts.

2. To become familiar with the key distinctive macroscopic features of the various cyst entities and to understand the basic microscopic diagnostic features.

3. To appreciate the considerable variation in macroscopic appearances and the potential overlap between certain entities.

4. To become familiar with the macroscopic features of malignant transformation within primarily benign cystic lesions.

16:21A-146 Radiological diagnosis

S. Skehan; Dublin/IE

Learning Objectives:1. To become familiar with the optimal imaging modalities for cystic

pancreatic lesions.2. To learn about the characteristic imaging features of cystic pancreatic

lesions and to describe how imaging can contribute to preoperative diagnosis.

3. To discuss the appropriate imaging surveillance of selected cystic pancreatic lesions.

16:39A-147 Current role of endoscopic ultrasonography

P. Bauerfeind; Zurich/CH

Learning Objectives:1. To appreciate the technical aspects, performance characteristics and

limitations of EUS and EUS-FNA in PCNs.2. To understand how EUS and EUS-guided FNA help to establish a

diagnosis in PCNs.3. To appreciate the added information that EUS brings in staging pre-

malignant and malignant PCNs and in orientating surgical decision-making.

16:57A-148 How aggressive should the surgeon be?

K. Conlon; Dublin/IE

Learning Objectives:1. To understand the clinical indications for surgical intervention.2. To appreciate the rationale for deciding on a particular procedure.3. To discuss the outcomes of observation versus surgery.

Panel discussion: 17:15 The multidisciplinary assessment and management of

pancreatic cystic neoplasia

16:00–17:30 Room C

New Horizons Session NH 7 Cartilage imaging 16:00A-149 Chairman‘s introduction


Session Objectives:1. To review the basics of articular cartilage physiology.2. To introduce the quantitative MR tools used to assess collagen and

proteoglycan depletion.3. To learn about the problems arising from the avascular nature of

articular cartilage.

16:03A-150 Sodium imaging

S. Trattnig; Vienna/AT

Learning Objectives:1. To get familiar with the basic principles of sodium imaging.2. To understand technical challenges of sodium imaging and how to

handle them.3. To learn about clinical applications of sodium imaging in cartilage,

cartilage repair and other MSK structures.

16:21A-151 dGEMRIC (delayed gadolinium-enhanced MR imaging of

cartilage) G. Welsch1, S. Trattnig2; 1Erlangen/DE, 2Vienna/AT

Learning Objectives:1. To learn the basic principles of dGEMRIC and the current used

techniques for clinical imaging.2. To learn about the current clinical applications of dGEMRIC.3. To get an overview of future uses of dGEMRIC in therapeutic studies.

16:39A-152 Diffusion tensor imaging

C. Glaser; Munich/DE

Learning Objectives:1. To discuss basic principles of diffusion imaging in MSK.2. To review technical challenges and current achievements.3. To look into potential future directions.

16:57A-153 CEST (chemical exchange saturation transfer)

B. Schmitt; Vienna/AT

Learning Objectives:1. To understand basic principles of CEST imaging.2. To learn about the current status of gagCEST imaging.3. To become aware of technical pitfalls and future approaches.


168

A-15

4 –

A-16

6Panel discussion:17:15 What are the envisaged future advances in these cartilage

imaging techniques and can we expect to introduce them into clinical practice?

16:00–17:30 Room D1

Controversies in Breast Imaging MC 723 Should we add ultrasound to

mammographic screening of dense breasts? Moderator: F.J. Gilbert; Cambridge/UK Teaser: A. Tardivon; Paris/FR

16:00A-154 A. We can reduce the interval cancer rate

W.A. Berg; Pittsburgh, PA/US

16:25A-155 B. Do we have enough radiologists to do it? Alternatives

to ultrasound to reduce interval cancers A. Frigerio; Turin/IT


F.J. Gilbert1, A. Tardivon2; 1Cambridge/UK, 2Paris/FR

16:00–17:30 Room D2

Oncologic Imaging: Follow-up of Systemic and Local Therapies CC 719 Imaging after systemic therapies:

the standards Moderator: E.L. van Persijn van Meerten; Leiden/NL

16:00A-157 A. RECIST criteria

Y. Menu; Paris/FR

Learning Objectives:1. To consolidate knowledge of evaluation of solid tumour response.2. To learn about tips and tricks to help bring RECIST to everyday

practice.3. To understand advantages and limitations of RECIST.

16:30A-158 B. PERCIST: evolving considerations for PET response

criteria in solid tumours T.F. Hany; Zurich/CH

Learning Objectives:1. To learn about the evaluation of solid tumours through metabolic

imaging.2. To understand the benefits of metabolic imaging.

17:00A-159 C. Evaluation of brain tumours

C. Majós; L‘Hospitalet de Llobregat/ES

Learning Objectives:1. To learn about evaluation criteria for brain tumours.2. To become familiar with the evaluation of brain tumours after

treatment with various therapies.

16:00–17:30 Room E1

Musculoskeletal RC 710 Peripheral nerve imaging: MRI and US 16:00A-160 Chairman‘s introduction

J. Renoux; Paris/FR

16:05A-161 A. Applied radiological anatomy and pathology of the

brachial plexus S. Gerevini; Milan/IT

Learning Objectives:1. To understand the anatomy of the brachial plexus as demonstrated

with MRI.2. To appreciate the range of pathology seen at the brachial plexus.3. To become familiar with the MRI findings of brachial plexus

pathology.

16:28A-162 B. Upper limb nerve entrapment

D. Weishaupt; Zurich/CH

Learning Objectives:1. To become familiar with the strengths and weaknesses of US and

MRI for assessing upper limb nerves.2. To appreciate the imaging findings of upper limb nerve entrapment.

16:51A-163 C. Lower limb nerve entrapment

C. Martinoli, A. Tagliafico; Genoa/IT

Learning Objectives:1. To become familiar with the strengths and weaknesses of US and

MRI for assessing lower limb nerves.2. To appreciate the imaging findings of lower limb nerve entrapment.

Panel discussion:17:14 Which on-going technological advances in MRI and US could

influence the way we image peripheral nerves in the future?

16:00–17:30 Room E2

Foundation Course: Neuroimaging E³ 720b Infection and inflammation

Moderator: A. Gouliamos; Athens/GR

16:00A-164 A. Infection

E.T. Tali; Ankara/TR

Learning Objectives:1. To understand the concept of ‚leaky vessels‘ in the infectious

meningeal, parenchymal and ventricular involvement.2. To learn how to proceed with imaging when ‚time is of the essence‘.3. To become familiar with the specific imaging patterns of bacterial,

viral, fungal, parasitic and prion infections.

16:30A-165 B. Multiple sclerosis

F. Barkhof; Amsterdam/NL

Learning Objectives:1. To learn about the role of MRI in detecting focal and diffuse multiple

sclerosis pathology.2. To consolidate knowledge of lesion distribution, signal intensity

characteristics and patterns of contrast enhancement.3. To be able to apply the 2010 McDonald criteria to the diagnosis of

MS.

17:00A-166 C. Mimics of multiple sclerosis

V. Dousset; Bordeaux/FR

Learning Objectives:1. To be aware of the top ten mimics of multiple sclerosis.2. To become familiar with the imaging findings suggestive of other

disorders.3. To be informed of the importance of imaging the spinal cord for the

differential diagnosis of MS/MS mimics.


169

Friday

A-16

7 –

A-17

7 16:00–17:30 Room F1

Special Focus Session SF 7a Radiographers and ultrasonography in

Europe 16:00A-167 Chairmen‘s introduction

D. Pekarovic1, V. Vilgrain2; 1Ljubljana/SI, 2Clichy/FR

Session Objectives:1. To understand why ultrasound continues to be a growth area in

diagnostic imaging.2. To identify the challenges posed by the growth of this field.3. To understand the challenges faced by radiographers carrying out US

across Europe.

16:05A-168 Levels of training and competencies across Europe

M.T. Stanton; Dublin/IE

Learning Objectives:1. To appreciate the similarities between radiographer competencies

across Europe.2. To become familiar with the regulations for radiographers to train

and practice in Europe.3. To understand an expert-derived consensus of educational standards

for radiographer in Europe.

16:28A-169 The role and impact of the radiographer conducted US in

Portugal R.T. Ribeiro; Lisbon/PT

Learning Objectives:1. To become familiar with the radiographers’ role in the context of a

professional progression framework.2. To understand the synergies at play in interprofessional relationships

and team-work.3. To learn the benefits of having radiographers in the management and

optimisation of health systems.

16:51A-170 Evolution of radiography education for US in the

Netherlands since 1990, and its influence on their role G. Plug; Haarlem/NL

Learning Objectives:1. To learn about US education over an entire four year bachelor

programme.2. To understand the role of the radiographers as a result of this

bachelor programme.3. To appreciate changes in the education programme following changes

in the role of the radiographers.

Panel discussion:17:14 What are the challenges and barriers facing role extension?

16:00–17:30 Room F2

Special Focus Session SF 7b Imaging and radiotherapy:

all you need to know 16:00A-171 Chairman‘s introduction

V.J. Goh; London/UK

Session Objectives:1. To understand the principles of modern radiotherapy.2. To learn how functional and metabolic imaging have been integrated

into radiotherapy planning, adaptation and response evaluation.3. To become familiar with imaging findings after radiotherapy.4. To understand how imaging affects radiotherapy outcomes.

16:05A-172 Modern radiotherapy: what are the new technologies?

V. Valentini; Rome/IT

Learning Objectives:1. To become familiar with 3D conformal radiotherapy and intensity

modulated radiation therapy (IMRT) and intensity modulated radiosurgery (IMRS).

2. To learn about brachytherapy and intraoperative radiotherapy (IORT) and its indications.

3. To understand how IMRT contributes to better treatment outcomes as compared with conventional radiotherapy.

16:23A-173 PET/CT for radiotherapy planning: how does it assist

IMRT? A. Loft; Copenhagen/DK

Learning Objectives:1. To learn about anatomical imaging risk compartments that define

gross tumour volume (GTV).2. To understand how PET/CT assists in delineating the GTV.3. To understand the role of PET/CT guided IMRT and how it can lead

to treatment adaptation.

16:41A-174 Response evaluation and treatment adaptation

K. Haustermans; Leuven/BE

Learning Objectives:1. To understand the molecular tumour microenvironment (tumour

hypoxia, -apoptosis and -proliferation) that may impact response to radiation treatment.

2. To learn how tumour heterogeneity, reflecting tumour microenvironment, influences dose distribution in IMRT.

3. To learn how response assessment during IMRT leads to adaptation and tailoring of radiation treatment.

16:59A-175 MR imaging biomarkers for response evaluation


Learning Objectives:1. To learn about the range of MR imaging biomarkers that can be used

for markers of tumor microenvironment and heterogeneity.2. To understand the role and accuracy of diffusion and perfusion (MR)

imaging for evaluation of response during and after radiotherapy.3. To become familiar with the MR imaging findings after radiotherapy

and understand the pitfalls and interpretation difficulties.

Panel discussion:17:17 How can imaging improve outcomes in radiotherapy?

16:00–17:30 Room G/H

Genitourinary RC 707 Diagnosis and management of GU tract

trauma Moderator: A. Magnusson; Uppsala/SE

16:00A-176 A. Imaging the kidney and ureter

M.-F. Bellin; Le Kremlin-Bicêtre/FR

Learning Objectives:1. To learn the indications, advantages and disadvantages of imaging

modalities after trauma.2. To learn the appropriate diagnostic imaging studies and imaging

findings of different types of trauma.3. To be able to identify a kidney that is in danger after trauma.

16:30A-177 B. Imaging the bladder and urethra

U.G. Mueller-Lisse; Munich/DE

Learning Objectives:1. To be able to identify patients requiring urgent cysto-urethrography.2. To learn to identify bladder and urethral injury.3. To learn the imaging techniques necessary for accurate initial

evaluation of the urethra in cases of complicated pelvic trauma.


170

A-17

8 –

A-18

917:00A-178 C. Interventional radiology for GU trauma

B. Peynircioglu; Ankara/TR

Learning Objectives:1. To be able to determine which cases deserve management by

interventional radiology.2. To understand the techniques to manage fistulas and ruptures of the

ureter and urethra.3. To appreciate the vascular and non-vascular interventional

techniques in kidney trauma.

16:00–17:30 Room I/K


radiologists need to know (part 4) Moderator: M.F. Reiser; Munich/DE

16:00A-179 A. Lymphoma

H. Schoder; New York, NY/US

Learning Objectives:1. To get a practical, clinically relevant summary of key imaging issues

in Hodgkin and non-Hodgkin lymphoma.2. To learn how imaging, especially PET and PET-CT can optimally

assess and measure tumour treatment response, providing a value-added radiology report.

16:30A-180 B. Musculoskeletal neoplasms

M.F. Reiser; Munich/DE

Learning Objectives:1. To become familiar with the imaging modalities which enable to

detect and differentiate benign and malignant bone neoplasms.2. To consolidate knowledge of radiographic, CT and MRI findings

which enable to classify and stage bone tumours.3. To understand the potential role of PET-CT and whole body MRI.4. To learn the signs indicative of favourable and poor response to

preoperative chemotherapy and for recurrence of malignant bone tumours.

16:55A-181 C. Chemo- and radiation therapy-induced toxicity

H.-U. Kauczor; Heidelberg/DE

Learning Objectives:1. To get an overview of organ-specific toxicity and other adverse effects

of chemo- and radiotherapy.2. To review the key imaging findings of therapy-induced organ toxicity

and adverse effects.3. To understand how to differentiate inflammatory, infectious, fibrotic,

and necrotic changes from tumour recurrence.

17:20 Questions

16:00–17:30 Room L/M

Organs from A to Z: Heart MC 722 Ischaemic heart disease

Moderator: C. Catalano; Rome/IT

16:00A-182 A. Imaging of the coronary arteries: the Holy Grail

G. Roditi; Glasgow/UK

Learning Objectives:1. To learn about the meaning of CT coronary calcium screening for

risk assessment.2. To identify suitable modalities and challenges for non-invasive

coronary angiography.3. To understand the potential of coronary plaque imaging beyond

calcium.

16:20A-183 B. The ischaemic myocardium: what to do?

C. Loewe; Vienna/AT

Learning Objectives:1. To learn how to evaluate the function of the ischaemic myocardium.2. To identify methods of assessing the viability of the ischaemic

myocardium.3. To get an overview of the therapeutic consequences depending on

imaging findings.

16:40A-184 C. The ischaemic heart after treatment: still alive?

G. Bastarrika; Toronto, ON/CA

Learning Objectives:1. To learn how to analyse cardiac images following bypass grafting.2. To understand the value of cardiac imaging after coronary

interventions (PTA and stenting).3. To assess potential therapeutic consequences.


C. Catalano; Rome/IT

16:00–17:30 Room N/O

Interventional Radiology RC 709 Expanding the role of interventional

radiology in hepatocellular carcinoma 16:00A-186 Chairman‘s introduction

V. Válek; Brno/CZ

16:05A-187 A. RF ablation

J. del Cura; Bilbao/ES

Learning Objectives:1. To understand the indications for RF ablation.2. To learn about the technique and devices for RF ablation.3. To learn about results, complications and follow-up strategies.

16:28A-188 B. Intra-arterial procedures

F. Orsi; Milan/IT

Learning Objectives:1. To become familiar with the indications for intra-arterial treatment

of HCC.2. To learn the techniques of intra-arterial treatment.3. To learn about results, complications and follow-up strategies.

16:51A-189 C. Portal vein embolisation before surgery

A. Denys, P. Bize; Lausanne/CH

Learning Objectives:1. To become familiar with imaging strategies and indications for

embolisation.2. To understand embolisation methods.3. To learn about results, complications and follow-up strategies.

Panel discussion:17:14 How to allow for more patients with HCC to be treated?


171

Friday

A-19

0 –

A-19

7 16:00–17:30 Room P

Radiographers RC 714 Clinical audit: from EURATOM to the

clinical environment Moderators: E.J. Adam; London/UK, D. Pronk-Larive; Middelburg/NL

16:00A-190 A. Clinical audit: from the EURATOM treaty to EU

guidelines: clinical audit RP 159 P. Wood; Helsinki/FI

Learning Objectives:1. To understand the background to the publication of RP 159 along

with its purpose and scope.2. To become familiar with the principles and prerequisites of clinical

audit as outlined by RP 159.3. To become familiar with the relationship between clinical audit and

regulatory controls.4. To gain an insight into potential national, regional and international

issues associated with clinical audit.

16:30A-191 B. Implementation in practice:

a comparison of different models S. Geers-van Gemeren; Utrecht/NL

Learning Objectives:1. To understand the key components required to allow clinical audit to

be implemented in practice.2. To gain an insight into different implementation models.3. To be informed about the key considerations that must be made prior

to implementing an audit model: organisation, auditors, process, financing, the roles of professional bodies, and outcomes.

17:00A-192 C. A perspective on the impact and

benefits of clinical audit S. O‘Connor; Dublin/IE

Learning Objectives:1. To gain an insight into the use of clinical audit from the perspective

of a clinical audit lead in an international diagnostic imaging service provider.

2. To become familiar with the challenges that may be encountered when undertaking clinical audit.

3. To understand the significant impact that clinical audit can have from the perspective of the patient, the healthcare team and on service delivery.

16:00–17:30 Room Q

Special Focus Session SF 7c Imaging in intensive care patients 16:00A-193 Chairman‘s introduction

A. Palkó; Szeged/HU

Session Objectives:1. To understand the importance of imaging diagnostics in the unique

and challenging clinical setting of the intensive care units.2. To learn about the technical and methodological considerations to be

taken into account with this patient group.3. To learn more about the most important conditions and the imaging

findings as well as the diagnostic imaging algorithms to be used in the intensive care environment.

16:05A-194 Value of MRI for intensive care coma patients with

unclear brain pathology P.C. Maly Sundgren; Lund/SE

Learning Objectives:1. To understand the importance of magnetic resonance imaging in

cases of unclear brain pathology causing severe dysfunction of the central nervous system.

2. To understand the significance of imaging in the evaluation of brain function and potential outcome following anesthesia, injuries and hypoxia.

3. To become familiar with the imaging signs and their predictive value and accuracy regarding brain death, and future role of imaging in decisions concerning the termination of intensive treatment.

16:23A-195 Computed tomography of pathologic lung conditions

complicating intensive care treatment C.M. Schaefer-Prokop; Amersfoort/NL

Learning Objectives:1. To understand the spectrum of pathological lung conditions, which

complicate intensive care treatment.2. To learn about the role of diagnostic imaging and its technical

difficulties and requirements in the intensive care environment.3. To become familiar with the most important imaging signs and

symptoms of tracheobronchial and lung conditions, influencing the treatment and survival of the intensive care patient.

16:41A-196 Point-of-care versus diagnostic ultrasound in the

intensive care unit E. Danse, P.-F. Laterre, L. Jacquet, A. Dragean, I. Nica, P. Trefois, L. Annet; Brussels/BE

Learning Objectives:1. To understand the concept and role of point-of-care ultrasound and

its technical and training requirements.2. To become familiar with the role and tasks of diagnostic ultrasound

versus point-of-care ultrasound in the most common pathologic conditions in intensive care.

3. To learn more about typical ultrasound findings and their significance in the diagnosis, differential diagnosis and therapy of intensive care patients.

16:59A-197 Imaging in polytrauma

U. Linsenmaier; Munich/DE

Learning Objectives:1. To appreciate the clinical significance of conditions characterised

by multiple severe injuries and their systemic and multi-organ complications.

2. To explain the special role of imaging, the diagnostic algorithm and the technical, organisational and training requirements for the diagnosis and follow-up of polytrauma patients.

3. To consolidate knowledge of imaging signs and symptoms and their diagnostic value in patients with polytrauma.

Panel discussion:17:17 What training and special skills are radiologists expected to

have in order to work with intensive care units? How should we manage the clinical and technical challenges posed by this very specific environment?


172

A-19

8 –

A-20

016:00–17:30 Room Z

Vascular RC 715 Dialysis fistula

Moderator: H.A. Deutschmann; Graz/AT

16:00A-198 A. Preoperative mapping

L. Turmel-Rodrigues; Tours/FR

Learning Objectives:1. To become familiar with the indications and techniques for pre-

operative arterial venous mapping.2. To learn about the venous anatomy.3. To become familiar with the potential pitfalls of preoperative

mapping.

16:30A-199 B. Screening for problems

D. Vorwerk; Ingolstadt/DE

Learning Objectives:1. To understand the spectrum of problems with dialysis fistula.2. To learn about screening protocols and the results of screening.3. To learn about the most common problems and how to detect them.

17:00A-200 C. Evaluation of malfunction

R. Uberoi; Oxford/UK

Learning Objectives:1. To understand the main indications and results of angioplasty.2. To learn about thrombectomy and aspiration.3. To become familiar with the indications for stenting.


173

Friday


174

A-20

1 –

A-21

208:30–10:00 Room A

Interactive Teaching Session E³ 820a Pitfalls in heart imaging 08:30A-201 A. CT

G. Bastarrika; Toronto, ON/CA

Learning Objectives:1. To learn about practical aspects of postprocessing, reading and

reporting non-invasive cardiac CT examinations.2. To learn how to improve reading of results by recognising technical

causes for various artifacts in cardiac CT.3. To become familiar with approaches to reducing false inaccuracies

and misinterpretations when assessing coronary artery stenosis.

09:15A-202 B. MRI

M. Francone; Rome/IT

Learning Objectives:1. To learn about common pitfalls in MRI evaluation of the heart.2. To become familiar with cardiac anatomical variants, potentially

mimicking disease.

08:30–10:00 Room B

Special Focus Session SF 8a Is diagnostic catheter angiography still

useful in neuroimaging? 08:30A-203 Chairman‘s introduction

M. Essig; Erlangen/DE

Session Objectives:1. To become familiar with the current debate on the need for

diagnostic catheter angio.2. To learn about the pros and cons of diagnostic catheter angio.3. To learn about the pros and cons of alternative non-invasive

angiography techniques.

08:35A-204 What can we expect from vascular diagnostic procedures?

R. Siemund; Lund/SE

Learning Objectives:1. To learn about the expectations from vascular diagnostic procedures

in the diagnostic work-up.2. To become familiar with the expectations from vascular diagnostic

procedures in therapy planning and therapeutic procedures.3. To learn about the expectations from vascular diagnostic procedures

in the follow-up assessments.

08:58A-205 Can non-invasive techniques as CTA and MRA replace

catheter angio for diagnostic work-up? L. van den Hauwe, M. Voormolen, T. van der Zijden, R. Salgado, J.W. Van Goethem, P.M. Parizel; Antwerp/BE

Learning Objectives:1. To become familiar with the diagnostic potential of CTA and MRA.2. To understand the current proved clinical indications where CTA

and MRA can replace catheter angio.3. To learn about safety issues in non-invasive procedures.

09:21A-206 Diagnostic catheter angiography is not dead: current

indications and advantages over the non-invasive techniques T. Engelhorn; Erlangen/DE

Learning Objectives:1. To learn about the current indications for diagnostic catheter

angiography.2. To become familiar with complication rates of selective catheter

angiography in high volume centers.3. To appreciate some technical innovations for diagnostic catheter

angiography.

Panel discussion:09:44 The pros and cons of diagnostic catheter angiography in

neuroimaging

08:30–10:00 Room C

New Horizons Session NH 8 MR/PET:

a marriage made in heaven or hell? 08:30A-207 Chairman‘s introduction

B. Hamm; Berlin/DE

Session Objectives:1. To introduce the potential of this new imaging modality.2. To appreciate a new opportunity for cooperation between radiology

and nuclear medicine.

08:33A-208 MR/PET in neuroimaging: nuclear medicine

O. Sabri; Leipzig/DE

Learning Objectives:1. To learn about what we are able to do now.2. To understand the nuclear aspect of neuroimaging.3. To learn about the possibilities and limitations of neuroimaging.

08:51A-209 MR/PET in neuroimaging: radiology

B.R. Rosen; Charlestown, MA/US

Learning Objectives:1. To demonstrate the value of this hybrid technique.2. To understand the radiological aspect of neuroimaging.3. To learn about the possibilities and limitations of neuroimaging.

09:09A-210 MR/PET in oncologic imaging: nuclear medicine

O. Ratib; Geneva/CH

Learning Objectives:1. To learn about what we are able to do now.2. To understand the nuclear aspect of oncologic imaging.3. To learn about the possibilities and limitations of oncologic imaging.

09:27A-211 MR/PET in oncologic imaging: radiology

H.-P. Schlemmer; Heidelberg/DE

Learning Objectives:1. To demonstrate the value of this hybrid technique.2. To become familiar with the radiologic aspect of oncologic imaging.3. To learn about possibilities and limitations of oncologic imaging.

Panel discussion:09:45 What benefits and risks should we expect in terms of basic

research, clinical service, and economics?

08:30–10:00 Room D1

CLICK (Clinical Lessons for Imaging Core Knowledge): Never without Arteries CC 818 How old are you in reality? Vascular

age and clinical events Moderator: L. Lonn; Copenhagen/DK

08:30A-212 A. Clinical considerations

E. Minar; Vienna/AT

Learning Objectives:1. To learn about the frequency and importance of vascular diseases.2. To become familiar with clinical risk stratification strategies.3. To learn about the possibility of reducing cardiovascular risk.


175

Saturday

A-21

3 –

A-22

4 09:00A-213 B. Imaging techniques and typical findings

H.J. Lamb; Leiden/NL

Learning Objectives:1. To learn about the imaging modalities used for the assessment of

cardiovascular risk.2. To learn how to select the right test for the right patient.3. To become familiar with the newest innovations and newest

guidelines in non-invasive cardiovascular risk assessment.

09:30A-214 C. Interactive case discussion: how to deal with the

results? A. van der Lugt; Rotterdam/NL

Learning Objectives:1. To understand the strength of non-invasive risk stratification in

properly selected patient populations.2. To consolidate knowledge of the selection of the appropriate

imaging technique, image interpretation and image-based treatment recommendation.

3. To learn about the risks of the inappropriate use of such risk stratification tests (Ca-scoring) in symptomatic patients.

08:30–10:00 Room D2

Oncologic Imaging: Follow-up of Systemic and Local Therapies CC 819 Imaging after systemic therapies:

advanced techniques Moderator: D.-M. Koh; Sutton, Surrey/UK

08:30A-215 A. What can we expect from biomarkers

B. Van Beers; Clichy/FR

Learning Objectives:1. To become familiar with biomarkers.2. To consolidate knowledge of various biomarkers and their utility.

09:00A-216 B. MRI biomarkers: from acquisition to post-processing

O. Lucidarme, M. Wagner, C. Pellot Barakat, F. Frouin; Paris/FR

Learning Objectives:1. To become familiar with MRI biomarkers.2. To learn about tips and tricks for MRI biomarker evaluation.

09:30A-217 C. Assessing the precision and accuracy of biomarker

imaging: is it reproducible? C.B. Sirlin; San Diego, CA/US

Learning Objectives:1. To understand imaging biomarker precision (repeatability and

reproducibility) and accuracy and how it is evaluated.2. To understand how to interpret biomarker precision and accuracy in

the context of the biomarker‘s intended use.

08:30–10:00 Room E1

Emergency Radiology RC 817 Polytrauma: redefining imaging issues

for management priorities 08:30A-218 Chairman‘s introduction: advanced imaging, logistics and

management priorities in patients after polytrauma H. Alkadhi; Zurich/CH

08:40A-219 A. Vascular trauma

G. Schueller; Bülach/CH

Learning Objectives:1. To become familiar with the use of dedicated MDCT protocols,

classification of vascular injuries and treatment options.

2. To become familiar with alternative imaging modalities such as US, DSA and MR.

3. To learn about typical and atypical imaging findings.

09:00A-220 B. Chest and abdomen

M. Scaglione; Castel Volturno/IT

Learning Objectives:1. To become familiar with the most important imaging findings and

their impact on patient management.2. To understand common classification systems, trauma scoring

systems and their impact on patient management.3. To learn about typical and atypical imaging findings.

09:20A-221 C. Extremities

U. Linsenmaier, L.L. Geyer; Munich/DE

Learning Objectives:1. To become familiar with imaging strategies, the role of CR, CT and

MR.2. To understand common classification systems and their impact on

patient management.3. To learn about typical and atypical imaging findings.

Panel discussion:09:40 How to speed up your diagnoses?

08:30–10:00 Room E2

Foundation Course: Neuroimaging E³ 820b Metabolic and neurodegenerative

disorders Moderator: S. Lehéricy; Paris/FR

08:30A-222 A. Dementia

B. Gómez-Ansón; Barcelona/ES

Learning Objectives:1. To understand when and why you should image dementia.2. To become familiar with the imaging findings of the most common

primary degenerative and secondary vascular dementias.3. To understand how to recognise normal pressure hydrocephalus as

an underlying cause of subcortical dementia.

09:00A-223 B. Movement disorders

T.A. Yousry; London/UK

Learning Objectives:1. To learn the typical imaging findings, their anatomic substrate and

the limitations of conventional MRI.2. To understand the contribution of advanced imaging techniques such

as DTI, SWI and high field imaging as well as quantitative MR post-processing techniques.

3. To understand the role of MR in the diagnosis and differential diagnosis of movement disorders.

09:30A-224 C. Metabolic disorders

J.F. Schneider; Basle/CH

Learning Objectives:1. To become familiar with the imaging findings of the most important

innate metabolic defects affecting CNS.2. To learn how to recognise patterns of gray and white matter

involvement.3. To learn about specific discriminating imaging findings.


176

A-22

5 –

A-23

608:30–10:00 Room F1

Breast RC 802 Clinical challenges in breast MRI 08:30A-225 Chairman‘s introduction

F.J. Gilbert; Cambridge/UK

08:35A-226 A. High risk patients: establishing clinical protocols

J. Veltman; Almelo/NL

Learning Objectives:1. To become familiar with the literature on the role of breast MRI in

screening of high risk patients.2. To understand current protocols in clinical practice.3. To appreciate the challenges of breast MRI imaging in this patient

group.

08:58A-227 B. Non-mass like enhancement (NMLE): when to biopsy?

C.K. Kuhl; Aachen/DE

Learning Objectives:1. To learn about the clinical significance of NMLE.2. To understand differential diagnosis for NMLE.3. To become familiar with a work-up algorithm of NMLE cases.

09:21A-228 C. Monitoring response to neo-adjuvant chemotherapy

T.H. Helbich; Vienna/AT

Learning Objectives:1. To understand the clinical aspects of neo-adjuvant chemotherapy.2. To appreciate evidence-based protocols for imaging in this clinical

setting.3. To learn about particular imaging challenges of assessing response to

neo-adjuvant chemotherapy.

Panel discussion:09:44 How can the specificity and sensitivity of breast MRI in these

indeterminate clinical and imaging scenarios be maximised?

08:30–10:00 Room F2

Special Focus Session SF 8b GI imaging: technological advances

and clinical applications 08:30A-229 Chairman‘s introduction

S.A. Jackson; Plymouth/UK

Session Objectives:1. To review the significant recent advances in GI imaging.2. To understand the place of these advances in the clinical imaging of

patients.3. To summarise the future directions of GI radiology in the 21st

century.

08:35A-230 CEUS of the bowel wall: when and how

F. Maccioni; Rome/IT

Learning Objectives:1. To review the relevant clinical indications for CEUS of the bowel.2. To learn how to optimally perform a CEUS examination of the bowel

wall.3. To appreciate important findings in patients with IBD and learn how

to evaluate inflammatory activityof the bowel wall.

08:58A-231 Dual-energy (spectral) CT: GI applications

P. Rogalla; Toronto, ON/CA

Learning Objectives:1. To review the concept and technique of dual-energy CT.2. To understand the clinical application of dual-energy CT in GI

imaging.3. To appreciate the additional benefits of the technique in routine

clinico-radiological practice.

09:21A-232 MR imaging of GI tract motility

S.A. Taylor; London/UK

Learning Objectives:1. To learn about the MRI protocols that can best assess bowel motility.2. To understand the various software approaches to quantifying bowel

motility.3. To become familiar with how motility MRI can be used in clinical

practice.

Panel discussion:09:44 When should we integrate these technological advances into

our routine practice?

08:30–10:00 Room G/H

EFOMP Workshop

New technology in diagnostic radiology: new frontiers in imaging of the lung EF 1 Lung and chest imaging: new

approaches Moderators: P. Sharp; Aberdeen/UK, W.J.M. van der Putten; Galway/IE

08:30A-233 Welcome address

J.I. Bilbao1, P. Sharp2; 1Pamplona/ES, 2Aberdeen/UK

08:40A-234 Radiologist’s point of view: clinical and technical

requirements for imaging of the lung H.-U. Kauczor; Heidelberg/DE

Learning Objectives:1. To comprehend the new approaches towards functional and

molecular lung imaging.2. To understand their potential in comprehensive and quantitative lung

imaging.3. To become familiar with new applications of structural functional

and molecular imaging in lung disease.

09:10A-235 Respiratory motion correction in lung imaging

J.A. Schnabel; Oxford/UK

Learning Objectives:1. To comprehend the problem of motion corruption and difference in

breath holds in lung imaging.2. To become familiar with state-of-the-art motion correction methods

in single- and multi-modality lung imaging.3. To understand the concept of modelling complex sliding motion of

the lungs.

09:35A-236 Role of tomosynthesis in lung imaging

M. Båth; Gothenburg/SE

Learning Objectives:1. To understand the technical principles of chest tomosynthesis.2. To become familiar with the results of the latest clinical evaluations of

chest tomosynthesis.


177

Saturday

A-23

7 –

A-24

8 08:30–10:00 Room I/K

Chest RC 804 Patterns in chest radiology: are there

subtype patterns of ground glass opacity (GGO)?


A. Oikonomou; Alexandroupolis/GR

Session Objectives:1. To learn about the prevalence and low specificity of GGO.2. To appreciate the need for definition of GGO subtypes to improve

radiological diagnoses.

08:35A-238 A. Ground glass opacification: why do we see it and what

does it mean? S.R. Desai; London/UK

Learning Objectives:1. To appreciate the different physiological conditions which cause

GGO pattern.2. To learn about the associations and reversibility of physiology-related

GGO.

08:58A-239 B. Inflammatory and infectious GGO

K. Marten-Engelke; Göttingen/DE

Learning Objectives:1. To learn more about the inflammatory conditions which cause GGO.2. To appreciate the histopathological correlates of inflammatory and

infectious GGO.3. To become familiar with GGO in autoimmune and infectious lung

disease.

09:21A-240 C. GGO in dysplasia and neoplasia

G.R. Ferretti, S. Lantuejoul; Grenoble/FR

Learning Objectives:1. To learn more about the dysplastic and neoplastic conditions causing

GGO.2. To appreciate the histopathological correlates of dysplastic and

neoplastic GGO.3. To understand how to estimate malignancy on the basis of GGO

pattern.

Panel discussion:09:44 How should we report and manage ground glass opacity?

08:30–10:00 Room L/M

Vascular RC 815 How I report

Moderator: D. Bilecen; Basle/CH

08:30A-241 A. CTA and MRA of supra-aortic arteries

J.H. Gillard; Cambridge/UK

Learning Objectives:1. To learn about a structured reporting approach to angiographic

studies of supra-aortic arteries.2. To understand the role of post-processing techniques and

quantitative analysis of arterial stenosis.3. To be able to answer specific clinical questions about supra-aortic

arterial occlusive diseases.

09:00A-242 B. CTA and MRA of thoracic and abdominal aorta

H.J. Michaely; Mannheim/DE

Learning Objectives:1. To learn about a structured reporting approach to aneurysmal and

obstructive diseases.2. To learn the classifications of aneurysmatic aortic diseases.3. To understand the role of post-processing techniques in aortic

diseases.4. To be able to answer specific clinical questions about aortic diseases.

09:30A-243 C. CTA and MRA of peripheral arteries

T. Leiner; Utrecht/NL

Learning Objectives:1. To learn about a structured reporting approach to peripheral arterial

obstructive diseases.2. To understand the importance of quantitative analysis of peripheral

arterial obstructions and how to report these analyses.3. To be able to answer specific clinical questions about peripheral

arterial diseases.

08:30–10:00 Room N/O

Interventional Radiology RC 809 What should every radiologist know

about the endovascular treatment of abdominal aortic aneurysms?


H. Rousseau, J. Auriol, C. Lions, F. Mokrane; Toulouse/FR

08:35A-245 A. Pre-therapeutic radiological evaluation

J. Raupach, O. Renc, P. Hoffmann, J. Zizka; Hradec Kralove/CZ

Learning Objectives:1. To learn about the best pretreatment imaging modality.2. To understand planning and sizing of appropriate stent-graft.3. To become familiar with critical criteria and vessel morphology.

08:58A-246 B. EVAR techniques and results

F. Fanelli; Rome/IT

Learning Objectives:1. To understand indications and contraindications for EVAR.2. To know more about advantages of different types of stent-graft.3. To become familiar with percutaneous vascular access.4. To learn about the latest trials.

09:21A-247 C. Imaging follow-up and treatment of complications

R. Morgan; London/UK

Learning Objectives:1. To learn about available imaging methods for follow-up.2. To become familiar with complications and failure of EVAR.3. To understand how to treat endoleaks.

Panel discussion:09:44 What are the best imaging methods for follow-up?

08:30–10:00 Room P

Cardiac RC 803 Practical approach to cardiovascular

risk stratification with CT and MRI Moderator: C. Peebles; Southampton/UK

08:30A-248 A. Modern views on value of coronary calcium scoring for

risk assessment A. Stadler; Vienna/AT

Learning Objectives:1. To understand what kind of information calcium scoring can deliver

and the appropriate indications.2. To become familiar with its role in an asymptomatic and in a

symptomatic population.3. To learn about the current data and guidelines supporting its use for

assessment of cardiac risk.


178

A-24

9 –

A-26

109:00A-249 B. Coronary CTA: from detection of stenosis to prognosis

N.R. Mollet1, F. Cademartiri2; 1Turnhout/BE, 2Rotterdam/NL

Learning Objectives:1. To understand the accuracy of CTA in the diagnosis of coronary

disease.2. To become familiar with the strengths and limitations of the various

quantification techniques.3. To appreciate the prognostic value of CTA in coronary disease.

09:30A-250 C. Myocardial perfusion and viability for risk scoring

A. de Roos; Leiden/NL

Learning Objectives:1. To become familiar with the current status of CT and MRI for

evaluation of myocardial perfusion and viability.2. To understand the accuracy of myocardial perfusion in identifying

ischaemia and its role in risk assessment.3. To learn the prognostic value of viability imaging in ichaemic heart

disease.

08:30–10:00 Room Q

Paediatric RC 812 Imaging the paediatric spine

Moderator: C.J. Kellenberger; Zurich/CH

08:30A-251 A. Craniocervical junction abnormalities

B. Ozgen Mocan; Ankara/TR

Learning Objectives:1. To learn about normal cervical junction development and anatomy.2. To understand congenital cervical junction anomalies.3. To appreciate acquired cervical junction pathology.

09:00A-252 B. Inflammation, infection and tumours: the role of

imaging M.I. Argyropoulou; Ioannina/GR

Learning Objectives:1. To learn about the etiologies and the imaging findings of infectious,

para-infectious and autoimmune disorders.2. To appreciate the role of spinal MRI in the differential diagnosis of

multiple sclerosis vs its mimics.3. To become familiar with the imaging findings of primary and

metastatic tumours.4. To learn about the indications of whole spine MRI with presence of

brain tumours.

09:30A-253 C. Imaging spinal trauma in childhood


Learning Objectives:1. To understand how best to investigate suspected spinal trauma in a

child.2. To appreciate the imaging findings.3. To consolidate knowledge about the differences between paediatric

and adult spinal trauma.

10:30–12:00 Room A

Interactive Teaching Session E³ 920a Tips and tricks in chest imaging 10:30A-254 A. Plain radiography

J. Cáceres; Barcelona/ES

Learning Objectives:1. To become familiar with useful signs in the diagnosis of chest

disorders in the chest radiograph.2. To learn about common pitfalls in plain radiography of the chest.3. To understand the mechanisms that cause errors in image

interpretation of chest radiographs.

11:15A-255 B. CT

J. Vilar; Valencia/ES

Learning Objectives:1. To become familiar with useful signs in the diagnosis of chest

disorders in CT.2. To learn about common pitfalls in CT of the chest.3. To understand the mechanisms that cause errors in image

interpretation of chest CT.

10:25–12:00 Room B

ESR meets South Africa EM 3 Imaging HIV and TB

Welcome by the ESR President: G.P. Krestin; Rotterdam/NL

Presiding:J.I. Bilbao; Pamplona/ESC. Sperryn; Cape Town/ZA


C. Sperryn; Cape Town/ZA

Session Objectives:1. To learn about cerebrovascular disease in HIV infected patients in

South Africa.2. To understand the pathogenesis of TB meningitis and its implications

for treatment.3. To become familiar with the MR imaging of spinal TB in children

and possible differential diagnoses.4. To consolidate knowledge of chest radiograph reporting in HIV-

infected children.5. To appreciate South Africa, the country, its diversity and how its

radiologists are trained.

10:35A-257 HIV-related cerebrovascular disease: the South African

experience V. Mngomezulu; Johannesburg/ZA

Learning Objectives:1. To learn about the clinical and imaging spectrum of cerebrovascular

disease in HIV infected patients in South Africa.2. To appreciate the role of other co-factors in the pathogenesis of HIV

related cerebrovascular disease.3. To become familiar with the challenges and technical strategies in the

medical and interventional management of these conditions.

10:50A-258 Interlude: Radiology training in South Africa

Z. Lockhat; Pretoria/ZA

10:55A-259 New concepts in the pathogenesis of cerebral TB

P. Janse van Rensburg, R. Hewlett; Stellenbosch/ZA

Learning Objectives:1. To learn more about the morphological spectrum of tuberculous

meningoencephalitis as shown on contrast MRI.2. To understand the pathogenesis of TBM and its implications for

disease progression and treatment.3. To appreciate the importance of imaging-pathologic correlation.4. To become familiar with imaging of TBM.5. To consolidate knowledge of neurotuberculosis.

11:10A-260 Interlude: South Africa: the country, its people, its

diversity and its attractions Z. Lockhat; Pretoria/ZA

11:15A-261 Spinal tuberculosis in children

T. Kilborn; Cape Town/ZA

Learning Objectives:1. To learn about the spectrum of tuberculous infection of the spine in

children namely; intramedullary spinal tuberculomas, tuberculous spondylitis and rarely tuberculous epidural abscess.


179

Saturday

A-26

2 –

A-27

0 2. To appreciate the incidence of tuberculous arachnoiditis and tuberculomas in patients presenting with tuberculous meningitis and its implications for management.

3. To become familiar with MR imaging of spinal TB and possible differential diagnoses.

4. To discuss the role of ultrasound and CT in the imaging algorithm.5. To understand the importance of accurate and timely radiological

diagnosis for guiding management.

11:30A-262 Chronic chest radiographic changes in a cohort of HIV-

infected South African children R. Pitcher, C. Lombard, M. Cotton, S. Beningfield, H. Zar; Cape Town/ZA

Learning Objectives:1. To learn about the level of chronic chest radiographic changes

encountered in HIV-infected children who do not have access to HAART.

2. To better understand the clinical and immunological correlates of chest radiographic changes in HAART-naïve HIV-infected children.

3. To appreciatea. the burden of paediatric pulmonary disease on resource-limited healthcare environment with a high prevalence of paediatric HIV-infection.b. the impact of HAART on chest radiographic changes in HIV-infected children.c. the importance of the early initiation of HAART in HIV-infected children.d. the challenges to healthcare delivery in a resource-limited healthcare environment.4. To become familiar with standardised chest radiographic reporting

techniques utilised for research in paediatric pulmonary radiology.5. To consolidate knowledge of paediatric chest radiograph reporting,

with particular emphasis on:i. The impact of technical factorsii. The importance of standardised terminologyiii. Paediatric-specific normal variantsiv. Useful chest radiographic signs

Panel discussion:11:45 HIV and TB: What impact do they have on health care workers?

10:30–12:00 Room E2

Foundation Course: Neuroimaging E³ 920b Tumours and phacomatosis

Moderator: N. Girard; Marseille/FR

10:30A-263 A. Brain tumours

M.M. Thurnher; Vienna/AT

Learning Objectives:1. To learn about the imaging findings and the limitations of

conventional MRI in the evaluation of brain tumours.2. To become familiar with new MRI techniques available for advanced

brain tumour imaging.3. To learn about the potential of ‚functional imaging‘ (fMRI, PET,

SPECT) in tumour characterisation, treatment decisions, and follow up.

11:00A-264 B. Tumours of the spinal cord

J. Van Goethem, C. Venstermans, F. De Belder, L. van den Hauwe, P. Parizel; Antwerp/BE

Learning Objectives:1. To become familiar with the imaging findings of primary and

metastatic tumours of the spinal cord.2. To be able to recognise metastatic disease in the extradural, epidural,

subdural and paraspinal compartments.3. To learn how best to use imaging and create the appropriate protocol.

11:30A-265 C. Phacomatosis

M.A. Papathanasiou; Athens/GR

Learning Objectives:1. To learn how and when you should image.2. To consolidate knowledge about conventional neuroimaging findings

of the more common phacomatoses.3. To be informed of the possible applications of advanced

neuroimaging techniques.

10:30–12:00 Room G/H

Physics in Radiology

EFOMP Workshop

New technology in diagnostic radiology: new frontiers in imaging of the lung EF 2 Lung imaging: multidisciplinary

scenario Moderators: A. Torresin; Milan/IT, J.N. Vassileva; Sofia/BG

10:30A-266 Pulmonary nodule detection using CAD

A. Retico; Pisa/IT

Learning Objectives:1. To comprehend the basic steps to design a CAD system for lung

nodule detection in CT scans.2. To be aware of the possible usage of CAD as second reader in the

clinical practice.3. To understand how the impact of CAD on the reader sensitivity is

evaluated.

10:50A-267 Optimisation in lung imaging of children

C. Owens; London/UK

Learning Objectives:1. To understand the importance of a dynamic team approach to

optimisation of local CT techniques in all hospitals.2. To appreciate the iterative nature and concept of sharing protocols

across sites.3. To become familiar with the techniques, tips and tricks to perform ‚as

low as reasonably achievable‘ CT imaging that is ‚fit for purpose‘.4. To consolidate knowledge of low dose acquisition of CT images

and post-processing techniques to optimise images using images to illustrate.

11:10A-268 Lung imaging: developments in role of PET

M.-E. Meyer, P. Bailly, J. Daouk; Amiens/FR

Learning Objectives:1. To learn about respiratory motion management in PET acquisitions.2. To understand techniques of respiratory motion compensation or full

motion correction to prevent inappropriate attenuation correction and errors in quantification.

3. To consolidate knowledge of adaptive treatment and advanced follow-up: optimisation of radiotherapy planning.

11:35A-269 Lung imaging: developments in role of MR

J.M. Wild; Sheffield/UK

Learning Objectives:1. To comprehend the basic MR physics of imaging protons and

hyperpolarised gases in the lungs.2. To understand the techniques that are in use in clinical lung and

pulmonary vascular MRI.3. To become familiar with established and future clinical applications

of MRI in lung and pulmonary vascular disease.

10:30–12:00 Room L/M

Standards and Audit Session Assessment of radiologists‘ professional performance Moderator: E.J. Adam; London/UK

10:30A-270 Radiologists‘ performance: assessment using peer review

G. Boland; Wellesley, MA/US

Learning Objectives:1. To comprehend the importance of peer review to education, clinical

care, research, best practices and cost.2. To understand how to implement an effective peer review program.3. To become familiar with the differing peer review tools including

electronic decision support.


180

A-27

1 –

A-28

811:00A-271 Radiologists‘ individual performance: use of standardised

test images A.G. Gale; Loughborough/UK

Learning Objectives:1. To understand the use of standardised test sets.2. To comprehend the advantages and limitations of using test sets to

measure the radiological performance.

11:30A-272 Radiologists‘ performance: referrers‘ view

J.M.L. Bosmans; Gent/BE

Learning Objectives:1. To become familiar with the views and expectatations of referring

clinicians concerning communication with the radiologist and more specifically regarding the radiology report.

2. To understand the different needs of particular subgroups of referrers.

3. To become familiar with the views and expectations of referrers regarding structured reporting and its potential effect on productivity and training.

12:15–12:45 Room A

Plenary Session HL 2 Wilhelm Conrad Röntgen Honorary

Lecture Presiding: J.I. Bilbao; Pamplona/ES

12:15A-273 Interventional oncology: the era of molecular targeted

therapy J.-F. Geschwind; Baltimore, MD/US

Learning Objectives:1. To learn about basic principles of cancer biology.2. To understand the importance of tumour metabolism and recognise

its role in cancer growth.3. To appreciate the growing impact of image-guided therapies for

cancer.

12:30–13:30 Room N/O

The Beauty of Basic Knowledge: Head and Neck MC 24C Main pipelines of the neck: pharynx

and larynx 12:30A-274 Main pipelines of the neck: pharynx and larynx

M. Becker; Geneva/CH

Learning Objectives:1. To become familiar with the anatomy of the pharynx and larynx.2. To learn how to choose and tailor imaging techniques according to

clinical presentation.3. To appreciate the most common pathologies affecting these

structures.4. To be able to provide a useful differential diagnosis of pharyngeal and

laryngeal lesions.

12:30–13:30 Room P

The Beauty of Basic Knowledge: Musculoskeletal Imaging MC 25C Inflammatory/infectious disorders 12:30A-275 Inflammatory/infectious disorders


Learning Objectives:1. To understand the pathophysiology of inflammatory conditions of

the musculoskeletal system.2. To learn about the basic imaging criteria for the diagnosis of arthritis,

osteomyelitis, and spondylitis.3. To become familiar with the differential diagnosis of the most

common inflammatory diseases.

14:00–15:30 Room B

EFRS meets Spain EM 5 Knowledge development as a tool

for radiographers’ professional improvement Presiding: G. Paulo; Coimbra/PT, C. Ruiz Blanco; Madrid/ES


G. Paulo1, C. Ruiz Blanco2; 1Coimbra/PT, 2Madrid/ES

Session Objectives:1. To understand Spanish radiographers‘ education and professional

status and its comparison with other European countries.2. To learn about the role of radiographer within the framework of the

Spanish health system.3. To learn about areas of professional development for radiographers

in Spain.

14:05A-285 The Spanish radiographer‘s role in advanced MRI research

E. Alfayate Sáez; Madrid/ES

Learning Objectives:1. To understand the role of radiographer in a MRI research centre.2. To understand the daily activity in a MRI research center and the

continuous professional development related to it.3. To learn about the potential areas of research development in MRI.

14:23A-286 The radiographer‘s specialisation in ultrasound: two

decades of experience in a public hospital M.P. Peña Fernández; Getafe/ES

Learning Objectives:1. To understand the role of the radiographer in ultrasound.2. To learn about inter-professional relations in ultrasound.3. To appreciate the advantages of a radiographer in ultrasound for

radiology department outcomes and for the quality of patient care.

14:41A-287 Interlude: Radiology and Spanish art

C. Ruiz Blanco; Madrid/ES

14:46A-288 The radiographer as the interface between patient and

technology in promoting safety in radiation protection J.A. Soria Jerez; Madrid/ES

Learning Objectives:1. To learn how to enhance patient safety in radiation protection.2. To learn about radiographers‘ role in optimising procedures.3. To understand the continuous professional development

requirements needed to maintain high standards in patient safety.


181

Saturday

A-28

9 –

A-30

6 15:04A-289 Educational status of radiographers in Spain: comparison

with the EU M.R. Soto García; Barcelona/ES

Learning Objectives:1. To understand the Spanish radiography education model.2. To learn about the limitations of Spanish education on free

movement on professionals in Europe.3. To learn about solutions for education-model development regarding

professional harmonisation.

Panel discussion:15:22 Could a transnational and multi-professional combined

statement contribute to professional development?16:00 - 17:30 Room A

16:00–17:30 Room A

Interactive Teaching Session E³ 1120 Breast cancer 16:00A-296 A. Detection

C.S. Balleyguier; Villejuif/FR

Learning Objectives:1. To understand the respective role of each imaging technique in the

diagnosis of breast cancer.2. To learn about common pitfalls in the diagnosis of breast cancer.

16:45A-297 B. Follow-up

G. Forrai; Budapest/HU

Learning Objectives:1. To understand the common features of recurrent breast cancer.2. To learn how to establish imaging follow-up protocols or breast

cancer.

16:00–17:30 Room B

State of the Art Symposium SA 11 Evaluation of response in

haematological malignancy 16:00A-298 Chairman‘s introduction

E. de Kerviler; Paris/FR

Session Objectives:1. To become reacquainted with the standard criteria for therapeutic

response in myeloma and lymphoma.2. To demonstrate the role of CT, MRI and PET in the assessment of

therapeutic response.3. To show that functional imaging is now essential for patient

evaluation at baseline and follow-up.4. To consider future imaging biomarkers in the assessment of response.

16:05

A-299 Opportunities and limitations of PET, CT and MRI answering the haematologist‘s questions T.C. Kwee; Utrecht/NL

Learning Objectives:1. To learn the various imaging features of lymphoma.2. To learn the advantages and limitations of CT, PET, and MRI in the

evaluation of lymphoma.3. To understand the importance of and opportunities provided by

(new) functional imaging methods for staging and follow-up of lymphoma.

16:28A-300 Evaluation of response in multiple myeloma

J. Hillengass; Heidelberg/DE

Learning Objectives:1. To understand the pathophysiologic mechanisms of multiple

myeloma.

2. To be able to compare the significance of imaging and serological markers for response evaluation in myeloma.

3. To assess the significance of the depth of response to systemic treatment.

16:51A-301 Evaluation of response in lymphoma with PET/CT

S.F. Barrington; London/UK

Learning Objectives:1. To understand the role of interim PET/CT in the evaluation of

metabolic response to lymphoma.2. To become aware of proposed reporting criteria developed for

assessment of interim PET/CT.3. To get an overview of current clinical trials exploring the role of

response adapted therapy according to PET/CT.

Panel discussion:17:14 Is it time for biomarker response criteria in haematological

malignancies?

16:00–17:30 Room C

Urogenital Imaging CC 1121 Stones: diagnosis and intervention

Moderator: N.C. Cowan; Oxford/UK

16:00A-302 A. Imaging patients with renal colic

G. Heinz-Peer; St. Pölten/AT

Learning Objectives:1. To learn about imaging approaches to patients with renal colic.2. To become familiar with the strengths and limitations of various

imaging techniques.3. To learn about the management of patients with renal colic.

16:20A-303 B. Percutaneous treatment of renal stones

S. Moussa; Edinburgh/UK

Learning Objectives:1. To appreciate the importance of imaging, stone selection and

planning for percutaneous nephron-lithotomy (PCNL).2. To become familiar with the technical aspects and different

approaches to PCNL.3. To appreciate the importance of recognising and avoiding

complications.

16:40A-304 C. Intervention in ureteral obstruction and ureteral trauma

A. Magnusson; Uppsala/SE

Learning Objectives:1. To learn how to manage a patient with ureteral obstruction.2. To understand when and how to treat a patient with ureteral trauma.3. To learn more about how to perform a nephrostomy.

17:00A-305 D. Interactive case discussion

N.C. Cowan; Birmingham/UK

16:00–17:30 Room D1

CLICK (Clinical Lessons for Imaging Core Knowledge): Never without Arteries CC 1118 Stroke

Moderator: M.M. Thurnher; Vienna/AT


P.M. Parizel, P. Cras, T. Menovsky, T. Van der Zijden, M. Voormolen; Antwerp/BE

Learning Objectives:1. To become familiar with the frequency and causes of stroke.2. To learn about the most important risk factors and predisposing

diseases.3. To learn about the importance of imaging for treatment decision-

making and planning.


182

A-30

7 –

A-31

716:30A-307 B. Imaging techniques and typical findings

J. Vymazal; Prague/CZ

Learning Objectives:1. To learn about state-of-the art imaging in cases of suspected stroke.2. To discuss potential pros and cons of using MR and CT.3. To become familiar with most recent innovations in stroke imaging.

17:00A-308 C. Interactive case discussion: what is next after diffusion

and perfusion? A. Dörfler; Erlangen/DE

Learning Objectives:1. To become familiar with typical cases demonstrating the crucial

role of imaging modalities in the diagnosis and treatment decision-making in ischaemic stroke.

2. To consolidate knowledge of the selection of the appropriate imaging technique, image interpretation and image based treatment recommendation.

3. To learn about the importance of imaging for treatment decisions and planning.

16:00–17:30 Room D2

Head and Neck RC 1108 Skull base lesions: imaging studies

and differential diagnosis Moderator: L. Grzycka-Kowalczyk; Lublin/PL

16:00A-309 A. Anterior cranial fossa with special emphasis on

olfactory apparatus lesions T.P.J. Duprez; Brussels/BE

Learning Objectives:1. To learn the imaging techniques of the anterior skull base with an

emphasis on the olfactory apparatus.2. To become familiar with the imaging findings.3. To understand how to differentiate between lesions in the anterior

skull base.

16:30A-310 B. Middle cranial fossa pathologies


Learning Objectives:1. To become familiar with imaging strategies for the middle cranial

fossa.2. To know more about imaging findings of common lesions.3. To learn how to differentiate between the lesions in middle cranial

fossa.

17:00A-311 C. Posterior cranial fossa pathologies

H. Tanghe; Rotterdam/NL

Learning Objectives:1. To learn the imaging techniques in the posterior cranial fossa.2. To become familiar with the imaging findings of common posterior

cranial fossa pathologies.3. To understand how to differentiate between the lesions in the

posterior cranial fossa.

16:00–17:30 Room E1

Musculoskeletal RC 1110 The knee 16:00A-312 Chairman‘s introduction

F.M.H.M. Vanhoenacker; Antwerp/BE

16:05A-313 A. Patterns of injury

P. Van Dyck; Antwerp/BE

Learning Objectives:1. To know more about the imaging appearances of soft tissue and

osteoarticular injury.2. To become familiar with the patterns of bone and soft tissue injury in

the knee.

16:28A-314 B. Inflammatory disease

A. Cotten; Lille/FR

Learning Objectives:1. To know more about the imaging appearances of soft tissue and

osteoarticular inflammation.2. To become familiar with imaging findings of specific inflammatory

conditions.

16:51A-315 C. Soft tissue tumours/tumour-like lesions

J.C. Vilanova; Girona/ES

Learning Objectives:1. To know more about the spectrum of intra and para-articular soft

tissue tumours, and soft tissue tumour-like lesions.2. To become familiar with US and MRI findings of specific soft tissue

lesions.

Panel discussion:17:14 What are the remaining clinical questions that imaging

currently cannot answer and how can we answer them in the future?

16:00–17:30 Room E2

Multidisciplinary Session: Managing Patients with Cancer MS 11 Cholangiocarcinoma 16:00A-316 Chairman‘s introduction

B. Hamm; Berlin/DE

Session Objectives:1. To learn about state-of-the-art diagnosis of cholangiocarcinoma.2. To understand the value of surgical and systemic strategies in therapy.3. To appreciate image-guided interventional treatment.

16:05A-317 Surgery of hilar and extrahepatic cholangiocarcinoma

P. Neuhaus; Berlin/DE

Learning Objectives:1. To become familiar with prognosis depending on the evolution of

surgical approach.2. To become familiar with surgical decision making: left/right liver

resection, hilar resection, pancreatic head resection.3. To become familiar with technique of extended right

hemihepatectomy.4. To become familiar with liver function, volume.5. To become familiar with biliary decompression left/right, internal/

external.


183

Saturday

A-31

8 –

A-32

9 16:20A-318 Radiology - diagnostics and portal vein embolisation in

hilar and extrahepatic cholangiocarcinoma T. Denecke; Berlin/DE

Learning Objectives:1. To learn about diagnosis/differential diagnosis.2. To learn about surgical planning through imaging: bile ducts,

vascular system, hyperplasia induction, liver function testing.

16:35A-319 Medical treatment of cholangiocarcinomas

H. Riess; Berlin/DE

Learning Objectives:1. To become familiar with chemotherapy of extrahepatic

cholangiocarcinoma.2. To become familiar with treatment concepts for intrahepatic

cholangiocarcinomas.3. To become familiar with systemic vs. intra-arterial chemotherapy.

16:50A-320 Radiology - diagnostics and image guided therapies in

intrahepatic cholangiocarcinomas B. Gebauer; Berlin/DE

Learning Objectives:1. To learn about image guided therapy decisions.2. To learn about local ablation in non-surgical candidates (RFA, CT-

brachytherapy).3. To learn about intra-arterial port implantation.4. To learn about transarterial radioembolisation.

17:05 Case presentation (part 1): hilar cholangiocarcinoma 17:17 Case presentation (part 2): CCC multimodal treatment

16:00–17:30 Room F1

Special Focus Session SF 11 Adults with congenital heart disease

(GUCH) 16:00A-321 Chairman‘s introduction: Why should a radiologist gather

information on GUCH patients? M. Gutberlet; Leipzig/DE

Session Objectives:1. To learn about the increasing number of GUCH patients.2. To appreciate the importance of lifelong imaging follow-ups.3. To become familiar with the need for specialised GUCH centres.

16:05A-322 A list of typical surgical procedures: the top ten in GUCH

M. Hübler, D. Hitendu, M. Schweiger, M. Greutmann; Zurich/CH

Learning Objectives:1. To become familiar with the most common surgical procedures in

congenital heart disease (CHD).2. To know more about the typical postoperative problems in GUCH

patients.3. To learn about how imaging can help the cardiac surgeon.

16:30A-323 ‚Adults are not just big children‘: differences between

children and adults A.M. Taylor; London/UK

Learning Objectives:1. To understand the age dependency in the selection of imaging

modalities.2. To learn about radiation exposure issues in GUCH patients.3. To understand what the difference between imaging of children and

adults.

16:55A-324 Which modality, for which patient? MRI or CT, that‘s the

question J. Bremerich; Basle/CH

Learning Objectives:1. To learn about the pros and cons of different imaging modalities for

GUCH patients.2. To become familiar with imaging of the most common entities in

GUCH.3. To consolidate knowledge of imaging protocols after surgical

correction of CHD.

Panel discussion:17:20 Can we now get all the information we need to treat GUCH

patients, non-invasively?

16:00–17:30 Room F2

Professional Challenges Session PC 11 Personalised radiology 16:00A-325 Chairman‘s introduction

G.P. Krestin; Rotterdam/NL

Session Objectives:1. To understand the concept of personalised radiology.2. To get an overview of the role of imaging in personalised medicine.3. To learn about the concept of personalised medicine and

personalised healthcare.

16:06A-326 Personalised medicine: hope or hype?

O. Golubnitschaja; Bonn/DE

Learning Objectives:1. To understand the definition of personalised medicine.2. To learn about some of the successful examples of personalised

healthcare.3. To understand the present limitations in adapting personalised

medicine.

16:22A-327 Imaging for disease prediction

M. Vernooij; Rotterdam/NL

Learning Objectives:1. To learn about population imaging.2. To become familiar with the role of imaging in disease prediction.3. To understand the need for validated imaging biomarkers.

16:38A-328 Molecular imaging: a solution for personalised diagnosis

and treatment? F.M.A. Kiessling; Aachen/DE

Learning Objectives:1. To become familiar with the role of molecular imaging for disease

localisation and characterisation, patient selection to therapy and therapy monitoring.

2. To learn about individualised image-guided drug delivery systems.3. To understand the concept of theranostics: the combination of

targeted imaging and targeted therapy.

16:54A-329 Role of imaging in personalised therapy monitoring

A.R. Padhani; Northwood/UK

Learning Objectives:1. To become familiar with the general role of imaging in treatment

monitoring and drug development.2. To understand the requirements of imaging biomarker development

for treatment monitoring in personalised medicine.3. To understand how to develop the evidence base so that imaging

biomarkers can be used for personalised therapeutic approaches.

Panel discussion:17:10 Is imaging providing an added value to the ‚omics‘ of

personalised medicine?


184

A-33

0 –

A-34

016:00–17:30 Room G/H

Neuro RC 1111 Brain tumours: advanced imaging

techniques in daily practice - do we really need them? Moderator: Z. Merhemic; Sarajevo/BA

16:00A-330 A. Diffusion-weighted imaging (DWI) and diffusion tensor

imaging (DTI) M. Law; Los Angeles, CA/US

Learning Objectives:1. To appreciate DWI in the characterisation of focal brain lesions.2. To understand how to differentiate between tumoural and non-

tumoural disease using DWI.3. To consolidate knowledge on how to combine DWI with other

advanced MRI tools.4. To find out if DTI is really useful in the clinical setting or merely a

mathematical algorithm of the tensor.

16:30A-331 B. Perfusion imaging

Y. Özsunar; Aydin/TR

Learning Objectives:1. To appreciate the value of perfusion imaging.2. To understand why perfusion imaging is needed.3. To become familiar with principles, applications, and pitfalls of

various perfusion imaging techniques.4. To consolidate knowledge of perfusion imaging of various brain

masses that can be encountered in daily practice.

17:00A-332 C. Follow-up after treatment

P.C. Maly Sundgren; Lund/SE

Learning Objectives:1. To understand the present traditional model for the follow-up and

monitoring of brain tumour treatment.2. To become familiar with different imaging biomarkers for early

assessment of brain tumour treatment response.3. To consolidate presently available knowledge and ideas on brain

tumour imaging follow-up for future brain tumour treatment and monitoring of response.

16:00–17:30 Room I/K

Chest RC 1104 Pulmonary infections:

the old and the new Moderator: F. Gleeson; Oxford/UK

16:00A-333 A. Mycobacterial infections

C. Beigelman; Lausanne/CH

Learning Objectives:1. To appreciate the imaging features of primary and post-primary

infections in TB.2. To learn about the similarities and differences between TB and non-

TB mycobacterial infections.3. To understand the radiologist‘s role in diagnosis.

16:30A-334 B. Infectious disease in immuno-compromised patients

C.-P. Heussel; Heidelberg/DE

Learning Objectives:1. To appreciate the various types of immuno-deficiencies and their

related infections.2. To become familiar with the role of the radiologist in immuno-

compromised patients.3. To learn how to follow pulmonary infections in immuno-

compromised patients.

17:00A-335 C. Emerging infections

T. Franquet; Barcelona/ES

Learning Objectives:1. To learn more about emerging infections.2. To become familiar with radiological patterns and conditions which

suggest viral infections.3. To learn how to improve diagnostic accuracy.

16:00–17:30 Room L/M

Physics in Radiology RC 1113 Cone-beam imaging

Moderators: O. Ciraj-Bjelac; Belgrade/RS, A. Trianni; Udine/IT

16:00A-336 A. Fundamentals of cone-beam imaging

M. Kachelrieß; Heidelberg/DE

Learning Objectives:1. To understand the principles of volumetric image formation with flat

detectors.2. To understand the difference between CBCT and MSCT.3. To learn about reconstruction techniques and image processing.4. To become acquainted with the important image quality parameters.

16:30A-337 B. Medical applications of CB imaging

M. Grass; Hamburg/DE

Learning Objectives:1. To become acquainted with the applications of CB imaging.2. To learn about systems design and parameters.3. To understand image quality characteristics.4. To learn how to use cone beam images in image guided interventions.

17:00A-338 C. 3D dentomaxillofacial imaging

K. Horner; Manchester/UK

Learning Objectives:1. To become acquainted with CBCT systems for dentomaxillofacial

imaging.2. To learn about image quality characteristics and patient dose

compared to other techniques.3. To learn how to access CB images and influence the clinical outcome.

16:00–17:30 Room N/O

Interventional Radiology RC 1109 Update on biliary interventions 16:00A-339 Chairman‘s introduction

M. Krokidis1, A.A. Hatzidakis2; 1Cambridge/UK, 2Iraklion/GR

Session Objective:1. To review the various interventional techniques for the treatment of

complex biliary diseases.

16:05A-340 A. Fistula and benign stenosis

M. Bezzi; Rome/IT

Learning Objectives:1. To know about the etiology of fistulas and benign stenoses.2. To become familiar with the various imaging modalities and findings

in benign fistulas and stenoses.3. To understand the techniques, results, and complications of

interventional treatments.


185

Saturday

A-34

1 –

A-34

5 16:28A-341 B. Interventions after liver transplantation

P.P. Goffette; Brussels/BE

Learning Objectives:1. To know about the appropriate imaging algorithm for the detection

of biliary complications after liver transplantation.2. To become familiar with the techniques of interventional treatment

of biliary complications after liver transplantion.3. To understand the results and complications in comparison with

surgical management.

16:51A-342 C. In tandem with endoscopy

D.F. Martin; Manchester/UK

Learning Objectives:1. To be aware of the indications for tandem use of percutaneous and

endoscopic approach.2. To learn the tips and tricks of tandem technique.3. To learn about the results and complications of tandem treatment.

Panel discussion:17:14 Are there new possibilities in the area of biliary interventions?

16:00–17:30 Room P

Radiographers RC 1114 Hot topics in magnetic resonance

imaging Moderators: K. Haller; Wiener Neustadt/AT, L. Martí-Bonmatí; Valencia/ES

16:00A-343 A. New trends in MR safety

P. Bauer; Vienna/AT

Learning Objectives:1. To become familiar with the standard MRI safety measures (metal

check and SAR limits).2. To understand the new challenges for MRI safety given the

technological advances in high-field magnets, faster gradients coils, hybrid MR imaging and new contrast agents.

3. To learn about updated MRI safety guidelines with reference to recent literature, white papers and accredited MRI safety websites.

4. To appreciate the MRI safety implications for pregnant women, neonates and the general paediatric population.

16:30A-344 B. MR spectroscopy: the role of radiographers in data

optimisation J. McNulty; Dublin/IE

Learning Objectives:1. To learn about the basic principles of MR spectroscopy contrasting

them to the basic principles of MR imaging.2. To understand the benefits of using MRS in clinical practice.3. To appreciate how image quality is defined in MRS, to highlight the

parameters which affect image quality in MRS and how these can be modified by the radiographer.

4. To become familiar with examples of common MRS artefacts and how these can be corrected by the radiographer.

17:00A-345 C. Challenges and opportunities in paediatric MR

V. Syrgiamiotis; Athens/GR

Learning Objectives:1. To learn about the basic anatomical/physiological differences within

the paediatric population, contrasting it with the general adult population.

2. To understand the MRI scan parameter modifications required to accommodate these differences and their trade-offs.

3. To become familiar with examples of improved, optimised imaging protocols against standard, preset, commercially available adult imaging protocols.

4. To consolidate knowledge on the optimal use of equipment to achieve a successful and clinically useful paediatric MRI exam.


186

A-34

6 –

A-35

608:30–10:00 Room A

Interactive Teaching Session E³ 1220 Pitfalls in brain imaging 08:30A-346 A. CT

L. van den Hauwe1, S. Pugliese2, J.W. Van Goethem1, C. Venstermans1, F. De Belder1, T. van der Zijden1, M. Voormolen1, P.M. Parizel1; 1Antwerp/BE, 2Rome/IT

Learning Objectives:1. To learn about common pitfalls in CT evaluation of the brain.2. To become familiar with anatomical variants, potentially mimicking

disease.

09:15A-347 B. MRI

M. Essig; Erlangen/DE

Learning Objectives:1. To learn about common pitfalls in MRI evaluation of the brain.2. To become familiar with anatomical variants, potentially mimicking

disease.

08:30–10:00 Room B

GI Tract RC 1201 How I report

Moderator: G.A. Rollandi; Genoa/IT

08:30A-348 A. MDCT in the post-operative abdomen

D.J.M. Tolan; Leeds/UK

Learning Objectives:1. To become familiar with an optimised MDCT protocol for the

detection of post-operative complications.2. To learn the normal post-operative appearance of common surgical

material including mesh, packing and sutures.3. To understand the expected findings of peritoneal air, fluid and bowel

dilatation in the immediate post operative course.4. To learn the most common causes of clinical deterioration in the

post-operative state and their imaging findings.

09:00A-349 B. MDCT in a patient with small bowel ischaemia

S. Romano; Naples/IT

Learning Objectives:1. To understand the patho-physiologic mechanism leading to arterial,

venous or low-flow state vascular injury.2. To learn how to differentiate different stages of disease from early

potentially transient ischaemia to late infarction.3. To become familiar with reperfusion damage of the intestine.4. To understand the accuracy of the various radiological signs of bowel

ischaemia.

09:30A-350 C. MDCT in a patient with small bowel obstruction

P. Taourel; Montpellier/FR

Learning Objectives:1. To understand a simple classification for the causes of bowel

obstruction.2. To become familiar with CT protocols.3. To learn a structured approach to the reporting of CT.4. To understand the accuracy of the various radiological signs of bowel

obstruction.

08:30–10:00 Room C

Urogenital Imaging CC 1221 Retroperitoneal anatomy, variants and

diseases Moderator: U.G. Mueller-Lisse; Munich/DE

08:30A-351 A. Retroperitoneal anatomy: an embryology based

approach F.M. Danza; Rome/IT

Learning Objectives:1. To understand the development of the retroperitoneum during

the embryo development, introducing the concept of a unique subperitoneal space.

2. To understand the importance of fascial planes in determining the pattern of diffusion of diseases.

3. To apply these new concepts signs during routine diagnostic work.

08:50A-352 B. Anatomical variants and benign diseases

S. Merran; Paris/FR

Learning Objectives:1. To learn about the most important variants of retroperitoneal vessels

and about renal anomalies.2. To understand the role of radiology in patients with retroperitoneal

fibrosis and infections.3. To become familiar with benign retroperitoneal tumours and learn

about the clues for differential diagnosis.

09:10A-353 C. Malignant tumours

R.H. Oyen, F. Claus, D. Hompes, L. De Wever; Leuven/BE

Learning Objectives:1. To learn about the spectrum of malignant retroperitoneal neoplasms.2. To understand the role of preoperative cytology/histology by needle

aspiration/biopsy.3. To learn about the predictors for survival after resection of

retroperitoneal sarcoma.


U.G. Mueller-Lisse; Munich/DE

08:30–10:00 Room D1

CLICK (Clinical Lessons for Imaging Core Knowledge): Never without Arteries CC 1218 Chest pain: vascular non-cardiac

causes Moderator: E. Brountzos; Athens/GR


R. Iezzi; Rome/IT

Learning Objectives:1. To become familiar with clinical diagnostic algorithms in cases of

non-cardiac acute chest pain.2. To learn about the constituents of acute aortic syndrome.3. To become familiar with prognosis, treatment and outcome and learn

about the influence of imaging on treatment decisions in acute chest pain.


F. Wolf; Vienna/AT

Learning Objectives:1. To learn about state-of-the-art CT angiographic imaging in acute

chest pain (after ruling out MI).2. To become familiar with the techniques and advantages of ECG

gating in CT angiographies of acute chest pain.3. To discuss the potential role of additional MR angiography.


187

Sun

day

A-35

7 –

A-36

8 09:30A-357 C. Interactive case discussion: what is really important?

T.R.C. Johnson; Munich/DE

Learning Objectives:1. To become familiar with typical cases illustrating the role of imaging

modalities in the diagnosis and differential diagnosis of acute chest pain.


3. To understand the most important information urgently needed for treatment decisions and planning.

08:30–10:00 Room D2

Oncologic Imaging: Follow-up of Systemic and Local Therapies CC 1219 Assessing HCC response

Moderator: R. Lencioni; Pisa/IT

08:30A-358 A. Systemic therapies

V. Vilgrain, M. Ronot, M. Zappa, S. Faivre, E. Raymond; Clichy/FR

Learning Objectives:1. To learn about difficulties in HCC assessment with local therapy.2. To become familiar with various evaluation criteria of HCC.

09:00A-359 B. Endovascular therapies

R. Salem; Chicago, IL/US

Learning Objectives:1. To appreciate the value of different imaging techniques for

assessment of intra-arterial therapies of HCC.2. To become familiar with post-treatment imaging after intra-arterial

therapies according to type of therapy.

09:30A-360 C. Ablative therapies


Learning Objectives:1. To learn about the value of different imaging techniques for the

assessment of ablative therapies of HCC.2. To become familiar with post-treatment imaging after ablative

therapies according to type of therapy.

08:30–10:00 Room E1

Musculoskeletal RC 1210 Overuse injuries in sport: a

multimodality approach Moderator: E. Llopis; Valencia/ES

08:30A-361 A. Overuse injuries in the footballer‘s ankle

S.J. Eustace; Dublin/IE

Learning Objectives:1. To learn the spectrum of overuse injuries sustained by footballers at

the ankle joint.2. To understand the mechanisms by which these injuries occur.3. To become familiar with the imaging findings seen in overuse

injuries at the ankle.

09:00A-362 B. Overuse injuries in the gymnast‘s spine

M.C. De Jonge; Amsterdam/NL

Learning Objectives:1. To become familiar with the types of chronic injuries seen in the

gymnast‘s spine.2. To understand the strengths and weaknesses of different imaging

modalities for imaging these injuries.

09:30A-363 C. Upper limb overuse injuries in golfers

P.J. O‘Connor; Leeds/UK

Learning Objectives:1. To understand the types and mechanisms of overuse injuries seen in

the upper limb in golfers.2. To understand the advantages and disadvantages of different imaging

modalities.3. To become familiar with the imaging findings seen in overuse

injuries of the upper limb.

08:30–10:00 Room E2

Neuro RC 1211 Stroke: is the prognosis getting

any better? 08:30A-364 Chairman‘s introduction

J.-P. Pruvo; Lille/FR

08:35A-365 A. Initial imaging work-up: CT or MR?

P.M. Parizel, T. Van der Zijden, F. De Belder, C. Venstermans, L. van den Hauwe, R. Salgado, J. Van Goethem, M. Voormolen; Antwerp/BE

Learning Objectives:1. To become familiar with a comprehensive imaging protocol in

patients with suspected stroke.2. To know the advantages and disadvantages of CT and MR in the

initial work-up of stroke patients.3. To recognise the different imaging patterns in stroke.

08:58A-366 B. Stroke: is there really any therapy?

V. Mendes Pereira, K.-O. Lovblad; Geneva/CH

Learning Objectives:1. To learn the natural evolution of untreated stroke.2. To understand the advantages and disadvantages of the different

therapeutic options in stroke patients.3. To recognise imaging patterns that may determine therapy in stroke

patients.

09:21A-367 C. Stenting: does it prevent stroke?

P. Vilela; Almada/PT

Learning Objectives:1. To understand the natural history of extracranial and intracranial

carotid and vertebral artery atherosclerotic and non-atherosclerotic diseases.

2. To become familiar with the endovascular treatment indications of extracranial and intracranial arterial disorders.

3. To understand the endovascular treatment strategies aimed at stroke prevention.

4. To recognise the present and future challenges for PTA and stenting of extracranial and intracranial arteries.

Panel discussion:09:44 What is the future of stroke prevention and treatment?

08:30–10:00 Room F1

Special Focus Session SF 12 Quantitative imaging biomarkers in

cardiac radiology 08:30A-368 Chairman‘s introduction

A. van der Lugt; Rotterdam/NL

Session Objectives:1. To appreciate the increasing role of imaging biomarkers in

radiological research and clinical practice.2. To understand the importance of quantification and standardisation

of imaging biomarkers.3. To become familiar with the spectrum of quantitative imaging

biomarkers in cardiac radiology


188

A-36

9 –

A-38

108:33A-369 Imaging biomarkers

J.-P. Vallée; Geneva/CH

Learning Objectives:1. To understand the concept of imaging biomarkers.2. To learn about the different types of biomarkers (anatomical/

functional/molecular).3. To understand the different applications of imaging biomarkers

(detection, prediction, response).4. To learn about the standardisation and validation of imaging

biomarkers.

08:45A-370 Imaging biomarkers for myocardial function

J. Bogaert; Leuven/BE

Learning Objectives:To become familiar with the quantitative imaging biomarkers of:1) cardiac mass (MRI/CT)2) ventricular volume (MRI/CT)3) ventricular function (MRI/CT)

09:05A-371 Imaging biomarkers of myocardial viability

P. Croisille; Saint-Etienne/FR

Learning Objectives:To become familiar with the quantitative imaging biomarkers of:1) infarct size using delayed enhancement (MRI/CT)2) areas at risk in myocardial infarction using T2w MRI3) cardiac contractility using cine or tag MRI after low dose dobutamine challenge

09:25A-372 Imaging biomarkers of myocardial ischaemia

L. Natale; Rome/IT

Learning Objectives:To become familiar with the quantitative imaging biomarkers of:1) myocardial perfusion (MRI/CT),2) cardiac contraction after high dose dobutamine challenge (MRI)3) coronary atherosclerosis (CT)

Panel discussion:09:45 How should we implement quantitative biomarkers in clinical

practice?

08:30–10:00 Room F2

Breast RC 1202 Multi-modality breast imaging 08:30A-373 Chairman‘s introduction

M. Lesaru; Bucharest/RO

08:35A-374 A. Conventional, functional and interventional lymph node

assessment P.D. Britton; Cambridge/UK

Learning Objectives:1. To learn about normal lymph node morphology.2. To understand criteria suggestive of morphological abnormality.3. To become familiar with factors affecting overall sensitivity of pre-

operative lymph node assessment.

08:58A-375 B. Multi-modality assessment of the breast following

oncoplastic surgery M. Torres-Tabanera, S. Perez-Rodrigo; Madrid/ES

Learning Objectives:1. To learn about the range of oncoplastic breast procedures in current

clinical practice.2. To become familiar with imaging features resulting from oncoplastic

surgery.3. To appreciate the potential pitfalls encountered while imaging such

cases.

09:21A-376 C. Image guided therapy in breast lesions: indications and

techniques G. Manenti, G. Simonetti; Rome/IT

Learning Objectives:1. To understand indications for therapeutic interventions in malignant

and benign lesions.2. To learn about current image guided therapeutic techniques in

malignant and benign lesions.3. To appreciate possible future developments of therapeutic

interventions.

Panel discussion:09:44 How is the evolution of multi-modality breast imaging

changing the nature of the multi-disciplinary meeting (MDM)?

08:30–10:00 Room G/H

Genitourinary RC 1207 How I report

Moderator: G.M. Villeirs; Gent/BE

08:30A-377 A. Female pelvis MRI

A.G. Rockall; London/UK

Learning Objectives:1. To learn a structured reporting approach to MR imaging.2. To learn a structured reporting approach to uterine and cervical

cancer staging.3. To learn a structured reporting approach to adnexal masses.

09:00A-378 B. Prostate MRI

J.J. Fütterer; Nijmegen/NL

Learning Objectives:1. To learn a structured reporting approach to MR imaging.2. To learn the most essential points and details to be reported in

prostate cancer patients.3. To understand the major weaknesses of a prostate MR report.

09:30A-379 C. CT urography

N.C. Cowan; Birmingham/UK

Learning Objectives:1. To learn how to read and report CT urography.2. To understand how to optimise CT urography for haematuria and

urothelial cancer.3. To report specimen cases and self-assess your own performance.

08:30–10:00 Room I/K

Chest RC 1204 Lung cancer staging in 2013 08:30A-380 Chairman‘s introduction: the latest TNM classification

J. Biederer; Heidelberg/DE

08:35A-381 A. Local tumour staging

L. Bonomo; Rome/IT

Learning Objectives:1. To learn about the T staging of lung cancer.2. To become familiar with the current state of the different imaging

technique to assess the T stage.3. To appreciate limitations and pitfalls.


189

Sun

day

A-38

2 –

A-39

3 08:58A-382 B. Lymph node staging

W.F.M. De Wever; Leuven/BE

Learning Objectives:1. To learn about N staging in lung cancer.2. To learn the current state of endobronchial ultrasound for

intrathoracic intervention.3. To become familiar with limitations and pitfalls.

09:21A-383 C. Distant metastasis and whole body imaging

G. Antoch; Düsseldorf/DE

Learning Objectives:1. To appreciate the role of PET/CT and whole-body MRI.2. To learn about the sensitivity and specificity.3. To become familiar with the role of imaging in early response

evaluation and in follow-up.

Panel discussion:09:44 Facts and controversies in lung cancer staging

08:30–10:00 Room L/M

Physics in Radiology RC 1213 Risk assessment and risk

communication 08:30A-384 Chairmen‘s introduction

M.M. Rehani1, P. Vock2; 1Vienna/AT, 2Berne/CH

Session Objectives:1. To learn about risk, risk estimation, risk perception and

communication.2. To become familiar with radiation risk: past and present.3. To appreciate why we need to inform patients and the public about

the risks and how.4. To understand what referring doctors should know about risk.

08:35A-385 A. Radiation risks for patients and staff

E. Vaño; Madrid/ES

Learning Objectives:1. To get the latest information on stochastic risks in radiology.2. To understand the risks for children compared to adults.3. To get the latest information on tissue reaction to medical

procedures.4. To learn about radiation cataract and its dose dependence.

08:58A-386 B. Risk in MRI

R.R. Peeters; Leuven/BE

Learning Objectives:1. To learn about the risks for patients from MRI procedures.2. To be informed about the contraindications for MRI scan.3. To learn about risks for staff in an MRI department.

09:21A-387 C. Communication of risk to patients and public

G. Gamhewage; Geneva/CH

Learning Objectives:1. To become familiar with communicating risk according to the

imaging modality.2. To become familiar with important rules in communication.3. To understand the relationship between threat/hazard and perception

of parents regarding imaging for their child.4. To learn how to select an appropriate risk communications strategy

suited to parents and children.

Panel discussion:09:44 How to communicate risk to patients and the public?

08:30–10:00 Room N/O

Interventional Radiology RC 1209 Gynaecological and obstetrical

haemorrhagic emergencies 08:30A-388 Chairman‘s introduction

A.-M. Belli; London/UK

08:35A-389 A. Etiology and treatment of gynaecological benign and

malignant causes of massive bleeding A. Keeling; Dublin/IE

Learning Objectives:1. To know more about causes of massive bleeding due to

gynaecological disorders.2. To learn about diagnostic imaging and therapeutic embolisation.3. To review published results obtained through embolisation.

08:58A-390 B. Can we prevent post-partum haemorrhage in high-risk

patients? J.-P. Pelage; Caen/FR

Learning Objectives:1. To learn how to identify a high-risk patient.2. To become familiar with preventive measures and medication.3. To know more about techniques for invasive prevention.4. To learn about the results obtained through preventive techniques.

09:21A-391 C. Treatment of post-partum haemorrhage

M. Szczerbo-Trojanowska; Lublin/PL

Learning Objectives:1. To learn about clinical evaluation of post-partum haemorrhage.2. To become familiar with relevant anatomy.3. To understand catheterisation and embolisation techniques.4. To become familiar with results of embolisation.

Panel discussion:09:44 How to reduce the radiation doses of these methods?

08:30–10:00 Room P

Radiographers RC 1214 Dose optimisation in computed

tomography Moderators: G. Frija; Paris/FR, D. Pekarovic; Ljubljana/SI

08:30A-392 A. Innovations in dose optimisation

S. Foley; Dublin/IE

Learning Objectives:1. To consolidate knowledge in the area.2. To become familiar with recent developments based on scanner

design features and to be aware of the evidence base that supports these developments.

3. To become familiar with recent developments based on non-scanner based approaches such as shielding and to be aware of the evidence base that supports these approaches.

4. To learn more about the potential for future developments in the area.

09:15A-393 B. Developing patient specific examination protocols

H. Precht; Odense/DK

Learning Objectives:1. To understand the importance of employing patient specific

examination protocols in computed tomography by exploring the benefits of such protocols.

2. To understand the categories of patients for which specifically tailored protocols must always be employed.


190

A-39

4 –

A-40

43. To appreciate the potential impact of patient specific protocols on image quality and patient dose through the use of sample cases.

4. To discover a simple framework which could assist radiographers in introducing patient specific examination protocols to their departments.

08:30–10:00 Room Q

Paediatric RC 1212 Oncologic imaging: how to image,

follow up and report 08:30A-394 Chairman‘s introduction

D. Roebuck; London/UK

08:35A-395 A. Renal and adrenal tumours in children

A.M.J.B. Smets; Amsterdam/NL

Learning Objectives:1. To appreciate the role of US, CT, MRI and scintigraphy.2. To become familiar with the imaging findings and the main

differential diagnoses.3. To learn about the imaging strategies for diagnosis and staging.

08:58A-396 B. Paediatric liver malignancies

D. Roebuck; London/UK

Learning Objectives:1. To understand the role of US, CT and MRI.2. To become familiar with the imaging findings and the main

differential diagnoses.3. To learn the imaging strategies for diagnosis and in staging.

09:21A-397 C. Oncologic imaging in the paediatric brain

G. Hahn; Dresden/DE

Learning Objectives:1. To understand the role of CT, MRI and MRS.2. To become familiar with the imaging findings and the main

differential diagnoses.3. To learn about the imaging findings of post-chemo/radiation therapy

conditions and complications.

Panel discussion:09:44 How far should the radiologist go in suggesting tumour

recurrence or post-treatment complications?

08:30–10:00 Room Z

Professional Challenges Session PC 12 Legal matters related to

multimodality techniques 08:30A-398 Chairman‘s introduction

K. Åhlström Riklund; Umea/SE

Session Objectives:1. To learn about legal matters in multimodality imaging in different

parts of Europe, in radiology and nuclear medicine.2. To understand the challenges in hybrid imaging, with respect to both

radiology and nuclear medicine.3. To consolidate knowledge of the situation in different parts of

Europe.

08:35A-399 Radiological legal matters in eastern Europe

M. Studniarek; Gdansk/PL

Learning Objectives:1. To learn about legal matters in multimodality imaging in eastern

Europe.2. To understand the specific role and diagnostic applications of PET/

CT imaging as a result of national guidelines in eastern Europe, with the example of Poland.

3. To consolidate knowledge of the limits of the application of diagnostic CT in PET/CT units in radiology and nuclear medicine procedures listed (officially identified) in Poland.

08:53A-400 Legal matters in nuclear medicine

G.K. von Schulthess; Zurich/CH

Learning Objectives:1. To understand issues facing tracer development and clinical use of

tracers.2. To understand the process of getting new tracers approved for clinical

use.3. To understand the process of getting reimbursement for integrated

imaging procedures.

09:11A-401 Legal matters in Scandinavia

K. Åhlström Riklund; Umeå/SE

Learning Objectives:1. To learn about the educational situation in multimodality imaging in

northern Europe.2. To learn about national guidelines for multimodality imaging in

northern Europe.3. To learn what you need to run a PET/CT and cyclotron facility in

northern Europe.

09:29A-402 International, regional, national and local framework

requirements A. Perkins; Nottingham/UK

Learning Objectives:1. To learn about the origin of the radiation protection framework.2. To appreciate the framework for radiation protection at international,

regional and national levels.3. To understand the responsibilities of different parties within the

working environment.

Panel discussion:09:47 A discussion with questions from the audience about the

differences across Europe

10:30–12:00 Room B

ESR meets Chile EM 4 Topics of ongoing radiological research

from the Andes Welcome by the ESR President: G.P. Krestin; Rotterdam/NL

Presiding:J.I. Bilbao; Pamplona/ESM.A. Pinochet; Santiago/CL

10:30A-403 Introduction: Radiology in Chile: reality and challenges

P. Soffia; M.A. Pinochet Santiago/CL

Session Objectives:1. To learn about some interesting recent and ongoing Chilean

radiological research projects in the field of diagnostic imaging.2. To get a glimpse of unique radiological and non-radiological topics

in Chile.

10:35A-404 TI-RADS: a US classification of thyroid nodules related to

cancer risk E. Horvath; Santiago/CL

Learning Objectives:1. To learn about an ultrasonographic-based pattern classification that

enables a cancer risk approach to an accurate selection of thyroid nodules that require fine needle aspiration biopsy (FNAB).

2. To understand the description of the 10 US pattern for thyroid nodule classification.

3. To correctly classify the pattern into the TIRADS categories.4. To learn how to determine those patterns most closely related with

malignancy.


191

Sun

day

A-40

5 –

A-41

7 10:55A-405 Interlude: Chile, land of geographical and cultural

contrasts G. Soto Giordani; Santiago/CL

11:00A-406 Neuroimaging in epilepsy: in search of invisible lesions

M. Galvez; Santiago/CL

Learning Objective:1. To learn about solutions to improve visualisation of epileptogenic

lesions not visible on conventional MRI.

11:20A-407 Interlude: Chile, land of wine and poets

G. Soto Giordani; Santiago/CL

11:25A-408 MDCT patterns in mesenteric ischaemia: usefulness in

predicting clinical outcome A. Huete; Santiago/CL

Learning Objectives:1. To learn to identify the most frequent patterns of ischaemic bowel

wall damage in patients with arterial mesenteric ischaemia using MDCT angiography.

2. To correlate patterns of bowel wall ischaemia on MDCT with clinical outcome.

3. To identify secondary, non-specific findings of bowel ischaemia on MDCT that signal a potential adverse clinical course.

Panel discussion:11:45 Creating networks between Latin American and European

radiology: a unique opportunity for collaborative research projects

10:30–12:00 Room C

Urogenital Imaging CC 1321 The female pelvis

Moderator: E. Sala; New York, NY/US

10:30A-409 A. Imaging congenital anomalies of the female genital

system K. Kinkel; Chêne-Bougeries/CH

Learning Objectives:1. To understand Mullerian duct anomalies through embryology and its

classification.2. To learn about the indications of MRI or 3D US according to clinical

and sonographic findings.3. To understand imaging technique and report requirements and the

impact of imaging results on treatment options.

10:50A-410 B. Benign ovarian masses

R. Forstner; Salzburg/AT

Learning Objectives:1. To become familiar with common and rare benign adnexal lesions.2. To appreciate the added value of CT and MRI in the differential

diagnosis of benign adnexal masses.3. To learn about an algorithm for evaluating incidental adnexal masses

with imaging.

11:10A-411 C. Imaging the infertile couple

J. McHugo; Birmingham/UK

Learning Objectives:1. To understand the incidence and causes of infertility in female and

male patients.2. To learn about cost-effective strategies for imaging in cases of female

and male infertility.3. To understand the rationale for best outcomes.


E. Sala; New York, NY/US

10:30–12:00 Room Q

RTF - Radiology Trainees Forum TF 1 Highlighted Lectures

Moderators: D. Bulja; Sarajevo/BA, V.H. Koen; Harleem/NL

10:30A-413 Emergency radiology management in patients with

polytrauma U. Linsenmaier, L.L. Geyer, S. Wirth; Munich/DE

Learning Objectives:1. To understand the complex up to date radiological management of

patients with polytrauma/multiple trauma.2. To become familiar with basic concepts, MDCT protocols and major

findings in patients with polytrauma/multiple trauma.

11:00A-414 Imaging of non-traumatic intracranial haemorrhage

Z. Merhemic; Sarajevo/BA

Learning Objectives:1. To review different underlying pathologies of non-traumatic

intracranial haemorrhage.2. To learn how to use CT/CTA, MRI/MRA, and DSA in patients with

non-traumatic intracranial haemorrhage.3. To discuss the value of T2* (GRE/SWI) in evaluation of causes of

intracranial haemorrhage.

11:30A-415 Case-based learning in radiology

P. Pokieser; Vienna/AT

Learning Objectives:1. To learn about the basics of case based learning.2. To understand the pedagogic potentials of „real world settings“.3. To become familiar with case based ESR learning facilities.

12:15–12:45 Room A

Plenary Session HL 3 Santiago Ramón y Cajal Honorary

Lecture Presiding: J.I. Bilbao; Pamplona/ES

12:15A-416 Research and science: from individuals to societies - the

Ramón y Cajal background L. Martí-Bonmatí; Valencia/ES

Learning Objectives:1. To learn about Santiago Ramón y Cajal, a Spanish histologist,

neuroscientist, and Nobel laureate.2. To appreciate the change from individual research to

multidisciplinary working groups.3. To understand the concept of science and research, and how

communication, grouping and socialisation do influence both.

12:30–13:30 Room P

The Beauty of Basic Knowledge: Musculoskeletal Imaging MC 25D Neoplastic/non-neoplastic lesions 12:30A-417 Neoplastic/non-neoplastic lesions

F.M.H.M. Vanhoenacker; Antwerp/Ghent/Mechelen/BE

Learning Objectives:1. To understand the basic principles of diagnosing bone and soft tissue

tumours.2. To become familiar with the most important entities and their typical

imaging presentations.3. To learn about the specific advantages and weaknesses of the different

imaging modalities.


192

A-41

8 –

A-42

7 12:30–13:30 Room Q

The Beauty of Basic Knowledge: Head and Neck MC 24D The suprahyoid neck: anatomy and

diagnostic algorithm of the neck mass 12:30A-418 The suprahyoid neck: anatomy and diagnostic algorithm

of the neck mass A. Trojanowska; Lublin/PL

Learning Objectives:1. To become familiar with the compartmental anatomy of the

suprahyoid neck.2. To understand the central role of the parapharyngeal space in the

localisation of suprahyoid neck masses.3. To be able to localise and provide a useful differential diagnosis of a

SHN mass.4. To learn the best imaging approach to the suprahyoid neck.

14:00–15:30 Room A

Interactive Teaching Session E³ 1420 Common and uncommon errors in plain

film and CT imaging of the chest: how to improve your performance

14:00A-419 Common and uncommon errors in plain film and CT

imaging of the chest: how to improve your performance D. Tack1, N. Howarth2; 1Baudour/BE, 2Chêne-Bougeries/CH

Learning Objectives:1. To learn about the common reasons for errors in interpretation of

plain film and CT imaging.2. To understand how a side-by-side comparison of chest x-rays and

MDCT of missed lesions can help reduce the busy radiologist‘s error rate.

3. To improve the skills required for accurate interpretation of plain film and CT imaging of the chest.

14:00–15:30 Room B

New Horizons Session NH 14 Imaging of the mind 14:00A-420 Chairman‘s introduction: New insights into the state of

consciousness through neuroimaging S. Sunaert; Leuven/BE

Session Objectives:1. To become familiar with recent advances in functional brain imaging,

and how these lead to ‚the imaging of consciousness‘ and ‚reading the mind‘.

2. To understand how imaging contributes to the study of the functional connectivity and network topology of the human brain.

3. To understand how these new techniques and insight lead to (pre-) clinical applications.

14:05A-421 Brain wiring: resting state fMRI

F. Barkhof; Amsterdam/NL

Learning Objectives:1. To understand the basics of resting-state fMRI.2. To become familiar with the organisation of intrinsic connections as

detected with resting state fMRI in the human brain.3. To consolidate the current knowledge of brain networks in aging and

dementia, and pharmacology research.

14:28A-422 fMRI in disorders of consciousness: diagnostic and legal

challenges C. Di Perri, S. Laureys; Liège/BE

Learning Objectives:1. To understand the role of structural MRI, DTI and spectroscopy in

severe brain injury.2. To become familiar with the role of resting state and activation fMRI

in diagnosis and prognosis after coma.3. To understand which fMRI paradigms are „consciousness tests“ in

coma and related condition.

14:51A-423 fMRI of cognitive functions: discriminating normal aging,

minimal cognitive impairment and Alzheimer‘s disease A. Falini; Milan/IT

Learning Objectives:1. To consolidate knowledge of dementia and Alzheimer’s disease

clinically.2. To become familiar with common imaging features of dementia and

Alzheimer’s disease.3. To appreciate the results from fMRI and DTI and other advanced

neuroimaging techniques used in research of dementia and Alzheimer’s disease.

Panel discussion:15:14 New insights into the state of consciousness through

neuroimaging. Where are we and where should we go?

14:00–15:30 Room C

Urogenital Imaging CC 1421 The male genital system

Moderator: J.O. Barentsz; Nijmegen/NL

14:00A-424 A. Imaging of prostate cancer: an update

J.J. Fütterer; Nijmegen/NL

Learning Objectives:1. To understand multiparametric MR imaging techniques.2. To learn how to interpret prostate MRIs.3. To understand the potential of new MRI developments.

14:20A-425 B. Scrotal tumours

P.S. Sidhu; London/UK

Learning Objectives:1. To understand the pathological types of primary and secondary

tumours of the testis.2. To appreciate the US features of the various histological types of

testicular tumours.3. To appreciate the role of newer US imaging techniques, and the role

of further imaging.

14:40A-426 C. The penis

M. Bertolotto; Trieste/IT

Learning Objectives:1. To learn about the most relevant penile diseases that can be

diagnosed by imaging.2. To know the diagnostic roles of US, MRI and other imaging

techniques.3. To understand how imaging influences treatment and follow-up.

15:00A-427 D. Interactive case discussion J.O. Barentsz; Nijmegen/NL


193

Sun

day

A-42

8 –

A-43

9 14:00–15:30 Room D1

CLICK (Clinical Lessons for Imaging Core Knowledge): Never without Arteries CC 1418 Angina, non-occlusive mesenteric

ischaemia (NOMI) and friends: vascular causes of acute abdomen Moderator: O. Chan; London/UK


P. Rogalla; Toronto, ON/CA

Learning Objectives:1. To learn about the frequency and importance of the vascular causes

of an acute abdomen.2. To learn about the differential diagnosis as well as the different

vascular causes of acute abdomen.3. To learn about prognosis, treatment and outcome of acute abdomen

caused by vascular diseases.


M. Prokop; Nijmegen/NL

Learning Objectives:1. To learn about the importance of selecting the appropriate imaging

technique in cases of acute abdomen to detect vascular causes.2. To become familiar with the typical imaging appearance of the

different vascular causes of acute abdomen and their most important differential diagnosis.

3. To become familiar with potential pitfalls and problems of identifying vascular causes of acute abdomen.

15:00A-430 C. Interactive case discussion: how to proceed?

A. Palkó; Szeged/HU

Learning Objectives:1. To become familiar with typical cases, illustrating the role of imaging

modalities in the diagnosis and differential diagnosis of acute abdomen.



14:00–15:30 Room D2

Oncologic Imaging: Follow-up of Systemic and Local Therapies CC 1419 Follow-up of thermal ablation (part I)

Moderator: W. Prevoo; Amsterdam/NL

14:00A-431 A. The zone of cell death and collateral phenomena on

cross-sectional imaging: from histopathology to the standardisation of terms A. Denys, P. Bize; Lausanne/CH

Learning Objectives:1. To understand histopathologic changes after various ablation

techniques.2. To become familiar with post-ablation imaging based on histo-

pathologic correlation of ablation zones in various organs.3. To learn about the adequate terms for reporting and publishing on

post-ablation imaging.

14:30A-432 B. PET/CT for the evaluation of ablative therapy: Who?

Where? When? Does it help? D. Deandreis; Villejuif/FR

Learning Objectives:1. To understand who are the best candidates for a PET/CT follow-up

of ablation therapies.2. To learn about what is the optimal timing of PET/CT in the follow-

up of ablative therapies.

15:00A-433 C. Everyday practice: MR and CT for evaluating response

to thermal ablation C. Dromain, C. Caramella, L. Vilcot, S. Bidault, F. Bidault, F. Deschamps; Villejuif/FR

Learning Objectives:1. To become familiar with the imaging aspects of successful ablation.2. To learn about the main pitfalls of post-ablation imaging.3. To consolidate knowledge of the imaging aspects of most common

complications.

14:00–15:30 Room E1

Musculoskeletal RC 1410 How I report

Moderator: M. Padrón; Madrid/ES

14:00A-434 A. Soft tissue mass: US/MR

C. van Rijswijk; Leiden/NL

Learning Objectives:1. To become familiar with the strengths/weaknesses of US/MRI in

assessing soft tissue tumours.2. To understand the US/MRI specific findings that aid diagnosis.3. To learn a structured approach to reporting.

14:30A-435 B. MR of vertebral body collapse

R. Lalam; Oswestry/UK

Learning Objectives:1. To be able to differentiate benign from malignant causes.2. To learn about the changes of the vertebral body with time, disease

progression and therapy.3. To learn a structured reporting approach.

15:00A-436 C. MR of the unstable shoulder

M. Zanetti; Zurich/CH

Learning Objectives:1. To learn about the specific imaging findings of instability.2. To become familiar with the different types of shoulder instability.3. To learn a structured approach to reporting.

14:00–15:30 Room E2

Oncologic Imaging RC 1416 The essentials of lymph node imaging

of solid tumours: what the radiologist needs to know



14:05A-438 A. The current criteria for nodal involvement on CT/MRI

W. Schima; Vienna/AT

Learning Objectives:1. To become familiar with current criteria.2. To learn about imaging features which are highly specific for nodal

disease.3. To understand the diagnostic performance of cross-sectional

imaging.

14:28A-439 B. DWI MR: what does it contribute?

H.C. Thoeny; Berne/CH

Learning Objectives:1. To understand the principles of DWI of nodes.2. To recognise the imaging appearance of nodes on DWI MRI.3. To become familiar with studies evaluating the diagnostic

performance of DWI MRI.


194

A-44

0 –

A-45

014:51A-440 C. Nuclear medicine: PET and other nuclear medicine

techniques P.L. Choyke; Bethesda, MD/US

Learning Objectives:1. To learn which tumours are typically FDG-avid.2. To understand the factors that contribute to the diagnostic

performance of FDG-PET.3. To become familiar with other nuclear imaging techniques for lymph

node imaging.

Panel discussion:15:14 When and how could imaging make diagnostic biopsy

unnecessary?

14:00–15:30 Room F1

Special Focus Session SF 14a Palliative interventional techniques

in cancer 14:00A-441 Chairman‘s introduction

K.A. Hausegger; Klagenfurt/AT

Session Objectives:1. To learn about different palliative techniques in cancer.2. To understand when to indicate different palliative techniques.3. To become familiar with the limitations of palliative techniques.4. To learn when palliation does not help the patient.

14:03A-442 Cementoplasty of lytic bone metastasis


Learning Objective:1. To learn about the indications, techniques, clinical results and

complications of cementoplasty.

14:21A-443 Pleural drainage, pleurodesis

F. Gleeson; Oxford/UK

Learning Objectives:1. To become familiar with the indication for drainage of malignant

pleural effusion.2. To learn about the indications, technique and clinical results of

pleurodesis.

14:39A-444 Percutaneous nephrostomy (PCN) and ureteral stenting

F. Orsi; Milan/IT

Learning Objectives:1. To become familiar with the indication for percutaneous

nephrostomy in patients with malignant urinary obstruction.2. To learn about the technique, clinical results and complications of

PCN and antegrade ureteral stenting.

14:57A-445 Biliary procedures

M. Krokidis1, A.A. Hatzidakis2; 1Cambridge/UK, 2Iraklion/GR

Learning Objectives:1. To become familiar with the indications for drainage in malignant

biliary obstruction.2. To learn about the technique, clinical results and complications of

percutaneous cholangiography and biliary stenting.

Panel discussion:15:15 How invasive can palliation be? When to say no to palliative

treatment?

14:00–15:30 Room F2

Breast RC 1402 How I report

Moderator: A. Tardivon; Paris/FR

14:00A-446 A. Mammography

E. Azavedo; Stockholm/SE

Learning Objectives:1. To become familiar with the basic parts of a structured report.2. To understand which information a clinician needs in a report of a

breast cancer patient.3. To learn how to compose a report on a patient with a BI-RADS 3

lesion.

14:30A-447 B. Breast US

J. Camps Herrero; Valencia/ES

Learning Objectives:1. To become familiar with BI-RADS categories of breast US.2. To learn how to integrate clinical information and radiological

findings.3. To learn how to compose a US report in a breast cancer patient.

15:00A-448 C. Breast MRI

R.M. Mann; Nijmegen/NL

Learning Objectives:1. To understand how to integrate conventional (mammography and

US) findings in a breast MRI report.2. To learn how to include morphological and kinetic information and

why this needs to be done thoroughly.3. To become familiar with the necessary skills to compose a report on a

breast cancer patient (staging, follow-up, relapse, etc).

14:00–15:30 Room G/H

Special Focus Session SF 14b Comprehensive CT cardiothoracic

imaging: a new challenge for radiologists


L. Bonomo; Rome/IT

Session Objectives:1. To understand the importance of looking at the heart on a CT scan

of the chest.2. To learn how to optimise integrated cardiothoracic imaging with CT.3. To become familiar with the key imaging findings and learn how to

report.

14:05A-450 How to optimise integrated cardiothoracic imaging with

CT U.J. Schoepf; Charleston, SC/US

Learning Objectives:1. To learn how to select CT protocols that enable assessment of the

heart-lung axis with the lowest possible radiation dose.2. To become familiar with the ECG-synchronisation protocols for

cardio-thoracic CT image acquisitions.3. To understand strategies for image post-processing and displaying for

evaluating diseases affecting the heart-lung axis.


195

Sun

day

A-45

1 –

A-46

3 14:28A-451 Coronary artery imaging from a chest CT examination:

when and how R. Marano; Rome/IT

Learning Objectives:1. To become familiar with the main clinical indications that could

require assessment of the heart and coronary arteries in the course of chest CT.

2. To learn how to recognise the normal and abnormal appearance of heart and coronary arteries commonly observed on chest CT.

3. To learn about the acquisition protocol to couple chest CT with ECG-gated cardiac CT.

14:51A-452 Cardiopulmonary functional imaging from a chest CT

examination: when and how E.J.R. van Beek; Edinburgh/UK

Learning Objectives:1. To understand the feasibility of CT based cardiopulmonary

functional imaging.2. To be able to grasp clinical scenarios where cardiopulmonary

functional CT imaging may be helpful.3. To be able to set the use of CT within a larger framework of imaging

modalities.

Panel discussion:14:14 Is a single CT scan technique and protocol feasible for all the

cardiothoracic problems?

14:00–15:30 Room I/K

Genitourinary RC 1407 Contrast media safety: update 14:00A-453 Chairman‘s introduction

P. Reimer; Karlsruhe/DE

Session Objectives:1. To discuss the safety steps to be taken before contrast administering.2. To present the newest safety guidelines.

14:05A-454 A. Acute non-renal reactions to contrast media: new

concepts O. Clément; Paris/FR

Learning Objectives:1. To understand what are allergic and non-allergic hypersensitivity

reactions.2. To learn the clinical symptoms according to the Ring and Messmer

classification.3. To understand the importance of tryptase sampling and skin testing

in the follow-up.

14:28A-455 B. Nephrogenic systemic fibrosis: from pathophysiology to

recommendations H.S. Thomsen; Herlev/DK

Learning Objectives:1. To understand the underlying pathophysiology.2. To learn about the clinical implications of the recent

recommendations/guidelines.3. To become familiar with legal issues.

14:51A-456 C. Contrast medium-induced nephropathy and new

guidelines F. Stacul; Trieste/IT

Learning Objectives:1. To become familiar with newest guidelines on contrast induced

nephropathy (CIN).2. To understand the future clinical implications of the new guidelines.

Panel discussion:15:14 What is the most appropriate radiological approach to

patients with falling eGFR and when should contrast media be administered and when should it not?

14:00–15:30 Room L/M

Physics in Radiology RC 1413 Hybrid imaging systems

Moderators: D.G. Sutton; Dundee/UK, J. Votrubová; Prague/CZ

14:00A-457 A. Clinical SPECT/CT and PET/CT

T. Beyer; Zurich/CH

Learning Objectives:1. To review the origins of SPECT/CT and PET/CT imaging systems.2. To understand the basic principles and general clinical applications.3. To speculate on trends in dual-modality PET- and SPECT-based

imaging technology.

14:30A-458 B. Clinical MR/PET

G. Antoch; Düsseldorf/DE

Learning Objectives:1. To become acquainted with the origins and evolution of MR/PET.2. To be informed of the current applications.

15:00A-459 C. Preclinical hybrid imaging

N. Belcari; Pisa/IT

Learning Objectives:1. To learn about hybrid imaging tools in animal imaging/pre-clinical

research.2. To understand possible clinical applications.

14:00–15:30 Room N/O

Head and Neck RC 1408 Laryngeal cancer and radiology 14:00A-460 Chairman‘s introduction

J.E. Kabala; Bristol/UK

Session Objectives:1. To discuss the epidemiology.2. To learn about the available diagnostic imaging modalities.3. To become familiar with the available treatment options.

14:05A-461 A. Staging of laryngeal cancer: pearls and pitfalls

R. Maroldi; Brescia/IT

Learning Objectives:1. To become familiar with the typical findings of T1-T4 laryngeal

cancer.2. To learn about the patterns of local nodal involvement.3. To understand possible imaging pitfalls in staging.

14:28A-462 B. Evaluation after surgery and non-surgical treatment:

expected findings S. Bisdas; Tübingen/DE

Learning Objectives:1. To appreciate the expected imaging findings after surgery of laryngeal

cancer.2. To become familiar with imaging findings after non surgical

treatment.3. To know about the possible imaging pitfalls.

14:51A-463 C. Cancer recurrence: how to address clinical dilemmas

B. Verbist; Leiden/NL

Learning Objectives:1. To understand the limitations of clinical examination.2. To appreciate the value of different imaging techniques in the

detection of recurrence.3. To become familiar with the imaging findings of recurrent laryngeal

cancer.

Panel discussion:15:14 Diagnostic algorithms for diagnosis and follow-up of laryngeal

cancer


196

A-46

4 –

A-47

414:00–15:30 Room P

Radiographers RC 1414 Towards advancing and developing the

role of radiographers 14:00A-464 Chairmen‘s introduction

S. Mathers1, D. Tscholakoff2; 1Aberdeen/UK, 2Vienna/AT

Session Objectives:1. To appreciate the potential importance of advancing and developing

the role of radiographers for the profession and for healthcare.2. To become familiar with the level of activity across international

societies in fostering this.3. To understand the importance of such role developments meeting

real clinical needs.

14:05A-465 A. The current status: a clinical perspective

C. McLaren; London/UK

Learning Objectives:1. To become familiar with the current status from the perspective of a

radiographer in an advanced practice in a paediatric interventional role.

2. To understand the key factors that facilitate this advanced role, as well as the challenges faced during implementation.

3. To become familiar with the impact that this advanced role has had on patient care, interprofessional relationships and service delivery, in one institution.

14:28A-466 B. The importance of evidence-based practice for the

future of advanced practice in radiography A. England; Liverpool/UK

Learning Objectives:1. To become familiar with examples of evidence-based practice in the

area of advanced practice and role development in radiography.2. To understand the importance of such an evidence-based approach

when considering the introduction of advanced roles in a clinical setting.

3. To gain an insight into the education and training requirements for advanced practice and role development.

14:51A-467 C. The view from the European level

G. Paulo; Coimbra/PT

Learning Objectives:1. To understand the influence of evidence-based practice on the future

of the radiography profession in Europe.2. To become familiar with the advantage of advanced practice and role

development in radiography in health systems.3. To understand the benefits of advanced practice and role

development in radiography for the patients.

Panel discussion:15:14 How to use the EFRS guidance document on role development

14:00–15:30 Room Q

Paediatric RC 1412 Paediatric emergencies

Moderator: V. Donoghue; Dublin/IE

14:00A-468 A. The acute non-traumatic neurological patient: CT or

MRI? E. Vázquez; Barcelona/ES

Learning Objectives:1. To learn about the currently limited role of CT in the non-traumatic

acute setting.2. To become familiar with radioprotection strategies and protocols

adapted to children.

3. To consolidate the role of MRI as the modality of choice for acute non-traumatic neurologically ill children, with an emphasis on newer techniques.

4. To become familiar with imaging findings and the main differential diagnosis of acute neurological conditions in children.

14:30A-469 B. Imaging of acute chest pain and/or distress in children

C.E. de Lange; Oslo/NO

Learning Objectives:1. To understand the role of radiographs, US, CT and MRI.2. To become familiar with the most common conditions that cause

acute chest pain and/or distress in children.3. To appreciate the different differential diagnoses, depending on the

age of the patient.4. To understand the consequences of delaying in their diagnosis and

treatment.

15:00A-470 C. The role of the interventional radiologist in paediatric

trauma J.B. Karani; London/UK

Learning Objectives:1. To understand the role of CT, CTA and conventional angiography in

the diagnosis of traumatic vascular complications.2. To understand the importance of vascular and non-vascular

intervention following trauma in children.

14:00–15:30 Room Z

Special Focus Session SF 14c Advances in forensic radiology 14:00A-471 Chairman‘s introduction

G. Guglielmi; Foggia/IT

Session Objectives:1. To become familiar with the role of imaging in forensic pathology.2. To learn how the use of a contrast medium may help the native scan

to recognise vascular lesions.3. To learn about the possibilities of MDCT in anthropological

identification.

14:05A-472 Imaging in forensic medicine

M. Thali; Zurich/CH

Learning Objectives:1. To learn why imaging methods are becoming essential modalities in

forensic medicine.2. To become familiar with the modalities that can be used in forensic

imaging.3. To learn what the future developments in forensic radiology and

imaging will be.

14:23A-473 Advances in post-mortem CT angiography

S. Grabherr; Lausanne/CH

Learning Objectives:1. To consolidate knowledge of the advantages and limits of post-

mortem CT angiography.2. To understand the method of multi-phase post-mortem CT

angiography and the indication for its performance.3. To become familiar with the objectives and latest achievements of the

Technical Working Group of Post-mortem Angiography Methods (TWGPAM).

14:41A-474 Virtual anthropology and forensic identification using

MDCT F. Dedouit; Toulouse/FR

Learning Objectives:1. To learn about the different paleo-pathological diagnoses and

anthropological identification of bone lesions with MSCT.2. To learn about the possibilities of MSCT for comparative

identification.3. To understand reconstructive identification and the main techniques

useful for age-at-death assessment and sex determination.


197

Sun

day

A-47

5 –

A-48

5 14:59A-475 Forensic MR imaging

T.D. Ruder; Zurich/CH

Learning Objectives:1. To learn about typical post-mortem alterations in MR imaging.2. To become familiar with application of MR imaging in the post-

mortem setting.3. To understand the added value of post-mortem cardiac MR in cases

of cardiac death.

Panel discussion:15:17 Which imaging technique for which forensic scenario?

16:00–17:30 Room A

Interactive Teaching Session E³ 1520 Thoracic emergencies 16:00A-476 A. Vascular

E. Castañer; Sabadell/ES

Learning Objectives:1. To become familiar with the main causes of thoracic vascular

emergencies.2. To understand the role of MDCT angiography in thoracic

emergencies.3. To learn about the radiological signs in vascular thoracic emergencies

and its impact on the management of these patients.

16:45A-477 B. Pulmonary

C.M. Schaefer-Prokop; Amersfoort/NL

Learning Objectives:1. To learn about the role of imaging in severe attacks of obstructive

lung disease.2. To become familiar with direct and indirect signs of pleural disease

causing respiratory failure with special emphasis on the intensive care patient.

3. To learn about imaging features that are helpful for the differential diagnosis of pulmonary consolidations causing respiratory failure.

4. To understand the interaction of comorbidity, age and extent of pulmonary disease resulting in severe respiratory failure and the role of imaging in it.

16:00–17:30 Room B

GI Tract RC 1501 CT colonography: when the ‚new‘

becomes ‚ordinary‘ 16:00A-478 Chairman‘s introduction

A. Laghi; Rome/IT

16:05A-479 A. State-of-the-art techniques in 2013

T. Mang; Vienna/AT

Learning Objectives:1. To become familiar with an optimised technique and how it can be

optimised for specific patient groups.2. To briefly describe basic interpretation and the role of CAD.3. To understand the most common interpretative pitfalls and potential

complications, and how they can be avoided.

16:28A-480 B. How to set up a service

P. Lefere; Roeselare/BE

Learning Objectives:1. To appreciate the need for training prior to CTC and understand the

role of training courses and double reporting.2. To become familiar with ways of maximising service efficiency,

including cost effectiveness, and how best to replace the barium enema.3. To appreciate the differences in approach from setting up a service for

older symptomatic patients to setting up colorectal cancer screening.4. To learn a basic audit framework.

16:51A-481 C. Interaction with gastroenterologists: friends or

enemies? A. Graser1, C. Hassan2; 1Munich/DE, 2Rome/IT

Learning Objectives:1. To understand what the gastroenterologists wants to know when

referring their patients for CTC in both symptomatic and screening patients.

2. To learn how to formulate local polyp reporting guidelines and how best to integrate the service with the needs of patients.

3. To propose the most effective method for integrating endoscopic and CTC services, minimising competition and maximising cooperation.

Panel discussion:17:14 How to create an efficient CTC team?

16:00–17:30 Room C

Urogenital Imaging CC 1521 Paediatrics

Moderator: M. Claudon; Vandoeuvre-lès-Nancy/FR

16:00A-482 A. Imaging strategies for children: urinary tract infection

and vesico-ureteral reflux M. Riccabona; Graz/AT

Learning Objectives:1. To learn about the information provided by ultrasonography, MRI

and nuclear medicine examinations.2. To become familiar with the technique and indications for

micturating cystourethrogram and contrast-enhanced voiding urosonography.

3. To become familiar with an imaging algorithm for diagnostic approaches, and different strategies.

16:20A-483 B. Paediatric adrenal tumours

P.-H. Vivier; Rouen/FR

Learning Objectives:1. To become familiar with the different adrenal tumours in paediatrics.2. To learn how imaging can help in differentiating neuroblastoma from

Wilm’s tumour.3. To understand the value of adequate examinations for the initial

workup of adrenal tumours.

16:40A-484 C. Prenatal detection of GU diseases

F.E. Avni; Lille/FR

Learning Objectives:1. To learn how to assess the diagnostic criteria of foetal uropathies.2. To learn how to apply a standardised post-natal approach.3. To understand the rationale behind a standardised approach.

17:00A-485 D. Interactive case discussion M. Claudon; Vandoeuvre-lès-Nancy/FR


198

A-48

6 –

A-49

616:00–17:30 Room D1

CLICK (Clinical Lessons for Imaging Core Knowledge): Never without Arteries CC 1518 When every step counts: imaging and

management of peripheral arterial occlusive disease (PAOD) Moderator: J.F.M. Meaney; Dublin/IE


M. Schillinger; Vienna/AT

Learning Objectives:1. To become familiar with clinical diagnosis and classification of

peripheral arterial occlusive disease.2. To learn about the most important clinical differential diagnosis.3. To learn about the importance of imaging for treatment decision-

making and planning.


T. Leiner; Utrecht/NL

Learning Objectives:1. To learn about state-of-the art MR angiographic imaging of the

peripheral arteries (including modern non-enhanced techniques).2. To learn about state-of-the art CT angiographic imaging of the

peripheral arteries (including modern dose-saving techniques).3. To become familiar with the appropriate selection of the right patient

for the right imaging test.

17:00A-488 C. Interactive case discussion: how to deal with the

results? Typical cases, pitfalls, and what is next? L.P. Lawler; Dublin/IE

Learning Objectives:1. To become familiar with typical cases illustrating the role of different

imaging modalities in the diagnosis and differential diagnosis of PAOD.


3. To understand the needs and principles in modern multidisciplinary management of PAOD.

16:00–17:30 Room D2

Oncologic Imaging: Follow-up of Systemic and Local Therapies CC 1519 Follow-up of thermal ablation (part II)

Moderator: P.L. Pereira; Heilbronn/DE

16:00A-489 A. Follow-up imaging of thermal ablative therapies for

lung tumours A.R. Gillams; London/UK

Learning Objectives:1. To consolidate knowledge of imaging aspect of successful ablation.2. To become familiar with the main pitfalls of post-ablation imaging.3. To learn about the imaging aspects of most common complications.

16:30A-490 B. Follow-up imaging of percutaneous local treatment of

bone tumours F. Deschamps, G. Farouil, T. de Baere; Villejuif/FR

Learning Objectives:1. To learn about the post-ablation aspects, according to the ablation

technique used.2. To consolidate knowledge of the imaging aspects of successful

ablation on various types of follow-up imaging, including CT and MRI.

17:00A-491 C. Follow-up imaging of thermal ablative therapies for

kidney tumours D.J. Breen; Southampton/UK

Learning Objectives:1. To learn about the post-ablation aspects, according to ablation

technique used.2. To become familiar with the imaging aspect of successful ablation.3. To appreciate the imaging aspect of most common complications.

16:00–17:30 Room E1

Emergency Radiology RC 1517 ER: comprehensive imaging of non-

traumatic abdominal emergencies 16:00A-492 Chairman‘s introduction: logistics and management of

critical patients with abdominal complaints S. Wirth, M.F. Reiser; Munich/DE

Session Objectives:1.To learn about requirements for abdominal imaging for an emergency radiology department.2. To learn about current developments with a clinical focus on who

should undergo what and when, what kind of CT exam to use in order to triage emergency patients to the appropriate therapy options.

16:15A-493 A. Imaging of the most frequent emergencies of the upper

abdomen C.J. Zech; Basle/CH

Learning Objectives:1. To become familiar with dedicated MDCT protocols.2. To learn about other types of imaging such as US and MR.3. To learn about typical and atypical imaging findings.

16:35A-494 B. Imaging of the most frequent emergencies of the

gastrointestinal tract M. Zins, I. Boulay-Coletta; Paris/FR


16:55A-495 C. Imaging of the most frequent emergencies of the

genitourinary tract L.E. Derchi; Genoa/IT


Panel discussion:17:15 How to speed up your diagnoses?

16:00–17:30 Room E2

State of the Art Symposium SA 15 Imaging impingement syndromes 16:00A-496 Chairman‘s introduction

C.W.A. Pfirrmann; Zurich/CH

Session Objectives:1. To learn about the role of imaging for the diagnosis of impingement

syndromes.2. To understand what the clinician needs to know from the radiologist.3. To learn the diagnostic value of different imaging modalities to

answer the clinical questions.


199

Sun

day

A-49

7 –

A-50

8 16:05A-497 Shoulder

P. Robinson; Leeds/UK

Learning Objectives:1. To understand impingement mechanisms of the shoulder.2. To become familiar with external and internal shoulder

impingement.3. To learn about the typical imaging findings.4. To appreciate the strength and weaknesses of different imaging

modalities.

16:28A-498 Ankle


Learning Objectives:1. To understand impingement mechanisms of the ankle.2. To become familiar with anterior and posterior ankle impingement.3. To learn about the typical imaging findings.4. To appreciate the strength and weaknesses of different imaging

modalities.

16:51A-499 Hip

K. Wörtler; Munich/DE

Learning Objectives:1. To understand impingement mechanisms of the hip.2. To become familiar with cam and pincer type femoroacetabular

impingement (FAI).3. To learn about the typical imaging findings.4. To appreciate the strength and weaknesses of different imaging

modalities.

Panel discussion:17:14 Form or function: is impingement a clinical or imaging

diagnosis?

16:00–17:30 Room F1

Special Focus Session SF 15a Traumatic brain injury 16:00A-500 Chairman‘s introduction

A. Rovira-Cañellas; Barcelona/ES

Session Objectives:1. To understand the role of neuroradiology in the initial assessment.2. To appreciate the role of conventional and non-conventional

imaging techniques in the diagnosis and monitoring of primary and secondary traumatic lesions of the brain.

3. To learn about the prognostic value of neuroimaging.4. To become familiar with the various types of cerebrovascular traumas

and their treatment options.

16:05A-501 Acute brain trauma: CT vs MRI

M. Muto; Naples/IT

Learning Objectives:1. To understand the role of neuroradiology in the management of

brain trauma patients.2. To learn about the correlation between neuroradiological features

and clinical findings.3. To understand the importance of imaging follow-up.

16:23A-502 New imaging techniques in the detection and

quantification of brain damage S. Sunaert; Leuven/BE

Learning Objectives:1. To consolidate knowledge of new advanced imaging techniques.2. To learn about quantifying brain damage using these techniques.3. To understand the challenges of performing MR examinations in

these patients.

16:41A-503 Advanced imaging of brain trauma: outcome prediction

D. Galanaud; Paris/FR

Learning Objectives:1. To understand the value of diffusion tensor imaging and MR

spectroscopy in severe cases.2. To understand the role of these techniques in early- and late-phase

diagnosis and treatment follow-up.3. To learn about the lesion patterns associated with favourable and

unfavourable outcomes.

16:59A-504 Cerebrovascular trauma: diagnosis and therapy

T. Krings; Toronto, ON/CA

Learning Objectives:1. To learn about the classification of the different types of

cerebrovascular trauma.2. To become familiar with vascular emergencies requiring urgent

treatment.3. To become familiar with treatment strategies in cerebrovascular

trauma.

Panel discussion:17:17 Role of neuroimaging in traumatic brain injury in 2013

16:00–17:30 Room F2

Special Focus Session SF 15b Digital breast tomosynthesis 16:00A-505 Chairman‘s introduction

G. Gennaro; Padua/IT

Session Objectives:1. To understand the physical parameters and reconstruction methods

which determine digital breast tomosynthesis (DBT) image quality.2. To learn about DBT clinical performance and potential clinical

applications.3. To understand if CAD could be successfully applied compensate for

the time required to review DBT images.

16:05A-506 Optimisation of image acquisition and reconstruction in

DBT M.J. Yaffe, J.G. Mainprize; Toronto, ON/CA

Learning Objectives:1. To understand DBT principles.2. To learn about DBT acquisition and optimisation.3. To understand DBT reconstruction algorithms.4. To become familiar with radiation dose from DBT.

16:28A-507 Current role of DBT in diagnostic imaging

S. Zackrisson, K. Lång, A. Tingberg, P. Timberg, D. Förnvik, M. Dustler, I. Andersson; Malmö/SE

Learning Objectives:1. To understand the potential impact of DBT on sensitivity and

specificity of breast cancer detection.2. To appreciate limitations of DBT and its impact on image

interpretation time and effort.3. To understand if DBT is applicable to screening.

16:51A-508 Clinical aspects of computer aided detection and

diagnosis in DBT H.-P. Chan; Ann Arbor, MI/US

Learning Objectives:1. To learn about the challenges of DBT interpretation in clinical

practice.2. To understand the potential impact of computer-aided detection on

DBT.3. To learn about CAD as a second reader to improve DBT sensitivity.4. To appreciate CAD as a concurrent reader to improve DBT workflow.

Panel discussion:17:14 Digital breast tomosynthesis: replacing or just supporting

standard mammography?


200

A-50

9 –

A-52

016:00–17:30 Room G/H

Neuro RC 1511 Epilepsy: a lack of knowledge can be

dangerous Moderator: M.A. Papathanasiou; Athens/GR

16:00A-509 A. Anatomy of the limbic system

T.A. Yousry; London/UK

Learning Objectives:1. To learn the components of the limbic system.2. To understand the structure of the hippocampus proper.3. To become familiar with the imaging characteristics at 1.5T, 3T, and

9.4T.

16:30A-510 B. Temporal lobe epilepsy

I.N. Pronin; Moscow/RU

Learning Objectives:1. To become familiar with MR-characteristics of neoplastic and non-

neoplastic causes of temporal lobe epilepsy.2. To learn about optimised imaging protocol.3. To appreciate the potential impact of modern MR-imaging

techniques to improve visualisation of structural brain changes.

17:00A-511 C. fMRI in epilepsy

N. Bargalló; Barcelona/ES

Learning Objectives:1. To become familiar with the application and limitations of fMRI.2. To appreciate technical aspects and interpretation of fMRI for

language localisation and memory testing.3. To consolidate of advanced fMRI applications.

16:00–17:30 Room I/K

Cardiac RC 1503 Cardiac CT and MRI in difficult patients:

what to do? 16:00A-512 Chairman‘s introduction

M. Hamilton; Bristol/UK

16:05A-513 A. Coronary CTA in patients with severe arrhythmias and

high heart rate C. Loewe; Vienna/AT

Learning Objectives:1. To understand the criteria for optimal patient selection and

preparation to achieve best results.2. To learn about acquisition techniques in patients with arrhythmias

and tachycardia.3. To become familiar with the post-processing techniques available for

optimising images quality following the scan.

16:28A-514 B. Severe coronary calcinosis and stents: tips and tricks in

image acquisition and interpretation F. Pugliese1, A. Rossi2; 1London/UK, 2Trieste/IT

Learning Objectives:1. To understand the challenge of calcification and stents when

performing coronary CTA.2. To become familiar with technical features that maximise image

quality in this patient group.3. To be aware of the accuracy of coronary CTA in stented or calcified

vessels with the optimum imaging techniques.

16:51A-515 C. Cardiac MRI: possible problems and how to avoid them

E. Mershina; Moscow/RU

Learning Objectives:1. To learn the importance of patient selection and preparation in

achieving high quality scans.2. To understand the practical techniques available for performing a

successful scan in difficult patients such as those with arrhythmia or poor breath-holding ability.

3. To learn how imaging parameters can be changed for optimal results.

Panel discussion:17:14 When to scan and when not to? How can we make the best of

what we have?

16:00–17:30 Room L/M

Physics in Radiology RC 1513 Novel developments in CT and their

impact on dose Moderators: M. Prokop; Nijmegen/NL, V. Tsapaki; Athens/GR

16:00A-516 A. Patient dose assessment in CT

P.C. Shrimpton; Didcot/UK

Learning Objectives:1. To become familiar with technical dose parameters in CT.2. To understand how to assess patient dose.3. To be informed about the role of diagnostic reference levels in CT.

16:30A-517 B. New frontiers in CT: functional and spectral imaging

N. Pelc; Stanford, CA/US

Learning Objectives:1. To learn about new developments in functional and spectral CT

imaging.2. To learn about impact on patient dose.

17:00A-518 C. New image reconstruction techniques

J. Sijbers; Antwerp/BE

Learning Objectives:1. To understand the principles of iterative reconstruction techniques

in CT.2. To learn about novel algorithms.3. To learn about the impact on patient dose.

16:00–17:30 Room N/O

Head and Neck RC 1508 Performing and reporting head and

neck examinations: how should I do it? Moderator: K. Surlan Popovič; Ljubljana/SI

16:00A-519 A. Sinonasal CT scans: technique and evaluation

H.B. Eggesbø; Oslo/NO

Learning Objectives:1. To learn how to perform a state-of-the-art CT examination of the

sinuses.2. To understand how to evaluate and what to report on CT

examinations of the sinuses.

16:30A-520 B. Temporal bone: CT and MRI

M.M. Lemmerling; Gent/BE

Learning Objectives:1. To learn how to perform a state-of-the art CT and MRI examination

of the temporal bone.2. To learn how to create a complete temporal bone report.


201

Sun

day

A-52

1 –

A-52

7 17:00A-521 C. CT and MRI of the neck: how to address key clinical

questions D. Farina; Brescia/IT

Learning Objectives:1. To understand key clinical questions.2. To learn how to do a structured reading of the CT and MRI scans of

the head and neck.3. To become familiar with reporting in order to address the needs of

the clinician.

16:00–17:30 Room P

Radiographers RC 1514 Hybrid imaging technologies

Moderators: C.D. Claussen; Tübingen/DE, C. Malamateniou; London/UK

16:00A-522 A. Recent developments

S. Rep; Ljubljana/SI

Learning Objectives:1. To become familiar with the basic principles of hybrid imaging.2. To learn about the newest techniques in hybrid imaging.3. To understand the potential technical implications of the use of

hybrid imaging.

16:30A-523 B. Clinical applications

T. Lindner; Ternitz/AT

Learning Objectives:1. To become familiar with the major clinical applications of hybrid

imaging.2. To understand its benefits and drawbacks compared with a single

modality.3. To become familiar with some case studies.

17:00A-524 C. Trends in radiography education

P. Hogg; Manchester/UK

Learning Objectives:1. To understand the impact on education.2. To learn how these new requirements can be met by changes in the

curriculum of educational institutions in Europe.3. To understand what further changes in European laws, research

infrastructure, and collaboration might be required to strengthen and protect the introduction of hybrid imaging in clinical practice.

16:00–17:30 Room Q

Paediatric RC 1512 Paediatric MSK radiology:

what is important? Moderator: M. Raissaki; Iraklion/GR

16:00A-525 A. Scoliosis: what the radiologist needs to know

J.-F. Chateil, S. Missonnier; Bordeaux/FR

Learning Objectives:1. To learn about the aetiology of scoliosis.2. To become familiar with imaging findings, measurements and

follow-up.3. To understand how to report imaging findings.

16:30A-526 B. Benign bone tumours and pseudotumours in children:

the pitfalls K.J. Johnson; Birmingham/UK

Learning Objectives:1. To recognise the most common benign bone tumours and

pseudotumours.2. To understand the differences between benign bone and pseudo

tumours and malignancies in children.3. To understand imaging modalities that could help in the differential

diagnosis of benign bone tumours and pseudo tumours in children.

17:00A-527 C. Congenital bone dysplasias

A.C. Offiah; Sheffield/UK

Learning Objectives:1. To understand the role of the radiologist in diagnosing congenital

bone dysplasias.2. To understand how to classify bone dysplasias.3. To become familiar with reporting radiological studies related to

bone dysplasias.


202

A-52

8 –

A-53

908:30–10:00 Room A

Interactive Teaching Session E³ 1620 Acute abdominal inflammatory

disorders 08:30A-528 A. Colitis and enterocolitis

D.J.M. Tolan; Leeds/UK

Learning Objectives:1. To know how to choose the appropriate imaging modality.2. To become familiar with the patterns of distribution and appearance

in imaging.3. To learn how to differentiate ischaemia from inflammation.

09:15A-529 B. Liver and bile ducts

C.D. Becker; Geneva/CH

Learning Objectives:1. To know the advantages of each imaging technique.2. To become familiar with the findings in infrequent infections.3. To learn how to study obstructive jaundice.

08:30–10:00 Room B

Special Focus Session SF 16a My most beautiful mistakes in

paediatric radiology 08:30A-530 Chairman‘s introduction

P. Tomà; Rome/IT

Session Objectives:1. To become familiar with growth and development of newborns to

teens.2. To become familiar with the main pitfalls in paediatric radiology.

08:35A-531 Abdomen

S.G.F. Robben; Maastricht/NL

Learning Objectives:1. To become familiar with the most important differential diagnoses.2. To learn about imaging strategies for children.3. To understand the role, importance of, and information obtained,

from ultrasonography.

08:58A-532 CNS

B. Bernardi, T. Verdolotti; Rome/IT

Learning Objectives:1. To understand the significance of MR findings in a developing brain.2. To learn how to avoid misinterpretations of easily detectable MR

abnormalities.3. To become familiar with the differential diagnosis of uncommon

diseases.

09:21A-533 Musculoskeletal

K. Rosendahl; Bergen/NO

Learning Objectives:1. To become familiar with the various controversies regarding US

screening programmes for developmental dysplasia of the hip.2. To understand the value of ultrasonography in the study of the

musculoskeletal system.3. To learn how and when to use MRI for investigations and differential

diagnosis.

Panel discussion:09:44 How have you changed or improved yourself after recognising

your mistakes?

08:30–10:00 Room C

Urogenital Imaging CC 1621 The usual, the unusual

and the dangerous Moderator: S.K. Morcos; Sheffield/UK

08:30A-534 A. Imaging of renal trauma

V. Logager; Copenhagen/DK

Learning Objectives:1. To learn how to recognise and describe the different types of

traumatic renal injuries.2. To learn how to correlate these image findings with clinical severity.3. To understand treatment possibilities.

08:50A-535 B. Postoperative anatomy and complications after GU

interventions H.C. Thoeny; Berne/CH

Learning Objectives:1. To become familiar with expected imaging findings after (partial)

nephrectomy, ileal bladder substitute and radical prostatectomy.2. To understand common complications after surgery.3. To learn where and how to detect tumour recurrence.

09:10A-536 C. GU complications in patients with spinal cord damage

S. Agarwal; Wrexham/UK

Learning Objectives:1. To understand the pathophysiology of urinary tract problems in

patients with spinal cord damage.2. To become familiar with the urinary tract complications associated

with this group of patients.3. To understand the role of different modalities and common problems

during imaging.


S.K. Morcos; Sheffield/UK

08:30–10:00 Room D1

CLICK (Clinical Lessons for Imaging Core Knowledge): Never without Arteries CC 1618 The fast and the furious: vascular

trauma resulting from traffic accidents Moderator: U. Linsenmaier; Munich/DE


H. Hoppe; Berne/CH

Learning Objectives:1. To learn about the frequency and importance of arterial involvement

in deceleration trauma.2. To know more about the differential diagnosis as well as the different

localisations of arterial lesions.3. To learn about prognosis, treatment and outcome after arterial

involvement.


H. Alkadhi; Zurich/CH

Learning Objectives:1. To learn about the importance of selecting the appropriate imaging

technique to allow for the detection of arterial involvement in trauma patients.

2. To become familiar with the typical image appearance of arterial involvement in trauma patients.

3. To learn about the most important findings and diagnoses for treatment planning.


203

Mon

day

A-54

0 –

A-55

1 09:30A-540 C. Interactive case discussion

R. Morgan; London/UK

Learning Objectives:1. To become familiar with typical cases illustrating the role of

appropriate imaging modalities in the assessment of patients after deceleration trauma.



08:30–10:00 Room D2

Oncologic Imaging: Follow-up of Systemic and Local Therapies CC 1619 Follow-up of local treatments of

breast cancer Moderator: M.H. Fuchsjäger; Graz/AT

08:30A-541 A. MRI-guided HIFU therapies in the breast

M. Sklair-Levy; Tel Aviv/IL

Learning Objectives:1. To learn about HIFU in breast tumours.2. To become familiar with the post-HIFU aspects of various types of

imaging.

09:00A-542 B. Pre- and post- imaging appearance of breast lesion

excision system (BLES) lesions S.D. Allen; Sutton/UK

Learning Objectives:1. To understand the mechanism of the BLES technique.2. To become familiar with the post-BLES aspects of various types of

imaging.

09:30A-543 C. Common features and pitfalls in imaging the treated

breast J. Camps Herrero; Valencia/ES

Learning Objectives:1. To learn about the post-surgical and post-radiation therapies aspects

of the breast and their timing.2. To learn about how to diagnose a recurrence in the treated breast and

its differential diagnoses.3. To become familiar with the imaging findings of post-ablation (RFA)

of breast.

08:30–10:00 Room E1

GI Tract RC 1601a Diagnosis and staging of

esophageal cancer 08:30A-544 Chairman‘s introduction

Z. Tarján; Budapest/HU

08:35A-545 A. Diagnosis

M. Krokidis; Cambridge/UK

Learning Objectives:1. To become familiar with the pros and cons of each of the main

diagnostic imaging modalities available when assessing a patient with suspected esophageal cancer.

2. To learn the basic imaging findings of esophageal cancer through each modality with emphasis on local disease.

3. To understand the pitfall in diagnosis and staging of tumours located in the gastroesophageal junction.

08:58A-546 B. Staging

V. Válek; Brno/CZ

Learning Objectives:1. To learn about optimised EUS, MDCT and PET-CT techniques for

esophageal cancer staging.2. To critically review those imaging findings impacting on patient

management with regard to palliation, radiation therapy and surgery.3. To understand the potential of imaging prognostic markers.

09:21A-547 C. Treatment response

B. Mahon; Birmingham/UK

Learning Objectives:1. To learn the normal post-surgical and post-radiation therapy imaging

findings and criteria and to differentiate between these and local recurrence.

2. To become familiar with anatomical and functional imaging criteria to assess treatment response.

3. To learn the rationale for follow-up of patients after definitive or neo-adjuvant chemoradiotherapy.

Panel discussion:09:44 Cross-sectional techniques: developing an integrated imaging

algorithm in oesophageal cancer

08:30–10:00 Room E2

Oncologic Imaging RC 1616 Complications of cancer treatment

and the detection of recurrences 08:30A-548 Chairman‘s introduction

M. Laniado; Dresden/DE

08:35A-549 A. Head and neck cancer

L. Oleaga Zufiría; Barcelona/ES

Learning Objectives:1. To learn about the possible range of late toxicity effects after surgery

and chemoradiotherapy of the neck.2. To become familiar with the imaging findings after surgery and

chemoradiotherapy.3. To understand which imaging method to use to differentiate between

treatment sequelae and remaining tumour.

08:58A-550 B. Liver and pancreatic cancer

C. Catalano; Rome/IT

Learning Objectives:1. To become familiar with the imaging of complications following

pancreatic surgery and liver chemotherapy and/or radiotherapy.2. To understand how these changes can conceal or mimic active

disease.3. To learn how to distinguish post-treatment changes from residual or

recurrent disease.

09:21A-551 C. Rectal cancer

L.C.O. Blomqvist; Stockholm/SE

Learning Objectives:1. To understand the role of CT, PET and MRI in the surveillance of

patients after rectal cancer surgery.2. To become familiar with the imaging changes of the irradiated and

resected tumour bed.3. To understand the diagnostic algorithm for early detection of a local

recurrence in the treated tumour bed.

Panel discussion:09:44 How to differentiate between treatment sequelae and active

disease


204

A-55

2 –

A-56

308:30–10:00 Room F1

GI Tract RC 1601b Abdominal MRI: standard and advanced

protocols in clinical settings Moderator: M.A. Patak; Zurich/CH

08:30A-552 A. Fistula in ano

A. Gupta; London/UK

Learning Objectives:1. To learn optimised MRI state-of-the-art protocols to image patients

with fistula in ano.2. To understand of the role of imaging in fistula classification and

staging, impact on therapeutic decision-making, assessment of activity and in treatment monitoring.

3. To describe how to provide an optimal MRI fistula report.

09:00A-553 B. Pelvic floor disease

M. Bazot, L. Jarboui, I. Thomassin-Naggara, F. Haab, E. Darai; Paris/FR

Learning Objectives:1. To learn the clinical indications and the optimised dynamic MR

imaging protocol for investigating pelvic floor disease in patients.2. To understand common and uncommon findings related to the

posterior, middle and anterior compartments and how they impact on subsequent patient management.

3. To understand how to introduce MRI into a pelvic floor therapy and how to best integrate with conventional techniques.

09:30A-554 C. Suspected biliary tumour

C. Matos; Brussels/BE

Learning Objectives:1. To learn the basic MRI technique for patients with suspected biliary

tumour.2. To understand advanced imaging protocols for both structural and

functional imaging of the bile ducts, and when these are indicated.3. To understand the MR imaging findings which best differentiate

benign from malignant disease, and how to produce an optimised report.

08:30–10:00 Room G/H

Neuro RC 1611 Spine: update on postoperative

imaging and minimally invasive procedures


J. Van Goethem; Antwerp/BE

08:35A-556 A. Postoperative spine

L. van den Hauwe, J.W. Van Goethem, C. Venstermans, F. De Belder, P.M. Parizel; Antwerp/BE

Learning Objectives:1. To become familiar with the appropriate imaging technique in the

postoperative spine.2. To learn how to differentiate between normal and abnormal

postoperative findings.3. To recognise the most common postoperative complications.

08:58A-557 B. Indications for vertebroplasty


Learning Objectives:1. To consolidate knowledge of the actual indications for vertebral

augmentation.2. To understand the contraindications and limitations.3. To become familiar with the algorithm of patient selection.4. To understand the best timing for vertebral augmentation.

09:21A-558 C. Percutaneous treatment of spinal diseases

M. Muto; Naples/IT

Learning Objectives:1. To understand the clinical indications for percutaneous treatment of

spinal diseases.2. To know what diagnostic modality to suggest.3. To become familiar with the different percutaneous techniques

available.

Panel discussion:09:44 Minimally invasive spinal procedures: the radiologist‘s future

role?

08:30–10:00 Room I/K

Chest RC 1604 Pulmonary embolism: guidelines and

best practice throughout Europe 08:30A-559 Chairman‘s introduction

M. Rémy-Jardin; Lille/FR

08:35A-560 A. Pioped 1-2-3: what have we learned so far?

C. Engelke; Göttingen/DE

Learning Objectives:1. To appreciate the results of Pioped 1-2-3 in the light of technological

refinements in 2013.2. To become familiar with the pros and cons of CT versus MR.3. To understand the residual potential indications of scintigraphy.

08:58A-561 B. PE in oncologic patients

B. Ghaye; Brussels/BE

Learning Objectives:1. To learn about the increased risk of venous thromboembolism.2. To understand the means of recognising peripheral PE, including

CAD and new software tools.3. To learn how to deal with clinically unsuspected PE, both for

reporting and treatment.

09:21A-562 C. PE during pregnancy and puerperium

M.-P. Revel; Paris/FR

Learning Objectives:1. To learn more about the increased risk of venous thromboembolism.2. To appreciate the pros and cons of US, CT, MR and scintigraphy.3. To learn about specific diagnostic algorithms.

Panel discussion:09:44 Pulmonary embolism work-up in 2013

08:30–10:00 Room L/M

Special Focus Session SF 16c Making homogeneous the reading

in HCC 08:30A-563 Chairman‘s introduction

C. Bartolozzi; Pisa/IT

Session Objectives:1. To become familiar with common and uncommon findings in HCC

and with updated guidelines in HCC diagnosis and follow-up.2. To understand how interpretation and reporting in HCC influence

patient management.3. To learn about recent developments in computer-aided reporting.


205

Mon

day

A-56

4 –

A-57

4 08:35A-564 HCC diagnosis: how to report ‚typical‘ findings


Learning Objectives:1. To learn about AASLD/EASL imaging criteria for non-invasive

diagnosis of hepatocellular carcinoma.2. To understand the need for standardised interpretation and reporting

in HCC surveillance.3. To learn the current terminology in HCC reporting.

08:53A-565 How to interpret and report ‚atypical‘ findings

C.J. Zech; Basle/CH

Learning Objectives:1. To learn about common tricks and traps in interpreting atypical

findings in HCC surveillance.2. To learn about the key elements for homogeneous reading and

reporting in ‚atypical‘ HCC.3. To understand the key role that specific findings reported by

radiologists have in determining patient management.

09:11A-566 How to evaluate tumour response to therapies

J. Ricke; Magdeburg/DE

Learning Objectives:1. To understand imaging findings after HCC locoregional and systemic

treatments.2. To learn about the current guidelines for defining HCC response to

treatment.3. To learn about the key elements of homogeneous reading and

reporting after HCC treatment.

09:29A-567 Information technology: the practical impact on the

management of HCC patients I. Bargellini; Pisa/IT

Learning Objectives:1. To understand the need for new systems to improve standardization

of reading and reporting.2. To learn about now tools and software for managing oncologic

patients.3. To understand the added value of computer technology in the

management of HCC patients.

Panel discussion:09:47 Case-based discussion: a practical demonstration of how

interpretation and reporting affect patient management

08:30–10:00 Room N/O

Special Focus Session SF 16b Head and neck cancer battle:

the power of imaging studies 08:30A-568 Chairman‘s introduction

V. Vandecaveye; Leuven/BE

Session Objectives:1. To learn how to choose the optimal imaging modality for head and

neck cancer staging and detection of tumour recurrence.2. To understand which elements are key to writing a structured

radiological report in diagnosis and staging.3. To become familiar with the imaging features of tumour relapse

versus complications in the post-treatment neck.4. To understand the clinical role of imaging in post-treatment patient

management.

08:35A-569 Building blocks for locoregional staging of head and neck

tumours F.A. Pameijer; Utrecht/NL

Learning Objectives:1. To learn how to make a choice between CT and MRI.2. To understand which imaging findings should be assessed to obtain a

radiological TN-stage.3. To become familiar with structured radiological reporting of head

and neck tumours.

09:00A-570 Detection of tumour recurrence in head and neck cancer:

challenges and pitfalls M. Becker; Geneva/CH

Learning Objectives:1. To appreciate the spectrum of expected tissue alterations after therapy

and their temporal relationship.2. To understand the imaging aspects of common complications after

therapy.3. To become familiar with key imaging features of tumour recurrence.4. To learn the potential pitfalls in post-therapeutic image interpretation

and how to avoid them.

09:20A-571 Locoregional treatment failure in head and neck cancer:

causes and clinical implications R. Maroldi, P. Nicolai; Brescia/IT

Learning Objectives:1. To understand the most frequent causes of local and regional post-

treatment relapses.2. To become familiar with the indications and options for salvage

surgery and non-surgical procedures.3. To understand the role of imaging in decision-making concerning

local and regional recurrences.

Panel discussion:09:50 Advanced imaging in clinical practice: how does it help the

patient?

08:30–10:00 Room P

Cardiac RC 1603 How I report

Moderator: R. Vliegenthart; Groningen/NL

08:30A-572 A. Chest x-ray in cardiac disease

M.B. Rubens; London/UK

Learning Objectives:1. To be aware of the indications for performing a chest x-ray in patients

with cardiac disease.2. To become familiar with the most important and relevant findings for

the diagnosis of cardiac disease.3. To learn about a structured approach to reading chest x-ray in cardiac

patients.

09:00A-573 B. Coronary CTA

F. Wolf; Vienna/AT

Learning Objectives:1. To appreciate the scope of information needed by a referring

physician from a coronary CTA examination.2. To become familiar with protocols of cardiac CT and image

processing.3. To learn a structured approach to reading cardiac CT examinations.

09:30A-574 C. Cardiac MRI in ischaemic heart disease

J. Bremerich; Basle/CH

Learning Objectives:1. To know when to do cardiac MRI in ischaemic heart disease.2. To become familiar with protocols of cardiac MRI and image

processing.3. To learn about a structured reporting approach to cardiac MRI.


206

A-57

5 –

A-58

508:30–10:00 Room Q

Computer Applications RC 1605 Improving workflow efficiency

and quality 08:30A-575 Chairman‘s introduction

D. Caramella; Pisa/IT

Session Objectives:1. To highlight the need for IT tools to ensure quality control.2. To understand how to collect data concerning radiation dose.3. To learn about the integration of contrast media injectors into PACS.

08:35A-576 A. Improving quality and efficiency of computerised order

entry through decision support P. Mildenberger; Mainz/DE

Learning Objectives:1. To understand the relationship of decision support tools and

evidence-based medicine.2. To learn how decision support tools can be implemented for

requesting radiological studies.3. To appreciate potential effects of decision support tools on workflow

efficiency.

08:58A-577 B. Improving quality and efficiency of reporting by

structure and templates N. Dugar; Doncaster/UK

Learning Objectives:1. To learn about clinical requirements for structured reports.2. To become familiar with the IT requirements for report templates.3. To appreciate the potential to generate data for evidence-based

radiology.

09:21A-578 C. Improving quality and efficiency of dose management

through exchange between modalities and registries E. Vaño; Madrid/ES

Learning Objectives:1. To learn about current European regulation requirements and

standards on patient dosimetry.2. To become familiar with the dose reporting evolution and dose

structured reporting.3. To appreciate the potential for dose analysis and reporting as well as

future registries.

Panel discussion:09:44 Will novel IT tools really improve quality and efficiency in daily

radiological practice?

08:30–10:00 Room Z

Joint Session of the ESR and EFSUMB Advances in diagnostic ultrasound: better resultsthrough cooperation Moderators: L.E. Derchi; Genoa/IT, F. Piscaglia; Bologna/IT

08:30A-579 Introducing the EFSUMB: the world’s largest ultrasound

society N. Gritzmann; Vienna/AT

Learning Objectives:1. To learn about the work and responsibility of the different

committees.2. To understand the membership basis and objectives of the EFSUMB.3. To learn about the benefits for ultrasound societies and individual

members.4. To learn about the educational tools of the EFSUMB.

08:48A-580 ESR/EFSUMB collaboration: a newly established platform

for joint development of ultrasound in radiology and clinical specialties L.E. Derchi; Genoa/IT

Learning Objectives:1. To learn about the goals of the ESR Working Group on Ultrasound.2. To understand the cooperative agreement between the ESR and

EFSUMB.3. To learn about the initial results of the cooperation between the two

societies.

09:06A-581 Image fusion and intervention

T. Lorentzen; Herlev/DK

Learning Objectives:1. To understand the technical aspects of image fusion with ultrasound

(US) and other imaging modalities (most frequently CT or MRI).2. To learn how to align two sets of data, obtained through different

axial imaging techniques, with one another and perform live US scanning, where the fused image follows the live US.

3. To understand how a lesion, even when invisible, can be targeted for US-guided, using CT and MRI image fusion.

09:24A-582 The EFSUMB non-liver CEUS guidelines

F. Piscaglia, S. Marinelli, E. Terzi; Bologna/IT

Learning Objectives:1. To learn about new guidelines and clinical recommendations on the

use of contrast enhanced ultrasound in non-liver applications, which were released by the EFSUMB in 2012.

2. To learn about the process of producing the document.3. To learn, based on the evidence, which organs are suitable for CEUS

in daily practice, and which are only suitable for research using CEUS.

09:42A-583 The EFSUMB/WFUMB liver-CEUS guidelines

M. Claudon; Vandoeuvre-les-Nancy/FR

Learning Objectives:1. To learn about the current practice of contrast enhanced ultrasound

(CEUS) worldwide.2. To learn how the CEUS international guidelines were established.3. To learn about the main indications for CEUS in cases of liver

disease.

10:30–12:00 Room A

Interactive Teaching Session E³ 1720b Musculoskeletal emergencies 10:30A-584 A. Axial skeleton

E. Llopis; Valencia/ES

Learning Objectives:1. To understand the principal indications for emergency spinal

imaging.2. To be able to analyse the pros and cons of each imaging modality in

spinal trauma: how, why, when?3. To become familiar with key MRI findings in spinal infection,

tumour cord compression and other non-traumatic spine disorders.4. To become familiar with the main emergency complications

following spinal surgery.

11:15A-585 B. Peripheral skeleton


Learning Objectives:1. To learn when and how to use the different imaging modalities in

acute skeletal lesions.2. To learn about the US and MRI findings in infection.3. To understand the value of MDCT in acute MSK lesions.


207

Mon

day

A-58

6 –

A-59

5 10:30–12:00 Room B

Interactive Teaching Session E³ 1720a Pitfalls in pelvic imaging 10:30A-586 A. Pitfalls in MRI of the pelvis

E. Sala; New York, NY/US

Learning Objectives:1. To become familiar with normal variations in MRI appearances of

female pelvis resulting from physiologic conditions (e.g. different phases of menstrual cycle) and treatments (including exogenous hormone therapy, surgery and radiation) potentially mimicking disease.

2. To discuss the role of correct MR imaging plane in avoiding potential mis-classification of uterine anomalies and parametrial invasion in patients with cervical cancer.

3. To recognise certain pitfalls related to dynamic contrast-enhanced MRI and diffusion weighted MRI.

11:15A-587 B. Pitfalls in pelvic ultrasound

K. Kinkel; Chêne-Bougeries/Geneva/CH

Learning Objectives:1. To become familiar with anatomical variants, potentially mimicking

disease.2. To learn about common pitfalls in pelvic ultrasound.

12:30–13:30 Room N/O

The Beauty of Basic Knowledge: Head and Neck MC 24E Temporal bone: so beautiful, yet so

complicated 12:30A-588 Temporal bone: so beautiful, yet so complicated

B. De Foer; Wilrijk-Antwerp/BE

Learning Objectives:1. To become familiar with temporal bone anatomy.2. To learn how to choose and tailor imaging techniques according to

clinical presentation.3. To appreciate the most common pathologies affecting the three main

compartments of the temporal bone.

12:30–13:30 Room P

The Beauty of Basic Knowledge: Musculoskeletal Imaging MC 25E Metabolic/endocrine disease 12:30A-589 Metabolic/endocrine disease

J. Freyschmidt; Bremen/DE

Learning Objectives:1. To understand the basic pathophysiology of metabolic and endocrine

bone diseases.2. To become familiar with the most typical imaging findings of

metabolic and endocrine diseases.3. To appreciate specific imaging patterns and to discuss the value of

different imaging techniques.

16:00–17:30 Room C

GI Tract RC 1901 Cross-sectional imaging of colitis 16:00A-590 Chairman‘s introduction

S.A. Taylor; London/UK

16:05A-591 A. What protocol to use?

S. Schmidt; Lausanne/CH

Learning Objectives:1. To become familiar with the role of colonic distension prior to

imaging of suspected or known colitis.2. To understand typical CT, MRI and US protocols.3. To highlight the pros and cons of CT, MRI and US.

16:28A-592 B. Differentiating between the causes of colitis

B. Gallix; Montpellier/FR

Learning Objectives:1. To learn the most common cause of colitis through cross sectional

imaging in both immune competent and immune compromised patients.

2. To become familiar with differentiating infectious, inflammatory, ischaemic and autoimmune conditions based on cross sectional imaging criteria.

3. To understand the limitations of cross sectional imaging in differentiating between its causes.

16:51A-593 C. The role of cross-sectional imaging in colonic

inflammatory bowel disease J. Rimola; Barcelona/ES

Learning Objectives:1. To learn the optimised examination protocols for ulcerative colitis

and colonic Crohn‘s disease in the acute, subacute and chronic disease setting.

2. To describe criteria for the assessment of disease activity through CT, MRI and ultrasound.

3. To outline an integrated approach to the use of cross sectional imaging in colonic inflammatory bowel disease.

Panel discussion:17:14 The role of cross-sectional imaging in the diagnosis and

follow-up of colitis

16:00–17:30 Room D2

Contrast Media RC 1906 How I optimise contrast media

administration Moderator: W. Semmler; Heidelberg/DE

16:00A-594 A. CT

P. Leander; Malmö/SE

Learning Objectives:1. To understand the pharmacokinetics of iodinated contrast media.2. To learn about patient, contrast medium and scanning factors

associated with contrast enhancement and scan timing.3. To become familiar with protocols for optimised contrast

enhancement.

16:30A-595 B. MRI

G.M. Bongartz; Basle/CH

Learning Objectives:1. To understand the differences between iodinated contrast agents

and gadolinium chelates and their impact on contrast medium administration.

2. To learn about injection and scanning protocols for optimised vascular and parenchymal enhancement.

3. To review the influence of tissue-specific contrast media on the injection and scanning protocols.


208

A-59

6 –

A-60

917:00A-596 C. PET/CT

X. Montet; Geneva/CH

Learning Objectives:1. To become familiar with the role of contrast-enhanced CT in PET/

CT.2. To understand the influence of CT contrast-enhancement on

attenuation correction of PET images.3. To learn about the importance of adequately timing the injection of

CT and PET agents for optimal PET/CT.

16:00–17:30 Room E1

Musculoskeletal RC 1910 Intra-articular imaging 16:00A-597 Chairman‘s introduction

A.H. Karantanas; Iraklion/GR

16:05A-598 A. Standard MR techniques

C. Faletti; Turin/IT

Learning Objectives:1. To become familiar with the techniques used in standard MR.2. To learn about the strengths/weaknesses of standard MR along with

diagnostic problems related to anatomical variation.

16:28A-599 B. CT arthrography

C.W.A. Pfirrmann; Zurich/CH

Learning Objectives:1. To become familiar with the techniques used in CT arthrography.2. To learn about the strengths/weaknesses of CT arthrography.

16:51A-600 C. MR arthrography

J. Kramer; Linz/AT

Learning Objectives:1. To become familiar with the techniques used in MR arthrography.2. To learn about the strengths/weaknesses of MR arthrography.

Panel discussion:17:14 Which imaging technique for which clinical scenario?

16:00–17:30 Room E2

Oncologic Imaging RC 1916 Gastro-entero-pancreatic neuro-

endocrine tumours (GEP-NET): a multidisciplinary update


C. Matos; Brussels/BE

16:05A-602 A. Tumour biology, pathogenesis and classification

B. Wiedenmann; Berlin/DE

Learning Objectives:1. To learn about basic aspects of GEP-NET biology, pathogenesis and

classification.2. To understand the epidemiology and current treatment options.3. To become familiar with rational clinical management.

16:28A-603 B. The current role of nuclear medicine techniques

C.M. Deroose; Leuven/BE

Learning Objectives:1. To learn about the cellular properties of GEP-NET used in molecular

imaging.2. To become familiar with the different modalities and new tracers

being used.3. To learn about the performance of the different methods available.

16:51A-604 C. Anatomical imaging: transabdominal US, endoscopic

US, MDCT and MRI. What is the most appropriate imaging approach? V. Vilgrain, M.-P. Vullierme, P. Ruszniewski, A. Sauvanet; Clichy/FR

Learning Objectives:1. To learn how to recognise the specific imaging features of GEP-NET.2. To learn about the strengths and weaknesses of the different imaging

modalities.3. To understand the optimal use of the different imaging modalities in

relation to tumour localisation and staging.

Panel discussion:17:14 The future of hybrid imaging

16:00–17:30 Room F1

Special Focus SessionSF 19 Tablet-computers in radiology: friend

or foe? 16:00A-605 Chairman‘s introduction

E. Neri; Pisa/IT

Session Objectives:1. To give an overview of current tablet-computer technology and its

practical use in radiology.2. To discuss the pros and cons of using tablet-computers.3. To analyse specific and critical areas of utilisation (DICOM images

reading and teleradiology).

16:05A-606 Tablet-computers: a technical overview

J. Fernandez-Bayó; Sabadell/ES

Learning Objectives:1. To learn about PC evolution: from desktops, to laptops and tablets.2. To appreciate the portability of a tablet-computer.3. To become familiar with the hardware features with a specific focus

on displays and networks.

16:23A-607 Radiological features of the tablet-computer

P. Sacco1, L. Faggioni2; 1Siena/IT, 2Pisa/IT

Learning Objectives:1. To appreciate the radiological features available on a tablet-computer.2. To become familiar with radiological atlases, databases, social

networks.3. To learn how the tablet-computer can help at a congress and prepare

presentations.

16:41A-608 Reading DICOM images on the tablet

O. Ratib; Geneva/CH

Learning Objectives:1. To understand the DICOM readers available for tablet-computers.2. To become familiar with the different approaches to DICOM reading

(local vs remote) and the PACS/tablets integration.3. To appreciate the pros and cons of DICOM image-reading with

tablet-computers in regards to image quality and displays.

16:59A-609 Mobile teleradiology with tablet-computers: a critical

appraisal E.R. Ranschaert; ‚s-Hertogenbosch/NL

Learning Objectives:1. To learn about mobile teleradiology within and outside the hospital.2. To become familiar with the potential risks of mobile teleradiology

(data security, confidentiality, etc.).

Panel discussion:17:17 Are we ready and confident enough to use tablet-computers in

clinical practice? How and when?


209

Mon

day

A-61

0 –

A-61

9 16:00–17:30 Room F2

Breast RC 1902 Breast ultrasound

Moderator: M. Müller-Schimpfle; Frankfurt a. Main/DE

16:00A-610 A. Physics and practical aspects of high-quality hand-held

and automated breast US M.H. Fuchsjäger; Graz/AT

Learning Objectives:1. To understand the physics of hand-held and whole breast US.2. To become familiar with the practical technique of hand-held and

whole breast US.3. To appreciate the clinical applications of hand-held and whole breast

US including automated screening.

16:30A-611 B. Complicated cysts and complex-cystic lesions:

differentiation and management G. Rizzatto1, C.F. Weismann2; 1Gorizia/IT, 2Salzburg/AT

Learning Objectives:1. To learn about the US appearance of complicated cysts and complex-

cystic lesions.2. To consolidate knowledge on differential diagnosis for these

respective lesions.3. To understand the diagnostic algorithm for a work-up of these

lesions.

17:00A-612 C. The use of ultrasound in the evaluation of the nipple-

areolar complex R. Salvador; Barcelona/ES

Learning Objectives:1. To understand the normal anatomy of the nipple-areolar complex.2. To become familiar with conditions commonly affecting the nipple-

areolar complex.3. To appreciate the value of US for diagnosis and management of these

conditions.

16:00–17:30 Room G/H

Neuro RC 1911 Multiple sclerosis: 2013 update

Moderator: E. Tali; Ankara/TR

16:00A-613 A. Differential diagnosis of multiple T2-HI white matter

lesions A. Rovira-Cañellas; Barcelona/ES

Learning Objectives:1. To learn about recognition patterns that might be helpful in

suggesting the most likely etiology of brain multifocal T2 lesions.2. To understand the role of spinal cord imaging in the differential

diagnosis.3. To appreciate a neuroradiologic diagnostic strategy for multiple white

matter lesions of unknown origin.

16:30A-614 B. New developments in the diagnosis of multiple

sclerosis F. Barkhof; Amsterdam/NL

Learning Objectives:1. To understand the 2010 revision of the McDonald criteria for MS.2. To become aware of MRI red-flags in the diagnostic process.3. To become familiar with new developments in pulse-sequences and

field-strength.4. To understand how to use spinal cord imaging in a diagnostic setting.

17:00A-615 C. Imaging of MS treatment-related complications

M.M. Thurnher; Vienna/AT

Learning Objectives:1. To become familiar with therapy options in multiple sclerosis (MS).2. To understand therapy induced complications.3. To understand the pathophysiology of immune reconstitution

inflammatory syndrome (IRIS).4. To become familiar with imaging findings in IRIS.

16:00–17:30 Room I/K

Chest RC 1904 Phenotypes in obstructive airway

disease: how should I image, analyse and report? Moderator: P.A. Gevenois; Brussels/BE

16:00A-616 A. Asthma and associated conditions

P.-Y. Brillet; Bobigny/FR

Learning Objectives:1. To learn more about the imaging findings in asthma and associated

conditions, especially with low-dose and expiratory CT.2. To appreciate the potential to grade the severity of the disease from

CT.3. To learn how to report findings indicative of asthma and associated

conditions.

16:30A-617 B. Chronic obstructive pulmonary disease (COPD)

N. Sverzellati; Parma/IT

Learning Objectives:1. To learn more about the imaging findings in COPD, including low

dose and expiratory CT.2. To become familiar with the concept of CT phenotyping: airway

obstruction vs. alveolar destruction.3. To appreciate the radiological findings of remodelling of airways and

pulmonary vasculature.

17:00A-618 C. Cystic fibrosis and other bronchiectatic diseases

M.U. Puderbach; Heidelberg/DE

Learning Objectives:1. To learn more about the imaging findings in bronchiectasis,

especially at MRI.2. To appreciate the role of imaging in primary diagnosis, surveillance

and therapy monitoring.3. To become familiar with the role of imaging in surgical planning.

16:00–17:30 Room N/O

Head and Neck RC 1908 Temporal bone: imaging the most

common symptoms and signs Moderator: T. Beale; London/UK

16:00A-619 A. Conductive hearing loss: what‘s behind it?

A. Trojanowska; Lublin/PL

Learning Objectives:1. To review the most common causes of conductive hearing loss.2. To become familiar with the imaging findings in patients with

conductive hearing loss.3. To differentiate the most frequent causes of conductive hearing loss.


210

A-62

0 –

A-62

816:30A-620 B. Sensorineural hearing loss: a challenge for radiologists

J. Casselman1, B. De Foer2; 1Bruges/BE, 2Antwerp/BE

Learning Objectives:1. To learn which imaging techniques should be used.2. To become familiar with the different causes of sensorineural hearing

loss.3. To recognise and differentiate the imaging findings in the most

frequent causes of sensorineural hearing loss.

17:00A-621 C. Tinnitus and vertigo: diagnostic algorithm

R.B. de Bondt; Zwolle/NL

Learning Objectives:1. To learn the most common causes.2. To understand imaging strategies.3. To become familiar with typical imaging findings.

16:00–17:30 Room P

Vascular RC 1915 Lower extremity venous insufficiency 16:00A-622 Chairman‘s introduction

D.J. West; Stoke-on-Trent/UK

16:05A-623 A. Venous anatomy and ultrasound

H. Moschouris; Piraeus/GR

Learning Objectives:1. To become familiar with normal venous anatomy the indications for

imaging and the US techniques.2. To learn about the typical and atypical appearances of venous

pathology.3. To understand the potential pitfalls and limitations of US.

16:28A-624 B. Rare venous diseases of the lower extremities

M. Greiner1, P. Lemasle1, A. Bisdorff-Bresson2; 1Neuilly sur Seine/FR, 2Paris/FR

Learning Objectives:1. To become familiar with anatomic variants.2. To learn about anatomy with specific congenital disorders, such as

persistent sciatic vein Klippel Trenaunay-Weber syndrome.3. To become familiar with differential diagnosis and pitfalls in the

diagnosis of the above conditions.

16:51A-625 C. CT venography and MR venography

G. O‘Sullivan, D.G. Lohan; Galway/IE

Learning Objectives:1. To learn about its indications and pros and cons compared to US.2. To become familiar with imaging parameters, contrast media

protocols and flow dependent and flow independent techniques.3. To become familiar with pitfalls and artefacts that affect correct

evaluation of imaging findings after endovascular treatments.

Panel discussion:17:14 Which imaging modality is best for planning endovascular

management?

16:00–17:30 Room Q

Paediatric RC 1912 Normal variants in paediatric imaging:

not to be confused with disease Moderator: Ø.E. Olsen; London/UK

16:00A-626 A. Brain

A. Rossi; Genoa/IT

Learning Objectives:1. To learn about normal variants in the neonatal and child’s brain.2. To understand the typical imaging characteristics of normal variants

that should suffice for correct interpretation.3. To become familiar with the differentiation between normal variants

and disease.

16:30A-627 B. Chest and abdomen

S.G.F. Robben; Maastricht/NL

Learning Objectives:1. To learn about normal variants in the neonatal and paediatric chest

and abdomen.2. To familiarise oneself with the imaging appearances of common

normal variants.3. To understand how to differentiate between normal variants and

disease.

17:00A-628 C. Musculoskeletal

F. Saez; Bilbao/ES

Learning Objectives:1. To learn about normal variants in the neonatal and paediatric

musculoskeletal system.2. To familiarise oneself with the imaging appearances of common

normal variants.3. To understand how to differentiate between normal variants and

disease.4. To learn how to integrate age, location and clinical history with the

radiological features before establishing a diagnosis.


211

Mon

day

Scienti f icSessions

Session numbers are prefixed by SS

Presentation numbers are prefixed by the letter B

B-00

01 –

B-0

019 10:30–12:00 Room B

Cardiac SS 103 CT and MRI in preoperative and

postoperative evaluation Moderators: G.A. Krombach; Giessen/DE, R. Sanz-Requena; Valencia/ES

10:30B-0001 Multiparametric functional MRI for postoperative

follow-up in patients with the ROSS-procedure: comparison of the aortic root replacement versus the subcoronary implantation technique C.O. Ritter1, U. Baier1, S.P. Sommer1, R. Leyh1, H. Köstler1, D. Hahn1, M.J. Beer2; 1Würzburg/DE, 2Graz/AT

10:39B-0002 Flow pattern evaluation of apico-aortic conduit

(CORREX) in high-risk patients with severe aortic stenosis: a cardiac magnetic resonance (MR) investigation C. Mantini, A.R. Cotroneo, A. Tartaro, E. Di Gianfrancesco, C. Canosa, M. Foschi, D. Marinelli, G. Di Giammarco; Chieti/IT

10:48B-0003 Pre- and postinterventional evaluation of cardiac

function in patients suffering from mitral regurgitation using cardiac MRI P. Krumm, C.S. Zuern, T.H. Wurster, C. Bretschneider, S. Mangold, B. Klumpp, A. May, C.D. Claussen, U. Kramer; Tübingen/DE

10:57B-0004 Pre- and post-interventional analysis of myocardial

strain in patients undergoing mitral valve clipping using cardiac MRI P. Krumm, C.S. Zuern, T.H. Wurster, A. Seeger, S. Mangold, B. Klumpp, C.D. Claussen, A. May, U. Kramer; Tübingen/DE

11:06B-0005 Pressure overloaded right ventricles: importance of

trabeculae in evaluation of RV function by CMR M.M.P. Driessen1, V.J.M. Baggen1, H.G. Freling2, F.J. Meijboom1, G.T. Sieswerda1, R.J. Snijder3, T. Leiner1, T.P. Willems2; 1Utrecht/NL, 2Groningen/NL, 3Nieuwegein/NL

11:15B-0006 Opacification ratios to detect changes in coronary flow

by computed tomography angiography – comparison between pre- and post-stented lesions P.B. Rizzi1, R.J. Cerci1, P. Lemos2, C.E. Rochitte2, I. Gottlieb3, R.T. George1, J. Texter1, A.C. Lardo1, J.A.C. Lima1; 1Baltimore, MD/US, 2São Paulo/BR, 3Rio de Janeiro/BR

11:24B-0007 Additional value of cardiac computed tomography to

assess prosthetic valvular dysfunctions A.A. Azarine, N. Hrynchyshyn, A. Samadi, L. Perdrix, G. Ashrafpoor, A. Redheuil, L. Macron, E. Mousseaux, B. Diebold; Paris/FR

11:33B-0008 Cardiac computed tomography angiography results in

diagnostic and therapeutic change in prosthetic heart valve endocarditis J. Habets1, W. Tanis1, L.A. van Herwerden1, W.P.T.M. Mali1, R.B.A. van den Brink2, B.A.J.M. de Mol2, S.A.J. Chamuleau1, R.P.J. Budde1; 1Utrecht/NL, 2Amsterdam/NL

11:42B-0009 Anatomical variance of coronary venous system in

dual source computed tomography M. Krupinski, M. Kuniewicz, J. Lelakowski, M. Irzyk, B. Laskowicz, M. Urbanczyk; Krakow/PL

11:51B-0010 Feasibility of MRI in patients with implanted

subcutaneous loop recorder type REVEAL XT®: data from the surprise study L. Christensen, A. Christensen, H. Christensen; Copenhagen/DK

10:30–12:00 Room C

Neuro SS 111 From structure to function

Moderators: S.J. Bakke; Oslo/NO, B. Ertl-Wagner; Munich/DE

10:30B-0011 Regional cortical thickness is associated with

neurocognitive profile in progressive myoclonus epilepsy type 1 (EPM1, Unverricht-Lundborg disease) S. Suoranta1, E. Niskanen2, M. Äikiä1, P. Koskenkorva1, M. Könönen1, R. Kälviäinen1, R. Vanninen1; 1Kuopio/FI, 2Vaasa/FI

10:39B-0012 Language impairment and reduced structural

connectivity in Rolandic epilepsy R. Besseling, J. Jansen, W.H. Backes; Maastricht/NL

10:48B-0013 Relative contributory role of Interictal/Ictal SPECT,

interictal PET, MR spectroscopy and T2 relaxometry in localisation of seizure focus in temporal lobe epilepsies: a metaanalysis and systematic review V. Venugopal1, S.K. Puri1, I. Afshan1, A.D. Prabhu2; 1New Delhi/IN, 2Chennai/IN

10:57B-0014 Subtle changes in normal appearing white matter

precede development of white matter lesions B.F.J. Verhaaren, M. de Groot, R. de Boer, S. Klein, A. Hofman, A. van der Lugt, M.A. Ikram, W.J. Niessen, M.W. Vernooij; Rotterdam/NL

11:06B-0015 Retrograde degeneration of optic nerve and visual

pathway in open angle glaucoma: a morphologic evaluation using 3T MRI S. Sidek, F. A. Rahman, K. Rahmat, N. Mohd Ramli, N. Mohd Ramli; Kuala Lumpur/MY

11:15B-0016 High blood pressure and cerebral white matter lesion

progression in the general population B.F.J. Verhaaren, M.W. Vernooij, R. de Boer, A. Hofman, W.J. Niessen, A. van der Lugt, M.A. Ikram; Rotterdam/NL

11:24B-0017 MRI texture analysis in Unverricht-Lundborg disease

reveals more complex and heterogeneous textural appearance in thalami, putamen and amygdala than in controls K.K. Holli1, S. Suoranta2, E. Niskanen3, P. Dastidar1, H. Eskola1, R. Vanninen2; 1Tampere/FI, 2Kuopio/FI, 3Vaasa/FI

11:33B-0018 Structural MRI-assisted diagnosis of major depressive

disorder using surface-based volumetric parameter classification approach L. Qiu, S. Lui, X. Huang, J. Zhang, X. Yang, Q. Yue, L. Zou, Q. Gong; Chengdu/CN

11:42B-0019 Resting-state networks, and peculiarities of the brain

metabolism in patients with Parkinson’s disease (PD) and different level of cognitive impairment (CI): fMRI and 1H MRS study Z.Z. Rozhkova, O.M. Omelchenko; Kiev/UA

Scientific Sessions

214

B-00

20 –

B-0

03811:51

B-0020 Relationship among fractional anisotropy (FA) values, EEG activity and cognitive status in mild cognitive impairment (MCI) and Alzheimer’s disease (AD) patients F. Pitocco, G. Curcio, F. Scrascia, Y. Errante, A. Giona, C. Mallio, F. Vernieri, B. Beomonte Zobel, C. Quattrocchi; Rome/IT

10:30–12:00 Room D1

Chest SS 104 Lung cancer: from tissue

characterisation to treatment Moderators: E. Castañer; Sabadell/ES, N. Tacelli; Brussels/BE

10:30B-0021 Prognostic value of CT perfusion parameters in

patients with early stage resectable non-small cell lung cancer L. Calandriello, A.R. Larici, A. del Ciello, G. Rindi, G. Petrone, L. Bonomo; Rome/IT

10:39B-0022 Dynamic volume perfusion CT in patients with lung

cancer: baseline perfusion characteristics of different histological subtypes J. Shi1, C. Fink2, G. Schmid-Bindert3, L.R. Pilz3, P. Apfaltrer3, H. Haubenreisser3, U. Haberland4, S.O. Schönberg3, T. Henzler3; 1Shanghai/CN, 2Celle/DE, 3Mannheim/DE, 4Forchheim/DE

10:48B-0023 Correlation between grade and histological

subtype of pulmonary adenocarcinoma and [18F] fluorodeoxyglucose standardized uptake value after evaluation by PET/CT L. Xu, A. Burke, S. Feigenberg; Baltimore, MD/US

10:57B-0024 Which response criteria best help predict survival

of patients with EGFR-mutant lung adenocarcinoma following EGFR tyrosine kinase inhibitor? J. Lee, H. Lee, J.-H. Kim, M.-J. Ahn, H. Kang, K. Lee; Seoul/KR

11:06B-0025 Radiogenomic approach to identify anaplastic

lymphoma kinase-positive lung adenocarcinoma C. Jeong, H. Lee, J. Han, J. Jeong, K. Lee, K. Park, M.-J. Ahn, B.-T. Kim; Seoul/KR

11:15B-0026 Mucinous vs nonmucinous adenocarcinoma in situ

(AIS): imaging features, EGFR mutation and EGFR gene copy number status, and prognosis D. Kim, H.-J. Lee, J. Wi, S. Lee, C. Park, J. Goo; Seoul/KR

11:24B-0027 Validation of a computed-tomography-based risk

model for the prediction of cardiovascular disease in a lung cancer screening setting P.M. Jairam, P.A. de Jong, W.P.T.M. Mali, Y. van der Graaf; Utrecht/NL

11:33B-0028 Diagnostic accuracy of virtual 18F-FDG PET/CT

bronchoscopy for the detection of lymph node metastases in non-small cell lung cancer patients M.C. Herbrik1, C. Buchbender2, J. Treffert3, B. Geiger4, V. Hartung-Knemeyer1, H. Kühl1, G. Antoch2, M. Forsting1, T.A. Heusner2; 1Essen/DE, 2Düsseldorf/DE, 3Knoxville, TN/US, 4Princeton, NJ/US

11:42B-0029 Percutaneous transthoracic CT-guided biopsy using

large core needles: initial experience U.C. Lalji, J.E. Wildberger, M. Bendek, M. Das; Maastricht/NL

11:51B-0030 Primary lung cancer treated using radiofrequency

ablation: two-year outcome data J. Beeson, N. Wickings, V. Anikin, S. Kaul, P. Dalal; London/UK

10:30–12:00 Room D2

Interventional Radiology SS 109 Chemoembolisation and

radioembolisation of liver tumours Moderators: A. Denys; Lausanne/CH, P.M. Paprottka; Munich/DE

10:30B-0031 Repeated transarterial chemoembolization in the

treatment of liver metastases of colorectal cancer: local tumour control and survival data T. Gruber-Rouh, N.N.N. Naguib, M. Beeres, B. Bodelle, S. Zangos, N. Nour Eldin, R. Hammerstingl, T.J. Vogl; Frankfurt/DE

10:39B-0032 Holmium-166 radioembolisation: results of a phase 1,

dose escalation study in patients with unresectable, chemorefractory liver metastases – the HEPAR trial M.L.J. Smits, J.F.W. Nijsen, M.A.A.J. van den Bosch, M.G.E.H. Lam, M.A.D. Vente, W.P.T.M. Mali, A.D. van het Schip, B.A. Zonnenberg, J.F. Prince; Utrecht/NL

10:48B-0033 Repetitive transarterial chemoembolization as a

palliative treatment option for liver metastases from cutaneous malignant melanoma: indications, outcomes and role in patient’s management T. Gruber-Rouh, P. Weisser, N.N.N. Naguib, K. Eichler, M. Harth, S. Zangos, N.-E.A. Nour-Eldin, T.J. Vogl; Frankfurt/DE

10:57B-0034 Experimental study on transarterial administration

of survivin siRNA combined with transarterial chemoembolization in rats with hepatocellular carcinoma (HCC) T.J. Vogl1, J. Qian2, A. Tran1, E. Oppermann1, U. Imlau1, Y. Hamidavi1, H. Korkusuz1, W.O. Bechstein1; 1Frankfurt a. Main/DE, 2Wuhan/CN

11:06B-0035 Role of transarterial chemoembolization as bridging

strategy in T2 HCC patients on the waiting list E. Bozzi, I. Bargellini, F. Turini, A. Cicorelli, R. Cioni, C. Bartolozzi; Pisa/IT

11:15B-0036 Semi-automatic volumetric tumour segmentation for

hepatocellular carcinoma: comparison between C-arm cone-beam computed tomography and MRI V. Tacher1, M. Lin2, M. Chao1, L. Gjesteby1, N. Bhagat1; 1Baltimore, MD/US, 2Briarcliff Manor, NY/US

11:24B-0037 Transcatheter arterial chemoembolisation of

hepatocellular carcinoma in transplant patients: smaller bead diameter and hypervascularity lead to higher tumour necrosis M. Hakky, S. Amirifeli, C. Wald, C. Molgaard, H. Ahari; Burlington, MA/US

11:33B-0038 Initial RECIST tumour reduction as a predictive

parameter for transarterial chemoembolisation treatment success in patients with hepatocellular carcinoma D.B. Hasdemir, B.C. Meyer, N. Schweitzer, A. Vogel, C. von Falck, H. Rosenthal, F. Wacker, T. Rodt; Hannover/DE

Scientific SessionsTh

ursday

215

B-00

39 –

B-0

059 11:42

B-0039 Intraprocedural parenchymal blood volume measurement using repetitive C-arm CT in patient with hepatocellular carcinoma and breast cancer during TACE: therapy response and evaluation T.J. Vogl, S. Blösser, P. Schäfer, E. Mbalisike, S. Zangos; Frankfurt a. Main/DE

11:51B-0040 Study on the effect of chemoembolization combined

with microwave ablation for the treatment of hepatocellular carcinoma in rats T.J. Vogl1, J. Qian2, U. Imlau1, Y. Hamidavi1, H. Korkusuz1, E. Oppermann1, W.O. Bechstein1; 1Frankfurt a. Main/DE, 2Wuhan/CN

10:30–12:00 Room E1

Musculoskeletal SS 110 Shoulder and hand

Moderators: C. Schüller-Weidekamm; Vienna/AT, M. Shahabpour; Brussels/BE

10:30B-0041 Diagnosing adhesive capsulitis of shoulder on

sonography alone: is it possible? A. Tandon, S. Dewan, S. Bhatt, A.K. Jain; New Delhi/IN

10:39B-0042 MR imaging of glenoid bone loss

K.R. Lee, J.F. Griffith, W.A. Ng, M. Tong, S. Nimish; Hong Kong/HK

10:48B-0043 Rotator cuff tendon tear size and retraction and

quantification of muscle fatty infiltration using chemical shift-based water-fat MR imaging S. Lee, L. Nardo, R. Lucas, D. Karampinos, J. Carballido-Gamio, A. Lai, C.B. Ma, T. Link, R. Krug; San Francisco, CA/US

10:57B-0044 Comparison of 3D turbo spin-echo space sequences

with conventional 2D MRI sequences to assess the shoulder joint J.K. Kloth1, M. Winterstein1, M. Akbar1, E. Meyer2, D. Paul2, H.-U. Kauczor1, M.-A. Weber1; 1Heidelberg/DE, 2Erlangen/DE

11:06B-0045 Evaluation of MR-arthrography in identifying bony

Bankart lesions: usefulness of thin-slice T1 weighted GRE sequences G. Foti, E. Oliboni, L. Romano; Negrar/IT

11:15B-0046 Superior labral dimension of the glenoid labrum on

direct MR arthrography (MRA): relationship with presence of SLAP T. Im1, J.-A. Choi1, G. Lee1, J. Oh1, S. Hong2, H. Kang1; 1Seongnam/KR, 2Seoul/KR

11:24B-0047 Evaluation of concomitant osseous carpal injuries in

patients with distal radial fractures in MDCT A. von Schneider-Egestorf, C. von Falck, B. Meyer, F. Wacker, H. Rosenthal; Hannover/DE

11:33B-0048 Normal anatomy and variants of the

trapeziometacarpal joint at MR imaging in asymptomatic volunteers A. Hirschmann, R. Sutter, A. Schweizer, C.W.A. Pfirrmann; Zurich/CH

11:42B-0049 Safety of dorsal wrist arthroscopy portals: a magnetic

resonance study R. Cazzato, R. Del Vescovo, F. Giurazza, R.F. Grasso, B. Beomonte Zobel; Rome/IT

11:51B-0050 Comparison of three-dimensional indirect isotropic MR

arthrography and conventional MR arthrography for the diagnosis of rotator cuff tears J. Lee, Y. Yoon, S. Ji; Seoul/KR

10:30–12:00 Room E2

GI Tract SS 101a Acute bowel diseases: challenges and

solutions Moderators: J. Dormagen; Oslo/NO, S. Leschka; St. Gallen/CH

10:30B-0051 The emperor‘s new clothes? An evaluation of the

accuracy of transabdominal ultrasound in diagnosing acute appendicitis P. Yoong1, C.A. Johnson2, S. Fernando1, J.W. Graham1; 1King‘s Lynn/UK, 2London/UK

10:39B-0052 Added value of ultrasound re-evaluation for patients

with equivocal CT findings of acute appendicitis: a preliminary study J. Sim, H. Kim, J. Yeon, B. Suh, K. Kim, Y. Ha, S. Paik; Sungnam-si, Gyeonggi-do/KR

10:48B-0053 Reduced Z-axis coverage at multidetector-row CT

to decrease radiation dose and maintain diagnostic accuracy in adults suspected of acute appendicitis N. Brassart1, C. Winant2, D. Tack3, P. Gevenois1, V. de Maertelaer1, C. Keyzer1; 1Brussels/BE, 2Mons/BE, 3Baudour/BE

10:57B-0055 The effectiveness of multidetector computed

tomography in patients that underwent immediate intestinal resection due to acute abdominal pain M. İnci, F. Özkan, S. Bozkurt, M. Yüksel, O. Peker; Kahramanmaraş/TR

11:06B-0056 In the evaluation of patients with obscure

gastrointestinal bleed, does MDCT angiography have a role? C.B. Kulkarni, S. Moorthy, S.K. Pullara, R.R. Kannan, P.V. Ramchandran, S. Srinivasan; Kochi/IN

11:15B-0057 Venous mesenteric ischaemia vs acute arterial

mesenteric ischaemia with reperfusion: similarities and differences D. Berritto1, F. Iacobellis1, M.P. Belfiore1, M.A. Mazzei2, L. Saba3, R. Di Mizio4, S. Cappabianca1, A. Rotondo1, R. Grassi1; 1Naples/IT, 2Siena/IT, 3Cagliari/IT, 4Penne/IT

11:24B-0058 Non-occlusive mesenteric ischaemia (NOMI) with and

without reperfusion: CT features useful for diagnosis and their prognostic value M.A. Mazzei1, G. Imbriaco1, S. Guerrini1, N. Cioffi Squitieri1, E. Foderà1, D. Berritto2, P. Mercuri1, F.G. Mazzei1, L. Volterrani1; 1Siena/IT, 2Naples/IT

11:33B-0059 Diagnosis of acute arterial mesenteric ischaemia with

and without reperfusion using 7T-MRI in an animal model D. Berritto1, F. Iacobellis1, M.P. Belfiore1, M.A. Mazzei2, L. Saba3, M. Scaglione4, S. Cappabianca1, A. Rotondo1, R. Grassi1; 1Naples/IT, 2Siena/IT, 3Cagliari/IT, 4Castel Volturno/IT

Scientific Sessions

216

B-00

60 –

B-0

07611:42

B-0060 The potential benefit of abdominal CT to help differentiate between strains of clostridium difficile S.N. Reddy, S. Taori, I.R. Poxton, F. Ewing, D. Brown, J.T. Murchison; Edinburgh/UK

10:30–12:00 Room F1

Oncologic Imaging SS 116 Perfusion CT and MRI: ready for clinical

practice Moderators: S. Delorme; Heidelberg/DE, F.A. Gallagher; Cambridge/UK

10:30B-0061 Functional MRI changes in follow-up after external

beam radiation therapy of the prostate A.M. Weidner; Mannheim/DE

10:39B-0062 Acute changes in rectal cancer perfusion CT

parameters during short-course radiotherapy correlate with radiological response to therapy J.M. Franklin, E.J. Hill, T. Pwint, F.V. Gleeson, R.A. Sharma, E.M. Anderson; Oxford/UK

10:48B-0063 CT perfusion for evaluation of early

treatment response of liver metastases after 90Y-radioembolisation C.S. Reiner, F. Morsbach, B.-R. Sah, N. Schäfer, T. Pfammatter, H. Alkadhi; Zurich/CH

10:57B-0064 First-pass perfusion CT on 256-detector row CT in the

quantitative assessment of perfusion map for solid malignant neoplastic liver lesions: preliminary results O. Minutolo, D. Ippolito, A.C. Cadonici, P.A. Bonaffini, C.R.G.L. Talei Franzesi, S. Sironi; Monza/IT

11:06B-0065 CT perfusion imaging in stage II-III non-small cell

lung cancer patients undergoing chemo-radiotherapy-evaluation of metabolic tumour activity M. Das, B. Reymen, P. Lambin, H. Sharifi, J.E. Wildberger, D. De Ruysscher, W. van Elmpt; Maastricht/NL

11:15B-0066 Imaging of antivascular effects of multikinase

inhibitors (MKI) in patients with metastatic renal cell cancer (mRCC) using dynamic contrast- enhanced CT (DCE-CT, perfusion CT): a pilot study A. Sterzik, M. Staehler, J. Casuscelli, M. Karpitschka, F. Schwarz, M.F. Reiser, A. Graser; Munich/DE

11:24B-0067 Early vs late recurrent glioblastomas: added value of

T1-weighted perfusion MR imaging compared with T2-weighted perfusion MR imaging S.J. Kang, H.S. Kim, S.J. Kim, C.G. Choi; Seoul/KR

11:33B-0068 Monitoring the antivascular effects of a novel

multimodal therapy with dynamic contrast-enhanced MRI (DCE-MRI) in an experimental human squamous cell carcinoma model A. Sterzik, P. Paprottka, P. Zengel, S. Roßpunkt, E. Baloch, M. Moser, M.F. Reiser, K. Nikolaou, C. Cyran; Munich/DE

11:42B-0069 Fractional 3D quantification of early contrast-

enhancing tumour fractions on dynamic MRI acquisitions in soft tissue sarcoma: prospective comparison with partial tissue-stained pathological tumour viability estimates A.K. Singh, W. Cai, A. Imanzadeh, S. Saini, G. Harris; Boston, MA/US

11:51B-0070 A perfusion CT-derived patient-specific arterial input

function for pharmacokinetic modelling of dynamic contrast-enhanced MRI J.M. Franklin, M. Enescu, E.J. Hill, R.A. Sharma, J.A. Schnabel, F.V. Gleeson, E.M. Anderson; Oxford/UK

10:30–12:00 Room F2

Breast SS 102 Breast MRI: improving accuracy and

tissue characterisation Moderators: R. Schulz-Wendtland; Erlangen/DE, M. Telesca; Rome/IT

10:30B-0071 BI-RADS®-adapted combined contrast-enhanced

magnetic resonance and diffusion-weighted imaging reading for multiparametric imaging of breast lesions at 3T improves diagnostic accuracy K. Pinker-Domenig, H. Bickel, T.H. Helbich, S. Gruber, S. Trattnig, W. Bogner; Vienna/AT

10:39B-0072 The additional value of expert reading of 3 Tesla

breast MRI in patients with microcalcifications on mammography L.G. Merckel1, H.M. Verkooijen1, N.H.G.M. Peters1, R.M. Mann2, W.B. Veldhuis1, K.M. Duvivier1, T. van Dalen1, P.H.M. Peeters1, M.A.A.J. van den Bosch1; 1Utrecht/NL, 2Nijmegen/NL

10:48B-0073 Which threshold level is appropriate for analysis

of the computer-aided detection system of breast MRI? Effect of pathologic tumour characteristics and biological markers S. Song1, B. Seo1, K.-W. Hwang2, K. Cho3, O. Woo3; 1Ansan/KR, 2Incheon/KR, 3Seoul/KR

10:57B-0074 The additional value of diffusion-weighted imaging

(DWI) in MR-mammography: should we still look at curves? P.A.T. Baltzer1, M. Dietzel2, J.L. Halder3, W.A. Kaiser3; 1Vienna/AT, 2Erlangen/DE, 3Jena/DE

11:06B-0075 Apparent diffusion coefficient (ADC) measurements

of breast lesions: most suspect area versus complete lesion assessment P.A.T. Baltzer1, M. Dietzel2, J.L. Halder3, W.A. Kaiser3; 1Vienna/AT, 2Erlangen/DE, 3Jena/DE

11:15B-0076 Combined contrast-enhanced MRI (CE-MRI) and 3D

multivoxel proton magnetic resonance spectroscopy (3D-1H-MRSI) at 3 Tesla enables an improved characterization of breast tumours K. Pinker-Domenig, S. Gruber, W. Bogner, B. Brück, H. Bickel, P.A.T. Baltzer, T. Helbich; Vienna/AT


ursday

217

B-00

77 –

B-0

097 11:24

B-0077 Application of breast MRI vs. classical prognostic factors to predict survival in patients with primary breast cancer M. Dietzel1, P.A.T. Baltzer2, R. Zoubi3, H. Habrecht4, C. Jerowski4, I.B. Runnebaum4, W.A. Kaiser4; 1Erlangen/DE, Jena/DE, 2Jena/DE, Vienna/AT, 3Bielefeld/DE, Jena/DE, 4Jena/DE

11:33B-0079 Diagnosis of breast lesions using proton MR-

spectroscopy at 1.5 and 3 Tesla: a systematic review and meta-analysis P.A.T. Baltzer1, M. Dietzel2, W.A. Kaiser3; 1Vienna/AT, 2Erlangen/DE, 3Jena/DE

11:42B-0080 Volumetric assessment of MRI enhancement kinetics

of invasive breast cancers with a post-processing software with correlation of hormonal receptor subtypes L.C.H. Leong1, E. Gombos2; 1Singapore/SG, 2Boston, MA/US

10:30–12:00 Room G/H

Genitourinary SS 107 Prostate imaging

Moderators: S. Morozov; Moscow/RU, J. Richenberg; Brighton/UK

10:30B-0081 Reliability of the PI-RADS scoring system for

functional prostate MRI M. Quentin, L. Schimmoeller, C. Arsov, R. Rabenalt, R. Lanzman, G. Antoch, P. Albers, D. Blondin; Düsseldorf/DE

10:39B-0082 Preoperative multiparametric magnetic resonance

imaging (mp-MRI) reduces positive surgical margins after robotic-assisted laparoscopic prostatectomy (RALP): experience in 136 patients S. Alessi, G. Petralia, G. Musi, A. Alconchel, G. Bardo, S. Raimondi, G. Renne, O. De Cobelli, M. Bellomi; Milan/IT

10:48B-0083 The cost-effectiveness of MRI and MR-guided biopsy

versus TRUS-guided biopsy in the diagnosis of prostate cancer S. Crienen, M. de Rooij, J.O. Barentsz, J.A. Witjes, J.P.C. Grutters, M.M. Rovers; Nijmegen/NL

10:57B-0084 Quantitative shear wave elastography: detection and

characterisation of prostate cancer on 105 patients J.-M. Correas, A. Khairoune, A.-M. Tissier, V. Vassiliu, A. Méjean, O. Hélénon; Paris/FR

11:06B-0085 3T multi-parametric ultrahigh b values (b 2000) MR

imaging for detection and localisation of peripheral and transition zone prostate cancer G. Manenti, M. Nezzo, S. Altobelli, M. Antonicoli, S. Capuani, G. Simonetti; Rome/IT

11:15B-0086 Analysis of the dependence on b-values of DWI signal

model outcomes in peripheral healthy and cancerous prostate tissues S. Lucarini, L.N. Mazzoni, S. Chiti, S. Busoni, C. Gori, I. Menchi; Florence/IT

11:24B-0087 Comparison of diffusional kurtosis imaging and mono-

exponential DWI model in distinguishing healthy from cancerous peripheral prostate tissues S. Lucarini, L.N. Mazzoni, S. Chiti, S. Busoni, C. Gori, I. Menchi; Florence/IT

11:33B-0088 MRI+MRSI reliably detects and excludes high-grade

prostate cancer in patients with elevated PSA G.M. Villeirs, J. Schatteman, P.J. De Visschere, G.O. De Meerleer, N. Lumen, W. Oosterlinck; Gent/BE

11:42B-0089 Correlation between 1H-MR spectroscopy and

haematochemical evaluation (PSA) in patients undergoing radiation therapy for prostate cancer F. Barchetti, V. Panebianco, A. Pace, V. Forte, V. Forte, V. Tombolini, C. Catalano; Rome/IT

11:51B-0090 The role of 3 T diffusion imaging in prostate cancer

recurrence after radical prostatectomy F. Barchetti, V. Panebianco, V. Forte, A. Pace, V. Tombolini, C. Catalano; Rome/IT

10:30–12:00 Room I/K

Abdominal Viscera SS 101b Liver fibrosis and cirrhosis:

elastography and biomarkers Moderators: R. Faschingbauer; Innsbruck/AT, T.J. Kroencke; Berlin/DE

10:30B-0091 Estimation of reference values for liver elasticity in

biopsy-proven normal liver using Supersonic Shear Wave imaging: measurement reliability and effect of steatosis C. Suh, S. Kim, K. Kim; Seoul/KR

10:39B-0092 Accuracy of a new real-time shear wave elastography

technique in the assessment of significant liver fibrosis: preliminary results G. Ferraioli, C. Tinelli, B. Dal Bello, R. Lissandrin, M. Zicchetti, C. Filice; Pavia/IT

10:48B-0093 MR elastography for predicting progression of

cirrhosis U. Motosugi, T. Takamura, T. Ichikawa, K. Sano, H. Morisaka, S. Ichikawa, T. Araki; Yamanshi/JP

10:57B-0094 Evaluation of shear wave elastography for liver

fibrosis quantification A. Guibal, T. Lefort, C. Cohen-Bacrie, G. Renosi, J. Scoazec, J. Dumortier, P. Valette; Lyon/FR

11:06B-0095 Evaluation of shear wave elastography to monitor

development of fibrosis after liver transplantation O. Kolokythas1, R. Bhattacharya1, I.W. Liou1, A. Kang1, P. Bhargava1, L.M. Mitsumori1, C. Cuevas1, M.F. Bruce2; 1Seattle, WA/US, 2Aix-en-Provence/FR

11:15B-0096 The efficacy of Gadoxetate Disodium-enhanced

magnetic resonance (MR) imaging in staging liver fibrosis D.S. Feier1, C. Balassy2, N. Bastati-Huber2, J. Stift2, R. Badea1, A. Ba-Ssalamah2; 1Cluj-Napoca/RO, 2Vienna/AT

11:24B-0097 Differential portal venous flow response to terlipressin

in normal and cirrhotic rats: non-invasive assessment using phase-contrast MRI M. Chouhan, A. Bainbridge, N. Davies, R. Mookerjee, R. Jalan, S. Walker-Samuel, M. Lythgoe, S. Punwani, S.A. Taylor; London/UK

Scientific Sessions

218

B-00

98 –

B-0

11711:33

B-0098 Evaluation of T1rho as a potential MR biomarker for liver cirrhosis: comparison of healthy control subjects and patients with liver cirrhosis I. Rauscher1, C. Ganter1, P. Martirosian2, E.J. Rummeny1, K. Holzapfel1; 1Munich/DE, 2Tübingen/DE

11:42B-0099 Biomarkers of nonalcoholic fatty liver disease

diagnosed by 1H SRM 3T J. Martin-Rodriguez, J. Arrebola, J. Gonzalez-Calvin; Granada/ES

11:51B-0100 Absolute quantification of phosphorus compounds in

the liver on a clinical 3T scanner A. Laufs1, R. Livingstone2, S. Kahl1, B. Nowotny1, B. Klueppelholz1, G. Giani1, J. Bunke3, J.-H. Hwang1, M. Roden1; 1Düsseldorf/DE, 2Vellore/IN, 3Hamburg/DE

10:30–12:00 Room L/M

Physics in Radiology SS 113 Multi modality imaging and MR safety

Moderators: O. Ciraj-Bjelac; Belgrade/RS, O. Speck; Magdeburg/DE

10:30B-0101 MR tumour perfusion measurements: dual echo versus

multi-echo approach V. Hietschold, M. Riebisch, A. Abramyuk, M. Laniado, N. Abolmaali; Dresden/DE

10:39B-0102 PET/MR imaging of the pelvis in the presence of

endoprostheses: reducing image artefacts and increasing accuracy through inpainting C.N. Ladefoged, F. Andersen, S. Keller, J. Löfgren, A.E. Hansen, S. Holm, L. Hojgaard, T. Beyer; Copenhagen/DK

10:48B-0103 Combined PET/MR imaging: the effect of ignoring bone

during MR-based attenuation correction in oncology imaging J. Saa, J. Löfgren, R. Sersar, M. Aznar, C. Ladefoged, F. Andersen, R. Larsen, T. Beyer; Copenhagen/DK

10:57B-0104 Assessment of the performance of TOF-PET and PET

reconstructions on edge definition of cold regions in the presence of solitary hot spots and low count-rate studies Y. Bouchareb1, M. Masoomi2, M. Newell1; 1London/UK, 2Portsmouth/UK

11:06B-0105 The incidence of biological effects from 3.0 Tesla (T)

MRI compared to 1.5 T: an observational study in 911 consecutive outpatients F. Alghamdi, P. Bertrand, L. Barantin, M.A. Lauvin, X. Cazals, F. Domengie, R. Bibi, D. Herbreteau, J.-P. Cottier; Tours/FR

11:15B-0106 Static magnetic fields in 1.5 and 3 T MR scanners do

not influence perception of pain and touch compared with placebo exposition A. Pomschar, K. Kamm, R. Ruscheweyh, R. Laubender, M.F. Reiser, A. Straube, B. Ertl-Wagner; Munich/DE

11:24B-0107 Safety and efficiency of low-field magnetic resonance

imaging in patients with cardiac rhythm management devices C. Schukro, M. Lee; Vienna/AT

11:33B-0108 Possible hazardous effect of “MR safe” metallic

implants for workers N. Oberhofer1, P. Ferrari2; 1Bolzano/IT, 2Mattarello/IT

11:42B-0109 Swedish national study on modality choice and

justification of CT, MRI and US examinations in children B. Isberg1, H. Jorulf2, U. Svahn1, S. Richter1, W. Leitz1; 1Stockholm/SE, 2Uppsala/SE

11:51B-0110 In vitro comparison of ultrasound-based elastography

techniques S. Franchi-Abella1, J.-M. Correas2, C. Elie2; 1Le Kremlin-Bicêtre/FR, 2Paris/FR

10:30–12:00 Room N/O

Vascular SS 115 Carotid plaque evaluation

Moderators: M.A. Aschauer; Graz/AT, D. Filippiadis; Athens/GR

10:30B-0111 Arterial stiffness is associated with carotid intraplaque

haemorrhage in the general population: the Rotterdam study M. Selwaness, Q. van den Bouwhuijsen, F.U.S. Mattace-Raso, G. Verwoert, A. Hofman, O.H. Franco, J.J. Wentzel, J. Witteman, A. van der Lugt; Rotterdam/NL

10:39B-0112 Evaluation of carotid atherosclerotic plaque with lab-

based X-ray phase-contrast imaging H. Hetterich1, S. Fill1, M. Willner2, F. Bamberg1, J. Herzen2, A. Hipp2, M.F. Reiser1, F. Pfeiffer2, T. Saam1; 1Munich/DE, 2Garching/DE

10:48B-0113 Meta-analysis and systematic review of the predictive

value of carotid plaque haemorrhage by magnetic resonance imaging on cerebrovascular events T. Saam1, H. Hetterich1, V. Hoffmann2, C. Yuan3, M. Treitl1, M. Dichgans1, H. Poppert1, M.F. Reiser1, F. Bamberg1; 1Munich/DE, 2Neuherberg/DE, 3Seattle, WA/US

10:57B-0114 Genetic loci for coronary calcification and serum lipids

relate to aortic and carotid calcification D. Bos, M.A. Ikram, A. Isaacs, B.F.J. Verhaaren, A. Hofman, C.M. van Duijn, J.C.M. Witteman, A. van der Lugt, M.W. Vernooij; Rotterdam/NL

11:06B-0115 Is carotid intima-media (IMT) and extra media

thickness (EMT) a surrogate marker of early atherosclerosis in patients with inflammatory bowel disease? A. Oikonomou, E. Astrinakis, P. Zezos, N. Courcoutsakis, A. Mpampali, I. Karatzoglou, G. Kouklakis, P. Prassopoulos; Alexandroupolis/GR

11:15B-0116 Assessment of microvasculature in atherosclerotic

plaque with dynamic contrast-enhanced-MRI: model comparison, reproducibility and validation with histology M.E. Kooi1, M.E. Gaens1, R.H.M. van Hoof1, J.C. Sluimer1, S. Heeneman1, M.J.A.P. Daemen2, J.E. Wildberger1, R.M. Kwee1, W.H. Backes1; 1Maastricht/NL, 2Amsterdam/NL

11:24B-0117 Effect of expansive arterial remodelling on clinical

presentation and plaque composition: an in vivo MRI study of the carotid arteries A. Helck1, M. Buchholz1, A. Rominger1, C. Yuan2, M.F. Reiser1, K. Nikolaou1, M. Dichgans1, A. Karpinska1, T. Saam1; 1Munich/DE, 2Seattle, WA/US


ursday

219

B-01

18 –

B-0

139 11:33

B-0118 Determination of the vascular input function using magnitude or phase-based MRI: influence on dynamic contrast-enhanced MRI model parameters in carotid plaques R.H.M. van Hoof1, M.T.B. Truijman1, E. Hermeling1, R.J. van Oostenbrugge1, R.J. van der Geest2, M.J.A.P. Daemen3, J.E. Wildberger1, W.H. Backes1, M.E. Kooi1; 1Maastricht/NL, 2Leiden/NL, 3Amsterdam/NL

11:42B-0119 Low does CT angiography using iterative

reconstruction for the assessment of carotid artery stenosis L. Crush, M. O‘Keeffe, B. Normoyle, F. O‘Neill, E.M. Canniff, P.D. Mc Laughlin, S. O‘Neill, O. O‘Connor, M.M. Maher; Cork/IE

11:51B-0120 Determining the vulnerable plaque: correlation

between 18F-FDG PET and dynamic contrast-enhanced MRI in atherosclerotic plaques of symptomatic patients M.T.B. Truijman, R.M. Kwee, R.H.M. van Hoof, R.J. van Oostenbrugge, W.H. Mess, J.E. Wildberger, W.H. Backes, J.A. Bucerius, M.E. Kooi; Maastricht/NL

10:30–12:00 Room P

Emergency Radiology SS 117 An update on emergency thoraco-

abdominal imaging Moderators: B. Feragalli; Chieti/IT, A. Huete; Santiago/CL

10:30B-0121 Emergency CT: what is missed at first reading?

A. Platon, G. Varnay, C.D. Becker, P.-A. Poletti; Geneva/CH

10:39B-0122 Traumatic aortic injury: what is changing?

J.M. Artigas1, M. Martí De Gracia2, J.A. Soto3, A. Garcia-Valiente1, M. Marini4, P. Parrilla1; 1Zaragoza/ES, 2Madrid/ES, 3Boston, MA/US, 4A Coruña/ES

10:48B-0123 Comparison between dedicated coronary CT

angiogram and triple rule out using 320 multislice CT in cases of acute chest pain Y. Ragab, H. Hamza, H. Awadalla; Cairo/EG

10:57B-0124 Can the presence of active or recent bleeding in CT

angio of acute lower intestinal bleeding be predicted? M. Marti de Gracia1, J.M. Artigas Martín2, J.A. Soto3, A. Borobia1, A. Vicente1, G. Garzón1; 1Madrid/ES, 2Zaragoza/ES, 3Boston, MA/US

11:06B-0125 Accuracy of the AAST organ injury scale as a CT

imaging checklist for traumatic liver and spleen injuries G. Homann1, C.M. Toschke2, P. Gaßmann3, U. Hanning1, W. Heindel1, V. Vieth1; 1Münster/DE, 2Ahlen/DE, 3Mainz/DE

11:15B-0126 Comparison of efficacy and safety between distal

embolization and augmented embolization techniques for treating blunt splenic injuries with active haemorrhage Y.-C. Wong, L.-J. Wang, C.-H. Wu, H.-W. Chen; Taoyuan/TW

11:24B-0127 Diagnostic performance of MDCT in the evaluation of

bowel obstruction: can the radiologist‘s experience make a difference? A. Ferri, R. Basilico, N. Civitareale, A. Lella, V. Calamita, A. Cotroneo; Chieti/IT

11:33B-0128 Diagnosis of bowel obstruction performed by MSCT in

emergency department compared with the surgical findings E. Capalbo, F. Sajadidhekrodi, M. Cosentino, M. Peli, M. Lovisatti, A. Kluzer, S. Fornari, M. Cariati; Milan/IT

11:42B-0129 Accuracy of ultrasonographic diagnosis of acute

appendicitis in pregnant women N. Kokhanovsky, A.-R. Zeina, N. Reindorp, A. Levit-Kantor, Y. Glick, A. Nachtigal; Hadera/IL

11:51B-0130 Quality assessment of out sourced after-hours

computed tomography teleradiology reports in a central London University Hospital J. Hohmann1, P. de Villiers1, C. Urigo2, D. Sarpi1, C. Newerla3, J. Brookes1; 1London/UK, 2Lugano/CH, 3Basle/CH

10:30–12:00 Room Q

Radiographers SS 114 Importance of education in practice

Moderators: R. Ribeiro; Lisbon/PT, T. Roding; Haarlem/NL

10:30B-0131 Risk management in radiology: applying failure

mode effects and criticality analysis in computer tomography M. Antoniutti, C. Maso, N. Vecchiato, S. Doratiotto; Treviso/IT

10:39B-0132 How important is the experience in breast imaging for

radiographers performing breast-MRI? P. Clauser, V. Londero, C. Molinari, R. Girometti, S. Da Dalt, C. Zuiani, M. Bazzocchi; Udine/IT

10:48B-0133 Radiography authorship: a European and international

review B. Snaith; Wakefield/UK

10:57B-0134 The influence of clinical placement setting on

academic achievement within an undergraduate diagnostic radiography programme E. Lewis, M. Hardy; Bradford/UK

11:06B-0135 Use of radiation in operating theatres in Finland

P. Heikkilä1, A. Henner1, P. Tenkanen-Rautakoski2, M. Pirinen2, S.-M. Ahonen1; 1Oulu/FI, 2Helsinki/FI

11:15B-0136 Information-seeking behaviour of radiographers

L. Sancho1, A.F.C.L. Abrantes1, L.P.V. Ribeiro1, R.P.P. Almeida1, S.I. Rodrigues1, C.A. Silva2; 1Faro/PT, 2Evora/PT

11:24B-0137 Dose reduction in computer tomography, the effects

of technologist training on the number of extra anatomic images T.W.F. Pappot, M.E.J. Pijl; Arnhem/NL

11:33B-0138 Evidence-based practice in radiology

M. Dias1, A.F.C.L. Abrantes1, C.A. Silva2, R.P.P. Almeida1, L.P.V. Ribeiro1, J. Pinheiro1, K.B. Azevedo1; 1Faro/PT, 2Evora/PT

11:42B-0139 Radiographers quality assurance work: resistance and

cooperation R. Gullien, J.G. Andersen, A.E. Haakull; Oslo/NO

Scientific Sessions

220

B-01

40 –

B-0

15911:51

B-0140 Radiographers‘ knowledge about adverse reactions to iodinated contrast media A. Santos, L. Capitolina, I. Silva, A. Saraiva; Coimbra/PT

10:30–12:00 Room Z

Computer Applications SS 105 IT infrastructure, learning support and

teleradiology Moderators: B. Gibaud; Rennes/FR, A. Simisker; Tartu/EE

10:30B-0141 Development of the ViSion ontology

D.J. Vining1, U. Salem1, C. Popovici2, L. Jiang3, C. Duran1, A. Pitici2, I. Aghenitei2, M. Jurca2, R. Rosu2; 1Houston, TX/US, 2Chapel Hill, NC/US, 3Beijing/CN

10:39B-0142 IT infrastructure to support secondary use of routinely

acquired clinical imaging data for research K. Leung, F. Van der Lijn, H.A. Vrooman, W.J. Niessen, M.C.J.M. Sturkenboom; Rotterdam/NL

10:48B-0143 Interactive methods improve radiology long-term

learning J.C. Pueyo, J. Etxano, P. Slon, R. Zalazar, J. Ros, L. García del Barrio, G. Bastarrika, A. Villanueva; Pamplona/ES

10:57B-0144 The radiology events register (RaER): incident

reporting in radiology C. Mandel1, T. Schultz2, N. Hannaford2, J. Grimm3; 1Melbourne/AU, 2Adelaide/AU, 3Sydney/AU

11:06B-0145 The liver imaging atlas: an interactive multimodality

web-based reference and educational resource of liver imaging O. Kolokythas, S. Zaidi, S. Osman, A.P. Tornow, T.T. Pham, S. Bastawrous, G.S. Phillips, P. Bhargava, D.L. Coy; Seattle, WA/US

11:15B-0146 Evaluation of teleradiology and telemedicine

regarding financial and personnel benefit for regions with low population density M.C. Spoerl, N. Hosten; Greifswald/DE

11:24B-0147 Fast search for radiology cases in hospital systems via

content-based image retrieval G. Langs1, R. Donner1, M. Holzer1, D. Markonis2, H. Mueller2, E. Birngruber1; 1Vienna/AT, 2Sierre/CH

11:33B-0148 Internet-based surveys among referring in-hospital

clinicians and radiologists: a useful tool to evaluate report quality and interdisciplinary co-operation C. Neumann, O. Khalifa, D. Tscholakoff, G. Mostbeck; Vienna/AT

11:42B-0149 Cross regional diagnostic radiology network for

preoperative assessment of colorectal cancer: preliminary experiences L.C.O. Blomqvist1, C. Kling-Hassler1, A. Sjövall1, T. Almqvist1, P. Asp1, H. Walfridsson2, R. Sundqvist1, U. Hertin1; 1Stockholm/SE, 2Sollentuna/SE

14:00–15:30 Room C

Head and Neck SS 208 Head and neck cancer: functional

imaging and hybrid modalities Moderators: N. Abolmaali; Dresden/DE, S. Steens; Nijmegen/NL

14:00B-0150 CT perfusion of head and neck lymph nodes:

differentiation between untreated and treated lymphoma A.M. Tawfik1, N.M. Batouty1, A.A. Razek1, S. Eteiba1, M.A. Shaheed1, T.J. Vogl2; 1Mansoura/EG, 2Frankfurt am Main/DE

14:09B-0151 Prediction of treatment response in head and neck

carcinomas using IVIM-DWI: evaluation of lymph node metastasis T. Hauser1, M. Essig2, F.B. Laun1, M. Münter3, A. Jensen1, K.H. Fritsche1, B. Stieltjes1; 1Heidelberg/DE, 2Erlangen/DE, 3Stuttgart/DE

14:18B-0152 Combined perfusion-diffusion-weighted MRI for

staging of recurrent papillary thyroid cancer: a feasibility study K.N.A. De Paepe, R. Hermans, F. De Keyzer, V. Vander Poorten, S. Nuyts, E. Hauben, B. Decallonne, M. Bex, V. Vandecaveye; Leuven/BE

14:27B-0153 Diagnostic evaluation of patients with squamous

cell cancer of the head and neck after free flap reconstructions – the usefulness of functional imaging techniques M. Członkowski, A. Trojanowska, P. Trojanowski, J. Klatka, A. Drop; Lublin/PL

14:36B-0154 The role of MRI and FDG PET/CT imaging in the

detection of unknown primary tumours with cervical metastases A. Lévai; Budapest/HU

14:45B-0155 Diffusion-weighted MR imaging in characterization of

head and neck lesions F.U. Öztürk, F.Y. Dönmez, F. Kural, S. Çetiner, M. Ağıldere; Ankara/TR

14:54B-0156 Comparison of contrast-enhanced PET/CT and PET/

MRI with only T2-weighted images in patients with head and neck cancer – how much MR information is needed in PET/MRI? F.P. Kuhn, M. Hüllner, S.S. Kollias, G.K. Von Schulthess, P. Veit-Haibach; Zurich/CH

15:03B-0157 Comparison of contrast-enhanced PET/MRI and

contrast-enhanced PET/CT in patients with head and neck cancers F.P. Kuhn, M. Hüllner, S.S. Kollias, G.K. Von Schulthess, P. Veit-Haibach; Zurich/CH

15:12B-0158 Initial clinical results of simultaneous PET/MRI in

comparison with PET/CT in patients with head and neck cancer P. Stumpp, K. Kubiessa, S. Purz, M. Gawlitza, A. Kühn, K.G. Steinhoff, A. Boehm, R. Kluge, T. Kahn; Leipzig/DE

15:21B-0159 Diagnostic accuracy of 18F-FDG-PET/CT and fused

18F-FDG-PET-MR images for T and N staging of primary oral malignancies P. Heusch1, C. Buchbender1, C. Sproll1, J. Terjung2, A. Scherer1, G. Antoch1, J. Handschel1, T.A. Heusner1; 1Düsseldorf/DE, 2Essen/DE


ursday

221

B-01

60 –

B-0

179 14:00–15:30 Room D1

Chest SS 204 Airways and infiltrative lung diseases

Moderators: G.R. Ferretti; Grenoble/FR, C. Mueller-Mang; Vienna/AT

14:00B-0160 How does iterative image reconstruction effect

emphysema quantification with chest CT? H. Jafarov1, C. Fink2, H. Haubenreisser1, M. Meyer1, P. Apfaltrer1, S.O. Schönberg1, T. Henzler1; 1Mannheim/DE, 2Celle/DE

14:09B-0161 Assessing pulmonary perfusion in emphysema:

automated quantification of perfused blood volume in dual-energy CTPA F.G. Meinel, A. Graef, S.F. Thieme, F. Bamberg, C. Neurohr, M.F. Reiser, T.R.C. Johnson; Munich/DE

14:18B-0162 Densitometry on MDCT in cystic fibrosis: radiological

evidence for emphysema M.O. Wielpütz1, O. Weinheimer2, M. Eichinger1, M. Wiebel1, J. Biederer1, H.-U. Kauczor1, C.-P. Heussel1, M.A. Mall1, M. Puderbach1; 1Heidelberg/DE, 2Mainz/DE

14:27B-0163 The effect of inspiration on airway dimensions

measured in CT images from the Danish Lung Cancer Screening Trial J. Petersen1, M.M.W. Wille2, L.H. Thomsen2, A. Feragen1, A. Dirksen2, M. de Bruijne3; 1Copenhagen/DK, 2Hellerup/DK, 3Rotterdam/NL

14:36B-0164 Chronic bronchitis in large airway: airway wall

measurements on thin-slice low-dose CT X. Xie, A.E. Dijkstra, J.M. Vonk, M. Oudkerk, H.J.M. Groen, R. Vliegenthart; Groningen/NL

14:45B-0165 Value of inspiratory and expiratory lung volume und

lung density for detection of bronchiolitis obliterans syndrome (BOS): a feasibility study S. Dettmer1, O. Otten1, C. de Wall1, J.-M. Kuhnigk2, F. Wacker1, H.-O. Shin1; 1Hannover/DE, 2Bremen/DE

14:54B-0166 Value of density mappings in computed tomography

for detection of bronchiolitis obliterans syndrome (BOS) S. Dettmer, T. Kaireit, O. Solyanik, C. de Wall, F. Wacker, H.-O. Shin; Hannover/DE

15:03B-0167 Feasibility of krypton ventilation for CT imaging of

lung ventilation: preliminary animal data A.H. Mahnken1, G. Jost2, H. Pietsch2; 1Marburg/DE, 2Berlin/DE

15:12B-0168 Quantification of idiopathic pulmonary fibrosis by

semiquantitative HRCT score: correlation between radiologists and pulmonary function tests L. Navarro Vilar, M.L. Domingo Montañana, R. Peris Sanchez, E. Fernandez Fabrellas, C. Ramírez Fuentes, J. Vilar Samper; Valencia/ES

15:21B-0169 High-resolution computed tomography (HRCT) of the

lungs in brain dead pigs: a feasibility study G. Bozovic1, S. Steen1, T. Sjöberg1, C. Schaefer-Prokop2, J. Verschakelen3, Q. Liao1, R. Siemund1, I. Björkman-Burtscher1; 1Lund/SE, 2Amersfoort/NL, 3Leuven/BE

14:00–15:30 Room D2

Interventional Radiology SS 209 Ablation and biopsy of the prostate

and the kidney Moderators: J.J. Fütterer; Nijmegen/NL, J. Kettenbach; Berne/CH

14:00B-0170 1.5T magnetic resonance-guided transgluteal biopsies

of the prostate in patients with clinically suspected prostate cancer: technique and feasibility B. Bodelle, N.N.N. Naguib, K. Eichler, T.J. Vogl, S. Zangos; Frankfurt/DE

14:09B-0171 Magnetic resonance-guided biopsy (MRGB) in

combination with multiparametric MRI (mpMRI) after negative transrectal guided ultrasound (TRUS) biopsy of the prostate S. Polanec, T. Helbich, K. Pinker-Domenig, S. Leitner, P. Brader; Vienna/AT

14:18B-0172 MRI-guided biopsy of the prostate: evaluation of

patient acceptance and adverse effects T. Franiel, N. Egbers, C. Schwenke, A. Maxeiner, C. Stephan, B. Hamm; Berlin/DE

14:27B-0173 MRI+US fusion-guided prostate biopsy and ablation

H. Amalou, S. Xu, P. Pinto, B. Wood; Bethesda, MD/US

14:36B-0174 Non-invasive focal therapy of organ confined prostate

cancer: phase I study using magnetic resonance guided focused ultrasound technology and excision pathology for efficacy assessment A. Napoli, V. Panebianco, M. Anzidei, F. Boni, V. Noce, L. Bertaccini, G. Cartocci, F. Ciolina, C. Catalano; Rome/IT

14:45B-0175 Technical challenges, pitfalls and obstacles on

performing prostatic artery embolisation for benign prostatic hyperplasia H.A.M.R. Rio Tinto, T. Bilhim, L. Fernandes, J. Pereira, J.M. Pisco; Lisbon/PT

14:54B-0176 Mid-term results of percutaneous image-guided

radiofrequency ablation of renal tumours P. Balageas, F. Cornelis, Y. Le Bras, J.-M. Ferrière, A. Ravaud, N. Grenier; Bordeaux/FR

15:03B-0177 Retrospective study of renal tumors treated with radio

frequency ablation at Uppsala University Hospital since 2007: which factors affect ablation results? V. Acosta Ruiz, A. Magnusson, P. Dahlman, E. Brekkan, M. Lönnemark; Uppsala/SE

15:12B-0178 Irreversible electroporation (IRE) of the pig kidney

with involvement of the renal pelvis – technical aspects, clinical outcome and 3d lesion analysis C.M. Sommer, M.F. Wachter, S. Fritz, D. Vollherbst, U. Stampfl, N. Bellemann, T. Gockner, T. Mokry; Heidelberg/DE

15:21B-0179 Retrograde ureteral stent exchange: comparison

between the direct grasping and the simple snare technique R. Cazzato, R. Grasso, G. Luppi, E. Faiella, R. Del Vescovo, F. Giurazza, B. Beomonte Zobel; Rome/IT

Scientific Sessions

222

B-01

80 –

B-0

19914:00–15:30 Room E1

Musculoskeletal SS 210 Lower limb: tricks for improved

imaging Moderators: A. Klauser; Innsbruck/AT, L.M. Sconfienza; Milan/IT

14:00B-0180 MR imaging of articular cartilage at the ankle: utility

of axial traction J.S. Bauer, P. Jungmann, C. Schäffeler, M. Sauerschnig, A. Mann, T. Baum, E.J. Rummeny, K. Wörtler; Munich/DE

14:09B-0181 Do sagittal and coronal alignment of the hindfoot

change in upright weight-bearing position? Comparison of upright weight-bearing and supine non-weight-bearing computed tomography A. Hirschmann, C.W.A. Pfirrmann, N. Espinosa, G. Klammer, F.M. Buck; Zurich/CH

14:18B-0182 MRI in plantar plate disease evaluation: diagnostic

value of ‚stress test‘ C. Ottonello, I. D‘Ambrosio, P. Giuliani, P. Ronconi; Rome/IT

14:27B-0183 Stable or unstable tear of the medial meniscus of the

knee: can weight-bearing MRI solve the problem? A. La Marra, S. Mariani, E. Costantini, A. Conchiglia, A. Barile, C. Masciocchi; L‘Aquila/IT

14:36B-0184 Periosteal high volume image-guided injection of

recalcitrant medial collateral ligament injuries: a retrospective case series analysis O. Drumm, O. Chan, P. Malliaras, D. Morrissey, N. Maffulli; London/UK

14:45B-0185 Ischiofemoral impingement, do you want to believe?

R. Prada, R. Oca, A. Rocha, L. Fernández, M. Costas, G. Tardáguila; Vigo/ES

14:54B-0186 US-guided viscosupplementation of the hip:

therapeutic efficacy in patients affected by femoro-acetabular impingment C. Martini1, F. Lacelli2, E. Fabbro1, G. Ferrero1, G. Serafini2; 1Genoa/IT, 2Pietra Ligure/IT

15:03B-0187 A new way to measure lower limb length and

alignment using 3D models based on biplanar linear radiography: a comparison with measurements on supine CT scans and upright full-length radiographs R. Guggenberger, C.W. Pfirrmann, P. Koch, F. Buck; Zurich/CH

15:12B-0188 Dynamic contrast-enhanced MRI can assess

vascularity within pseudarthrotic clefts and predicts good clinical outcome M.-A. Weber1, K. Bloess1, I. Burkholder2, D. Bender1, G. Schmidmaier1, H.-U. Kauczor1, O. Schoierer1; 1Heidelberg/DE, 2Zweibrücken/DE

15:21B-0189 Osteoidosteoma – post-procedural MR-imaging

characteristics following percutaneous MR-guided laser ablation in an open 1.0 Tesla MRI S. Fuchs, B. Gebauer, L. Stelter, M. Maurer, D. Renz, P. Schwabe, B. Hamm, F. Streitparth; Berlin/DE

14:00–15:30 Room E2

GI Tract SS 201a Bowel imaging: protocol optimisation

and intervention Moderators: V. Cantisani; Rome/IT, P. Popovic; Ljubljana/SI

14:00B-0190 Abdominal and pelvic CT: is positive enteric contrast

still necessary? Preliminary results of a clinical investigation S. Kammerer, A. Knauer, B. Buerke, C. Schuelke, W.L. Heindel, J. Wessling; Münster/DE

14:09B-0191 Value of oral effervescent powder administration for

multidetector CT evaluation of the oesophagus K.I. Ringe, S. Meyer, F. Wacker, H.-J. Raatschen; Hannover/DE

14:18B-0192 Prospective study of using balloon duodenography

catheters in CT enteroclysis for small bowel diseases K.C.H. Lau, L.M.F. Tee; Hong Kong/HK

14:27B-0193 Role of preoperative imaging with multidetector

computed tomography (MDCT) in the management of patients with gastroesophageal reflux disease (GERD) symptoms, candidate to sleeve surgical revision M. Rengo, D. Caruso, F. Vecchietti, M.M. Maceroni, G. Silecchia, A. Laghi; Latina/IT

14:36B-0194 Accuracy of MDCT in preoperative definition of

maximum tumour diameter in patients with gastric cancer M.A. Mazzei, S. Guerrini, N. Salvini, P. Mercuri, A. Parrinello, N. Cioffi Squitieri, D. Marrelli, F.G. Mazzei, L. Volterrani; Siena/IT

14:45B-0195 Percutaneous endoscopic gastrostomy (PEG) and

jejunostomy (PEJ) placement guided by CT fluoroscopy with or without simultaneous endoscopy in otherwise untreatable patients C.G. Trumm1, R.-T. Hoffmann2, R.A. Lang3, H. Winter1, R. Weidenhagen1, K.-W. Jauch1, M.F. Reiser1, F.W. Spelsberg1; 1Munich/DE, 2Dresden/DE, 3Ottobeuren/DE

14:54B-0196 CT assessment of post-resection arterial stumps for

right-sided colorectal cancer: a potential marker of quality of resection? T.L. Kaye, D.G. Jayne, N.P. West, D.J.M. Tolan; Leeds/UK

15:03B-0197 Evaluation of Crohn‘s disease recurrence in patients

with ileocolic anastomosis: value of computed tomography enterography with water enema F. Paparo, M. Revelli, C. Puppo, I. Garello, L. Bacigalupo, L. Rollandi, R. Piccazzo, A. Garlaschi, G.A. Rollandi; Genoa/IT

15:12B-0198 Crohn‘s disease activity: correlation of inflammatory

mediators with overall small-bowel motility S. Bickelhaupt1, S. Pazahr1, J.M. Froehlich1, R. Cattin2, H. Bouquet3, G. Rogler1, P. Frei1, A. Boss1, M. Patak1; 1Zurich/CH, 2Biel/CH, 3Berne/CH

15:21B-0199 Pilot study to assess the diagnostic performance of

MRI in the identification of adhesions between the abdominal wall and small bowel loops, using a time-efficient protocol A. Gupta, A. Hansmann, P.F.C. Lung, R. Tandon, R. Ilangovan, M. Marshall; Middlesex/UK


ursday

223

B-02

00 –

B-0

217 14:00–15:30 Room F1

Oncologic Imaging SS 216 New biomarkers for tumour

quantification Moderators: C.J. Herold; Vienna/AT, C. Keyzer; Brussels/BE

14:00B-0200 3D CT-histogram analysis enables distinguishing

affected and FDG-negative lymph nodes in patients with lung cancer P. Flechsig1, C. Kratochwil1, J. Moltz2, C.-p. Heussel1, R. Talanow1, H.-U. Kauczor1, U. Haberkorn1, F.L. Giesel1; 1Heidelberg/DE, 2Bremen/DE

14:09B-0201 Tumour vascularization imaging without contrast

agents: the potential of IVIM-MRI M. Iima1, O. Reynaud2, T. Tsurugizawa2, L. Ciobanu2, J.-R. Li2, F. Geffroy2, B. Djemai2, D. Le Bihan2; 1Kyoto/JP, 2Gif-sur-Yvette/FR

14:18B-0202 Intravoxel incoherent motion (IVIM) diffusion-

weighted MRI for monitoring the therapeutic efficacy of a vascular disrupting agent (CKD-516) in rabbit VX2 liver tumours I. Joo, J. Lee, J. Han, B. Choi; Seoul/KR

14:27B-0203 Texture analysis on contrast-enhanced computed

tomography combined with FDG-PET in predicting the response to chemotherapy of advanced non-small cell lung cancer M. Ravanelli, F. Ferraroni, D. Farina, M. Morassi, P. Tessitore, P. Rossini, R. Maroldi; Brescia/IT

14:36B-0204 Texture analysis of advanced non-small cell lung

cancer on contrast-enhanced computed tomography: prediction of the response to the first-line chemotherapy M. Ravanelli, M. Morassi, D. Farina, E. Roca, R. Maroldi; Brescia/IT

14:45B-0205 Textural analysis of lymphoma on unenhanced

computed tomography: initial evidence for a relationship with tumour glucose metabolism, stage, end of treatment status and survival S. Babikir, B. Ganeshan, A.M. Groves, I. Kayani; London/UK

14:54B-0206 Improvement in both sensitivity and specificity of

readers with next generation of mammography CAD V. Nikitin, I. Lossev, A. Filatov, N. Bagotskaya; Longmont, CO/US

15:03B-0207 Assessing the contribution of hypoxia to R2*

differences between cancerous and normal prostate tissue A. Johnson, A. Latifoltojar, V. Hamy, H. Fitzke, K. Shmueli, S. Punwani; London/UK

15:12B-0208 Scatter amplitude is a good landmark for tumour

localisation and treatment assessment in time-domain diffuse optical tomography during neo-adjuvant chemotherapy in breast cancer M. Van de Giessen, B.E. Schaafsma, J.R. Kroep, M.N.J.M. Wasser, C.J.H. Van de Velde, B.P.F. Lelieveldt, J. Dijkstra, A.L. Vahrmeijer; Leiden/NL

15:21B-0209 Software validation of metastatic sarcoma lesion

assessment using CT volumetric density tumour trajectory L.R. Folio1, V.M. Derderian1, E.C. Jones1, M.S. Merchant1, A.M. Venkatesan1, E. Lotan2; 1Bethesda, MD/US, 2Tel Hashomer/IL

14:00–15:30 Room F2

Breast SS 202 Improvements in preoperative staging

of breast cancer Moderators: R.A. Kubik-Huch; Baden/CH, A. Zytoon; Shebin El-Kom/EG

14:00B-0210 Usefulness of ultrasonography (US) and

ultrasonography-guided fine-needle aspiration biopsy (FNAB) for axillary staging in breast cancer: is the breast imaging reporting and data system (BI-RADS) categorisation applicable? H. Ahn, S. Kim, B. Yun, M. Kim, M. Jang, S. Park, S.-W. Kim, E. Kang; Gyeonggi-do/KR

14:09B-0211 Improving diagnostic yield in axillary

lymphadenopathy sampling: core biopsy and vacuum-assisted core biopsy R. Salvador, X. Salvador, I. Miranda, O. Dominguez, L. Romero; Barcelona/ES

14:18B-0212 Gadofosveset-enhanced axillary MRI for nodal staging

in breast cancer R. Schipper, M.B.I. Lobbes, L.M. van Roozendaal, C.J.G. Castro, B. de Vries, E.M. Heuts, K.B.M.I. Keymeulen, M.L. Smidt, R.G.H. Beets-Tan; Maastricht/NL

14:27B-0213 Assessment of 18 Fluorodesoxyglucose positron

emission tomography (18FDG PET-CT) vs contrast-enhanced magnetic resonance imaging at 3 Tesla (3T CE-MRI) for lymph node staging in breast cancer patients H. Magometschnigg, H. Bickel, G.J. Wengert, G. Karanikas, P. Brader, K. Pinker-Domenig; Vienna/AT

14:36B-0214 Imaging of axillary lymph nodes in breast cancer

patients: How do enhancement kinetics of contrast-enhanced lymph nodes apparent on dynamic MR-mammography correlate with standardised uptake value of 18F-FDG PET/CT? J. Krammer, C.G. Kaiser, A. Schnitzer, S.O. Schönberg, K. Wasser; Mannheim/DE

14:45B-0215 Ultrasound elastography in the diagnostic assessment

of axillary lymph nodes in women presenting to a breast imaging centre L. Sim, L. Leong; Singapore/SG

14:54B-0216 The Z011 trial: is this the end of axillary ultrasound

in the pre-operative assessment of breast cancer patients? T.P. Farrell, M. Stenson, P.A. Carroll, M. Griffin, E.M. Connolly, S.A. O‘Keeffe; Dublin/IE

15:03B-0217 Surgical impact of preoperative breast MRI in women

under 40 A. Porto1, A. Petrillo1, R. Fusco1, S. Filice1, M. D‘Aiuto1, R.M. Trimboli2, F. Sardanelli2; 1Naples/IT, 2San Donato Milanese/IT

Scientific Sessions

224

B-02

18 –

B-0

23715:12

B-0218 Imaging features in mammography and breast ultrasound are related to HER-2 receptor over-expression of primary invasive breast cancer A. Adams1, K.G.A. Gilhuijs1, K.E. Pengel2, C.E. Loo2, W.P.T.M. Mali1, S.G. Elias1; 1Utrecht/NL, 2Amsterdam/NL

15:21B-0219 Is availability of breast MRI-guided intervention

associated with improved results of breast MRI screening of the contralateral breast in women with newly diagnosed breast carcinoma? V. Freitas1, S. Kulkarni2, S. Ghai2, R. Fleming2, A. Scaranelo2, P. Crystal2; 1Rio De Janeiro/BR, 2Toronto, ON/CA

14:00–15:30 Room G/H

Neuro SS 211 Infection and inflammation

Moderators: E. Marco de Lucas; Sancibrian/ES, G. Schroth; Berne/CH

14:00B-0220 Evaluation of plaque detection and optimum time of

enhancement in acute attack multiple sclerosis after contrast injection H. Hashemi, H. Ghanaati, S. Behzadi, M. Harirchian, M. Yaghoobi, M. Shakiba, A. Jalali, K. Firouznia; Tehran/IR

14:09B-0221 Respiratory syncytial virus-related encephalitis: brain

MR study with diffusion imaging A. Pak, S. Suh, G. Son, Y. Lee, H. Seo, K. Kim, B. Eun, N. Lee, H. Seol; Seoul/KR

14:18B-0222 Cortical-juxtacortical lesions in clinically isolated

syndromes: distribution and diagnostic value J.P. Salazar, C. Auger, D. Pareto, R. Mitjana, M. Tintore, J. Corral; Barcelona/ES

14:27B-0223 Regional MRI perfusion measures predict motor/

executive function in patients with clinically isolated syndrome E. Papadaki, P. Simos, T. Panou, V. Mastorodemos, E. Amanakis, T. Maris, A. Karantanas, A. Plaitakis; Iraklion/GR

14:36B-0224 The “central vein sign”: is there a place for

susceptibility-weighted imaging in possible multiple sclerosis? T. Kau, M. Taschwer, M. Schönfelder, J.R. Weber, K.A. Hausegger; Klagenfurt/AT

14:45B-0225 Single- and multi-voxel proton spectroscopy in

patients with pyogenic brain abscess P.-H. Lai, C.-W. Ko, S.-H. Hsu, J.-H. Fu, P.-C. Wang, H.-B. Pan; Kaohsiung/TW

14:54B-0227 Directional diffusivity changes describing micro-

structural damage in normal appearing and lesioned cervical cord white matter in multiple sclerosis N. Berkovitz, P. Gottlieb, S. Tal; Zrifin/IL

15:03B-0228 Cognitive deficits in clinically isolated syndrome

correlate with perfusion changes indicative of inflammation E. Papadaki, P. Simos, T. Panou, V. Mastorodemos, E. Amanakis, T. Maris, A. Karantanas, A. Plaitakis; Iraklion/GR

15:12B-0229 3T MRS alterations in brain metabolism in HAART-

naive HIV infection A. Trofimova, T. Trofimova, G. Kataeva, S. Medvedev, N. Belyakov, V. Rassokhin, A. Korotkov, E. Malakhova; St. Petersburg/RU

14:00–15:30 Room I/K

Abdominal Viscera SS 201b Hepatocellular carcinoma: diagnosis

and management Moderators: G. Brancatelli; Palermo/IT, M. Bruegel; Munich/DE

14:00B-0230 Intravoxel incoherent motion diffusion-weighted MR

imaging of hepatocellular carcinoma: correlation with enhancement degree and histological grade S. Woo, J. Lee, J.-H. Yoon, I. Joo, J. Han, B. Choi; Seoul/KR

14:09B-0231 Accuracy of contrast-enhanced imaging in the

pretransplantation staging of hepatocellular carcinoma (HCC) and pathologic predictive factors of HCC recurrence after liver transplantation (LT) G. Besutti, A. Pecchi, M. De Santis, G. Tarantino, F. Di Benedetto, P. Torricelli; Modena/IT

14:18B-0232 Detection of HCC and liver metastases with BR14:

final results of a multicentre phase IIA study J. Hohmann1, A. Müller2, J. Skrok3, K.-J. Wolf2, A. Martegani4, C.F. Dietrich5, T. Albrecht2; 1Basle/CH, 2Berlin/DE, 3Baltimore, MD/US, 4Como/IT, 5Bad Mergentheim/DE

14:27B-0233 Integrating contrast-enhanced sonography (CEUS)

in the follow-up algorithm of patients with percutaneously ablated hepatocellular carcinoma (HCC) O. Catalano, P. Vallone, V. Granata, F. Izzo, V. Albino, A. Nunziata, A. Petrillo; Naples/IT

14:36B-0234 Hepatocellular carcinoma (HCC) treated with

transarterial chemoembolization (TACE): volume CT perfusion (VCTP) imaging in the detection of early changes – preliminary results J. Steiner, T. Wimmer, D. Bohlsen, F. Quehenberger, H. Schöllnast; Graz/AT

14:45B-0235 Role of dynamic contrast-enhanced perfusion MR

imaging in monitoring of patients with HCC lesions treated by radiofrequency ablation or transarterial chemoembolization C. Trattenero, D. Ippolito, M. Colombo, P.A. Bonaffini, R. Corso, S. Sironi; Milan/IT

14:54B-0236 Diagnostic efficacy of combined dynamic perfusion

MRI with ADC mapping in the assessment of therapeutic effects of HCC-treated lesions: preliminary results D. Ippolito, C. Trattenero, P. Bonaffini, C. Capraro, R. Corso, S. Sironi; Monza/IT

15:03B-0237 Recurrence patterns of hepatocellular carcinoma

(HCC) after liver transplantation (LT) and variations in dynamic imaging and histopathological characteristics between the primary and the intrahepatic recurrent HCC G. Besutti, A. Pecchi, M. De Santis, G. Tarantino, F. Di Benedetto, P. Torricelli; Modena/IT


ursday

225

B-02

38 –

B-0

256 15:12

B-0238 Accuracy of mRECIST versus RECIST 1.1 in predicting outcome in hepatocellular carcinoma treated with Sorafenib G. Gallusi, M. Di Martino, C. Lombardo, M. Del Monte, R. Di Miscio, A.F. Attili, C. Catalano; Rome/IT

15:21B-0239 Could antiplatelet therapy prevent hepatocellular

carcinoma? 7 Tesla liver magnetic resonance imaging study in a mouse model of hbv-related chronic hepatitis P. Marra, A. Esposito, G. Sitia, A. Palmisano, T. Canu, F. De Cobelli, L.G. Guidotti, A. Del Maschio; Milan/IT

14:00–15:30 Room L/M

Physics in Radiology SS 213 Innovations in CT technology and data

processing Moderators: C. Leidecker; Forchheim/DE, R. Padovani; Udine/IT

14:00B-0240 Performance evaluation of a new CT detector with

minimal electronic noise for low dose abdominal perfusion imaging E. Klotz, U. Haberland, B. Schmidt; Forchheim/DE

14:09B-0241 Performance of a next-generation solid-state detector

with fully integrated readout electronics for MDCT: quantitative analysis of image quality and radiation exposure reduction potential in comparison with its predecessor G. Pahn, L.-S. Veloza, H.-P. Schlemmer, H.-U. Kauczor, W. Stiller; Heidelberg/DE

14:18B-0242 Integrated circuit detector technology in abdominal

computed tomography: value in obese patients F. Morsbach1, S. Bickelhaupt1, S. Raetzer1, B. Schmidt2, H. Alkadhi1; 1Zurich/CH, 2Forchheim/DE

14:27B-0243 Comparison of filtered back projection (FBP) with

hybrid and iterative reconstruction algorithms (HIR and IR) in low dose protocols including high and low kV settings in CT angiography by testing the detectability of simulated endoleak and thrombus in a phantom study Z. Deák, J. Grimm, F. Mück, M. Treitl, M.F. Reiser, S. Wirth; Munich/DE

14:36B-0244 Influence of sinogram affirmed iterative reconstruction

of CT data on image noise characteristics and low-contrast detectability in comparison with filtered back projection: an objective approach C. von Falck1, V. Bratanova1, T. Rodt1, B. Meyer1, S. Waldeck2, F. Wacker1, H.-o. Shin1; 1Hannover/DE, 2Koblenz/DE

14:45B-0245 CTDI measurements using radiochromic films

N. Tomic, N. Sharoubim, F. DeBlois, J. Seuntjens; Montreal, QC/CA

14:54B-0246 Physical characterization of iterative reconstruction

algorithms in computed tomography and assessment of image quality for the optimization of a dual-energy abdominal protocol L. Berta, L. Mascaro, M. Cataldo, R. Maroldi; Brescia/IT

15:03B-0248 The impact of tube voltage, scan direction and beam

collimation on the performance of automatic tube current modulation systems in paediatric and adult CT N. Buls1, J. Schoenaers2, G. Van Gompel1, K. Nieboer1, J. de Mey1; 1Jette/BE, 2Hasselt/BE

15:12B-0249 3D spatial resolution evaluation of clinical CT using a

spherical phantom T. Mäkelä, V. Sairanen, J.I. Peltonen, M. Kortesniemi; Helsinki/FI

14:00–15:30 Room N/O

Vascular SS 215 Major vessel imaging

Moderators: W.R. Jaschke; Innsbruck/AT, O. Pellerin; Paris/FR

14:00B-0250 Low dose runoff CTA: what protocol is preferred

without special reconstruction algorithms? E. Kondratyev, G. Karmazanovsky; Moscow/RU

14:09B-0251 Value of contrast-enhanced MRA of the peripheral

arteries at 3T: results of a large European multicentre trial comparing meglumine gadoterate to gadobutrol-MRA with DSA C. Loewe1, J. Arnaiz2, D. Krause3, L. Marti Bonmati4, M. Aschauer5, A. Tartaro6, M. Lombardi7, M. Burrel8, R. Izzillo9; 1Vienna/AT, 2Santander/ES, 3Dijon/FR, 4Valencia/ES, 5Graz/AT, 6Chieti/IT, 7Pisa/IT, 8Barcelona/ES, 9Saint-Denis/FR

14:18B-0252 Nonenhanced quiescent-interval single-shot (QISS)

MRA in assessment of peripheral artery disease: comparison with digital subtraction angiography (DSA) R.S. Lanzman1, P. Heusch1, J. Aissa1, P. Schmitt2, J. Klasen1, D. Blondin1, G. Antoch1, P. Kröpil1; 1Düsseldorf/DE, 2Erlangen/DE

14:27B-0253 Magnetic resonance thrombus characterisation

can identify patients with rapid abdominal aortic aneurysm expansion V.L. Nguyen1, T. Leiner2, M.C.J. Wishaupt1, F.A.M.V. Hellenthal1, R.J. van der Geest3, E.M. Kooi1, G.W.H. Schurink1; 1Maastricht/NL, 2Utrecht/NL, 3Leiden/NL

14:36B-0254 CT angiography of abdominal aorta with low kV

CT protocol and low contrast medium volume: a feasibility study C.R.G.L. Talei Franzesi, D. Ippolito, P. Bonaffini, A.C. Cadonici, A. Masetto, S. Sironi; Monza/IT

14:45B-0255 An international multi-centre comparison of the

non-contrast MR angiography technique time-spatial labelling inversion pulse (time-SLIP) against contrast-enhanced CT angiography for assessing renal artery stenosis: the renal artery contrast-free trial (REACT) T.S.E. Albert1, I. Parienty2, V. Catala3, H. Xue4, V. Katabathina5, J.E. Lopera5, Z.Y. Jin4, N. Yellin1, M. Akahane6; 1Monterey, CA/US, 2Antony/FR, 3Barcelona/ES, 4Beijing/CN, 5San Antonio, TX/US, 6Tokyo/JP

14:54B-0256 Zonal variations in the size of the atherosclerotic

aortic arch during cardiac cycle and their implications on endovascular stenting S. Puppala, A. Shah, C. Dadnam; Leeds/UK

Scientific Sessions

226

B-02

57 –

B-0

27415:03

B-0257 CT angiography for the evaluation of the thoracic aorta: dynamic changes in the cardiac cycle with implications for thoracic endograft treatment J. Vallejos, C. Capunay, P. Carrascosa, J.C. Parodi, M.I. Sagarduy, P. Cortines; Vicente López/AR

15:12B-0258 Peripheral artery occlusion disease (PAOD):

comparison of CE-MRA versus DSA in grading of stenosis and planning therapy T.J. Vogl, C. Wurz, S. Zangos, A. Thalhammer, T. Schmitz-Rixen; Frankfurt a. Main/DE

15:21B-0259 Iodine load reduction in CT aorta angiography with

gemstone spectral imaging: comparison with standard CT aorta angiography X. Luo, J. Wu, J. Sun, M. Chen; Yangzhou/CN

14:00–15:30 Room P

Cardiac SS 203 Planning cardiac interventions

Moderators: I. Arkhipova; Moscow/RU, P. Mildenberger; Mainz/DE

14:00B-0260 Anatomical angulation between the long axis of the

left ventricle and left ventricular outflow tract as possible predictor of postprocedural complications in patients undergoing transapical aortic valve implantation B. Foldyna, M. Haensig, C. Lücke, D. Holzhey, S. Nitzsche, M. Borger, F.W. Mohr, M. Gutberlet, L. Lehmkuhl; Leipzig/DE

14:09B-0261 Temporal dynamics of the aortic root and the aortic

valve: implications for transcatheter aortic valve implantation T. Jurencak, B. Kietselaer, C. Mihl, V. Van Ommen, L. van Garsse, J. Wildberger, M. Das; Maastricht/NL

14:18B-0262 Aortic annulus area assessment by multidetector

computed tomography for predicting paravalvular regurgitation in patients undergoing balloon-expandable transcatheter aortic valve implantation – a comparison with transthoracic and transoesophageal echocardiography G. Pontone, D. Andreini, E. Bertella, S. Mushtaq, S. Cortinovis, A. Annoni, A. Formenti, G. Ballerini, M. Pepi; Milan/IT

14:27B-0263 Transcatheter aortic valve replacement: performance

of an aortic valvular complex model for semi-automated quantification of aortic annulus dimensions at cardiac CT P. Blanke1, E.-M. Spira1, D. Bernhardt2, R. Ionasec3, U. Ebersberger4, T. Flohr2, M. Langer1, U.J. Schoepf5; 1Freiburg/DE, 2Forchheim/DE, 3Princeton, NJ/US, 4Munich/DE, 5Charleston, SC/US

14:36B-0264 Dimensions of the aortic root and the aortic valve

for transcatheter aortic valve implantation: non-ECG-triggered multi-detector CT high-pitch scans compared with retrospectively ECG-gated low-pitch cardiac scans T. Jurencak, B. Kietselaer, C. Mihl, P. Nelemans, V. Van Ommen, L. van Garsse, J. Wildberger, M. Das; Maastricht/NL

14:45B-0265 Is aortic valve calcium distribution a predictor

for outcome after transcutaneous aortic valve implantation? P. Apfaltrer1, G. Schymik2, T. Germann1, H. Schroefel2, M. Meyer1, C. Fink1, S.O. Schönberg1, T. Henzler1; 1Mannheim/DE, 2Karlsruhe/DE

14:54B-0266 Influence of observer experience and training on

proficiency in cardiac CT interpretation J.M. Kerl1, U.J. Schoepf2, R.W. Bauer1, P. Costello2, T.J. Vogl1, C. Herzog1; 1Frankfurt a. Main/DE, 2Charleston, SC/US

15:03B-0267 Utility of cardiac magnetic resonance in the

identification of patients eligible for early implantation of cardioverter defibrillator after acute myocardial infarction E. Belloni1, E. Emanuele2, G. Marchesi3, D. Aschieri3, S. Ferraro3, E. Michieletti3, G.Q. Villani3, P. Scagnelli1; 1Castel San Giovanni/IT, 2Robbio/IT, 3Piacenza/IT

15:12B-0268 Optimisation of contrast injection protocol for CT

angiography in transcatheter aortic valve implantation (TAVI): preliminary results D. Di Marco1, M. Giglio2, R. Fachechi1, S. Sironi1, P. Spagnolo2; 1Monza/IT, 2Milan/IT

15:21B-0269 Assessment of aortic valve area in patients with

severe aortic stenosis using cardiac dual-source computed tomography: comparison with transthoracic echocardiography and cardiac magnetic resonance H. An, S. Ko, H. Hwang, M. Song, J. Choi, J. Shin; Seoul/KR

14:00–15:30 Room Q

Radiographers SS 214 Managing quality and dose in CT

Moderators: E. Agadakos; Athens/GR, A. Yule; Cardiff/UK

14:00B-0270 Personalised low dose chest CT applying adaptive

iterative dose reduction algorithm (AIDR 3D) integrated automatic exposure control techniques with 320-slice MDCT: initial clinical trial X. Chen; Guangzhou/CN

14:09B-0271 Feasibility of low dose protocol at 640-slice dynamic

volume CT for diagnosing central airways narrowing Z.-X. Ding, Z. Wang; Hangzhou/CN

14:18B-0272 Conducting a national diagnostic reference level

survey for computed tomography examinations: the Portuguese experience J. Santos1, S. Foley2, G. Paulo1, M.F. McEntee3, L. Rainford2; 1Coimbra/PT, 2Dublin/IE, 3Sydney/AU

14:27B-0273 Comparison of image quality between left and

right arm injection of contrast agent in computed tomography of carotid arteries D. Hribar, N. Djuric, S. Sterzaj, T. Holc, M. Kovacic, A. Janezic; Ljubljana/SI

14:36B-0274 Dose assessment in paediatric head computed

tomography examinations C.L.D.C. Fernandes, S.I. Rodrigues, A.F.C.L. Abrantes, L.P.V. Ribeiro, R.P.P. Almeida, C.A. Silva, K.B. Azevedo; Faro/PT


ursday

227

B-02

75 –

B-0

289 14:45

B-0275 Dose values in eye lens in paediatric brain computed tomography: influence of different protocols C. Carriço1, M. Inácio1, A. Kristiansen2, M. Larsen2, J. Santos1, S. Holm2, G. Paulo1; 1Coimbra/PT, 2Odense/DK

14:54B-0276 Influence of different arm positioning of MSCT of chest

by apply automatic tube current modulation technique Z.-X. Ding, Z. Wang; Hangzhou/CN

15:03B-0277 The effectiveness of lead apron for radiation

protection in CT N. Weber, P. Monnin, C. Elandoy, S. Ding; Lausanne/CH

15:12B-0278 Optimisation of local diagnostic reference levels in

head computed tomography M. Monteiro, A. Carvalho, J. Matias, J. Santos; Coimbra/PT

15:21B-0279 Comparison of radiation dose and image quality

between sequential and spiral brain CT I. Pace, F. Zarb; Msida/MT

14:00–15:30 Room Z

Computer Applications SS 205 Quantitative image analysis and

optimisation Moderators: L. Faggioni; Pisa/IT, M. Fatehi; Tehran/IR

14:00B-0280 Consistent automatic adipose tissue quantification in

MR abdomen images D. Smeets, W. Van Hecke, D. Loeckx; Leuven/BE

14:09B-0281 Computational texture analysis in interstitial lung

disease: comparison of descriptors and classification accuracy J. Ofner1, C. Mueller-Mang1, A. Burner1, D. Markonis2, A. Depeursinge2, H. Mueller2, G. Langs1; 1Vienna/AT, 2Sierre/CH

14:18B-0282 Quantification of correlations between somatostatin

receptors expression in biopsies from neuroendocrine tumours and PET/CT uptake values in the context of personalised medicine M. Athelogou1, D. Kaemmerer2, A. Lupp3, V. Prasad4, R. Schoenmeyer1, G. Binnig1, R. Baum2; 1Munich/DE, 2Bad Berka/DE, 3Jena/DE, 4Berlin/DE

14:27B-0283 3D analysis CT software in volumetric and

densitometric analysis of urinary stones M. Moschetta, A. Scardapane, M. Telegrafo, G. Angelelli, A.A. Stabile Ianora; Bari/IT

14:36B-0284 The 3DSlicer open-source platform for segmentation,

registration, quantitative imaging and 3D visualization of biomedical image data S. Pujol1, S. Pieper2, R. Kikinis1; 1Boston, MA/US, 2Cambridge, MA/US

14:45B-0285 Can the CT acquisition protocol be used in

combination with the study description to optimise patient dose tracking for CT examinations? T. De Bondt1, Q. Collier1, R. Salgado1, M. Geldof1, F. Deferme1, J. Valette2, A. Jomier2, W. Van Hecke1, P.M. Parizel1; 1Antwerp/BE, 2Mutzig/FR

14:54B-0286 A patient dose managing solution identifies erroneous

parameter settings in CT acquisition protocols, and contributes towards lowering radiation exposure T. De Bondt1, Q. Collier1, R. Salgado1, M. Geldof1, F. Deferme1, J. Valette2, A. Jomier2, W. Van Hecke1, P.M. Parizel1; 1Antwerp/BE, 2Mutzig/FR

15:03B-0287 Evaluation of the quality of abdominal computed

tomography images reconstructed with iterative reconstruction technique L. Henriksson, A. Persson, M. Sandborg; Linköping/SE

15:12B-0288 Improved image quality of virtual non-contrast dual-

energy CT images using a new iodine subtraction algorithm A. Helck, N. Hummel, F. Meinel, S.F. Thieme, M.F. Reiser, A. Graser, T.R.C. Johnson; Munich/DE

15:21B-0289 Image quality of monoenergetic low-keV datasets for

lower extremity dual-energy CT angiography S. Sudarski, D. Schneider, P. Apfaltrer, S.O. Schönberg, T. Henzler; Mannheim/DE

Scientific Sessions

228

B-02

90 –

B-0

30910:30–12:00 Room D1

Chest SS 504 Lung nodules

Moderators: S. Diederich; Düsseldorf/DE, N. Karabulut; Denizli/TR

10:30B-0290 70kV computed tomography of the thorax: valence for

computer-assisted nodule evaluation and radiation dose – first clinical results B. Schulz1, B. Bodelle1, T. Lehnert1, F. Al-Butmeh1, M. Sedlmair2, R. Banckwitz2, D. Klement1, T.J. Vogl1, M.J. Kerl1; 1Frankfurt a. Main/DE, 2Erlangen/DE

10:39B-0291 Improved accuracy of lung cancer diagnosis for fast-

growing lung nodules in CT lung cancer screening by optimisation of volume-doubling time cut-off M.A. Heuvelmans1, M. Oudkerk1, G.H. De Bock1, X. Xie1, P.M.A. Van Ooijen1, M.J.W. Greuter1, P.A. De Jong2, H.J.M. Groen1, R. Vliegenthart1; 1Groningen/NL, 2Utrecht/NL

10:48B-0292 AIDR improves characterisation of sub-centimetre

pulmonary GGO on low dose HRCT S. Hashemi Amroabadi1, H. Mehrez2, R.S. Cobbold1, N.S. Paul1; 1Toronto, ON/CA, 2Markham, ON/CA

10:57B-0293 Comparison of capabilities for differentiating

malignant SPNs from benign SPNs among dynamic first-pass perfusion area-detector CT, dynamic first-pass MRI and FDG-PET/CT Y. Ohno1, S. Seki1, M. Nishio1, H. Koyama1, T. Yoshikawa1, S. Matsumoto1, Y. Fujisawa2; 1Kobe/JP, 2Ohtawara/JP

11:06B-0294 Can dual-energy index help to differentiate malignant

and benign lesions of lung? A. Kannivelu, S. Srinivasan, H.S. Teh, H.T. Koay, C.H.A. Tan, T.W. Choy, K.K. Yeow, S.K.J. Lim; Singapore/SG

11:15B-0295 Features of resolving and non-resolving indeterminate

pulmonary nodules on follow-up CT: the NELSON study Y. Zhao, M. Dorrius, M. Heuvelmans, P. van Ooijen, M. Oudkerk, R. Vliegenthart; Groningen/NL

11:24B-0296 Stratification of pure ground-glass opacity (GGO)

nodular lung adenocarcinoma using quantitative analysis of CT imaging metrics to select patients for limited-resection more precisely J. Son, H. Lee, J. Kim, J. Han, K. Lee, O. Kwon, B. Kim, H. Kim, Y. Shim; Seoul/KR

11:33B-0297 Non-solid, part-solid or solid? Classification of

pulmonary nodules in thoracic CT by radiologists and a computer-aided diagnosis system C. Jacobs1, E.M. van Rikxoort2, J.-M. Kuhnigk1, E.T. Scholten3, P.A. de Jong4, C. Schaefer-Prokop5, M. Prokop2, B. van Ginneken2; 1Bremen/DE, 2Nijmegen/NL, 3Haarlem/NL, 4Utrecht/NL, 5Amersfoort/NL

11:42B-0298 Solid pulmonary nodules detected by low-dose CT:

effect of semi-automatic software on volumetry in vitro and in vivo Y. Zhao, M. Dorrius, P. van Ooijen, M. Oudkerk, R. Vliegenthart; Groningen/NL

11:51B-0299 Feasibility of training radiographers to detect nodules

in CT lung cancer screening A. Nair1, N. Gartland1, B. Barton1, E. Ifeakor1, J. Hodgkinson1, R. Vliegenthart2, P.A. de Jong3, M. Prokop4, A. Devaraj1; 1London/UK, 2Groningen/NL, 3Utrecht/NL, 4Nijmegen/NL

10:30–12:00 Room D2

Interventional Radiology SS 509 Neurovascular and spine interventions

Moderators: E.R. Gizewski; Innsbruck/AT, L. Pierot; Reims/FR

10:30B-0300 Carotid artery stenting: results and analysis of a

single-centre experience after 12 years F. Fanelli, A. Cannavale, E. Boatta, M. Corona, C. Cirelli, F.M. Salvatori; Rome/IT

10:39B-0301 Additional value of mechanical thrombectomy

devices in thrombo-embolic complications during endovascular occlusion of intracranial aneurysms M.H.J. Voormolen, T. van der Zijden, T. Menovsky, P.N.M. Parizel; Antwerp/BE

10:48B-0302 Stent-assisted endovascular occlusion of intracranial

aneurysms M.H.J. Voormolen, T. Van der Zijden, T. Menovsky, P. Parizel; Antwerp/BE

10:57B-0303 Long-term results of microsurgical and endovascular

therapy of intracranial aneurysms in patients following subarachnoid haemorrhage K. Bojanowski1, J. Baron2, B. Kostkiewicz1, M. Zawadzki1, J. Walecki1; 1Warsaw/PL, 2Katowice/PL

11:06B-0304 Embolisation of cerebral aneurysms with hydrogel-

coated coils: systematic review and meta-analysis A. Pałys, Z. Serafin, W. Lasek; Bydgoszcz/PL

11:15B-0305 Effect of antiplatelet therapy on radiographic outcome

of positivity on diffusion-weighted imaging in elective endovascular coiling of unruptured cerebral aneurysm T. Matsushige, K. Shinagawa, Y. Akiyama, T. Okazaki, S. Sakamoto, Y. Kiura, K. Sugiyama, K. Kurisu; Hiroshima/JP

11:24B-0306 MR-guided lumbosacral nerve root injection therapy

using an open 1.0 Tesla MRI system: a clinical investigation F. Streitparth1, M. De Bucourt1, T. Hartwig1, T. Walter1, M. Maurer1, D. Renz1, B. Gebauer1, B. Hamm1, U. Teichgräber2; 1Berlin/DE, 2Jena/DE

11:33B-0307 Vertebral split fractures: the role of percutaneous

vertebroplasty L. Huwart1, O. Hauger2, P.-Y. Marcy1, P. Foti1, M.-E. Amoretti1, P. Brunner3, N. Amoretti1; 1Nice/FR, 2Bordeaux/FR, 3Monaco/MC

11:42B-0308 Percutaneous vertebroplasty in vertebra plana:

does the presence of intravertebral cleft impact the efficiency of the procedure? L. Huwart1, P.-Y. Marcy1, P. Foti1, M.-E. Amoretti1, O. Hauger2, P. Brunner3, N. Amoretti1; 1Nice/FR, 2Bordeaux/FR, 3Monaco/MC

11:51B-0309 Percutaneous ablation of spinal osteoid osteoma:

report of 37 patients G. Tsoumakidou, J. Garnon, I. Enescu, X. Buy, A. Gangi; Strasbourg/FR

Scientific Sessions

229

Friday

B-03

10 –

B-0

329 10:30–12:00 Room E1

Musculoskeletal SS 510 Tendon, muscle and tissue

composition Moderators: J. Healy; London/UK, A. Mileto; Durham, NC/US

10:30B-0310 Efficacy of intra-tendinous injection of platelet-

rich plasma to treat tendinosis: comprehensive assessment on a murine model B. Dallaudiere1, M. Lempicki1, L. Pesquer2, P. Meyer2, E. Schouman-Claeys1, J.-M. Serfaty1; 1Paris/FR, 2Bordeaux/FR

10:39B-0311 High volume image-guided injections in patellar

tendinopathy S.L. Morton, O. Chan, D. Morrissey, J. King, T. Crisp, N. Maffulli; London/UK

10:48B-0312 Biomechanical properties of the calcaneal tendon in

vivo assessed by transient shear wave elastography S. Aubry1, J.-R. Risson1, A. Kastler2, B. Barbier-Brion1, M. Runge1, B. Kastler1; 1Besancon/FR, 2Clermont-Ferrand/FR

10:57B-0313 Muscle elastography in patients affected by multiple

sclerosis G. Illomei, G. Spinicci, M. Arru, M. Marrosu; Cagliari/IT

11:06B-0314 Dixon-based MRI for assessment of muscle-fat

content in-vitro and in patients with achillodynia in comparison to healthy volunteers M.A.F. Fischer, C.W.A. Pfirrmann, N. Espinosa, D.A. Raptis, F.M. Buck; Zurich/CH

11:15B-0315 Postmortal 31P magnetic resonance spectroscopy of

the skeletal muscle: a-ATP/Pi ratio as a forensic tool? J. Yamamura1, T.M. Schidt1, R. Fischer1, Z.J. Wang2, M. Lorenzen1; 1Hamburg/DE, 2Dallas, TX/US

11:24B-0316 Visceral fat by DXA: current methods and potential

clinical implications A. Bazzocchi, D. Diano, F. Ponti, A. Andreone, C. Sassi, U. Albisinni, G. Battista; Bologna/IT

11:33B-0317 Post-exercise intramyocellular acetylcarnitine

levels in endurance trained and sedentary subjects measured with 1H-MRS L. Lindeboom, B.M.W. Brouwers, T. van de Weijer, C.I.H.C. Nabuurs, M.E. Kooi, M.K.C. Hesselink, P. Schrauwen, J.E. Wildberger, V.B. Schrauwen-Hinderling; Maastricht/NL

11:42B-0318 In vivo differentiation of muscle precursor cells using

MR relaxometry N.C. Chuck, F. Azzabi Zouraq, D. Eberli, A. Boss; Zurich/CH

11:51B-0319 MRI findings of the bone marrow related to unloading

with longitudinal follow-up L. Nardo1, D. Sandman1, W. Virayavanich1, S. Lee1, A. Lai1, L. Zhang2, R. Souza1, M. Guindani2, T. Link1; 1San Francisco, CA/US, 2Houston, TX/US

10:30–12:00 Room F1

Oncologic Imaging SS 516 Cutting edge imaging in oncology:

when and how? Moderators: K. Coenegrachts; Bruges/BE, E.J. Rummeny; Munich/DE

10:30B-0320 Virtual 3D 18F-FDG PET/CT panendoscopy for

assessing the upper airways of head and neck cancer patients: initial results P. Heusch1, C. Buchbender1, B. Geiger2, J. Treffert3, T. Lauenstein4, M. Forsting4, G. Antoch1, T.A. Heusner1; 1Duesseldorf/DE, 2Princeton, NJ/US, 3Knoxville, TN/US, 4Essen/DE

10:39B-0321 18F-FLT- PET in the diagnosis of gastric cancer

T. Staniuk1, M. Studniarek2, W. Zegarski1, E. Srutek1, B. Malkowski1; 1Bydgoszcz/PL, 2Bojano/PL

10:48B-0322 First clinical experience in restaging of patients

with recurrent prostate cancer by 11C-choline-PET/MR: comprehensive diagnostic MR protocol and comparison with 11C-choline-PET/CT M. Eiber, M. Souvatzoglou, E.J. Rummeny, M. Schwaiger, A.J. Beer; Munich/DE

10:57B-0323 Apparent diffusion coefficient for evaluating early

tumour response to neoadjuvant chemo-radiotherapy in locally advanced cervical cancer: correlation with histopathology. Preliminary results M. Miccò, A.L. Valentini, B. Gui, A.M. De Gaetano, M. Iacobucci, L. Bonomo; Rome/IT

11:06B-0324 The value of DWI in differentiating ocular tumours

from retinal detachment K. Erb, G. Willerding, M. Taupitz, B. Hamm, P. Asbach; Berlin/DE

11:15B-0325 Dosimetric impact of MR vs CT delineation of boost

volume in breast cancer M. Betti, L. Orlandini, C. Biagini, M. de Liguoro, F. Mungai, L. Natale, L. Cionini; Sesto Fiorentino/IT

11:24B-0326 PET/MR vs PET/CT in lung cancer N staging: initial

experience with a three-segment model attenuation correction A. Kohan, C. Rubbert, J.L. Vercher Conejero, S. Partovi, R. Jones, K. Herrmann, P. Faulhaber; Cleveland, OH/US

11:33B-0327 Incidental findings in the general adult population

using whole body MRI as a screening method S. Ulus, E. Karaarslan; Istanbul/TR

11:42B-0328 Bone metastasis at a glance: a new advanced

visualization algorithm for fast and easy detection in thoracoabdominal CT D.F. Toth, M. Toepker, M.E. Mayerhoefer, J. Furtner, U. Asenbaum, G. Karanikas, M. Weber, C. Czerny, H. Ringl; Vienna/AT

11:51B-0329 Comparison of the utility of whole body MRI with and

without contrast-enhanced quick 3D and double RF fat suppression techniques, conventional whole body MRI, PET/CT and conventional examination for assessment of recurrence in NSCLC patients Y. Ohno1, S. Seki1, M. Nishio1, H. Koyama1, T. Yoshikawa1, S. Matsumoto1, S. Satou2, K. Sugimura1; 1Kobe/JP, 2Ohtawara/JP

Scientific Sessions

230

B-03

30 –

B-0

34910:30–12:00 Room F2

Breast SS 502 Elastography and other advances in

breast ultrasound Moderators: D. Djilas-Ivanovic; Sremska Kamenica/RS, P. Skaane; Oslo/NO

10:30B-0330 Quantitative shear wave elastography: evaluating

an additional use with conventional ultrasound in diagnosis of breast lesions J. Moon, K.-S. Jung, S. Koh, J.-Y. Jung; Anyang-si/KR

10:39B-0331 Quantitative ShearWave ultrasound elastography:

initial experience in palpable breast masses S. Hari, S. Naga, A. Dhar, M. Jana; New Delhi/IN

10:48B-0332 Can the ring sign improve the performance of

shearwave elastography in benign/malignant differentiation of screen detected solid breast masses? M. Szewcyk-Bieda, A. Evans, S. Vinnicombe, P. Whelehan, K. Thomson; Dundee/UK

10:57B-0334 Influence of menopause in women on breast

elasticity measured by elasticity parameters with sonoelastography X. Wang, Y. Wang, P. Xu; Shanghai/CN

11:06B-0335 Stiffness measured by Shear Wave elastography: a

biomarker of the early chemotherapy response in a human breast cancer model? F. Chamming‘s, M. Le Frère-Belda, v. Fitoussi, L. Pidial, H. Latorre-Ossa, J.-L. Gennisson, O. Clément, C.-A. Cuenod, L.S. Fournier; Paris/FR

11:15B-0336 SONAZOID® (perflubutane) microbubble-enhanced

ultrasound for differential diagnosis of breast lesions: pooled analysis of phase 2 and 3 clinical studies Y. Miyamoto1, T. Ito2, E. Takada3, T. Hirai4, K. Omoto5, R. Sekiguchi3, T. Okuno6, S. Kanazawa1, F. Moriyasu1; 1Tokyo/JP, 2Osaka/JP, 3Tochigi/JP, 4Nara/JP, 5Saitama/JP, 6Kobe/JP

11:24B-0337 US-based automated breast volume scanner (ABVS):

improvement of breast lesion detection in 51 patients – initial study X. Wang, Y. Wang, P. Xu; Shanghai/CN

11:33B-0338 Useful of real-time virtual sonography (RVS) on the

evaluation of MRI-detected lesions of the breast in second-look sonography S. Nakano, K. Fujii, M. Yoshida, J. Kousaka, Y. Mori, T. Ando, R. Tetsuka, T. Fukutomi, T. Ishiguchi; Nagakute/JP

11:42B-0339 Targeting accuracy of real-time virtual sonography

(RVS) in sonographic identification of enhancing lesions in breast MRI S. Nakano, K. Fujii, M. Yoshida, J. Kousaka, Y. Mori, T. Ando, R. Tetsuka, T. Fukutomi, T. Ishiguchi; Nagakute/JP

10:30–12:00 Room G/H

Genitourinary SS 507 New frontiers in GU imaging

Moderators: G. Hagen; Oslo/NO, C.M.A. Hoeks; Nijmegen/NL

10:30B-0340 Functional evaluation of transplanted kidneys using

arterial spin labelling (ASL) MRI at 1.5T and 3T: results in 105 patients R.S. Lanzman, D. Blondin, P. Heusch, P. Bilk, P. Kröpil, F. Miese, G. Antoch, H.-J. Wittsack; Düsseldorf/DE

10:39B-0341 Assessment of novel chemokine-directed therapy of

renal allograft rejection in a murine animal model with multiparametric functional MRI M. Notohamiprodjo, A. Kalnins, M. Kolb, A. Wagner, M.F. Reiser, K. Nikolaou, J. Andrassy; Munich/DE

10:48B-0342 Assesment cisplatin-induced interstitial nephropathy

using diffusion-weighted MRI R. Del Vescovo, F. Giurazza, R.L. Cazzato, C.L. Piccolo, R.F. Grasso, B. Beomonte Zobel; Rome/IT

10:57B-0343 Value of diffusion-weighted-MR-imaging for the

detection of nephritis H.J. Michaely1, M. Reichert1, B. Henninger2, S. Haneder1, S.O. Schönberg1; 1Mannheim/DE, 2Innsbruck/AT

11:06B-0344 DCE-MRI assessment of kidney function and renal

masses: single slice versus whole organ/tumour M. Notohamiprodjo, A.D. Helck, S. Winter, M. Staehler, M. Braunagel, M. Ingrisch, M.F. Reiser, K. Nikolaou; Munich/DE

11:15B-0345 In vivo sodium (23Na) imaging of the human kidneys

at 7.0T: preliminary results S. Haneder1, V. Juras2, H.J. Michaely1, S.O. Schönberg1, S. Trattnig2, Š. Zbýň2; 1Mannheim/DE, 2Vienna/AT

11:24B-0346 Arterial spin labelling for the prostate: initial

experience at 3T MRI S. Takahashi1, N. Aoyama1, T. Kimura2, K. Kitajima1, Y. Ueno1, S. Sato3, K. Sugimura1; 1Kobe/JP, 2Otawara/JP, 3Osaka/JP

11:33B-0347 A new look at the female pelvis: ultra-high-field (7T)

MR imaging L. Umutlu, O. Kraff, A. Fischer, S. Kinner, S. Maderwald, M. Forsting, M.E. Ladd, T.C. Lauenstein; Essen/DE

11:42B-0348 Bridging septa in T2-weighted MRI of healthy

volunteers: is there an association with the peri- and pararenal fat thickness? B. Mensel, R. Bülow, F. Weber, J.-P. Kühn, N. Hosten, K. Hegenscheid; Greifswald/DE

11:51B-0349 Feasibility of 3T MR diffusion tensor imaging (DTI) for

reconstructing anatomic connectivity of sacral plexus V. Iotti1, A. Pecchi1, L. Nocetti1, F. Fiocchi1, C. Alboni2, P. Torricelli1; 1Modena/IT, 2Sassuolo/IT

Scientific Sessions

231

Friday

B-03

50 –

B-0

369 10:30–12:00 Room L/M

Neuro SS 511 Stroke-related arterial disease

Moderators: E. Avdagic; Sarajevo/BA, P. Barsi; Budapest/HU

10:30B-0350 Atherosclerotic calcification is related to cognitive

decline: the Rotterdam study D. Bos, M.W. Vernooij, A. Hofman, G.P. Krestin, J.C.M. Witteman, A. van der Lugt, M.A. Ikram; Rotterdam/NL

10:39B-0351 Does clinical severity in acute stroke reliably predict

large vessel occlusion? Results from a prospective cohort study of CT angiography (CTA) in hyper-acute stroke C. Hansen, C. Ovesen, H. Christensen, I. Havsteen, J. Nielsen, A. Christensen; Copenhagen/DK

10:48B-0352 Value of monoenergetic low KV dual-energy CT

datasets for improved image quality of cervical and cerebral CT-angiography D. Schneider, P. Apfaltrer, H. Haubenreisser, M. Meyer, S. Sudarski, C. Fink, S.O. Schönberg, T. Henzler; Mannheim/DE

10:57B-0353 Black blood MRI in patients with and without

suspected primary angiitis of the central nervous system T. Saam, T. Pfefferkorn, M. Habs, C. Opherk, A. Straube, M. Dichgans, M.F. Reiser, K. Nikolaou, J. Linn; Munich/DE

11:06B-0354 3T MRI reveals extra- and intracranial involvement in

giant cell arteritis (GCA) S. Siemonsen, C. Brekenfeld, T. Klink, J. Fiehler, T. Bley; Hamburg/DE

11:15B-0355 BOLD fMRI of cerebrovascular reserve in patients

with severe stenosis of the middle cerebral artery: preliminary results A. Krainik, A. Attye, M. Villien, K. Boubagra, K. Garambois, J. Bouvier, J. Warnking, F. Tahon, O. Detante; Grenoble/FR

11:24B-0356 Intracranial artery calcification on CT predicts poor

outcome after stroke: results from a prospective cohort study C. Ovesen, H. Christensen, A.-M. Abild, C. Hansen, I. Havsteen, J. Nielsen, A. Christensen; Copenhagen/DK

11:33B-0357 Intracranial artery stenosis on CT angiography (CTA)

predicts poor outcome after stroke: results from a prospective cohort study C. Ovesen, H. Christensen, A.-M. Abild, C. Hansen, I. Havsteen, J. Nielsen, A. Christensen; Copenhagen/DK

11:42B-0358 Contribution of the temporal maximum intensity

projection (tMIP) datasets for measurement of the middle cerebral artery (MCA) occlusion and predictive value for results of systemic thrombolytic therapy J. Baxa, R. Tupý, V. Rohan, B. Kreuzberg, J. Ferda; Pilsen/CZ

11:51B-0359 MRI findings in small vessel disease and their

relationship to cognitive impairment P. Benjamin, A.J. Lawrence, B. Patel, A.W. Chung, T.R. Barrick, A.D. Mackinnnon, R. Morris, H.S. Markus; London/UK

10:30–12:00 Room N/O

Vascular SS 515 Novel tools for blood flow evaluation

Moderators: J. Barkhausen; Lübeck/DE, F. Garaci; Rome/IT

10:30B-0361 Assessment of blood flow haemodynamics of liver

cirrhosis patients after treatment with a TIPS stent-graft using a flowsensitive 4D MRI imaging at 3 Tesla Z. Stankovic1, M.F. Russe2, B. Jung2, W. Euringer2, Z. Csatari2, L. Stehlin2, M. Langer2, M. Markl1; 1Chicago, IL/US, 2Freiburg/DE

10:39B-0362 Evaluation of atherosclerosis and endothelial

functions in nonalcoholic hepatosteatosis patients: comparison with ultrasound and biochemical markers M.G. Yilmabasar, A. Hayirlioglu, U. Ozdamarlar, I. Kuru; Istanbul/TR

10:48B-0363 CT angiography in renal donors using automated kVp

selection in combination with sinogram-affirmed iterative reconstruction: evaluation of radiation dose and image quality M.P.F. Botelho, F.D. Gonzalez-Guindalini, P. Entezari, H. Chalian, V. Yaghmai; Chicago, IL/US

10:57B-0364 Comparison of high pitch (3) and standard pitch (0.6)

CT angiography using 128-slice dual-source CT in patients with peripheral arterial disease K. Choo, J. Park, J. Kim, J. Roh; Busan/KR

11:06B-0365 Differential diagnosis of cervical artery dissection and

intra-arterial thrombosis using MRI and MRA M. Dreval, M. Krotenkova, L. Kalashnikova, L. Dobryinina, R. Konovalov; Moscow/RU

11:15B-0366 Impact of organ-specific dose reduction on image

quality of head and neck CT-angiography R.S. Lanzman, L. Schimmöller, P. Heusch, S. Dietrich, F. Miese, J. Aissa, T.A. Heusner, G. Antoch, P. Kröpil; Düsseldorf/DE

11:24B-0367 Precision of pulmonary vein diameter measurements

assessed by CE-MRA and steady-state-free precession imaging F. Henes, P. Bannas, M. Regier, J. Buhk, K. Müllerleile, G. Adam, M. Groth; Hamburg/DE

11:33B-0368 The application of CT angiography with whole brain

perfusion imaging in the evaluation of patients with transient ischaemic attack H. Shi, F. Yang, X. Ma, W. Guo, S. Dong, M. Qiao; Beijing/CN

11:42B-0369 Multicentre, intra-individual comparison of single

dose gadobenate dimeglumine and double dose gadopentetate dimeglumine for MR angiography of the peripheral arteries R. Iezzi1, J. Wang2, F. Yan2, J. Liu3, D. Li4, X. Wang3, Y. Li2, F. De Cobelli5, G. Pirovano6; 1Rome/IT, 2Shanghai/CN, 3Peking/CN, 4Hefei/CN, 5Milan/IT, 6Princeton, NJ/US

Scientific Sessions

232

B-03

70 –

B-0

38910:30–12:00 Room P

Cardiac SS 503 Advances in coronary CT angiography

Moderators: S. Bohata; Brno/CZ, L. Natale; Sesto Fiorentino/IT

10:30B-0370 Evaluation of a novel algorithm for coronary motion

compensation in prospective and retrospective coronary CT angiography (CCTA) J.-L. Sablayrolles1, J. Feignoux1, P. Ayestaran2, A. Sagniez2; 1Saint Denis/FR, 2Buc/FR

10:39B-0371 Estimating effective dose for cardiac CT with patient-

specific dose maps in comparison with DLP conversion („k factor“) method J.H. Yanof1, C. Thompson1, J. Wiegert2, K. Yaddanapudi1, S. Halliburton1; 1Cleveland, OH/US, 2Hamburg/DE

10:48B-0372 Impact of a new detector technology (Stellar, Siemens

Healthcare) on image noise in coronary CTA S.D.C. Deseive1, A.-L. Menges1, S. Martinoff1, M. Hadamitzky1, T. Flohr2, B. Schmidt2, C. Thierfelder2, T. Allmendinger2, J. Hausleiter1; 1Munich/DE, 2Erlangen/DE

10:57B-0373 Radiation dose reduction in computed tomography

myocardial perfusion imaging using iterative reconstruction and patient-tailored imaging M. Williams1, S. Golay1, N.W. Weir1, S. Mirsadraee1, E.J.R. Van Beek1, J. Reid2, G. McKillop1, N. Uren1, D.E. Newby1; 1Edinburgh/UK, 2Melrose/UK

11:06B-0374 Radiation dose reduction in cardiac CTA using a novel

iterative reconstruction algorithm in 320-row detector CT T. Durmus1, R. Luhur1, J. Blobel2, J. Mews2, A. Lembcke1; 1Berlin/DE, 2Neuss/DE

11:15B-0375 Computed tomography coronary angiography with a

consistent dose below 2 mSv using double high-pitch spiral acquisition in patients with atrial fibrillation Q. Wang, Y. Chen, B. He; Beijing/CN

11:24B-0376 Coronary artery calcium scoring from dual-source

chest CT: potentials for ungated, high-pitch scan technique in routine clinical practice F. Molinari, A. Hutt, M. Rémy-Jardin, J.-B. Faivre, A. Simeone, E. Algeri, J. Rémy; Lille/FR

11:33B-0377 Diagnostic accuracy of free-breathing coronary

CTA using dual-source CT high-pitch acquisition: comparison of single and double scans with conventional angiography M.C. So1, W.L. Chin2, C.M. Wong1, C.W. Tai1, M.W. Leung1; 1Hong Kong/HK, 2Singapore/SG

11:42B-0378 One beat coronary CT angiography using 640 slices

multidetector CT scanner in patients with atrial fibrillation A. Gennarelli, A. Di Sibio, M. Perri, F. Di Stasio, V. Felli, M. Di Luzio, A.V. Giordano, E. Di Cesare, C. Masciocchi; L‘Aquila/IT

11:51B-0379 Influence of AIDR on accuracy of plaque

characterisation and lumen assessment during CT coronary angiography A. Ursani, H. Mehrez, H. Kashani, N. Paul; Toronto, ON/CA

10:30–12:00 Room Q

Radiographers SS 514 The radiographer‘s role as health care

team member Moderators: V. Syrgiamiotis; Athens/GR, C. Vandulek; Kaposvár/HU

10:30B-0380 How do radiographers interact with children in the

radiographic examination? B. Björkman1, K. Enskär1, M. Golsäter1, R.J. Simeonsson2; 1Jönköping/SE, 2Chapel Hill, NC/US

10:39B-0381 Requesting x-rays at the right time to utilise the

capacity of the radiology department: an everyday challenge M. Mowinckel-Nilsen; Os/NO

10:48B-0382 Risk management in computed tomography using an

incident reporting system M. Antoniutti, S. Doratiotto; Treviso/IT

10:57B-0383 Is a radiographer-led immediate reporting service

for emergency department referrals a cost-effective initiative? M. Hardy1, B. Snaith2; 1Bradford/UK, 2Wakefield/UK

11:06B-0384 An investigation into the ability of Irish radiographers:

in the identification of wrist and scaphoid fractures A.P. Tyrrell1, L. Rainford2; 1Kilkenny/IE, 2Dublin/IE

11:15B-0385 Workloads of reporting radiographers and

sonographers: cost-effectiveness compared with consultant radiologist W.P. Hedges1, S.H. Khan2; 1Lancaster/UK, 2Blackburn/UK

11:24B-0386 Radiographer‘s expectations for role development:

a national survey in view of radiography students in final year of graduation C.M. Mendes, A.F.C.L. Abrantes, R.P.P. Almeida, L.P.V. Ribeiro, S.I. Rodrigues; Faro/PT

11:33B-0387 Job satisfaction among radiographers in Switzerland:

a national survey N. Richli Meystre, P. Lehmann, N. Mamboury; Lausanne/CH

11:42B-0388 Progression of quality improvement works in

radiography by radiographers R. Gullien, J.G. Andersen, A.E. Haakull; Oslo/NO

11:51B-0389 Radiographer contribution to the interpretation of

trauma radiographs: a survey of UK practice B. Snaith1, M. Hardy2, E. Lewis1; 1Wakefield/UK, 2Bradford/UK

Scientific Sessions

233

Friday

B-03

90 –

B-0

409 14:00–15:30 Room A

Genitourinary SS 607 Female pelvis imaging

Moderators: L.S. Fournier; Paris/FR, A.G. Rockall; London/UK

14:00B-0390 Diagnostic and prognostic value of 18F-FDG PET/

MR over MR and PET/CT in recurrent gynaecologic malignancies prior to pelvic exenteration I.A. Burger1, H.A. Vargas2, O.F. Donati2, V. Andikyan2, H. Schoder2, D. Chi2, E. Sala2, H. Hricak2; 1Zurich/CH, 2New York, NY/US

14:09B-0391 Diagnostic value of quantitative measurement of

microvascular changes achieved using perfusion MR imaging in the assessment of tumour grading in endometrial carcinoma O. Minutolo, D. Ippolito, A.C. Cadonici, P.A. Bonaffini, C. Capraro, S. Sironi; Monza/IT

14:18B-0392 Influence of pathophysiological parameters with

kinematic MRI in evaluation of female pelvic floor M. Palumbo, S. Carbone, L.S. Maltese, D. D‘Elia, A. Luceri, V. Ricci, L. Volterrani; Siena/IT

14:27B-0393 Origin of the uterine artery in females using three-

dimensional reconstructed contrast-enhanced MR angiography before uterine artery embolisation: where to look for it N.N.N. Naguib, N.-E.A. Nour-Eldin, T. Lehnert, B. Schulz, S. Zangos, T.J. Vogl; Frankfurt a. Main/DE

14:36B-0394 Fibre tracking evaluation of sacral nervous pathways

3D architecture in women affected by endometriosis M. Sergi, V. Vinci, S. Bernardo, P. Sollazzo, M. Saldari, L. Manganaro; Rome/IT

14:45B-0395 How to improve magnetic resonance accuracy in

detection of deep infiltrating colorectal endometriosis: correlation with laparoscopy and histopathology M. Miccò, A.L. Valentini, B. Gui, V. Ninivaggi, M. Marino, L. Bonomo; Rome/IT

14:54B-0396 Preliminary functional study with MR defecography in

patients suffering from deep endometriosis P. Sollazzo, S. Bernardo, M. Sergi, V. Vinci, M. Saldari, L. Manganaro; Rome/IT

15:03B-0397 Diffusion-weighted magnetic resonance imaging of

the female pelvis: do apparent diffusion coefficient values of the fat tissue change over the menstrual phases? F. Fornasa, A. Gasparini, F. Pantalone, M. Bellotti, A. Dibenedetto, C. Cicciò; San Bonifacio/IT

15:12B-0398 Effect of different birthing positions on pelvic bony

dimensions in healthy women and pregnant patients in MR pelvimetry S. Zangos, K. Eichler, A. Schollenberger, A. Reitter, F. Louwen, P. Siebenhandl, T. Gruber-Rouh, T.J. Vogl; Frankfurt a. Main/DE

15:21B-0399 Retrospective analysis of elements that can predict

short- and long-term outcome in patients affected by uterine leiomyomas and treated with MRgFUS F. Ciolina, A. Napoli, F. Zaccagna, F. Boni, L. Bertaccini, V. Noce, B. Cavallo Marincola, C. Catalano; Rome/IT

14:00–15:30 Room B

Neuro SS 611 Alzheimer‘s and Parkinson‘s

Moderators: B. Góraj; Nijmegen/NL, T. Meindl; Landshut/DE

14:00B-0400 MCI to AD conversion and the role of myoinositol (MI)

and N-acetylaspertate (NAA) as biomarkers for this process J. Walecki, M. Barcikowska, J.B. Ćwikła, T. Gabrylewicz, T. Bulski; Warsaw/PL

14:09B-0401 Evaluation of posterior cingulate region with FDG-PET

and MR advanced techniques (MRS, PWI and DTI) in patients with MCI – correlation of the methods A. Zimny, J. Bladowska, A. Macioszek, P. Szewczyk, E. Trypka, R. Wojtynska, J. Leszek, M.J. Sasiadek; Wroclaw/PL

14:18B-0402 The relation of uric acid with brain atrophy and

cognition: the Rotterdam scan study B.F.J. Verhaaren, M.W. Vernooij, A. Dehghan, H. Vrooman, R. de Boer, W.J. Niessen, A. van der Lugt, M.A. Ikram; Rotterdam/NL

14:27B-0403 MR spectroscopy in mild and moderate cognitive

impairment as illness outcome predictor: preliminary experience J. Forner Giner1, A. Alberich-Bayarri1, G. Garcia Marti1, A. Pomar-Nadal1, J. Rayón-Aledo2, L. Martí-Bonmatí1; 1Valencia/ES, 2Madrid/ES

14:36B-0404 Differentiating multiple system atrophy and

Parkinson’s disease on 3T MRI: a novel use of decision tree S. Rajandran Nair, L.K. Tan, N. Ramli, S.Y. Lim, K. Rahmat, H. Mohd Nor; Kuala Lumpur/MY

14:45B-0405 Subthalamic nuclei 3 Tesla T2-relaxometry correlated

to UPDRS scores in pre-deep brain stimulation (DBS) patients with Parkinson disease with consideration to the laterality of the disease T.M.L. Lönnfors-Weitzel, T. Weitzel, J. Slotboom, C. Kiefer, A. Kaelin-Lang, C. Pollo, R. Wiest; Berne/CH

14:54B-0406 Increased regional grey matter volume in Parkinson’s

disease patients with excessive daytime sleepiness: an MRI study M. Chondrogiorgi, L.C. Tzarouchi, A. Zikou, P. Kosta, M.I. Argyropoulou, S. Konitsiotis; Ioannina/GR

15:03B-0407 Olfactory tract evaluation in patients with Parkinson

disease (PD) and hyposmia: a diffusion tensor imaging (DTI) study F. Pitocco, L. Di Biase, A. Giona, L. Scarciolla, C. Mallio, Y. Errante, J. Melgari, B. Beomonte Zobel, C. Quattrocchi; Rome/IT

15:12B-0408 The neural correlates of anomia in the conversion

from mild cognitive impairment to Alzheimer’s disease E. Pravata‘1, J. Tavernier1, R. Parker2, H. Vavro3, J.E. Mintzer1, M. Spampinato1; 1Charleston, SC/US, 2Gainesville, FL/US, 3Zagreb/HR

15:21B-0409 Gender differences in grey matter atrophy patterns in

the mild cognitive and early Alzheimer’s disease M. Spampinato1, E. Pravata‘1, B. Langdon1, K. Patrick1, R. Parker2; 1Charleston, SC/US, 2Gainesville, FL/US

Scientific Sessions

234

B-04

10 –

B-0

42614:00–15:30 Room C

Cardiac SS 603a CT and MRI: risk stratification

Moderators: E.A. Mershina; Moscow/RU, M.R. Rees; Gwynedd/UK

14:00B-0410 Updated algorithms using „in-office-evaluation“

and calcium score may reduce referral of stable angina patients to computed tomography coronary angiography A.S. Dharampal, A. Rossi, A. Dedic, S.L. Papadopoulou, A. Weustink, K. Nieman, E. Boersma, P.J. de Feijter, G.P. Krestin; Rotterdam/NL

14:09B-0411 Dynamic CT perfusion imaging for the detection of

myocardial ischaemia: a first experience with a 3D semi-automated evaluation software U. Ebersberger1, R.P. Marcus2, U.J. Schoepf1, P. Blanke1, Y. Wang3, L. Geyer1, A.D. McQuiston1, D. Bernhardt4, F. Bamberg2; 1Charleston, SC/US, 2Munich/DE, 3Beijing/CN, 4Forchheim/DE

14:18B-0412 Quantitative evaluation of myocardial perfusion

reserve at 3 and 1.5 Tesla in comparison to invasive measurement of fractional flow reserve for detection of coronary artery disease T. Walcher, K. Ikuye, W. Rottbauer, J. Woehrle, P. Bernhardt; Ulm/DE

14:27B-0413 Dynamic stress computed tomography perfusion

imaging for the detection of functionally significant coronary lesions A. Rossi1, A. Dharampal1, S.E. Petersen2, E. Klotz3, G.P. Krestin1, K. Gruszczynska4, E. Capuano2, P.J. de Feyter1, F. Pugliese2; 1Rotterdam/NL, 2London/UK, 3Forchheim/DE, 4Katowice/PL

14:36B-0414 In vivo quantification of total atherosclerotic burden:

prognostic accuracy of whole body CTA in relation to traditional cardiovascular risk index and 5-year follow-up F. Zaccagna, A. Napoli, G. Cartocci, V. Noce, F. Boni, C. Catalano; Rome/IT

14:45B-0415 Diagnostic performance of computed tomography

coronary angiography to detect or exclude angiographic ‚high-risk-CAD‘ A.S. Dharampal, S.L. Papadopoulou, A. Rossi, W.B. Meijboom, E. Boersma, K. Nieman, P.J. de Feijter, G.P. Krestin; Rotterdam/NL

14:54B-0416 Cost effectiveness and rule-out strategy of MDCT-

CA in patients with undifferentiated chest pain in emergency department R. Malago, M. Tezza, C. Barbiani, A. Pezzato, G. Sala, G. Taioli, R. Pozzi Mucelli; Verona/IT

15:03B-0417 Transient ischaemic dilation of the left ventricle

on SPECT: correlation with findings at coronary CT angiography U. Ebersberger, W.T. Halligan, P.B. Morris, B.T. Mischen, S.A. Chiaramida, U.J. Schoepf; Charleston, SC/US

15:12B-0418 Relationship between myocardial scar and coronary

artery plaque in diabetes patients: from preliminary results of assessment with cardiac computed tomography angiography and magnetic resonance imaging in patients with type 2 diabetes for detection of unrecognised myocardial scar in subclinical coronary atherosclerosis (ACCREDIT) study J.-W. Kang1, S. Choi2, S. Ko1, Y. Choe1, B. Choi1, W. Lee1, T.-H. Lim1; 1Seoul/KR, 2Seongnam/KR

15:21B-0419 Epicardial fat volume and coronary artery disease at

CT: racial differences in African American and white patients with acute chest pain P. Apfaltrer1, A. Schindler2, U.J. Schoepf2, J. Nance2, U. Ebersberger2, R. Vliegenthart2; 1Mannheim/DE, 2Charleston, SC/US

14:00–15:30 Room D2

Interventional Radiology SS 609a Oncologic ablation and guided

interventions Moderators: P. Almeida; Coimbra/PT, A. Basile; Catania/IT

14:00B-0420 Radiation exposure in CT-guided interventions

R. Kloeckner, D. Pinto dos Santos, C. Düber, M. Pitton; Mainz/DE

14:09B-0421 Percutaneous image-guided cryotherapy: a new

therapeutic possibility for local recurrence of soft tissue sarcomas? N. Lippa, A. Italiano, P. Sargos, M. Kind, E. Stoeckle, B. N‘Guyen Bui, F. Cornelis; Bordeaux/FR

14:18B-0422 Robot-assisted radiofrequency ablation of liver

tumours: early experience B.J.J. Abdullah, C.H. Yeong, K.L. Goh, B.K. Yoong, G.F. Ho, C. Yim; Kuala Lumpur/MY

14:27B-0423 Image-guided percutaneous thermal ablation of

hepatic and renal tumours using high-frequency jet ventilation to minimise respiratory motion D.M.L. Tse, D.Y.F. Chung, S. Scott, P. Boardman, F.V. Gleeson, E.M. Anderson; Oxford/UK

14:36B-0424 Radiofrequency ablation of hepatocellular carcinoma

associated with chronic liver disease without cirrhosis: long-term experience L. Sottocornola, A. Salmi, A. Rossini, R. Maroldi, P. Cabassa; Brescia/IT

14:45B-0425 Safety and efficacy of sonographically guided

percutaneous radiofrequency ablation of left lobe hepatocellular carcinoma M.I.M.A. Ibrahim; Sohag/EG

14:54B-0426 Percutaneous, ultrasound-guided IRE ablations of

unresectable pancreatic cancer A. Nilsson, C. Månsson, J. Krause, R. Brahmstaedt, P. Nygren, B.-M. Karlson; Uppsala/SE

Scientific Sessions

235

Friday

B-04

27 –

B-0

446 15:03

B-0427 High-intensity focused ultrasound ablation of pancreatic cancer: a totally non-invasive treatment for tumour control of locally advanced lesions (stage III) F. Zaccagna, A. Napoli, G. Cartocci, G. Brachetti, L. DI Mare, F. Boni, V. Noce, L. Bertaccini, C. Catalano; Rome/IT

15:12B-0428 Fusion imaging-guided percutaneous biopsy of focal

hepatic lesions with poor conspicuity on conventional ultrasonography H. Park, M. Lee, M. Kim, M. Lee, J. Hwang, T. Kang, S. Lim, H. Lim, H. Lim; Seoul/KR

15:21B-0429 CTNAV: a prospective randomised clinical trial of a

navigation system for computer assisted CT guided interventions P. Durand, A. Moreau-Gaudry, J. Frandon, M. Medici, E. Chipon, C. Sengel, I. Bricault; Grenoble/FR

14:00–15:30 Room E1

Musculoskeletal SS 610a Musculoskeletal tumours

Moderators: E. Quaia; Trieste/IT, R. Lalam; Oswestry/UK

14:00B-0430 Magnetic resonance imaging parameters predictive for

malignancy: a prospective study of 100 consecutive soft-tissue musculoskeletal masses V. Vasilevska Nikodinovska, M. Samargiski, V. Janevska, S. K.Kunovska; Skopje/MK

14:09B-0431 Evaluation of features and role of ultrasound and

MR imaging in large lipomas and well-differentiated liposarcomas H. Gupta1, V. Bhat2, S. Edward1, E. Hensor1, P. Robinson1; 1Leeds/UK, 2Cardiff/UK

14:18B-0432 Comparison of efficacy of surgical-, CT- and PET-CT-

guided biopsy in musculoskeletal lesions J.L.M.A. Gielen, A.M. De Schepper, S. Ceyssens, D.H. Creytens, J. Somville, P. Van Dyck, P. Pauwels, M. Peeters, P.M. Parizel; Antwerp/BE

14:27B-0433 CT evaluation of thoracic bone metastasis: comparison

of 3D volume-rendered images and combined axial and coronal multiplanar reconstruction images K. Doo1, E.-Y. Kang1, H. Yong1, O. Woo1, K. Lee2, Y.-W. Oh1; 1Seoul/KR, 2Ansan/KR

14:36B-0434 DCE-MRI for assessment of vessel remodelling

associated with bone defect healing in experimental lytic bone metastases D. Komljenovic, W. Semmler, T. Bäuerle; Heidelberg/DE

14:45B-0435 View-angle tilting (VAT) and slice-encoding metal

artifact correction (SEMAC) for MR imaging of orthopaedic tumor prostheses P.M. Jungmann1, C. Ganter1, F. Pohlig1, C. Schaeffeler1, J.S. Bauer1, M. Nittka2, E.J. Rummeny1, H. Rechl1, K. Woertler1; 1Munich/DE, 2Erlangen/DE

14:54B-0436 Association of QCT bone mineral density and bone

structure with vertebral fractures in patients with multiple myeloma J. Borggrefe1, S. Giravent2, F. Thomsen2, J. Peña2, A. Wulff2, A. Günther1, M. Heller2, C.C. Glüer1; 1Cologne/DE, 2Kiel/DE

15:03B-0437 Imaging patterns in multiple myeloma: observations

at whole body MRI N.M. Long, O.M. Drumm, P. O‘ Gorman, S.J. Eustace; Dublin/IE

15:12B-0438 Efficacy of whole body low-dose CT (WBLDCT) in the

staging of patients with early multiple myeloma: comparison with whole body magnetic resonance imaging (WBMRI) V. Besostri, D. Ippolito, P.A. Bonaffini, A. Masetto, A. Cuccia, S. Sironi; Milan/IT

15:21B-0439 Role of apparent diffusion coefficient (ADC) maps in

the evaluation of tumour response in chemotherapy in patients with multiple myeloma P.A. Bonaffini, D. Ippolito, V. Besostri, A. Casiraghi, A. Di Lelio, S. Sironi; Monza/IT

14:00–15:30 Room F1

Abdominal Viscera SS 601 Liver steatosis: imaging and

quantification Moderators: I. Bargellini; Pisa/IT, B. Van Beers; Clichy/FR

14:00B-0440 Presence/absence of hepatic steatosis after

percutaneous intraportal pancreatic islet transplantation in 108 allo- and auto-transplanted patients: can ultrasound predict the clinical outcome? G. Agostini, M. Venturini, G. Querques, P. Maffi, C. Gremizzi, A. Palmisano, F. De Cobelli, A. Secchi, A. Del Maschio; Milan/IT

14:09B-0441 Phosphorus magnetic resonance spectroscopy

(31P-MRS) in non-alcoholic fatty liver disease (NAFLD) J.M. Abrigo, V.-S. Wong, D.-W. Yeung, G.-H. Wong, A.-h. Chan, H.-Y. Chan, W.-W. Chu; Shatin/HK

14:18B-0442 Clinical implications of fatty liver on hepatic diffusion-

weighted imaging studied in healthy subjects H. Dijkstra, A. Handayani, P. Kappert, M. Oudkerk, P.E. Sijens; Groningen/NL

14:27B-0443 Liver fat volume fraction quantification in patients

with chronic liver diseases with separated estimation of fat and water relaxation times at 1.5 and 3.0T B. Leporq, F. Pilleul, O. Beuf; Villeurbanne/FR

14:36B-0444 Combination of liver intravoxel incoherent motion

imaging with MR fat quantification at 3.0T to distinguish between pure steatosis and NASH B. Leporq1, F. Pilleul1, J. Dumortier2, O. Guillaud2, T. Lefort2, O. Beuf1; 1Villeurbanne/FR, 2Lyon/FR

14:45B-0445 Quantification of steatosis hepatitis and liver iron

overload in a population-based study using magnetic resonance imaging J.P. Kühn1, D. Hernando2, H. Völzke1, S.B. Reeder2, N. Hosten1, B. Mensel1, K. Hegenscheid1, M. Evert1, S. Baumeister1; 1Greifswald/DE, 2Madison, WI/US

14:54B-0446 Effect of Gd-EOB-DTPA on hepatic fat quantification

using high-speed T2-corrected multiecho acquisition (HISTO) at 1H MR spectroscopy Y. Park1, C. Lee1, I. Kim1, B. Kiefer2, K. Kim1, J. Choi1, J. Lee1, C. Park1; 1Seoul/KR, 2Erlangen/DE

Scientific Sessions

236

B-04

47 –

B-0

46515:03

B-0447 Brown adipose tissue influences body fat composition and hepatic steatosis M.K. Werner, S. Ripkens, M. Schmadl, I. Stef, A. Deckert, C.D. Claussen, C. Würslin, N. Stefan, C. Pfannenberg; Tübingen/DE

15:12B-0448 In-phase/opposed-phase MRI and MR spectroscopic

measurements for the quantification of liver fat content in morbidly obese patients H.H. Bertram1, G. Thörmer2, N. Garnov2, T. Schütz2, V. Peter2, T. Kahn2, H. Busse2; 1Munich/DE, 2Leipzig/DE

15:21B-0449 Dynamic contrast enhanced-MRI (DCE-MRI) functional

assessment of vascular events occurring during the intra-hepatic engraftment of pancreatic islets may predict long-term outcome of islets transplantation A. Palmisano, A. Esposito, G. Ironi, P. Maffi, F. De Cobelli, T. Canu, A. Secchi, A. Del Maschio; Milan/IT

14:00–15:30 Room F2

Breast SS 602 Breast imaging after neoadjuvant

therapy and surgery Moderators: G. Gennaro; Padua/IT, P. Martinez-Miravete; Logroño/ES

14:00B-0450 Early response monitoring of neoadjuvant

chemotherapy in breast cancer patients using magnetic resonance imaging: a systematic review M. Lobbes1, R. Prevos1, M. Smidt1, V. Tjan-Heijnen1, M. van Goethem2, R.G.H. Beets-Tan1, J. Wildberger1; 1Maastricht/NL, 2Antwerp/BE

14:09B-0451 The role of magnetic resonance imaging in assessing

residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy: a systematic review R. Prevos1, M. Smidt1, V. Tjan-Heijnen1, M. van Goethem2, R.-J. Schipper1, R.G.H. Beets-Tan1, J. Wildberger1, M. Lobbes1; 1Maastricht/NL, 2Antwerp/BE

14:18B-0452 Radiological evaluation of complete pathological

response after neoadjuvant chemotherapy treatment of breast carcinoma N.M.A. Abdel Razek, H.A. El Ghazaly, O.Z. Yousef; Cairo/EG

14:27B-0453 Breast MRI at 3T: a pilot study estimating the role

of unenhanced MRI (DWI combined with T2 IDEAL sequence) vs CE-MRI in the assessment of response to neo-adjuvant chemotherapy F. Vasselli, F. Pediconi, M. Telesca, M. Luciani, V. Casali, E. Miglio, A. Castrignanò, C. Catalano; Rome/IT

14:36B-0454 Radiological findings in breast autologous fat

injection: a retrospective review in 12-year follow-up L. Camera, I. Baglio, G. Barbazeni, A. Bianchin, M. Valdo, S. Montemezzi; Verona/IT

14:45B-0455 Invasive ductal carcinoma with marked necrosis on

neoadjuvant chemotherapy: RECIST or mRECIST in MRI assessment of tumour response? M.M. Nadrljanski, Z.C. Milosevic; Belgrade/RS

14:54B-0456 CAD-based assessment of therapy monitoring in

neoadjuvant chemotherapy of breast cancer J.S. Grueneisen1, S. Maderwald1, T. Heusner2, S. Kuemmel1, E.A. Hauth1, M. Forsting1, T.C. Lauenstein1, L. Umutlu1; 1Essen/DE, 2Düsseldorf/DE

15:03B-0457 Breast MRI for assessment of primary systemic

chemotherapy (PSC): computer assisted diagnosis (CAD) predicts degree of tissue response and residual tumour mass P.A.T. Baltzer1, M. Dietzel2, W.A. Kaiser3; 1Vienna/AT, 2Erlangen/DE, 3Jena/DE

15:12B-0458 Evaluation of residual breast tissue post-mastectomy

using breast MRI V. Tsehmaister Abitbol, A. Rundstein, A. Shalmon, E. Konen, M. Sklair-Levy; Tel Hashomer/IL

15:21B-0459 Breast cancer recurrence in DIEP flap reconstructed

breasts: a 12-year retrospective study J.A. Farras Roca, A. Luciani, R. Bosc, E. Meyblum, P. Beaussart, F. Pigneur, Y. Belkacemi, A. Rahmouni, T.-H. Dao; Créteil/FR

14:00–15:30 Room G/H

Cardiac SS 603b Cardiomyopathy and fibrosis

Moderators: P. Donato; Coimbra/PT, R. Maksimović; Belgrade/RS

14:00B-0460 Potential value of fibrosis quantification in dilated

cardiomyopathy A. Jacquier, A. Kallifatidis, B. Maurel, A. Flavian, J. Gaubert, J. Bartoli, G. Moulin; Marseille/FR

14:09B-0461 Potential value of fibrosis quantification in

hypertrophic cardiomyopathy A. Jacquier, A. Kallifatidis, B. Maurel, A. Flavian, J. Gaubert, J. Bartoli, G. Moulin; Marseille/FR

14:18B-0462 Extent of myocardial scar detected by late Gadolinium

enhancement-cardiac magnetic resonance (LGE-CMR) as a predictor of major adverse cardiac events (MACE) in HCM patients S. Bertugno, G. Ligabue, F. Fiocchi, L. Nocetti, S. Vasaturo, V. Morini, A. Barbieri, R. Lugli; Modena/IT

14:27B-0463 Myocardial scar extension detected by late Gadolinium

enhancement-cardiovascular magnetic resonance (LGE-CMR) for arrhythmic risk stratification of HCM patients S. Bertugno, G. Ligabue, F. Fiocchi, L. Nocetti, S. Vasaturo, V. Morini, A. Barbieri , R. Lugli, P. Torricelli; Modena/IT

14:36B-0464 Prognostic value of RV remodelling in pulmonary

hypertension: cardiac magnetic resonance study N. Galea, M. Francone, I. Carbone, I. Iacucci, P. David, C. Vizza, C. Catalano; Rome/IT

14:45B-0465 Evaluation of Brugada syndrome by cardiac magnetic

resonance L. Salvatori1, C. Tessa1, i. Del Meglio1, S. Diciotti2, C. Vignali1, G. Casolo1; 1Lido di Camaiore/IT, 2Firenze/IT

Scientific Sessions

237

Friday

B-04

66 –

B-0

486 14:54

B-0466 Sensitivity of cardiac magnetic resonance varies with clinical presentation of biopsy-proven acute myocarditis: correlation with necrosis/apoptosis patterns of viral aetiology G. Cannavale, M. Francone, R. Rosati, P. David, A. Frustaci, C. Catalano; Rome/IT

15:03B-0467 Cardiac magnetic resonance vs echocardiography for

the assessment of cardiac volumes and function in thalassemia intermedia patients C. Tudisca1, A. Meloni2, C. Ascioti3, S. Renne3, V. Santamaria4; 1Palermo/IT, 2Pisa/IT, 3Lamezia Terme/IT, 4Vibo Valentia/IT

15:12B-0468 Right heart involvement in thalassaemia major (TM)

patients: a cardiac MR (CMR) assessment F. Pitocco, I. Di Giampietro, A. De Vivo, P. Cianciulli, C. Liguori, B. Beomonte Zobel; Rome/IT

15:21B-0469 β-thalassaemia as a new potential risk factor for

left ventricular noncompaction (LVNC): a cardiac MRI evaluation C. Liguori, I. Di Giampietro, F. Pitocco, P. Cianciulli, B. Beomonte Zobel; Rome/IT

14:00–15:30 Room L/M

Head and Neck SS 608 Technical innovations, TMJ disease and

rare entities Moderators: J. Frühwald-Pallamar; Vienna/AT, J. Widelec; Brussels/BE

14:00B-0470 CT numbers of CBCT regarding position dependence on

different size of field-of-view M. Imura1, T. Todoroki2; 1Kyoto/JP, 2Osaka/JP

14:09B-0471 Dual-source 128-slice MDCT neck: radiation dose and

image quality estimation of a clinically relevant dual-energy, high-pitch, standard single-energy protocol J. Paul, E. Mbalisike, T.J. Vogl; Frankfurt a. Main/DE

14:18B-0472 Performance of filtered back-projection (FBP),

statistical (ASIR) and model-based (VEO) iterative reconstruction of neck CT staging examinations F.G. Mück, L. Geyer, J. Grimm, Z. Deak, M.F. Reiser, S. Wirth; Munich/DE

14:27B-0473 Maxillary sinus pyocele: a new radiological entity

A. Lacan-Melki, S. Espinoza-Boireau, I. Khettab, P. Halimi; Paris/FR

14:36B-0474 Carotid blowout syndrome in patients with

nasopharyngeal carcinoma treated with radiotherapy: a review of 12-year experience V.K. Fung, J.S. Shum, B.M. Lai, C. Chu, W.K. Kan; Hong Kong/HK

14:45B-0475 Nasal-type NK/T-cell lymphoma of the nasal cavity

and PNS: CT and MR imaging findings K. Kang1, S. Suh1, K. Kim1, K. Son1, Y. Lee2, H. Seo2, N. Lee1, H. Seol1; 1Seoul/KR, 2Ansan/KR

14:54B-0476 Temporomandibular joint internal derangement:

correlation of MRI findings with clinical symptoms K. Šurlan Popovič, U. Lamot, M. Vrabec, R. Klavžar; Ljubljana/SI

15:03B-0477 An investigation of relative signal intensity of MR

images in retrodiscal tissue and lateral pterygoid muscle in patients with temporomandibular joint disorder and its relation with MRI findings Z. Ghoncheh, M. Panjnosh, H. Banihashemi; Tehran/IR

15:12B-0478 High resolution 3D MR imaging of the

temporomandibular joint: feasibility and comparison with 2D sequences U. Navarro, M. Ravanelli, D. Farina, E. Botturi, R. Maroldi; Brescia/IT

15:21B-0479 Radiological anatomy of the ethmoidal arteries: a

cone beam CT study L. Sottocornola, M. Dal Corso, M. Ravanelli, L. Pianta, R. Maroldi; Brescia/IT

14:00–15:30 Room N/O

Musculoskeletal SS 610b Cartilage: advanced imaging

Moderators: A. Karpenko; St. Petersburg/RU, P. Omoumi; Brussels/BE

14:00B-0480 Direct comparison of MR imaging at 1.5- and 3.0-T for

evaluating the articular cartilage of the knee P. Van Dyck1, C. Kenis1, V. Lambrecht2, K. Wouters1, F.M.H.M. Vanhoenacker1, J.L. Gielen1, P.M. Parizel1; 1Antwerp/BE, 2Gent/BE

14:09B-0481 Biochemical imaging of the knee’s cartilage:

comparison of three techniques at 3 Tesla C. Rehnitz1, J. Kupfer1, N. Streich1, I. Burkholder2, B. Schmitt3, L. Lauer3, H.-U. Kauczor1, M.-A. Weber1; 1Heidelberg/DE, 2Zweibrücken/DE, 3Erlangen/DE

14:18B-0482 High-resolution flat-panel CT arthrography for

cartilage defect detection: comparison to multi-detector CT R. Guggenberger1, S. Winklhofer1, T. Redel2, J. Korporaal2, A. Meier2, J. von Spiczak1, G. Andreisek1, H. Alkadhi1; 1Zurich/CH, 2Forchheim/DE

14:27B-0483 Longitudinal evaluation of T2 relaxation time in

relation to baseline volume of femorotibial cartilage – data from the osteoarthritis initiative P. Beringer1, L. Nardo1, H. Liebl1, U.R. Heilmeier1, A. Lai1, F. Liu1, G.B. Joseph1, F. Eckstein2, T.M. Link1; 1San Francisco, CA/US, 2Salzburg/AT

14:36B-0484 Longitudinal increase of T2 relaxation time in

normal subjects indicating physiological aging of the collagen network and cartilage matrix: data from the osteoarthritis initiative (OAI) U.R. Heilmeier, P. Beringer, L. Nardo, H. Liebl, S. Lee, G. Joseph, C.E. McCulloch, M.C. Nevitt, T.M. Link; San Francisco, CA/US

14:45B-0485 3D delayed gadolinium-enhanced MRI of cartilage

(dGEMRIC) at 3T used to evaluate the effect of hyaluronic acid on cartilage quality in knee osteoarthritis patients J. van Tiel, M. Reijman, K. Bos, J. Verhaar, G.P. Krestin, S. Bierma - Zeinstra, H. Weinans, G. Kotek, E. Oei; Rotterdam/NL

14:54B-0486 T2* mapping and delayed gadolinium-enhanced

magnetic resonance imaging in cartilage (dGEMRIC) of glenohumeral cartilage in asymptomatic volunteers at 3T B. Bittersohl1, F.R. Miese1, C. Dekkers1, H. Senyurt1, J. Kircher2, H.-J. Wittsack1, G. Antoch1, R. Krauspe1, C. Zilkens1; 1Düsseldorf/DE, 2Cologne/DE

Scientific Sessions

238

B-04

87 –

B-0

50615:03

B-0487 Validity of gradient-echo three-dimensional delayed gadolinium-enhanced magnetic resonance imaging of hip joint cartilage: a histologically controlled study C. Zilkens1, F.R. Miese1, M. Herten1, S. Kurzidem1, M. Jäger2, D. König3, G. Antoch1, R. Krauspe1, B. Bittersohl1; 1Düsseldorf/DE, 2Essen/DE, 3Viersen/DE

15:12B-0488 In-vivo sodium magnetic resonance (MR) imaging of

healthy intervertebral discs during unloading K.M. Friedrich, J. Wimmer, V. Juras, S. Zbyn, I. Nöbauer-Huhmann, S. Trattnig; Vienna/AT

15:21B-0489 T2 mapping for assessment of lumbar disc repair after

autologous disc-derived chondrocyte transplantation (ADCT) M. Glowacki, M. Ostrowska, W. Gradkowski, J. Walecki; Warsaw/PL

14:00–15:30 Room P

Interventional Radiology SS 609b Gynaecological and obstetric

interventions Moderators: P. Andersen; Odense/DK, R. Nijenhuis; Maastricht/NL

14:00B-0490 Non-invasive treatment of uterine fibroids using MR-

guided high-intensity focused ultrasound: results on quality of life, non-perfused volume ratio and size reduction over 12 months F. Ciolina, A. Napoli, B. Cavallo Marincola, F. Boni, F. Zaccagna, V. Noce, L. Bertaccini, C. Catalano; Rome/IT

14:09B-0491 MRI-guided focused ultrasound treatment of

symptomatic uterine fibroids: impact of technology advancement on ablation volumes in 115 patients C.G. Trumm1, R. Stahl1, D.-A. Clevert1, P. Herzog2, I. Mindjuk2, S. Kornprobst2, R.-T. Hoffmann3, M.F. Reiser1, M. Matzko2; 1Munich/DE, 2Dachau/DE, 3Dresden/DE

14:18B-0492 Efficacy of MRI-guided focused ultrasound (MRgFUS)

treatment of uterine fibroids: evaluation of non-perfused volume (NPV), fibroid shrinkage and clinical improvement at 6-month follow-up I. Invernizzi1, M. Vaiani1, P. Colombo1, F. Zucconi1, S. Sironi2, C. Ticca1; 1Milan/IT, 2Monza/IT

14:27B-0493 Uterine adenomyosis treated by MRgFUS: technical

approach and clinical results F. Ferrari, A. Miccoli, F. Arrigoni, A.V. Giordano, E. Fascetti, G. Mascaretti, C. Masciocchi; L‘Aquila/IT

14:36B-0494 Is uterine artery embolisation in large sized myoma

as efficient as in normal sized myoma: a retrospective comparative study in 263 patients H. Choi1, G. Jeon1, M. Kim2, J. Lee1, J. Yoon1, S. Hwang1; 1Seongnam/KR, 2Seoul/KR

14:45B-0495 Usefulness of pelvic artery embolisation: a

comparison between caesarean section and vaginal delivery in 176 patients H. Lee, G. Jeon; Seongnam-si/KR

14:54B-0496 Transarterial embolization in the treatment of

postpartum haemorrhage Z. Wang, X. Li, Z. Jin; Beijing/CN

15:03B-0497 Uterine artery embolization for management of

secondary postpartum haemorrhage associated with placenta accreta Z. Wang, Z. Jin, X. Li; Beijing/CN

15:12B-0498 Placenta percreta: role of bilateral occlusion balloons

insertion in to internal iliac arteries to prevent haemorrhage and hysterectomy M. Teixidor Viñas, A.-M. Belli, E. Chandraharan; London/UK

15:21B-0499 Efficacy of bilateral uterine artery embolization as

a first-line therapeutic option for acquired uterine arteriovenous malformations J. Shin, H.-K. Yoon, G.-Y. Ko, D.-I. Gwon; Seoul/KR

14:00–15:30 Room Z

Molecular Imaging SS 606 MR/PET and PET/CT

Moderators: N. Belcari; Pisa/IT, P.R. Ros; Cleveland, OH/US

14:00B-0500 Simultaneous 68Ga-DOTATOC PET/MRI for whole body

staging in patients with neuroendocrine tumours: preliminary results K.J. Beiderwellen1, T.D. Poeppel1, V. Hartung-Knemeyer1, C. Buchbender2, H. Kuehl1, A. Bockisch1, T.C. Lauenstein1; 1Essen/DE, 2Düsseldorf/DE

14:09B-0501 Diffusion-weighted imaging as part of hybrid FDG-PET/

MRI protocols for whole body cancer staging: does it benefit lesion detection? T.A. Heusner1, P. Heusch1, V. Hartung-Knemeyer2, K. Beiderwellen2, T. Lauenstein2, M. Forsting2, G. Antoch1, C. Buchbender1; 1Düsseldorf/DE, 2Essen/DE

14:18B-0502 Molecular imaging of the prostate using

multiparametric functional [11C]-acetate PET/MRI: proof of concept S. Polanec, T. Helbich, K. Pinker-Domenig, S. Leitner, B. Füger, G. Karanikas, M. Margreiter, S. Kommata, P. Brader; Vienna/AT

14:27B-0503 PET/CT guided therapy planning in prostate cancer

patients eligible for radiotherapy: results from a bicentric clinical study E. Lopci1, B.A. Jereczek-Fossa2, M. Rodari1, G. Pepe1, C. Fodor2, D. Zerini2, O. De Cobelli2, R. Orecchia2, A. Chiti1; 1Rozzano/IT, 2Milan/IT

14:36B-0504 Detection of lung nodules in an integrated whole body

MR/PET scanner: comparison to PET/CT N.F. Schwenzer, C. Schraml, S. Gatidis, C. Brendle, H. Schmidt, C. Pfannenberg, C.D. Claussen; Tübingen/DE

14:45B-0505 Assessment of tumour aggressiveness with

quantitative perfusion imaging and tumour volume in patients with lung cancer: correlation with metabolic parameters of 18 FDG-PET/CT D. Fior, D. Ippolito, P.A. Bonaffini, C. Capraro, C. Messa, S. Sironi; Monza/IT

14:54B-0506 FDG-PET/CT for the early prediction of

histopathological complete response to neoadjuvant chemotherapy in breast cancer patients T.A. Heusner1, C. Riegger1, S. Kuemmel2, M. Forsting2, V. Hartung-Knemeyer2, G. Antoch1, C. Buchbender1; 1Düsseldorf/DE, 2Essen/DE

Scientific Sessions

239

Friday

B-05

07 –

B-0

508

15:03B-0507 Diagnostic accuracy of 11C-choline PET (CHO-PET) in

patient affected by hepatocellular carcinoma (HCC): comparison with CT/MRI E. Lopci, G. Torzilli, A. Palmisano, M. Scorsetti, A. Chiti; Rozzano/IT

15:12B-0508 PIB-PET as a pathological and functional marker in

Alzheimer‘s disease V. Abreu1, A. Nordberg2; 1Lorenskog/NO, 2Stockholm/SE

Scientific Sessions

240

B-05

09 –

B-0

52710:30–12:00 Room C

Neuro SS 911 New insights into brain gliomas

Moderators: L.C. Tzarouchi; Ioannina/GR, P. Vilela; Almada/PT

10:30B-0509 Data-driven grading of brain gliomas: a

multiparametric MRI study V. Panara, D. Tortora, P. Mattei, S. Salice, C. Briganti, A. Cotroneo, A. Tartaro, M. Caulo; Chieti/IT

10:39B-0510 Combining diffusion kurtosis imaging, dynamic

susceptibility-weighted MR imaging and short echo time chemical shift imaging for grading gliomas S. Van Cauter1, F. De Keyzer1, D. Sima1, J. Veraart2, F. D‘Arco1, R. Peeters1, S. Van Gool1, S. Sunaert1, U. Himmelreich1; 1Leuven/BE, 2Antwerp/BE

10:48B-0511 Dynamic contrast-enhanced (DCE) MRI of cerebral

gliomas: assessment of tumoral angiogenesis with low gadolinium-based contrast agent dose D. Gadda, L. Mazzoni, M. Moretti, S. Chiti, G. Giordano; Firenze/IT

10:57B-0512 Correction of CBV perfusion maps from T1 leakage

effect allows a better correlation of perfusion DSC MR imaging with histopathologic glioma grading and an estimation of vascular permeability F. Viry1, D. Galanaud1, A. Mitulescu2, Y. Chaibi2, V. Reina1, D. Leclercq1, D. Dormont1; 1Paris/FR, 2La Ciotat/FR

11:06B-0513 Paradoxical imaging features of high-grade gliomas

with oligodendroglial component: quantitative analysis on diffusion and DSC perfusion MR imaging L. Sunwoo, S. Choi, T. Kim, S.-H. Lee, C.-K. Park, J.-H. Kim, C.-H. Sohn, S.-H. Park, I. Kim; Seoul/KR

11:15B-0514 Survival predictive value of perfusion-weighted MRI

relative cerebral blood volume (rCBV) in glioblastoma multiforme adjusted by multiple biomarkers including MGMT promoter methylation G. Viteri, P. Slon, J. Etxano, G. Aldave, R. García-Eulate, J.L. Zubieta, S. Tejada, R. Díez-Valle, P.D. Dominguez; Pamplona/ES

11:24B-0515 Additive value of arterial spin labeling in

differentiating primary central nervous system lymphoma from glioblastoma multiforme: an observer performance study K. Yamashita, T. Yoshiura, A. Hiwatashi, O. Togao, K. Kikuchi, K. Yoshimoto, H. Honda; Fukuoka/JP

11:33B-0516 Glioma grading using pharmacokinetic parameters in

T1-weighted dynamic contrast-enhanced perfusion MR S.C. Jung, S. Choi, S. Kim, H. Shin, J. Yeom, I. Ryoo; Seoul/KR

11:42B-0517 Intravoxel incoherent motion MR imaging with

biexponential and stretched-exponential model in grading cerebral gliomas Y. Bai1, D. Shi1, S. Dou1, F. Sun2, M. Wang1; 1Zhengzhou/CN, 2Beijing/CN

11:51B-0518 Apparent diffusion coefficient obtained by magnetic

resonance imaging as a prognostic marker in glioblastomas: correlation with MGMT promoter methylation status L. Calabria1, M. Rossi Espagnet1, F. Tavanti1, A. Boellis1, V. Coppola2, M. Federici1, A. Romano1, L. Fantozzi1, A. Bozzao1; 1Rome/IT, 2Ronciglione/IT

10:30–12:00 Room D1

Chest SS 904 Image quality and dose reduction

Moderators: P.A. Grenier; Paris/FR, J. Vlahos; London/UK

10:30B-0519 Clinical evaluation of an automatic tube voltage

selection in chest CT angiography T. Niemann, S. Henry, F. Pontana, K. Yasunaga, J.-B. Faivre, J. Rémy, M. Rémy-Jardin; Lille/FR

10:39B-0520 Organ-based tube-current modulation: impact of

breast position in clinical practice S. Taylor1, D. Tack2, V. De Maertelaer3, P. Gevenois3; 1Montigny-le-Tilleul/BE, 2Baudour/BE, 3Brussels/BE

10:48B-0521 Reduced radiation exposure of the female breast

during low-dose chest CT using an organ-based tube-current modulation and bismuth shield: comparison of image quality and radiation dose Y. Kim, Y. Sung, E. Kim, H. Kim, J. Choi; Incheon/KR

10:57B-0522 Evaluation of automated attenuation-based tube

potential selection in combination with organ-specific dose reduction for clinical chest CT P. Kröpil, L. Schimmöller, S. Dietrich, P. Heusch, J. Aissa, G. Antoch, R.S. Lanzman; Düsseldorf/DE

11:06B-0523 Thoracic imaging with low-dose MDCT at low tube

voltages using iterative image reconstruction: where is the limit of diagnostic confidence compared to the clinical standard? W. Stiller1, G. Pahn1, J.L. Mayer1, M. Dadrich1, J. Hirsch2, S. Böhme3, K. Markstaller3, G. Szabó1, H.-U. Kauczor1; 1Heidelberg/DE, 2Witten/DE, 3Vienna/AT

11:15B-0524 Effect of acquisition parameters and reconstruction

algorithm on lesion conspicuity in low-dose MDCT of the thorax V. Yaghmai, H.G. Töre, M.P.F. Botelho, F.D. Gonzalez-Guindalini, S.K. Patel, K. Dill, C.B. Harmath; Chicago, IL/US

11:24B-0525 Evaluation of an iterative reconstruction algorithm

(iDose) to reduce image noise and improve image quality in submillisievert CT scans of the thorax M. Henninger, A.A. Fingerle, C. Markus, T. Zahel, P.B. Noël, E.J. Rummeny, M. Dobritz; Munich/DE

11:33B-0526 Phantom study for adaptive iterative dose reduction

3D (AIDR 3D) for low-dose chest CT examination: utility for identification of pulmonary ground glass opacity and nodule on 320-detector row CT using different scanning methods S. Seki1, H. Koyama1, Y. Ohno1, M. Nishio1, T. Yoshikawa1, S. Matsumoto1, N. Sugihara2, H. Inokawa2, K. Sugimura1; 1Kobe/JP, 2Ohtawara/JP

11:42B-0527 The lateral scan projection radiograph (topogram) in

CT pulmonary angiography: the effect on scan length and radiation dose J.C.L. Rodrigues, I. Negus, N.E. Manghat, M.C.K. Hamilton; Bristol/UK

Scientific Sessions

241

Saturday

B-05

28 –

B-0

548 11:51

B-0528 Accuracy of lung nodule volumetry using adaptive iterative dose reduction 3D for ultra-low dose of 320-detector row CT: a phantom study K. Doo1, E.-Y. Kang1, H. Yong1, O. Woo1, K. Lee2, Y.-W. Oh1; 1Seoul/KR, 2Ansan/KR

10:30–12:00 Room D2

Interventional Radiology SS 909 Thoracic interventions

Moderators: J. Tacke; Passau/DE, K. Zelenak; Martin/SK

10:30B-0529 CT-guided lung biopsy: core needle coaxial technique

with autologous blood needle tract embolisation compared with fine needle aspiration in diagnostic yield and post-biopsy pneumothorax rate S. Lee1, A. Montaser2, L. Nardo1, U.R. Heilmeier1, B.A. Aronson2; 1San Francisco, CA/US, 2Canton, OH/US

10:39B-0530 Computed tomography-guided lung biopsy with the

patient in lateral position and the biopsy side down: effect on pneumothorax rate and clinical significance G. Velonakis, D. Filippiadis, A. Mazioti, S.I. Argentos, K. Malagari, A. Kelekis, N. Kelekis; Athens/GR

10:48B-0531 C-arm cone-beam computed tomography (CBCT)

needle path overlay for percutaneous biopsy of pulmonary nodules C. Floridi, F. Fontana, A. Ierardi, G. DeMarchi, L. Nocchi-Cardim, C. Pellegrino, G. Carrafiello, C. Fugazzola; Varese/IT

10:57B-0532 Computed tomography guided trans-thoracic fine

needle aspiration biopsy of pulmonary nodule: pulmonary haemorrhage, complication or advantage? M. De Filippo, L. Saba, G. Concari, C. Rossi; Parma/IT

11:06B-0533 Feasibility and safety of CT-guided percutaneous

radiofrequency, microwave or cryoablation of the pulmonary and mediastinal unresectable tumours adjacent to the heart and large vessels C. Pusceddu, L. Melis, G. Meloni; Cagliari/IT

11:15B-0534 Factors influencing local tumour control in patients

with neoplastic pulmonary nodules treated with microwave ablation (MWA): a risk factor analysis T.J. Vogl, T.S. Worst, N.N.N. Naguib, N.-E.A. Nour-Eldin; Frankfurt a. Main/DE

11:24B-0535 Percutaneous microwave ablation of lung tumours

C. Pusceddu, L. Melis, G. Meloni; Cagliari/IT

11:33B-0536 MRI chest parameters used in the assessment

of tumour response post microwave ablation of pulmonary metastases N.-E.A. Nour-Eldin, N.N.N. Naguib, T. Gruber-Rouh, T. Lehnert, M. Sadegi, T.J. Vogl; Frankfurt a. Main/DE

11:42B-0537 Transpulmonary chemoembolisation (TPCE) and

transpulmonary chemoperfusion (TPCP) as a treatment for unresectable primary and secondary lung tumours: local tumour control and survival T.J. Vogl, A. Müller, S. Zangos, T. Lehnert; Frankfurt a. Main/DE

11:51B-0538 Endovascular treatment of haemoptysis of pulmonary

artery origin: a single-centre experience A. Khalil, S. Haddad, M. Tassart, A. Parrot, M.-F. Carette; Paris/FR

10:30–12:00 Room E1

Musculoskeletal SS 910 Spine: advancing the use of CT and MRI

Moderators: P.M. Cunningham; Navan/IE, J. Labuscagne; Bunbury, WA/AU

10:30B-0539 Cervical nerve root infiltration under CT and MRI

guidance: a cost comparison M.H. Maurer, M. deBucourt, T. Hartwig, B. Hamm, F. Streitparth; Berlin/DE

10:39B-0540 Fast inner volume imaging of the lumbar spine with a

zoomed SPACE sequence using parallel transmit P. Riffel1, S. Kannengiesser2, D. Paul2, S.O. Schönberg1, H.J. Michaely1; 1Mannheim/DE, 2Erlangen/DE

10:48B-0541 The importance of ispection of true FISP sequences

during MRI of the lumbar spine M. Papavasilopoulou, M. Raissaki, C. Voulgaris, A. Karantanas; Iraklion/GR

10:57B-0542 Computed tomography of the cervical spine:

comparison of image quality between standard-dose filtered back-projection and low-dose iterative reconstruction protocols F. Becce1, Y. Ben Salah2, F.R. Verdun1, B.C. Vande Berg2, F.E. Lecouvet2, R. Meuli1, P. Omoumi2; 1Lausanne/CH, 2Brussels/BE

11:06B-0543 Imaging quality of reduced radiation dose lumbar

spine CT with iterative reconstruction C.-J. Lin, S. Hung, W. Guo, T. Wu; Taipei/TW

11:15B-0544 Multidetector computed tomography of the cervical

spine: optimisation of iterative reconstruction strength levels P. Omoumi1, F.R. Verdun2, Y. Ben Salah1, B.C. Vande Berg1, F.E. Lecouvet1, R. Meuli2, F. Becce2; 1Brussels/BE, 2Lausanne/CH

11:24B-0545 Relationship among facet joint fluid (FJF) at MRI, age,

and disk degeneration in patients affected with low back pain C. Ottonello1, A. Giardino2, G.D.E. Papini3, A. Sharipova3, G. Di Leo3, F. Sardanelli3; 1Pomezia/IT, 2Milan/IT, 3San Donato Milanese/IT

11:33B-0546 Typification of posterior instability in patients with

spondylolysis or isthmic spondylolisthesis P. Niggemann1, J. Kuchta2, H. Urbach2, H.H. Schild2; 1Mannheim/DE, 2Bonn/DE

11:42B-0547 Differentiation of benign and malignant vertebral body

fractures with dynamic contrast-enhanced MRI T. Geith1, A. Biffar1, G. Schmidt1, S. Sourbron2, H.R. Duerr1, M.F. Reiser1, A. Baur-Melnyk1; 1Munich/DE, 2Leeds/UK

11:51B-0548 Trabecular bone structure analysis of the spine using

clinical MDCT: can it predict vertebral bone strength? T. Baum1, M. Gräbeldinger1, E. Grande Garcia1, R. Burgkart1, J. Patsch2, E.J. Rummeny1, T.M. Link3, J.S. Bauer1; 1Munich/DE, 2Vienna/AT, 3San Francisco, CA/US

Scientific Sessions

242

B-05

49 –

B-0

56810:30–12:00 Room F1

Oncologic Imaging SS 916 Whole-body imaging: how to do it

Moderators: T.F. Hany; Zurich/NL, D.M.J. Lambregts; Maastricht/NL

10:30B-0549 Cross over PET/MRI vs PET/CT study in oncological

patients: does it change management? J. Al-Kalbani, K. Alnabhani, A. Afaq, R. Syed, C. O‘Meara, A. Barnes, J. Boumanji; London/UK

10:39B-0550 Whole body magnetic resonance imaging, including

diffusion-weighted imaging, for staging malignant lymphoma: comparison to computed tomography in 135 patients T.C. Kwee1, M.A. Vermoolen1, E.A. Akkerman2, M. Kersten2, R. Fijnheer3, F.J. Beek1, M.S. van Leeuwen1, M.B. Bierings1, R.A.J. Nievelstein1; 1Utrecht/NL, 2Amsterdam/NL, 3Amersfoort/NL

10:48B-0551 Combination of continuously moving table MRI and

PET including image fusion: improved lesion detection in local and distant recurrence of rectal cancer T. Baumann, A.-O. Schäfer, M. Langer; Freiburg/DE

10:57B-0552 Does positron emission tomography data acquisition

impact simultaneous diffusion-weighted imaging in a whole body PET/MRI system? R.S. Lanzman1, C. Buchbender1, P. Heusch1, V. Hartung-Knemeyer2, T. Lauenstein2, M. Forsting2, G. Antoch1, T. Heusner1; 1Düsseldorf/DE, 2Essen/DE

11:06B-0553 Standardised uptake values for [18F]-FDG in normal

organ tissues: comparison of whole body PET/CT and PET/MRI C. Buchbender1, P. Heusch1, V. Hartung-Knemeyer2, H. Kühl2, T. Lauenstein2, M. Forsting2, G. Antoch1, T.A. Heusner1; 1Düsseldorf/DE, 2Essen/DE

11:15B-0554 Impact of FDG PET-CT on patient management and

radiotherapy treatment planning in locally advanced cervical carcinoma S. Fleming, R. Cooper, S. Swift, F. Chowdhury, A. Scarsbrook, C. Patel; Leeds/UK

11:24B-0555 Is there a role for standard uptake value in the

prognostic evaluation of lung nodules? A. Bazzocchi, S. Brocchi, G. Facchini, V. Ambrosini, S. Ascanio, G. Battista, S. Fanti; Bologna/IT

11:33B-0556 Detection of underlying malignancy in patients with

paraneoplastic neurological syndromes: comparison of 18F-FDG-PET/CT and contrast-enhanced CT N. Schramm, A. Rominger, C. Schmidt, C. Schmid-Tannwald, F.G. Meinel, M.F. Reiser, C. Rist; Munich/DE

11:42B-0557 FDG-avid duodenal lesions: a retrospective analysis of

their significance in oncology practice S. Puri, L. Jones, J. Strang; Rochester, NY/US

11:51B-0558 Feasibility and first clinical experiences with

simultaneous PET/MR imaging of cervical cancer: comparison of image quality with MRI and PET/CT P. Brandmaier, S. Purz, M. Reinhardt, M. Gawlitza, H. Barthel, O. Sabri, T. Kahn, R. Kluge, P. Stumpp; Leipzig/DE

10:30–12:00 Room F2

Breast SS 902 Increased risk of breast cancer

Moderators: L.A. Carbonaro; San Donato Milanese/IT, L. Ollivier; Paris/FR

10:30B-0559 Individual radiosensitivity: a key-issue to reconsider

high breast cancer risk patient screening modalities C. Colin1, N. Foray2, F. De Vathaire3, M. Bourguignon4, P.-J. Valette1; 1Pierre-Bénite/FR, 2Lyon/FR, 3Villejuif/FR, 4Paris/FR

10:39B-0560 Which screenings program should be offered to

women with BRCA1 or BRCA2 mutations? A simulation of comparative cost-effectiveness G.H. De Bock1, K.M. Vermeulen1, L. Jansen1, J.C. Oosterwijk1, S. Siesling1, T. Feenstra1, N. Houssami2, M.J.W. Greuter1; 1Groningen/NL, 2Syndey/AU

10:48B-0561 MRI of hereditary breast cancer: can hyper T2 signal

intensity be considered as a new semeiotic parameter of higher aggressiveness? G. Trecate, R. Agresti, S. Viganò, L. Suman, D. Vergnaghi, C. Ferranti, M. Marchesini, G. Scaperotta, P. Panizza; Milan/IT

10:57B-0562 Fully automated MRI breast density (BD)

measurement: comparison to standard mammographic density estimation G.J. Wengert, W.-D. Vogl, T.H. Helbich, H. Bickel, W. Bogner, K. Pinker-Domenig; Vienna/AT

11:06B-0563 Fully automated quantitative MRI breast density (BD)

measurement confirms higher breast density in breast cancer patients K.J. Pinker-Domenig, G.J. Wengert, H. Bickel, H.F. Magomatschnigg, M. Curda, T.H. Helbich; Vienna/AT

11:15B-0564 To excise or not to excise? Management of high-risk

breast lesions in a symptomatic population J.D. Cunningham, A. Corr, E. Kelliher, A. O‘Shea, J. Kerr, D. Duke, N. Hambly; Dublin/IE

11:24B-0565 The diagnostic value of 3 Tesla breast MRI in the

diagnosis of in situ and invasive breast cancer L.G. Merckel1, H.M. Verkooijen1, N.H.G.M. Peters1, R.M. Mann2, W.B. Veldhuis1, T. van Dalen1, W.P.T.M. Mali1, P.H.M. Peeters1, M.A.A.J. van den Bosch1; 1Utrecht/NL, 2Nijmegen/NL

11:33B-0566 Positive enhancement integral values in diagnostic

magnetic resonance imaging of breast carcinoma: ductal carcinoma in situ (DCIS) vs invasive ductal carcinoma (IDC) M.M. Nadrljanski, O.S. Radulovic, Z.C. Milosevic; Belgrade/RS

11:42B-0567 DCIS at image-guided needle biopsy: can breast MRI

pre-operatory predict invasivity? M. Marcon, V. Bertani, P. Clauser, E. Di Gaetano, V. Londero, A. Linda, R. Girometti, C. Zuiani, M. Bazzocchi; Udine/IT

11:51B-0568 Breast dynamic MRI in patient with DCIS percutaneous

biopsy diagnosis: are different grades associated with specific features? V. Bertani, M. Marcon, P. Clauser, A. Linda, V. Londero, R. Girometti, C. Zuiani, M. Bazzocchi; Udine/IT

Scientific Sessions

243

Saturday

B-05

69 –

B-0

587 12:00

B-0569 Triple negative breast cancers (TNBCs) versus non-triple negative breast cancers (non-TNBCs) diagnosed during a high-risk screening program: sensitivity of imaging modalities and patient outcome R.M. Trimboli1, F. Podo2, F. Santoro2, F. Sardanelli3; 1San Donato Milanese/IT, 2Rome/IT, 3Milan/IT

10:30–12:00 Room I/K

Abdominal Viscera SS 901 Cross-sectional pancreatic imaging

and biomarkers Moderators: B. Marincek; Cleveland, OH/US, G.A. Zamboni; Verona/IT

10:30B-0570 Dynamic contrast MR imaging of the pancreas

under free breathing in combination with navigator technique T. Masui1, M. Katayama1, K. Sato1, K. Terauchi1, K. Tsukamoto1, K. Mizuki1, Y. Iwadate2, H. Sakahara1, H. Kabasawa2; 1Hamamatsu/JP, 2Hino/JP

10:39B-0571 Diffusion-weighted magnetic resonance imaging of

healthy pancreas: a study to investigate the effect of age on apparent diffusion coefficient values C. Ma, C. Pan, H. Zhang, H. Wang, J. Wang, S. Chen, J. Lu; Shanghai/CN

10:48B-0572 Pancreatic cystic lesion fluid content virtual analysis

by means of acoustic radiation force impulse (ARFI) ultrasound imaging: fact or fiction? S. Canestrini, M. D‘Onofrio, R. De Robertis, S. Crosara, E. Demozzi, G. Puntel, R. Pozzi Mucelli; Verona/IT

10:57B-0573 Role of perfusion CT in the evaluation of pancreatic

masses R. Vasudevan, M. Kang, R. Gupta, D. Bhasin, S. Rana, N. Khandelwal; Chandigarh/IN

11:06B-0574 Comparison between CT and CEUS in the diagnosis of

pancreatic adenocarcinoma S. Crosara, M. D‘Onofrio, R. De Robertis, S. Canestrini, R. Pozzi Mucelli; Verona/IT

11:15B-0575 High-resolution diffusion-weighted imaging of

pancreatic ductal adenocarcinoma using 2D reduced field of view single-shot echo planar imaging at 3.0 Tesla C. Ma, Y. Li, H. Wang, S. Chen, J. Lu; Shanghai/CN

11:24B-0576 Imaging features of acinar cell cystadenoma: can we

differentiate them from branch duct IPMNs? C. Delavaud1, G. D‘Assignies1, J. Cros1, P. Ruszniewski1, P. Hammel1, A. Couvelard2, V. Vilgrain1, M.-P. Vullierme1; 1Clichy sur Seine/FR, 2Paris/FR

11:33B-0577 Diffusion-weighted 3T MR imaging with b-multiple SE-

EPI in the differential diagnosis of cystic pancreatic lesions P. Boraschi, F. Donati, R. Gigoni, G. Gherarducci, U. Boggi, F. Falaschi, C. Bartolozzi; Pisa/IT

11:42B-0578 Cystic fibrosis in juveniles and adults: association of

fatty involution of the pancreas at MDCT with CFTR genetic mutation and insulin-dependent diabetes mellitus U.G. Mueller-Lisse, N. Ashoori, H.A. Strube, M. Schmitz, R. Fischer, R.M. Huber, M.F. Reiser, E.M. Coppenrath; Munich/DE

11:51B-0579 Pancreatic atrophy in β-thalassaemia population:

morphological MR evaluation and correlation with pancreatic functional parameters C. Liguori, F. Pitocco, I. Di Giampietro, P. Cianciulli, B. Beomonte Zobel; Rome/IT

10:30–12:00 Room N/O

Cardiac SS 903 Myocardial perfusion and coronary

artery disease Moderators: F. Cademartiri; Monastier di Treviso/IT,

G.I. Kirova-Nedialkova; Sofia/BG

10:30B-0580 Dual bolus dynamic contrast-enhanced cardiac

perfusion imaging: comparison of eight reported analysis methods B.M. Müller-Bierl, K. Tanaka, N. Buls, Y. Fierens, T. van Cauteren, I. Willekens, R. Luypaert, J. De Mey; Brussels/BE

10:39B-0581 Image quality and radiation exposure of low-dose

dual-source dynamic CT stress myocardial perfusion Imaging: a randomized study comparing 80-kVp/370-mAs and 100-kVp/300-mAs protocols M. Fujita, K. Kitagawa, T. Ito, Y. Shiraishi, Y. Kurobe, M. Nagata, M. Ishida, H. Sakuma, K. Dohi; Tsu/JP

10:48B-0582 Feasibility of CT-based dynamic stress perfusion

imaging to differentiate ischaemic and infarcted myocardium as compared with magnetic resonance imaging F. Bamberg, R. Marcus, K. Hildebrandt, F. Schwarz, D. Theisen, K. Bauner, A. Becker, T. Johnson, K. Nikolaou; Munich/DE

10:57B-0583 Adenosine perfusion and late gadolinium

enhancement at 3 Tesla in comparison to 1.5 Tesla for the detection of coronary artery stenosis T. Walcher, K. Ikuye, W. Rottbauer, J. Woehrle, P. Bernhardt; Ulm/DE

11:06B-0584 Myocardial perfusion defects and late gadolinium

enhancement in asymptomatic subjects with subclinical atherosclerosis and mild coronary calcifications – results of the Heinz Nixdorf recall MRI substudy T. Schlosser, K. Nassenstein, P. Hunold, K.-H. Joeckel, J. Barkhausen, R. Erbel, B. Sievers; Essen/DE

11:15B-0585 Late enhancement multidetector computed

tomography (LE-MDCT) assessment of scar substrate in recurrent ventricular tachycardia (VT) C. Colantoni, A. Esposito, A. Palmisano, F. De Cobelli, F. Baratto, G. Maccabelli, P. Della Bella, A. Del Maschio; Milan/IT

11:24B-0586 Dynamic CT perfusion imaging of the myocardium

using a wide detector CT scanner: stress/rest or stress only A.M. Huber1, V. Leber1, B. Gramer1, M. Vembar2, A. Leber1, E. Hoffmann1, E.J. Rummeny1; 1Munich/DE, 2Cleveland, OH/US

11:33B-0587 Advanced age and apnoea-hypopnoea index

predict subclinical atherosclerosis in patients with obstructive sleep apnoea syndrome B. Arık1, C. Gümüş1, M. İnci2, M. Ege3, A. Zorlu4, K. Varol1, Ö. Doğan1; 1Sivas/TR, 2Kahramanmaraş/TR, 3Ankara/TR, 4Malatya/TR

Scientific Sessions

244

B-05

88 –

B-0

60911:42

B-0588 Prevalence of severe subclinical coronary artery disease on cardiac CT and MRI in patients with extra-cardiac arterial disease M.A.M. den Dekker1, J.J.A.M. van den Dungen1, I.F.J. Tielliu1, R.A. Tio1, R.M.J.J. Jaspers2, M. Oudkerk1, R. Vliegenthart1; 1Groningen/NL, 2Deventer/NL

11:51B-0589 Dual-energy CT with non-linear image blending

improves visualization of delayed myocardial contrast enhancement in acute myocardial infarction A.H. Mahnken1, P. Bruners2, K. Kartje2, B. Schmidt3; 1Marburg/DE, 2Aachen/DE, 3Forchheim/DE

10:30–12:00 Room P

Paediatric SS 912 Paediatric body and bones

Moderators: K.J. Johnson; Birmingham/UK, L.-S. Ording-Müller; Tromsø/NO

10:30B-0590 Accuracy of ultrasound using a computerised

technique to evaluate nonalcoholic fatty liver disease in obese and eutrophic adolescents as compared with MRI J.H.R.N. Nascimento, R.B.S. Soder, M.E. Epifanio, M.B. Baldisserotto; Porto Alegre/BR

10:39B-0591 Can ultrasonography reliably differentiate between

ileo-colic and small bowel intussusception? N. Simanovsky1, N. Lioubashevsky2, K. Rozovsky2, N. Hiller2; 1Beth Horon/IL, 2Jerusalem/IL

10:48B-0593 Early-stage disease activity of the wrist in juvenile

idiopathic arthritis: assessment with MRI in a pilot study C.M. Nusman, R. Hemke, D. Schonenberg, J.M. van den Berg, K.M. Dolman, T.W. Kuijpers, M.A.J. van Rossum, M. Maas; Amsterdam/NL

10:57B-0594 Clavicle radiographs in children: a waste of time and

radiation? M.R. Jackson, M.-P. Lirette, P. Leonard; Edinburgh/UK

11:06B-0595 A follow-up study of a delayed approach to managing

developmental hip dysplasia (DDH) L. Woods, M. Khalil, A. Witwit, S. Manickam, M. Churchill, V. Cook; London/UK

11:15B-0596 Value of lower-limb MRI in the staging and re-staging

of post-treatment osteonecrosis in paediatric patients with lymphoproliferative disease A. Masetto, D. Ippolito, P.A. Bonaffini, L. Longoni, A. Sala, A. Rovelli, S. Sironi; Monza/IT

11:24B-0597 Painful paediatric hip: frog-leg lateral view only!

J. Bomer, F. Klerx, H.C. Holscher; Den Haag/NL

11:33B-0598 DXA as a key instrument for the evaluation and the

follow-up of adolescents affected by anorexia nervosa F. Ciccarese, G. Facchini, E. Di Pietro, F. Moscano, L. Iero, E. Franzoni, G. Battista, A. Bazzocchi; Bologna/IT

11:42B-0599 Replacing conventional spine radiographs with dual-

energy X-ray absorptiometry (DXA) in children with suspected reduction in bone density E. Adiotomre, L. Summers, P. Broadley, I. Lang, G. Morrison, A. Offiah; Sheffield/UK

10:30–12:00 Room Q

Radiographers SS 914 Dose optimisation as daily challenge

Moderators: P. Blackburn Andersen; Kolding/DK, A. Petakovic; Novo Mesto/SI

10:30B-0600 Estimating organs cancer incidence related to patient

radiation exposure following PCI for acute and chronic coronary total occlusion D. Maccagni; Milan/IT

10:39B-0601 Project retake: quality assurance of radiation hygiene

by maintaining image quality S.M. Khan; Oslo/NO

10:48B-0602 Implementation of a quality control program in a

radiology department M. Leão, L.P.V. Ribeiro, A.F.C.L. Abrantes, J. Pinheiro, R.P.P. Almeida, K.B. Azevedo, S.I. Rodrigues; Faro/PT

10:57B-0603 Assessment of radiological imaging conformities

based in quality control charts S. Cândido, A.M. Ribeiro, L.P.V. Ribeiro, A.F.C.L. Abrantes, J. Pinheiro, K.B. Azevedo, R.P.P. Almeida; Faro/PT

11:06B-0604 A review of diagnostic imaging frequency to aid

research exploring the issue of consent for higher dose paediatric examinations J.L. Portelli1, J. McNulty2, S. Mohan2, P. Bezzina1, L. Rainford2; 1Msida/MT, 2Dublin/IE

11:15B-0605 An approach for Portuguese diagnostic reference

levels for bedside chest radiography A. Sousa, S. Serém, J. Santos, G. Paulo; Coimbra/PT

11:24B-0606 An investigation into the relationship between the

exposure index value and image quality M.-L. Butler, L. Rainford; Dublin/IE

11:33B-0607 Attenuation of anode heel effect with an aluminum

filter and their influence on patient dose in lumbar spine radiography J. Soares, R. Dores, P. Sousa, S.I. Rodrigues, L.P.V. Ribeiro, A.F.C.L. Abrantes, R.P.P. Almeida; Faro/PT

11:42B-0608 Antero-posterior (AP) pelvic radiography: collimator

errors and their effects on radiation dose H. Brookfield1, A.S. Manning-Stanley2, A. England1; 1Liverpool/UK, 2Salford/UK

11:51B-0609 Breast shielding significantly reduces breast dose

during lumbar spine radiography N. Mekiš, D. Žontar, D. Škrk; Ljubljana/SI

Scientific Sessions

245

Saturday

B-06

10 –

B-0

619 10:30–12:00 Room Z

Computer Applications SS 905 Computer-aided diagnosis

Moderators: T. Mang; Vienna/AT, D. Regge; Turin/IT

10:30B-0610 Automated characterization of pulmonary nodules

in thoracic CT images using a segmentation-based classification system C. Jacobs1, E.M. van Rikxoort2, J.-M. Kuhnigk1, E.T. Scholten3, P.A. de Jong4, C. Schaefer-Prokop5, M. Prokop2, B. van Ginneken2; 1Bremen/NL, 2Nijmegen/NL, 3Haarlem/NL, 4Utrecht/NL, 5Amersfoort/NL

10:39B-0611 Semiautomatic estimation of right ventricular

parameters from MR images: a new stereological approach M. Mazonakis, K. Pagonidis, C. Varveris, J. Damilakis; Iraklion/GR

10:48B-0612 Automated computerized software for diameter and

volume measurements of pulmonary metastatic disease: preliminary evaluation E. Lotan, D. Aharoni, S. Raskin, B. Boursi, R. Berger, E. Konen; Ramamt Gan/IL

10:57B-0613 Computerised morphological estimation of sex and

age – from subjective investigation to computer-assisted analysis A. Vlcek, F. Kanz, W. Weninger, J. Streicher, D. Risser, F. Kainberger; Vienna/AT

11:06B-0614 Semiautomatic evaluation of quantitative

pharmacokinetic parameters – systematic evaluation of a new CAD-tool and evaluation of clinical performance at high field 3T MRI M. Dietzel, A. Dörfler; Erlangen/DE

11:15B-0615 Rapid semi-automated volumetry of pleural effusion in

MDCT M.P.F. Botelho, F.D. Gonzalez-Guindalini, H. Chalian, V. Yaghmai; Chicago, IL/US

11:24B-0616 Software-supported evaluation of small-bowel

motility using free-breathing cine MRI S. Bickelhaupt1, R. Cattin2, S. Raible2, J.M. Froehlich1, H. Bouquet3, U. Bill3, M.A. Patak1; 1Zurich/CH, 2Biel/CH, 3Berne/CH

11:33B-0617 Automated system for CT carotid plaque

characterisation into symptomatic and asymptomatic classes L. Saba1, U. Acharia2, M. Anzidei3, M. Piga1, J.S. Suri4; 1Cagliari/IT, 2Singapore/SG, 3Rome/IT, 4Pocatello, ID/US

11:42B-0618 Automated labelling framework applied on full and

partial spine CT scans D. Major, J. Hladuvka, F. Schulze, K. Bühler; Vienna/AT

11:51B-0619 Segmentation-free scheme for computer-assisted

image interpretation: application to CT colonography F. Chandelier1, T. Cabrera2, P. Kocsis1, L. Stein2, V. Demers2; 1Granby, QC/CA, 2Montreal, QC/CA

Scientific Sessions

246

B-06

20 –

B-0

63910:30–12:00 Room A

Oncologic Imaging SS 1316 Rectal cancer imaging: the next step

Moderators: L. Curvo-Semedo; Coimbra/PT, C. Hoeffel; Reims/FR

10:30B-0620 Predictive value of combined quantitative parameters

obtained with ADC map and 18-FDG/PET study in assessment of treatment response of patients with advanced rectal cancer: histopathologic correlation D. Ippolito, A. Cadonici, C. Trattenero, L. Monguzzi, C. Capraro, S. Sironi; Monza/IT

10:39B-0621 Intrinsic gradient of the vascular function in rectal

tumours M.H. Martens, E. Kluza, S. Subhani, M. Maas, C. Jeukens, G.L. Beets, R.G.H. Beets-Tan; Maastricht/NL

10:48B-0622 Enhanced vascular structure and function in the

tumour-surrounding mesorectum: potential risk factors for patients with rectal cancer M.H. Martens, E. Kluza, J.-P.J.E. Kleijnen, M. Maas, C.R.L.P. Jeukens, W.H. Backes, G.L. Beets, R.G.H. Beets-Tan; Maastricht/NL

10:57B-0623 Value of 3D FSE Cube sequence at 3T MRI in

preoperative local staging of rectal cancer R. Scandiffio, P. Vagli, P. Bemi, A. Mantarro, L. Faggioni, R. Balestri, P. Buccianti, E. Neri, C. Bartolozzi; Pisa/IT

11:06B-0624 Prediction of subsequent metastatic disease by

dynamic contrast MRI in locally advanced rectal cancer E.M. Anderson, J.M. Franklin, L. Tanner, M. Brady, F.V. Gleeson; Oxford/UK

11:15B-0625 Features on MRI after transanal endoscopic

microsurgery in patients with rectal cancer L.A. Heijnen1, M. Maas1, M.H. Martens1, D.M.J. Lambregts1, J.W.A. Leijtens2, W. Deserno2, G.L. Beets1, R.G.H. Beets-Tan1; 1Maastricht/NL, 2Roermond/NL

11:24B-0626 Role of perfusional MRI and DWI to predict

pathological complete response to neoadjuvant chemoradiotherapy in rectal cancer C.N. De Cecco, M. Ciolina, M.M. Maceroni, G. Muscogiuri, F. Iafrate, A. Laghi; Rome/IT

11:33B-0627 Additional value of diffusion-weighted (DWI) MRI for

predicting complete tumour response (T0N0) in rectal cancer treated with neo-adjuvant chemoradiation therapy (CRT) S. Sassen1, M. de Booij1, M.N. Sosef1, G. Lammering2, C.M.M. Bakker1, R. Clarijs1, R.C.M. Berendsen1, J. Wals1, R.F.A. Vliegen1; 1Heerlen/NL, 2Maastricht/NL

11:42B-0628 Advanced characterisation of rectal cancer prior

surgery: preliminary results on the evaluation of multimodality functional MRI techniques in correlation to histopathology D. Hausmann, D. Dinter, P. Kienle, F. Doyan, S.O. Schönberg, U.I. Attenberger; Mannheim/DE

11:51B-0629 ColoCare: compartmental quantification of obesity on

CT as risk factor for colorectal cancer J. Welzel, H. Hogenauer, J. Staffa, D. Scherer, L. Grenacher, C. Ulrich, H.-U. Kauczor; Heidelberg/DE

10:30–12:00 Room D1

Chest SS 1304 CTPA techniques in lung perfusion and

pulmonary hypertension Moderators: I. Hartmann; Rotterdam/NL, E.J. Stern; Seattle, WA/US

10:30B-0630 Impact of iterative reconstructions on the diagnosis

of acute pulmonary embolism (PE) on low-dose CT angiograms: clinical experience in 53 patients F. Pontana, S. Henry, J.-B. Faivre, N. Tacelli, S. Bendaoud, M. Rémy-Jardin, J. Rémy; Lille/FR

10:39B-0631 Comparison of image quality and radiation dose

between 64-MDCT and high pitch 128-DSCT protocols in triple rule-out studies A. Fernandez del Valle, C. Delgado, R. Oca, N. Silva, G. Tardáguila; Vigo/ES

10:48B-0632 Sinogram-affirmed iterative reconstructed simulated

ECG-gated ultra high pitch CT pulmonary angiography in the acute setting: effect on dose and image quality S.J. Co1, S. Nicolaou1, J. Mayo1, T. Liang1, D. Hou1, K. Krzymyk2; 1Vancouver, BC/CA, 2Topanga, CA/US

10:57B-0633 70 kV CT pulmonary angiography in clinical routine:

initial experience, radiation dose and image quality R.W. Bauer, F. Al-Butmeh, C. Frellesen, J.A. Wichmann, T. Lehnert, T.J. Vogl, M. Kerl; Frankfurt am Main/DE

11:06B-0634 Automated quantification of pulmonary perfused

blood volume in acute pulmonary embolism using dual-energy CTPA F.G. Meinel, A. Graef, F. Bamberg, S.F. Thieme, C. Neurohr, C. Kupatt, M.F. Reiser, T.R.C. Johnson; Munich/DE

11:15B-0635 Dual-source CT perfusion maps: do they increase the

diagnostic confidence in the diagnosis of pulmonary embolism by CT? E. Stiefsohn, S. Scharer, H. Prosch, C. Neumann, K. Osinger, M. Weber, G. Mostbeck; Vienna/AT

11:24B-0636 CT-pulmonary angiography follow-up in acute

pulmonary embolism: resolution of emboli and change of CT signs of right heart dilatation and pulmonary hypertension C. Neumann, H. Prosch, K. Osinger, D. Vedrilla, M. Weber, G. Mostbeck; Vienna/AT

11:33B-0637 Clinical significance of high density thrombi on

non-enhanced CT scan in patients with pulmonary thromboembolism K.S. Beck, B. Lee, H. Kim, D. Han; Seoul/KR

11:42B-0638 Automated quantification of pulmonary perfused

blood volume by dual-energy CTPA in chronic thromboembolic pulmonary hypertension F.G. Meinel, A. Graef, M. Armbruster, C. Neurohr, M.F. Reiser, T.R.C. Johnson; Munich/DE

11:51B-0639 Non-invasive diagnosis of pulmonary hypertension

with dynamic contrast-enhanced computed tomography M. Pienn1, G. Kovacs1, M. Tscherner1, T.R.C. Johnson2, P. Kullnig1, R. Stollberger1, A. Olschewski1, H. Olschewski1, Z. Bálint1; 1Graz/AT, 2Munich/DE

Scientific Sessions

247

Sun

day

B-06

40 –

B-0

659 10:30–12:00 Room D2

Interventional Radiology SS 1309 Skeletal and endocrinologic

interventions Moderators: L. Crocetti; Pisa/IT, D.K. Tsetis; Iraklion/GR

10:30B-0640 Selective arterial embolisation for bone tumours

G. Rossi1, E. Rimondi1, A.F. Mavrogenis2, A. Andreone1, P. Spinnato1, G. Garzillo1, P. Ruggieri1, D. Vanel1, A. Bazzocchi1; 1Bologna/IT, 2Athens/GR

10:39B-0641 Radiofrequency ablation of osteoid osteoma:

technique with special tricks for difficult anatomical locations and atypical nidus A.K. Janu, B. Jankharia, K. Pilania, P. Thakrar; Mumbai/IN

10:48B-0642 Osteoid osteomas of the elbow: a challenging location

A. Bazzocchi, G. Facchini, G. Bettelli, E. Castiello, M. Cavaciocchi, R. Rotini, U. Albisinni; Bologna/IT

10:57B-0643 MR-guided high-intensity focused ultrasound for non-

invasive treatment of osteoid osteoma M. Anzidei, A. Napoli, G. Brachetti, B. Cavallo Marincola, G. Cartocci, F. Boni, V. Noce, L. Bertaccini, C. Catalano; Rome/IT

11:06B-0644 MR-guided focused ultrasound ablation on bone

metastases: role of dynamic contrast-enhanced MRI in the evaluation of treatment response A. Napoli, V. Noce, M. Anzidei, F. Boni, G. Brachetti, G. Cartocci, L. Bertaccini, C. Catalano, F. Ciolina; Rome/IT

11:15B-0645 Palliative treatment of bone metastases: analysis of

biological effects of MR-guided focused ultrasound (MRgFUS) versus external beam radiation therapy (EBRT). A randomised comparative trial using functional diffusion maps as molecular activity indicator A. Napoli, G. Brachetti, D.S. De Oliveira, G. Cartocci, F. Boni, V. Noce, C. Marsecano, V. Tombolini, C. Catalano; Rome/IT

11:24B-0646 Percutaneous laser ablation of metastatic lymph

nodes in the neck from papillary thyroid carcinoma: 1-year results G. Mauri1, T. Tondolo1, L. Cova1, T. Ierace1, N.S. Goldberg2, L. Solbiati1; 1Busto Arsizio/IT, 2Jerusalem/IL

11:33B-0648 Arterial spin labelling (ASL) MRI for monitoring kidney

perfusion before and after renal denervation: initial results C. Schleich, D. Blondin, P. Kröpil, O. Vonend, P. Heusch, H.-J. Wittsack, G. Antoch, R.S. Lanzman; Düsseldorf/DE

11:42B-0649 Reliable and reproducible sampling of adrenal veins in

the management of hyperaldosteronism, a technically demanding yet feasible procedure: an institutional experience C.H. Lam, H.L. Chow, S.H. Chiu, H.Y. Cho, S. Lau; Hong Kong/HK

10:30–12:00 Room E1

Musculoskeletal SS 1310 Arthritis and metabolic bone disease

Moderators: A.J. Grainger; Leeds/UK, A. Plagou; Athens/GR

10:30B-0650 Radiological peripheral involvement in a cohort of

polyarticular juvenile idiopathic arthritis at adulthood A. Feydy, R. Bazeli, V. Freire, M. Elhai, J. Wipff, C. Job-Deslandre, A. Kahan, J.-L. Drapé; Paris/FR

10:39B-0651 Monitoring of initial methotrexate therapy effect on

cartilage composition in early rheumatoid arthritis with biochemical MRI of finger cartilage C. Schleich, B. Ostendorf, C. Buchbender, C. Nowak, P. Sewerin, M. Schneider, G. Antoch, A. Scherer, F. Miese; Düsseldorf/DE

10:48B-0652 Quantification of synovitis in the cranio-cervical

region in early rheumatoid arthritis using dynamic contrast-enhanced (DCEI) and diffusion-weighted (DWI) magnetic resonance imaging (MRI) M. Jeromel1, V. Jevtič1, M. Tomšič1, I. Pisanec2, J. Markota1, I. Serša,1, A. Ambrožič1; 1Ljubljana/SI, 2Celje/SI

10:57B-0653 Slow radiographic progression of bone destruction

in the hands in early psoriatic arthritis without correlation to clinical disease activity M. Geijer1, U. Lindqvist2, T. Husmark3, G.-M. Alenius4, P.T. Larsson5, A. Teleman6, E. Theander7; 1Lund/SE, 2Uppsala/SE, 3Falun/SE, 4Umeå/SE, 5Stockholm/SE, 6Oskarström/SE, 7Malmö/SE

11:06B-0654 Role of dynamic MRI in predicting outcome of patients

affected with early stage arthritis C.A. Mattiuz1, L.M. Sconfienza1, M. Cimmino2, G. Garlaschi2, G. Di Leo1, F. Sardanelli1; 1Milan/IT, 2Genoa/IT

11:15B-0655 Association of trochlear dysplasia with degenerative

abnormalities in the knee: data from the osteoarthritis initiative P.M. Jungmann1, S.-C. Tham2, H. Liebl3, M. Nevitt3, C.E. McCulloch3, J. Lynch3, T.M. Link3; 1Munich/DE, 2Singapore/SG, 3San Francisco, CA/US

11:24B-0656 Reliability of tomosynthesis for semiquantitative

assessment of knee osteoarthritis features by radiologists with different levels of expertise D. Hayashi1, L. Xu1, J. Gusenburg1, F.W. Roemer1, D.J. Hunter2, L. Li1, A. Guermazi1; 1Boston, MA/US, 2Sydney/AU

11:33B-0657 Scoring hip abnormalities using MR images (SHAMRI):

a novel hip whole joint osteoarthritis evaluation system S. Lee1, L. Nardo1, A. Lai1, D. Kumar1, C.R. Wyatt1, R.B. Souza1, N.E. Lane2, S. Majumdar1, T.M. Link1; 1San Francisco, CA/US, 2Sacramento, CA/US

11:42B-0658 Cortical thickness mapping reveals effects of age,

weight and osteophytes in the proximal femur T.D. Turmezei, G.M. Treece, A.H. Gee, C.J. Tonkin, K.E.S. Poole; Cambridge/UK

11:51B-0659 Multifocal endosteal thickening of the femur in

patients on long-term bisphosphonate therapy presenting with atypical femoral fractures M.A. Png, P.C. Mohan, J.S.B. Koh, T.S. Howe; Singapore/SG

Scientific Sessions

248

B-06

60 –

B-0

67810:30–12:00 Room E2

Cardiac SS 1303 Towards improved image quality and

detection Moderators: G. Feuchtner; Innsbruck/AT, C. Herzog; Munich/DE

10:30B-0660 Stenosis quantification in coronary CT angiography:

impact of an integrated circuit detector with iterative reconstruction F. Morsbach1, L. Desbiolles2, A. Plass1, S. Leschka2, B. Schmidt3, V. Falk1, H. Alkadhi1, P. Stolzmann1; 1Zurich/CH, 2St. Gallen/CH, 3Forchheim/DE

10:39B-0661 CT coronary angiography: effect of iodine

CONcentration on vascular attenuation. The CT-CON multicentric study preliminary results M. Rengo1, A.S. Dharampal2, D. Caruso1, K. Nieman2, A. Laghi1, G.P. Krestin2; 1Latina/IT, 2Rotterdam/NL

10:48B-0662 MDCT coronary angiography evolution of phasic

critical stenosis in myocardial bridges R. Malago, M. Tezza, G. Sala, A. Pezzato, C. Barbiani, R. Pozzi Mucelli; Verona/IT

10:57B-0663 Quantitative CT coronary angiography: does it predict

functionally significant coronary stenoses? A. Rossi1, S. Papadopoulou1, F. Pugliese2, B. Russo1, A. Dharampal1, P.H. Kitslaar3, S.E. Petersen2, P. de Feyter1, G.P. Krestin1; 1Rotterdam/NL, 2London/UK, 3Leiden/NL

11:06B-0664 Impact of iterative CT image reconstruction on

calcium score measurements J.A.C. van Osch1, M. Mouden1, J.A. van Dalen1, J.R. Timmer1, S. Reiffers1, M.J.W. Greuter2, J.P. Ottervanger1, S. Knollema1, P.L. Jager1; 1Zwolle/NL, 2Groningen/NL

11:15B-0665 Accuracy of prospectively ECG-triggered ultra low-

dose coronary dual-source CT angiography using iterative reconstruction M. Lell, C. Layritz, T. Pflederer, W. Wuest, S. Achenbach, M. Uder; Erlangen/DE

11:24B-0666 Influence of iterative reconstruction on coronary

calcium score in cardiac computed tomography K. Jaspers1, J.A.C. Van Osch2, J.M. Groen1, M.J.W. Greuter1; 1Groningen/NL, 2Zwolle/NL

11:33B-0667 Magnetic resonance velocity mapping-based

evaluation of elevated mean pulmonary arterial pressure: the impact of visualisation techniques U. Reiter1, G. Reiter1, G. Kovacs1, A. Stalder2, M.A. Gulsun3, A. Greiser2, H. Olschewski1, M.H. Fuchsjäger1; 1Graz/AT, 2Erlangen/DE, 3Princeton, NJ/US

11:42B-0668 Undersampled real time cine SSFP with through-time

radial GRAPPA: evaluation of RV function in breath-hold and free breathing B.J. Wintersperger1, A. Pellow1, G. Bastarrika1, M.A. Griswold2, N. Seiberlich2, M. Sussman1; 1Toronto, ON/CA, 2Cleveland, OH/US

11:51B-0669 Diagnostic accuracy of delayed phase dual-energy

CT for the detection of chronic myocardial infarction compared to 3-T MRI late gadolinium enhancement J.L. Wichmann, J.M. Kerl, T. Lehnert, M. Doss, T.J. Vogl, R.W. Bauer; Frankfurt am Main/DE

10:30–12:00 Room F1

Neuro SS 1311 Brain tumours: imaging and therapy

Moderators: X. Golay; London/US; A. Zimny; Wroclaw/PL

10:30B-0670 Intra-arterial ophthalmic artery chemotherapy for

group D retinoblastoma in children: 4-years Lausanne experience S. Binaghi, J.-B. Zerlauth, M. Beck-Popovic, F. Munier, R. Meuli; Lausanne/CH

10:39B-0671 Neurocutaneous melanosis in children with giant

congenital melanocytic nevi O. Szczygielski, M. Boczar, E. Sawicka, M. Bekiesinska-Figatowska, J. Madzik, A. Romaniuk-Doroszewska, M. Uliasz, T. Klepacka, E. Michalak; Warsaw/PL

10:48B-0672 Surveillance neuroimaging in patients with

medulloblastoma should include diffusion-weighted imaging L. van den Hauwe, C. Gidding, E. van Lindert, P. Wesseling, B. Goraj; Nijmegen/NL

10:57B-0673 Preoperative evaluation of consistency of

meningiomas: diagnostic efficacy of MRI A. Hiwatashi, T. Yoshiura, O. Togao, K. Yamashita, K. Kikuchi, K. Yoshimoto, M. Mizoguchi, S.O. Suzuki, H. Honda; Fukuoka/JP

11:06B-0674 Radiation-induced telangiectasia in the long-term

survivors of intracranial germ cell tumours: whole-ventricle vs whole-brain radiation L. Li, S. Mugikura, T. Murata, T. Kumabe, K. Jingu, T. Fujii, E. Mori, S. Takahashi; Sendai/JP

11:15B-0675 Dynamic sequences in Intraoperative MRI during

transsphenoidal resection of pituitary adenomas: quantitative analysis M. Rossi Espagnet1, A. Boellis1, V. Coppola2, A. Romano1, S. Pugliese1, F. Tavanti1, L. Calabria1, L. Fantozzi1, A. Bozzao1; 1Rome/IT, 2Ronciglione/IT

11:24B-0676 Preoperative classification of cerebral tumours by

applying whole brain VPCT: which parameter to use in order to achieve the highest prognostic value? A. Xyda1, E. Klotz2, U. Haberland2, R. Schramm3, M. Knauth3, P. Schramm3; 1Iraklion/GR, 2Forchheim/DE, 3Göttingen/DE

11:33B-0677 Apparent diffusion coefficient in determination of

histological subtype of meningioma D.A. Stojanov; Nis/RS

11:42B-0678 Evaluation of diffusivity in pituitary adenoma in the

Sella Turcica with 3D turbo field echo with diffusion-sensitized driven-equilibrium preparation: initial experience A. Hiwatashi1, T. Yoshiura1, O. Togao1, K. Yamashita1, K. Kikuchi1, H. Honda1, M. Obara2; 1Fukuoka/JP, 2Tokyo/JP

Scientific Sessions

249

Sun

day

B-06

79 –

B-0

696 10:30–12:00 Room F2

Breast SS 1302 How to get more from breast imaging

modalities Moderators: N. Houssami; Sydney/AU, M. Nadrljanski; Belgrade/RS

10:30B-0679 Magnetic resonance imaging of fibroadenomas in

the female breast: new insights on dynamic and morphologic profiles and differential diagnosis from malignant breast lesions M. Dietzel1, P.A.T. Baltzer2, W.A. Kaiser3; 1Erlangen, Jena/DE, 2Jena/DE, Vienna/AT, 3Jena/DE

10:39B-0680 Texture analysis of malignant breast tumours: is a

differentiation of ductal carcinoma in situ, invasive ductal and invasive lobular breast cancer possible? T. Knogler1, K. Pinker-Domenig1, N. Perry2, S. Milner2, K. Mokbel2, M.E. Mayerhoefer1; 1Vienna/AT, 2London/UK

10:48B-0681 Variation of apparent diffusion coefficients (ADC)

measured in the normal breast using diffusion-weighted MR mammography: effects of menopausal status, anthropometric measures and hormone intake K. Hegenscheid, R. Seipel, R. Laqua, C.O. Schmidt, H. Völzke, N. Hosten, B. Mensel; Greifswald/DE

10:57B-0682 Second-look US with MR volume navigation (V Nav) of

breast lesions: a way to make it objective A. Fausto, P. Mercuri, L. Mantovani, L. Volterrani; Siena/IT

11:06B-0683 Dense breasts as a new standard indication for

MR mammography: prospective analysis of 1488 consecutive patients C.G. Kaiser1, C. Reich2, K. Wasser1, S.O. Schönberg1, W.A. Kaiser2; 1Mannheim/DE, 2Jena/DE

11:15B-0684 Is 2D central projection obtained with digital breast

tomosynthesis qualitatively equivalent to digital mammmography? P. Clauser1, V. Londero1, C. Molinari1, R. Girometti1, A. Taibi2, S. Vecchio3, C. Zuiani1, M. Bazzocchi1; 1Udine/IT, 2Ferrara/IT, 3Bologna/IT

11:24B-0685 The role of additional ultrasound and tomosynthesis

after normal digital mammography: comparison between both techniques P. Slon, J. Etxano, I. Simon-Yarza, G. Viteri, A. Elizalde, L.J. Pina Insausti; Pamplona/ES

11:33B-0686 Lesion detection and characterization of one-view

digital breast tomosynthesis combined with one-view mammography compared to two-view mammography G. Gennaro1, E.R. Hendrick2, A. Toledano3, R. Chersevani4, C. di Maggio1, M. La Grassa5, L. Pescarini1, I. Polico1, A. Proietti1; 1Padua/IT, 2Denver, CO/US, 3Washington, DC/US, 4Gorizia/IT, 5Aviano/IT

11:42B-0687 Does the adjunct of digital breast tomosynthesis

(DBT) increase inter-reader reproducibility of two-dimensional digital mammography (2D-DM)? G. Di Leo1, L.A. Carbonaro1, M. Bazzocchi2, V. Londero2, A. Dal Col2, R.M. Trimboli1, F. Sardanelli1; 1San Donato Milanese/IT, 2Udine/IT

11:51B-0688 One-to-one comparison between digital

mammography and digital breast tomosynthesis using a fully automated software: breast density underestimation on digital breast tomosynthesis varies in different BI-RADS classes A. Tagliafico, S. Airaldi, F. Cavagnetto, B. Bingotti, S. Tosto, D. Astengo, M. Calabrese; Genoa/IT

10:30–12:00 Room G/H

Genitourinary SS 1307 The bladder and below

Moderators: M. Baramia; Tbilisi/GE, R.H. Oyen; Leuven/BE

10:30B-0689 The role of CT as a staging tool and prognostic

biomarker in the pretreatment evaluation of intra-diverticular bladder tumours P.L. Di Paolo, H.A. Vargas, H. Hricak; New York, NY/US

10:39B-0690 Usefulness of diffusion-weighted magnetic resonance

imaging in patients with muscle-invasive bladder cancer selected for radical cystectomy: lymph node staging prospective study and comparison with CT scan J. Borrego Gómez, J. Martel Villagrán, E. De la Peña, J. Culebras, C. Llorente; Madrid/ES

10:48B-0691 Use of FLAIR sequences for detection and local

staging of bladder tumours with MRI M. Di Girolamo, G. Muscogiuri, M. Cappucci, V. Catena, R. Persechino, V. David; Rome/IT

10:57B-0692 Magnetic resonance virtual cystoscopy versus

conventional cystoscopy in the detection of urinary bladder cancer S. Elangovan; Puducherry/IN

11:06B-0693 Voiding MR cystourethrography: a new diagnostic

imaging technique for the evaluation of male lower urinary tract M. Di Girolamo, C. Cantone, E.M. Pandolfi, R. Persechino, F. Caporilli Razza, V. David; Rome/IT

11:15B-0694 Micturition MRI: voiding assessment in continent ileal

urinary reservoir J. Lopater1, A. Scherrer1, V. Delmas2, S. Gey2, Y. Neuzillet1, T. Lebret1; 1Suresnes/FR, 2Paris/FR

11:24B-0695 Clinical relevance of magnetic resonance dynamic

spongiourethrotomography of male urethral stricture detection E. Banchik, V. Dombrovsky, M. Kogan, V. Mitusov; Rostov-on-Don/RU

11:33B-0696 Urinary bladder neck dysfunction in male patients:

evaluation with MRI and with voiding MR-cystourethrography M. Di Girolamo, A. Trucchi, S. Mariani, G. Muscogiuri, I. Casazza, V. David; Rome/IT

Scientific Sessions

250

B-06

97 –

B-0

71411:42

B-0697 MRI findings of radiation-induced changes in the urethra and periurethral tissues in patients with prostate cancer C. Marigliano1, O.F. Donati2, O. Akin2, D. Goldman2, J. Eastham2; 1Rome/IT, 2New York, NY/US

11:51B-0698 MRI anatomic evaluation in patients with persistent

urinary incontinence after advance male sling: a work in progress study with a 3T system V. Zampa, D. Pistolesi, S. Ortori, L. Faggioni, M. Marletta, C. Bartolozzi; Pisa/IT

10:30–12:00 Room I/K

Abdominal Viscera SS 1301 Abdominal CT: dose reduction and

technical improvements Moderators: D. Tack; Baudour/BE, A. Taibbi; Palermo/IT

10:30B-0699 Hybrid iterative reconstruction for abdominal CT: can

the radiation dose be decreased while preserving the low-contrast detectability? S.T. Schindera1, D. Odedra2, S. Arsalan Raza2, T.K. Kim2, H.-J. Jang2, Z. Szucs-Farkas3, P. Rogalla2; 1Basle/CH, 2Toronto, ON/CA, 3Biel/CH

10:39B-0700 Image quality on liver CT based on sinogram-affirmed

iterative reconstruction algorithm B. Schulz, B. Bodelle, P. Siebenhandl, M. Beeres, F. Al-Butmeh, C. Frellesen, T.J. Vogl; Frankfurt a. Main/DE

10:48B-0701 Efficacy of a liver detection algorithm for noise

reduction in abdominal CT N. Ardley1, K. Buchan2, K. Lau1; 1Clayton/AU, 2Melbourne/AU

10:57B-0702 Impact of modified abdominal CT protocols for obese

patients with filtered back projection and hybrid iterative reconstruction technique on image quality, radiation dose and low-contrast detectability: a phantom study S.T. Schindera1, D. Odedra2, D. Mercer2, S. Thipphavong2, P. Chou2, Z. Szucs-Farkas3, P. Rogalla2; 1Basle/CH, 2Toronto, ON/CA, 3Biel/CH

11:06B-0703 Automated attenuation-based tube potential selection

for abdominal CT examinations: impact on image quality and dose reduction P. Kröpil, P. Heusch, L. Schimmöller, F. Miese, S. Dietrich, G. Antoch, R.S. Lanzman; Düsseldorf/DE

11:15B-0704 Second generation dual-energy CT of the abdomen:

radiation dose comparison with 64- and 128-row single energy acquisition C.N. De Cecco, A. Darnell, N. Macias, G. Muscogiuri, C. Ayuso, A. Laghi; Rome/IT

11:24B-0705 Can iterative reconstructions improve the detection

of small hypervascular liver nodules with dual-energy CT? L. Facchetti1, L. Berta2, L. Mascaro1, F. Pittiani1, L. Romanini1, R. Maroldi1; 1Brescia/IT, 2Milan/IT

11:33B-0706 Low-voltage CT of the abdomen: correlation between

patient diameters and subjective image quality, toward identifying cutoff patient diameters for patient selection. G.A. Zamboni, M. Ambrosetti, R. Pozzi Mucelli; Verona/IT

11:42B-0707 Preliminary application of spectral CT imaging in the

differentiation of hepatic tumours W. Chen, X. Ye, C. Zhou; Beijing/CN

11:51B-0708 Ultra-high-field imaging of the biliary tract at 7 Tesla:

initial results of Gd-EOB-DTPA-enhanced magnetic resonance cholangiography A. Fischer, O. Kraff, S. Orzada, F. Nensa, L.C. Schäfer, M.E. Ladd, L. Umutlu, T.C. Lauenstein; Essen/DE

10:30–12:00 Room L/M

Head and Neck SS 1308 Advanced imaging of the ear, orbit and

glands Moderators: R. Elias; Rotterdam/NL, B.F. Schuknecht; Zurich/CH

10:30B-0709 Volume-rendering 3D-MRI for detection of auditory

pathways in children under evaluation for cochlear implantation I. Burck, N.N. Nagy, M. Harth, T. Stöver, T.J. Vogl, S. Strieth; Frankfurt a. Main/DE

10:39B-0710 Congenital sensorineural hearing loss and ABI surgery:

pre-operative radiological protocol and considerations after 12 years of experience M. Barillari, R. Cerini, F. Spagnolli, N. Cardobi, M. Carner, L. Colletti, V. Colletti, R. Pozzi Mucelli; Verona/IT

10:48B-0711 Three dimensional and multiplanar reconstruction of

the internal auditory canal using high-resolution MR imaging before cochlear implantation: does the size of the cochlear nerve affect the results of speech recognition outcome after implantation? N.N.N. Naguib, N.-E.A. Nour-Eldin, T. Lehnert, T. Lehnert, M. Harth, T.J. Vogl, C. Hey; Frankfurt a. Main/DE

10:57B-0712 Local tumour control in uveal melanoma (UM)

after gamma knife radiosurgery (GKR): quantitative assessment of tumour response with contrast-enhanced ultrasound (CEUS) C. Colantoni, M. Venturini, G. Modorati, A. Colucci, M. Di Nicola, G. Agostini, F. De Cobelli, F. Bandello, A. Del Maschio; Milan/IT

11:06B-0713 Evaluation of lacrimal drainage system obstruction

using combined multidetector CT and instillation dacryocystography M. Shweel, A. ElShafaey, M. Nasar, R. MohyElDien; ElMinia/EG

11:15B-0714 Parotid gland tumours shear wave elastography: a

preliminary study S. Espinoza-Boireau, I. Khettab, A. Lacan Melki, P. Halimi; Paris/FR

Scientific Sessions

251

Sun

day

B-07

15 –

B-0

735 11:24

B-0715 Does heterogeneous echogenicity of the thyroid parenchyma influence the detection of multifocality and bilaterality for papillary thyroid carcinoma on preoperative ultrasound staging? S. Herh, E.-K. Kim, H. Moon, J. Kwak; Seoul/KR

11:33B-0716 Role of elastography in the characterisation of thyroid

nodules F. Sogaro, P. Tessitore, A. Scrimieri, F. Pittiani, A. Borghesi, R. Maroldi; Brescia/IT

11:42B-0717 The new approach to thyroid elastosonography –

time-strain curves – may aid the differentiation of nodules R.Z. Slapa, B. Migda, W.S. Jakubowski, J. Bierca, J. Slowinska-Srzednicka; Warsaw/PL

11:51B-0718 Semiquantitative strain elastography for the

evaluation of chronic thyroiditis F. Ozkan, M. Sahin, K. Gul, M.F. Inci, M. Yuksel; Kahramanmaras/TR

10:30–12:00 Room N/O

Emergency Radiology SS 1317 Technical issues and clinical results

Moderators: M. Brink; Nijmegen/NL, G. Schueller; Bülach/CH

10:30B-0719 Advanced visualisation of intracranial hematomas of

cranial computed tomography H. Ringl, F. Stiassny, W. Schima, M. Toepker, C. Czerny, G. Schueller, U. Asenbaum, J. Furtner, C.J. Herold; Vienna/AT

10:39B-0720 Simple and easy way using time-intensity curve of

perfusion-weighted images to find penumbra in stroke patients within 4.5 hours of onset due to the carotid artery occlusion T. Mori, T. Iwata, Y. Miyazaki, M. Nakazaki, Y. Takahashi; Kamakura/JP

10:48B-0721 CT imaging in an emergency setting is not

substantially delayed by iterative reconstruction M.J. Willemink, A.M.R. Schilham, T. Leiner, W.P.T.M. Mali, P.A. de Jong, R.P.J. Budde; Utrecht/NL

10:57B-0722 Patient-tailored automatic kVp selection with

sinogram-affirmed iterative reconstruction (SAFIRE) to reduce dose in patients undergoing emergent CT imaging of abdomen and pelvis: an intra-patient comparison F.D. Gonzalez-Guindalini, M.P.F. Botelho, H. Chalian, V. Yaghmai; Chicago, IL/US

11:06B-0723 Automated selection of tube potential in thoraco-

abdominal trauma CT results in significant dose savings C. Frellesen, J. Kerl, T. Lehnert, M. Harth, B. Schulz, B. Bodelle, M. Beeres, T.J. Vogl, R.W. Bauer; Frankfurt/DE

11:15B-0724 Usefulness of low-dose CT with or without adaptive

statistical iterative reconstruction (ASIR) in the diagnosis of acute appendicitis J.J. Fondevila, M.S. Carreras, I. Arrieta, J. Mesa, A.R. Gil, T. Marquina, A. Castrillo, I. Aguirregoicoa, L. Martinez; Barakaldo/ES

11:24B-0725 The diagnostic yield of MSCT in the detection of

obscure infection focuses S. Schleder, L. Luerken, L.-M. Dendl, P. Wiggermann, C. Stroszczynski, A. Schreyer; Regensburg/DE

11:33B-0726 Impact and appropriateness of emergency department

ultrasonography requests: a prospective study E.S. Ventura, Y. Costa, F.V. Gomes; Faro/PT

11:42B-0727 Post mortem computed tomography (PMCT) quality

management in critical care? S. Kirchhoff, M.F. Reiser, O. Peschel, M. Graw, K.-G. Kanz; Munich/DE

11:51B-0728 Portrayal of radiology in major medical television

series: does it influence the perception of radiology in the general population? T. Heye1, E.M. Merkle2, J.R. Leyendecker3, D.T. Boll1, R.T. Gupta1; 1Durham, NC/US, 2Basle/CH, 3Winston-Salem, NC/US

10:30–12:00 Room P

Paediatric SS 1312 Chest, heart and radiation awareness

Moderators: W. Hirsch; Leipzig/DE, P.D. Humphries; London/UK

10:30B-0729 Radiation dose levels in paediatric chest CT:

experience in 506 children evaluated with dual-source CT T. Santangelo, L. Colas, T. Niemann, A. Simeone, M. Rémy-Jardin, J. Rémy; Lille/FR

10:39B-0730 Multi-detector CT studies in children: a comparison of

radiation doses between paediatric and non-paediatric radiology units. Results from the first 2011 Italian SIRM survey C. Granata1, F. Palorini2, D. Origgi2, D. Matranga3, S. Salerno3; 1Genoa/IT, 2Milan/IT, 3Palermo/IT

10:48B-0731 Is paediatric chest CT achievable at 70 kV? A

feasibility study in 130 children T. Niemann, S. Henry, L. Colas, J.-B. Faivre, T. Santangelo, J. Rémy, M. Rémy-Jardin; Lille/FR

10:57B-0732 Anthropometry of children and mathematical

phantoms applied to dose reconstruction in paediatric radiology M.C. Seidenbusch, K. Schneider; Munich/DE

11:06B-0733 Radiation exposure during scanograms (scoutviews)

in paediatric computed tomography (CT) K. Schneider, V. Teusch, M.C. Seidenbusch; Munich/DE

11:15B-0734 Reference values for cardiac valve diameters in

extreme preterm infants A. Adams, N. Wesseling, J.L.M. Strengers, W.B. de Vries, M.C. Molenschot; Utrecht/NL

11:24B-0735 Asymmetric lung perfusion in congenital heart

disease: impact of differential pulmonary arterial anatomy and pulmonary vascular resistance O. Kondrachuk, T. Yalynska, R. Tammo, I. Iershova, N. Rokytska; Kiew/UA

Scientific Sessions

252

B-07

36 –

B-0

74811:33

B-0736 Whole heart 4D haemodynamics in patients with transposition of the great arteries after switch procedure J. Geiger1, M. Markl2, D. Hirtler1, B. Jung1, B. Stiller1, M. Langer1; 1Freiburg/DE, 2Chicago, IL/US

11:42B-0737 Chest-CT protocol standardization for multicentre trial

in cystic fibrosis (CF) infants P. Ciet1, K. Gonzalez Graniel1, S. Stick2, M. de Bruijne1, H.A.W.M. Tiddens1, M. Van straten1; 1Rotterdam/NL, 2Perth/AU

11:51B-0738 Cystic fibrosis lung disease in children: correlation

between MRI and HRCT scores C. Sileo, H. Corvol, P.-Y. Boelle, E. Blondiaux, A. Clement, H. Ducou Le Pointe; Paris/FR

10:30–12:00 Room Z

Contrast Media SS 1306 New agents and protocols

Moderators: L. Grazioli; Brescia/IT, T.C. Lauenstein; Essen/DE

10:30B-0739 Magnetic resonance imaging diagnosis of

metastatic lymph nodes: efficacy of the novel ultrasmall superparamagnetic iron oxide agent with monodisperse iron oxide core and multiple-interaction ligands R.-E. Yoo1, S. Choi1, H. Cho1, E.-g. Kim2, J. Park2, W.-J. Myeong2; 1Seoul/KR, 2Daejeon/KR

10:39B-0740 Gold as a potential contrast agent for dual-energy CT

R. Krissak, M. Elgert, B. Kusch, R. Hünerbein; Bad Langensalza/DE

10:48B-0741 Potential use of intra-articular diluted high-relaxivity

gadolinium-based contrast agent for magnetic resonance arthrography (MRA): an in-vitro study L.M. Sconfienza, A. Aliprandi, P. Cannaò, S. Sdao, M. Bandirali, F. Sardanelli; Milan/IT

10:57B-0742 Feasibility of contrast agent volume reduction on

640-slice CT coronary angiography in patients with low heart rate Z.-X. Ding, Z. Wang; Hangzhou/CN

11:06B-0743 The influence of the contrast media protocol and the

scan mode on arterial enhancement in cardiac CT E. Talakic, D. Stocker, P. Täubl, R. Maderthaner, F. Quehenberger, H. Schoellnast, M. Tillich; Graz/AT

11:15B-0744 Multislice CT angiography with direct intra-arterial

ultra-low-dose-contrast injection for the evaluation of renal graft failure: initial study M. Guzinski, J. Kurcz, J. Garcarek, M. Sasiadek; Wrocław/PL

11:24B-0745 Feasibility in low kV CT angiography of the abdominal

aorta: assessment of image quality, radiation exposure and contrast material volume C.R.G.L. Talei Franzesi, D. Ippolito, P.A. Bonaffini, V. Bartolo, C. Trattenero, S. Sironi; Monza/IT

11:33B-0746 CT coronary angiography with low concentration (240

mg Iodine/ml) contrast material C. Mihl1, J.F. Kalafut2, M. Yanniello2, G. Muehlenbruch3, F.F. Behrendt3, J.E. Wildberger1, M. Das1; 1Maastricht/NL, 2Pittsburgh, PA/US, 3Aachen/DE

11:42B-0747 The impact of MR contrast agent concentration on

bolus geometry G. Jost, H. Pietsch; Berlin/DE

11:51B-0748 Transarterial chemoembolization (TACE) in malignant

liver metastases: evaluation of a fast C-arm CT acquisition protocol with a robotic multi-axis C-arm system T.J. Vogl1, M. von Roden2, E. Mbalisike1, S. Zangos1; 1Frankfurt a. Main/DE, 2Forchheim/DE

Scientific Sessions

253

Sun

day

Scientific Session

254

B-07

49 –

B-0

76710:30–12:00 Room C

Neuro SS 1711 Brain ischaemia: perfusion and

diffusion Moderators: L. Oleaga Zufiría; Bilbao/ES, M. Vernooij; Rotterdam/NL

10:30B-0749 Prognostic impact of perfusion CT data in the early

period after subarachnoid haemorrhage C. Mathys, D. Martens, D.C. Reichelt, J. Aissa, K. Rybacki, K.-G. Klein, G. Antoch, B. Turowski; Düsseldorf/DE

10:39B-0750 Advanced MRI sequences in the acute evaluation

of transient ischaemic attack (TIA). A comparison between DTI, DWI and ASL including 8 weeks follow-up scans: preliminary results from the Copenhagen TIA-MRI-study A. Christensen, C. Ovesen, J. Damm, J. Nielsen, H. Christensen; Copenhagen/DK

10:48B-0751 Normal laterality index of cerebrovascular reserve of

the middle cerebral artery: a 100 volunteers‘ BOLD fMRI study A. Krainik, A. Attye, I. Tropres, L. Lamalle, J.-F. Le Bas; Grenoble/FR

10:57B-0752 In-vivo validation of velocity measurements by

quantitative phase contrast MR angiography of the brain supplying arteries: a comparison with Doppler sonography K.W. Hsieh, F. Kellner-Weldon, C. Zubler, R. Verma, M.-L. Mono, M. Reinert, J. Gralla, G. Schroth, M. El-Koussy; Berne/CH

11:06B-0754 Eligibility of 3-dimensional CT perfusion blood flow-

volume mismatch to predict time from symptom onset in acute ischemic stroke K.M. Thierfelder, L. von Baumgarten, F.G. Meinel, A.B. Baumann, K. Nikolaou, M.F. Reiser, W.H. Sommer; Munich/DE

11:15B-0755 Whole brain CT perfusion: volumetric assessment

of perfusion deficits in patients with acute ischemic stroke K.M. Thierfelder1, L. von Baumgarten1, E. Klotz2, A.B. Baumann1, K. Nikolaou1, M.F. Reiser1, W.H. Sommer1; 1Munich/DE, 2Erlangen/DE

11:24B-0756 Time-to-peak (TTP) maps using whole brain CT

perfusion in minor stroke: a diagnostic tool beyond penumbra measurement S. Chakraborty, M.E. Ahmad, J.K. Wasserman, K. Keyhanian, D. Dowlatshahi, G. Stotts; Ottawa, ON/CA

11:33B-0757 Reliability of flow-volume mismatch assessment in

whole brain coverage CT perfusion in acute stroke patients K.M. Thierfelder, L. von Baumgarten, F.G. Meinel, K. Nikolaou, F.F. Strobl, M.F. Reiser, W.H. Sommer; Munich/DE

11:42B-0758 Influence of temporal sampling rate of CTP

acquisitions on cerebral perfusion maps using a digital phantom M. Oei1, R. van den Boom1, L.J. Oostveen1, H.O.A. Laue2, B. van Ginneken1, R. Manniesing1, M. Prokop1; 1Nijmegen/NL, 2Bremen/DE

10:30–12:00 Room D1

Chest SS 1704 Technological refinements: from x-rays

to micro-imaging Moderators: A.P. Parkar; Bergen/NO, C.M. Schaefer-Prokop;

Amersfoort/NL

10:30B-0759 Evaluation of pulmonary nodules by serial radiographs

obtained by a flat-panel detector Y. Nakano, K. Maeda, S. Kitahara, T. Toyama, M. Kuwabara; Kusatsu/JP

10:39B-0760 Function ventilation analysis in dynamic chest

x-ray examination: in comparison with 133Xe lung ventilation scintigraphy T. Abe, T. Izuka, N. Motohashi, Y. Shiraishi, N. Koyanagi, A. Kurosaki, M. Ito, H. Ogata, S. Kudou; Kiyose, Tokyo/JP

10:48B-0761 Performance evaluation of automatic chest radiograph

reading for detection of tuberculosis (TB): a comparative study with clinical officers and certified readers on TB suspects in sub-Saharan Africa P. Maduskar1, L. Hogeweg1, B. van Ginneken1, H. Ayles2; 1Nijmegen/NL, 2London/UK

10:57B-0762 Diagnostic imaging costs before and after

digital tomosynthesis implementation in patient management after suspected thoracic lesions on chest radiography E. Quaia, E. Baratella, G. Grisi, R. Cuttin, G. Poillucci, S. Kus, M. Cova; Trieste/IT

11:06B-0763 Lung ultrasound in the elderly population:

investigating the limit between physiological and pathological patterns A. Chiesa, F. Ciccarese, G. Gardelli, F. Feletti, U. Regina, M. Zompatori; Bologna/IT

11:15B-0764 Digital X-ray optical densitometry in assessment

of respiratory function in patients with COPD exacerbation N. Gorbunov, V. Laptev; Novosibirsk/RU

11:24B-0765 Diffusion-weighted echo-planar MRI with multiple

b-values in primary lung cancer: a new approach to the non-invasive differentiation of histological subtypes? M. Regier, D. Schwarz, A. Laqmani, F.O.G. Henes, G. Adam; Hamburg/DE

11:33B-0766 Non-contrast-enhanced perfusion MRI for preoperative

assessment of lung function in patients with non-small-cell lung cancer (NSCLC) G. Sommer, G. Bauman, C. Draenkow, C.-P. Heussel, H.-U. Kauczor, H.-P. Schlemmer, M. Puderbach; Heidelberg/DE

11:42B-0767 Comparison of assessment of preoperative pulmonary

vasculature in non-small cell lung cancer patients by non-contrast-enhanced and 4D contrast-enhanced MR angiography at 3T and by contrast-enhanced thin-section MDCT using a 64-detector row system Y. Ohno1, S. Seki1, M. Nishio1, H. Koyama1, T. Yoshikawa1, S. Matsumoto1, S. Satou2, K. Sugimura1; 1Kobe/JP, 2Ohtawara/JP

Scientific Sessions

255

Mon

day

B-07

68 –

B-0

787 11:51

B-0768 In vivo micro-CT and 18F-FDG micro-PET imaging of SPC-raf and SPC-myc transgenic mouse models of lung adenocarcinoma T. Rodt, C. von Falck, M. Luepke, K. Hueper, R. Halter, S. Dettmer, C. Boehm, J. Borlak, F. Wacker; Hannover/DE

10:30–12:00 Room D2

Interventional Radiology SS 1709 Abdominal interventions: from TIPS to

bile ducts Moderators: R.F. Dondelinger; Liège/BE, B. Sekovsky; Split/HR

10:30B-0769 Clinical relevance and interventional-radiological

management of early complications after pancreatic surgery: a 12-year single-centre experience on 1285 patients G. Agostini, M. Venturini, F. De Cobelli, S. Cappio, M. Salvioni, E. Di Rosa, G. Balzano, P. Maffi, A. Del Maschio; Milan/IT

10:39B-0770 Management of post-surgical biliary leakage with

retrievable covered stent: preliminary results A. Gioppo, A. Campari, J. Parraga, C. Michelozzi, L. Rahali, A. Sacrini, F. Melchiorre, G. Cornalba; Milan/IT

10:48B-0771 Bioabsorbable biliary stent in the percutaneous

treatment of benign biliary stricture: preliminary experience G. Mauri, C. Michelozzi, V. Pedicini, D. Poretti, M. Tramarin, F. Melchiorre, G. Cornalba, G. Brambilla; Milan/IT

10:57B-0772 Patient doses in liver-transplanted children with

biliary strictures treated with interventional radiology procedures: a single centre survey L. Maruzzelli, G. Mamone, R. Miraglia, L. Indovina, A. Luca; Palermo/IT

11:06B-0773 Endoluminal RFA with subsequent ductoplasty

for biliary and pancreatic duct malignant block recanalisation M. Mizandari1, N. Habib2; 1Tbilisi/GE, 2London/UK

11:15B-0774 Effectiveness of therapeutic lymphography on

lymphatic leakage T. Gruber-Rouh, N.N.N. Naguib, T. Lehnert, A. Thalhammer, S. Zangos, B. Schulz, V. Jacobi, T.J. Vogl; Frankfurt/DE

11:24B-0775 Tips for TIPS: 12-year experience

C. Zini, F. Fanelli, M. Bezzi, E. Boatta, M. Corona, P. Lucatelli, A. Cannavale, C. Cirelli, F.M. Salvatori; Rome/IT

11:33B-0776 A new trial with a newly designed Y-shaped covered

stent for the palliative treatment of hilar malignant obstruction of liver: mid-term result B. Kang1, G. Jung2; 1Seoul/KR, 2Busan/KR

11:42B-0777 The comparison of balloon-occluded retrograde

transvenous obliteration for gastric varices using liquid and foam sclerosants J. Koizumi1, K. Myojin1, C. Itou1, N. Mori1, T. Sekiguchi1, T. Hara1, T. Ichikawa1, Y. Imai1, B. Janne d’Othée2; 1Isehara/JP, 2Baltimore, MD/US

11:51B-0778 Comparison of outcomes of endovascular treatment

with stent placement in patients with early and late hepatic venous outflow obstruction (HVOO) G. Viteri, J. Etxano, P. Slon, F. Rotellar, J.I. Herrero, A. Benito, J.I. Bilbao; Pamplona/ES

10:30–12:00 Room E1

Musculoskeletal SS 1710 Hip: CT and MRI applications

Moderators: M.H. Maurer; Berlin/DE, A. Vieira; Porto/PT

10:30B-0779 Retrospective analysis of CT as secondary imaging in

the diagnosis of occult femoral neck fracture K.J. Partington, P. Robinson, H. Gupta; Leeds/UK

10:39B-0780 MRI or CT for occult hip fracture: Do either miss

clinically relevant fractures? K. Sneddon, H. Rehman, Z. Davis, F. Perks, T.O. White, R.G.E. Clement; Edinburgh/UK

10:48B-0781 Digital tomosynthesis in diagnosis of occult hip

fractures M. Geijer1, D. Collin2, J.H. Göthlin2; 1Lund/SE, 2Mölndal/SE

10:57B-0782 Advanced core decompression for patients with

avascular necrosis of the hip: therapeutic success monitored by MRI A. Lazik, O. Kraff, T. Claßen, S. Landgraeber, F. Grabellus, T.C. Lauenstein, J.M. Theysohn; Essen/DE

11:06B-0783 Lower-limb MRI examination as a predictive factor of

articular collapse in haematological young patients with femoral head osteonecrosis: lesion surface versus lesion volume A. Masetto, D. Ippolito, P.A. Bonaffini, D. Fior, A.S. Casiraghi, S. Sironi; Monza/IT

11:15B-0784 Alpha angles and herniation pits: revisited on MRI in

80 asymptomatic hip joints E. Lee, J.-A. Choi, G. Lee, H. Kang; Seongnam-si/KR

11:24B-0785 Gluteus tendinopathy in femoroacetabular

impingement (FAI): findings with MR-artrography of the hip E. Lanza1, G. Pozzi1, C. Garcia Parra2, R. Bisogno1, A. Zerbi1; 1Milan/IT, 2Bergamo/IT

11:33B-0786 Evaluation of a new method for the assessment of

anterior acetabular coverage and hip joint space narrowing R. Ferré, E. Gibon, A. Feydy, H. Guerini, R. Campana, N. Zee, C. Bourdet, M. Hammadouche, J.-l. Drapé; Paris/FR

11:42B-0787 Diagnostic value of MR enterography (MRE), after

oral administration of glucose-polyethylene, in the determination of the activity of disease in patients with known Crohn‘s disease: a prospective single centre study V. Bartolo, D. Ippolito, C. Trattenero, P.A. Bonaffini, V. Besostri, S. Sironi; Monza/IT

Scientific Sessions

256

B-07

88 –

B-0

80711:51

B-0788 Metal artefact reduction in hip prosthesis with iterative reconstructions F. Morsbach1, S. Bickelhaupt1, G. Wanner1, A. Krauss2, B. Schmidt2, H. Alkadhi1; 1Zurich/CH, 2Forchheim/DE

10:30–12:00 Room E2

GI Tract SS 1701a CT/MR colonography: technical issues

and clinical studies Moderators: D. Cano; Pamplona/ES, D.Z. Saranovic; Belgrade/RS

10:30B-0789 CT colonography: accurate registration of prone and

supine endoluminal surfaces of the colon T.E. Hampshire, H.R. Roth, E. Helbren, A. Plumb, D. Boone, G. Slabaugh, S. Halligan, D.J. Hawkes; London/UK

10:39B-0790 A multi-centre randomised double-blind placebo-

controlled trial to evaluate the value of a single bolus intravenous alfentanil in CT colonography T.N. Boellaard, M.P. van der Paardt, M.W. Hollmann, S. Eberl, J. Peringa, G. Kavaliauskiene, J.H. Runge, J.A.W. Tielbeek, J. Stoker; Amsterdam/NL

10:48B-0791 The possible role of contrast material-enhanced

computed tomographic colonography (CTC) in the surveillance after surgery for colorectal cancer M. Morone, G. Mazza, T. Natilla, G. Baiocchi, M. Ghedi, E. Dettori, B. Frittoli, L. Grazioli; Brescia/IT

10:57B-0792 CT colonography: comparative study of experienced

vs non-experienced radiologists using 3D flythrough approach with and without CAD software F. Vecchietti, M. Rengo, D. Caruso, C.N. De Cecco, D. Bellini, A. Laghi; Latina/IT

11:06B-0793 CT colonography bowel preparation: influence of a

laxative agent on a fluid tagging preparation M. Rengo, D. Bellini, M.M. Maceroni, F. Vecchietti, D. Caruso, P. Lucchesi, A. Laghi; Latina/IT

11:15B-0794 Flat lesions: CTC with and without CAD

G. Mazza, T. Natilla, M. Morone, B. Frittoli, G. Baiocchi, L. Grazioli; Brescia/IT

11:24B-0795 MR colonography to screen for colorectal neoplasia in

asymptomatic adults A. Graser, A. Melzer, E. Lindner, P. Stieber, M.F. Reiser, B. Göke, F.T. Kolligs; Munich/DE

11:33B-0796 Retrospective evaluation of diverticular disease in

a large cohort of 1091 patients who underwent CT colonography M. Ciolina1, C. De Cecco2, P. Baldassari1, M. Iannitti1, A. Pichi1, F. Iafrate1, A. Laghi2; 1Rome/IT, 2Latina/IT

11:42B-0797 Accuracy of water enema-MDCT in colon cancer

staging: a prospective study C. Ridereau-Zins1, E. Sibileau1, A. Pavageau1, D. Vanel2, E. Lermite1, E. Metivier-Cesbron1, C. Aube1; 1Angers/FR, 2Bologna/IT

11:51B-0798 Feasibility study of low-dose CT colonography using

model-based iterative reconstruction: preliminary findings in 20 patients V. Vardhanabhuti, C. Roobottom; Plymouth/UK

10:30–12:00 Room F1

Oncologic Imaging SS 1716 Response evaluation in oncology:

beyond RECIST Moderators: T. Denecke; Berlin/DE, M.I. Furmanek; Warsaw/PL

10:30B-0799 Calibration of computed tomography (CT) volumetric

measurements for assessing tumour response to drug therapy in a randomised multicentre oncology study R. Avila1, D. Yankelevitz2, V. Archer3, G. Zahlmann4; 1Clifton Park, NY/US, 2New York, NY/US, 3Welwyn Garden City/UK, 4Basle/CH

10:39B-0800 Evaluating the agreement between tumour volumetry

and the estimated volumes of tumour lesions using an algorithm M. D‘Anastasi, R.P. Laubender, V. Heinemann, M.F. Reiser, M. Schlichting, A. Graser; Munich/DE

10:48B-0801 Chemotherapy response evaluation with magnetic

resonance (MR) and FDG-PET/CT in gastroesophageal tumours (GT): apparent diffusion coefficient (ADC) and standardised uptake volume (SUV) changes compared with tumour regression grade (TRG) at histology F. Giganti, F. De Cobelli, C. Canevari, E. Orsenigo, L. Albarello, E. Mazza, C. Staudacher, L. Gianolli, A. Del Maschio; Milan/IT

10:57B-0802 Treatment response assessment in Hodgkin

lymphoma: in search for morphological correlates of metabolic activity T. Knogler, G. Karanikas, M. Weber, K. El-Rabadi, M.E. Mayerhoefer; Vienna/AT

11:06B-0803 Predictive values of MRI parameters for the

progression-free survival after radioembolisation in patients with metastases of neuroendocrine tumours W.H. Sommer, F. Ceelen, P. Paprottka, M.F. Reiser, D. Theisen; Munich/DE

11:15B-0804 One-month apparent diffusion coefficient-

determined response at diffusion-weighted MRI is an independent predictor of response to transarterial chemoembolization for hepatocellular carcinoma V. Vandecaveye, K. Michielsen, F. De Keyzer, W. Laleman, M. Komuta, F. Nevens, T. Roskams, C. Verslype, G. Maleux; Leuven/BE

11:24B-0805 Real-time imaging of the therapeutic response

of tumours to anti-vascular treatment in mice by gadofosveset-enhanced MRI A.J. Höink1, T. Persigehl2, J. Ring1, R.M. Mesters1, W.E. Berdel1, W.L. Heindel1, C. Bremer1, C. Schwöppe1; 1Münster/DE, 2Cologne/DE

11:33B-0806 Reproducibility of therapy response evaluation

between experienced and less experienced readers of pleural mesothelioma by mRECIST, RECIST 1.0, RECIST 1.1, and WHO L. Stahlhut1, A. Bunck1, Y. Tan2, M. Steen1, X. Guo2, D. Maintz1, L. Schwartz2, B. Zhao2, T. Persigehl1; 1Cologne/DE, 2New York, NY/US

11:42B-0807 Use of multimedia structured reporting for tumour

response assessment D.J. Vining1, A. Pitici2, I. Aghenitei2, C. Popovici2, M. Jurca2, R. Rosu2, A. Tsimberidou1; 1Houston, TX/US, 2Chapel Hill, NC/US

Scientific Sessions

257

Mon

day

B-08

08 –

B-0

827 11:51

B-0808 Comparison of breast-MRI vs. standard prognostic factors for the prediction of local recurrence after treatment of primary breast cancer P.A.T. Baltzer1, M. Dietzel2, H. Habrecht3, R. Zoubi4, C. Jerowski3, I.B. Runnebaum3, W.A. Kaiser3; 1Jena/DE, Vienna/AT, 2Erlangen/DE, Jena/DE, 3Jena/DE, 4Bielefeld/DE, Jena/DE

10:30–12:00 Room F2

Breast SS 1702 Tomosynthesis: a role in clinical

practice? Moderators: S. Allen; Sutton/UK, E.M. Jung; Regensburg/DE

10:30B-0809 The role of additional tomosynthesis combined with

digital mammography P. Martínez1, J. Echano2, M. Sainz1, I. Simon2, G. Viteri2, A. Garcia Lallana1, C. Minguillon1, L. Pina2; 1Zaragoza/ES, 2Pamplona/ES

10:39B-0810 Does breast tomosynthesis combined with 2D digital

mammography increase the detection rate of breast cancer? R. Saiz-Mendiguren1, C. Marginet-Mangas1, A. Garcia-Lallana2, E. Martinez1, C. Ibarburen1, L. Pina Insausti3; 1Palma de Mallorca/ES, 2Santurce/ES, 3Pamplona/ES

10:48B-0811 Detection rate for suspicious lesions of digital

breast tomosynthesis in combination with digital mammography or 2D central projection imaging C. Zuiani1, P. Clauser1, V. Londero1, C. Molinari1, R. Girometti1, A. Taibi2, S. Vecchio3, M. Bazzocchi1; 1Udine/IT, 2Ferrara/IT, 3Bologna/IT

10:57B-0812 Digital mammography in comparison with digital

breast tomosynthesis in detection of multicentric breast cancer N. Prvulovic, D. Djilas, M. Prvulovic, D. Bogdanovic, K. Koprivsek; Novi Sad/RS

11:06B-0813 The role of tomosynthesis after normal mammography

according to ACR density patterns J. Etxano, P. Slon, I. Simon-Yarza, R. Zalazar, A. Elizalde, L. Pina; Pamplona/ES

11:15B-0814 Influence of breast density on diagnostic performance

of digital breast tomosynthesis (DBT) after digital mammography (DM) focusing on recall rate reduction L.A. Carbonaro1, R.M. Trimboli1, N. Verardi1, M. Fedeli2, G. Di Leo1, F. Sardanelli1; 1San Donato Milanese/IT, 2Milan/IT

11:24B-0815 Recall rate reduction by adding double reading digital

breast tomosynthesis (DBT) to digital mammography (DM) L.A. Carbonaro1, R.M. Trimboli1, N. Verardi1, K. Khouri Chalouhi2, G. Di Leo1, F. Sardanelli1; 1San Donato Milanese/IT, 2Milan/IT

11:33B-0816 Breast tomosynthesis versus digital mammography:

evaluation of diagnostic potential in women with abnormal screening mammograms M.A. Shaaban; Cairo/EG

11:42B-0817 Analysis of discordant screening-detected cancers

at FFDM (2D) versus 2D plus tomosynthesis (combo mode) in a population-based screening program: results from the Oslo tomosynthesis screening trial P. Skaane, R. Gullien, M. Krager, U. Haakenaasen, M. Izadi, I.N. Jebsen, U. Ekseth, E.B. Eben; Oslo/NO

11:51B-0818 The STORM trial of screening mammography:

screening with tomosynthesis or standard mammography S. Ciatto (posthumous)1, N. Houssami2, D. Bernardi1, F. Caumo3, P. Macaskill2; 1Trento/IT, 2Sydney/AU, 3Verona/IT

10:30–12:00 Room G/H

Genitourinary SS 1707 Hints on haematuria and adrenals for

all Moderators: O. Nikolic; Novi Sad/RS, H. Sugimura; Miyazaki/JP

10:30B-0819 Impact of patient mobilisation on interpretation

of upper urinary tract filling defects seen on MDCT urography J.M. Froehlich, A. Joeres, P.J. Probst, F. Nussberger, H.C. Thoeny; Berne/CH

10:39B-0820 Evaluation of diagnostic strategies for hematuria

using risk stratification N.C. Cowan; Birmingham/UK

10:48B-0821 Use of novel iterative reconstruction in CT KUB:

approach on improving image quality V. Vardhanabhuti, C. Roobottom, S. Ilyas; Plymouth/UK

10:57B-0822 Renal cell carcinoma subtype differentiation on

single-phase contrast-enhanced CT F. Veloso Gomes1, J. Palas2, A. Matos2, V. Mascarenhas3, V. Herédia4, S. Duarte3, M. Ramalho2; 1Faro/PT, 2Almada/PT, 3Lisbon/PT, 4Évora/PT

11:06B-0823 To assess parameters within CT findings to aid

distinction of histological subtype of renal cell carcinoma within our institute M.J. Conneely, D. Ferguson, C. Donagh, M. Quinlan, T. McHale, P. McCarthy; Galway/IE

11:15B-0824 MDCT in differentiating pT1-2 from pT3 tumours in

clear cell RCC O. Le, C. Wood, P. Tamboli, R. Vikram; Houston, TX/US

11:24B-0825 Reader variability in urinary stone size estimation:

training does not help M. Lidén, T. Andersson, H. Geijer; Örebro/SE

11:33B-0826 Contrast-enhanced CT and chemical shift MRI:

accuracy for lipid-poor adenoma characterization Y.A. Choi, B.K. Park, J.M. Seo, S.Y. Park, C.K. Kim; Seoul/KR

11:42B-0827 Functional MRI with diffusion-weighted imaging and

ADC map in characterization of undetermined adrenal lesions: comparison with chemical shift imaging C.R.G.L. Talei Franzesi, D. Ippolito, P.A. Bonaffini, C. Capraro, V. Besostri, S. Sironi; Monza/IT

Scientific Sessions

258

B-08

28 –

B-0

84711:51

B-0828 Non-contrast-enhanced MR adrenal venography for adrenal venous sampling H. Ota, K. Takase, N. Satani, T. Kimura, K. Seiji, Y. Ono, R. Morimoto, F. Sato, S. Takahashi; Sendai/JP

10:30–12:00 Room I/K

Abdominal Viscera SS 1701b DWI in pancreatic and hepatobiliary

diseases Moderators: G.J. Munneke; London/UK, D. Weishaupt; Zurich/CH

10:30B-0829 Feasibility of abdominal diffusion Kurtosis imaging

compared to standard diffusion weighted imaging at 1.5 and 3 Tesla J. Hansmann, A. Lemke, J. Wambsganss, S.O. Schönberg, U. Attenberger; Mannheim/DE

10:39B-0830 Differential diagnosis of benign from malignant distal

biliary strictures: value of adding diffusion-weighted imaging to conventional magnetic resonance cholangiopancreatography R.-E. Yoo, J. Lee, J. Yoon, J. Kim, J. Han, B. Choi; Seoul/KR

10:48B-0831 Correlation of measurements of diffusion-weighted

MR imaging and Gd-EOB-DTPA-enhanced MR imaging in hepatic malignant tumours: ADC versus signal intensity on hepatobiliary phase S. Choi, Y. Park, C. Lee, K. Kim, J. Choi, J. Lee, C. Park; Seoul/KR

10:57B-0832 Non-invasive assessment of solid benign and

malignant focal liver lesions by quantitative analysis of functional MRI with diffusion-weighted imaging M. Colombo, D. Ippolito, P.A. Bonaffini, C. Trattenero, V. Bartolo, S. Sironi; Monza/IT

11:06B-0833 Quantitative data analysis of the diffusion-weighted

MR-images in the differential diagnosis of metastatic liver disease of colorectal and pancreatic aetiology Y. Savchenkov, S. Bagnenko, G. Trufanov, V. Fokin; St. Petersburg/RU

11:15B-0834 Does the ADC-map eradicate the T2-shine-through

effect affecting DW images of focal liver lesions? A study with exponential ADC-maps R. Girometti, M. Maieron, S. Pullini, E. Minighin, L. Cereser, G. Como, M. Bazzocchi, C. Zuiani; Udine/IT

11:24B-0835 Prevalence of the T2-shine-through effect on DW

images of focal liver lesions: a study with exponential ADC-maps at 1.5T R. Girometti, M. Maieron, E. Minighin, S. Pullini, L. Cereser, G. Como, M. Bazzocchi, C. Zuiani; Udine/IT

11:33B-0836 DWI magnetic resonance imaging in the evaluation of

HCC recurrence after trans-arterial chemoembolization (TACE): comparison with contrast-enhanced MR imaging M. Di Martino, R. Di Miscio, M. Del Monte, C. Lombardo, D. Geiger, C. Catalano; Rome/IT

11:42B-0837 MRI of pancreatic adenocarcinoma including diffusion-

weighted imaging: assessment of tumour conspicuity and pathologic correlation L. Legrand, V. Duchatelle, V. Molinié, I. Boulay-Coletta, E. Sibileau, M. Zins; Paris/FR

11:51B-0838 Evaluation of diffusion-weighted MR imaging for

detection of infection in acute pancreatic collections and/or necrosis: preliminary results F. Islim, A.E. Salik, S. Bayramoglu, K. Guven, H. Alis, A.N. Turhan; Istanbul/TR

10:30–12:00 Room L/M

Physics in Radiology SS 1713 Breast imaging and novel CT

techniques Moderators: N. Karssemeijer; Nijmegen/NL, M. Koutalonis; Colchester/UK

10:30B-0839 Comparative detector evaluation of full field digital

mammography (FFDM) systems using the Fourier definition of the Hotelling-observer signal-to-noise ratio (SNR) R. Wise, I. Delakis, E. Kulama, D. McRobbie; London/UK

10:39B-0840 Spectral reconstruction algorithm for digital breast

tomosynthesis I. Sechopoulos, V. Mejia-Bustamante, S.S.J. Feng, J. Nagy; Atlanta, GA/US

10:48B-0841 Contrast-detail visibility analysis for digital breast

tomosynthesis versus digital mammography S. Elie, W.J.H. Veldkamp, R.E. van Engen, M.J.M. Broeders; Nijmegen/NL

10:57B-0842 Can a colour representation of grey-scale images

improve object detectability in mammography? E. Salvagnini1, L. Cockmartin1, K. Michielsen1, J. Jacobs2, N.W. Marshall1, L. Struelens3, H. Bosmans1; 1Leuven/BE, 2Heverlee/BE, 3Mol/BE

11:06B-0843 Volumetric breast-density measurement using

spectral mammography A. Gooßen1, M. Lundqvist2, K. Erhard1, E. Fredenberg2; 1Hamburg/DE, 2Solna/SE

11:15B-0844 Monochromatic dual-energy X-rays for precise

measurement of bone mineral density: preliminary results C.-H. Lee, K.-H. Yoon, Y.-H. Lee, E. Kang, D. Kang; Iksan/KR

11:24B-0845 Phase contrast imaging using grating interferometer:

preliminary results D. Kang, K.-H. Yoon, Y.-H. Lee, E. Kang, C.-H. Lee; Iksan/KR

11:33B-0846 First in-vitro results of microbubbles as a scattering

contrast agent for X-ray dark-field imaging measured at a first pre-clinical X-ray phase-contrast and dark-field CT scanner A. Velroyen1, M. Bech1, A. Tapfer1, M. Ingrisch2, C.C. Cyran2, S. Auweter2, K. Nikolaou2, M.F. Reiser2, F. Pfeiffer1; 1Garching/DE, 2Munich/DE

11:42B-0847 In vivo urinary stones chemical compound

identification using dual-energy CT T. Kraśnicki, M. Guziński, P. Podgórski, J. Bladowska, A. Czarnecka, K. Tupikowski, M. Sąsiadek; Wrocław/PL

Scientific Sessions

259

Mon

day

B-08

48 –

B-0

865 11:51

B-0848 Value of monoenergetic low-keV dual-energy CT datasets for improved image quality of abdominal CT angiography S. Sudarski, D. Schneider, P. Apfaltrer, S.O. Schönberg, T. Henzler; Mannheim/DE

10:30–12:00 Room N/O

Cardiac SS 1703 Biomarkers, tissue characterisation

and remodelling Moderators: M. Das; Maastricht/NL, K. Gruszczynska; Katowice/PL

10:30B-0849 Biomarkers of atherosclerotic and myocardial

remodelling: correlation with plaque volume in cardiac CT L.L. Geyer1, A. Krazinski1, J.R. Silverman1, F. Bamberg2, U. Ebersberger2, P. Costello1, U.J. Schoepf1; 1Charleston, SC/US, 2Munich/DE

10:39B-0850 Morpho-functional and metabolic assessment of the

heart in adult-onset growth hormone (GH) deficiency patients with cardiac magnetic resonance (CMR) and 31P MR spectroscopy (31P-MRS) M. Cava, F. De Cobelli, A. Esposito, G. Perseghin, A. Rossini, R. Lanzi, M. Losa, T. Canu, A. Del Maschio; Milan/IT

10:48B-0851 Right ventricular remodelling after ST-elevation

myocardial infarction M. Tille, M. Gutberlet, H. Thiele, M. Grothoff; Leipzig/DE

10:57B-0852 Influence of periprocedural myonecrosis assessed by

magnetic resonance delayed enhancement in patients with bifurcation lesions angioplasty on prognosis at one-year follow-up R. Gil, J. Walecki, D. Vassilev, M. Furmanek, A. Michałek, M. Odyniec-Nowacka, A.J. Piliszek; Warsaw/PL

11:06B-0853 Exposure to a high fat diet during early development

increases the susceptibility to cardiac lipid accumulation P.A. van Ewijk, S. Paglialunga, J. Slenter, J.E. Wildberger, J. Glatz, M.K.C. Hesselink, P. Schrauwen, V.B. Schrauwen-Hinderling, M.E. Kooi; Maastricht/NL

11:15B-0854 Cardiac and hepatic iron and heart function by MR in

thalassaemia major patients treated with combined deferiprone and desferrioxamine regimen versus monotherapies: a multi-centre, observational and prospective study C. Tudisca1, P. Ricchi2, A. Meloni3, E. Grassedonio1, M. Santodirocco4; 1Palermo/IT, 2Naples/IT, 3Pisa/IT, 4San Giovanni Rotondo/IT

11:24B-0855 Are the preferential patterns of myocardial iron

overload preserved at the CMR follow-up? C. Tudisca1, A. Meloni2, G. Giuffrida3, E. Grassedonio1, E. Chiodi4, A. Pietrapertosa5, M. Lombardi2, M. Midiri1, A. Pepe2; 1Palermo/IT, 2Pisa/IT, 3Catania/IT, 4Ferrara/IT, 5Bari/IT

11:33B-0856 The effect of partial volume averaging on peak

velocity measurements in phase contrast magnetic resonance angiography (PCMRA) J.C.L. Rodrigues1, K. Minhas1, G. Pieles1, C. Bucciarelli-Ducci1, R. Tulloh1, N.E. Manghat1, C.J. Occleshaw2, M.C.K. Hamilton1; 1Bristol/UK, 2Auckland/NZ

11:42B-0857 Different patterns of delayed cardiac enhancement

in symptomatic patients with post-total correction of tetralogy of fallot assessed by cardiac MRI and its correlation with right ventricular function: a report from Iran F. Akhavan, M. Motevalli, N. Abolfat-h-Zadeh Ghale Joughi; Tehran/IR

11:51B-0858 Diastolic versus systolic acquisition of T1 maps

of normal human myocardium at 1.5T magnetic resonance imaging U. Reiter1, G. Reiter1, K. Dorr1, A. Greiser2, R. Maderthaner1, M.H. Fuchsjäger1; 1Graz/AT, 2Erlangen/DE

10:30–12:00 Room P

Paediatric SS 1712 Foetal and neonatal imaging

Moderators: N. De Graaf; Rotterdam/NL, H. Ringertz; Linköping/SE

10:30B-0859 Antenatal blood flow quantification by phase-contrast

MRI using a new triggering method: comparison with Doppler ultrasound in a sheep model B.P. Schönnagel, C. Much, J. Yamamura, G. Adam, F. Ueberle, M. Tavares de Sousa, H. Kooijman, U. Wedegärtner; Hamburg/DE

10:39B-0860 Relationship between body growth and regional brain

volume changes in extremely premature small for gestational age babies L.C. Tzarouchi, A. Drougia, A. Zikou, A. Charisiadi, P. Kosta, L. Astrakas, S. Andronikou, M.I. Argyropoulou; Ioannina/GR

10:48B-0861 Do vascular events impact brain maturation of

twin pregnancies complicated with twin-to-twin transfusion syndrome? S. Bargy; Paris/FR

10:57B-0862 Microstructural changes of white matter tracts

in small for gestational age very preterm infants evaluated at term equivalent age L.C. Tzarouchi, A. Drougia, A. Zikou, P. Kosta, L. Astrakas, S. Andronikou, M.I. Argyropoulou; Ioannina/GR

11:06B-0863 The “tail sign” in the differential diagnosis of vermian

pathologies in foetuses under 24 weeks: role of foetal MRI P. Sollazzo, M. Sergi, V. Vinci, S. Bernardo, M. Saldari, L. Manganaro; Rome/IT

11:15B-0864 Real time cine-MRI in children and foetuses with head

and neck pathology T. Feygin, A. Pollock, J. Stein, T. Victoria; Philadelphia, PA/US

11:24B-0865 Magnetic-resonance-imaging-based ratio of fetal lung

volume to foetal body volume as a new prognostic marker in congenital diaphragmatic hernia M. Weidner, C. Hagelstein, A. Debus, A. Walleyo, S.O. Schönberg, T. Schaible, K.A. Büsing, S. Kehl, K.W. Neff; Mannheim/DE

Scientific Sessions

260

B-08

66 –

B-0

88611:33

B-0866 Repetitive MR measurements of lung volume in foetuses with congenital diaphragmatic hernia to investigate the individual development of pulmonary hypoplasia during pregnancy C. Hagelstein, M. Weidner, A. Debus, A. Walleyo, S.O. Schönberg, T. Schaible, S. Kehl, K.A. Büsing, K.W. Neff; Mannheim/DE

11:42B-0867 Periventricular nodular heterotopia: prenatal

ultrasound findings E. Blondiaux, C. Sileo, C. Nahama-Allouche, M.-L. Moutard, A. Gelot, J.-M. Jouannic, H. Ducou le Pointe, C. Garel; Paris/FR

11:51B-0868 Role of foetal MR in the evaluation of gastrointestinal

tract anomalies S. Bernardo, V. Vinci, P. Sollazzo, M. Sergi, M. Saldari, L. Manganaro; Rome/IT

10:30–12:00 Room Q

Radiographers SS 1714 Mammography

Moderators: S.J. Foley; Dublin/IE, P. Vahtramae; Pärnu/EE

10:30B-0869 Online portfolio for radiographers attending the

breast cancer screening mammography certificate in Switzerland N. Richli Meystre, L. Flaction, R. Le Coultre; Lausanne/CH

10:39B-0870 Inter-observer agreement among PGMI radiographer in

Cambridge/UK and Oslo/NO in assessing each other’s and their own mammography screening exams R. Gullien1, E. Rostad1, A.E. Haakull1, R.L. Hammond1, M. Hauge1, K. Taylor2, J.G. Andersen1; 1Oslo/NO, 2Cambridge/UK

10:48B-0871 Radiation dose levels assessment in mammography

C. Lourenço, P. Sousa, S.I. Rodrigues, A.F.C.L. Abrantes, L.P.V. Ribeiro, K.B. Azevedo, R.P.P. Almeida; Faro/PT

10:57B-0872 Quality control in digital mammography: radiographers

practice at 5 hospitals of Lisbon C. Tomás, C. Gonçalves, C.I.S. Reis; Lisbon/PT

11:06B-0873 An investigation into the psychological anxiety of

Maltese women before and after a mammogram C. Falzon; Sta Lucija/MT

11:15B-0874 Ergonomic and environmental assessment in digital

mammography room: impact on radiographers’ activity S. Costa, E. Oliveira, F. Serranheira, S. Viegas, C.I.S. Reis; Lisbon/PT

11:24B-0875 Accuracy of students, and radiographers, with

and without, mammography post-graduation in interpretation of mammography images R.B.J. Cópio1, K.B. Azevedo1, A.F.C.L. Abrantes1, L.P.V. Ribeiro1, R.P.P. Almeida1, C.A. Silva2; 1Faro/PT, 2Evora/PT

11:33B-0876 Patient satisfaction assessment in mammography

exams L. Borralho, L.P.V. Ribeiro, C.A. Silva, A.F.C.L. Abrantes, J. Pinheiro, R.P.P. Almeida; Faro/PT

11:42B-0877 Impacts of digital mammography in radiographers

practice L. Painho, T. Fernandes, C.I.S. Reis; Lisbon/PT

11:51B-0878 Imaging ethics

B. Hofmann; Oslo/NO

10:30–12:00 Room Z

Molecular Imaging SS 1706 Molecular imaging in cancer and

degenerative diseases Moderators: J. Hakumäki; Kuopio/FI, E. Lopci; Rozzano/IT

10:30B-0879 Improving current preclinical therapy monitoring

methods by multiparametric MR using a hNIS-expressing tumour xenograft mouse model E.J. Koziolek1, I. Apostolova2, A. Tarkowska1, U. Schumacher1, W. Brenner2, G. Adam1, M.G. Kaul1; 1Hamburg/DE, 2Berlin/DE

10:39B-0880 In vivo assessment of the anti-apoptotic effect of

c-kit+ pluripotent bone marrow cells on ischaemic myocardium in mice with hybrid fluorescence molecular tomography – x-ray computed tomography M. Wildgruber, A. Ale, K. Kosanke, R. Braren, R. Meier, E.J. Rummeny, V. Ntziachristos; Munich/DE

10:48B-0881 Magnetic resonance imaging of murine myocardial

infarction with an elastin-binding contrast agent M. Wildgruber1, M. Settles1, I. Bielicki1, K. Kosanke1, A.M. Huber1, E.J. Rummeny1, R.M. Botnar2; 1Munich/DE, 2London/DE

10:57B-0882 Comparison of nanobodies and conventional

monoclonal antibodies for in vivo fluorescence imaging of lymphomas P. Bannas, A. Lenz, V. Kunick, W. Danquah, F. Haag, M. Trepel, G. Adam, H. Ittrich, F. Koch-Nolte; Hamburg/DE

11:06B-0883 The design of a dual-functional imaging contrast

agent for targeting to tumour endothelial marker (TEM8) Q. Quan1, X. Huang2, J. Xie2, Y. Yan3, H. Gao2, G. Zhang1, X. Chen2; 1Shanghai/CN, 2Bethesda, MD/US, 3Madison, WI/US

11:15B-0884 Folic acid-modified dendrimer-entrapped gold

nanoparticles as nanoprobes for targeted computed tomography imaging of human lung adenocarcinoma L.-F. Zheng, H. Wang, C. Peng, M.-W. Shen, X.-Y. Shi, G.-X. Zhang; Shanghai/CN

11:24B-0885 Imaging of the therapeutic efficiency of photodynamic

therapy with a new designed fluorescence optical annexin probe K. Haedicke, S. Gräfe, F. Lehmann, W.A. Kaiser, I. Hilger; Jena/DE

11:33B-0886 Bimodal NIRF nanoparticles as an optical and MRI

contrast agent for imaging cells of the mononuclear phagocyte system J. Domey1, C. Bergemann2, I. Krumbein1, J.R. Reichenbach1, S. Bremer-Streck1, W.A. Kaiser1, I. Hilger1; 1Jena/DE, 2Berlin/DE

Scientific Sessions

261

Mon

day

B-08

87 –

B-0

907 11:42

B-0887 Assessment of in vivo cell viability of Gd or SPIO cells using MRI and BLI J. Guenoun, A. Ruggiero, G. Doeswijk, R. Janssens, G.A. Koning, G. Kotek, G.P. Krestin, M.R. Bernsen; Rotterdam/NL

11:51B-0888 Interaction of magnetically labelled multipotent

mesenchymal stromal cells and E-/P-selectins monitored by magnetic resonance imaging in mice J. Salamon, K. Peldschus, D. Wicklein, C. Lange, H. Ittrich, U. Schumacher, G. Adam; Hamburg/DE

14:00–15:30 Room B

Neuro SS 1811a Latest developments in neuroimaging

Moderators: S. Haller; Geneva/CH, E. Papadaki; Iraklion/GR

14:00B-0889 Improved image quality for higher diagnostic accuracy

of cranial computed tomography using iterative image reconstruction H. Haubenreisser1, C. Fink2, P. Apfaltrer1, B. Schmidt3, M. Sedlmair3, S.O. Schönberg1, T. Henzler1; 1Mannheim/DE, 2Celle/DE, 3Forchheim/DE

14:09B-0890 Synchrotron radiation micro-CT imaging of the mouse

brain A. Chabrol1, H. Rositi1, M. Marinescu1, M. Langer2, C. Olivier2, F. Peyrin2, C. Frindel1, M. Wiart1, Y. Berthezène1; 1Lyon/FR, 2Grenoble/FR

14:18B-0891 Effect of dose reduction on cerebral CT perfusion

maps: results from a hybrid digital perfusion phantom R. van den Boom1, M. Oei1, L.J. Oostveen1, H. Laue2, B. van Ginneken1, R. Manniesing1, M. Prokop1; 1Nijmegen/NL, 2Bremen/DE

14:27B-0892 iDose hybrid iterative reconstruction algorithm

improves image quality in brain CT and partly compensates for radiation dose reduction A. Löve, R. Siemund, P. Höglund, D. van Westen, L. Stenberg, C. Petersen, I.M. Björkman-Burtscher; Lund/SE

14:36B-0893 MRI susceptibility-weighted imaging (SWI): role in the

differentiation of inflammatory pathologies from high-grade glioma S. Chu1, Y. Wang1, Z. Yang1, F. Xv1, O. Boyko2; 1Shanghai/CN, 2Los Angeles, CA/US

14:45B-0894 Inter-session reproducibility of cerebral blood flow

(CBF) in the primary motor cortex as assessed in the VESPA (vendor-specific features of ASL-MRI) study R.M.E. Steketee1, H.-J.M.M. Mutsaerts2, G.C. Houston3, C.B.L.M. Majoie2, A.J. Nederveen2, M. Smits1; 1Rotterdam/NL, 2Amsterdam/NL, 3Zeist/NL

14:54B-0895 Are quantitative pharmacokinetic data of dynamic

contrast-enhanced MRI influenced by observer-related bias? New data with special focus on reproducibility, precision, accuracy, reliability, repeatability and systematic bias M. Dietzel1, M. Saake1, P.A.T. Baltzer2, S. Lang1, B. Volbers1, T. Struffert1, T. Engelhorn1, A. Dörfler1; 1Erlangen/DE, 2Vienna/AT

15:03B-0896 MR elastography (MRE) for non-invasive

differentiation of intracranial tumours: results of a histology correlated study M. Simon1, J. Guo2, M. Bonsanto1, D. Petersen1, I. Sack2, J. Würfel3; 1Lübeck/DE, 2Berlin/DE, 3Göttingen/DE

15:12B-0897 Intra- and inter-scanner test-retest reliability of

whole-brain arterial spin labeling perfusion MRI B. Wu, X. Wu, X. Lou, M. Ge, L. Ma; Beijing/CN

15:21B-0898 Software for the radiological view: fully automated

CT-based quantification of microangiopathic density reduction in white matter in comparison to gold standard MRI U. Hanning1, I. Noelte2, G. Homann1, T. Niederstadt1, V. Hesselmann1, W. Heindel1, A. Kemmling3; 1Münster/DE, 2Mannheim/DE, 3Hamburg/DE

14:00–15:30 Room C

Neuro SS 1811b Spinal imaging

Moderators: M. Buruian; Targu-Mures/RO, A. Cianfoni; Lugano/CH

14:00B-0899 Diagnosis of lumbosacral transitional vertebrae on

lumbar MRI: role of spinal and paraspinal anatomic markers and value of additional whole-spine localizer N. Tokgoz, M. Ucar, B. Erdogan Sendur, K. Kılıc, C. Ozcan; Ankara/TR

14:09B-0900 Intravertebral gas in the cervical spine

P. Slon, J. Etxano, G. Viteri, I. Simón-Yarza, M. Páramo, P. García, J.C. Pueyo, J. Larrache; Pamplona/ES

14:18B-0901 The importance of craniovertebral and

cervicomedullary angle on cervicogenic headache G. Çoban1, I. Çöven1, E.B. Çifçi1, E. Yıldırım1, C.A. Yazıcı2, B. Horasanlı1; 1Konya/TR, 2Ankara/TR

14:27B-0902 Acute low back/leg pain due to lumbar disc herniation:

intradiscal and intraforaminal injections of oxygen-ozone vs steroid and anaesthetics A. Alexandre1, G. Izzo1, G.G. Giardina1, L. Coro‘2, A. Alexandre2; 1Rome/IT, 2Treviso/IT

14:36B-0903 Optimising a BLADE sequence for T2-weighted MRI of

the cervical spine in transverse orientation: is there a chance for artefact reduction? C. Fellner1, C.M. Wendl1, C. Stroszczynski1, T. Finkenzeller2; 1Regensburg/DE, 2Nürnberg/DE

14:45B-0904 Role of 3D MRI with ProSet technique in the

evaluation of lumbar radiculopathy D. Grasso, C. Borreggine, C. Bristogiannis, L.P. Stoppino, D. Melchionda, L. Macarini; Foggia/IT

14:54B-0905 Assessing severity of peripheral neuropathy with DTI

C. Mathys, J. Aissa, G. Meyer zu Hörste, D.C. Reichelt, G. Antoch, B. Turowski, H.-P. Hartung, K.A. Sheikh, H.C. Lehmann; Düsseldorf/DE

15:03B-0906 Leukodystrophy with brainstem and spinal cord

involvement and lactate elevation (LBSL): assessment of the involved white matter tracts by MRI H.M.H. Kassem1, S. Radwan1, M.H.I. Elmahdy1, A.A.S.W. Wafae2, H.R.S. Farghaly1; 1Riyadh/SA, 2Cairo/EG

15:12B-0907 Diffusion tensor imaging of the spondylotic cervical

spinal cord: a new biomarker in cervical spinal cord myelopathy? A preliminary study F.W. Cartes-Zumelzu, S. Ingorokva, H. Kostron, G.M. Feuchtner, C. Kremser, R. Granata, G. Broessner, C. Thomé; Innsbruck/AT

Scientific Sessions

262

B-09

08 –

B-0

92615:21

B-0908 Diffusion tensor imaging and magnetisation transfer imaging of spinal cord in MS patients M. Gencturk, Y. Anik, H. Efendi, A. Demirci; Kocaeli/TR

14:00–15:30 Room D1

Cardiac SS 1803 Cardiac imaging: into the future

Moderators: R.W. Bauer; Frankfurt a. Main/DE, E. Canet Soulas; Bron/FR

14:00B-0909 Ablation of atrial flutter guided by magnetic

resonance imaging M. Grothoff, P. Sommer, C. Piorkowski, J. Hoffmann, G. Hindricks, M. Gutberlet; Leipzig/DE

14:09B-0910 Quantitative BOLD response of the left ventricular

myocardium to hyperoxic respiratory challenge at 1.5 T and 3.0T cardiac magnetic resonance imaging S. Winklhofer, S. Pazahr, R. Manka, H. Alkadhi, A. Boss, P. Stolzmann; Zurich/CH

14:18B-0911 High-resolution susceptibility-weighted magnetic

resonance imaging of rat heart microvasculature E. Blondiaux, L. Pidial, G. Autret, D. Balvay, C.-A. Cuenod, H. Ducou le Pointe, O. Clément; Paris/FR

14:27B-0912 T2-weighted dark blood cardiac imaging using a dual-

source parallel radiofrequency transmission with RF shimming at 3 T compared with standard MR imaging at 3 T M. Rasper, M. Settles, B. Gramer, M. Souvatzoglou, E.J. Rummeny, A. Huber; Munich/DE

14:36B-0913 Myocardial T1-mapping and myocardial extracellular

volume (ECV) fraction: intraindividual comparison of gadobutrol and gadoterate meglumine in an animal model K.U. Bauner1, T. Sander1, D. Theisen1, H. Pietsch2, G. Jost2, M.F. Reiser1, K. Nikolaou1, B.J. Wintersperger3; 1Munich/DE, 2Berlin/DE, 3Toronto, ON/CA

14:45B-0914 Noninvasive diagnosis of pulmonary hypertension via

magnetic resonance vortex flow detection: definition of cut-off criteria G. Reiter1, U. Reiter1, G. Kovacs1, A. Stalder2, M.A. Gulsun3, A. Greiser2, H. Olschewski1, M.H. Fuchsjäger1; 1Graz/AT, 2Erlangen/DE, 3Princeton, NJ/US

14:54B-0915 Feasibility study for an image-based enhancement

of low-dose intra-procedural 4D C-arm cardiac flat-detector CT (4D-FD-CT) Y. Kyriakou1, C. Koehler1, S. de Buck2, D. Nuyens2, H. Heidbuchel2; 1Forchheim/DE, 2Leuven/BE

15:03B-0916 Assessment of HU-value stability in dynamic CT-scans

for quantitative estimation of myocardial perfusion M. Handler1, T. Rienmüller1, P. Ourednicek2, V. Makarenko3, L. Bockeria3, S. Zhorzholiani3, I. Krestinich3, R. Rienmüller4, C. Baumgartner1; 1Hall in Tirol/AT, 2Prague/CZ, 3Moscow/RU, 4Graz/AT

15:12B-0917 Impact of iterative image reconstruction algorithms

on the feasibility of automated plaque assessment in coronary computed tomographic angiography S. Puchner, M. Ferencik, M. Károlyi, S. Do, P. Maurovich-Horvat, U. Hoffmann, C. Schlett; Boston, MA/US

15:21B-0918 Calcium score of small coronary calcifications on

multi detector computed tomography: a phantom study J.M. Groen1, K.F. Kofoed2, M. Zacho2, R. Vliegenthart1, T.P. Willems1, M.J.W. Greuter1; 1Groningen/NL, 2Copenhagen/DK

14:00–15:30 Room D2

Interventional Radiology SS 1809 New approaches to aortic and

peripheral interventions Moderators: S. Kudrnova; Budapest/HU, R. Morgan; London/UK

14:00B-0919 Paclitaxel-coated balloons for the failing dialysis

access: a prospective randomized controlled trial P.M. Kitrou, K. Katsanos, S. Spiliopoulos, N. Cristeas, M. Kuriakopoulou, D. Karnabatidis, D. Siablis; Patras/GR

14:09B-0920 Lower limb multilevel treatment with drug eluting

balloon: 12-month results from the “DEBELLUM” trial F. Fanelli, A. Cannavale, P. Lucatelli, A. Wlderk, C. Cirelli, F.M. Salvatori, L. Scarciolla; Rome/IT

14:18B-0921 Directional atherectomy of chronic total

femoropopliteal occlusions: middle-term outcomes M. Rossi, G.M. Varano, F. Laurino, G. Orgera, A. Zolovkins, N. Maltzeff, M. Citone, V. David; Rome/IT

14:27B-0922 Predictive value of angiographic scores for the

integrated management of the ischaemic diabetic foot F.M. Turini, I. Bargellini, A. Piaggesi, A. Cicorelli, R. Cervelli, E. Iacopi, R. Cioni, C. Bartolozzi; Pisa/IT

14:36B-0923 12 months results of a randomised trial comparing

mono- or dual-antiplatelet therapy in interventionally treated patients with peripheral arterial disease F.F. Strobl1, J. Schmehl2, K. Brechtel2, T. Zeller3, C.D. Claussen2, G. Tepe4; 1Munich/DE, 2Tübingen/DE, 3Bad Krozingen/DE, 4Rosenheim/DE

14:45B-0924 Comparing 2D angiography, 3D rotational angiography,

and pre-procedural CT image fusion with 2D fluoroscopy for endovascular repair of thoraco-abdominal aortic aneurysm V. Tacher1, M. Lin2, P. Desgranges1, T. Grünhagen3, A. Luciani1, J.-P. Becquemin 1, J.-F. Deux 1, A. Rahmouni 1; 1Creteil/FR, 2Briarcliff Manor, NY/US, 3Best/NL

14:54B-0925 Endoleak complications of thoracic endovascular

aortic repair (TEVAR): long-term outcomes and survival A. Rampoldi, P. Fratto, M. Solcia, R. Vercelli, C. Migliorisi, F. Barbosa, D. Foresti, M. Nichelatti, G. Cornalba; Milan/IT

15:03B-0926 Selective coverage of the left subclavian artery

without recanalization in patients with patent vertebro-vertebral arterial communications during TEVAR: a single centre study M. Lee; Seoul/KR

Scientific Sessions

263

Mon

day

B-09

27 –

B-0

945 15:12

B-0927 Completely CT-guided treatment of lumbar artery fed type 2 endoleaks after stent graft repair of abdominal aortic aneurysms with direct sac puncture and embolization with the liquid embolic agent ethylene vinyl alcohol copolymer (Onyx) M. Treitl1, M. Sadeghi2, K. Eberhardt1, D. Maxien1, M.F. Reiser1; 1Munich/DE, 2Erding/DE

15:21B-0928 Endovascular treatment of type 1 endoleaks after

stent graft repair of aortic aneurysms: effectiveness and safety of the ethylene vinyl alcohol copolymer Onyx as liquid embolic agent M. Treitl1, M. Sadeghi2, K. Eberhardt1, D. Maxien1, M.F. Reiser1; 1Munich/DE, 2Erding/DE

14:00–15:30 Room E1

Musculoskeletal SS 1810 Knee: new horizons

Moderators: M. Aparisi Gomez; Valencia/ES, A. Cotten; Lille/FR

14:00B-0929 PCL index as an objective MRI tool to evaluate

anatomic ACL reconstruction during functional activities A. Ntoulia1, F. Zampeli1, E. Pappas2, S. Ristanis1, A. Georgoulis1; 1Ioannina/GR, 2Brooklyn, NY/US

14:09B-0930 Microstructural evaluation of the cruciate ligaments

with MR diffusion tensor imaging (DTI): correlations with knee stability L. Di Clemente1, D. Tortora1, V. Panara1, M. Savastano1, V. Calvisi2, P. Palumbo2, A. Tartaro1, A.R. Cotroneo1, M. Caulo1; 1Chieti/IT, 2L‘Aquila/IT

14:18B-0931 Dynamic contrast-enhanced imaging for detection of

complications after double-bundle reconstruction of the anterior cruciate ligament Y.-C. Lin1, Y.-H. Juan1, Y.-C. Cheung1, W.-L. Yeh1, C.-H. Chiu1, C.-F. Tan1, C.-M. Kuo2; 1Taoyuan/TW, 2Ilan/TW

14:27B-0932 Susceptibility artifacts on knee MRI: their frequency,

change over time, and their relation with radiography-detected calcifications and joint space narrowing, and MR-detected meniscal tears M. Jarraya1, D. Hayashi1, A. Guermazi1, C.K. Kwoh2, M.J. Hannon2, C.E. Moore3, J.M. Jakicic2, S.M. Green2, F.W. Roemer4; 1Boston, MA/US, 2Pittsburgh, PA/US, 3Houston, TX/US, 4Augsburg/DE

14:36B-0933 Meniscal pathology demonstraded by MRI and

low level laser therapy: a double-blinded placebo controlled trial O. Kiritsi1, N. Malliaropoulos2, K. Tsitas2, K. Omar1; 1Gorleston on sea, Great Yarmouth/UK, 2Thessaloniki/GR

14:45B-0934 Meniscal tears are associated with adjacent

tibiofemoral cartilage degeneration assessed using 3T MRI T2 relaxation time H. Alizai, W. Lin, H. Liebl, L. Nardo, C. McCulloch, J. Lynch, M. Nevitt; San Francisco, CA/US

14:54B-0935 Articular depression assessed by MDCT as a predictor

of soft-tissue injuries in tibial plateau fractures: intraindividual correlation to findings at magnetic resonance imaging M. Regier, A. Spiro, F.O.G. Henes, G. Adam; Hamburg/DE

15:03B-0936 Anatomical risk factors in patients after patellar

dislocation: a case-control study using MRI T. Köhlitz, S. Scheffler, T. Jung, E. Wiener, B. Vollnberg, G. Diederichs; Berlin/DE

15:12B-0937 Early changes of trabecular bone structure in

asymptomatic subjects with knee malalignment T. Baum, J. Penzel, M. Sauerschnig, E.J. Rummeny, K. Wörtler, J.S. Bauer; Munich/DE

15:21B-0938 Total knee arthroplasty MR imaging with the

WARP-technique, featuring slice-encoding metal artefact correction (SEMAC) and view-angle tilting (VAT): reduction of metal artefacts for STIR and intermediate-weighted sequences R. Sutter, R. Hodek, S.F. Fucentese, C.W.A. Pfirrmann; Zurich/CH

14:00–15:30 Room E2

GI Tract SS 1801a Colorectal cancer: diagnostic

biomarkers and response assessment Moderators: A. Filippone; Chieti/IT, J. Husty; Brno/CZ

14:00B-0939 MR imaging evaluation of rectal cancer before and

after chemoradiation therapy R. Cazzato, C.L. Piccolo, R. Del Vescovo, F. Giurazza, R.F. Grasso, B. Beomonte Zobel; Rome/IT

14:09B-0940 MRI-based selection of clinical complete and good

responders after chemoradiation for rectal cancer allows for successful minimal invasive treatment L. Heijnen1, M. Maas1, M.H. Martens1, D.M.J. Lambregts1, J.W.A. Leijtens2, R.G.H. Beets-Tan1, G.L. Beets1; 1Maastricht/NL, 2Roermond/NL

14:18B-0941 Diffusion-weighted-based volumetry in the

assessment of response in patients with rectal cancer treated with neo-adjuvant therapy: feasibility study S.F. Carbone, M. Palumbo, V. Ricci, L. Pelliccia, E. Cacchiarelli, L. Volterrani; Siena/IT

14:27B-0942 Therapy response assessment in locally advanced

rectal cancer: comparison between functional dynamic and diffusion parameters in MRI R. Fusco, V. Granata, M. Petrillo, M. Sansone, A. Petrillo; Naples/IT

14:36B-0943 Reproducibility of MRI texture analysis in primary

rectal cancer S. Gourtsoyianni1, G. Ljungqvist1, A. Khan2, R. Glynne- Jones2, B. Ganeshan3, K. Miles3, V. Goh1; 1London/UK, 2Northwood/UK, 3Falmer/UK

14:45B-0944 Predictors of mesorectal fascia infiltration on spectral

pre-saturation inversion-recovery (SPIR) MR imaging sequence after gadolinium injection in patients with rectal carcinoma after neoadjuvant chemo- and radiation therapy E. Quaia, L. De Paoli, A. Gennari, B. Cabibbo, M. Cova; Trieste/IT

14:54B-0945 Neoadjuvant therapy in locally advanced colon cancer:

the role of MDCT I. Gonzalez Crespo, D. Cano, J. Etxano, P. Slon, J. Arredondo; Pamplona/ES

Scientific Sessions

264

B-09

46 –

B-0

96415:03

B-0946 Assessment of the variation in the contrast-to-noise ratio across a range of CT scanners in a multicentre perfusion CT study of colorectal cancer (PROSpeCT): a phantom study M. Lewis, V.J. Goh; London/UK

15:12B-0947 Diffusion-weighted-based MRI: volumetry and

apparent diffusion coefficient S.F. Carbone, M. Palumbo, T. Carfagno, V. Ricci, L. Pirtoli, L. Volterrani; Siena/IT

15:21B-0948 Computed tomography of the bowel: a prospective

comparison study between four techniques M. Revelli, F. Paparo, L. Bacigalupo, A. Garlaschi, L. Cevasco, E. Biscaldi, G. Rollandi; Genoa/IT

14:00–15:30 Room F1

Breast SS 1802a Newer techniques in breast imaging

and therapy Moderators: F. Chamming‘s; Paris/FR, M. Sklair-Levy; Tel Aviv/IL

14:00B-0949 The impact of contrast-enhanced digital

mammography on the characterization of breast lesions M.H. Helal, R.M.K. Fouad, M.A. Aly, R. Wessam, I. Gouda, N. AbdelShafi, O.M. Nada, S. Mansour, M. Elbadawy; Cairo/EG

14:09B-0950 Clinical feasibility of contrast-enhanced dual-energy

mammography (CEDEM) with a tungsten (W)/titanium (Ti) anode/filter combination: a prototype report T. Knogler1, R. Leithner1, M. Hörnig2, F. Semturs1, M. Waitzbauer1, G. Langs1, P. Homolka1, K. Pinker-Domenig1, T.H. Helbich1; 1Vienna/AT, 2Erlangen/DE

14:18B-0951 Comparison of contrast-enhanced dual-energy

mammography (CEDEM) with contrast-enhanced magnetic resonance imaging (CE-MRI) in breast lesions: a prototype report T. Knogler1, R. Leithner1, M. Hörnig2, M. Waitzbauer1, F. Semturs1, G. Langs1, P. Homolka1, K. Pinker-Domenig1, T.H. Helbich1; 1Vienna/AT, 2Erlangen/DE

14:27B-0952 Metabolic imaging of breast tumours with dedicated

breast 18F-FDG PET-CT: comparison with contrast-enhanced MRI at 3T (3T CE-MRI) H.F. Magometschnigg, T.H. Helbich, H. Bickel, G. Wengert, B. Brück, K. Pinker-Domenig; Vienna/AT

14:36B-0953 High spatial and temporal resolution breast imaging

at 7 Tesla goes clinical K. Pinker-Domenig, P.A.T. Baltzer, T. Helbich, S. Gruber, W. Bogner, O. Zaric, L. Minarikova, H. Moosbauer, S. Trattnig; Vienna/AT

14:45B-0954 Evaluation of T1/T2 ratios in a pilot study as a

potential biomarker of biopsy: proven benign and malignant breast lesions in correlation with histopathological disease stage M.A. Malikova, J.N. Tkacz, P.J. Slanetz, A. Aakil, C.-Y. Guo, H. Jara; Boston, MA/US

14:54B-0955 Improved differentiation of breast tumours using

novel imaging system based on co-registered opto-acoustic tomography and ultrasound P. Otto1, K. Kist1, N.C. Dornbluth1, T. Stavros1, D. Herzog1, B. Clingman1, J. Zalev1, P. Lavin2, A. Oraevsky3; 1San Antonio, TX/US, 2Southborough, MA/US, 3Houston, TX/US

15:03B-0956 Breast lesion excision system (BLES) – innovative

breast biopsy technology: experience under sterotactic guidance in small microcalcification clusters S. Vigano‘, G.P. Scaperrotta, C. Ferranti, L. Suman, M. Marchesini, E. Capalbo, P. Panizza; Milan/IT

15:12B-0957 Percutaneous breast lesion excision system (BLES):

a new tool for complete closed excision of high risk lesions N.M. Abdel Razek; Cairo/EG

15:21B-0958 Cryoablation as local therapy for patients with breast

cancer bone metastases (BCBM) C. Pusceddu1, S. Pilleri2, G. Amucano1, L. Melis1, G. Meloni2; 1Cagliari/IT, 2Sassari/IT

14:00–15:30 Room F2

Breast SS 1802b Maximising cancer detection in breast

screening Moderators: M. Álvarez-Benito; Córdoba/ES, E. Szabó; Szeged/HU

14:00B-0959 Breast cancer prediction modelling based on common

mammographic findings in screening J. Timmers1, A.L.M. Verbeek1, R.M. Pijnappel2, J. in ‚t Hout1, M.J.M. Broeders1, G.J. den Heeten3; 1Nijmegen/NL, 2Utrecht/NL, 3Amsterdam/NL

14:09B-0960 Non-blinded versus blinded double reading of

screening mammograms in the Netherlands: a population-based study L.E.M. Duijm1, G.J. den Heeten2, J. Nederend1, M.J.M. Broeders2; 1Eindhoven/NL, 2Nijmegen/NL

14:18B-0961 Discrepant screening mammography assessments at

double reading: impact of arbitration by a third reader on screening outcome L.E.M. Duijm1, G.J. den Heeten2, J. Nederend1, M.J.M. Broeders2; 1Eindhoven/NL, 2Nijmegen/NL

14:27B-0962 First experiences with a self-test for Dutch breast

screening radiologists as a quality assurance tool J. Timmers1, A. Verbeek1, R. Pijnappel2, M. Broeders1, G. den Heeten3; 1Nijmegen/NL, 2Utrecht/NL, 3Amsterdam/NL

14:36B-0963 Transition from analogue to digital screening

mammography significantly increases the proportion of women referred twice for the same lesion L.E.M. Duijm, H. Wiersma; Eindhoven/NL

14:45B-0964 Audits as part of quality assurance in the Dutch breast

cancer screening programme T.D. Geertse, R. Holland, C.G.C.M. van Landsveld-Verhoeven, J.M.H. Timmers, K.H. Schuur, R. Pijnappel, F. Jansen, M.J.M. Broeders, G.J. den Heeten; Nijmegen/NL

Scientific Sessions

265

Mon

day

B-09

65 –

B-0

984 14:54

B-0965 Avoidable surgical consultations in women with a positive screening mammogram: experience from a southern region of the Dutch breast screening programme I.L. Schreutelkamp, R.M. Kwee, M. de Booij, M.E.A.P. Adriaensen van Roij; Heerlen/NL

15:03B-0966 BI-RADS 3 category, a pain in the neck for the

radiologist: which technique detects more cases? J. Etxano, I. Simon-Yarza, G. Viteri, M. Paramo, A. Elizalde, L.J. Pina Insausti; Pamplona/ES

15:12B-0967 Adding 3D automated breast ultrasound (ABUS) to

service screening mammography in dense breasts B. Wilczek, K. Hågemo, B. Adalsteisson, M. Janicijevic, K. Thorneman, C. Hinzer, K. Leifland; Stockholm/SE

15:21B-0968 Feasibility of automated 3D breast ultrasound

scanning in screening of women with high risk J.C.M. van Zelst, R.D.M. Mus, T. Tan, N. Karssemeijer, R.M. Mann; Nijmegen/NL

14:00–15:30 Room G/H

Genitourinary SS 1807 Mixed modalities in GU imaging

Moderators: A.J. Beer; Munich/DE, I. Vivas; Pamplona/ES

14:00B-0969 Simultaneous [18F] choline PET/MRI of the prostate:

initial results A. Wetter, C. Lipponer, F. Nensa, T. Olbricht, H. Rübben, A. Bockisch, T. Lauenstein; Essen/DE

14:09B-0970 Advantage of hybrid whole body 3T PET-MRI scanner

for prostate cancer imaging T. de Perrot, O. Rager, M. Pusztaszeri, L. Koehl, A. Figueiral, M.-F. Pelte, C. Iselin, O. Ratib, J.-P. Vallee; Geneva/CH

14:18B-0971 Renal cell carcinoma subtype differentiation: CT vs

MRI F. Veloso Gomes1, A. Matos2, J. Palas2, V. Herédia3, V. Mascarenhas4, M. Ramalho2; 1Faro/PT, 2Almada/PT, 3Évora/PT, 4Lisboa/PT

14:27B-0972 Characterization of complex cystic renal masses

according to the Bosniak criteria: results after a 5-year follow-up with CEUS M. Bertolotto, V. Savoca, W. Toscano, S. Kus, C. Cercato, M.A. Cova; Trieste/IT

14:36B-0973 Differentiation between benign Leydig cell and

malignant germ cell testicular tumours with qualitative and quantitative contrast-enhanced ultrasound assessments D.Y. Huang, R.J. Eckersly, M.E. Sellars, P.S. Sidhu; London/UK

14:45B-0974 US and colour-Doppler findings in testicular lymphoma

and their mimics M. Bertolotto1, L.E. Derchi2, M. Secil3, M. Valentino4, P. Pavlica5, M.A. Cova1; 1Trieste/IT, 2Genova/IT, 3Izmir/TR, 4Tolmezzo/IT, 5Bologna/IT

14:54B-0975 Perfusion and permeability DCE-MRI measurements

in renal cell carcinoma and metastases: effect of ROI size and positioning on inter- and intraobserver variability M. Braunagel, E. Radler, M. Ingrisch, M. Staehler, A. Crispin, K. Nikolaou, M.F. Reiser, M. Notohamiprodjo; Munich/DE

15:03B-0976 Can a contrast-enhanced ultrasound nephrostogram

be used instead of a fluoroscopic nephrostogram: preliminary findings M. Daneshi, K. Patel, D. Huang, M. Sellars, P. Sidhu; London/UK

15:12B-0977 Vena cava anomalies associated with horseshoe

kidney on MDCT T. Ichikawa, J. Koizumi, S. Kawada, Y. Imai; Isehara/JP

15:21B-0978 Comparison of dynamic transperineal ultrasound

with evacuation proctography for the evaluation of patients with posterior compartment pelvic disorders M.J. Webb, Y. Ron, S. Zelber-Sagi, E. Tiomni, Z. Halpern, E. Santo; Tel Aviv/IL

14:00–15:30 Room I/K

Abdominal Viscera SS 1801b Liver volume, function and focal

lesions Moderators: B. Choi; Seoul/KR, C.M. Nyhsen; Sunderland/UK

14:00B-0979 ROC curve analysis of diagnostic confidence of CT and

MR in focal liver pathology L. Saba1, M. Di Martino2, C. Catalano2, M. Piga1; 1Cagliari/IT, 2Rome/IT

14:09B-0980 Diagnostic accuracy of dynamic gadoxetic-acid-

enhanced MRI and PET-CT in patients with liver metastases from neuroendocrine neoplasms W.H. Sommer1, C. Zech1, S. Sourbron2, M. Armbruster1, M.F. Reiser1; 1Munich/DE, 2Leeds/UK

14:18B-0981 The LiMAx test as adjunct to CT for assessing liver

function after portal vein embolization A.H. Mahnken1, A. Roeth2, P.H. Alizai2, C. Kuhl2, R.M. van Dam3, U. Neumann2, M. Schmeding2; 1Marburg/DE, 2Aachen/DE, 3Maastricht/NL

14:27B-0982 Future remnant liver function after portal vein

occlusion measured with 99mTc-mebrofenin SPECT/CT I. Dudás, T. Györke, C. Korom, P. Pajor, A. Zsirka-Klein, E. Horvath, A. Bozó, P. Kupcsulik, O. Hahn; Budapest/HU

14:36B-0983 Comparison of percutaneous portal vein embolization,

portal vein ligation and portal vein occlusion combined with ipsilateral hepatic artery cannula implantation prior to major liver resection P. Pajor, I. Dudás, A. Zsirka Klein, P. Kupcsulik, J. Tamás, O. Hahn; Budapest/HU

14:45B-0984 Hepatic parenchymal and vascular contrast

improvement in super-delayed phase images of Gd-EOB-DTPA-enhanced MRI S. Kobayashi, O. Matsui, T. Gabata, W. Koda, T. Minami, K. Kozaka, A. Kitao; Kanazawa/JP

Scientific Sessions

266

B-09

85 –

B-1

00614:54

B-0985 Estimation of liver function using T1 mapping on Gd-EOB-DTPA-enhanced MR imaging M. Haimerl, N. Verloh, C. Fellner, C. Nießen, C. Stroszczynski, P. Wiggermann; Regensburg/DE

15:03B-0986 Liver dysfunction induced by amiodarone therapy:

evaluation by sequential CT studies Y. Sonoyama, T. Tajima, T. Shiga, N. Hagiwara, S. Sakai; Tokyo/JP

15:12B-0987 Feasibility of a volumetric measurement of the left

liver lobe with 3D ultrasound compared with MRI E. Danse, O. Lebecque, N. Michoux, R. Reding; Brussels/BE

15:21B-0988 An accurate formula for a quick estimate of liver

volume in polycystic liver disease M. Chrispijn, T.J.G. Gevers, J.P.H. Drenth; Nijmegen/NL

14:00–15:30 Room L/M

Physics in Radiology SS 1813 Patient dose management and dose

surveys Moderators: H. Bosmans; Leuven/BE, W. Stiller; Heidelberg/DE

14:00B-0989 European population dose and differences in

radiological procedures between European countries R. Bly1, A. Jahnen2, H. Olerud3, J. Vassileva4, H. Järvinen1, S. Vogiatzi5; 1Helsinki/FI, 2Luxembourg/LU, 3Østerås/NO, 4Sofia/BG, 5Athens/GR

14:09B-0990 Radiation dose from multidetector CT examinations in

adults in Italy: result of the first Italian survey S. Salerno1, C. Granata2, D. Matranga1, F. Palorini3, D. Origgi3; 1Palermo/IT, 2Genoa/IT, 3Milan/IT

14:18B-0991 Patient-specific whole body voxel model for accurate

Monte Carlo CT dose estimation N. Saltybaeva, Y. Smal, D. Kolditz, W. Kalender; Erlangen/DE

14:27B-0992 A simple algorithm for dose estimation in CT imaging

considering patient size Y. Smal, N. Saltybaeva, W. Kalender; Erlangen/DE

14:36B-0993 Monte Carlo tool for 3D-dose simulation in computed

tomography taking into account tube current modulation N. Saltybaeva1, D. Kolditz1, B. Schmidt2, W. Kalender1; 1Erlangen/DE, 2Forchheim/DE

14:45B-0994 Evaluation of patient dose reduction after introduction

of iterative reconstruction in routine MDCT D. Defez1, P. Coulon2, P.C. Douek3, L. Boussel4; 1Pierre Benite/FR, 2Suresnes/FR, 3Bron/FR, 4Lyon/FR

14:54B-0995 Adjusting and measuring CT dose in severely obese

patients R. Marcus, F. Bamberg, K. Neumaier, M.F. Reiser, T.R.C. Johnson; Munich/DE

15:03B-0996 The effects of head size/shape, head positioning, and

bow-tie filter selection on peak tissue doses from brain perfusion 256-slice CT K. Perisinakis1, I. Seimenis2, A. Tzedakis1, A.E. Papadakis1, J. Damilakis1; 1Iraklion/GR, 2Alexandroupolis/GR

15:12B-0997 Detector dose vs image quality in radiography with

digital detectors: a visual grading analysis R. Decoster, H. Mol, D. Smits; Brussels/BE

15:21B-0998 Active personal dosimeters to support optimisation of

radiation protection in interventional radiology R. Padovani, F. Bonutti, A. Trianni, G. Bernardi; Udine/IT

14:00–15:30 Room N/O

Vascular SS 1815 Vascular research

Moderators: S. Kuribayashi; Tokyo/JP, A. Pellegrin; Trieste/IT

14:00B-0999 Hybrid-MRA steady state VIBE imaging – a delayed

closer look at the vessels: evaluation of the additional diagnostic benefit in patients who undergo a peripheral magnetic resonance angiographic protocol M. Ong, K. Hausotter, S.O. Schönberg, H.J. Michaely; Mannheim/DE

14:09B-1000 Multimodal imaging of atherosclerotic plaques

using SPIO and quantum dot labelled high density lipoproteins in ApoE-/- mice C.S.L. Jung, H. Ittrich, M.G. Kaul, T. Ducic, O. Bruns, B. Freund, J. Hereren, G. Adam; Hamburg/DE

14:18B-1001 Skin autofluorescence, a non-invasive marker for AGE

accumulation, is elevated in subjects with evidence for subclinical atherosclerosis M.A.M. den Dekker, M. Zwiers, E.R. van den Heuvel, L.C. de Vos, A.J. Smit, M. Oudkerk, R. Vliegenthart, J.D. Lefrandt, D.J. Mulder; Groningen/NL

14:27B-1002 Vascular enhancement and image quality of lower-

extremity CT venography using 100 kVp and ultrahigh pitch: comparison of conventional lower-extremity CT venography using 120 kVp and standard pitch K. Choo, J. Park, J. Kim, J. Roh, C. Park; Busan/KR

14:36B-1003 CT textural analysis of culprit lesions in transient

ischaemic attack and/or stroke: correlation with immunohistochemistry E. Barden1, L. Menezes1, B. Ganeshan1, M. Rodriguez-Justo1, R. Endozo1, C.W. Kotze2, S.W. Yusuf2, A.M. Groves1; 1London/UK, 2Brighton/UK

14:45B-1004 Non-contrast-enhanced MR angiography combined

with peripheral cardiac gating at 3T: comparison of respiratory triggered and breath held technique T. Masui1, M. Katayama1, K. Sato1, K. Terauchi1, N. Takei2, K. Tsukamoto1, K. Mizuki1, M. Miyoshi2, H. Sakahara1; 1Hamamatsu/JP, 2Hino/JP

14:54B-1005 Low kV settings CT-angiography with ultra low

contrast medium volume for the assessment of thoracic and abdominal aorta disease: a feasibility study C.R.G.L. Talei Franzesi, D. Ippolito, P.A. Bonaffini, D. Fior, O. Minutolo, S. Sironi; Monza/IT

15:03B-1006 X-ray phase-contrast imaging of arterial vessel

wall: translation from synchrotron radiation to a conventional lab-based X-ray source H. Hetterich1, M. Willner2, S. Fill1, F. Bamberg1, J. Herzen2, M. Stockmar2, F. Pfeiffer2, M.F. Reiser1, T. Saam1; 1Munich/DE, 2Garching/DE

Scientific Sessions

267

Mon

day

B-10

07 –

B-1

028 15:12

B-1007 Single contrast medium dose peripheral MR angiography is feasible without subtraction using two-point Dixon fat saturation T. Leiner1, J. Habets1, B. Versluis2, L. Geerts3, J. Hendrikse1, E.-J. Vonken1, H. Eggers4; 1Utrecht/NL, 2Maastricht/NL, 3Best/NL, 4Hamburg/DE

15:21B-1008 Correlation of cardiovascular risk factors and occult

atherosclerotic findings using whole body magnetic resonance imaging of the vascular system in an asymptomatic patient collective: initial results S. Mangold, E. Randrianarisoa, P. Krumm, C. Bretschneider, A. Seeger, K. Rittig, B. Balletshofer, C.D. Claussen, U. Kramer; Tübingen/DE

14:00–15:30 Room P

Paediatric SS 1812 Paediatric brain

Moderators: M.A. Lucic; Sremska Kamenica/RS, M. Stenzel; Jena/DE

14:00B-1010 Ultra-low-dose CT of the inner ear with adaptive

statistical image reconstruction in infants candidate to cochlear prosthesis implantation: preliminary experience L. Faggioni, E. Neri, L. Bruschini, V. Seccia, S. Sellari Franceschini, C. Bartolozzi; Pisa/IT

14:09B-1011 Traumatic subdural hygromas in children between 0

and 2 years: a retrospective CT and MRI study M.L. Hahnemann1, A. Schmeling2, M. Schlamann1, M. Forsting1, H. Pfeiffer2, D. Wittschieber2; 1Essen/DE, 2Münster/DE

14:18B-1012 Apparent kurtosis coefficient (AKC) in brain: a

feasibility study in paediatric populations I. D‘Errico, A. Ciccarone, M. Esposito, M. Mortilla, C. Fonda; Florence/IT

14:27B-1013 Which T1 pulse should be used to study the preterm

brain with a 3 Tesla scanner? D. Tortora, V. Panara, P.A. Mattei, S. Salice, M. Tagliamonte, C. Briganti, A.R. Cotroneo, A. Tartaro, M. Caulo; Chieti/IT

14:36B-1014 Paediatric brain tumour classification by quantitative

methods of magnetic resonance imaging: combination of DTI, PWI and MRS S. Chełstowska, E. Jurkiewicz, I. Pakuła-Kościesza, K. Nowak, K. Malczyk, S. Rączkowska, M. Armata, J. Walecki; Warsaw/PL

14:45B-1015 Perfusion parameters of pilocytic astrocytomas:

additional oddities of these tumours M. Martucci, S. Gaudino, E. Gangemi, R. Colantonio, G. Di Lella, C. Colosimo; Rome/IT

14:54B-1016 Evaluation of metabolic changes within the normal

appearing grey and white matters in children with growth hormone deficiency: magnetic resonance spectroscopy and hormonal correlation J. Bladowska, A. Zimny, A. Zacharzewska, T.M. Gondek, A. Banaszek, T. Żak, A. Noczyńska, M. Sąsiadek; Wroclaw/PL

15:03B-1017 Functional correlation of the spastic hemiplegic

patients with MR findings K. Hayakawa, S. Yoshida, H. Tatekawa, Y. Yamori, T. Kanda, N. Yoshida, H. Hirota, M. Iwami, K. Nakamura; Kyoto/JP

15:12B-1018 Diffusion tensor tractography and fractional

anisotropy in paediatric cortical abnormalities evaluation with TBSS analysis A. Ciccarone, I. D‘Errico, M. Esposito, M. Mortilla, C. Fonda; Florence/IT

14:00–15:30 Room Q

Radiographers SS 1814 Challenges of different imaging

techniques Moderators: H.H. Hjemly; Olso/NO, J. McNulty; Dublin/IE

14:00B-1019 Occupational exposition to electromagnetic fields in

MR: understanding the discussion around the directive 2004/40/EC C.S.L. Santos, D.P. Rocha, M.M.C.P. Ribeiro; Lisbon/PT

14:09B-1020 Radiographers perceptions of magnetic resonance

imaging: a study of the causes that lead to the repetition of exams T.R. Filipe1, L.P.V. Ribeiro1, R.P.P. Almeida1, S.I. Rodrigues1, K.B. Azevedo1, C.A. Silva2, A.F.L. Abrantes1; 1Faro/PT, 2Évora/PT

14:18B-1021 Functional mapping of the visual word form area with

frequent words of the Portuguese lexicon: an fMRI study C. Ferreira1, P. Martins2, G. Cunha1, N. Canário1, C. Nunes1, A.C. Miranda2, J. Ribeiro2, S. Afonso2, M. Castelo-Branco1; 1Coimbra/PT, 2Aveiro/PT

14:27B-1022 A survey of the various methods and techniques

employed in myocardial stress testing K. Borg Grima1, L. Rainford2, P. Bezzina1, D. O‘Leary2; 1Msida/MT, 2Dublin/IE

14:36B-1023 Importance of scout imaging in neuroradiologic

studies D.C. Martin, S.H. Erbay, M. Hakky, K.D. Erbay, N. Erbay, D. Marrero; Burlington, MA/US

14:45B-1024 Comparison of a 12-channel- with a 32-channel head

coil using SNR measurements C. Vandulek, D. Kaczur, E. Vinczen, I. Repa; Kaposvár/HU

14:54B-1025 Psychological effect of chronic exposure to high

magnetic field on MRI technologists N.M. Mishah, W. Hamed; Jeddah/SA

15:03B-1026 Development and implementation of a synthetic

data evaluation scenario for image fusion algorithms based on discrete wavelet transform and principal component analysis V. Weiss; Wiener Neustadt/AT

15:12B-1027 Image registration and fusion of CT and micro-CT of a

sheep‘s cochlea S. Leitner; Berndorf/AT

15:21B-1028 Evaluation of image quality optimisation using VGC

and ordinal regression analysis F. Zarb1, M.F. McEntee2, S. Foley3, L. Rainford3; 1Msida/MT, 2Sydney/AU, 3Dublin/IE

Scientific Sessions

268

B-10

29 –

B-1

03814:00–15:30 Room Z

Contrast Media SS 1806 Functional studies and safety

Moderators: T. Gleeson; Wexford/UK, E.M. Merkle; Basle/CH

14:00B-1029 Measuring hepatic functional reserve using low

temporal resolution Gd-EOB-DTPA dynamic contrast-enhanced MRI: a comparison study with galactosyl-human serum albumin scintigraphy and indocyanine green retention K. Saito1, J.R. Ledsam2, S.P. Sourbron2, T. Hashimoto1, Y. Araki1, S. Akata1, K. Tokuuye1; 1Tokyo/JP, 2Leeds/UK

14:09B-1030 Dynamic enhancement pattern of Gd-EOB-DTPA

compared to gadobutrol in patients with HCC S. Kinner, C. Kloeters, L. Umutlu, N. Sippel, T.C. Lauenstein; Essen/DE

14:18B-1031 Gadoxetic acid-enhanced hepatobiliary phase MRI and

high b-value diffusion-weighted imaging (DWI) in the differential diagnosis between benign to malignant liver lesions P. Arcuri, G. Fodero, S. Roccia, S. Molica, V. Arcuri; Catanzaro/IT

14:27B-1032 Gadoxetic acid-enhanced MRI of the liver: correlation

between Gadoxetic acid uptake and serum hepatic enzymes levels E. Talakic, H. Schoellnast, T. Wimmer, J. Steiner, F. Quehenberger, U. Reiter; Graz/AT

14:36B-1033 MRCP using hepatospecific contrast media (GD-EOB-

DTPA) in biliary leaks R. Faletti, M. Fronda, F. Barisone, C. Bogetti, A. Dominguez, A. Rapellino, L. Marchisio, P. Fonio, G. Gandini; Turin/IT

14:45B-1034 N-acetylcysteine for the prevention of contrast-

induced nephropathy in rats M.F. İnci1, I. Şalk2, O. Solak2, Ü. Vurdem3, R. İnci1; 1Kahramanmaraş/TR, 2Sivas/TR, 3Kayseri/TR

14:54B-1035 Evaluation of enhancement properties of gadolinium-

labelled nanoparticles for contrast-enhanced MRI in rats with experimental liver tumours at 9.4 T P. Fries1, D. Morr1, A. Müller1, F. Lux2, O. Tillement2, J. Palm1, G. Schneider1, R. Seidel1, A. Buecker1; 1Homburg/DE, 2Lyon/FR

15:03B-1036 Regorafenib monotherapy effects on experimental

human colon carcinoma xenografts monitored by DCE-CT with immunohistochemical validation P.M. Kazmierczak, H. Hirner, L. Havla, M. Schneider, O. Dietrich, C. Bruns, M.F. Reiser, K. Nikolaou, C.C. Cyran; Munich/DE

15:12B-1037 Contrast-induced nephropathy in patients undergoing

intravenous contrast-enhanced computed tomography and the relationship with risk factors: a meta-analysis S.I. Moos, J. Stoker, S. Bipat; Amsterdam/NL

15:21B-1038 Renal MR angiography at 7 Tesla: how much

gadolinium do we need? L. Umutlu, A. Fischer, M. Forsting, M.E. Ladd, S. Maderwald, O. Kraff, T.C. Lauenstein; Essen/DE

Scientific Sessions

269

Mon

day

List ofAuthors & Co-Authors

List of Authors and Co-Authors

272

AA. Rahman F.: B-0015Aakil A.: B-0954Abdel Razek N.M.: B-0957Abdel Razek N.M.A.: B-0452Abdel Rehim M.: A-021AbdelShafi N.: B-0949Abdullah B.J.J.: B-0422Abe T.: B-0760Abild A.-M.: B-0356, B-0357Abolfat-h-Zadeh Ghale Joughi N.: B-0857Abolmaali N.: B-0101Abramyuk A.: B-0101Abrantes A.F.C.L.: B-0136, B-0138, B-0274, B-0386,

B-0602, B-0603, B-0607, B-0871, B-0875, B-0876Abrantes A.F.L.: B-1020Abreu V.: B-0508Abrigo J.M.: B-0441Acharia U.R.: B-0617Achenbach S.: B-0665Acosta Ruiz V.: B-0177Adalsteisson B.: B-0967Adam A.: A-104Adam G.: B-0367, B-0765, B-0859, B-0879, B-0882,

B-0888, B-0935, B-1000Adam E.J.: A-280Adams A.: B-0218, B-0734Adiotomre E.: B-0599Adriaensen van Roij M.E.A.P.: B-0965Afaq A.: B-0549Afonso S.: B-1021Afshan I.: B-0013Agarwal S.: A-536Aghenitei I.: B-0141, B-0807Ağıldere M.: B-0155Agostini G.: B-0440, B-0712, B-0769Agresti R.: B-0561Aguirregoicoa I.: B-0724Ahari H.: B-0037Aharoni D.: B-0612Åhlström Riklund K.: A-398, A-401Ahmad M.E.: B-0756Ahn H.S.: B-0210Ahn M.-J.: B-0024, B-0025Ahonen S.-M.: B-0135Äikiä M.: B-0011Airaldi S.: B-0688Aissa J.: B-0252, B-0366, B-0522, B-0749, B-0905Akahane M.: B-0255Akata S.: B-1029Akbar M.: B-0044Akhavan F.: B-0857Akin O.: B-0697Akiyama Y.: B-0305Akkerman E.A.: B-0550Albarello L.: B-0801Alberich-Bayarri A.: B-0403Albers P.: B-0081Albert T.S.E.: B-0255Albino V.: B-0233Albisinni U.: B-0316, B-0642Alboni C.: B-0349Albrecht T.: B-0232Al-Butmeh F.: B-0290, B-0633, B-0700Alconchel A.: B-0082Alcorn D.: SK 27Aldave G.: B-0514

Ale A.: B-0880Alenius G.-M.: B-0653Alessi S.: B-0082Alexandre A.: B-0902Alfayate Sáez E.: A-285Algeri E.: B-0376Alghamdi F.: B-0105Aliprandi A.: B-0741Alis H.: B-0838Alizai H.: B-0934Alizai P.H.: B-0981Alkadhi H.: A-037, A-218, A-539, B-0063, B-0242,

B-0482, B-0660, B-0788, B-0910, SY 10Al-Kalbani J.: B-0549Aleksandrova-Moiseja M.: Rising Stars Allen S.D.: A-542Allmendinger T.: B-0372Almeida P.: SK 27Almeida R.P.P.: B-0136, B-0138, B-0274, B-0386,

B-0602, B-0603, B-0607, B-0871, B-0875, B-0876, B-1020

Almqvist T.: B-0149Alnabhani K.: B-0549Altobelli S.: B-0085Aly M.A.: B-0949Amalou H.: B-0173Amanakis E.: B-0223, B-0228Ambrosetti M.C.: B-0706Ambrosini V.: B-0555Ambrožič A.: B-0652Amirifeli S.: B-0037Amoretti M.-E.: B-0307, B-0308Amoretti N.: B-0307, B-0308Amucano G.: B-0958An H.S.: B-0269Andersen F.: B-0102, B-0103Andersen J.G.: B-0139, B-0388, B-0870Anderson E.M.: B-0062, B-0070, B-0423, B-0624,

SK 27Andersson I.: A-507Andersson T.: B-0825Andikyan V.: B-0390Ando T.: B-0338, B-0339Andrassy J.: B-0341Andreini D.: B-0262Andreisek G.: B-0482Andreone A.: B-0316, B-0640Andronikou S.: B-0860, B-0862Angelelli G.: B-0283Anik Y.: B-0908Anikin V.: B-0030Annet L.: A-196Annoni A.: B-0262Antoch G.: A-383, A-458, B-0028, B-0081, B-0159,

B-0252, B-0320, B-0340, B-0366, B-0486, B-0487, B-0501, B-0506, B-0522, B-0552, B-0553, B-0648, B-0651, B-0703, B-0749, B-0905

Antonicoli M.: B-0085Antoniutti M.: B-0131, B-0382Anzidei M.: B-0174, B-0617, B-0643, B-0644Aoyama N.: B-0346Apfaltrer P.: B-0022, B-0160, B-0265, B-0289,

B-0352, B-0419, B-0848, B-0889Apostolova I.: B-0879Araki T.: B-0093Araki Y.: B-1029Archer V.: B-0799

Arcuri P.P.: B-1031Arcuri V.: B-1031Ardies P.: SY 21Ardley N.: B-0701Argentos S.I.: B-0530Argyropoulou M.I.: A-119, A-252, B-0406, B-0860,

B-0862Arık B.: B-0587Armata M.: B-1014Armbruster M.: B-0638, B-0980Arnaiz J.: B-0251Aronson B.A.: B-0529Arrebola J.P.: B-0099Arredondo J.: B-0945Arrieta I.: B-0724Arrigoni F.: B-0493Arru M.: B-0313Arsalan Raza S.: B-0699Arsov C.: B-0081Artigas J.M.: B-0122Artigas Martín J.M.: B-0124Asbach P.: B-0324Ascanio S.: B-0555Aschauer M.: B-0251Aschieri D.: B-0267Ascioti C.: B-0467Asenbaum U.: B-0328, B-0719Ashoori N.: B-0578Ashrafpoor G.: B-0007Asp P.: B-0149Astengo D.: B-0688Astrakas L.: B-0860, B-0862Astrinakis E.: B-0115Athanasiou A.: A-028Athelogou M.: B-0282Attenberger U.: B-0829Attenberger U.I.: B-0628Attili A.F.: B-0238Attye A.: B-0355, B-0751Aube C.: B-0797Aubry S.: B-0312Auger C.: B-0222Auriol J.: A-244Autret G.: B-0911Auweter S.: B-0846Avila R.: B-0799Avni F.E.: A-484Awadalla H.: B-0123Ayestaran P.: B-0370Ayles H.: B-0761Ayuso C.: A-111, A-360, A-564, B-0704Azarine A.A.: B-0007Azavedo E.: A-446Azevedo K.B.: B-0138, B-0274, B-0602, B-0603,

B-0871, B-0875, B-1020Aznar M.: B-0103Azzabi Zouraq F.: B-0318

BBabikir S.: B-0205Bacigalupo L.: B-0197, B-0948Backes W.H.: B-0012, B-0116, B-0118, B-0120,

B-0622Badea R.: B-0096Baggen V.J.M.: B-0005Baglio I.: B-0454Bagnenko S.: B-0833


273

Bagotskaya N.: B-0206Bai Y.: B-0517Baier U.: B-0001Bailly P.: A-268Bainbridge A.: B-0097Baiocchi G.: B-0791, B-0794Bakker C.M.M.: B-0627Balageas P.: B-0176Balassy C.: B-0096Baldassari P.: B-0796Baldisserotto M.B.: B-0590Bale R.: SK 27Balestri R.: B-0623Bálint Z.: B-0639Ballerini G.: B-0262Balletshofer B.: B-1008Balleyguier C.S.: A-027, A-296Baloch E.: B-0068Baltzer P.A.T.: A-029, B-0074, B-0075, B-0076,

B-0077, B-0079, B-0457, B-0679, B-0808, B-0895, B-0953

Balvay D.: B-0911Balzano G.: B-0769Bamberg F.: B-0112, B-0113, B-0161, B-0411,

B-0582, B-0634, B-0849, B-0995, B-1006Banaszek A.: B-1016Banchik E.: B-0695Banckwitz R.: B-0290Bandello F.: B-0712Bandirali M.: B-0741Banihashemi H.: B-0477Bannas P.: B-0367, B-0882Barantin L.: B-0105Baratella E.: B-0762Baratto F.: B-0585Barbazeni G.: B-0454Barbiani C.: B-0416, B-0662Barbier-Brion B.: B-0312Barbieri A.: B-0462, B-0463Barbosa F.: B-0925Barchetti F.: B-0089, B-0090Barcikowska M.: B-0400Barden E.: B-1003Bardo G.: B-0082Barentsz J.O.: A-136, A-427, B-0083Bargalló N.: A-511Bargellini I.: A-567, B-0035, B-0922Bargy S.: B-0861Barile A.: B-0183Barillari M.: B-0710Barisone F.: B-1033Barkhausen J.: B-0584Barkhof F.: A-165, A-421, A-614Barnes A.: B-0549Baron J.: B-0303Baron R.L.: A-135Barrau V.: A-021Barrick T.R.: B-0359Barrington S.F.: A-301Barthel H.: B-0558Bartoli J.M.: B-0460, B-0461Bartolo V.: B-0745, B-0787, B-0832Bartolozzi C.: A-563, B-0035, B-0577, B-0623,

B-0698, B-0922, B-1010Barton B.: B-0299Basilico R.: B-0127Ba-Ssalamah A.: B-0096

Bastarrika G.: A-184, A-201, B-0143, B-0668Bastati-Huber N.: B-0096Bastawrous S.: B-0145Båth M.: A-236Batouty N.M.: B-0150Battista G.: B-0316, B-0555, B-0598Bauer J.S.: B-0180, B-0435, B-0548, B-0937Bauer P.: A-343Bauer R.W.: B-0266, B-0633, B-0669, B-0723Bauerfeind P.: A-147Bäuerle T.: B-0434Baum R.: B-0282Baum T.: B-0180, B-0548, B-0937Bauman G.: B-0766Baumann A.B.: B-0754, B-0755Baumann T.: B-0551Baumeister S.: B-0445Baumgartner C.: B-0916Bauner K.: B-0582Bauner K.U.: B-0913Baur-Melnyk A.: B-0547Baxa J.: B-0358Bayramoglu S.: B-0838Bazeli R.: B-0650Bazot M.: A-553Bazzocchi A.: B-0316, B-0555, B-0598, B-0640,

B-0642Bazzocchi M.: B-0132, B-0567, B-0568, B-0684,

B-0687, B-0811, B-0834, B-0835Beaussart P.: B-0459Becce F.: B-0542, B-0544Bech M.: B-0846Bechstein W.O.: B-0034, B-0040Beck K.S.: B-0637Becker A.: B-0582Becker C.D.: A-529, B-0121Becker H.-C.: Becker M.: A-274, A-570Beck-Popovic M.: B-0670Becquemin J.-P.: B-0924Beek F.J.: B-0550Beer A.J.: B-0322Beer M.J.: B-0001Beeres M.: B-0031, B-0700, B-0723Beeson J.: B-0030Beets G.L.: B-0621, B-0622, B-0625, B-0940Beets-Tan R.G.H.: A-007, A-141, A-175, A-437,

B-0212, B-0450, B-0451, B-0621, B-0622, B-0625, B-0940

Behrendt F.F.: B-0746Behzadi S.: B-0220Beiderwellen K.: B-0501Beiderwellen K.J.: B-0500Beigelman C.: A-333Bekiesinska-Figatowska M.: B-0671Belcari N.: A-459Belfiore M.P.: B-0057, B-0059Belghiti J.: A-019Belkacemi Y.: B-0459Bellemann N.: B-0178Belli A.-M.: A-388, B-0498Bellin M.-F.: A-176Bellini D.: B-0792, B-0793Bellomi M.: B-0082Belloni E.: B-0267Bellotti M.: B-0397Belyakov N.: B-0229

Bemi P.: B-0623Ben Lakhdar Z.: A-021Ben Salah Y.: B-0542, B-0544Bendaoud S.: B-0630Bendek M.: B-0029Bender D.: B-0188Beningfield S.: A-262Benito A.: A-076, B-0778Benjamin P.: B-0359Beomonte Zobel B.: B-0020, B-0049, B-0179, B-0342,

B-0407, B-0468, B-0469, B-0579, B-0939Berdel W.E.: B-0805Berendsen R.C.M.: B-0627Berg W.A.: A-154Bergemann C.: B-0886Berger R.: B-0612Beringer P.: B-0483, B-0484Berkouk K.: A-291, EIBIRBerkovitz N.: B-0227Bernardi B.: A-532Bernardi D.: B-0818, SY 17Bernardi G.: B-0998Bernardo S.: B-0394, B-0396, B-0863, B-0868Bernhardt D.: B-0263, B-0411Bernhardt P.: B-0412, B-0583Bernsen M.R.: B-0887Berritto D.: B-0057, B-0058, B-0059Berta L.: B-0246, B-0705Bertaccini L.: B-0174, B-0399, B-0427, B-0490,

B-0643, B-0644Bertani V.: B-0567, B-0568Bertella E.: B-0262Berthezène Y.: B-0890Bertolotto M.: A-426, B-0972, B-0974Bertram H.H.: B-0448Bertrand P.: B-0105Bertugno S.: B-0462, B-0463Besostri V.: B-0438, B-0439, B-0787, B-0827Besseling R.: B-0012Besutti G.: B-0231, B-0237Bettelli G.: B-0642Betti M.: B-0325Beuf O.: B-0443, B-0444Bex M.: B-0152Beyer T.: A-457, B-0102, B-0103Bezzi M.: A-340, B-0775Bezzina P.: B-0604, B-1022Bhagat N.: B-0036Bhargava P.: B-0095, B-0145Bhasin D.: B-0573Bhat V.: B-0431Bhatt S.: B-0041Bhattacharya R.: B-0095Biagini C.: B-0325Bianchin A.L.: B-0454Bibi R.: B-0105Bick U.: A-063Bickel H.: B-0071, B-0076, B-0213, B-0562, B-0563,

B-0952Bickelhaupt S.: B-0198, B-0242, B-0616, B-0788Bidault F.: A-433Bidault S.: A-433Biederer J.: A-082, A-380, B-0162Bielicki I.: B-0881Bierca J.: B-0717Bierings M.B.: B-0550Bierma - Zeinstra S.: B-0485


274

Biffar A.: B-0547Bilbao J.I.: A-077, A-233, B-0778Bilhim T.: B-0175Bilk P.: B-0340Bill U.: B-0616Binaghi S.: B-0670Bingotti B.: B-0688Binnig G.: B-0282Bipat S.: B-1037Birngruber E.: B-0147Biscaldi E.: B-0948Bisdas S.: A-462Bisdorff-Bresson A.: A-624Bisogno R.: B-0785Bittersohl B.: B-0486, B-0487Bize P.: A-189, A-431Björkman B.: B-0380Björkman-Burtscher I.: B-0169Björkman-Burtscher I.M.: B-0892Bladowska J.: B-0401, B-0847, B-1016Blanke P.: B-0263, B-0411Bley T.: B-0354Blobel J.: B-0374Bloess K.: B-0188Blomqvist L.C.O.: A-551, B-0149Blondiaux E.: B-0738, B-0867, B-0911Blondin D.: B-0081, B-0252, B-0340, B-0648Blösser S.: B-0039Bly R.: B-0989Boardman P.: B-0423Boatta E.: B-0300, B-0775Bockeria L.: B-0916Bockisch A.: B-0500, B-0969Boczar M.: B-0671Bodelle B.: B-0031, B-0170, B-0290, B-0700, B-0723Boehm A.: B-0158Boehm C.: B-0768Boellaard T.N.: B-0790Boelle P.-Y.: B-0738Boellis A.: B-0518, B-0675Boersma E.: B-0410, B-0415Bogaert J.: A-092, A-370Bogdanovic D.: B-0812Bogetti C.: B-1033Boggi U.: B-0577Bogner W.: B-0071, B-0076, B-0562, B-0953Bohlsen D.: B-0234Böhme S.: B-0523Bojanowski K.: B-0303Bojarovska J.: Rising Stars Boland G.: A-270Boll D.T.: B-0728Bolle N.: SY 12 Bomer J.: B-0597Bonaffini P.: B-0254Bonaffini P.A.: B-0064, B-0235, B-0236, B-0391,

B-0438, B-0439, B-0505, B-0596, B-0745, B-0783, B-0787, B-0827, B-0832, B-1005

Bonanno E.: SK 27Bongartz G.M.: A-595Boni F.: B-0174, B-0399, B-0414, B-0427, B-0490,

B-0643, B-0644, B-0645Bonomo L.: A-381, A-449, B-0021, B-0323, B-0395Bonsanto M.: B-0896Bonutti F.: B-0998Boone D.: B-0789Boraschi P.: B-0577

Borg Grima K.: B-1022Borger M.: B-0260Borges A.: A-001, A-310Borggrefe J.: B-0436Borghesi A.: B-0716Borlak J.: B-0768Borobia A.: B-0124Borralho L.: B-0876Borreggine C.: B-0904Borrego Gómez J.: B-0690Bos D.: B-0114, B-0350Bos K.: B-0485Bosc R.: B-0459Bosmans H.: B-0842Bosmans J.M.L.: A-272Boss A.: B-0198, B-0318, B-0910Botelho M.P.F.: B-0363, B-0524, B-0615, B-0722Botnar R.M.: B-0881Botturi E.: B-0478Boubagra K.: B-0355Bouchareb Y.: B-0104Boulay-Coletta I.: A-494, B-0837Boumanji J.: B-0549Bouquet H.: B-0198, B-0616Bourdet C.: B-0786Bourguignon M.: B-0559Boursi B.: B-0612Boussel L.: B-0994Bouvier J.: B-0355Boyko O.B.: B-0893Bozkurt S.: B-0055Bozó A.: B-0982Bozovic G.: B-0169Bozzao A.: B-0518, B-0675Bozzi E.: B-0035Brachetti G.: B-0427, B-0643, B-0644, B-0645Brader P.: A-095, B-0171, B-0213, B-0502Brady M.: B-0624Brahmstaedt R.: B-0426Brambilla G.: B-0771Brandmaier P.: B-0558Braren R.: B-0880Brassart N.: B-0053Bratanova V.: B-0244Braunagel M.: B-0344, B-0975Brechtel K.: B-0923Breen D.J.: A-491, SK 27Breikss M.: Rising Stars Brekenfeld C.: B-0354Brekkan E.: B-0177Bremer C.: B-0805Bremerich J.: A-324, A-574Bremer-Streck S.: B-0886Brendle C.: B-0504Brenner W.: B-0879Bretschneider C.: B-0003, B-1008Bricault I.: B-0429Briganti C.: B-0509, B-1013Brkljacic B.: SK 27Brillet P.-Y.: A-616Bristogiannis C.: B-0904Britton P.D.: A-374Broadley P.: B-0599Brocchi S.: B-0555Broeders M.: B-0962Broeders M.J.M.: B-0841, B-0959, B-0960, B-0961,

B-0964

Broessner G.: B-0907Brookes J.: B-0130Brookfield H.: B-0608Brouwer P.A.: SY 19Brouwers B.M.W.: B-0317Brown D.: B-0060Bruce M.F.: B-0095Brück B.: B-0076, B-0952Bruners P.: B-0589Brunner P.: B-0307, B-0308Bruno O.: A-109Bruns C.: B-1036Bruns O.: B-1000Bruschini L.: B-1010Buccianti P.: B-0623Bucciarelli-Ducci C.: B-0856Bucerius J.A.: B-0120Buchan K.: B-0701Buchbender C.: B-0028, B-0159, B-0320, B-0500,

B-0501, B-0506, B-0552, B-0553, B-0651Buchholz M.: B-0117Buck F.: B-0187Buck F.M.: B-0181, B-0314Budde R.P.J.: B-0008, B-0721Buecker A.: B-1035Buerke B.: B-0190Buhk J.: B-0367Bühler K.: B-0618Bülow R.: B-0348Buls N.: B-0248, B-0580Bulski T.: B-0400Bunck A.: B-0806Bunke J.: B-0100Burck I.: B-0709Burger I.A.: B-0390Burgkart R.: B-0548Burke A.: B-0023Burkholder I.: B-0188, B-0481Burner A.: B-0281Burrel M.: A-116, B-0251Büsing K.A.: B-0865, B-0866Busoni S.: B-0086, B-0087Busse H.: B-0448Butler M.-L.: B-0606Buy X.: B-0309, SK 27

CCabassa P.: B-0424Cabibbo B.: B-0944Cabrera T.: B-0619Cacchiarelli E.: B-0941Cáceres J.: A-254Cademartiri F.: A-249Cadonici A.: B-0620Cadonici A.C.: B-0064, B-0254, B-0391Cai W.: B-0069Calabrese M.: B-0688Calabria L.F.: B-0518, B-0675Calamita V.: B-0127Calandriello L.: B-0021Calvisi V.: B-0930Camera L.: B-0454Campana R.: B-0786Campari A.: B-0770Camps Herrero J.: A-447, A-543Canale S.: A-027Canário N.: B-1021


275

Cândido S.: B-0603Canestrini S.: B-0572, B-0574Canevari C.: B-0801Cannaò P.: B-0741Cannavale A.: B-0300, B-0775, B-0920Cannavale G.: B-0466Canniff E.M.: B-0119Cano D.: B-0945Canosa C.: B-0002Cantone C.: B-0693Canu T.: B-0239, B-0449, B-0850Capalbo E.: B-0128, B-0956Capitolina L.: B-0140Caporilli Razza F.: B-0693Cappabianca S.: B-0057, B-0059Cappio S.: B-0769Cappucci M.: B-0691Capraro C.: B-0236, B-0391, B-0505, B-0620, B-0827Capuani S.: B-0085Capuano E.: B-0413Capunay C.: B-0257Caramella C.: A-433Caramella D.: A-575Carballido-Gamio J.: B-0043Carbonaro L.A.: B-0687, B-0814, B-0815Carbone I.: B-0464Carbone S.F.: B-0392, B-0941, B-0947Cardobi N.: B-0710Carette M.-F.: B-0538Carfagno T.: B-0947Cariati M.: B-0128Carner M.: B-0710Carrafiello G.: B-0531Carrascosa P.: B-0257Carreras M.S.: B-0724Carriço C.: B-0275Carroll P.A.: B-0216Cartes-Zumelzu F.W.: B-0907Cartocci G.: B-0174, B-0414, B-0427, B-0643, B-0644,

B-0645Caruso D.: B-0193, B-0661, B-0792, B-0793Carvalho A.: B-0278Casali V.: B-0453Casazza I.: B-0696Caseiro-Alves F.: A-070, A-122Casiraghi A.: B-0439Casiraghi A.S.: B-0783Casolo G.: B-0465Cassar-Pullicino V.N.: A-149, A-275, A-585Casselman J.W.: A-620Castañer E.: A-476Castelo-Branco M.: B-1021Castiello E.: B-0642Castrignanò A.: B-0453Castrillo A.: B-0724Castro C.J.G.: B-0212Casuscelli J.: B-0066Catala V.: B-0255Catalano C.: A-127, A-185, A-550, B-0089, B-0090,

B-0174, B-0238, B-0399, B-0414, B-0427, B-0453, B-0464, B-0466, B-0490, B-0643, B-0644, B-0645, B-0836, B-0979

Catalano O.: B-0233Cataldo M.: B-0246Catena V.: B-0691Cattin R.: B-0198, B-0616Caulo M.: B-0509, B-0930, B-1013Caumo F.: B-0818

Cava M.: B-0850Cavaciocchi M.: B-0642Cavagnetto F.: B-0688Cavallo Marincola B.: B-0399, B-0490, B-0643Cazals X.: B-0105Cazzato R.L.: B-0049, B-0179, B-0342, B-0939Ceelen F.: B-0803Cercato C.: B-0972Cerci R.J.: B-0006Cereser L.: B-0834, B-0835Cerini R.: B-0710Cervelli R.: B-0922Çetiner S.: B-0155Cevasco L.: B-0948Ceyssens S.: B-0432Chabrol A.: B-0890Chaibi Y.: B-0512Chakraborty S.: B-0756Chalian H.: B-0363, B-0615, B-0722Chamming’s F.: B-0335Chamuleau S.A.J.: B-0008Chan A.W.-H.: B-0441Chan H.L.-Y.: B-0441Chan H.-P.: A-508Chan O.: B-0184, B-0311Chandelier F.: B-0619Chandraharan E.: B-0498Chao M.: B-0036Charisiadi A.: B-0860Chateil J.-F.: A-525Chełstowska S.: B-1014Chen H.-W.: B-0126Chen M.: B-0259Chen S.: B-0571, B-0575Chen W.: B-0707Chen X.: B-0270, B-0883Chen Y.: B-0375Chersevani R.: B-0686Cheung Y.-C.: B-0931Chi D.: B-0390Chiaramida S.A.: B-0417Chiesa A.M.: B-0763Chin W.L.: B-0377Chiodi E.: B-0855Chipon E.: B-0429Chiti A.: B-0503, B-0507Chiti S.: B-0086, B-0087, B-0511Chiu C.-H.: B-0931Chiu S.H.: B-0649Cho H.R.: B-0739Cho H.Y.: B-0649Cho K.R.: B-0073Choe Y.H.: B-0418Choi B.I.: B-0202, B-0230, B-0830Choi B.W.: B-0418Choi C.G.: B-0067Choi H.J.: B-0494Choi J.-A.: B-0046, B-0784Choi J.H.: B-0521Choi J.W.: B-0269, B-0446, B-0831Choi S.H.: B-0513, B-0516, B-0739, B-0831Choi S.I.: B-0418Choi Y.A.: B-0826Chondrogiorgi M.: B-0406Choo K.S.: B-0364, B-1002Chou P.: B-0702Chouhan M.: B-0097Chow H.L.: B-0649

Chowdhury F.: B-0554Choy T.W.: B-0294Choyke P.L.: A-014, A-440Chrispijn M.: B-0988Christensen A.: B-0010, B-0351, B-0356, B-0357,

B-0750Christensen H.: B-0010, B-0351, B-0356, B-0357,

B-0750Christensen L.: B-0010Chu C.: B-0474Chu S.: B-0893Chu W.C.-W.: B-0441Chuck N.C.: B-0318Chung A.W.: B-0359Chung D.Y.F.: B-0423Churchill M.: B-0595Cianciulli P.: B-0468, B-0469, B-0579Ciatto (posthumous) S.: B-0818Ciccarese F.: B-0598, B-0763Ciccarone A.: B-1012, B-1018Cicciò C.: B-0397Cicorelli A.: B-0035, B-0922Ciet P.: B-0737Çifçi E.B.: B-0901Cimmino M.: B-0654Ciobanu L.: B-0201Cioffi Squitieri N.: B-0058, B-0194Ciolina F.: B-0174, B-0399, B-0490, B-0644Ciolina M.: B-0626, B-0796Cioni R.: B-0035, B-0922Cionini L.: B-0325Cirelli C.: B-0300, B-0775, B-0920Citone M.: B-0921Civitareale N.: B-0127Clarijs R.: B-0627Claßen T.: B-0782Claudon M.: A-108, A-485, A-583Claus F.: A-353Clauser P.: B-0132, B-0567, B-0568, B-0684, B-0811Claussen C.D.: B-0003, B-0004, B-0447, B-0504,

B-0923, B-1008Clavien P.-A.: A-144Clement A.: B-0738Clément O.: A-454, B-0335, B-0911Clement R.G.E.: B-0780Clevert D.-A.: B-0491, SY 23Clingman B.: B-0955Co S.J.: B-0632Çoban G.: B-0901Cobbold R.S.: B-0292Coche E.E.J.G.: MSY 1Cockmartin L.: B-0842Cohen-Bacrie C.: B-0094Colantoni C.: B-0585, B-0712Colantonio R.: B-1015Colas L.: B-0729, B-0731Colin C.: B-0559Colletti L.: B-0710Colletti V.: B-0710Collier Q.: B-0285, B-0286Collin D.: B-0781Colombo M.: B-0235, B-0832Colombo P.: B-0492Colosimo C.: B-1015Colucci A.: B-0712Como G.: B-0834, B-0835Concari G.: B-0532Conchiglia A.: B-0183


276

Conlon K.: A-144, A-148Conneely M.J.: B-0823Connolly E.M.: B-0216Cook V.: B-0595Cooper R.: B-0554Cópio R.B.J.: B-0875Coppenrath E.M.: B-0578Coppola V.: B-0518, B-0675Cornalba G.: B-0771, B-0925Cornalba G.P.: B-0770Cornelis F.: B-0176, B-0421Coro’ L.: B-0902Coroiu R.: Rising Stars Corona M.: B-0300, B-0775Corr A.: B-0564Corral J.F.: B-0222Correas J.-M.: B-0084, B-0110, SK 26Corso R.: B-0235, B-0236Cortines P.: B-0257Cortinovis S.: B-0262Corvol H.: B-0738Cosentino M.: B-0128Cossu E.: SK 27Costa S.: B-0874Costa Y.: B-0726Costantini E.: B-0183Costas M.: B-0185Costello P.: B-0266, B-0849Cotroneo A.: B-0509Cotroneo A.R.: B-0002, B-0127, B-0930, B-1013Cotten A.: A-314Cottier J.-P.: B-0105Cotton M.: A-262Coulon P.: B-0994Courcoutsakis N.: B-0115Couvelard A.: B-0576Cova L.: B-0646Cova M.A.: B-0762, B-0944, B-0972, B-0974Çöven I.: B-0901Cowan N.C.: A-305, A-379, B-0820Coy D.L.: B-0145Cras P.: A-306Creytens D.H.: B-0432Crienen S.: B-0083Crisp T.: B-0311Crispin A.: B-0975Cristeas N.: B-0919Crocetti L.: SK 27Croisille P.: A-371Cros J.: B-0576Crosara S.: B-0572, B-0574Crush L.: B-0119Crystal P.: B-0219Csatari Z.: B-0361Cuccia A.: B-0438Cuenod C.-A.: B-0335, B-0911Cuevas C.: B-0095Culebras J.: B-0690Cunha G.: B-1021Cunningham J.D.: B-0564Curcio G.: B-0020Curda M.: B-0563Curvo-Semedo L.: A-009Cuttin R.: B-0762Ćwikła J.B.: B-0400Cyran C.C.: B-0068, B-0846, B-1036Czarnecka A.: B-0847

Czerny C.: B-0328, B-0719Członkowski M.: B-0153

DDa Dalt S.: B-0132Dadnam C.: B-0256Dadrich M.: B-0523Daemen M.J.A.P.: B-0116, B-0118Dahlman P.: B-0177D’Aiuto M.: B-0217Dal Bello B.: B-0092Dal Col A.: B-0687Dal Corso M.: B-0479Dalal P.: B-0030Dallaudiere B.: B-0310D’Ambrosio I.: B-0182Damilakis J.: A-051, B-0611, B-0996Damm J.: B-0750D‘Anastasi M.: B-0800Daneshi M.: B-0976Danquah W.: B-0882Danse E.: A-196, B-0987, SY 23Danza F.M.: A-351Dao T.-H.: B-0459Daouk J.: A-268Dappa E.: Rising Stars Darai E.: A-553D’Arco F.: B-0510Darnell A.: B-0704Das M.: B-0029, B-0065, B-0261, B-0264, B-0746D‘Assignies G.: B-0576Dastidar P.: B-0017David P.: B-0464, B-0466David V.: B-0691, B-0693, B-0696, B-0921Davies N.: B-0097Davis Z.: B-0780de Baere T.: A-490De Belder F.: A-131, A-264, A-346, A-365, A-556De Bock G.H.: B-0291, B-0560de Boer R.: B-0014, B-0016, B-0402de Bondt R.B.-J.: A-621De Bondt T.: B-0285, B-0286de Booij M.: B-0627, B-0965de Bruijne M.: B-0163, B-0737de Buck S.: B-0915De Bucourt M.: B-0306De Cecco C.N.: B-0626, B-0704, B-0792, B-0796De Cobelli F.: B-0239, B-0369, B-0440, B-0449,

B-0585, B-0712, B-0769, B-0801, B-0850De Cobelli O.: B-0082, B-0503de Feijter P.J.: B-0410, B-0415de Feyter P.: B-0663de Feyter P.J.: B-0413De Filippo M.: B-0532De Foer B.: A-588, A-620De Gaetano A.M.: B-0323de Groot M.: B-0014de Jong P.A.: B-0027, B-0291, B-0297, B-0299,

B-0610, B-0721De Jonge M.C.: A-362de Kerviler E.: A-103, A-298De Keyzer F.: B-0152, B-0510, B-0804de Koning H.J.: A-064De la Peña E.: B-0690de Lange C.E.: A-469de Liguoro M.: B-0325de Maertelaer V.: B-0053, B-0520

De Meerleer G.O.: B-0088de Mey J.: B-0248, B-0580de Mol B.A.J.M.: B-0008De Oliveira D.S.: B-0645De Paepe K.N.A.: B-0152De Paoli L.: B-0944de Perrot T.: B-0970De Robertis R.: B-0572, B-0574de Rooij M.: B-0083de Roos A.: A-039, A-250De Ruysscher D.: B-0065De Santis M.: B-0231, B-0237De Schepper A.M.: B-0432De Vathaire F.: B-0559de Villiers P.: B-0130De Visschere P.J.: B-0088De Vivo A.E.: B-0468de Vos L.C.: B-1001de Vries B.: B-0212de Vries W.B.: B-0734de Wall C.: B-0165, B-0166De Wever L.: A-353De Wever W.F.M.: A-382Deák Z.: B-0243, B-0472Deandreis D.: A-432DeBlois F.: B-0245deBucourt M.: B-0539Debus A.: B-0865, B-0866Decallonne B.: B-0152Deckert A.: B-0447Decoster R.: B-0997Dedic A.: B-0410Dedouit F.: A-474Deferme F.: B-0285, B-0286Defez D.: B-0994Dehghan A.: B-0402Dekkers C.: B-0486del Ciello A.: B-0021del Cura J.L.: A-024, A-187Del Maschio A.: B-0239, B-0440, B-0449, B-0585,

B-0712, B-0769, B-0801, B-0850, SY 16Del Meglio I.: B-0465Del Monte M.: B-0238, B-0836Del Vescovo R.: B-0049, B-0179, B-0342, B-0939Delakis I.: B-0839Delavaud C.: B-0576Delgado C.: B-0631D’Elia D.: B-0392Della Bella P.: B-0585Delmas V.: B-0694DeMarchi G.: B-0531Demers V.: B-0619Demeter Z.: Rising Stars Demirci A.: B-0908Demozzi E.: B-0572den Dekker M.A.M.: B-0588, B-1001den Heeten G.: B-0962den Heeten G.J.: B-0959, B-0960, B-0961, B-0964Dendl L.-M.: B-0725Denecke T.: A-056, A-318Denjoy N.: EIBIRDenys A.: A-189, A-431Depeursinge A.: B-0281Deray G.: SY 14Derchi L.E.: A-495, A-580, B-0974Derderian V.M.: B-0209Deroose C.M.: A-603


277

D’Errico I.: B-1012, B-1018Desai S.R.: A-238Desbiolles L.: B-0660Deschamps F.: A-433, A-490, SK 26Deseive S.D.C.: B-0372Deserno W.: B-0625Desgranges P.: B-0924deSouza N.M.: A-096Detante O.: B-0355Dettmer S.: B-0165, B-0166, B-0768Dettori E.: B-0791Deux J.-F.: B-0924Devaraj A.: B-0299Dewan S.: B-0041Dhar A.: B-0331Dharampal A.: B-0413, B-0663Dharampal A.S.: B-0410, B-0415, B-0661Di Benedetto F.: B-0231, B-0237Di Biase L.: B-0407Di Cesare E.: B-0378Di Clemente L.: B-0930Di Gaetano E.: B-0567Di Giammarco G.: B-0002Di Giampietro I.: B-0468, B-0469, B-0579Di Gianfrancesco E.: B-0002Di Girolamo M.: B-0691, B-0693, B-0696Di Lelio A.: B-0439Di Lella G.M.: B-1015Di Leo G.: B-0545, B-0654, B-0687, B-0814, B-0815,

EuroAIMDi Luzio M.: B-0378di Maggio C.: B-0686Di Marco D.: B-0268DI Mare L.: B-0427Di Martino M.: B-0238, B-0836, B-0979Di Miscio R.: B-0238, B-0836Di Mizio R.: B-0057Di Nicola M.: B-0712Di Paolo P.L.: B-0689Di Perri C.: A-422Di Pietro E.: B-0598Di Rosa E.: B-0769Di Sibio A.: B-0378Di Stasio F.: B-0378Diano D.: B-0316Dias M.: B-0138Dibenedetto A.: B-0397Dichgans M.: B-0113, B-0117, B-0353Diciotti S.: B-0465Diebold B.: B-0007Diederich S.: A-003Diederichs G.: B-0936Dietrich C.F.: B-0232Dietrich O.: B-1036Dietrich S.: B-0366, B-0522, B-0703Dietzel M.: B-0074, B-0075, B-0077, B-0079, B-0457,

B-0614, B-0679, B-0808, B-0895Díez-Valle R.: B-0514Dijkstra A.E.: B-0164Dijkstra H.: B-0442Dijkstra J.: B-0208Dill K.: B-0524Ding S.: B-0277Ding Z.-X.: B-0271, B-0276, B-0742Dinter D.: B-0628Dirksen A.: B-0163Djemai B.: B-0201

Djilas D.: B-0812Djuric N.: B-0273Do S.: B-0917Dobritz M.: B-0525Dobryinina L.: B-0365Doeswijk G.: B-0887Doğan Ö.T.: B-0587Dohi K.: B-0581Dolman K.M.: B-0593Dombrovsky V.: B-0695Domengie F.: B-0105Domey J.: B-0886Domingo Montañana M.L.: B-0168Dominguez A.: B-1033Dominguez O.: B-0211Dominguez P.D.: B-0514Donagh C.: B-0823Donati F.: B-0577Donati O.F.: B-0390, B-0697Dong S.: B-0368Dönmez F.Y.: B-0155Donner R.: B-0147D‘Onofrio M.: B-0572, B-0574Donoso L.: A-279Doo K.W.: B-0433, B-0528Doratiotto S.: B-0131, B-0382Dores R.: B-0607Dörfler A.: A-308, B-0614, B-0895Dormont D.: B-0512Dornbluth N.C.: B-0955Dorr K.: B-0858Dorrius M.: B-0295, B-0298Doss M.: B-0669Dou S.: B-0517Douek P.C.: B-0994Dousset V.: A-166Dowlatshahi D.: B-0756Doyan F.: B-0628Draenkow C.: B-0766Dragean A.: A-196Drapé J.-L.: B-0650, B-0786Drenth J.P.H.: B-0988Dreval M.: B-0365Driessen M.M.P.: B-0005Dromain C.: A-027, A-433Drop A.: B-0153Drougia A.: B-0860, B-0862Drumm O.M.: B-0184, B-0437Duarte S.: B-0822Düber C.: B-0420Duchatelle V.: B-0837Ducic T.: B-1000Ducou Le Pointe H.: B-0738, B-0867, B-0911Dudás I.: B-0982, B-0983Duerr H.R.: B-0547Dugar N.: A-577Duijm L.E.M.: B-0960, B-0961, B-0963Duke D.: B-0564Dumortier J.: B-0094, B-0444Duprez T.P.J.: A-309Duran C.: B-0141Durand P.: B-0429Durmus T.: B-0374Dustler M.: A-507Duvivier K.M.: B-0072

EEastham J.A.: B-0697Eben E.B.: B-0817Eberhardt K.M.: B-0927, B-0928Eberl S.: B-0790Eberli D.: B-0318Ebersberger U.: B-0263, B-0411, B-0417, B-0419,

B-0849Echano J.: B-0809Eckersly R.J.: B-0973Eckstein F.: B-0483Edjlali-Goujon M.: A-283Edward S.: B-0431Efendi H.: B-0908Egbers N.: B-0172Ege M.R.: B-0587Eggers H.: B-1007Eggesbø H.B.: A-519Eibel R.: A-033Eiber M.: B-0322Eichinger M.: B-0162Eichler K.: B-0033, B-0170, B-0398Ekseth U.: B-0817El Ghazaly H.A.: B-0452Elandoy C.: B-0277Elangovan S.: B-0692Elbadawy M.: B-0949Elgert M.: B-0740Elhai M.: B-0650Elias S.G.: B-0218Elie C.: B-0110Elie S.: B-0841Elizalde A.: B-0685, B-0813, B-0966El-Koussy M.: B-0752Elmahdy M.H.I.: B-0906El-Rabadi K.: B-0802ElShafaey A.: B-0713Emanuele E.: B-0267Emich H.: Rising Stars Endozo R.: B-1003Enescu I.: A-043, A-442, A-557, B-0309Enescu M.: B-0070Engelhorn T.: A-206, B-0895Engelke C.: A-560England A.: A-466, B-0608Enskär K.: B-0380Entezari P.: B-0363Epifanio M.E.: B-0590Erb K.: B-0324Erbay K.D.: B-1023Erbay N.: B-1023Erbay S.H.: B-1023Erbel R.: B-0584Erdogan Sendur B.: B-0899Erhard K.: B-0843Errante Y.: B-0020, B-0407Ertl-Wagner B.: A-085 A-278, B-0106Eskola H.: B-0017Espinosa N.: B-0181, B-0314Espinoza-Boireau S.: B-0473, B-0714Esposito A.: B-0239, B-0449, B-0585, B-0850Esposito M.: B-1012, B-1018Essig M.: A-203, A-347, B-0151Eteiba S.: B-0150Etxano J.: B-0143, B-0514, B-0685, B-0778, B-0813,

B-0900, B-0945, B-0966Eun B.: B-0221


278

Euringer W.: B-0361Eustace S.J.: A-361, B-0437Evans A.: B-0332Evert M.: B-0445Ewing F.: B-0060

FFabbro E.: B-0186Facchetti L.: B-0705Facchini G.: B-0555, B-0598, B-0642Fachechi R.: B-0268Faggioni L.: A-607, B-0623, B-0698, B-1010Faiella E.: B-0179Faivre J.-B.: B-0376, B-0519, B-0630, B-0731Faivre S.: A-020, A-358Falaschi F.: B-0577Faletti C.: A-598Faletti R.: B-1033Falini A.: A-423Falk V.: B-0660Fallenberg E.: A-027Fallenberg E.M.: Falzon C.: B-0873Fanelli F.: A-246, B-0300, B-0775, B-0920Fanti S.: B-0555Fantozzi L.M.: B-0518, B-0675Farghaly H.R.S.: B-0906Farina D.: A-521, B-0203, B-0204, B-0478Farouil G.: A-490Farras Roca J.A.: B-0459Farrell T.P.: B-0216Fascetti E.: B-0493Faulhaber P.: B-0326Fausto A.: B-0682Fedeli M.P.: B-0814Federici M.: B-0518Feenstra T.: B-0560Feier D.S.: B-0096Feigenberg S.: B-0023Feignoux J.: B-0370Feletti F.: B-0763Felli V.: B-0378Fellner C.: B-0903, B-0985Feng S.S.J.: B-0840Feragen A.: B-0163Ferda J.: B-0358Ferencik M.: B-0917Ferguson D.: B-0823Fernandes C.L.D.C.: B-0274Fernandes L.: B-0175Fernandes T.: B-0877Fernandez del Valle A.: B-0631Fernandez Fabrellas E.: B-0168Fernández L.: B-0185Fernandez-Bayó J.: A-606Fernando S.: B-0051Ferraioli G.: B-0092, SY 23Ferranti C.: B-0561, B-0956Ferrari F.: B-0493Ferrari P.: B-0108Ferrari V.: A-049Ferraro S.: B-0267Ferraroni F.: B-0203Ferré R.: B-0786Ferreira C.: B-1021Ferrero G.: B-0186Ferretti G.R.: A-240

Ferri A.: B-0127Ferrière J.-M.: B-0176Feuchtner G.M.: B-0907Feydy A.: B-0650, B-0786Feygin T.: B-0864Fiehler J.: B-0354Fierens Y.: B-0580Figueiral A.: B-0970Fijnheer R.: B-0550Filatov A.: B-0206Filice C.: B-0092, SY 23Filice S.: B-0217Filipe T.R.: B-1020Filippiadis D.: B-0530Fill S.: B-0112, B-1006Fingerle A.A.: B-0525Fink C.: B-0022, B-0160, B-0265, B-0352, B-0889Finkenzeller T.: B-0903Fiocchi F.: B-0349, B-0462, B-0463Fior D.: B-0505, B-0783, B-1005Firouznia K.: B-0220Fischer A.: B-0347, B-0708, B-1038Fischer M.A.F.: B-0314Fischer R.: B-0315, B-0578Fischer T.: Fishman E.K.: A-123Fitoussi V.: B-0335FitzGerald R.: A-293Fitzke H.: B-0207Flaction L.: B-0869Flavian A.: B-0460, B-0461Flechsig P.: B-0200Fleming R.: B-0219Fleming S.: B-0554Flohr T.: B-0263, B-0372Floridi C.: B-0531Foderà E.: B-0058Fodero G.: B-1031Fodor C.: B-0503Fokin V.: B-0833 Foldyna B.: B-0260Foley S.: A-392, B-0272, B-1028Folio L.R.: B-0209Fonda C.: B-1012, B-1018Fondevila J.J.: B-0724Fonio P.: B-1033Fontana F.: B-0531Foray N.: B-0559Foresti D.: B-0925Formenti A.: B-0262Fornari S.: B-0128Fornasa F.: B-0397Forner Giner J.: B-0403Förnvik D.: A-507Forrai G.: A-297Forsting M.: B-0028, B-0320, B-0347, B-0456,

B-0501, B-0506, B-0552, B-0553, B-1011, B-1038Forstner R.: A-410Forte V.: B-0089, B-0090Foschi M.: B-0002Foti G.: B-0045Foti P.: B-0307, B-0308Fouad R.M.K.: B-0949Fournier L.S.: B-0335Fraile Moreno E.: A-113Franchi-Abella S.: B-0110Franco O.H.: B-0111

Francone M.: A-202, B-0464, B-0466, Rising StarsFrandon J.: B-0429Franiel T.: B-0172Franklin J.M.: B-0062, B-0070, B-0624Franquet T.: A-335Fransen H.: SY 19Franzoni E.: B-0598Fratto P.: B-0925Fredenberg E.: B-0843Frei P.: B-0198Freire V.: B-0650Freitas V.: B-0219Freling H.G.: B-0005Frellesen C.: B-0633, B-0700, B-0723Freund B.: B-1000Freyschmidt J.: A-589Friedrich K.M.: B-0488Fries P.: B-1035Frigerio A.: A-155Frindel C.: B-0890Fritsche K.H.: B-0151Frittoli B.: B-0791, B-0794Fritz S.: B-0178Froehlich J.M.: B-0198, B-0616, B-0819Fronda M.: B-1033Frouin F.: A-216Frustaci A.: B-0466Fu J.-H.: B-0225Fucentese S.F.: B-0938Fuchs S.: B-0189Fuchsjäger M.H.: A-610, B-0667, B-0858, B-0914,

SK 27Fugazzola C.: B-0531Füger B.: B-0502Fujii K.: B-0338, B-0339Fujii T.: B-0674Fujisawa Y.: B-0293Fujita M.: B-0581Fukutomi T.: B-0338, B-0339Fung V.K.: B-0474Furmanek M.: B-0852Furtner J.: B-0328, B-0719Fusco R.: B-0217, B-0942Fütterer J.J.: A-378, A-424

GGabata T.: B-0984Gabrylewicz T.: B-0400Gadda D.: B-0511Gaens M.E.: B-0116Galanaud D.: A-503, B-0512Gale A.G.: A-271Galea N.: B-0464Gallagher F.A.: A-015Gallix B.: A-592Gallucci M.: A-042Gallusi G.: B-0238Galvez M.: A-406Gamhewage G.: A-387Ganai B.: Rising StarsGandini G.: B-1033Ganeshan B.: B-0205, B-0943, B-1003Gangemi E.: B-1015Gangi A.: A-043, A-442, A-557, B-0309Ganter C.: B-0098, B-0435Gao H.: B-0883Garambois K.: B-0355


279

Garcarek J.: B-0744García del Barrio L.: B-0143Garcia Lallana A.: B-0809, B-0810Garcia Marti G.: B-0403García P.: B-0900Garcia Parra C.: B-0785García-Eulate R.: B-0514Garcia-Valiente A.: B-0122Gardelli G.: B-0763Garel C.: A-121, B-0867Garello I.: B-0197Garlaschi A.: B-0197, B-0948Garlaschi G.: B-0654Garnon J.: A-043, A-442, A-557, B-0309Garnov N.: B-0448Gartland N.: B-0299Garzillo G.: B-0640Garzón G.: B-0124Gasparini A.: B-0397Gasparotti R.: A-074Gaßmann P.: B-0125Gatidis S.: B-0504Gaubert J.Y.: B-0460, B-0461Gaudino S.: B-1015Gawlitza M.: B-0158, B-0558Ge M.: B-0897Gebauer B.: A-320, B-0189, B-0306Gee A.H.: B-0658Geers-van Gemeren S.: A-191Geerts L.: B-1007Geertse T.D.: B-0964Geffroy F.: B-0201Geiger B.: B-0028, B-0320Geiger D.: B-0836Geiger J.: B-0736Geijer H.: B-0825Geijer M.: B-0653, B-0781Geith T.: B-0547Geldof M.: B-0285, B-0286Gelot A.: B-0867Gencturk M.: B-0908Gennarelli A.: B-0378Gennari A.: B-0944Gennaro G.: A-505, B-0686Gennisson J.-L.: B-0335George R.T.: B-0006Georgoulis A.: B-0929Gerevini S.: A-161Germann T.: B-0265Geschwind J.-F.: A-273Gevenois P.A.: B-0053, B-0520Gevers T.J.G.: B-0988Gey S.: B-0694Geyer L.: B-0411, B-0472Geyer L.L.: A-221, A-413, B-0849Ghai S.: B-0219Ghanaati H.: B-0220Ghaye B.: A-561Ghedi M.: B-0791Gherarducci G.: B-0577Ghoncheh Z.: B-0477Giani G.: B-0100Gianolli L.: B-0801Giardina G.G.: B-0902Giardino A.: B-0545Gibaud B.: A-050Gibon E.: B-0786

Gibson R.N.: A-023Gidding C.: B-0672Gielen J.L.: B-0480Gielen J.L.M.A.: B-0432Giesel F.L.: B-0200Giganti F.: B-0801Giglio M.: B-0268Gigoni R.: B-0577Gil A.R.: B-0724Gil R.: B-0852Gilbert F.J.: A-156, A-225Gilca G.-E.: Rising Stars Gilhuijs K.G.A.: B-0218Gillams A.R.: A-489Gillard J.H.: A-241Giona A.: B-0020, B-0407Gioppo A.: B-0770Giordano A.V.: B-0378, B-0493Giordano G.P.: B-0511Giravent S.: B-0436Girometti R.: B-0132, B-0567, B-0568, B-0684,

B-0811, B-0834, B-0835Giuffrida G.: B-0855Giuliani P.: B-0182Giurazza F.: B-0049, B-0179, B-0342, B-0939Gjesteby L.: B-0036Glaser C.: A-152Glatz J.: B-0853Gleeson F.: A-004, A-443Gleeson F.V.: B-0062, B-0070, B-0423, B-0624Glick Y.: B-0129Glowacki M.: B-0489Glüer C.C.: B-0436Glynne- Jones R.: B-0943Gockner T.: B-0178Goffette P.P.: A-341Goh K.L.: B-0422Goh V.: B-0943Goh V.J.: A-010, A-171, B-0946Göke B.: B-0795Golay S.: B-0373Goldberg N.S.: B-0646Golding S.J.: A-022Goldman D.: B-0697Golsäter M.: B-0380Golubnitschaja O.: A-326Gombos E.: B-0080Gomes F.V.: B-0726Gómez-Ansón B.: A-222, Rising StarsGonçalves C.: B-0872Gondek T.M.: B-1016Gong Q.: B-0018Gonzalez Crespo I.: B-0945Gonzalez Graniel K.: B-0737Gonzalez-Calvin J.L.: B-0099Gonzalez-Guindalini F.D.: B-0363, B-0524, B-0615,

B-0722Goo J.M.: B-0026Gooßen A.: B-0843Goraj B.: B-0672Gorbunov N.: B-0764Gore R.M.: A-090Gori C.: B-0086, B-0087Göthlin J.H.: B-0781Gottlieb I.: B-0006Gottlieb P.: B-0227Gouda I.: B-0949

Gourtsoyianni S.: A-008, A-071, B-0943Gourtsoyiannis N.: A-138Gräbeldinger M.: B-0548Grabellus F.: B-0782Grabherr S.: A-473Gradkowski W.: B-0489Graef A.: B-0161, B-0634, B-0638Gräfe S.: B-0885Graham J.W.: B-0051Graif M.: A-282Gralla J.: B-0752Gramer B.: B-0586, B-0912Granata C.: B-0730, B-0990Granata R.: B-0907Granata V.: B-0233, B-0942Grande Garcia E.: B-0548Grant D.: Rising Stars Graser A.: A-481, B-0066, B-0288, B-0795, B-0800Grass M.: A-337Grassedonio E.: B-0854, B-0855Grassi R.: B-0057, B-0059Grasso D.: B-0904Grasso R.F.: B-0049, B-0179, B-0342, B-0939Graw M.: B-0727Grazioli L.: B-0791, B-0794Green S.M.: B-0932Greiner M.: A-624Greiser A.: B-0667, B-0858, B-0914Gremizzi C.: B-0440Grenacher L.: B-0629Grenier N.: B-0176Greuter M.J.W.: B-0291, B-0560, B-0664, B-0666,

B-0918Greutmann M.: A-322Griffin M.: B-0216Griffith J.F.: B-0042Grimm J.: B-0144, B-0243, B-0472Grischenko V.I.: SY 20Grisi G.: B-0762Griswold M.A.: B-0668Gritzmann N.: A-579Groen H.J.M.: B-0164, B-0291Groen J.M.: B-0666, B-0918Groth M.: B-0367Grothoff M.: B-0851, B-0909Groves A.M.: B-0205, B-1003Gruber S.: B-0071, B-0076, B-0953Gruber-Rouh T.: B-0031, B-0033, B-0398, B-0536,

B-0774Grueneisen J.S.: B-0456Grünhagen T.: B-0924Gruszczynska K.: B-0413Grutters J.P.C.: B-0083Guenoun J.: B-0887Guerini H.: B-0786Guermazi A.: B-0656, B-0932Guerrini S.: B-0058, B-0194Guggenberger R.: B-0187, B-0482Guglielmi G.: A-471Gui B.: B-0323, B-0395Guibal A.: B-0094Guidotti L.G.: B-0239Guillaud O.: B-0444Guindani M.: B-0319Gul K.: B-0718Gullien R.: B-0139, B-0388, B-0817, B-0870Gulsun M.A.: B-0667, B-0914


280

Gümüş C.: B-0587Günther A.: B-0436Guo C.-Y.: B-0954Guo J.: B-0896Guo W.: B-0368Guo W.Y.: B-0543Guo X.: B-0806Gupta A.: A-552, B-0199Gupta H.: B-0431, B-0779Gupta R.: B-0573Gupta R.T.: B-0728Gusenburg J.: B-0656Gutberlet M.: A-091, A-321, B-0260, B-0851, B-0909Guven K.: B-0838Guzinski M.: B-0744, B-0847Gwon D.-I.: B-0499Györke T.: B-0982

HHa Y.R.: B-0052Haab F.: A-553Haag F.: B-0882Haakenaasen U.: B-0817Haakull A.E.: B-0139, B-0388, B-0870Haberkorn U.: B-0200Haberland U.: B-0022, B-0240, B-0676Habets J.: B-0008, B-1007Habib N.: B-0773Habrecht H.: B-0077, B-0808Habs M.: B-0353Hadamitzky M.: B-0372Hadaschik B.A.: A-059Haddad S.: B-0538Haedicke K.: B-0885Haensig M.: B-0260Hagelstein C.: B-0865, B-0866Hågemo K.: B-0967Hagiwara N.: B-0986Hahn D.: B-0001Hahn G.: A-397Hahn O.: B-0982, B-0983Hahnemann M.L.: B-1011Haimerl M.: B-0985Hakky M.: B-0037, B-1023Halder J.L.: B-0074, B-0075Halimi P.: B-0473, B-0714Halliburton S.: B-0371Halligan S.: B-0789Halligan W.T.: B-0417Halpern Z.: B-0978Halter R.: B-0768Hambly N.: B-0564Hamed W.: B-1025Hamidavi Y.: B-0034, B-0040Hamilton M.: A-512Hamilton M.C.K.: B-0527, B-0856Hamm B.: A-207, A-316, B-0172, B-0189, B-0306,

B-0324, B-0539Hammadouche M.: B-0786Hammel P.: B-0576Hammerstingl R.: B-0031Hammond R.L.: B-0870Hampshire T.E.: B-0789Hamy V.: B-0207Hamza H.: B-0123Han D.H.: B-0637Han J.: B-0025

Han J.H.: B-0296Han J.K.: B-0202, B-0230, B-0830Handayani A.: B-0442Handler M.: B-0916Handschel J.: B-0159Haneder S.: B-0343, B-0345Hanelore H.A.: Rising Stars Hannaford N.: B-0144Hanning U.: B-0125, B-0898Hannon M.J.: B-0932Hansen A.E.: B-0102Hansen C.: B-0351, B-0356, B-0357Hansmann A.: B-0199Hansmann J.: B-0829Hany T.F.: A-158Hara T.: B-0777Hardy M.: B-0134, B-0383, B-0389Hari S.: B-0331Harirchian M.H.: B-0220Harmath C.B.: B-0524Harris G.: B-0069Harth M.: B-0033, B-0709, B-0711, B-0723Hartmann A.: SY 4Hartung H.-P.: B-0905Hartung-Knemeyer V.: B-0028, B-0500, B-0501,

B-0506, B-0552, B-0553Hartwig T.: B-0306, B-0539Hasdemir D.B.: B-0038Hashemi Amroabadi S.: B-0292Hashemi H.: B-0220Hashimoto T.: B-1029Hassan C.: A-481Hatzidakis A.A.: A-339, A-445Hauben E.: B-0152Haubenreisser H.: B-0022, B-0160, B-0352, B-0889Hauge M.: B-0870Hauger O.: B-0307, B-0308Hausegger K.A.: A-441, B-0224Hauser T.: B-0151Hausleiter J.: B-0372Hausmann D.: B-0628Hausmann R.: Hausotter K.: B-0999Haustermans K.: A-174Hauth E.A.: B-0456Havla L.: B-1036Havsteen I.: B-0351, B-0356, B-0357Hawkes D.J.: B-0789Hayakawa K.: B-1017Hayashi D.: B-0656, B-0932Hayirlioglu A.: B-0362He B.: B-0375Hedges W.P.: B-0385Heeneman S.: B-0116Hegenscheid K.: B-0348, B-0445, B-0681Heidbuchel H.: B-0915Heijnen L.: B-0940Heijnen L.A.: B-0625Heikkilä P.: B-0135Heilmeier U.R.: B-0483, B-0484, B-0529Heindel W.: B-0125, B-0898Heindel W.L.: B-0190, B-0805Heinemann V.: B-0800Heinz-Peer G.: A-030, A-302Helal M.H.: B-0949Helbich T.: B-0076, B-0953

Helbich T.H.: A-064, A-228, B-0071, B-0171, B-0502, B-0562, B-0563, B-0950, B-0951, B-0952

Helbren E.: B-0789Helck A.: B-0117, B-0288Helck A.D.: B-0344Hélénon O.: A-032, B-0084Hellenthal F.A.M.V.: B-0253Heller M.: B-0436Helmberger T.: SK 27Hemke R.: B-0593Hendrick E.R.: B-0686Hendrikse J.: B-1007Henes F.O.: B-0367Henes F.O.G.: B-0765, B-0935Henner A.: B-0135Hennig J.: EIBIRHenninger B.: B-0343Henninger M.: B-0525Henriksson L.: B-0287Henry S.: B-0519, B-0630, B-0731Hensor E.: B-0431Henzler T.: B-0022, B-0160, B-0265, B-0289, B-0352,

B-0848, B-0889Herbreteau D.: B-0105Herbrik M.C.: B-0028Herédia V.: B-0822, B-0971Hereren J.: B-1000Herh S.J.: B-0715Hermans J.: SY 18Hermans R.: A-118, B-0152Hermeling E.: B-0118Hernando D.: B-0445Herold C.J.: A-089, B-0719Herrero J.I.: B-0778Herrmann K.: B-0326Herten M.: B-0487Hertin U.: B-0149Herzen J.: B-0112, B-1006Herzog C.: B-0266Herzog D.: B-0955Herzog P.: B-0491Hesselink M.K.C.: B-0317, B-0853Hesselmann V.: B-0898Hetterich H.: B-0112, B-0113, B-1006Heusch P.: B-0159, B-0252, B-0320, B-0340, B-0366,

B-0501, B-0522, B-0552, B-0553, B-0648, B-0703Heusner T.: B-0456, B-0552Heusner T.A.: B-0028, B-0159, B-0320, B-0366,

B-0501, B-0506, B-0553Heussel C.-P.: A-334, B-0162, B-0200, B-0766Heuts E.M.: B-0212Heuvelmans M.: B-0295Heuvelmans M.A.: B-0291Hewlett R.: A-259Hey C.: B-0711Heye T.: B-0728Heywang-Köbrunner S.H.: SY 5Hietschold V.: B-0101Hildebrandt K.: B-0582Hilger I.: B-0885, B-0886Hill E.J.: B-0062, B-0070Hillengass J.: A-300Hiller N.: B-0591Hillman B.J.: A-277Himmelreich U.: B-0510Hindricks G.: B-0909Hinzer C.: B-0967


281

Hipp A.: B-0112Hirai T.: B-0336Hirner H.: B-1036Hirota H.: B-1017Hirsch J.: B-0523Hirschmann A.: B-0048, B-0181Hirtler D.: B-0736Hitendu D.: A-322Hiwatashi A.: B-0515, B-0673, B-0678Hizhnyak A.: Rising Stars Hladuvka J.: B-0618Ho G.F.: B-0422Hoare T.: SY 24Hodek R.: B-0938Hodgkinson J.: B-0299Hoffmann C.: A-087Hoffmann E.: B-0586Hoffmann J.: B-0909Hoffmann P.: A-245Hoffmann R.-T.: B-0195, B-0491Hoffmann U.: B-0917Hoffmann V.: B-0113Hofman A.: B-0014, B-0016, B-0111, B-0114, B-0350Hofmann B.: B-0878Hogenauer H.: B-0629Hogeweg L.: B-0761Hogg P.: A-524Höglund P.: B-0892Hohmann J.: B-0130, B-0232Höink A.J.: B-0805Hojgaard L.: B-0102Holc T.: B-0273Holland R.: B-0964Holli K.K.: B-0017Hollmann M.W.: B-0790Holm S.: B-0102, B-0275Holscher H.C.: B-0597Holzapfel K.: B-0098Holzer M.: B-0147Holzhey D.: B-0260Homann G.: B-0125, B-0898Homolka P.: B-0950, B-0951Hompes D.: A-353Honda H.: B-0515, B-0673, B-0678Hong S.H.: B-0046Hoppe H.: A-538Horasanlı B.: B-0901Horner K.: A-338Hörnig M.: B-0950, B-0951Horvath E.: A-404, B-0982Hosten N.: B-0146, B-0348, B-0445, B-0681Hou D.: B-0632Houssami N.: A-130, B-0560, B-0818Houston G.C.: B-0894Howarth N.: A-419Howe T.S.: B-0659Hribar D.: B-0273Hricak H.: A-061, A-124, B-0390, B-0689Hrynchyshyn N.: B-0007Hsieh K.W.-V.: B-0752Hsu S.-H.: B-0225Huang D.: B-0976Huang D.Y.: B-0973Huang X.: B-0018, B-0883Huber A.: B-0912Huber A.M.: B-0586, B-0881Huber R.M.: B-0578

Hübler M.: A-322Hueper K.: B-0768Huete A.: A-408Hüllner M.: B-0156, B-0157Hummel N.: B-0288Hünerbein R.: B-0740Hung S.C.: B-0543Hunink M.G.M.: EuroAIMHunold P.: B-0584Hunter D.J.: B-0656Husmark T.: B-0653Hutt A.: B-0376Huwart L.: B-0307, B-0308Hwang H.K.: B-0269Hwang J.: B-0428Hwang J.-H.: B-0100Hwang K.-W.: B-0073Hwang S.M.: B-0494

IIacoban C.G.: Rising Stars Iacobellis F.: B-0057, B-0059Iacobucci M.: B-0323Iacopi E.: B-0922Iacucci I.: B-0464Iafrate F.: B-0626, B-0796Iannitti M.: B-0796Ibarburen C.: B-0810Ibrahim M.I.M.A.: B-0425Ichikawa S.: B-0093Ichikawa T.: B-0093, B-0777, B-0977Ierace T.: B-0646Ierardi A.M.: B-0531Iero L.: B-0598Iershova I.: B-0735Iezzi R.: A-355, B-0369Ifeakor E.: B-0299Iima M.: B-0201Ikram M.A.: B-0014, B-0016, B-0114, B-0350, B-0402Ikuye K.: B-0412, B-0583Ilangovan R.: B-0199Illing R.: SK 27Illomei G.: B-0313Ilyas S.: B-0821Im T.S.: B-0046Imai Y.: B-0777, B-0977Imanzadeh A.: B-0069Imbriaco G.: B-0058Imlau U.: B-0034, B-0040Imura M.: B-0470in ‘t Hout J.: B-0959Inácio M.: B-0275İnci M.F.: B-0055, B-0587, B-0718, B-1034İnci R.: B-1034Indovina L.: B-0772Ingorokva S.: B-0907Ingrisch M.: B-0344, B-0846, B-0975Inokawa H.: B-0526Invernizzi I.: B-0492Ionasec R.: B-0263Iotti V.: B-0349Ippolito D.: B-0064, B-0235, B-0236, B-0254, B-0391,

B-0438, B-0439, B-0505, B-0596, B-0620, B-0745, B-0783, B-0787, B-0827, B-0832, B-1005

Ironi G.: B-0449Irzyk M.: B-0009Isaacs A.: B-0114

Isberg B.: B-0109Iselin C.: B-0970Ishida M.: B-0581Ishiguchi T.: B-0338, B-0339Islim F.: B-0838Italiano A.: B-0421Ito M.: B-0760Ito T.: B-0336, B-0581Itou C.: B-0777Ittrich H.: B-0882, B-0888, B-1000Ivanac G.: SY 2, SK 27Iwadate Y.: B-0570Iwami M.: B-1017Iwata T.: B-0720Izadi M.: B-0817Izuka T.: B-0760Izzillo R.: B-0251Izzo F.: B-0233Izzo G.: B-0902

JJackson M.R.: B-0594Jackson S.A.: A-229Jacobi V.: B-0774Jacobs C.: B-0297, B-0610Jacobs J.: B-0842Jacquet L.: A-196Jacquier A.: B-0460, B-0461Jafarov H.: B-0160Jäger H.R.: A-046, Rising StarsJäger M.: B-0487Jager P.L.: B-0664Jahnen A.: B-0989Jain A.K.: B-0041Jairam P.M.: B-0027Jakicic J.M.: B-0932Jakubowski W.S.: B-0717Jalali A.H.: B-0220Jalan R.: B-0097Jana M.: B-0331Janevska V.: B-0430Janezic A.: B-0273Jang H.-J.: B-0699Jang M.: B-0210Janicijevic M.: B-0967Jankharia B.: B-0641Janne d’Othée B.: B-0777Janse van Rensburg P.: A-259Jansen F.: B-0964Jansen J.: B-0012Jansen L.: B-0560Janssens R.: B-0887Janu A.K.: B-0641Jara H.: B-0954Jarboui L.: A-553Jargiello T.: A-044Jarraya M.: B-0932Järvinen H.: B-0989Jaspers K.: B-0666Jaspers R.M.J.J.: B-0588Jauch K.-W.: B-0195Jayne D.G.: B-0196Jebsen I.N.: B-0817Jensen A.: B-0151Jeon G.S.: B-0494, B-0495Jeong C.J.: B-0025Jeong J.Y.: B-0025


282

Jereczek-Fossa B.A.: B-0503Jeromel M.: B-0652Jerowski C.: B-0077, B-0808Jeukens C.: B-0621Jeukens C.R.L.P.: B-0622Jevtič V.: B-0652Ji S.K.: B-0050Jiang L.: B-0141Jin Z.: B-0496, B-0497Jin Z.Y.: B-0255Jingu K.: B-0674Job-Deslandre C.: B-0650Joeckel K.-H.: B-0584Joeres A.: B-0819Johnson A.: B-0207Johnson C.A.: B-0051Johnson K.J.: A-526Johnson T.: B-0582Johnson T.R.C.: A-357, B-0161, B-0288, B-0634,

B-0638, B-0639, B-0995Jomier A.: B-0285, B-0286Jones E.C.: B-0209Jones L.: B-0557Jones R.: B-0326Joo I.: B-0202, B-0230Jorulf H.: B-0109Joseph G.: B-0484Joseph G.B.: B-0483Jost G.: B-0167, B-0747, B-0913Jouannic J.-M.: B-0867Juan Y.-H.: B-0931Jung B.: B-0361, B-0736Jung C.S.L.: B-1000Jung E.M.: SY 24Jung G.S.: B-0776Jung J.-Y.: B-0330Jung K.-S.: B-0330Jung S.C.: B-0516Jung T.: B-0936Jungmann P.: B-0180Jungmann P.M.: B-0435, B-0655Juras V.: B-0345, B-0488Jurca M.: B-0141, B-0807Jurencak T.: B-0261, B-0264Jurkiewicz E.: B-1014

KK.Kunovska S.: B-0430Kabala J.E.: A-460Kabasawa H.: B-0570Kachelrieß M.: A-336Kaczur D.: B-1024Kaelin-Lang A.: B-0405Kaemmerer D.: B-0282Kahan A.: B-0650Kahl S.: B-0100Kahn T.: B-0158, B-0448, B-0558Kainberger F.: B-0613Kaireit T.: B-0166Kaiser C.G.: B-0214, B-0683Kaiser W.A.: A-128, B-0074, B-0075, B-0077, B-0079,

B-0457, B-0679, B-0683, B-0808, B-0885, B-0886Kalafut J.F.: B-0746Kalashnikova L.: B-0365Kalender W.: B-0991, B-0992, B-0993Kalender W.A.: A-106Kallifatidis A.: B-0460, B-0461

Kalnins A.: B-0341Kälviäinen R.: B-0011Kamm K.: B-0106Kammerer S.: B-0190Kan W.K.: B-0474Kanazawa S.: B-0336Kanda T.: B-1017Kang A.: B-0095Kang B.C.: B-0776Kang D.M.: B-0844, B-0845Kang E.G.: B-0844, B-0845Kang E.Y.: B-0210Kang E.-Y.: B-0433, B-0528Kang H.: B-0024Kang H.S.: B-0046, B-0784Kang J.-W.: B-0418Kang K.W.: B-0475Kang M.: B-0573Kang S.J.: B-0067Kang T.W.: B-0428Kannan R.R.: B-0056Kannengiesser S.: B-0540Kannivelu A.: B-0294Kanz F.: B-0613Kanz K.-G.: B-0727Kappert P.: B-0442Karaarslan E.: B-0327Karampinos D.: B-0043Karani J.B.: A-470Karanikas G.: B-0213, B-0328, B-0502, B-0802Karantanas A.: B-0223, B-0228, B-0541Karantanas A.H.: A-597Karatzoglou I.: B-0115Karlson B.-M.: B-0426Karmazanovsky G.: B-0250Karnabatidis D.: B-0919Károlyi M.: B-0917Karpinska A.: B-0117Karpitschka M.: B-0066Karssemeijer N.: B-0968Kartje K.: B-0589Kashani H.: B-0379Kassarjian A.: A-002Kassem H.M.H.: B-0906Kastler A.: B-0312Kastler B.: B-0312Katabathina V.: B-0255Kataeva G.: B-0229Katayama M.: B-0570, B-1004Katsanos K.: B-0919Kau T.: B-0224Kauczor H.-U.: A-080, A-181, A-234, B-0044, B-0162,

B-0188, B-0200, B-0241, B-0481, B-0523, B-0629, B-0766

Kaufmann P.A.: A-013Kaul M.G.: B-0879, B-1000Kaul S.: B-0030Kavaliauskiene G.: B-0790Kawada S.: B-0977Kayani I.: B-0205Kaye T.L.: B-0196Kazmierczak P.M.: B-1036Keeling A.: A-389Kehl S.: B-0865, B-0866Kelekis A.: B-0530Kelekis A.D.: A-040Kelekis N.L.: A-038, B-0530

Keller S.: B-0102Kelliher E.: B-0564Kellner-Weldon F.: B-0752Kemmling A.: B-0898Kemp M.: A-053Kenis C.: B-0480Kerbaol A.: A-109Kerl J.: B-0723Kerl J.M.: B-0266, B-0669Kerl M.: B-0633Kerl M.J.: B-0290Kerr J.: B-0564Kersten M.J.: B-0550Keyhanian K.: B-0756Keymeulen K.B.M.I.: B-0212Keyzer C.: A-035, B-0053Khairoune A.: B-0084Khalifa O.: B-0148Khalil A.: B-0538Khalil M.: B-0595Khan A.: B-0943Khan S.H.: B-0385Khan S.M.: B-0601Khandelwal N.: B-0573Khettab I.: B-0473, B-0714Khouri Chalouhi K.: B-0815Kiefer B.: B-0446Kiefer C.: B-0405Kienle P.: B-0628Kiessling F.M.A.: A-016, A-328Kietselaer B.: B-0261, B-0264Kikinis R.: B-0284Kikuchi K.: B-0515, B-0673, B-0678Kilborn T.: A-261Kılıc K.: B-0899Kim B.T.: B-0296Kim B.-T.: B-0025Kim C.K.: B-0826Kim D.H.: B-0026Kim E.-G.: B-0739Kim E.-K.: B-0715Kim E.Y.: B-0521Kim H.J.: B-0052Kim H.K.: B-0296Kim H.L.: B-0637Kim H.S.: B-0067, B-0521Kim I.H.: B-0513Kim I.S.: B-0446Kim J.H.: B-0296, B-0830Kim J.-H.: B-0024, B-0513Kim J.W.: B-0364, B-1002Kim K.: B-0221Kim K.A.: B-0446, B-0831Kim K.H.: B-0052Kim K.M.: B-0475Kim K.W.: B-0091Kim M.D.: B-0494Kim M.S.: B-0210Kim M.Y.: B-0428Kim S.C.: B-0516Kim S.J.: B-0067Kim S.M.: B-0210Kim S.-W.: B-0210Kim S.Y.: B-0091Kim T.K.: B-0699Kim T.M.: B-0513Kim Y.K.: B-0521


283

Kimura T.: B-0346, B-0828Kind M.: B-0421King J.: B-0311Kinkel K.: A-409, A-587Kinner S.: B-0347, B-1030Kircher J.: B-0486Kirchhoff S.: B-0727Kiritsi O.: B-0933Kist K.: B-0955Kitagawa K.: B-0581Kitahara S.: B-0759Kitajima K.: B-0346Kitao A.: B-0984Kitrou P.M.: B-0919Kitslaar P.H.: B-0663Kiura Y.: B-0305Klammer G.: B-0181Klasen J.: B-0252Klatka J.: B-0153Klavžar R.: B-0476Kleijnen J.-P.J.E.: B-0622Klein K.-G.: B-0749Klein S.: B-0014Klement D.: B-0290Klepacka T.: B-0671Klerx F.: B-0597Kling-Hassler C.: B-0149Klink T.: B-0354Kloeckner R.: B-0420Kloeters C.: B-1030Kloth J.K.: B-0044Klotz E.: B-0240, B-0413, B-0676, B-0755Klueppelholz B.: B-0100Kluge R.: B-0158, B-0558Klumpp B.: B-0003, B-0004Kluza E.: B-0621, B-0622Kluzer A.: B-0128Knauer A.: B-0190Knauth M.: B-0676Knogler T.: B-0680, B-0802, B-0950, B-0951Knollema S.: B-0664Ko C.-W.: B-0225Ko G.-Y.: B-0499Ko S.M.: B-0269, B-0418Koay H.T.: B-0294Kobayashi S.: B-0984Koch P.: B-0187Koch-Nolte F.: B-0882Kocsis P.: B-0619Koda W.: B-0984Koehl L.: B-0970Koehler C.: B-0915Kofoed K.F.: B-0918Kogan M.: B-0695Koh D.-M.: ESOR CourseKoh J.S.B.: B-0659Koh S.H.: B-0330Kohan A.: B-0326Köhlitz T.: B-0936Koizumi J.: B-0777, B-0977Kokhanovsky N.: B-0129Kolb M.: B-0341Kolditz D.: B-0991, B-0993Kollias S.S.: B-0156, B-0157Kolligs F.T.: B-0795Kolokythas O.: B-0095, B-0145Kolossvary M.: Rising Stars

Komljenovic D.: B-0434Kommata S.: B-0502Komuta M.: B-0804Kondrachuk O.: B-0735Kondratyev E.: B-0250Konen E.: B-0458, B-0612König D.: B-0487Koning G.A.: B-0887Konitsiotis S.: B-0406Könönen M.: B-0011Konovalov R.: B-0365Kooi E.M.: B-0253Kooi M.E.: B-0116, B-0118, B-0120, B-0317, B-0853Kooijman H.: B-0859Kool D.R.: A-066Kopf H.: SK 26Koprivsek K.: B-0812Korkusuz H.: B-0034, B-0040Körner M.: A-065Kornprobst S.: B-0491Korom C.: B-0982Korotkov A.: B-0229Korporaal J.G.: B-0482Kortesniemi M.: B-0249Kosanke K.: B-0880, B-0881Koskenkorva P.: B-0011Kosta P.: B-0406, B-0860, B-0862Kostkiewicz B.: B-0303Köstler H.: B-0001Kostron H.: B-0907Kotek G.: B-0485, B-0887Kotze C.W.: B-1003Kouklakis G.: B-0115Kousaka J.: B-0338, B-0339Kovacic M.: B-0273Kovacs G.: B-0639, B-0667, B-0914Koyama H.: B-0293, B-0329, B-0526, B-0767Koyanagi N.: B-0760Kozaka K.: B-0984Koziolek E.J.: B-0879Kraff O.: B-0347, B-0708, B-0782, B-1038Krager M.: B-0817Krainik A.: B-0355, B-0751Kramer J.: A-600Kramer U.: B-0003, B-0004, B-1008Krammer J.: B-0214Kraśnicki T.: B-0847Kratochwil C.: B-0200Krause D.: B-0251Krause J.: B-0426Krauspe R.: B-0486, B-0487Krauss A.: B-0788Krazinski A.: B-0849Kremser C.: B-0907Krestin G.P.: A-137, A-325, B-0350, B-0410, B-0413,

B-0415, B-0485, B-0661, B-0663, B-0887Krestinich I.: B-0916Kreuzberg B.: B-0358Krings T.: A-504Krissak R.: B-0740Kristiansen A.: B-0275Kroep J.R.: B-0208Krokidis M.: A-339, A-445, A-545Kröpil P.: B-0252, B-0340, B-0366, B-0522, B-0648,

B-0703Krotenkova M.: B-0365Krug R.: B-0043

Krumbein I.: B-0886Krumm P.: B-0003, B-0004, B-1008Krupinski M.: B-0009Krzymyk K.: B-0632Kubiessa K.: B-0158Kuchta J.: B-0546Kudou S.: B-0760Kuehl H.: B-0500Kuemmel S.: B-0456, B-0506Kuhl C.: B-0981Kuhl C.K.: A-227Kühl H.: B-0028, B-0553Kühn A.: B-0158Kuhn F.P.: B-0156, B-0157Kühn J.P.: B-0445Kühn J.-P.: B-0348Kuhnigk J.-M.: B-0165, B-0297, B-0610Kuijpers T.W.: B-0593Kulama E.: B-0839Kulkarni C.B.: B-0056Kulkarni S.: B-0219Kullnig P.: B-0639Kumabe T.: B-0674Kumar D.: B-0657Kunick V.: B-0882Kuniewicz M.: B-0009Kuo C.-M.: B-0931Kupatt C.: B-0634Kupcsulik P.K.: B-0982, B-0983Kupfer J.: B-0481Kural F.: B-0155Kurcz J.: B-0744Kuriakopoulou M.: B-0919Kurisu K.: B-0305Kurobe Y.: B-0581Kurosaki A.: B-0760Kuru I.: B-0362Kurzidem S.: B-0487Kus S.: B-0762, B-0972Kusch B.: B-0740Kuwabara M.: B-0759Kwak J.Y.: B-0715Kwee R.M.: B-0116, B-0120, B-0965Kwee T.C.: A-299, B-0550Kwoh C.K.: B-0932Kwon O.J.: B-0296Kyriakou Y.: B-0915

LLa Grassa M.: B-0686La Marra A.: B-0183Lacan Melki A.: B-0714Lacan-Melki A.: B-0473Lacelli F.: B-0186Ladd M.E.: B-0347, B-0708, B-1038Ladefoged C.: B-0103Ladefoged C.N.: B-0102Laghi A.: A-478, B-0193, B-0626, B-0661, B-0704,

B-0792, B-0793, B-0796Lai A.: B-0043, B-0319, B-0483, B-0657Lai B.M.: B-0474Lai P.-H.: B-0225Lalam R.: A-435Laleman W.: B-0804Lalji U.C.: B-0029Lam C.H.S.: B-0649Lam M.G.E.H.: B-0032


284

Lamalle L.: B-0751Lamb H.J.: A-213Lambin P.: B-0065Lambrecht V.: B-0480Lambregts D.M.J.: B-0625, B-0940Lammering G.: B-0627Lamot U.: B-0476Landgraeber S.: B-0782Lane N.E.: B-0657Lang I.: B-0599Lång K.: A-507Lang R.A.: B-0195Lang S.: B-0895Langdon B.: B-0409Lange C.: B-0888Langer M.: B-0263, B-0361, B-0551, B-0736, B-0890Langs G.: B-0147, B-0281, B-0950, B-0951Laniado M.: A-548, B-0101Lantuejoul S.: A-240Lanza E.: B-0785Lanzi R.: B-0850Lanzman R.S.: B-0081, B-0252, B-0340, B-0366,

B-0522, B-0552, B-0648, B-0703Laptev V.: B-0764Laqmani A.: B-0765Laqua R.: B-0681Lardo A.C.: B-0006Larici A.R.: B-0021Larrache J.: B-0900Larsen M.: B-0275Larsen R.: B-0103Larsson P.T.: B-0653Lasek W.: B-0304Laskowicz B.: B-0009Laterre P.-F.: A-196Latifoltojar A.: B-0207Latorre-Ossa H.: B-0335Lau K.: B-0701Lau K.C.H.: B-0192Lau S.: B-0649Laubender R.: B-0106Laubender R.P.: B-0800Laue H.: B-0891Laue H.O.A.: B-0758Lauenstein T.: B-0320, B-0501, B-0552, B-0553,

B-0969Lauenstein T.C.: B-0347, B-0456, B-0500, B-0708,

B-0782, B-1030, B-1038Lauer L.: B-0481Laufs A.: B-0100Laun F.B.: B-0151Laureys S.: A-422Laurino F.: B-0921Lauvin M.A.: B-0105Lavin P.: B-0955Law M.: A-330Lawler L.P.: A-488Lawrence A.J.: B-0359Layritz C.: B-0665Lazik A.: B-0782Le Bas J.-F.: B-0751Le Bihan D.: B-0201Le Bras Y.: B-0176Le Coultre R.: B-0869Le Frère-Belda M.A.: B-0335Le O.: B-0824Leander P.: A-594

Leão M.: B-0602Lebecque O.: B-0987Leber A.: B-0586Leber V.: B-0586Lebret T.: B-0694Leclercq D.: B-0512Lecouvet F.E.: B-0542, B-0544Ledsam J.R.: B-1029Lee B.Y.: B-0637Lee C.H.: B-0446, B-0831Lee C.-H.: B-0844, B-0845Lee E.: B-0784Lee G.Y.: B-0046, B-0784Lee H.J.: B-0495Lee H.-J.: B-0026Lee H.Y.: B-0024, B-0025, B-0296Lee J.: B-0831, Rising StarsLee J.H.: B-0024, B-0050Lee J.L.: B-0446Lee J.M.: B-0202, B-0230, B-0830Lee J.T.: B-0494Lee K.L.R.: B-0042Lee K.S.: B-0024, B-0025, B-0296Lee K.Y.: B-0433, B-0528Lee M.: B-0107, B-0926Lee M.H.: B-0428Lee M.W.: B-0428Lee N.: B-0221Lee N.J.: B-0475Lee S.: B-0043, B-0319, B-0484, B-0529, B-0657Lee S.-H.: B-0513Lee S.M.: B-0026Lee W.: B-0418Lee Y.: B-0221Lee Y.H.: B-0475Lee Y.-H.: B-0844, B-0845Lefere P.: A-480Lefort T.: B-0094, B-0444Lefrandt J.D.: B-1001Legrand L.: B-0837Lehmann F.: B-0885Lehmann H.C.: B-0905Lehmann P.: B-0387Lehmkuhl L.: B-0260Lehnert T.: B-0290, B-0393, B-0536, B-0537, B-0633,

B-0669, B-0711, B-0723, B-0774Leifland K.: B-0967Leijtens J.W.A.: B-0625, B-0940Leiner T.: A-243, A-487, B-0005, B-0253, B-0721,

B-1007Leithner R.: B-0950, B-0951Leitner S.: B-0171, B-0502, B-1027Leitz W.: B-0109Lelakowski J.: B-0009Lelieveldt B.P.F.: B-0208Lell M.: B-0665Lella A.: B-0127Lemasle P.: A-624Lembcke A.: B-0374Lemke A.: B-0829Lemke H.U.: A-047Lemmerling M.M.: A-520Lemos P.: B-0006Lempicki M.: B-0310Lenz A.: B-0882Leonard P.: B-0594Leong L.: B-0215

Leong L.C.H.: B-0080Leporq B.: B-0443, B-0444Lermite E.: B-0797Lesaru M.: A-373Leschka S.: B-0660Leszek J.: B-0401Leung K.Y.E.: B-0142Leung M.W.: B-0377Lévai A.: B-0154Levit-Kantor A.: B-0129Lewis E.: B-0134, B-0389Lewis M.: B-0946Leyendecker J.R.: B-0728Leyh R.: B-0001Li D.: B-0369Li J.-R.: B-0201Li L.: B-0656, B-0674Li X.: B-0496, B-0497Li Y.: B-0369, B-0575Liang T.: B-0632Liao Q.: B-0169Lidén M.: B-0825Liebl H.: B-0483, B-0484, B-0655, B-0934Ligabue G.: B-0462, B-0463Liguori C.: B-0468, B-0469, B-0579Lim H.: B-0428Lim H.K.: B-0428Lim S.: B-0428Lim S.K.J.: B-0294Lim S.Y.Y.: B-0404Lim T.-H.: B-0418Lima J.A.C.: B-0006Lin C.-J.: B-0543Lin M.: B-0036, B-0924Lin W.: B-0934Lin Y.-C.: B-0931Linda A.: B-0567, B-0568Lindeboom L.: B-0317Lindner E.: B-0795Lindner T.: A-523Lindqvist U.: B-0653Link T.: B-0043, B-0319Link T.M.: A-125, B-0483, B-0484, B-0548, B-0655,

B-0657Linn J.: B-0353Linsenmaier U.: A-197, A-221, A-413Lions C.: A-244Liou I.W.: B-0095Lioubashevsky N.: B-0591Lippa N.: B-0421Lipponer C.: B-0969Lirette M.-P.: B-0594Lissandrin R.: B-0092Liu F.: B-0483Liu J.: B-0369Liu Y.: A-095Livingstone R.: B-0100Ljungqvist G.: B-0943Llopis E.: A-584Llorente C.: B-0690Lobbes M.: B-0450, B-0451Lobbes M.B.I.: B-0212Lockhat Z.: A-258, A-260Loeckx D.: B-0280Loewe C.: A-183, A-513, B-0251Löfgren J.: B-0102, B-0103Loft A.: A-173


285

Logager V.: A-534Lohan D.G.: A-625Lombard C.: A-262Lombardi M.: B-0251, B-0855Lombardo C.V.: B-0238, B-0836Londero V.: B-0132, B-0567, B-0568, B-0684, B-0687,

B-0811Long N.M.: B-0437Longoni L.: B-0596Lönnemark M.: B-0177Lönnfors-Weitzel T.M.L.: B-0405Loo C.E.: B-0218Lopater J.: B-0694Lopci E.: B-0503, B-0507Lopera J.E.: B-0255Lorentzen T.: A-581Lorenzen M.: B-0315Losa M.: B-0850Lossev I.: B-0206Lotan E.: B-0209, B-0612Lou X.: B-0897Lourenço C.: B-0871Louwen F.: B-0398Lovblad K.-O.: A-366Löve A.: B-0892Lovisatti M.: B-0128Lu J.: B-0571, B-0575Luca A.: B-0772Lucarini S.: B-0086, B-0087Lucas R.: B-0043Lucatelli P.: B-0775, B-0920Lucchesi P.: B-0793Luceri A.M.: B-0392Luciani A.: B-0459, B-0924Luciani M.L.: B-0453Lucidarme O.: A-216Lücke C.: B-0260Luepke M.: B-0768Luerken L.: B-0725Lugli R.: B-0462, B-0463Luhur R.: B-0374Lui S.: B-0018Lukianchenko A.: Lumen N.: B-0088Lundqvist M.: B-0843Lung P.F.C.: B-0199Luo X.: B-0259Lupp A.: B-0282Luppi G.: B-0179Lux F.: B-1035Luypaert R.: B-0580Lynch J.: B-0655, B-0934Lythgoe M.: B-0097

MMa C.: B-0571, B-0575Ma C.B.: B-0043Ma L.: B-0897Ma X.: B-0368Maas M.: A-102, A-253, A-498, B-0593, B-0621,

B-0622, B-0625, B-0940Macarini L.: B-0904Macaskill P.: B-0818Maccabelli G.: B-0585Maccagni D.: B-0600Maccioni F.: A-230Maceroni M.M.: B-0193, B-0626, B-0793

Macho J.: A-112Macias N.: B-0704Macioszek A.: B-0401Mack M.G.: A-126Mackinnnon A.D.: B-0359Macron L.: B-0007Maderthaner R.: B-0743, B-0858Maderwald S.: B-0347, B-0456, B-1038Madureira A.J.B.S.: A-036, Rising StarsMaduskar P.: B-0761Madzik J.: B-0671Maeda K.: B-0759Maffi P.: B-0440, B-0449, B-0769Maffulli N.: B-0184, B-0311Magnusson A.: A-304, B-0177Magomatschnigg H.F.: B-0563Magometschnigg H.: B-0213Magometschnigg H.F.: B-0952Maher M.M.: B-0119Mahnken A.H.: B-0167, B-0589, B-0981Mahon B.: A-547Maieron M.: B-0834, B-0835Mainprize J.G.: A-506Maintz D.: B-0806Majoie C.B.L.M.: B-0894Major D.: B-0618Majós C.: A-159Majumdar S.: B-0657Makarenko V.: B-0916Mäkelä T.: B-0249Malagari K.: B-0530Malago R.: B-0416, B-0662Malakhova E.: B-0229Malczyk K.: B-1014Maleux G.: B-0804Mali W.P.T.M.: B-0008, B-0027, B-0032, B-0218,

B-0565, B-0721Malich A.: SK 27Malikova M.A.: B-0954Malkowski B.: B-0321Mall M.A.: B-0162Malliaras P.: B-0184Malliaropoulos N.: B-0933Mallio C.A.: B-0020, B-0407Maltese L.S.: B-0392Maltzeff N.: B-0921Maly Sundgren P.C.: A-072, A-194, A-332Mamboury N.: B-0387Mamone G.: B-0772Mandel C.: B-0144Manenti G.: A-376, B-0085Manfredi R.: A-110Mang T.: A-479Manganaro L.: B-0394, B-0396, B-0863, B-0868Manghat N.E.: B-0527, B-0856Mangold S.: B-0003, B-0004, B-1008Manickam S.: B-0595Manka R.: B-0910Mann A.: B-0180Mann R.M.: A-448, B-0072, B-0565, B-0968Manniesing R.: B-0758, B-0891Manning-Stanley A.S.: B-0608Mansour S.: B-0949Månsson C.: B-0426Mantarro A.: B-0623Mantini C.: B-0002Mantovani L.: B-0682

Marano R.: A-451Marchesi G.: B-0267Marchesini M.: B-0561, B-0956Marchisio L.: B-1033Marcon M.: B-0567, B-0568Marcus R.: B-0582, B-0995Marcus R.P.: B-0411Marcy P.-Y.: B-0307, B-0308Marginet-Mangas C.: B-0810Margreiter M.: B-0502Mariani S.: B-0183, B-0696Marigliano C.: B-0697Marinelli D.: B-0002Marinelli S.: A-582Marinescu M.: B-0890Marini M.: B-0122Marino M.: B-0395Maris T.: B-0223, B-0228Markl M.: B-0361, B-0736Markonis D.: B-0147, B-0281Markota J.: B-0652Markstaller K.: B-0523Markus C.: B-0525Markus H.S.: B-0359Marletta M.: B-0698Maroldi R.: A-461, A-571, B-0203, B-0204, B-0246,

B-0424, B-0478, B-0479, B-0705, B-0716Marquina T.: B-0724Marra P.: B-0239Marrelli D.: B-0194Marrero D.: B-1023Marrosu M.G.: B-0313Marsecano C.: B-0645Marshall M.: B-0199Marshall N.W.: B-0842Martegani A.: B-0232, SY 23Martel Villagrán J.: B-0690Marten-Engelke K.: A-239Martens D.: B-0749Martens M.H.: B-0621, B-0622, B-0625, B-0940Marti Bonmati L.: B-0251Martí De Gracia M.: B-0122, B-0124Martí-Bonmatí L.: A-115, A-139, A-416, B-0403, ESOR

Course, EIBIRMartin D.C.: B-1023Martin D.F.: A-342Martinez de Vega V.: SY 13Martinez E.: B-0810Martinez L.: B-0724Martínez P.: B-0809Martínez Rodrigo J.J.: A-114Martini C.: B-0186Martinoff S.: B-0372Martinoli C.: A-163Martin-Rodriguez J.L.: B-0099Martins P.: B-1021Martirosian P.: B-0098Martucci M.: B-1015Maruzzelli L.: B-0772Mascarenhas V.: B-0822, B-0971Mascaretti G.: B-0493Mascaro L.: B-0246, B-0705Masciocchi C.: B-0183, B-0378, B-0493Masetto A.: B-0254, B-0438, B-0596, B-0783Maso C.: B-0131Masoomi M.: B-0104Mastorodemos V.: B-0223, B-0228


286

Masui T.: B-0570, B-1004Mátéka I.: A-026Mathers S.: A-464Mathys C.: B-0749, B-0905Matias J.M.: B-0278Matos A.: B-0822, B-0971Matos C.: A-554, A-601Matranga D.: B-0730, B-0990Matsui O.: B-0984Matsumoto S.: B-0293, B-0329, B-0526, B-0767Matsushige T.: B-0305Mattace-Raso F.U.S.: B-0111Mattei P.A.: B-0509, B-1013Mattiuz C.A.: B-0654Matzko M.: B-0491Maurel B.: B-0460, B-0461Maurer M.: B-0189, B-0306Maurer M.H.: B-0539Mauri G.: B-0646, B-0771, SK 26Maurovich-Horvat P.: B-0917Mavrogenis A.F.: B-0640Maxeiner A.: B-0172Maxien D.: B-0927, B-0928May A.: B-0003, B-0004Mayer J.L.: B-0523Mayerhoefer M.E.: B-0328, B-0680, B-0802Mayo J.: B-0632Mazioti A.: B-0530Mazonakis M.: B-0611Mazza E.: B-0801Mazza G.: B-0791, B-0794Mazzei F.G.: B-0058, B-0194Mazzei M.A.: B-0057, B-0058, B-0059, B-0194Mazzoni L.: B-0511Mazzoni L.N.: B-0086, B-0087Mbalisike E.: B-0039, B-0471, B-0748Mc Laughlin P.D.: B-0119McCarthy P.: B-0823McCulloch C.: B-0934McCulloch C.E.: B-0484, B-0655McEntee M.F.: B-0272, B-1028McHale T.: B-0823McHugo J.: A-411McKillop G.: B-0373McLaren C.: A-465McNulty J.: A-344, B-0604McQuiston A.D.: B-0411McRobbie D.: B-0839Medici M.: B-0429Medvedev S.: B-0229Mehrez H.: B-0292, B-0379Meier A.K.: B-0482Meier R.: B-0880Meijboom F.J.: B-0005Meijboom W.B.: B-0415Meinel F.: B-0288Meinel F.G.: B-0161, B-0556, B-0634, B-0638,

B-0754, B-0757Méjean A.: B-0084Mejia-Bustamante V.: B-0840Mekiš N.: B-0609Melchionda D.: B-0904Melchiorre F.: B-0770, B-0771Melgari J.M.: B-0407Melis L.: B-0533, B-0535, B-0958Meloni A.: B-0467, B-0854, B-0855Meloni G.B.: B-0533, B-0535, B-0958

Melzer A.: B-0795Menchi I.: B-0086, B-0087Mendes C.M.: B-0386Mendes Pereira V.: A-366Menezes L.: B-1003Menges A.-L.: B-0372Menovsky T.: A-306, B-0301, B-0302Mensel B.: B-0348, B-0445, B-0681Menu Y.: A-068, A-134, A-157, A-281Mercer D.: B-0702Merchant M.S.: B-0209Merckel L.G.: B-0072, B-0565Mercuri P.: B-0058, B-0194, B-0682Merhemic Z.: A-414Merkle E.M.: B-0728Merran S.: A-352Mershina E.: A-515Mershina E.A.: Mertelmeier T.: SY 5Mesa J.: B-0724Mess W.H.: B-0120Messa C.: B-0505Mesters R.M.: B-0805Metivier-Cesbron E.: B-0797Meuli R.: B-0542, B-0544, B-0670Mews J.: B-0374Meyblum E.: B-0459Meyer B.: B-0047, B-0244Meyer B.C.: B-0038Meyer E.: B-0044Meyer M.: B-0160, B-0265, B-0352Meyer M.-E.: A-268Meyer P.: B-0310Meyer S.: B-0191Meyer zu Hörste G.: B-0905Miccò M.: B-0323, B-0395Miccoli A.: B-0493Michaely H.J.: A-242, B-0343, B-0345, B-0540,

B-0999, SY 12Michalak E.: B-0671Michałek A.: B-0852Michelozzi C.: B-0770, B-0771Michieletti E.: B-0267Michielsen K.: B-0804, B-0842Michoux N.: B-0987Midiri M.: B-0855Miese F.: B-0340, B-0366, B-0651, B-0703Miese F.R.: B-0486, B-0487Migda B.: B-0717Miglio E.: B-0453Migliorisi C.: B-0925Mihl C.: B-0261, B-0264, B-0746Mildenberger P.: A-576Miles K.: B-0943Milner S.: B-0680Milosevic Z.C.: B-0455, B-0566Minami T.: B-0984Minar E.: A-212Minarikova L.: B-0953Mindjuk I.: B-0491Minguillon C.: B-0809Minhas K.: B-0856Minighin E.: B-0834, B-0835Mintzer J.E.: B-0408Minutolo O.: B-0064, B-0391, B-1005Miraglia R.: B-0772Miranda A.C.: B-1021

Miranda I.: B-0211Mirsadraee S.: B-0373Mischen B.T.: B-0417Mishah N.M.: B-1025Missonnier S.: A-525Mitjana R.: B-0222Mitsumori L.M.: B-0095Mitulescu A.: B-0512Mitusov V.: B-0695Miyamoto Y.: B-0336Miyazaki Y.: B-0720Miyoshi M.: B-1004Mizandari M.: B-0773Mizoguchi M.: B-0673Mizuki K.: B-0570, B-1004Mngomezulu V.: A-257Modorati G.: B-0712Mohan P.C.: B-0659Mohan S.: B-0604Mohd Nor H.: B-0404Mohd Ramli N.: B-0015Mohr F.W.: B-0260MohyElDien R.: B-0713Mokbel K.: B-0680Mokrane F.: A-244Mokry T.: B-0178Mol H.: B-0997Molenschot M.C.: B-0734Molgaard C.: B-0037Molica S.: B-1031Molinari C.: B-0132, B-0684, B-0811Molinari F.: B-0376Molinié V.: B-0837Mollet N.R.: A-249Moltz J.: B-0200Monguzzi L.: B-0620Monnin P.: B-0277Mono M.-L.: B-0752Montaser A.: B-0529Monteiro M.: B-0278Montemezzi S.: B-0454Montet X.: A-596Mookerjee R.: B-0097Moon H.J.: B-0715Moon J.H.: B-0330Moore C.E.: B-0932Moorthy S.: B-0056Moos S.I.: B-1037Moosbauer H.: B-0953Morana G.: A-006Morassi M.: B-0203, B-0204Morcos S.K.: A-537Moreau-Gaudry A.: B-0429Moretti M.: B-0511Morgan R.: A-247, A-540, Rising StarsMori E.: B-0674Mori N.: B-0777Mori T.: B-0720Mori Y.: B-0338, B-0339Morimoto R.: B-0828Morini V.: B-0462, B-0463Morisaka H.: B-0093Moriyasu F.: B-0336Morone M.: B-0791, B-0794Morr D.: B-1035Morris P.B.: B-0417Morris R.: B-0359


287

Morrison G.: B-0599Morrissey D.: B-0184, B-0311Morsbach F.: B-0063, B-0242, B-0660, B-0788Mortilla M.: B-1012, B-1018Morton S.L.: B-0311Morvay Z.: A-026Moscano F.: B-0598Moschetta M.: B-0283Moschouris H.: A-623Moser M.: B-0068Mostbeck G.: B-0148, B-0636, B-0635, SK 26Motevalli M.: B-0857Motohashi N.: B-0760Motosugi U.: B-0093Mouden M.: B-0664Moulin G.: B-0460, B-0461Moussa S.: A-303Mousseaux E.: B-0007Moutard M.-L.: B-0867Mowinckel-Nilsen M.L.: B-0381Mpampali A.: B-0115Much C.: B-0859Mück F.: B-0243Mück F.G.: B-0472Muehlenbruch G.: B-0746Mueller H.: B-0147, B-0281Mueller-Lisse U.G.: A-177, A-354, B-0578Mueller-Mang C.: B-0281Mugikura S.: B-0674Mulder D.J.: B-1001Müller A.: B-0232, B-0537, B-1035Müller-Bierl B.M.: B-0580Müllerleile K.: B-0367Mundinger A.: SY 13Mungai F.: B-0325Munier F.: B-0670Münter M.: B-0151Murata T.: B-0674Murchison J.T.: B-0060Mus R.D.M.: B-0968Muscogiuri G.: B-0626, B-0691, B-0696, B-0704Mushtaq S.: B-0262Musi G.: B-0082Muto M.: A-501, A-558Mutsaerts H.-J.M.M.: B-0894Myeong W.-J.: B-0739Myojin K.: B-0777

NNabuurs C.I.H.C.: B-0317Nachtigal A.: B-0129Nada O.M.: B-0949Nadrljanski M.M.: B-0455, B-0566Naga S.: B-0331Nagata M.: B-0581Naguib N.N.N.: B-0031, B-0033, B-0170, B-0393,

B-0534, B-0536, B-0711, B-0774Nagy E.: A-026Nagy J.: B-0840Nagy N.N.: B-0709Nahama-Allouche C.: B-0867Nair A.: B-0299Nakamura K.: B-1017Nakano S.: B-0338, B-0339Nakano Y.: B-0759Nakazaki M.: B-0720Nance J.W.: B-0419

Napoli A.: B-0174, B-0399, B-0414, B-0427, B-0490, B-0643, B-0644, B-0645

Nardo L.: B-0043, B-0319, B-0483, B-0484, B-0529, B-0657, B-0934

Nasar M.: B-0713Nascimento J.H.H.R.N.: B-0590Nassenstein K.: B-0584Natale L.: A-372, B-0325Natilla T.: B-0791, B-0794Navarro U.: B-0478Navarro Vilar L.: B-0168Nechaev V.: Rising Stars Nederend J.: B-0960, B-0961Nederveen A.J.: B-0894Neff K.W.: B-0865, B-0866Negus I.: B-0527Nelemans P.: B-0264Nensa F.: B-0708, B-0969Neri E.: A-605, B-0623, B-1010Nestle U.: A-099Neubauer B.J.: Rising Stars Neuhaus P.: A-317Neumaier K.: B-0995Neumann C.: B-0148, B-0635, B-0636Neumann U.: B-0981Neurohr C.: B-0161, B-0634, B-0638Neuzillet Y.: B-0694Nevens F.: B-0804Nevitt M.: B-0655, B-0934Nevitt M.C.: B-0484Newby D.E.: B-0373Newell M.: B-0104Newerla C.: B-0130Nezzo M.: B-0085Ng W.H.A.: B-0042N’Guyen Bui B.: B-0421Nguyen V.L.L.: B-0253Nica I.: A-196Nichelatti M.: B-0925Nicolai P.: A-571Nicolaou S.: B-0632Nieboer K.: B-0248Niederstadt T.: B-0898Nielsen J.: B-0351, B-0356, B-0357, B-0750Nieman K.: B-0410, B-0415, B-0661Niemann T.: B-0519, B-0729, B-0731Nießen C.: B-0985Niessen W.J.: B-0014, B-0016, B-0142, B-0402Nievelstein R.A.J.: B-0550Niggemann P.: B-0546Nijsen J.F.W.: B-0032Nikitin V.: B-0206Nikolaou K.: A-012, B-0068, B-0117, B-0341, B-0344,

B-0353, B-0582, B-0754, B-0755, B-0757, B-0846, B-0913, B-0975, B-1036

Nilsson A.: B-0426, SY 9Nimish S.: B-0042Ninivaggi V.: B-0395Nishio M.: B-0293, B-0329, B-0526, B-0767Niskanen E.: B-0011, B-0017Nittka M.: B-0435Nitzsche S.: B-0260Nöbauer-Huhmann I.: B-0488Nocchi-Cardim L.: B-0531Noce V.: B-0174, B-0399, B-0414, B-0427, B-0490,

B-0643, B-0644, B-0645Nocetti L.: B-0349, B-0462, B-0463

Noczyńska A.: B-1016Noël P.B.: B-0525Noelte I.: B-0898Nordberg A.: B-0508Normoyle B.: B-0119Notohamiprodjo M.: B-0341, B-0344, B-0975Nour Eldin N.E.: B-0031Nour-Eldin N.-E.A.: B-0033, B-0393, B-0534, B-0536,

B-0711Nowak C.: B-0651Nowak K.: B-1014Nowotny B.: B-0100Ntoulia A.: B-0929Ntziachristos V.: B-0880Nunes C.: B-1021Nunziata A.: B-0233Nusman C.M.: B-0593Nussberger F.: B-0819Nuyens D.: B-0915Nuyts S.: B-0152Nygren P.: B-0426

OO’ Gorman P.: B-0437Obara M.: B-0678Oberhofer N.: B-0108Oca R.: B-0185, B-0631Occleshaw C.J.: B-0856O’Connor O.: B-0119O’Connor P.J.: A-363O’Connor S.: A-192Odedra D.: B-0699, B-0702Odyniec-Nowacka M.: B-0852Oei E.: B-0485Oei M.: B-0758, B-0891Offiah A.: B-0599Offiah A.C.: A-527Ofner J.: B-0281Ogata H.: B-0760Oh J.H.: B-0046Oh Y.-W.: B-0433, B-0528Ohno Y.: B-0293, B-0329, B-0526, B-0767Oikonomou A.: A-237, B-0115Okada T.: SY 19Okazaki T.: B-0305O’Keeffe M.: B-0119O’Keeffe S.A.: B-0216Okuno T.: B-0336Olbricht T.: B-0969Oleaga Zufiría L.: A-549O’Leary D.: B-1022Olerud H.: B-0989Oliboni E.: B-0045Oliveira E.: B-0874Olivier C.: B-0890Olschewski A.: B-0639Olschewski H.: B-0639, B-0667, B-0914Omar K.: B-0933O‘Meara C.: B-0549Omelchenko O.M.: B-0019Omoto K.: B-0336Omoumi P.: B-0542, B-0544O’Neill F.: B-0119O’Neill S.: B-0119Ong M.: B-0999Ono Y.: B-0828Oosterlinck W.: B-0088


288

Oosterwijk J.C.: B-0560Oostveen L.J.: B-0758, B-0891Op de Beeck B.J.: A-055Opherk C.: B-0353Oppermann E.: B-0034, B-0040Oraevsky A.: B-0955Orecchia R.: B-0503Orgera G.: B-0921Origgi D.: B-0730, B-0990Orlandini L.C.: B-0325Orsenigo E.: B-0801Orsi F.: A-188, A-444Ortori S.: B-0698Orzada S.: B-0708O‘Shea A.: B-0564Osinger K.: B-0635, B-0636Osman S.: B-0145Ostendorf B.: B-0651Ostrowska M.: B-0489O’Sullivan G.: A-625Ota H.: B-0828Otten O.: B-0165Ottervanger J.P.: B-0664Otto P.: B-0955Ottonello C.: B-0182, B-0545Oudkerk M.: B-0164, B-0291, B-0295, B-0298,

B-0442, B-0588, B-1001Ourednicek P.: B-0916Ovesen C.: B-0351, B-0356, B-0357, B-0750Owens C.: A-105, A-107, A-267Oyen R.H.: A-353Ozcan C.: B-0899Ozdamarlar U.: B-0362Ozdoba C.: A-142Ozgen Mocan B.: A-251Özkan F.: B-0055, B-0718Özsunar Y.: A-331Öztürk F.U.: B-0155

PPace A.: B-0089, B-0090Pace I.: B-0279Paci E.: A-062Padhani A.R.: A-060, A-329, ESOR CoursePadovani R.: B-0998Padrón M.: SY 8Paglialunga S.: B-0853Pagonidis K.: B-0611Pahn G.: B-0241, B-0523Paik S.Y.: B-0052Painho L.: B-0877Pajor P.: B-0982, B-0983Pak A.: B-0221Pakuła-Kościesza I.: B-1014Palas J.: B-0822, B-0971Palkó A.: A-193, A-430Palm J.: B-1035Palmisano A.: B-0239, B-0440, B-0449, B-0507,

B-0585Palorini F.: B-0730, B-0990Palumbo M.: B-0392, B-0941, B-0947Palumbo P.: B-0930Pałys A.: B-0304Pameijer F.A.: A-117, A-569Pan C.: B-0571Pan H.-B.: B-0225Panara V.: B-0509, B-0930, B-1013

Pandolfi E.M.: B-0693Panebianco V.: B-0089, B-0090, B-0174Panicek D.M.: A-088Panizza P.: B-0561, B-0956, SY 16Panjnosh M.: B-0477Panou T.: B-0223, B-0228Pantalone F.: B-0397Papadaki E.: B-0223, B-0228Papadakis A.E.: B-0996Papadopoulou S.L.: B-0410, B-0415, B-0663Paparo F.: B-0197, B-0948Papathanasiou M.A.: A-265Papavasilopoulou M.: B-0541Papini G.D.E.: B-0545Pappas E.: B-0929Pappot T.W.F.: B-0137Paprottka P.: B-0068, B-0803Páramo M.: B-0900, B-0966Pardo F.: A-078Pareto D.: B-0222Parienty I.: B-0255Parizel P.: A-264, B-0302Parizel P.M.: A-055, A-131, A-205, A-306, A-346,

A-365, A-556, B-0285, B-0286, B-0432, B-0480Parizel P.N.M.: B-0301Park B.K.: B-0826Park C.K.: B-1002Park C.-K.: B-0513Park C.M.: B-0026, B-0446, B-0831Park H.J.: B-0428Park J.: B-0739Park J.H.: B-0364, B-1002Park K.: B-0025Park S.-H.: B-0513Park S.Y.: B-0210, B-0826Park Y.S.: B-0446, B-0831Parker R.: B-0408, B-0409Parodi J.C.: B-0257Parraga J.: B-0770Parrilla P.: B-0122Parrinello A.: B-0194Parrot A.: B-0538Partington K.J.: B-0779Partovi S.: B-0326Patak M.: B-0198Patak M.A.: B-0616Patel B.: B-0359Patel C.: B-0554Patel K.: B-0976Patel S.K.: B-0524Patrick K.: B-0409Patsch J.: B-0548Paul D.: B-0044, B-0540Paul J.: B-0471Paul N.: B-0379Paul N.S.: B-0292Paulo C.: Rising Stars Paulo G.: A-284, A-467, B-0272, B-0275, B-0605Pauwels P.: B-0432Pavageau A.H.: B-0797Pavlica P.: B-0974Pazahr S.: B-0198, B-0910Pecchi A.: B-0231, B-0237, B-0349Pedicini V.: B-0771Pediconi F.: B-0453Peeters M.: B-0432Peeters P.H.M.: B-0072, B-0565

Peeters R.: B-0510Peeters R.R.: A-386Pekarovic D.: A-167Peker O.: B-0055Pelage J.-P.: A-390Pelc N.: A-517Peldschus K.: B-0888Peli M.: B-0128Pellegrino C.: B-0531Pelliccia L.: B-0941Pellot Barakat C.: A-216Pellow A.: B-0668Pelte M.-F.: B-0970Peltonen J.I.: B-0249Peña Fernández M.P.: A-286Peña J.: B-0436Peng C.: B-0884Pengel K.E.: B-0218Penzel J.: B-0937Pepe A.: B-0855Pepe G.: B-0503Pepi M.: B-0262Perdrix L.: B-0007Pereira J.: B-0175Pereira P.L.: SK 27Perez-Rodrigo S.: A-375Peri A.: A-049Peringa J.: B-0790Peris Sanchez R.: B-0168Perisinakis K.: B-0996Perkins A.: A-402Perks F.: B-0780Perri M.: B-0378Perry N.: B-0680Persechino R.: B-0691, B-0693Perseghin G.: B-0850Persigehl T.: B-0805, B-0806Persson A.: B-0287Pescarini L.: B-0686Peschel O.: B-0727Pesquer L.: B-0310Peter V.: B-0448Peters N.H.G.M.: B-0072, B-0565Petersen C.: B-0892Petersen D.: B-0896Petersen J.: B-0163Petersen S.E.: B-0413, B-0663Petralia G.: B-0082Petrillo A.: B-0217, B-0233, B-0942Petrillo M.: B-0942Petrone G.: B-0021Peynircioglu B.: A-178Peyrin F.: B-0890Pezzato A.: B-0416, B-0662Pfammatter T.: B-0063Pfannenberg C.: B-0447, B-0504Pfefferkorn T.: B-0353Pfeiffer F.: B-0112, B-0846, B-1006Pfeiffer H.: B-1011Pfirrmann C.W.: B-0187Pfirrmann C.W.A.: A-496, A-599, B-0048, B-0181,

B-0314, B-0938Pflederer T.: B-0665Pham T.T.: B-0145Phillips G.S.: B-0145Piaggesi A.: B-0922Piano M.: A-045


289

Pianta L.: B-0479Piccazzo R.: B-0197Piccolo C.L.: B-0342, B-0939Pichi A.: B-0796Pidial L.: B-0335, B-0911Pieles G.: B-0856Pienn M.: B-0639Pieper S.: B-0284Pierot L.: A-132Pietrabissa A.: A-049Pietrapertosa A.: B-0855Pietsch H.: B-0167, B-0747, B-0913Piga M.: B-0617, B-0979Pigneur F.: B-0459Pijl M.E.J.: B-0137Pijnappel R.: B-0962, B-0964Pijnappel R.M.: B-0959Pilania K.: B-0641Piliszek A.J.: B-0852Pilleri S.: B-0958Pilleul F.: B-0443, B-0444Pilz L.R.: B-0022Pina Insausti L.: B-0810Pina Insausti L.J.: B-0685, B-0966Pina L.: B-0809Pina L.J.: B-0813Pinheiro J.: B-0138, B-0602, B-0603, B-0876Pinker-Domenig K.: B-0071, B-0076, B-0171, B-0213,

B-0502, B-0562, B-0680, B-0950, B-0951, B-0952, B-0953

Pinker-Domenig K.J.: B-0563Pinochet M.A.: A-403Pinto dos Santos D.: B-0420Pinto P.: B-0173Piorkowski C.: B-0909Pirinen M.: B-0135Pirovano G.: B-0369Pirtoli L.: B-0947Pisanec I.: B-0652Piscaglia F.: A-582Pisco J.M.: B-0175Pistolesi D.: B-0698Pitcher R.: A-262Pitici A.: B-0141, B-0807Pitocco F.: B-0020, B-0407, B-0468, B-0469, B-0579Pittiani F.: B-0705, B-0716Pitton M.: B-0420Plaitakis A.: B-0223, B-0228Plass A.: B-0660Platon A.: B-0121Plug G.: A-170Plumb A.: B-0789Png M.A.: B-0659Podgórski P.: B-0847Podo F.: B-0569Poeppel T.D.: B-0500Pohlig F.: B-0435Poillucci G.: B-0762Pokieser P.: A-415Pokieser W.: SK 26Polanec S.: B-0171, B-0502Poletti P.-A.: B-0121Polico I.: B-0686Pollo C.: B-0405Pollock A.: B-0864Pomar-Nadal A.: B-0403Pomschar A.: B-0106

Pontana F.: B-0519, B-0630Ponti F.: B-0316Pontone G.: B-0262Poole K.E.S.: B-0658Popovici C.: B-0141, B-0807Poppert H.: B-0113Poretti D.: B-0771Portelli J.L.: B-0604Porto A.: B-0217Postema S.: SY 1Poxton I.R.: B-0060Pozzi G.: B-0785Pozzi Mucelli R.: B-0416, B-0572, B-0574, B-0662,

B-0706, B-0710Pozzi-Mucelli R.: A-031Prabhu A.D.: B-0013Prada R.: B-0185Prasad V.: B-0282Prassopoulos P.: B-0115Pravata’ E.: B-0408, B-0409Precht H.: A-393Prevos R.: B-0450, B-0451Prieto J.M.: A-054Prince J.F.: B-0032Probst P.J.: B-0819Proietti A.: B-0686Prokop M.: A-429, B-0297, B-0299, B-0610, B-0758,

B-0891Pronin I.N.: A-510Prosch H.: B-0635, B-0636Provenzale J.: SY 6Pruvo J.-P.: A-364Prvulovic M.: B-0812Prvulovic N.: B-0812Puchner S.: B-0917Puderbach M.: B-0162, B-0766Puderbach M.U.: A-083, A-618Pueyo J.C.: B-0143, B-0900Pugliese F.: A-514, B-0413, B-0663Pugliese L.: A-049Pugliese S.: A-346, B-0675Pujol S.: B-0284Puliti D.: A-062Pullara S.K.: B-0056Pullini S.: B-0834, B-0835Puntel G.: B-0572Punwani S.: B-0097, B-0207, SY 15Puppala S.: B-0256Puppo C.: B-0197Puri S.: B-0557Puri S.K.: B-0013Purz S.: B-0158, B-0558Pusceddu C.: B-0533, B-0535, B-0958Pusztaszeri M.: B-0970Pwint T.: B-0062

QQian J.: B-0034, B-0040Qiao M.: B-0368Qiu L.: B-0018Quaia E.: B-0762, B-0944Quan Q.: B-0883Quattrocchi C.C.: B-0020, B-0407Quehenberger F.: B-0234, B-0743, B-1032Quentin M.: B-0081Querques G.: B-0440Quinlan M.: B-0823

RRaatschen H.-J.: B-0191Rabenalt R.: B-0081Rączkowska S.: B-1014Radler E.: B-0975Radulovic O.S.: B-0566Radwan S.: B-0906Raetzer S.: B-0242Ragab Y.: B-0123Rager O.: B-0970Rahali L.: B-0770Rahmat K.: B-0015, B-0404Rahmouni A.: B-0459, B-0924Raible S.: B-0616Raimondi S.: B-0082

Rainford L.: B-0272, B-0384, B-0604, B-0606, B-1022, B-1028

Raissaki M.: B-0541Rajandran Nair S.: B-0404Ramalho M.: B-0822, B-0971Ramchandran P.V.: B-0056Ramírez Fuentes C.: B-0168Ramli N.: B-0404Rampoldi A.: B-0925Rana S.: B-0573Randrianarisoa E.: B-1008Ranschaert E.R.: A-290, A-609Rapellino A.: B-1033Raptis D.A.: B-0314Raskin S.: B-0612Rasper M.: B-0912Rassokhin V.: B-0229Ratib O.: A-210, A-608, B-0970Raupach J.: A-245Rauscher I.: B-0098Ravanelli M.: B-0203, B-0204, B-0478, B-0479Ravaud A.: B-0176Raymond E.: A-358Rayón-Aledo J.C.: B-0403Razek A.A.: B-0150Rechl H.: B-0435Reddy S.N.: B-0060Redel T.: B-0482Redheuil A.: B-0007Reding R.: B-0987Reeder S.B.: B-0445Reekers J.A.: A-100, A-101Regier M.: B-0367, B-0765, B-0935Regina U.M.V.: B-0763Rehani M.M.: A-384Rehman H.: B-0780Rehnitz C.: B-0481Reich C.: B-0683Reichelt D.C.: B-0749, B-0905Reichenbach J.R.: B-0886Reichert M.: B-0343Reid J.: B-0373Reiffers S.: B-0664Reijman M.: B-0485Reimer P.: A-453Reina V.: B-0512Reindorp N.: B-0129Reiner C.S.: B-0063Reinert M.: B-0752Reinhardt M.: B-0558Reis C.I.S.: B-0872, B-0874, B-0877


290

Reiser M.F.: A-180, A-492, B-0066, B-0068, B-0106, B-0112, B-0113, B-0117, B-0161, B-0195, B-0243, B-0288, B-0341, B-0344, B-0353, B-0472, B-0491, B-0547, B-0556, B-0578, B-0634, B-0638, B-0727, B-0754, B-0755, B-0757, B-0795, B-0800, B-0803, B-0846, B-0913, B-0927, B-0928, B-0975, B-0980, B-0995, B-1006, B-1036

Reiter G.: B-0667, B-0858, B-0914Reiter U.: B-0667, B-0858, B-0914, B-1032Reitter A.: B-0398Remedios D.: A-292Rémy J.: B-0376, B-0519, B-0630, B-0729, B-0731Rémy-Jardin M.: A-559, B-0376, B-0519, B-0630,

B-0729, B-0731Renc O.: A-245Rengo M.: B-0193, B-0661, B-0792, B-0793Renne G.: B-0082Renne S.: B-0467Renosi G.: B-0094Renoux J.: A-160Renz D.: B-0189, B-0306Rep S.: A-522Repa I.: B-1024Reponen J.: A-048Retico A.: A-266Revel M.-P.: A-562Revelli M.: B-0197, B-0948Reymen B.: B-0065Reynaud O.: B-0201Ribeiro A.M.: B-0603Ribeiro J.: B-1021Ribeiro L.P.V.: B-0136, B-0138, B-0274, B-0386,

B-0602, B-0603, B-0607, B-0871, B-0875, B-0876, B-1020

Ribeiro M.M.C.P.: B-1019Ribeiro R.T.: A-169Riccabona M.: A-482Ricchi P.: B-0854Ricci V.: B-0392, B-0941, B-0947Richli Meystre N.: B-0387, B-0869Richter S.: B-0109Ricke J.: A-566Ridereau-Zins C.: B-0797Riebisch M.: B-0101Rieger M.: A-067Riegger C.: B-0506Rienmüller R.: B-0916Rienmüller T.: B-0916Riess H.: A-319Riffel P.: B-0540Rimola J.: A-593Rimondi E.: B-0640Rindi G.: B-0021Ring J.: B-0805Ringe K.I.: B-0191Ringl H.: B-0328, B-0719Rio Tinto H.A.M.R.: B-0175Ripkens S.: B-0447Risser D.U.: B-0613Risson J.-R.: B-0312Rist C.: B-0556Ristanis S.: B-0929Ritter C.O.: B-0001Rittig K.: B-1008Rizzatto G.: A-611Rizzi P.B.: B-0006Robben S.G.F.: A-531, A-627

Robinson P.: A-497, B-0431, B-0779Roca E.: B-0204Roccia S.: B-1031Rocha A.: B-0185Rocha D.P.: B-1019Rochitte C.E.: B-0006Rockall A.G.: A-377Rodari M.: B-0503Roden M.: B-0100Roditi G.: A-182Rodrigues J.C.L.: B-0527, B-0856Rodrigues S.I.: B-0136, B-0274, B-0386, B-0602,

B-0607, B-0871, B-1020Rodriguez-Justo M.: B-1003Rodt T.: B-0038, B-0244, B-0768Roebuck D.: A-394, A-396Roemer F.W.: B-0656, B-0932Roeth A.: B-0981Rogalla P.: A-231, A-428, B-0699, B-0702Rogler G.: B-0198Roh J.: B-0364, B-1002Rohan V.: B-0358Rokytska N.: B-0735Rollandi G.A.: B-0197, B-0948Rollandi L.: B-0197Romanini L.: B-0705Romaniuk-Doroszewska A.: B-0671Romano A.: B-0518, B-0675Romano L.: B-0045Romano S.: A-349Romero L.: B-0211Rominger A.: B-0117, B-0556Ron Y.: B-0978Ronconi P.: B-0182Ronot M.: A-109, A-358Roobottom C.: B-0798, B-0821Ros J.: B-0143Rosati R.: B-0466Rosen B.R.: A-209Rosendahl K.: A-533Rosenthal H.: B-0038, B-0047Rositi H.: B-0890Roskams T.: B-0804Rossi A.: A-086, A-120, A-514, A-626, B-0410,

B-0413, B-0415, B-0663Rossi C.: B-0532Rossi Espagnet M.C.: B-0518, B-0675Rossi G.: B-0640Rossi M.: B-0921Rossini A.: B-0424, B-0850Rossini P.: B-0203Roßpunkt S.: B-0068Rostad E.: B-0870Rosu R.: B-0141, B-0807Rotellar F.: B-0778Roth H.R.: B-0789Rotini R.: B-0642Rotondo A.: B-0057, B-0059Rottbauer W.: B-0412, B-0583Rousseau H.: A-244Rovelli A.: B-0596Rovers M.M.: B-0083Rovira-Cañellas A.: A-500, A-613Rozhkova Z.Z.: B-0019Rozovsky K.: B-0591Rübben H.: B-0969Rubbert C.: B-0326

Rubens M.B.: A-572Ruder T.D.: A-475Rüfenacht D.A.: A-133Ruggieri P.: B-0640Ruggiero A.: B-0887Ruiz Blanco C.: A-284, A-287Rummeny E.J.: B-0098, B-0180, B-0322, B-0435,

B-0525, B-0548, B-0586, B-0880, B-0881, B-0912, B-0937

Rundstein A.: B-0458Runge J.H.: B-0790Runge M.: B-0312Runnebaum I.B.: B-0077, B-0808Ruscheweyh R.: B-0106Russe M.F.: B-0361Russo B.: B-0663Ruszniewski P.: A-604, B-0576Rutten M.J.C.M.: SY 4Rybacki K.: B-0749Ryoo I.: B-0516

SSaa J.: B-0103Saake M.: B-0895Saam T.: B-0112, B-0113, B-0117, B-0353, B-1006Saba L.: B-0057, B-0059, B-0532, B-0617, B-0979Sablayrolles J.-L.: B-0370Sabri O.: A-208, B-0558Sacco P.: A-607Sack I.: B-0896Sacrini A.: B-0770Sadeghi M.: B-0927, B-0928Sadegi M.: B-0536Saez F.: A-628Sagarduy M.I.: B-0257Sagniez A.: B-0370Sah B.-R.: B-0063Sahin M.: B-0718Saini S.: B-0069Sainz M.: B-0809Sairanen V.: B-0249Saito K.: B-1029Saiz-Mendiguren R.: B-0810Sajadidhekrodi F.: B-0128Sakahara H.: B-0570, B-1004Sakai S.: B-0986Sakamoto S.: B-0305Sakuma H.: B-0581Sala A.: B-0596Sala E.: A-412, A-586, B-0390Sala G.: B-0416, B-0662Salamon J.: B-0888Salazar J.P.: B-0222Saldari M.: B-0394, B-0396, B-0863, B-0868Salem R.: A-359Salem U.: B-0141Salerno S.: B-0730, B-0990Salgado R.: A-055, A-205, A-365, B-0285, B-0286Salice S.: B-0509, B-1013Salik A.E.: B-0838Şalk I.: B-1034Salmi A.: B-0424Saltybaeva N.: B-0991, B-0992, B-0993Salvador R.: A-612, B-0211Salvador X.: B-0211Salvagnini E.: B-0842Salvatori F.M.: B-0300, B-0775, B-0920


291

Salvatori L.: B-0465Salvini N.: B-0194Salvioni M.: B-0769Samadi A.R.: B-0007Samargiski M.: B-0430Sancho L.: B-0136Sandborg M.: B-0287Sander T.: B-0913Sandman D.: B-0319Sangro B.: A-075, A-079Sano K.: B-0093Sansone M.: B-0942Santamaria V.: B-0467Santangelo T.: B-0729, B-0731Santo E.: B-0978Santodirocco M.: B-0854Santoro F.: B-0569Santos A.: B-0140Santos C.S.L.: B-1019Santos J.: B-0272, B-0275, B-0278, B-0605Saraiva A.: B-0140Sardanelli F.: A-130, B-0217, B-0545, B-0569,

B-0654, B-0687, B-0741, B-0814, B-0815Sargos P.: B-0421Sarpi D.: B-0130Sasiadek M.: B-0744, B-0847, B-1016Sasiadek M.J.: B-0401Sassen S.: B-0627Sassi C.: B-0316Satani N.: B-0828Sato F.: B-0828Sato K.: B-0570, B-1004Sato S.: B-0346Satou S.: B-0329, B-0767Sauerschnig M.: B-0180, B-0937Sauvanet A.: A-604Savastano M.: B-0930Savchenkov Y.: B-0833Savoca V.: B-0972Sawicka E.: B-0671Scaglione M.: A-220, B-0059Scagnelli P.: B-0267Scandiffio R.: B-0623Scaperotta G.: B-0561Scaperrotta G.P.: B-0956Scaranelo A.: B-0219Scarciolla L.: B-0407, B-0020Scardapane A.: B-0283Scarsbrook A.: B-0554Schaafsma B.E.: B-0208Schaefer-Prokop C.: B-0169, B-0297, B-0610Schaefer-Prokop C.M.: A-195, A-477Schaeffeler C.: B-0435Schäfer A.-O.: B-0551Schäfer F.K.W.: SY 2Schäfer L.C.: B-0708Schäfer N.: B-0063Schäfer P.: B-0039Schäffeler C.: B-0180Schaible T.: B-0865, B-0866Scharer S.: B-0635Schatteman J.: B-0088Scheffler S.: B-0936Scherer A.: B-0159, B-0651Scherer D.: B-0629Scherrer A.: B-0694Schidt T.M.: B-0315

Schild H.H.: B-0546Schilham A.M.R.: B-0721Schillinger M.: A-486Schima W.: A-005, A-438, B-0719Schimmoeller L.: B-0081Schimmöller L.: B-0366, B-0522, B-0703Schindera S.T.: B-0699, B-0702Schindler A.: B-0419Schipper R.J.: B-0212Schipper R.-J.: B-0451Schlamann M.: B-1011Schleder S.: B-0725Schleich C.: B-0648, B-0651Schlemmer H.-P.: A-058, A-211, B-0241, B-0766Schlett C.: B-0917Schlichting M.: B-0800Schlosser T.: B-0584Schmadl M.: B-0447Schmeding M.: B-0981Schmehl J.: B-0923Schmeling A.: B-1011Schmid-Bindert G.: B-0022Schmidmaier G.: B-0188Schmidt B.: B-0240, B-0242, B-0372, B-0589,

B-0660, B-0788, B-0889, B-0993Schmidt C.: B-0556Schmidt C.O.: B-0681Schmidt G.: B-0547Schmidt H.: B-0504Schmidt S.: A-591Schmid-Tannwald C.: B-0556Schmitt B.: A-153, B-0481Schmitt P.: B-0252Schmitz M.: B-0578Schmitz-Rixen T.: B-0258Schnabel J.A.: A-235, B-0070Schneider D.: B-0289, B-0352, B-0848Schneider G.: B-1035Schneider J.F.: A-224Schneider K.: B-0732, B-0733Schneider M.: B-0651, B-1036Schnitzer A.: B-0214Schoder H.: A-179, B-0390Schoellnast H.: B-0743, B-1032Schoenaers J.: B-0248Schoenmeyer R.: B-0282Schoepf U.J.: A-450, B-0263, B-0266, B-0411, B-0417,

B-0419, B-0849, Rising StarsSchoierer O.: B-0188Schollenberger A.: B-0398Schöllnast H.: B-0234, SK 27Scholten E.T.: B-0297, B-0610Schönberg S.O.: B-0022, B-0160, B-0214, B-0265,

B-0289, B-0343, B-0345, B-0352, B-0540, B-0628, B-0683, B-0829, B-0848, B-0865, B-0866, B-0889, B-0999

Schonenberg D.: B-0593Schönfelder M.: B-0224Schönnagel B.P.: B-0859Schouman-Claeys E.: B-0310Schraml C.: B-0504Schramm N.: B-0556Schramm P.: B-0676Schramm R.: B-0676Schrauwen P.: B-0317, B-0853Schrauwen-Hinderling V.B.: B-0317, B-0853Schreutelkamp I.L.: B-0965

Schreyer A.: B-0725Schroefel H.: B-0265Schroth G.: B-0752Schuelke C.: B-0190Schueller G.: A-219, B-0719Schukro C.: B-0107Schultz T.: B-0144Schulz B.: B-0290, B-0393, B-0700, B-0723, B-0774Schulze F.: B-0618Schulz-Menger J.: SY 6Schumacher U.: B-0879, B-0888Schurink G.W.W.H.: B-0253Schuster H.: SK 26Schütz T.: B-0448Schuur K.H.: B-0964Schwabe P.: B-0189Schwaiger M.: B-0322Schwartz L.: B-0806Schwarz D.: B-0765Schwarz F.: B-0066, B-0582Schweiger M.: A-322Schweitzer N.: B-0038Schweizer A.: B-0048Schwenke C.: B-0172Schwenzer N.F.: B-0504Schwöppe C.: B-0805Schymik G.: B-0265Scoazec J.Y.: B-0094Sconfienza L.M.: B-0654, B-0741, EuroAIMScorsetti M.: B-0507Scott S.: B-0423Scrascia F.: B-0020Scrimieri A.: B-0716Sdao S.: B-0741Secchi A.: B-0440, B-0449Seccia V.: B-1010Sechopoulos I.: B-0840Secil M.: B-0974Sedlacek S.: SY 5Sedlmair M.: B-0290, B-0889Seeger A.: B-0004, B-1008Seiberlich N.: B-0668Seidel R.: B-1035Seidenbusch M.C.: B-0732, B-0733Seiji K.: B-0828Seimenis I.: B-0996Seipel R.: B-0681Seker F.: Rising StarsSeki S.: B-0293, B-0329, B-0526, B-0767Sekiguchi R.: B-0336Sekiguchi T.: B-0777Sellari Franceschini S.: B-1010Sellars M.: B-0976Sellars M.E.: B-0973Selwaness M.: B-0111Semmler W.: B-0434Semturs F.: B-0950, B-0951Sengel C.: B-0429Senol U.: A-294Senyurt H.: B-0486Seo B.K.: B-0073Seo H.: B-0221Seo H.S.: B-0475Seo J.M.: B-0826Seol H.: B-0221Seol H.Y.: B-0475Serafin Z.: B-0304


292

Serafini G.: B-0186Serém S.: B-0605Serfaty J.-M.: B-0310Sergi M.E.: B-0394, B-0396, B-0863, B-0868Serranheira F.: B-0874Serša, I.: B-0652Sersar R.: B-0103Settles M.: B-0881, B-0912Seuntjens J.: B-0245Sewerin P.: B-0651Shaaban M.A.: B-0816Shah A.: B-0256Shaheed M.A.: B-0150Shakiba M.: B-0220Shalmon A.: B-0458Sharifi H.: B-0065Sharipova A.: B-0545Sharma R.A.: B-0062, B-0070Sharoubim N.: B-0245Sharp P.: A-233Sheikh K.A.: B-0905Shen M.-W.: B-0884Shi D.: B-0517Shi H.: B-0368Shi J.: B-0022Shi X.-Y.: B-0884Shiga T.: B-0986Shim Y.M.: B-0296Shin H.-O.: B-0165, B-0166, B-0244Shin H.S.: B-0516Shin J.H.: B-0499Shin J.K.: B-0269Shinagawa K.: B-0305Shiraishi Y.: B-0581, B-0760Shmueli K.: B-0207Shrimpton P.C.: A-516Shum J.S.: B-0474Shweel M.: B-0713Siablis D.: B-0919Sibert A.: A-021Sibileau E.: B-0797, B-0837Sidek S.: B-0015Sidhu P.S.: A-425, B-0973, B-0976Siebenhandl P.: B-0398, B-0700Siemonsen S.: B-0354Siemund R.: A-204, B-0169, B-0892Siesling S.: B-0560Sieswerda G.T.: B-0005Sievers B.: B-0584Sijbers J.: A-518Sijens P.E.: B-0442Silecchia G.: B-0193Sileo C.: B-0738, B-0867Silva C.A.: B-0136, B-0138, B-0274, B-0875, B-0876,

B-1020Silva I.: B-0140Silva N.: B-0631Silverman J.R.: B-0849Silvers R.: A-090Sim J.Y.: B-0052Sim L.: B-0215Sima D.: B-0510Simanovsky N.: B-0591Simeone A.: B-0376, B-0729Simeonsson R.J.: B-0380Simon I.: B-0809Simon M.: B-0896

Simonetti G.: A-376, B-0085Simon-Yarza I.: B-0685, B-0813, B-0900, B-0966Simos P.: B-0223, B-0228Singh A.K.: B-0069Sinitsyn V.E.: A-094Sipola P.: A-093Sippel N.: B-1030Sirlin C.B.: A-217Sironi S.: B-0064, B-0235, B-0236, B-0254, B-0268,

B-0391, B-0438, B-0439, B-0492, B-0505, B-0596, B-0620, B-0745, B-0783, B-0787, B-0827, B-0832, B-1005

Sitia G.: B-0239Sjöberg T.: B-0169Sjövall A.: B-0149Skaane P.: B-0817, SY 17Skehan S.: A-146Sklair-Levy M.: A-541, B-0458Škrk D.: B-0609Skrok J.: B-0232Slabaugh G.: B-0789Slanetz P.J.: B-0954Slapa R.Z.: B-0717Slenter J.: B-0853Slon P.: B-0143, B-0514, B-0685, B-0778, B-0813,

B-0900, B-0945Slotboom J.: B-0405Slowinska-Srzednicka J.: B-0717Sluimer J.C.: B-0116Smal Y.: B-0991, B-0992Smeets D.: B-0280Smets A.M.J.B.: A-395Smidt M.: B-0450, B-0451Smidt M.L.: B-0212Smit A.J.: B-1001Smith A.: SY 17 Smits D.: B-0997Smits M.: A-098, B-0894Smits M.L.J.: B-0032Snaith B.: B-0133, B-0383, B-0389Sneddon K.: B-0780Snijder R.J.: B-0005Snoeckx A.: A-055So M.C.: B-0377Soares J.: B-0607Soder R.B.S.: B-0590Soens J.: SY 1Soffia P.: A-403Sogaro F.: B-0716Sohn C.-H.: B-0513Solak O.: B-1034Solbiati L.: B-0646, SK 26Solcia M.: B-0925Sollazzo P.: B-0394, B-0396, B-0863, B-0868Solyanik O.: B-0166Sommer C.M.: B-0178Sommer G.: B-0766Sommer P.: B-0909Sommer S.P.: B-0001Sommer W.H.: B-0754, B-0755, B-0757, B-0803,

B-0980Somville J.: B-0432Son G.: B-0221Son J.Y.: B-0296Son K.R.: B-0475Song K.: Rising Stars Song M.G.: B-0269

Song S.E.: B-0073Sonoyama Y.: B-0986Soria Jerez J.A.: A-288Sosef M.N.: B-0627Soto García M.R.: A-289Soto Giordani G.: A-405, A-407Soto J.A.: B-0122, B-0124Sottocornola L.: B-0424, B-0479Sourbron S.: B-0547, B-0980Sourbron S.P.: B-1029Sousa A.: B-0605Sousa P.: B-0607, B-0871Souvatzoglou M.: B-0322, B-0912Souza R.: B-0319Souza R.B.: B-0657Spagnolli F.: B-0710Spagnolo P.: B-0268Spampinato M.V.: B-0408, B-0409Spelsberg F.W.: B-0195Sperryn C.W.: A-256Spiliopoulos S.: B-0919Spinhoven M.: A-055Spinicci G.: B-0313Spinnato P.: B-0640Spira E.-M.: B-0263Spiro A.: B-0935Spoerl M.C.: B-0146Sproll C.: B-0159Srinivasan S.: B-0056, B-0294Srutek E.: B-0321Stabile Ianora A.A.: B-0283Stacul F.: A-456Stadler A.: A-248Staehler M.: B-0066, B-0344, B-0975Staffa J.: B-0629Stahl R.: B-0491Stahlhut L.: B-0806Stajgis M.: A-143Stalder A.: B-0667, B-0914Stampfl U.: B-0178Staniuk T.: B-0321Stankovic Z.: B-0361Stanton M.T.: A-168Staudacher C.: B-0801Stavros T.: B-0955Steen M.: B-0806Steen S.: B-0169Stef I.: B-0447Stefan N.: B-0447Stehlin L.: B-0361Stein J.: B-0864Stein L.: B-0619Steiner J.: B-0234, B-1032Steinhoff K.G.: B-0158Steketee R.M.E.: B-0894Stelter L.: B-0189Stenberg L.: B-0892Stenson M.: B-0216Stephan C.: B-0172Sterzaj S.: B-0273Sterzik A.: B-0066, B-0068Stiassny F.: B-0719Stick S.: B-0737Stieber P.: B-0795Stiefsohn E.: B-0635Stieltjes B.: B-0151Stift J.: B-0096


293

Stiller B.: B-0736Stiller W.: B-0241, B-0523Stocker D.: B-0743Stockmar M.: B-1006Stoeckle E.: B-0421Stojanov D.A.: B-0677Stoker J.: B-0790, B-1037Stollberger R.: B-0639Stolzmann P.: B-0660, B-0910Stoppino L.P.: B-0904Stork A.: SY 13Stotts G.: B-0756Stöver T.: B-0709Strang J.: B-0557Straube A.: B-0106, B-0353Streich N.: B-0481Streicher J.: B-0613Streitparth F.: B-0189, B-0306, B-0539Strengers J.L.M.: B-0734Strieth S.: B-0709Strobl F.F.: B-0757, B-0923Stroszczynski C.: B-0725, B-0903, B-0985Strube H.A.: B-0578Struelens L.: B-0842Struffert T.: B-0895Studniarek M.: A-399, B-0321Stumpp P.: B-0158, B-0558Sturkenboom M.C.J.M.: B-0142Subhani S.: B-0621Sudarski S.: B-0289, B-0352, B-0848Sugihara N.: B-0526Sugimura K.: B-0329, B-0346, B-0526, B-0767Sugiyama K.: B-0305Suh B.S.: B-0052Suh C.: B-0091Suh S.: B-0221Suh S.I.: B-0475Suman L.: B-0561, B-0956Summers L.: B-0599Sun F.: B-0517Sun J.: B-0259Sunaert S.: A-420, A-502, B-0510Sundqvist R.: B-0149Sung Y.M.: B-0521Sunwoo L.: B-0513Suoranta S.: B-0011, B-0017Suri J.S.: B-0617Šurlan Popovič K.: B-0476Suryanarayanan S.: SY 16Sussman M.: B-0668Sutter R.: B-0048, B-0938Suzuki S.O.: B-0673Svahn U.: B-0109Sverzellati N.: A-617Swift S.: B-0554Syed R.: B-0549Syrgiamiotis V.: A-345Szabó E.: A-026Szabó G.: B-0523Szczerbo-Trojanowska M.: A-391Szczygielski O.: B-0671Szewcyk-Bieda M.: B-0332Szewczyk P.: B-0401Szucs-Farkas Z.: B-0699, B-0702

TTacelli N.: B-0630Tacher V.: B-0036, B-0924Tack D.: A-419, B-0053, B-0520Tacke J.: SK 27Tagliafico A.: A-163, B-0688Tagliamonte M.: B-1013Tahon F.: B-0355Tai C.W.: B-0377Taibi A.: B-0684, B-0811Taioli G.: B-0416Tajima T.: B-0986Takada E.: B-0336Takahashi S.: B-0346, B-0674, B-0828Takahashi Y.: B-0720Takamura T.: B-0093Takase K.: B-0828Takei N.: B-1004Tal S.: B-0227Talakic E.: B-0743, B-1032Talanow R.: B-0200Talei Franzesi C.R.G.L.: B-0064, B-0254, B-0745,

B-0827, B-1005Tali E.T.: A-164Tamás J.: B-0983Tamboli P.: B-0824Tammo R.: B-0735Tan C.-F.: B-0931Tan C.H.A.: B-0294Tan L.K.K.: B-0404Tan T.: B-0968Tan Y.: B-0806Tanaka K.: B-0580Tandon A.: B-0041Tandon R.: B-0199Tanghe H.: A-311Tanis W.: B-0008Tanner L.: B-0624Taori S.: B-0060Taourel P.: A-350Tapfer A.: B-0846Tarantino G.: B-0231, B-0237Tardáguila G.: B-0185, B-0631Tardivon A.: A-156Tarján Z.: A-544Tarkowska A.: B-0879Tartaro A.: B-0002, B-0251, B-0509, B-0930, B-1013Taschwer M.: B-0224Taşkın F.: SY 5Tassart M.: B-0538Tatekawa H.: B-1017Täubl P.: B-0743Taupitz M.: B-0324Tavanti F.: B-0518, B-0675Tavares de Sousa M.: B-0859Tavernier J.: B-0408Tawfik A.M.: B-0150Taylor A.M.: A-323Taylor K.: B-0870Taylor S.: B-0520Taylor S.A.: A-232, A-590, B-0097Tee L.M.F.: B-0192Teh H.S.: B-0294Teichgräber U.: B-0306Teixidor Viñas M.: B-0498Tejada S.: B-0514Telegrafo M.: B-0283

Teleman A.: B-0653Telesca M.: B-0453Tenkanen-Rautakoski P.: B-0135Tepe G.: B-0923Terauchi K.: B-0570, B-1004Terjung J.: B-0159Terzi E.: A-582Tessa C.: B-0465Tessitore P.: B-0203, B-0716Tetsuka R.: B-0338, B-0339Teusch V.: B-0733Texter J.: B-0006Tezza M.: B-0416, B-0662Thakrar P.: B-0641Thalhammer A.: B-0258, B-0774Thali M.: A-472Tham S.-C.: B-0655Theander E.: B-0653Theisen D.: B-0582, B-0803, B-0913Theysohn J.M.: B-0782Thiele H.: B-0851Thieme S.F.: B-0161, B-0288, B-0634Thierfelder C.: B-0372Thierfelder K.M.: B-0754, B-0755, B-0757Thipphavong S.: B-0702Thoeny H.C.: A-069, A-439, A-535, B-0819Thomassin-Naggara I.: A-553Thomé C.: B-0907Thompson C.: B-0371Thomsen F.: B-0436Thomsen H.S.: A-455Thomsen L.H.: B-0163Thomson K.: B-0332Thörmer G.: B-0448Thorneman K.: B-0967Thurnher M.M.: A-263, A-615, Rising StarsTicca C.: B-0492Tiddens H.A.W.M.: B-0737Tielbeek J.A.W.: B-0790Tielliu I.F.J.: B-0588Tille M.: B-0851Tillement O.: B-1035Tillich M.: B-0743Timberg P.: A-507Timmer J.R.: B-0664Timmers J.: B-0959, B-0962Timmers J.M.H.: B-0964Tinelli C.: B-0092Tingberg A.: A-507Tinozzi F.P.: A-049Tintore M.: B-0222Tio R.A.: B-0588Tiomni E.: B-0978Tissier A.-M.: B-0084Tjan-Heijnen V.: B-0450, B-0451Tkacz J.N.: B-0954Todoroki T.: B-0470Toepker M.: B-0328, B-0719Togao O.: B-0515, B-0673, B-0678Tokgoz N.: B-0899Tokuuye K.: B-1029Tolan D.J.M.: A-348, A-528, B-0196Toledano A.: B-0686Tomà P.: A-530Tomás C.: B-0872Tombolini V.: B-0089, B-0090, B-0645Tomic N.: B-0245


294

Tomšič M.: B-0652Tondolo T.: B-0646Tong M.P.: B-0042Tonkin C.J.: B-0658Töre H.G.: B-0524Tornow A.P.: B-0145Torres-Tabanera M.: A-375Torricelli P.: B-0231, B-0237, B-0349, B-0463Tortora D.: B-0509, B-0930, B-1013Torzilli G.: B-0507Toscano W.: B-0972Toschke C.M.: B-0125Tosto S.: B-0688Toth D.F.: B-0328Toyama T.: B-0759Tramarin M.: B-0771Tran A.: B-0034Trattenero C.: B-0235, B-0236, B-0620, B-0745,

B-0787, B-0832Trattnig S.: A-140, A-150, A-151, ESOR Course,

B-0071, B-0345, B-0488, B-0953Trecate G.: B-0561Treece G.M.: B-0658Treffert J.: B-0028, B-0320Trefois P.: A-196Treitl M.: B-0113, B-0243, B-0927, B-0928Trepel M.: B-0882Trianni A.: B-0998Triantopoulou C.: A-057Trimboli R.M.: B-0217, B-0569, B-0687, B-0814,

B-0815, EuroAIMTrofimova A.: B-0229Trofimova T.: B-0229Trojanowska A.: A-418, A-619, B-0153Trojanowski P.: B-0153Tropres I.: B-0751Trucchi A.: B-0696Trufanov G.: B-0833Truijman M.T.B.: B-0118, B-0120Trumm C.G.: B-0195, B-0491Trypka E.: B-0401Tscherner M.: B-0639Tscholakoff D.: A-464, B-0148Tse D.M.L.: B-0423Tsehmaister Abitbol V.: B-0458Tsimberidou A.: B-0807Tsitas K.: B-0933Tsoumakidou G.: A-043, A-442, A-557, B-0309Tsukamoto K.: B-0570, B-1004Tsurugizawa T.: B-0201Tudisca C.: B-0467, B-0854, B-0855Tulloh R.: B-0856Tupikowski K.: B-0847Tupý R.: B-0358Turhan A.N.: B-0838Turini F.: B-0035Turini F.M.: B-0922Turmel-Rodrigues L.: A-198Turmezei T.D.: B-0658Turowski B.: B-0749, B-0905Tyrrell A.P.: B-0384Tzarouchi L.C.: B-0406, B-0860, B-0862Tzedakis A.: B-0996

UUberoi R.: A-200Ucar M.: B-0899Uder M.: B-0665Ueberle F.: B-0859Ueno Y.: B-0346Uhlenbrock D.: SY 4Uliasz M.: B-0671Ulrich C.: B-0629Ulus S.: B-0327Umutlu L.: B-0347, B-0456, B-0708, B-1030, B-1038Urbach H.: B-0546Urbanczyk M.: B-0009Uren N.: B-0373Urigo C.: B-0130Ursani A.: B-0379

VVagli P.: B-0623Vahrmeijer A.L.: B-0208Vaiani M.: B-0492Valdo M.: B-0454Válek V.: A-186, A-546Valentini A.L.: B-0323, B-0395Valentini V.: A-172Valentino M.: B-0974Valette J.: B-0285, B-0286Valette P.J.: B-0094Valette P.-J.: B-0559Vallée J.-P.: A-369, B-0970, ESOR CourseVallejos J.: B-0257Vallone P.: B-0233Valvassori L.: A-045van Beek E.J.R.: A-084, A-452, B-0373Van Beers B.: A-097, A-215, ESOR Coursevan Buchem M.A.: SY 15Van Cauter S.: B-0510van Cauteren T.: B-0580van Dalen J.A.: B-0664van Dalen T.: B-0072, B-0565van Dam R.M.: B-0981Van de Giessen M.: B-0208Van de Velde C.J.H.: B-0208van de Weijer T.: B-0317van den Berg J.M.: B-0593van den Boom R.: B-0758, B-0891van den Bosch M.A.A.J.: B-0032, B-0072, B-0565,

Rising Starsvan den Bouwhuijsen Q.: B-0111van den Brink R.B.A.: B-0008van den Dungen J.J.A.M.: B-0588van den Hauwe L.: A-131, A-205, A-264, A-346, A-365,

A-556, B-0672van den Heuvel E.R.: B-1001van der Geest R.J.: B-0118, B-0253van der Graaf Y.: B-0027Van der Lijn F.: B-0142van der Lugt A.: A-214, A-368, B-0014, B-0016,

B-0111, B-0114, B-0350, B-0402van der Paardt M.P.: B-0790Van der Zijden T.: A-131, A-205, A-306, A-346, A-365,

B-0301, B-0302van Duijn C.M.: B-0114Van Dyck P.: A-313, B-0432, B-0480van Elmpt W.: B-0065van Engen R.E.: B-0841van Ewijk P.A.: B-0853

van Garsse L.: B-0261, B-0264van Ginneken B.: B-0297, B-0610, B-0758, B-0761,

B-0891Van Goethem J.: A-131, A-264, A-365, A-555Van Goethem J.W.: A-205, A-346, A-556van Goethem M.: B-0450, B-0451Van Gompel G.: B-0248Van Gool S.: B-0510Van Hecke W.: B-0280, B-0285, B-0286van Herwerden L.A.: B-0008van het Schip A.D.: B-0032van Hoof R.H.M.: B-0116, B-0118, B-0120van Landsveld-Verhoeven C.G.C.M.: B-0964van Leeuwen M.S.: B-0550van Lindert E.: B-0672van Mourik J.H.: Rising Stars Van Ommen V.: B-0261, B-0264Van Ongeval C.: SY 1van Ooijen P.: B-0295, B-0298Van Ooijen P.M.A.: B-0291van Oostenbrugge R.J.: B-0118, B-0120van Osch J.A.C.: B-0664, B-0666van Rijswijk C.: A-434van Rikxoort E.M.: B-0297, B-0610van Roozendaal L.M.: B-0212van Rossum M.A.J.: B-0593Van Steen A.: SY 1Van straten M.: B-0737van Tiel J.: B-0485van Westen D.: B-0892van Zelst J.C.M.: B-0968Vande Berg B.C.: B-0542, B-0544Vandecaveye V.: A-568, B-0152, B-0804Vander Poorten V.: B-0152Vandulek C.: B-1024Vanel D.: B-0640, B-0797Vanhoenacker F.M.H.M.: A-312, A-417, B-0480Vanninen R.: B-0011, B-0017Vaño E.: A-385, A-578Varano G.M.: B-0921Vardhanabhuti V.: B-0798, B-0821Vargas H.A.: B-0390, B-0689Varnay G.: B-0121Varol K.: B-0587Varveris C.: B-0611Vasaturo S.: B-0462, B-0463Vasilevska Nikodinovska V.: B-0430Vasselli F.: B-0453Vassilev D.: B-0852Vassileva J.: B-0989Vassiliu V.: B-0084Vasudevan R.: B-0573Vaudano E.: EIBIR Vavro H.: B-0408Vázquez E.: A-468Vecchiato N.: B-0131Vecchietti F.: B-0193, B-0792, B-0793Vecchio S.: B-0684, B-0811Vedrilla D.: B-0636Veillon F.: A-073Veit-Haibach P.: B-0156, B-0157Veldhuis W.B.: B-0072, B-0565Veldkamp W.J.H.: B-0841Velonakis G.: B-0530Veloso Gomes F.: B-0822, B-0971Veloza L.-S.: B-0241Velroyen A.: B-0846


295

Veltman J.: A-226Vembar M.: B-0586Venkatesan A.M.: B-0209Venstermans C.: A-131, A-264, A-346, A-365, A-556Vente M.A.D.: B-0032Ventura E.S.: B-0726Venturini M.: B-0440, B-0712, B-0769Venugopal V.: B-0013Veraart J.: B-0510Verardi N.: B-0814, B-0815Verbeek A.: B-0962Verbeek A.L.M.: B-0959Verbeke C.: A-145Verbist B.: A-463Vercelli R.: B-0925Vercher Conejero J.L.: B-0326Verdolotti T.: A-532Verdun F.R.: B-0542, B-0544Vergnaghi D.: B-0561Verhaar J.: B-0485Verhaaren B.F.J.: B-0014, B-0016, B-0114, B-0402Verkooijen H.M.: B-0072, B-0565Verloh N.: B-0985Verma R.: B-0752Vermeulen K.M.: B-0560Vermoolen M.A.: B-0550Vernieri F.: B-0020Vernooij M.: A-327Vernooij M.W.: B-0014, B-0016, B-0114, B-0350,

B-0402Verschakelen J.: B-0169Versluis B.: B-1007Verslype C.: B-0804Verstraete K.L.A.: A-025Verwoert G.: B-0111Vicente A.: B-0124Victoria T.: B-0864Viegas S.: B-0874Vieth V.: B-0125Viganò S.: B-0561Vigano’ S.: B-0956Vignali C.: B-0465Vikram R.: B-0824Vilanova J.C.: A-315Vilar J.: A-255Vilar Samper J.: B-0168Vilcot L.: A-433Vilela P.: A-367Vilgrain V.: A-017, A-018, A-021, A-109, A-167, A-358,

A-604, B-0576Villani G.Q.: B-0267Villanueva A.: B-0143Villeirs G.M.: B-0088Villien M.: B-0355Vinci V.: B-0394, B-0396, B-0863, B-0868Vinczen E.: B-1024Vining D.J.: B-0141, B-0807Vinnicombe S.: B-0332Virayavanich W.: B-0319Viry F.: B-0512Viteri G.: B-0514, B-0685, B-0778, B-0809, B-0900,

B-0966Vivier P.-H.: A-483Vizza C.D.: B-0464Vlcek A.: B-0613Vliegen R.F.A.: B-0627

Vliegenthart R.: B-0164, B-0291, B-0295, B-0298, B-0299, B-0419, B-0588, B-0918, B-1001

Vock P.: A-052, A-384Voelckel S.: A-067Vogel A.: B-0038Vogiatzi S.: B-0989Vogl T.J.: B-0031, B-0033, B-0034, B-0039, B-0040,

B-0150, B-0170, B-0258, B-0266, B-0290, B-0393, B-0398, B-0471, B-0534, B-0536, B-0537, B-0633, B-0669, B-0700, B-0709, B-0711, B-0723, B-0748, B-0774, SY 12

Vogl W.-D.: B-0562Volbers B.: B-0895Vollherbst D.: B-0178Vollnberg B.: B-0936Volterrani L.: B-0058, B-0194, B-0392, B-0682,

B-0941, B-0947Völzke H.: B-0445, B-0681von Baumgarten L.: B-0754, B-0755, B-0757von Falck C.: B-0038, B-0047, B-0244, B-0768von Roden M.: B-0748von Schneider-Egestorf A.: B-0047von Schulthess G.K.: A-400, B-0156, B-0157von Spiczak J.: B-0482Vonend O.: B-0648Vonk J.M.: B-0164Vonken E.-J.: B-1007Voormolen M.: A-131, A-205, A-306, A-346, A-365Voormolen M.H.J.: B-0301, B-0302Vorwerk D.: A-199Voulgaris C.: B-0541Vrabec M.: B-0476Vrooman H.: B-0402Vrooman H.A.: B-0142Vullierme M.-P.: A-604, B-0576Vurdem Ü.E.: B-1034Vymazal J.: A-307

WWachter M.F.: B-0178Wacker F.: B-0038, B-0047, B-0165, B-0166, B-0191,

B-0244, B-0768Wafae A.A.S.W.: B-0906Wagner A.: B-0341Wagner M.: A-216Waitzbauer M.: B-0950, B-0951Walcher T.: B-0412, B-0583Wald C.: B-0037Waldeck S.: B-0244Walecki J.: B-0303, B-0400, B-0489, B-0852, B-1014Walfridsson H.: B-0149Walker-Samuel S.: B-0097Walleyo A.: B-0865, B-0866Wallis M.G.: A-129, SY 16Wals J.: B-0627Walter T.: B-0306Wambsganss J.: B-0829Wang H.: B-0571, B-0575, B-0884Wang J.: B-0369, B-0571Wang L.-J.: B-0126Wang M.: B-0517Wang P.-C.: B-0225Wang Q.: B-0375Wang X.: B-0334, B-0337, B-0369Wang Y.: B-0334, B-0337, B-0411, B-0893Wang Z.: B-0271, B-0276, B-0496, B-0497, B-0742Wang Z.J.: B-0315

Wanke I.: A-133Wanner G.: B-0788Warnking J.: B-0355Wasser K.: B-0214, B-0683Wasser M.N.J.M.: B-0208Wasserman J.K.: B-0756Webb M.J.: B-0978Weber F.: B-0348Weber J.R.: B-0224Weber M.: B-0328, B-0635, B-0636, B-0802Weber M.-A.: B-0044, B-0188, B-0481Weber N.: B-0277Wedegärtner U.: B-0859Weidenhagen R.: B-0195Weidner A.M.: B-0061Weidner M.: B-0865, B-0866Weinans H.: B-0485Weinheimer O.: B-0162Weir N.W.: B-0373Weishaupt D.: A-162Weismann C.F.: A-611Weiss V.: B-1026Weisser P.: B-0033Weitzel T.: B-0405Welsch G.: A-151Welzel J.: B-0629Wendl C.M.: B-0903Wengert G.: B-0952Wengert G.J.: B-0213, B-0562, B-0563Weninger W.: B-0613Wenkel E.: SY 1Wentzel J.J.: B-0111Werner M.K.: B-0447Wessam R.: B-0949Wesseling N.: B-0734Wesseling P.: B-0672Wessling J.: B-0190West D.J.: A-622West N.P.: B-0196Wetter A.: B-0969Weustink A.: B-0410Whelehan P.: B-0332White T.O.: B-0780Wi J.Y.: B-0026Wiart M.: B-0890Wichmann J.A.: B-0633Wichmann J.L.: B-0669Wickings N.: B-0030Wicklein D.: B-0888Wiebel M.: B-0162Wiedenmann B.: A-602Wiegert J.: B-0371Wielpütz M.O.: B-0162Wiener E.: B-0936Wiersma H.: B-0963Wiest R.: B-0405Wiggermann P.: B-0725, B-0985Wilczek B.: B-0967Wild J.M.: A-081, A-269Wildberger J.: B-0261, B-0264, B-0450, B-0451Wildberger J.E.: A-034, B-0029, B-0065, B-0116,

B-0118, B-0120, B-0317, B-0746, B-0853, SY 10Wildgruber M.: B-0880, B-0881Wille M.M.W.: B-0163Willekens I.: B-0580Willemink M.J.: B-0721Willems T.P.: B-0005, B-0918


296

Willerding G.: B-0324Williams M.: B-0373Willner M.: B-0112, B-1006Wilson D.J.: A-041Wimmer J.: B-0488Wimmer T.: B-0234, B-1032Winant C.: B-0053Winklhofer S.: B-0482, B-0910Winter H.: B-0195Winter S.: B-0344Wintersperger B.J.: A-011, B-0668, B-0913Winterstein M.: B-0044Wipff J.: B-0650Wirth S.: A-413, A-492, B-0243, B-0472Wise R.: B-0839Wishaupt M.C.J.: B-0253Witjes J.A.: B-0083Witteman J.: B-0111Witteman J.C.M.: B-0114, B-0350Wittsack H.-J.: B-0340, B-0486, B-0648Wittschieber D.: B-1011Witwit A.: B-0595Wlderk A.: B-0920Woehrle J.: B-0412, B-0583Woertler K.: B-0435Wojtynska R.: B-0401Wolf F.: A-356, A-573Wolf K.-J.: B-0232Wong C.M.: B-0377Wong G.L.-H.: B-0441Wong V.W.-S.: B-0441Wong Y.-C.: B-0126Woo O.H.: B-0073, B-0433, B-0528Woo S.: B-0230Wood B.: B-0173Wood C.: B-0824Wood P.: A-190Woods L.: B-0595Worst T.S.: B-0534Wörtler K.: A-499, B-0180, B-0937Wouters K.: B-0480Wu B.: B-0897Wu C.-H.: B-0126Wu J.: B-0259Wu T.H.: B-0543Wu X.: B-0897Wuest W.: B-0665Wulff A.: B-0436Wulz-Horber S.: SY 5Würfel J.: B-0896Würslin C.: B-0447Wurster T.H.: B-0003, B-0004Wurz C.: B-0258Wüstner M.: SY 24Wyatt C.R.: B-0657

XXie J.: B-0883Xie X.: B-0164, B-0291Xu L.: B-0023, B-0656Xu P.: B-0334, B-0337Xu S.: B-0173Xue H.: B-0255

Xv F.: B-0893Xyda A.: B-0676

YYaddanapudi K.: B-0371Yaffe M.J.: A-506Yaghmai V.: B-0363, B-0524, B-0615, B-0722Yaghoobi M.: B-0220Yalynska T.: B-0735Yamamura J.: B-0315, B-0859Yamashita K.: B-0515, B-0673, B-0678Yamori Y.: B-1017Yan F.: B-0369Yan Y.: B-0883Yang F.: B-0368Yang X.: B-0018Yang Z.: B-0893Yankelevitz D.: B-0799Yanniello M.: B-0746Yanof J.H.: B-0371Yasunaga K.: B-0519Yazıcı C.A.: B-0901Ye X.: B-0707Yeh W.-L.: B-0931Yellin N.: B-0255Yeom J.A.: B-0516Yeon J.W.: B-0052Yeong C.H.: B-0422Yeow K.K.: B-0294Yeung D.K.-W.: B-0441Yıldırım E.: B-0901Yilmabasar M.G.: B-0362Yim C.: B-0422Yong H.S.: B-0433, B-0528Yoo R.-E.: B-0739, B-0830Yoon H.-K.: B-0499Yoon J.H.: B-0494, B-0830Yoon J.-H.: B-0230Yoon K.-H.: B-0844, B-0845Yoon Y.C.: B-0050Yoong B.K.: B-0422Yoong P.: B-0051Yoshida M.: B-0338, B-0339Yoshida N.: B-1017Yoshida S.: B-1017Yoshikawa T.: B-0293, B-0329, B-0526, B-0767Yoshimoto K.: B-0515, B-0673Yoshiura T.: B-0515, B-0673, B-0678Yousef O.Z.: B-0452Yousry T.A.: A-223, A-509Yuan C.: B-0113, B-0117Yue Q.: B-0018Yüksel M.: B-0055, B-0718Yun B.L.: B-0210Yusuf S.W.: B-1003

ZZaccagna F.: B-0399, B-0414, B-0427, B-0490Zacharzewska A.: B-1016Zacho M.: B-0918Zackrisson S.: A-507Zahel T.: B-0525Zahlmann G.: B-0799

Zaidi S.: B-0145Żak T.: B-1016Zalazar R.: B-0143, B-0813Zalev J.: B-0955Zamboni G.A.: B-0706Zampa V.: B-0698Zampeli F.: B-0929Zanetti M.: A-436Zangos S.: B-0031, B-0033, B-0039, B-0170, B-0258,

B-0393, B-0398, B-0537, B-0748, B-0774Zappa M.: A-358Zar H.: A-262Zarb F.: B-0279, B-1028Zaric O.: B-0953Zawadzki M.: B-0303Zbýň Š.: B-0345, B-0488Zech C.: B-0980Zech C.J.: A-493, A-565Zee N.: B-0786Zegarski W.: B-0321Zeina A.-R.: B-0129Zelber-Sagi S.: B-0978Zeller T.: B-0923Zengel P.: B-0068Zerbi A.: B-0785Zerini D.: B-0503Zerlauth J.-B.: B-0670Zezos P.: B-0115Zhang G.: B-0883Zhang G.-X.: B-0884Zhang H.: B-0571Zhang J.: B-0018Zhang L.: B-0319Zhao B.: B-0806Zhao Y.R.: B-0295, B-0298Zheng L.-F.: B-0884Zhorzholiani S.: B-0916Zhou C.: B-0707Zicchetti M.: B-0092Zikou A.: B-0406, B-0860, B-0862Zilkens C.: B-0486, B-0487Zimny A.: B-0401, B-1016Zini C.: B-0775Zins M.: A-494, B-0837Zizka J.: A-245Zolovkins A.: B-0921Zompatori M.: B-0763Zonnenberg B.A.: B-0032Žontar D.: B-0609Zorlu A.: B-0587Zou L.: B-0018Zoubi R.: B-0077, B-0808Zoumpoulis P.S.: SY 2Zsirka Klein A.: B-0983Zsirka-Klein A.: B-0982Zubieta J.L.: B-0514Zubler C.: B-0752Zucconi F.: B-0492Zuern C.S.: B-0003, B-0004Zuiani C.: B-0132, B-0567, B-0568, B-0684, B-0811,

B-0834, B-0835Zwiers M.: B-1001

ModeratorsList of

This part lists all moderators followed by the session number in italic letters.

List of Moderators

298

AAbolmaali N.: SS 208Adam E.J.: RC 714, Standards and AuditAgadakos E.: SS 214Alguersuari A.: JIIQAllen S.: SS 1702Almeida P.: SS 609aÁlvarez-Benito M.: SS 1802bAndersen P.E.: SS 609bAparisi Gomez M.P.: SS 1810Argyropoulou M.I.: FC Self-Assessment TestArkhipova I.: SS 203Aschauer M.A.: SS 115Avdagic E.: SS 511Ayuso C.: EM 1

BBakke S.J.: SS 111Baramia M.: SS 1307Barentsz J.O.: CC 1421Bargellini I.: SS 601Barkhausen J.: SS 515, SY 4Barsi P.: SS 511Basile A.: SS 609aBauer R.W.: SS 1803Beale T.: RC 1908Beer A.J.: SS 1807Belcari N.: SS 606Bilbao J.I.: EM 1, EM 2, EM 3, EM 4Bilecen D.: RC 815Blackburn Andersen P.: SS 914Bohata S.: SS 503Bosmans H.: SS 1813Brader P.: EIBIR/EORTC Joint WorkshopBrambs H.-J.: RC 401Brancatelli G.: SS 201bBrink M.: SS 1317Brkljacic B.: RC 307Brountzos E.: CC 1218Brouwer P.A.: SY 19Bruegel M.: SS 201bBulja D.: TF 1Buruian M.: SS 1811b

CCáceres J.: RC 304Cademartiri F.: SS 903Camps Herrero J.: SY 3Canet Soulas E.: SS 1803Cano D.: SS 1701aCantisani V.: SS 201aCarbonaro L.A.: SS 902Caseiro-Alves F.: SY 6Castañer E.: SS 104Catalano C.: MC 722Chamming’s F.: SS 1802aChan O.: CC 1418Choi B.I.: SS 1801bCianfoni A.: SS 1811bCiraj-Bjelac O.: RC 1113, SS 113Claudon M.: CC 1521Claussen C.D.: RC 1514Clavien P.-A.: EM 2Clément O.: RC 306Coenegrachts K.: SS 516Cotten A.: SS 1810Cowan N.C.: CC 1121Crocetti L.: SS 1309Cunningham P.M.: SS 910Curvo-Semedo L.: SS 1316

DDamilakis J.: ESR Radiation Protection SessionD' Anastasi M.: 6th Post-Processing Face-Off SessionDanielsson M.: SY 16Das M.: SS 1703de Bruijne M.: EIBIR presents IMAGINE WorkshopDe Foer B.: E³ 420De Graaf N.: SS 1712de Koning H.J.: MC 423de Roos A.: MC 322De Vries L.: MSY 1Delorme S.: SS 116Denecke T.: SS 1716Denys A.: SS 109Derchi L.E.: Joint Session of the ESR and EFSUMB,

EPOS DiscussionsDeutschmann H.A.: RC 715Di Cesare E.: RC 303Diederich S.: SS 504Djilas-Ivanovic D.: SS 502Donato P.: SS 603bDondelinger R.F.: SS 1709Donoghue V.: RC 1412Dormagen J.B.: SS 101a

EElias R.: SS 1308Elliott S.T.: SY 23Ertl-Wagner B.: SS 111Esen G.: RC 302

FFaggioni L.: SS 205Faschingbauer R.: SS 101bFatehi M.: SS 205Feragalli B.: SS 117Ferretti G.R.: SS 204Feuchtner G.: SS 1303Filippiadis D.: SS 115Filippone A.: SS 1801aFoley S.J.: SS 1714Fournier L.S.: SS 607Frija G.: RC 1214, MIR 2Frühwald-Pallamar J.: SS 608Fuchsjäger M.H.: CC 1619Furmanek M.I.: SS 1716Fütterer J.J.: SS 209

GGallagher F.A.: SS 116Garaci F.G.: SS 515Gennaro G.: SS 602Gevenois P.A.: RC 1904Gibaud B.: SS 105Gilbert F.J.: MC 723Girard N.: E³ 920bGizewski E.R.: SS 509Gleeson F.: RC 1104Gleeson T.: SS 1806Golay X.: SS 1311Góraj B.: SS 611Gouliamos A.D.: E³ 720bGourtsoyiannis N.: ESOR SessionGrainger A.J.: SS 1310Graser A.: 6th Post Processing Face-Off SessionGrazioli L.: SS 1306Grenier P.A.: SS 904Gruszczynska K.: SS 1703Grzycka-Kowalczyk L.: RC 1108

HHagen G.: SS 507Hakumäki J.: SS 1706Haller K.: RC 1114Haller S.: SS 1811aHamm B.: SY 18Hany T.F.: SS 916Hartley T.: SY 1Hartmann I.: SS 1304Healy J.: SS 510Helbich T.H.: MC 423, SY 5Hendrikse J.: RC 315Hennig J.: EIBIR Herold C.J.: SS 216Herzog C.: SS 1303Hirsch W.: SS 1312Hjemly H.H.: SS 1814Hoeffel C.: SS 1316Hoeks C.M.A.: SS 507Houssami N.: MC 623, SS 1302Hricak H.: MC 528Huete A.: SS 117Humphries P.D.: SS 1312Hunink M.G.M.: EuroAIMHusty J.: SS 1801a

JJaschke W.R.: SS 215Johnson K.J.: SS 912Jung E.M.: SS 1702

KKarabulut N.: SS 504Karpenko A.: SS 610bKarssemeijer N.: SS 1713Kellenberger C.J.: RC 812Kettenbach J.: SS 209Keyzer C.: SS 216Kirova-Nedialkova G.I.: SS 903Klauser A.: SS 210Koen V.H.: TF 1Koh D.-M.: CC 819Kornienko V.N.: SY 20Koutalonis M.: SS 1713Krestin G.P.: ESOR Session, EIBIRKroencke T.J.: SS 101bKrombach G.A.: SS 103Kubik-Huch R.A.: SS 202Kudrnova S.: SS 1809Kuribayashi S.: SS 1815

LLabuscagne J.: SS 910Lalam R.: SS 610aLambregts D.M.J.: SS 916Lauenstein T.C.: SS 1306Lehéricy S.: E³ 820bLeidecker C.: SS 213Lencioni R.: CC 1219Leschka S.: SS 101aLinsenmaier T.: CC 1618Liu Y.: EIBIR/EORTC Joint WorkshopLlopis E.: RC 1210Loewe C.: EPOS DiscussionsLonn L.: CC 818Lopci E.: SS 1706Lucic M.A.: SS 1812

List of Moderators

299

MMagnusson A.: RC 707Maksimović R.: SS 603bMalamateniou C.: RC 1514Mang T.: SS 905Marco de Lucas E.: SS 211Marincek B.: SS 901Martí-Bonmatí L.: RC 1114, ESOR CourseMartinez-Miravete P.: SS 602Matos C.: ESOR CourseMaurer M.H.: SS 1710McNulty J.: SS 1814Meaney J.F.M.: CC 1518Meindl T.: SS 611Menu Y.: MC 628, MIR 1Merhemic Z.: RC 1111Merkle E.M.: SS 1806Mershina E.A.: SS 603aMildenberger P.: MIR 1, SS 203Mileto A.: SS 510Molyneux A.: E³ 620Morcos S.K.: CC 1621Morgan R.: SS 1809Morozov S.: SS 107Mostbeck G.H.: SY 24Mueller-Lisse T.G.: CC 1221Mueller-Mang C.: SS 204Müller-Schimpfle M.: RC 1902Munneke G.J.: SS 1701b

NNadrljanski M.: SS 1302Natale L.: SS 503Nijenhuis R.: SS 609bNikolic O.: SS 1707Nyhsen C.M.: SS 1801b

OOleaga Zufiría L.: SS 1711Ollivier L.: SS 902Olsen Ø.E.: RC 1912Omoumi P.: SS 610bOrding-Müller L.-S.: SS 912Oyen R.H.: SS 1307

PPadovani R.: SS 213Padrón M.: RC 1410Panicek D.M.: MC 428Papadaki E.: SS 1811aPapathanasiou M.A.: RC 1511Paprottka P.M.: SS 109Parkar A.P.: SS 1704Patak M.A.: RC 1601bPaulo G.: EM 5Peebles C.: RC 803Pekarovic D.: RC 1214Pellegrin A.: SS 1815Pellerin O.: SS 215Pereira P.L.: CC 1519Petakovic A.: SS 914

Pickuth D.: SY 8Pierot L.: SS 509Pinochet M.A.: EM 4Piscaglia F.: Joint Session of the ESR and EFSUMBPlagou A.: SS 1310Popovic P.: SS 201aPrayer D.: E³ 520cPrevoo W.: CC 1419Prokop M.: RC 1513, SY 11Pronk-Larive D.: RC 714

QQuaia E.: SS 610a

RRaissaki M.: RC 1512Rees M.R.: SS 603aRegge D.: SS 905Reiser M.F.: MC 728Ribeiro R.: SS 114Richenberg J.: SS 107Ringertz H.: SS 1712Rockall A.G.: SS 607Roding T.: SS 114Rollandi G.A.: RC 1201Ros P.R.: SS 606, EPOS DiscussionsRossi A.: EPOS DiscussionsRuiz Blanco C.: EM 5Rummeny E.J.: SS 516

SSala E.: CC 1321Sanz-Requena R.: SS 103Saranovic D.Z.: SS 1701aSardanelli F.: MC 623, EuroAIMSchaefer-Prokop C.M.: SS 1704Schillebeeckx J.: MIR 2Schönberg S.O.: SY 14Schroth G.: SS 211Schueller G.: SS 1317Schuknecht B.F.: SS 1308Schüller-Weidekamm C.: SS 110Schulz-Wendtland R.: SS 102Schwarz F.: 6th Post Processing Face-Off SessionSconfienza L.M.: SS 210Sekovsky B.: SS 1709Semmler W.: RC 1906Shahabpour M.: SS 110Sharp P.: EF 1Sidhu P.S.: SY 9Sigal R.C.: SY 13Simisker A.: SS 105Sinitsyn V.E.: MC 422, SY 21, EPOS DiscussionsSkaane P.: SS 502Sklair-Levy M.: SS 1802aSmith A.: SY 17Souquet J.: SY 2Speck O.: SS 113Sperryn C.W.: EM 3Steens S.: SS 208Stenzel M.: SS 1812

Stern E.J.: SS 1304Stiller W.: SS 1813Sugimura H.: SS 1707Šurlan Popovič K.: RC 1508Sutton D.G.: RC 1413Syrgiamiotis V.: SS 514Szabó E.: SS 1802b

TTacelli N.: SS 104Tack D.: SS 1301Tacke J.: SS 909Taibbi A.: SS 1301Tali E.T.: RC 1911Tardivon A.: MC 723, RC 1402Telesca M.: SS 102Thurnher M.M.: CC 1118Torresin A.: EF 2Trianni A.: RC 1113Tsapaki V.: RC 1513Tsetis D.K.: SS 1309Tyurin I.E.: SY 20Tzarouchi L.C.: SS 911

VVahtramae P.: SS 1714Valdés Solís P.: RC 417Van Beers B.: SS 601van der Putten W.J.M.: EF 1Vandulek C.: SS 514van den Heuvel J.: SY 15van Persijn van Meerten E.L.: CC 719van Rijn R.R.: EPOS DiscussionsVassileva J.N.: EF 2Venstermans C.: RC 411Vernooij M.: SS 1711Vieira A.: SS 1710Vilela P.: SS 911Villeirs G.M.: RC 1207Vivas I.: SS 1807Vlahos J.: SS 904Vliegenthart R.: RC 1603Vock P.: ESR Radiation Protection SessionVogl T.J.: SY 12Vorwerk D.: IIQVotrubová J.: RC 1413

WWeishaupt D.: SS 1701bWidelec J.: SS 608Wildberger J.E.: SY 10

YYule A.: SS 214

ZZamboni G.A.: SS 901Zelenak K.: SS 909Zimny A.: SS 1311Zytoon A.A.: SS 202

300

Credits

Coordination:ESROffice|Neutorgasse9|1010Vienna,AustriaPhone:(+431)5334064-0|Fax:(+431)5334064-441E-mail:[email protected]

Managing Editor: JuliaPatuzziLayout: ESRGraphicDepartment,PhilippStöhr

Photo Credits:Unlessotherwiseindicatedallpictures©ESR–EuropeanSocietyofRadiology

PrintedbyHolzhausen,Vienna,2013Alldataasperdateofprinting:February2013

ESR accepts no responsibility for errors or misprints.

Printedonenviromentalfriendlypaper

Date post:	29-Mar-2023
Category:	Documents
Upload:	khangminh22
View:	0 times
Download:	0 times

Final Programme - OptiMed France

Documents